Here - American Geriatrics Society
Here - American Geriatrics Society
Here - American Geriatrics Society
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Dear Annual Meeting Attendee:<br />
The <strong>American</strong> <strong>Geriatrics</strong> <strong>Society</strong> Annual Scientific Meeting is the premier educational event in geriatrics, providing the latest<br />
information on clinical geriatrics, research on aging, and innovative models of care delivery. The 2012 Annual Meeting<br />
will address the professional and educational needs of geriatrics professionals from all disciplines through state-of-the-art<br />
educational sessions and research presentations.<br />
This supplement of the Journal of the <strong>American</strong> <strong>Geriatrics</strong> <strong>Society</strong> is devoted to abstracts of the scientific presentations<br />
that are scheduled for the 2012 AGS Annual Scientific Meeting. We are hopeful that this supplement will be helpful to<br />
those of you who are planning to attend the meeting so as to maximize your attendance at educational, research, and clinical<br />
presentations of interest to you.<br />
We are also pleased to provide these abstracts to subscribers of the Journal. We believe that they are an important way of<br />
keeping JAGS readers up-to-date on the latest advances in the field.<br />
Sincerely,<br />
Belinda Vicioso, MD<br />
Barbara Resnick, PhD, CRNP<br />
2012 AGS Annual Meeting Program Chair AGS President
P APER<br />
A BSTRACTS<br />
Paper Session<br />
Clinical Decision-Making<br />
Thursday, May 3<br />
7:30 am – 9:00 am<br />
P1<br />
Lagtime to Benefit for Colorectal Cancer Screening: A Survival<br />
Meta-Analysis.<br />
S. J. Lee, 1 W. J. Boscardin, 1,2 I. Stijacic-Cenzer, 1,2 J. Conell-Price, 1<br />
S. O’Brien, 1 L. C. Walter. 1,2 1. Division of <strong>Geriatrics</strong>, SFVAMC, UCSF,<br />
San Francisco, CA; 2. Department of Epidemiology and Biostatistics,<br />
University of California, San Francisco, San Francisco, CA.<br />
Supported By: Dr. Sei Lee was supported by Hartford <strong>Geriatrics</strong><br />
Health Outcomes Research Scholars Award, the Hellman Family<br />
Award for Early Career Faculty at UCSF and the KL2RR024130<br />
from the National Center for Research Resources, a component of<br />
the NIH.<br />
Dr. Louise Walter was supported by R01CA134425 from the<br />
National Cancer Institute, which was administered by the Northern<br />
California Institute for Research and Education.<br />
This work was supported with resources of the Veterans Affairs<br />
Medical Center, San Francisco, California.<br />
Background: Guidelines recommend targeting colorectal cancer<br />
(CRC) screening to healthy patients whose life expectancy exceeds<br />
the cancer screening’s lagtime to benefit (i.e. time between screening<br />
and when the benefits of screening are seen). However, the lagtime of<br />
CRC screening is uncertain. Our goal was to determine a pooled,<br />
quantitative estimate of the lagtime to benefit for CRC screening<br />
from randomized controlled trial (RCT) data.<br />
Methods: We conducted a survival meta-analysis of CRC<br />
screening RCTs focusing on older patients (age greater than 50) identified<br />
by Cochrane and USPSTF reviews as high quality. Four population-based<br />
RCTs of fecal occult blood testing from Denmark, England,<br />
Sweden, and the United States (n=327,043) were included in<br />
our meta-analysis.<br />
Results: 4.9 years (95%CI: 2.1 to 9.5) passed before one CRC<br />
death was prevented for 5000 persons screened (absolute risk reduction<br />
or ARR=0.0002). It took 10.4 years (95%CI: 6.1 to 16.6) before<br />
one CRC death was prevented for 1000 persons screened<br />
(ARR=0.001) and 14.6 years (95%CI: 9.7 to 21.2) for 2 CRC deaths<br />
to be prevented for 1000 persons screened (ARR=0.002).<br />
Conclusions:The lagtime to prevent one CRC death per 1000 persons<br />
screened is 10.4 years suggesting that CRC screening should be<br />
targeted toward patients with a life expectancy greater than ten years.<br />
P2<br />
Preferences for Deactivation of Implantable Cardioverter<br />
Defibrillators in the Setting of Advanced Illness.<br />
J. A. Dodson, 1 T. Fried, 1 P. H. Van Ness, 1 N. Goldstein, 2 R. Lampert. 1<br />
1. Yale University School of Medicine, New Haven, CT; 2. Mount Sinai<br />
School of Medicine, New York, NY.<br />
Background: Some implantable cardioverter defibrillator (ICD)<br />
recipients with advanced illness receive painful shocks at the end of<br />
life. The purpose of our study was to explore preferences for ICD deactivation<br />
in the setting of hypothetical advanced illness.<br />
Methods: We conducted a cross-sectional telephone survey of<br />
patients age ≥50 with ICDs followed in a single electrophysiology<br />
practice in New Haven, CT. Sociodemographic and clinical characteristics,<br />
as well as self-reported functional status, were obtained. Patients<br />
were then asked whether they would opt for ICD deactivation<br />
in five distinct scenarios: (1) permanently unable to get out of bed, (2)<br />
permanent memory problems, (3) burden to family members, (4) on<br />
breathing machine >1 month, (5) advanced incurable disease. Patients<br />
who answered “possibly yes” or “definitely yes” to any scenario<br />
were categorized as considering deactivation.<br />
Results: Surveys were completed in 100 patients. Mean age was 71<br />
years, 28% were female, and 18% were nonwhite.Among respondents,<br />
71 patients (71%) would consider ICD deactivation in one or more<br />
scenarios. Responses varied considerably by scenario. Patients considered<br />
deactivation most often in the setting of advanced incurable disease<br />
(61%), and least often if permanently unable to get out of bed<br />
(25%) (Figure). Patients were more likely to consider deactivation if<br />
they were white, had not received a prior ICD shock, or were disabled.<br />
Conclusions: The majority of patients with ICDs would consider<br />
deactivation in at least one scenario reflecting advanced illness.This preference<br />
was most common in the setting of incurable disease, but also not<br />
uncommon in the setting of cognitive impairment or burden to family.<br />
P3 Encore Presentation<br />
Self-rated Health and Walking Ability Predict 10-year Mortality in<br />
Older Women with Breast Cancer.<br />
J. A. Eng, 1,2 K. M. Clough-Gorr, 3,4 R. A. Silliman. 1,2 1. Medicine-<br />
<strong>Geriatrics</strong>, Boston University School of Medicine, Boston, MA; 2.<br />
Boston University School of Public Health, Boston, MA; 3. Institute<br />
of Social and Preventive Medicine, University of Bern, Bern,<br />
Switzerland; 4. National Institute for Cancer Epidemiology and<br />
Registration, Institute of Social and Preventive Medicine, University of<br />
Zurich, Zurich, Switzerland.<br />
Supported By: John A. Hartford Foundation, Health Resources and<br />
Services Administration (D01HP08796-05-00), National Institutes of<br />
Health (K05 CA92395), National Cancer Institute (R01 CA106979,<br />
R01 CA/AG 70818, R01 CA84506)<br />
Background: Self-rated health (SRH) and mobility predict mortality<br />
in general populations but have not been well-studied in older<br />
women with breast cancer. Methods: Women aged ≥65 years with primary<br />
stage I-IIIA breast cancer were enrolled at 4 sites. Data were<br />
collected over 10 years from medical records, annual interviews, and<br />
AGS 2012 ANNUAL MEETING<br />
S1
P APER<br />
A BSTRACTS<br />
the National Death Index. We created a 4-level variable combining<br />
baseline SRH and ability to walk several blocks (SRHWALK). Cox<br />
proportional hazards models were used to examine the impact of<br />
SRHWALK on 10-year all-cause mortality. Analyses were adjusted<br />
for age, socio-demographic and tumor characteristics, initial therapies,<br />
BMI, comorbidity, emotional health, social support, and upper<br />
body function. Results: 660 women with breast cancer were studied<br />
(18% age 80+, 48% stage II-III, 59% with ≥1 comorbidity). At 10<br />
years, 80% of women with low SRH and walking limitations had died<br />
vs. 50% of those with high SRH and no walking limitations (Figure 1,<br />
p0.85 (p=0.02). OS<br />
was associated with ECOG PS (HR 1.8, p=0.05), Activities of Daily<br />
Living (ADL) impairment (HR 5.6, p=0.005), and Vulnerable Elders<br />
Survey (VES-13, HR 5.3, p=0.002), but only VES-13 (HR 15.61,<br />
p=0.016) was significant in a backward stepwise multivariate regression<br />
model. Age was not associated with either RDI or OS.<br />
Conclusions: ECOG PS was associated with completing<br />
RDI>85%, a commonly used and validated cut-off for chemotherapy<br />
efficacy. SPPB may help further risk-stratify. VES-13, a validated 13-<br />
item questionnaire which is easily administered in clinic, was the<br />
strongest correlate of OS, stronger than age or ECOG PS. Age was<br />
not correlated with completion of full dose chemotherapy or OS in<br />
this older cohort. Geriatric screening measures including SPPB and<br />
VES-13 should be used in addition to ECOG PS to risk-stratify older<br />
patients with CRC.<br />
P5 Encore Presentation<br />
Preparing for Decision Making Beyond Advance Directives:<br />
Perspectives from Patients and Surrogates.<br />
R. McMahan, 1,2 S. J. Knight, 2,1 M. Fuez, 2 R. L. Sudore. 2,1 1. <strong>Geriatrics</strong>,<br />
UCSF, San Francisco, CA; 2. San Francisco VA, San Francisco, CA.<br />
Supported By: Veterans Affairs<br />
Background: Traditional advance care planning (ACP) has focused<br />
on documenting life-sustaining treatment preferences in advance<br />
directives (ADs). This focus fails to provide direction for or decrease<br />
the stress of making many, complex decisions over the course<br />
of serious illness. To identify steps beyond ADs to better prepare patients<br />
and their families, we sought to understand diverse, older patients’<br />
and surrogates’ experiences with decision making for serious<br />
illness.<br />
Methods: We conducted 13 English and Spanish-speaking focus<br />
groups with participants from San Francisco VA and county hospitals.<br />
Seven groups included patients (n=38), aged ≥65 years, who reported<br />
making serious medical decisions. Six groups included surrogate<br />
decision makers (n=31), aged ≥18 years. Semi-structured<br />
interviews asked about decision making experiences and what best<br />
prepared participants. Two reviewers performed qualitative, thematic<br />
content analysis.<br />
Results: Mean patient age was 78±8 years and 61% were nonwhite.<br />
Mean surrogate age was 57±10 years and 91% were nonwhite.<br />
Analysis revealed 5 themes to best prepare for decision making.<br />
(1) Identify and ask a surrogate to make decisions – “My wife<br />
wouldn’t be objective. My daughter would make good judgments,<br />
but she didn’t know I wanted her to. You have to ask.” (2) Discuss<br />
leeway in surrogate decision making – “As a child, I would feel better<br />
knowing he would want me to evaluate and change decisions<br />
based upon things which have occurred since he put that in writing.”<br />
(3) Reflect on past experiences to define values for care – “My father<br />
had cancer of the bile duct – he died a miserable death. I don’t<br />
want to put myself or my family through it. I know this.” (4) Tell<br />
others about one’s wishes – “We have three boys and a girl, and we<br />
selected the daughter. When the brothers got the directives they<br />
said, ‘Hey, dad, what’s going on?’ and so we had to talk about it.” (5)<br />
Ask clinicians about the outcomes of treatment – “I would ask<br />
about the side effects. You have to know how your life is going to<br />
be. Will it be good?”<br />
Conclusions: 5 additional ACP steps, beyond ADs, may better<br />
prepare patients and surrogates for complex medical decisions. To be<br />
effective, ACP needs to expand beyond asking patients to make decisions<br />
about life-sustaining treatment and must also focus on preparation<br />
for medical decision making.<br />
S2<br />
AGS 2012 ANNUAL MEETING
P APER<br />
A BSTRACTS<br />
P6<br />
CRASH: A Brief Screening Tool to Identify High-Risk Older<br />
Drivers.<br />
M. E. Betz, 1 R. Schwartz, 2 J. Haukoos, 1,3 C. DiGuiseppi, 4 M. Valley, 1<br />
R. Johnson, 1 S. Lowenstein. 1 1. Emergency Medicine, University of<br />
Colorado School of Medicine, Aurora, CO; 2. Division of <strong>Geriatrics</strong>,<br />
University of Colorado School of Medicine, Aurora, CO; 3.<br />
Emergency Medicine, Denver Health Medical Center, Denver, CO; 4.<br />
Epidemiology, Colorado School of Public Health, Aurora, CO.<br />
Supported By: Funding: Emergency Medicine Foundation and John<br />
A Hartford University of Colorado Denver Center of Excellence.<br />
This study was also supported in part by Grant Number<br />
R49/CCR811509 from the Centers for Disease Control and<br />
Prevention. Its contents are solely the responsibility of the authors<br />
and do not necessarily represent the official views of the CDC.<br />
Background: Current older driver screening tools are impractical<br />
for use in busy clinical settings. We sought to develop and internally<br />
validate a brief questionnaire to identify drivers needing further<br />
evaluation.<br />
Methods: Cross-sectional study of patients aged 65+ years at a<br />
geriatric clinic or emergency department (ED) who drove at least occasionally,<br />
spoke English and had no significant cognitive impairment.<br />
Study staff administered a confidential survey to 246 participants,<br />
enrolled equally from the clinic and ED (participation rate:<br />
43%). Logistic regression was used to identify characteristics associated<br />
with an adverse driving event (ADE), defined as 1+ reported<br />
crash or police stop while driving within the preceding 12 months.<br />
Results: Median participant age was 76 years; half were women.<br />
Most participants (82%, 95%CI 77-86%) reported daily or near-daily<br />
driving; 15% (95%CI 11-19%) reported an ADE. Age and gender<br />
were not associated with ADEs. The final model included five variables<br />
associated with an ADE, to which the CRASH tool assigns one<br />
point each (table): “C” ever feels confused or disoriented while driving;<br />
“R” regular (daily or near-daily) driver; “A” avoids driving alone;<br />
“S” has difficulty seeing the license plate in front while stopped; and<br />
“H” reports that someone has recommended handing over the keys<br />
in the past year. In internal validation, the CRASH tool maintained<br />
its goodness-of-fit (average p=0.70) and had an averaged area under<br />
the ROC curve of 0.72. A score of two or higher was 64% (95%CI 46-<br />
79) sensitive and 70% (95%CI 64-77) specific for an ADE.<br />
Conclusions: The simple, history-based CRASH screening tool<br />
may be useful to identify older drivers who need additional evaluation.<br />
Prospective testing is needed to validate the tool and determine<br />
optimal cut-points for clinical use.<br />
Paper Session<br />
Plenary<br />
Thursday, May 3<br />
11:00 am – 12:00 pm<br />
P7<br />
Out of Pocket Spending in the Last 5 Years of Life.<br />
A. S. Kelley, 1 K. McGarry, 2 J. S. Skinner. 3 1. <strong>Geriatrics</strong> and Palliative<br />
Medicine, Mount Sinai School of Medicine, New York, NY; 2.<br />
Department of Economics, University of California, Los Angeles, Los<br />
Angeles, CA; 3. Department of Economics, Dartmouth College,<br />
Hanover, NH.<br />
Background: A key objective of the Medicare program was to<br />
reduce the risk of financial catastrophe arising from out-of-pocket<br />
(OOP) health-related expenditures among older adults. Yet little is<br />
known about the financial risks faced by Medicare beneficiaries related<br />
to the death of a household head or spouse. We aimed to measure<br />
risks to financial security arising from OOP health-related expenditures<br />
among a nationally representative cohort of adults over<br />
age 65.<br />
Methods: We included participants from the Health and Retirement<br />
Study (HRS) aged 65 years or older, who died between 2003 -<br />
2008 (N = 3,809). We used detailed HRS survey data for each subject<br />
and spouse, when applicable, to examine total OOP health-related<br />
expenditures in the 5 years preceding the subject’s death. We also<br />
measured OOP spending by category of spending (e.g. nursing home,<br />
insurance, and others) and examined OOP spending stratified by<br />
cause of death and quartile of household wealth.<br />
Results: Average OOP expenditures in the five years prior to<br />
death were $34,497.99 (median, $20,876; 90th percentile, $77,910) for<br />
individuals and $46,767 (median $36,874; 90th percentile, $87,081) for<br />
married couples in which one spouse dies. Median expenditures were<br />
84% of median net financial wealth. By cause of death, individuals’<br />
average total spending ranged from $33,699 for those with infectious<br />
disease to $59,314 for those with Alzheimer’s disease. Spending on<br />
long-term care needs was substantial. For the entire sample, 24% of<br />
spending was for nursing home care and 9% for helpers and other expenses<br />
to retain independence at home. Spending differed sharply by<br />
wealth; ranging from $20,241 in the lowest wealth quartile to $49,477<br />
in the highest.<br />
Conclusion: Despite nearly universal insurance coverage under<br />
the Medicare program, older adults face considerable financial risk<br />
from out-of-pocket medical expenses in the last 5 years of life. Longterm<br />
care expenses appear large yet insurance coverage for these expenses<br />
is limited.Wealth-related differences in the components of care<br />
could exacerbate existing inequalities in well-being at the end of life.<br />
P8 Encore Presentation<br />
Geriatric versus General Medical Conditions have Opposite Effects<br />
on Overall Quality of Ambulatory Care.<br />
L. Min, 1,2 E. Kerr, 1,2 C. Blaum, 1,2 C. Cigolle, 1,2 D. Reuben, 4<br />
N. Wenger. 4,3 1. Medicine, University of Michigan, Ann Arbor, MI; 2.<br />
GRECC and Center for Clinical Management Research, VA<br />
Healthcare Systems, Ann Arbor, MI; 3. RAND, Santa Monica, CA; 4.<br />
UCLA, Los Angeles, CA.<br />
Supported By: Agency for Healthcare Quality and Research (Min<br />
and Blaum), VA Healthcare System Health Services Research<br />
(Kerr) and the Geriatric Research Clinical Care Center (GRECC,<br />
Min, Cigolle, and Blaum), Hartford Foundation (Min), RAND<br />
(Wenger, Min), NIA-Pepper Center (Min), NIH-LRP (Min), NIH-<br />
K08 (Cigolle).<br />
Background: Contrary to expectations, patients with greater comorbidity<br />
receive better - rather than worse - quality of care. We evaluated<br />
whether time-consuming geriatric conditions differ from general<br />
medical conditions in their effect on quality.<br />
Sample: 644 older (age >=75) ambulatory care patients in the<br />
Assessing the Care of Vulnerable Elders-2 (ACOVE-2) study.<br />
Methods: Predictors: Condition counts, defined as general medical<br />
(atrial fibrillation, coronary artery disease, heart failure, cerebrovascular<br />
disease, diabetes, hypertension) vs geriatric (falls, dementia,<br />
hearing impairment, incontinence, malnutrition, and<br />
osteoporosis). Outcome: Overall quality of care (QOC) using 65<br />
process-of-care quality indicators, calculated as a mean score across<br />
preventive and eligible general medical, and geriatric-specific care<br />
over 13 months. We used multivariable regression to test for relationships<br />
between overall quality and both geriatric and general medical<br />
condition counts, controlling for age, gender, functional status, and<br />
number of primary care visits.<br />
Results: General medical condition counts (mean 1.9, range 0-6)<br />
were comparable to geriatric conditions (mean 1.6, range 0-4) but the<br />
AGS 2012 ANNUAL MEETING<br />
S3
P APER<br />
A BSTRACTS<br />
two counts were uncorrelated (r=.04, p=.3). Nearly all had at least<br />
one condition in each category, and more than half (52%) had at least<br />
2 conditions in each category. Each additional general medical condition<br />
was associated with a 5% point increment in QOC, while each<br />
additional geriatric condition was associated with a 3.2% point decrement,<br />
independent of each other and the multivariable controls<br />
(p
P APER<br />
A BSTRACTS<br />
growth in NP care of Medicare patients from 1997-2008 and its relationship<br />
with state regulations and also with the availability of primary<br />
care physicians.<br />
Methods: Medicare beneficiaries aged 65 or above with Parts A<br />
and B coverage who were not enrolled in a health maintenance organization<br />
for the entire 12 months of each year during 1996-2008<br />
were selected. We assessed the percentage of community-dwelling<br />
and long term nursing home residents billed by an NP or who received<br />
the majority of their primary care from NPs.<br />
Results: The percentage of community-dwelling Medicare beneficiaries<br />
billed for outpatient NP services rose from 0.3% in 1997 to<br />
7.9% in 2008, while for nursing home patients the increase was from<br />
3.0% to 24.7%. By 2008, 2.2% of community-dwelling and 15.5% of<br />
nursing home residents received the majority of their primary care<br />
from NPs. The percent of community dwelling residents receiving the<br />
majority of their primary care from NPs in 2008 ranged from 0.7% in<br />
Hawaii to 10.8% in Alaska, while for nursing home patients it ranged<br />
from 0% in Wyoming to 44.3% in Tennessee. Compared with states<br />
with the most restrictive regulations, the odds of receiving the majority<br />
of primary care from NPs was 2.5 fold higher for communitydwelling<br />
patients in states with the most liberal regulations. Similar<br />
associations with state laws were found when we measured the number<br />
of NPs practicing per 100,000 adults in the state, using data from<br />
state licensing boards. The availability of primary care physicians<br />
modestly affected NP activity in community-dwelling patients. Neither<br />
availability of primary care physicians nor state regulations were<br />
associated with odds of receiving care from NPs for long term nursing<br />
home residents. In five states that modified their regulations during<br />
1997-2007, the percentage of patients with an NP as PCP increased<br />
significantly (P
P APER<br />
A BSTRACTS<br />
management in collaboration with primary care (PCP) improved care<br />
quality and reduced acute care utilization for seniors at high risk of<br />
hospitalization.<br />
Objective: To assess the impact of GRACE Team Care on hospital<br />
readmissions in older veterans at a Veterans Affairs Medical Center<br />
(VAMC).<br />
Methods: Veterans 65 or older with PCPs from 4 of 5 VAMC<br />
clinics were enrolled following discharge home from an acute hospitalization<br />
on the medicine service from April 2010 to June 2011. After<br />
an initial home-based transition visit, a nurse practitioner and social<br />
worker (GRACE Team) returned to conduct a geriatric assessment<br />
visit. Guided by 12 geriatric protocols and input from the GRACE<br />
geriatrician, pharmacist, and psychologist, the GRACE Team developed<br />
a veteran-centric care plan and collaborated with the PCP to<br />
implement that plan. Hospitalized veterans with PCPs from the fifth<br />
VAMC clinic that did not get GRACE but who otherwise met enrollment<br />
criteria served as a comparison group. Data on demographics,<br />
comorbidity, hospital utilization, and mortality were drawn from VA<br />
databases.<br />
Results: 174 veterans (mean age 78 years, range 65-97; 97%<br />
male) were enrolled in GRACE and followed for an average of 8.5<br />
months (range 0.4-15.5), and 77 veterans (mean age 77 years, range<br />
65-93; 94% male) in the comparison group were followed for an average<br />
of 8.6 months (range 0.4-16.0). Charlson Comorbidity Index<br />
scores were similar between groups: GRACE mean 2.40 (range 0-13)<br />
vs. comparison mean 2.17 (range 0-10). GRACE veterans vs. comparison<br />
had lower readmission rates at 7 days (2/174 [1.1%] vs. 5/77<br />
[6.5%], p=0.03); 14 days (8/174 [4.6%] vs. 7/77 [9.1%], p=0.25); 30<br />
days (17/174 [9.8%] vs. 13/77 [16.9%], p=0.11); and 60 days (26/164<br />
[15.9%] vs. 17/73 [23.3%], p=0.17). Over the follow-up period,<br />
GRACE veterans had a lower mortality rate than the comparison<br />
group (17/174 [10%] vs. 13/77 [17%], p=0.11).<br />
Conclusion: GRACE Team Care, which provided in-home, veteran-centric,<br />
geriatric care management while supporting VA primary<br />
care, had a positive impact on reducing hospital readmissions.<br />
GRACE may offer an opportunity for better care at lower costs in<br />
high risk older veterans.<br />
P15<br />
The Falls and Fractures Clinic: Testing an Integrated Model of<br />
Secondary Prevention in a High-Risk Older Population.<br />
G. Duque, 1,2 P. Suriyaarachchi, 1,2 D. Boersma, 1,2 O. Demontiero, 1,2<br />
G. Loza-Diaz, 1 A. Sharma. 2 1. Ageing Bone Research Program, The<br />
University of Sydney, Penrith, NSW, Australia; 2. Geriatric Medicine,<br />
Nepean Hospital, Penrith, NSW, Australia.<br />
Supported By: Nepean Medical Research Foundation<br />
INTRODUCTION: Although falls and fractures are highly<br />
prevalent in older persons, there is still a fragmentation in terms of<br />
falls being assessed by geriatricians and fractures remaining within<br />
the scope of other specialties. Therefore, an integrated model of secondary<br />
prevention for falls and fractures run by geriatricians is highly<br />
needed.<br />
OBJECTIVE: To evaluate the effectiveness of a multidisciplinary<br />
Falls and Fractures Clinic as an optimal integrated model to assess<br />
risk and to prevent new events in a high-risk older population.<br />
METHODS: Four hundred and thirty subjects (mean age=82,<br />
65% female) were assessed between January 2009-June 2011 at the<br />
Falls and Fractures Clinic, Nepean Hospital (Penrith, NSW, Australia).<br />
Assessment included fear of falling (SAFFE), risk factors for<br />
falls and fractures, physical examination, nutrition, depression, grip<br />
strength (dynamometer), densitometry, posturography (Medicaa,<br />
Uruguay), gait parameters (GaitRITE®), and blood tests for secondary<br />
causes of osteoporosis including vitamin D and parathyroid hormone<br />
(PTH). An integrated plan was then designed according to the<br />
subject’s risk factors. Subjects were surveyed by phone (month 3) and<br />
fully re-assessed at the clinic nine months later.<br />
RESULTS: 77% had suffered a fall and 38% had suffered a fracture<br />
before the assessment. An average of 6.5+/-2.8 falls and 3.5+/-1.8<br />
fracture risk factors were identified per subject. At the time of the<br />
second assessment, the incidence of falls was reduced in -<br />
65%(p
P APER<br />
A BSTRACTS<br />
ent. We hypothesize that resveratrol may be acting through SIRT-1,<br />
which in turn inhibits p53-regulated senescence. Because colon cancer<br />
is a disease whose incidence rises with age, the ability of resveratrol<br />
to inhibit senescence and the aging process in colonic mucosa will<br />
potentially have profound applicability to colon cancer prevention.<br />
P17<br />
The Role of SIRT3-dependent Autophagy in Age-Related<br />
Hearing Loss.<br />
I. Pena , F. A. Pereira. Huffington Center on Aging, Departments of<br />
Otolaryngology-HNS and Molecular & Cellular Biology, Baylor<br />
College of Medicine, Houston, TX.<br />
Supported By: <strong>American</strong> Federation for Aging Research / Medical<br />
Student Training in Aging Research Program, The Oticon<br />
Foundation / The <strong>American</strong> Academy of Otolaryngology–Head &<br />
Neck Surgery Foundation, Huffington Center on Aging–Baylor<br />
College of Medicine.<br />
Background: In 2005, the WHO estimated that 278 million people<br />
suffered moderate-to-profound hearing impairments. This number is<br />
expected to reach 900 million people by 2050, creating immense socioeconomic<br />
burdens worldwide. Age-related hearing loss (AHL), a<br />
disorder associated with accumulated cellular oxidative damage, affects<br />
more than 40% of <strong>American</strong>s over age 65. The mitochondrial<br />
deacetylase SIRT3 improves antioxidant defenses by activating isocitrate<br />
dehydrogenase 2, thereby increasing the reduced-to-oxidized glutathione<br />
ratio. Oxidative stress induces autophagy, a process by which<br />
cells degrade and recycle their contents to preserve cellular health.The<br />
precise molecular mechanisms by which cells respond to oxidative<br />
stress and induce autophagy via SIRT3 have not yet been elucidated.<br />
Methods: We investigated the role of SIRT3 in regulating autophagy<br />
in model systems. We used inner ears, brain, heart, and fibroblasts<br />
from wild type (WT), SIRT3-overexpressing, and Little<br />
mice (have 40% longer lifespan and reduced oxidative stress). Experiments<br />
included activation and inhibition of autophagy and expression<br />
of SIRT3 to determine its potential role in SIRT3-dependent<br />
protective mechanisms against cellular damage and AHL.<br />
Results: The average SIRT3 levels were increased 18% in 24-<br />
month-old WT mice and increased 628% in 24—month-old Little mice,<br />
compared to their 4-month-old littermate controls.When SIRT3 levels<br />
were depleted in WT fibroblasts using siRNA, autophagy was activated<br />
as measured by LC3-II/LC3-I ratio. After an 18- or 24-hour treatment<br />
with 100nM rapamycin, autophagy levels also increased 1.8-fold while<br />
SIRT3 levels decreased 1.37-fold.Activating autophagy by 2 or 4 hours<br />
of starvation increased activation 8.35-fold and SIRT3 levels decreased<br />
3.9-fold. Inhibiting autophagy with 50uM Wortmannin for 2 or 4 hours<br />
decreased autophagy 2.78-fold and increased SIRT3 levels 1.35-fold.<br />
Conclusion: These preliminary results suggest autophagy is<br />
linked to SIRT3: increased SIRT3 is associated with improved oxidative<br />
protection and decreased autophagy and vice versa. These findings<br />
may provide therapeutic insight into rational drug design of new<br />
medications that activate SIRT3 or autophagy for the prevention of<br />
age-related hearing loss and to improve health span.<br />
P18 Encore Presentation<br />
Lipid-depleted apolipoproteins and amyloid peptides are influenced<br />
by APOE genotype and cognitive diagnosis.<br />
A. J. Hanson, 1,2 J. L. Bayer-Carter, 1,2 P. S. Green, 1,2 T. J. Montine, 1,2<br />
L. D. Baker, 1,2 G. S. Watson, 1,2 L. M. Bonner, 2 M. Callaghan, 2<br />
J. B. Leverenz, 1,2 B. K. Walter, 2 E. C. Tsai, 1,2 C. W. Wilkinson, 1,2<br />
J. Zhang, 1 S. Craft. 1,2 1. University of Washington Medical Center,<br />
Seattle, WA; 2. GRECC, VA Puget Sound Health Care System,<br />
Seattle, WA.<br />
Supported By: T32 AG-000258-13 to Dr. Hanson, R37 AG-10880<br />
from NIA to Dr Craft, P50 AG-05136 to Dr. Montine.<br />
BACKGROUND: Sporadic Alzheimer’s disease (AD) is caused<br />
in part by decreased clearance of the Aβ amyloid breakdown products.<br />
Apolipoproteins play an important yet unclear role in Aβ peptide<br />
clearance, particularly ApoE since its E4 variant is a risk factor<br />
for AD. Work in cell culture and animal models have shown that<br />
lipid-depleted apolipoproteins are less effective at binding Aβ, and<br />
that lipoprotein-depleted (LD) fractions of Aβ peptides are more<br />
toxic to neurons. However, not much is known about the lipid states<br />
of these proteins in human CSF.<br />
METHODS: Cerebrospinal fluid (CSF) was obtained from 20<br />
participants with normal cognition (mean age 69 ± 7) and 27 with<br />
amnestic mild cognitive impairment (MCI) (mean age 67 ± 6). We determined<br />
the APOE genotype status of each participant. Lipid-depleted<br />
ApoE and ApoJ and lipoprotein-depleted Aβ peptides were<br />
separated by density gradient ultracentrifugation and levels were<br />
then measured by ELISA. Groups were compared using analysis of<br />
covariance.<br />
RESULTS: Subjects with an APOE ε4 allele (E4+) had higher<br />
lipid-depleted ApoE levels, for both normal and MCI groups<br />
(p
P APER<br />
A BSTRACTS<br />
control collagen had greater expression of alpha 2 integrin, which mediates<br />
cell-extracellular matrix interactions (Hynes, 1987). In conclusion,<br />
collagen from aged mice that have received short-term caloricrestriction<br />
or rapamycin display impaired capacity to polymerize into<br />
a 3D matrix. Fibroblasts placed in these gels display lower cell count<br />
and increased expression of SPARC, but decreased alpha 2 integrin.<br />
These data show that short-term caloric-restriction and rapamycin interventions<br />
alter collagen’s structural properties and influence fibroblast<br />
behavior in ways that might impair wound healing.<br />
P20<br />
Platelet and Monocyte Responses are Impaired in Elderly Septic<br />
Patients.<br />
M. Rondina, 1 C. K. Grissom, 2 E. S. Harris, 1 S. Kalva, 1 S. Men, 1<br />
G. A. Zimmerman, 1 A. S. Weyrich. 1 1. Internal Medicine, Univ. of<br />
Utah, SLC, UT; 2. Critical Care, IMC, SLC, UT.<br />
Supported By: Supported by grants from the NIH (HL091754,<br />
HL066277, K23HL092161, ULI-RRO25764).<br />
The ligand P-selectin (P-SEL) on the platelet surface allows for<br />
heterotypic formation of platelet-monocyte aggregates (PMAs) that<br />
augment innate immune responses. Impaired PMA formation in elderly<br />
patients may contribute to their higher risk of sepsis and subsequent<br />
adverse events but remains unexplored. We prospectively compared<br />
P-SEL expression and PMA levels in elderly (age≥65, n=29)<br />
and young (age
P APER<br />
A BSTRACTS<br />
centration ≤ 37.5 ng/ml. Sixty-four patients received either weekly vitamin<br />
D3(n=31) or placebo (n=33) for 6 months; both groups received<br />
800 mg calcium citrate daily. Baseline and 6 month measures<br />
included peak VO2, 6 minute walk distance (6MW) and Get Up and<br />
Go. Isokinetic muscle strength was measured at 60 and 120 degrees<br />
using knee extensors and flexors. Health status was measured with<br />
the Kansas City Cardiomyopathy Questionnaire (KCCQ). Between<br />
group comparisons were made using ANCOVA models that adjust<br />
for baseline measures.<br />
Results: Subjects in the vitamin D group were 65.8 ± 10.6 years<br />
old, 52% women, and 61% African <strong>American</strong>. Subjects in the placebo<br />
group were 66.0 ± 10.4 years old, 46% women and 67% African<br />
<strong>American</strong>. At baseline the vitamin D group mean serum 25OHD was<br />
19.1 ± 9.3ng/ml and increased by 42.3 ± 16.4 ng/ml at 6 months. Baseline<br />
mean serum vitamin D in the placebo group was 17.8 ± 9.0 ng/ml,<br />
and decreased by 0.2 ± 6.6 ng/ml at 6 months (between groups<br />
p0.15). Adjustment for baseline characteristics sex,<br />
race, and ejection fraction did not change results.<br />
Conclusions: There is no evidence to suggest that high dose vitamin<br />
D3 improves physical performance or health status for older<br />
adults with HF. Vitamin D repletion in patients with HF should conform<br />
to standard vitamin D guidelines for older adults.<br />
P23<br />
Improving 25-hydroxyvitamin D Status in Home-bound Elders and<br />
its Effect on Falls.<br />
D. K. Houston, 1 J. A. Tooze, 1 J. L. Demons, 1 B. Davis, 1 R. Shertzer-<br />
Skinner, 1 L. Kearsley, 2 R. Gottlieb, 2 J. D. Williamson. 1 1. Sticht Center<br />
on Aging, Wake Forest School of Medicine, Winston Salem, NC; 2.<br />
Senior Services, Inc., Winston Salem, NC.<br />
Supported By: Supported by the Wake Forest Translational<br />
Science Institute, Center for Integrative Medicine and Pepper<br />
Center (P30-AG21332).<br />
Background: Home-bound older adults are a particularly vulnerable<br />
subgroup of older adults for poor dietary intake and nutritional<br />
health, nutrition-related health conditions, and functional decline.<br />
Although vitamin D supplementation has been shown to be<br />
effective in preventing falls in controlled clinical trials, whether these<br />
findings can be successfully translated to community-based programs<br />
has not yet been determined. We conducted a 5-month randomized,<br />
placebo-controlled pilot study to assess the feasibility of delivering vitamin<br />
D supplements to home-bound older adults receiving Meals on<br />
Wheels (MOW) and the effectiveness of the vitamin D supplements<br />
to improve 25-hydroxyvitamin D (25(OH)D) levels and reduce falls.<br />
Methods: Sixty-eight MOW clients in Forsyth Co, NC, who were<br />
not currently taking prescription vitamin D 2<br />
or >1000 IU/day of vitamin<br />
D 3<br />
were enrolled from December 2010 through March 2011<br />
(mean age, 77.8 yrs; 72% women; 75% black). Serum 25(OH)D was<br />
measured at baseline and 5-month follow-up and falls assessed by<br />
monthly fall calendars and phone calls. Participants were randomized<br />
by MOW route to receive 100,000 IU vitamin D 3<br />
(n=38) or an active<br />
placebo control (n=30) once a month along with their MOW meal.<br />
Results: Serum 25(OH)D levels (mean±SD) at baseline were<br />
22.5±12.2 and 18.9±10.6 ng/mL in the intervention and control group,<br />
respectively (p=0.22). Ninety percent of participants received 4 or<br />
more of the 5 vitamin D/placebo monthly doses. Serum 25(OH)D<br />
levels improved significantly in the intervention group compared to<br />
the control group (LS means±SE: +20.4±1.8 vs. -2.2±2.1 ng/mL adjusted<br />
for age, gender, race, randomization group and baseline<br />
25(OH)D, p1.0 m/s and impaired<br />
motor skill (by Figure of 8 walk time, F8WT > 8 secs).<br />
Methods: Forty older adults were randomized to MS or SE<br />
treatment arms. Both arms were 1 hour, twice weekly, PT-supervised<br />
interventions for 12 weeks. Pre and post intervention assessments<br />
performed by masked assessors included gait efficiency or energy<br />
cost of walking (mean rate of O2 consumption for 3 minutes of preferred<br />
speed treadmill walking divided by speed, ml/kg-m), gait<br />
speed, obstacle walk, F8WT and the Late Life Function and Disability<br />
Index disability subscale (LLFDI). Outcomes between arms were<br />
compared with ANCOVA, adjusted for the pre-intervention value.<br />
Results: Of 40 randomized subjects; 38 completed the trial (MS,<br />
n=18; SE, n=20; mean age 77.1±6.0 years). Gait efficiency improved<br />
(energy cost decreased) marginally more in MS than SE (- 0.04 vs. -<br />
0.02 ml/kg-m, adjusted difference, AD=0.03, p=0.13). MS improved<br />
more than SE in gait speed (0.13 vs. 0.05 m/s; AD=0.11, p=0.008); obstacle<br />
walk time (-0.89 vs. -0 .42 secs; AD=0.60, p=0.01), and F8WT (-<br />
0. 22 vs. -0.89 seconds; AD=1.39, p
P APER<br />
A BSTRACTS<br />
creating a barrier to treatment. A simple 3-item measure (the 3IQ)<br />
was developed to facilitate diagnosis, but the efficacy and safety of<br />
using the 3IQ to initiate treatment are unknown.<br />
Methods: In this double-blinded trial, 645 ambulatory women<br />
diagnosed with urgency incontinence using the 3IQ rather than an extended<br />
evaluation were randomized to 12 weeks of pharmacologic<br />
therapy with fesoterodine (4-8 mg daily) (N=322) or placebo<br />
(N=323). Change in urgency incontinence over 12 weeks was assessed<br />
by voiding diaries. Safety was assessed through adverse event monitoring<br />
and measurement of post-treatment postvoid residual volume<br />
(PVR), with specialist referral for PVR ≥ 250 mL or safety concern.<br />
Results: Mean (SD) baseline urgency incontinence frequency<br />
was 3.9(3.0) episodes/day. After 12 weeks, women in the fesoterodine<br />
group reported an average of 0.9 fewer urgency incontinence, 1.0<br />
fewer total incontinence, and 0.9 fewer urgency-associated voids per<br />
day, compared to placebo (P 65 should receive 1-1.5<br />
mg/kg. We determined whether older patients were less likely than<br />
younger patients to be given propofol for induction; whether propofol<br />
dose decreased with increasing age, per published guidelines; and<br />
whether, for patients > 65 years, increasing doses of propofol were associated<br />
with post-induction hypotension.<br />
Methods: We conducted a retrospective multivariate analysis of<br />
data from the Anesthesia Information Management System at Mount<br />
Sinai Hospital with IRB approval. We obtained data for 41,156 cases<br />
age 18-90, undergoing GA between 2006 and 2010, after excluding<br />
cardiac and obstetric cases. Post-induction hypotension was defined<br />
by meeting either of 2 criteria: (1) mean arterial pressure (MAP) decrease<br />
> 40% and MAP < 70 mmHg, or (2) MAP < 60 mmHg.<br />
Results: In the population studied, 31,827 patients (77%) received<br />
propofol. The cohort receiving propofol was younger (53 years<br />
vs. 60 years), non-emergent (88% vs. 75%), and had lower ASA physical<br />
status (51% ASA I-II vs. 23%) (p < 0.001 for each). Propofol dose<br />
decreased with increasing age (Pearson correlation = -0.35). The median<br />
dose for patients 65 population,<br />
47% received > 1.5 mg/kg. A larger dose of propofol was associated<br />
with an increased likelihood of hypotension in the post-induction period,<br />
and this effect was age-dependent. For the same increase in<br />
propofol dose (0.5 mg/kg), a 65 year old was less likely to experience<br />
hypotension than an 80 year old (OR=1.09 vs. 1.15, respectively).<br />
Conclusions: A large cohort of patients > 65 were given higherthan-recommended<br />
doses of propofol for induction of GA. Higher<br />
doses were associated with increased incidence of significant hypotension<br />
in the post-induction period. This is clinically important because<br />
significant post-induction hypotension has been associated<br />
with increased incidence of post-operative adverse events.<br />
Paper Session<br />
Epidemiology<br />
Saturday, May 5<br />
10:45 am – 12:15 pm<br />
P28<br />
Risk Factors for Restricting Back Pain in Community-Living Older<br />
Persons.<br />
U. E. Makris, 1,2 L. Han, 3 L. Leo-Summers, 3 L. Fraenkel, 3,4 T. M. Gill. 3<br />
1. Internal Medicine, UT Southwestern Medical Center, Dallas, TX; 2.<br />
Medicine, Veterans Affairs, Dallas, TX; 3. Internal Medicine, Yale<br />
School of Medicine, New Haven, CT; 4. Medicine, Veterans Affairs,<br />
West Haven, CT.<br />
Supported By: T32 AG019134 Yale <strong>Geriatrics</strong> Training Program in<br />
Aging Related Research and Clinical Epidemiology; ACR<br />
REF/ASP Junior Career Development Award in Geriatric<br />
Medicine; RO3 AG040653 NIA GEMSSTAR.<br />
Background: Back pain is a common and costly condition<br />
among older persons. Few prospective studies have evaluated the risk<br />
factors for back pain in older persons.<br />
Methods: We evaluated the 731 participants (mean age 78.8<br />
years, 65% women) of the Precipitating Events Project, a prospective<br />
study of community-living persons, aged 70+ years, who completed<br />
monthly interviews of restricting back pain, defined as staying in bed<br />
for at least 1/2 day and/or cutting down on one’s usual activities due<br />
to back pain, for up to 126 months. Candidate risk factors were measured<br />
from five domains (demographic, cognitive-psychosocial, health<br />
related, habitual, physical capacity) during comprehensive homebased<br />
assessments that were completed every 18 months for up to 108<br />
months. Among participants without restricting back pain, two distinct<br />
outcomes were determined during each 18-month interval: (1)<br />
short-term (1 episode lasting 1 month) and (2) persistent (1 episode<br />
lasting >= 2 months) or recurrent (>= 2 episodes of any duration) restricting<br />
back pain. The cumulative incidence of the outcomes were<br />
estimated during the total follow-up period using a GEE binomial<br />
model. A multivariable Cox model was used to evaluate the adjusted<br />
associations between each candidate risk factor and the two outcomes<br />
of interest.<br />
Results: The cumulative incidence was 17.8% (95% CI: 16.5,<br />
19.3) for the short-term outcome and 17.9% (16.1, 19.9) for the persistent/recurrent<br />
outcome. Factors independently associated with a<br />
higher risk of developing short-term restricting back pain included female<br />
sex (HR 1.30, P=0.01), hip weakness (HR 1.19, P=.001) and poor<br />
grip strength (HR 1.24, P=.04); and for the persistent/ recurrent outcome<br />
included female sex (HR 1.48, P=0.01), depressive symptoms<br />
(HR 1.57, P=
P APER<br />
A BSTRACTS<br />
be amenable to interventions designed to prevent the occurrence,<br />
persistence, or recurrence of this common disorder in older persons.<br />
P29<br />
Falls and Orthostatic Hypotension: Re-examining Limits.<br />
A. Cleinman, 1 M. E. Griswold, 2 E. Simonsick, 3 W. M. Meeks, 1<br />
K. Gregg, 1 L. Ferrucci, 3 B. G. Windham. 1 1. Department of Medicine,<br />
Division of <strong>Geriatrics</strong>, University of Mississippi Medical Center,<br />
Jackson, MS; 2. Center of Biostatistics and Bioinformatics, University<br />
of Mississippi Medical Center, Jackson, MS; 3. Clinical Research<br />
Branch, NIH - National Institute on Aging, Baltimore, MD.<br />
Supported By: National Institutes of Health, National Institute<br />
on Aging<br />
Background: Guidelines recommend treating orthostatic hypotension<br />
(OH) to reduce risk of falls in older adults. We hypothesized<br />
that low systolic blood pressure (SBP) upon standing and/or decreases<br />
from usual SBP, even without meeting OH criteria, would also<br />
be related to falls risk.<br />
Methods: Baltimore Longitudinal Study of Aging participants (<br />
>65y) with a first visit that evaluated OH and self-report of falls in the<br />
previous 12 months were examined. Participants with >10 visits were<br />
excluded to minimize extended cohort participation bias. OH was defined<br />
using the classical definition of SBP decrease >20mmHg or diastolic<br />
BP decrease > 10mmHg, 3 minutes after standing from a<br />
supine, resting position. Logistic regression was used to examine associations<br />
between falls and BP measures, adjusting for age, sex, race,<br />
education, stroke, diabetes, hypertension, and vision.<br />
Results: Among 412 participants, (aged 65-97, 45% female, 64%<br />
white), 115 (28%) reported falling: 77 had one fall and 38 reported >2<br />
falls. Only 19 participants (4.6%) had formally defined OH. Falls<br />
were more common in those with OH (53% vs 27%, p=0.033). In adjusted<br />
models, falls were significantly associated with OH, OR=3.05<br />
(95% CI: 1.06, 8.78) p=0.038, but not with final standing SBP,<br />
OR=1.01 (0.99, 1.02) p=0.358. Furthermore, each 1mmHg decrease in<br />
SBP upon standing was associated with an additional 6% increase in<br />
risk, OR=1.06 (1.01, 1.10) p=0.008. This is equivalent to 31%, 73%,<br />
and 198% increases in risk for 5, 10, and 20mmHg drops in SBP. The<br />
risk associated with decreases in SBP upon standing did not depend<br />
on the final standing SBP (p=0.74 for interaction).<br />
Conclusions: The risk of falls in this sample depended on decreases<br />
in SBP upon standing rather than the final standing SBP. Although<br />
classically defined OH was associated with falls, increased<br />
risks were seen for any decrease in SBP upon standing, even those<br />
not meeting OH criteria. This suggests that a continuous spectrum of<br />
SBP drops upon standing conveys important information about risk.<br />
Any SBP drop may warrant consideration in falls risk assessments.<br />
P30<br />
Sensory and motor nerve function differentially relate to gait<br />
parameters: the Health ABC Study.<br />
E. S. Hile, 1 J. S. Brach, 1 M. Yang, 1 S. A. Studenski, 1 R. M. Boudreau, 1<br />
P. Caserotti, 2,3 S. Satterfield, 5 A. V. Schwartz, 4 E. Simonsick, 2<br />
L. Ferrucci, 2 T. B. Harris, 2 A. B. Newman, 1 E. S. Strotmeyer. 1 1.<br />
University of Pittsburgh, Pittsburgh, PA; 2. National Institute on<br />
Aging, Baltimore, Bethesda, MD; 3. University of Southern Denmark,<br />
Odense, Denmark; 4. University of California, San Francisco, CA; 5.<br />
University of Tennessee, Memphis, TN.<br />
Supported By: National Institute on Aging (NIA) Contracts N01-<br />
AG-6-2101; N01-AG-6-2103; N01-AG-6-2106; NIA grant R01-<br />
AG028050, and NINR grant R01-NR012459.<br />
Pittsburgh Claude D. Pepper Older <strong>American</strong>s Independence<br />
Center (P30 AG024827)<br />
BACKGROUND: Many older adults have subclinical or undiagnosed<br />
peripheral nerve decline. Sensory decline is associated with<br />
gait deviations [reduced speed; increased double support time (DST)<br />
and base of support (BOS)] in diabetic or neuropathic cohorts, but<br />
less is known about age-related decline. Poor sensory and motor<br />
nerve function associate with slower speed in the Health ABC cohort,<br />
but how biomechanical gait parameters explain this is unknown.<br />
We investigated relationships between nerve function and spatial or<br />
temporal gait parameters. METHODS: Of 3075 baseline Health<br />
ABC participants, we included 544 (83.4±2.7 yrs, 52.9% women,<br />
35.5% black) with Year 11 gait parameters [4-m usual walk speed,<br />
BOS, step length, step time, DST, stance and swing time] and nerve<br />
function [sensory:1.4 and 10g monofilament (MF) detection, vibration<br />
threshold (VT); motor: peroneal nerve conduction velocity<br />
(NCV) and amplitude (CMAP)]. Gait parameters were outcomes<br />
modeled with each nerve predictor by multivariate regression adjusted<br />
for age, sex, race, BMI, diabetes, PVD, stroke, physical activity,<br />
smoking and vision. Most gait parameters vary with speed, so final<br />
models were adjusted for speed to assess independence. RESULTS:<br />
Worse sensory and motor nerve function by VT or CMAP (but not<br />
MF or NCV) related to slower speed. Worse VT associated with<br />
longer stance and step times (p
P APER<br />
A BSTRACTS<br />
Conclusion: This study provides evidence that use of medications<br />
with strong or moderate AC effects in older women is associated<br />
with increased risk of falls, clinical vertebral fracture, and total<br />
fractures, but is not associated with hip fracture or lower arm/wrist<br />
fracture.<br />
P32<br />
Falls among Adult Patients Hospitalized in the United States:<br />
Prevalence and Trends.<br />
E. L. Bouldin, 1,2 E. M.Andresen, 2,3 N. E. Dunton, 4 M. Simon, 5<br />
T. M.Waters, 8 M. Liu, 2 M. J. Daniels, 2 L. C. Mion, 6 R. I. Shorr. 7,2 1.VA<br />
Puget Sound HSR&D, Seattle,WA; 2. University of Florida,<br />
Gainesville, FL; 3. Instistute on Disability and Development, Oregon<br />
Health & Science University, Portland, OR; 4. Health Policy and<br />
Management, University of Kansas Medical Center, Kansas City, KS; 5.<br />
Health Sciences, University of Southampton, Southampton, United<br />
Kingdom; 6. School of Nursing,Vanderbilt University, Nashville,TN; 7.<br />
Geriatric Research Education & Clinical Center, Malcolm Randall VA<br />
Medical Center, Gainesville, FL; 8. Department of Preventive Medicine,<br />
University of Tennessee Health Science Center, Memphis,TN.<br />
Supported By: NIH/NIA R01-AG025285, NIH/NIA R01-AG033005<br />
Background:The purpose of this study was to provide normative<br />
data on fall prevalence in US hospitals and to determine 27-month<br />
secular trend in falls prior to the implementation of the Centers for<br />
Medicare and Medicaid Service (CMS) rule which does not reimburse<br />
hospitals for care related to injury resulting from hospital falls.<br />
Methods: We used data from the National Database of Nursing<br />
Quality Indicators (NDNQI) collected between July 1, 2006 and September<br />
30, 2008 to estimate prevalence and secular trends of falls occurring<br />
in adult medical, medical-surgical and surgical nursing units.<br />
More than 88 million patient days (pd) of observation were contributed<br />
from 6,100 medical, surgical, and medical-surgical nursing<br />
units in 1,263 hospitals across the United States.<br />
Results: A total of 315,817 falls occurred (rate=3.56 falls/1,000<br />
pd) during the study period, of which 82,332 (26.1%) resulted in an<br />
injury (rate=0.93/1,000 pd). Both total fall and injurious fall rates<br />
were highest in medical units (fall rate=4.03/1,000 pd; injurious fall<br />
rate=1.08/1,000 pd) and lowest in surgery units (fall rate=2.76/1,000<br />
pd; injurious fall rate=0.67/1,000 pd). Falls (0.4% decrease/quarter,<br />
p
P APER<br />
A BSTRACTS<br />
age increased, the overall rate of catheterization for all older inpatients<br />
declined from 19.9% to 11.9%, a 40% reduction. The greatest<br />
improvement was seen on the ACE Unit, where the rate of catheterization<br />
declined from 20.4% to 9.7%, a 53% reduction. The catheter<br />
utilization ratio decreased from 68% to 20%, while the average<br />
catheter days per patient declined from 11.7 to 2.8 days per patient<br />
across all inpatient units. Conclusions: This study demonstrates the<br />
dramatic and sustained improvements in catheter utilization that can<br />
be achieved with the support of a multi-modal educational intervention<br />
in improving patient safety and quality care efforts around the<br />
appropriate use of urinary catheters in a variety of inpatient settings.<br />
P35<br />
A <strong>Geriatrics</strong> rotation as a Medicine elective: A smart option for<br />
medical students?<br />
A. Nguyen , 1 E. Duthie, 1 E. Duthie, 2 K. Denson, 2 J. Franco. 2 1.<br />
Institute for Health and <strong>Society</strong>, Medical College of Wisconsin,<br />
Milwaukee, WI; 2. Internal Medicine, Medical College of Wisconsin,<br />
Milwaukee, WI.<br />
Background: Medical schools must look at innovative ways to<br />
ensure that graduates achieve basic competencies in geriatrics and<br />
encourage new physicians to consider the subspecialty. Our objectives<br />
are to: 1) assess the impact of a month-long geriatrics rotation,<br />
as part of the internal medicine clerkship, on M3 students’ knowledge,<br />
skills, and attitudes toward geriatric practice and career choice;<br />
and 2) assess knowledge outcomes by comparing mean NBME internal<br />
medicine shelf exam scores between students who completed the<br />
geriatrics rotation and students who completed the internal medicine<br />
ward rotations.<br />
Methods: This study was conducted at a medical school where a<br />
month-long geriatrics evaluation and management (GEM) rotation<br />
fulfills a graduation requirement in internal medicine. One-hour<br />
focus groups were conducted with two cohorts: 1) students who rotated<br />
through GEM and 2) students who did not. Thematic analyses<br />
using the principles of grounded theory were performed to compare<br />
group responses between the two cohorts. One focus group of 4-6<br />
participants was conducted for each cohort. Independent t-test was<br />
performed to compare mean NBME internal medicine shelf exam<br />
scores between all GEM (n=124) and non-GEM (n=1318) students<br />
who matriculated between 2005 and 2011. ANOVA was used to compare<br />
the means after controlling for Step 1 exam scores.<br />
Results: Focus groups revealed differences in reported comfort<br />
and attitudes toward geriatric care with the GEM cohort reporting<br />
higher levels of confidence with geriatric assessment skills. Mean<br />
NBME internal medicine shelf exam scores between GEM students<br />
[mean (SD)=73.66 (±7.2)] and non-GEM students [mean (SD)=73.60<br />
(±7.4)] were not statistically significant (p=0.938). Controlling for<br />
Step 1 scores did not produce statistically significant differences<br />
(p=0.371).<br />
Conclusion: Completing an internal medicine ward rotation requirement<br />
using a geriatrics rotation is an innovation that medical<br />
schools should consider. Comparisons of NBME scores show that<br />
GEM students perform just as well on the internal medicine board<br />
exam as their non-GEM colleagues but were more comfortable<br />
with elder care. Evaluating geriatrics curricula will add to understanding<br />
of student perspectives about geriatrics as a career field<br />
and allow curriculum developers to identify areas of strength and<br />
areas for improvement.<br />
P36<br />
Case Presentation as a Direct Observation Method to Evaluate<br />
Internal Medicine Residents’ Systems-Based Practice Competency.<br />
K. Ouchida, S. Ramsaroop, S. Mehta, L. Logio, R. Adelman,<br />
E. Siegler. Medicine, Weill Cornell Medical Center New York<br />
Presbyterian Hospital, New York, NY.<br />
PURPOSE: Of the 6 core competencies the Accreditation<br />
Council of Graduate Medical Education requires, systems-based<br />
practice (SBP) often poses the greatest challenge for curriculum development<br />
and evaluation. A redesigned geriatrics rotation for internal<br />
medicine (IM) residents incorporates a SBP module with direct<br />
exposure to health care sites and services utilized by older adults. This<br />
study describes the use of a case presentation to evaluate IM residents’<br />
knowledge of the health care system and ability to navigate it.<br />
METHODS: Starting June 2011, all PGY-2 IM residents (N=48)<br />
complete a 1-week SBP module as part of the required 4-week geriatrics<br />
rotation. The module combines structured exposures to community-based<br />
programs, supervised patient care on house calls and in<br />
a transitional care clinic, and self-directed learning. Residents present<br />
an older continuity patient to the geriatrics interdisciplinary team,<br />
which then models a collaborative problem-solving approach. One<br />
faculty member takes notes and emails residents a summary of the<br />
identified problems and the team’s “action plan.” The problems and<br />
recommendations were analyzed to generate a list of themes for coding.<br />
Discrepancies in coding were resolved by discussion until consensus<br />
was reached.<br />
RESULTS: To date 21 (44%) IM residents have presented cases.<br />
Presentations generated 19 types of biopsychosocial issues (mean 3.8<br />
per patient) and 12 types of recommendations (mean 5.4). Lack of social<br />
support (15.1%), care coordination challenges (13.9%), and negative<br />
illness behaviors such as refusal of care (10.1%) represent the<br />
most frequently identified problems. The interdisciplinary team’s recommendations<br />
most often focused on care coordination strategies<br />
(15%), community resources (14.2%), medical treatment or workup<br />
(14.2%) and goals of care (13.3%). The case presentation received<br />
one of the highest ratings from residents on the module evaluation<br />
(4.75 out of 5).<br />
CONCLUSIONS: A case presentation represents an effective<br />
strategy for directly observing and evaluating IM residents’ systemsbased<br />
practice competency. Presentations reveal residents’ struggles<br />
with the health care system and comprehension of their older patients’<br />
needs, and offer exposure to geriatric approaches through<br />
practical advice. This evaluation method is feasibly implemented and<br />
well-received by residents.<br />
P37<br />
Replicating a Chief Resident Immersion Training in <strong>Geriatrics</strong><br />
(CRIT).<br />
S. Levine, 1 L. Caruso, 1 B. Brett, 2 H. Auerbach, 1 A. Jackson, 1<br />
A. Burrows, 1 S. Chao. 1 1. Boston Univerisity Medical Center<br />
(BUMC), Boston, MA; 2. Brett Consulting Group, Boston, MA.<br />
Supported By: John A. Hartford Foundation, Association of<br />
Directors of Geriatric Academic Programs (ADGAP)<br />
Background: Chief residents (CRs) play crucial roles in resident<br />
and student training and in quality patient care. They typically receive<br />
minimal formal education in geriatrics, teaching skills and leadership.<br />
With support from the John A. Hartford Foundation and ADGAP,<br />
BUMC disseminated its successful 2-day offsite CRIT program, addressing<br />
these deficiencies, to demonstrate national replicability.<br />
Methods: Through a competitive RFP, 12 institutions in 3 cohorts<br />
were selected to implement CRIT across specialties for 2 years<br />
each. The modular curriculum included an unfolding case discussed in<br />
small groups, evidence-based mini-lectures on geriatrics topics, and<br />
interactive seminars on teaching and leadership skills. 1-to-1 consults<br />
helped CRs develop an action project. Social opportunities were provided<br />
to develop relationships. Faculty mentors were invited to increase<br />
institutional “buy-in.” BUMC’s support to each institution included<br />
attending BUMC’s CRIT. National evaluation of CRIT<br />
included a self-report pre-survey, a 12-item pre- and immediate post-<br />
CRIT knowledge test, and a 6-month follow-up survey, administered<br />
by each institution. Results across institutions and cohorts were<br />
merged for analysis.<br />
Results: Over 3 years in 12 institutions, 301 CRs and 86 faculty<br />
mentors participated in CRIT, representing 29 specialties. Response<br />
AGS 2012 ANNUAL MEETING<br />
S13
P APER<br />
A BSTRACTS<br />
rates for CRs were 99% (n=299) for the pre-survey, 97% (n=293) for<br />
the pre-post test, and 78% (n=234) for matching pre to 6-month followup.<br />
CRs showed significant gains in knowledge (p
P APER<br />
A BSTRACTS<br />
Methods: Data for acute hospital admissions were obtained<br />
from 61 PACE programs across the US(over 25,000 enrollees), for the<br />
time period 6/1/2008-5/31/2010. Program enrollment data for this<br />
time period were also used together with diagnostic data on program<br />
participants. For each program, exposure-adjusted hospitalization, 30-<br />
day all-cause readmission, and PAH rates were calculated. Multivariate<br />
analyses, with program fixed-effects, were used to assess the impact<br />
of individual-level risk factors on hospitalization rates.<br />
Results: The average hospitalization rate in PACE (547/1000<br />
participants) was 43% lower than for non-PACE dually eligible recipients<br />
of home and community-based services (HCBS) (962/1000).<br />
PACE 30-day average readmission rate (19.1%) was 17% lower compared<br />
to non-PACE dually eligible beneficiaries, age 65+ (22.9%).<br />
The average PAH rate in PACE (175/1000) was 30% lower than<br />
among duals in HCBS programs (250/1000). There were significant<br />
variations across PACE sites in all hospital measures, which remained<br />
after risk-adjustment.<br />
Conclusions: Although PACE participants are among the<br />
frailest of Medicare and Medicaid beneficiaries, their risk of hospital<br />
use is significantly reduced in an integrated clinical care model that is<br />
reinforced by integrated financing. Variations in hospital rates across<br />
PACE indicate continued opportunities for further improvement<br />
with regard to hospital use.<br />
P41<br />
Evaluation of a National Care Transition Program.<br />
S. Wee, 1 P. Wang, 1 E. Koh, 1,2 A. Gan, 2 G. Ganesan. 2 1. Research,<br />
Health Information Management and Evaluation, Agency for<br />
Integrated Care, Singapore, Singapore; 2. Health Services Research<br />
and Evaluation, Ministry of Health, Singapore, Singapore.<br />
Background: Transitional care interventions for carefully selected<br />
patients from hospital to other settings had shown promise in<br />
reducing rates of subsequent hospitalizations. We evaluated the effectiveness<br />
of a state funded national care transition care program involving<br />
our five largest public hospitals to reduce acute care utilization.<br />
The program was adapted from Coleman’s Care Transition<br />
Program®.<br />
Objectives: To compare the risk of hospital re-admission and<br />
emergency department (ED) attendance of acutely ill patients on the<br />
program to other patients admitted during a similar time frame,<br />
matched for age, gender and hospital subsidy status.<br />
Methods: Retrospective cohort study of 4132 patients discharged<br />
from the five acute hospitals from Feb 2009 to Jul 2010 on<br />
care transition program and 4132 control patients chosen from the<br />
State Hospital Claim System. Propensity (conditional probability of<br />
enrolment into program) scores were derived by multiple logistic regression<br />
with the covariates age, gender, length of initial hospital stay,<br />
Charlson index, past 180 days hospital admission, past 180 days ED<br />
attendance. A logistic regression model was fitted to the data. Re-admission<br />
and ED attendance were compared after covariate adjustment<br />
and weighting by propensity scores.<br />
Results: The baseline characteristics of patients in the two<br />
groups were similar after weighting by propensity. Baseline characteristics<br />
for the program patients were: age (SD) 79.2 (7.7) y, 44%<br />
male, mean length of hospital stay (SD) 11.6 (13.1) days, mean Charlson<br />
index (SD) 1.6 (1.8), mean no. of hospitalization and ED attendance<br />
180 days prior to index admission were 0.79 and 1.9 respectively.<br />
Subjects enrolled on the program were less likely to be readmitted<br />
and visit the ED. The adjusted odds ratio (95% CI) comparing rehospitalisation<br />
and ED re-attendance of program subjects with that<br />
of controls at 30 days, were 0.68 (0.61, 0.76) and 0.79 ( 0.71, 0.89) respectively;<br />
and at 180 days, were 0.79 (0.72, 0.87) and 0.88 (0.80, 0.97)<br />
respectively.<br />
Conclusion: Supporting patients and caregivers to take a more<br />
active role during care transition through a care transition program is<br />
effective in reducing subsequent re-hospitalization and ED attendance<br />
in acutely ill patients at risk for transitions.<br />
P42<br />
The Epidemiology of Physically and Verbally Aggressive Behaviors<br />
of Nursing Home Residents Directed at Staff.<br />
M. Lachs, 1 A. Rosen, 2 K. Pillemer, 3 J. Teresi. 4 1. Medicine, <strong>Geriatrics</strong>,<br />
Weill Cornell Medical College, New York, NY; 2. Emergency Medicine<br />
Residency, New York Presbyterian Hospital, New York, NY; 3. Human<br />
Development, Cornell University, Ithaca, NY; 4. Research Division,<br />
Hebrew Home at Riverdale, Riverdale, NY.<br />
Supported By: National Institute on Aging<br />
National Institute of Justice<br />
New York State Department of Health<br />
Background: While considerable media attention has focused on<br />
abuse of nursing home residents by staff, little research focus has<br />
been directed towards examining the opposite phenomenon: physical<br />
and verbal aggression directed at staff by nursing home residents. We<br />
hypothesized that resident-to-staff aggression (RSA) is a potentially<br />
common phenomenon, as dementia-related behavioral problems are<br />
frequent in nursing home residents and often an impetus for nursing<br />
home placement.<br />
Objective: To perform the first methodologically rigorous study<br />
on the prevalence of RSA in nursing homes.<br />
Methods: We conducted this study as part of a large, multisite<br />
NIA-funded study attempting to estimate the prevalence of residentto-resident<br />
elder mistreatment in long term care facilities. For this<br />
project, the behavior of 1,550 residents of 5 nursing homes was evaluated.<br />
Certified nursing assistants primarily responsible for the care of<br />
residents under study in the parent project were asked whether any<br />
physical, verbal, or sexual behaviors were directed at them by the resident<br />
in the previous two weeks using an instrument validated for this<br />
purpose.<br />
Results: Staff reported that 15.7% of residents directed abuse<br />
towards them within the past two weeks. The most commonly reported<br />
types of verbally abusive behavior reported were screaming<br />
(9.0% of residents) and using bad words (7.2%). The most commonly<br />
reported types of physically abusive behavior reported were hitting<br />
(3.9% of residents) and kicking (2.6%). Aggressive behaviors reportedly<br />
occurred most commonly in the patient room (84.8%) and in the<br />
morning (84.3%).<br />
Conclusion: RSA in nursing homes is highly prevalent. This phenomenon<br />
may negatively affect quality of care, resident and staff<br />
safety, and job satisfaction and staff turnover. Further studies are<br />
needed to understand how and why it occurs, and to develop interventions<br />
to mitigate its potential impact.<br />
P43<br />
Defining medically complex patients using chronic conditions,<br />
healthcare utilization and functional status.<br />
W. W. Hung, 1,2 A. S. Kelley, 1 E. Livote, 2 J. Penrod, 1,2 A. Federman, 1<br />
A. L. Siu. 1,2 1. Mt Sinai School of Medicine, NY, NY; 2. JJP VAMC,<br />
Bronx, NY.<br />
Supported By: VA HSRD<br />
Background:<br />
The majority of healthcare costs are concentrated among a<br />
small proportion of medically complex older adults. While complexity<br />
is often defined by multiple chronic conditions, not all patients with<br />
chronic conditions are complex and patients with a single serious illness<br />
can have complex and costly medical needs. Our objective is to<br />
evaluate 3 different definitions of complexity based on chronic conditions,<br />
healthcare utilization, and functional measures by examining<br />
AGS 2012 ANNUAL MEETING<br />
S15
P APER<br />
A BSTRACTS<br />
each definition’s predictive value for healthcare costs and survival.<br />
We hypothesized that complexity should be predictive of healthcare<br />
costs and survival.<br />
Methods:<br />
We used Medicare Current Beneficiary Survey data from 2000<br />
(year 1) & 2001 (year 2). We excluded those under age 65, managed<br />
care participants, & decedents in 2000. Using year 1 data, we developed<br />
3 definitions of complexity from candidate variables including:<br />
chronic conditions from claims; healthcare utilization patterns associated<br />
with high costs in year 1; and self-reported functional status (i.e.<br />
performance of activities of daily living). For each definition, we<br />
measured prevalence, year 1 & 2 costs, and mortality in year 2 compared<br />
to the full sample.<br />
Results:<br />
Older adults with 4 or more chronic conditions accounted for<br />
24% of the population but accounted for 36% of health care costs in<br />
year 2. Those who had a major chronic condition (i.e. high cost conditions<br />
such as diabetes, dementia) and either 2 or more acute hospitalizations<br />
or 3 or more other conditions accounted for 14% of the sample<br />
but accounted for 29% of year 2 costs and had a year 2 mortality<br />
rate of 20% vs. 5%. Adding the functional limitation in bathing identified<br />
23% of the sample which accounted for 48% of costs in year 2<br />
and had a year 2 mortality rate of 20% vs. 3%.<br />
Conclusion:<br />
Using chronic conditions alone identifies a population that has a<br />
moderate concentration in future costs. Identification of medically<br />
complex adults is improved when prior hospitalizations and functional<br />
status are also considered. These measures can be used to identify<br />
patients as appropriate targets for interventions to improve care<br />
and reduce the costs of serious illness.<br />
P44<br />
Risk Factors for Early Hospital Readmission among Low Income<br />
Seniors.<br />
T. C. Iloabuchi, 1 W. Tu, 1,2 D. Mi, 2 S. R. Counsell. 1,2 1. Indiana<br />
University School of Medicine, Indianapolis, IN; 2. Indiana University<br />
Center for Aging Research, Indianapolis, IN.<br />
Background: Early hospital readmission among older persons<br />
often represents suboptimal care transitions and may result in adverse<br />
health outcomes and avoidable costs.<br />
Purpose: To identify risk factors available on admission that<br />
could be used in identifying hospitalized low-income seniors at increased<br />
likelihood for experiencing early readmission.<br />
Methods: Prospective cohort study using data from the Geriatric<br />
Resources for Assessment and Care of Elders (GRACE) randomized<br />
controlled trial (RCT), which enrolled and followed over two years<br />
951 adults ≥ 65 years with annual income
P OSTER<br />
A BSTRACTS<br />
Poster Session A<br />
Thursday, May 3<br />
12:00 pm – 1:30 pm<br />
A1<br />
FROZEN WITH PAIN.<br />
A. Bhagavan, 1 A. Talsania, 1 S. Bellantonio. 2 1. Internal medicine,<br />
Baystate Medical Center, Springfield, MA; 2. Geriatric medicine,<br />
Baystate Medical Center, Springfield, MA.<br />
Introduction:<br />
Sternoclavicular joint (SCJ) septic arthritis, first described in<br />
1896, constitutes
P OSTER<br />
A BSTRACTS<br />
been ruled out. It is then recommended that in patients who present<br />
with delirium, ammonia level should be considered as part of the<br />
workup especially if they have accompanying constipation.<br />
A4 Encore Presentation<br />
Delirious Because of Treatment: An Adverse Effect of Imipenem.<br />
B. L. Africa, 1,2 D. Carthen, 1,2 H. Arabelo. 1,2 1. <strong>Geriatrics</strong>, St. Luke’s<br />
Roosevelt Hospital Center, New York, NY; 2. Columbia University<br />
College of Physicians and Surgeons, New York, NY.<br />
The mainstay treatment of delirium is the reversal of the underlying<br />
cause. In the elderly population, this is often caused by an infection,<br />
for which antibiotics are initiated. However in this case, it was<br />
the antibiotic that led to the delirium.<br />
This is a case of a 91 year old woman with a history of chronic osteomyelitis<br />
from an infected hip implant, who was admitted due to<br />
weakness and lethargy. She was found to have a sinus tract in the left<br />
hip with draining fluid and a urinary tract infection. She was started<br />
on cefepime and vancomycin. On the subsequent day, her mental status<br />
and leukocytosis has improved. Fluid cultures taken from her hip<br />
grew Pseudomonas resistant to cefepime and thus imipenem was<br />
started. Two days later she was found to be lethargic. She was diagnosed<br />
that time with hypoactive delirium from the<br />
osteomyelitis/hardware infection. Orthopedic surgery was consulted<br />
for removal of her hip hardware; however she was deemed not a candidate<br />
for surgery. Her symptoms progressed and she became comatose.<br />
The family was informed regarding her poor prognosis. Subsequently,<br />
her antibiotics were stopped due to futility. Two days after<br />
stopping imipenem, she was awake and asking for food. Her condition<br />
continued to improve and she was then eventually discharged home.<br />
This case shows the clinical implication of an adverse effect of a<br />
medication. Hypoactive delirium although not a known side effect of<br />
imipenem, was observed in this particular case. This indicates the investigation<br />
of other underlying causes of delirium, in which antibiotics<br />
maybe one of them. There have been no known published articles<br />
relating hypoactive delirium due to imipenem. It may be<br />
worthwhile to investigate on this matter.<br />
A5<br />
Title: Multiple myeloma with spontaneous tumor lysis syndrome in<br />
an elderly patient; a rare entity.<br />
H. Chataut, M. Bednarczyk, M. Gorbien, M. Leiding, J. Olson.<br />
Division of <strong>Geriatrics</strong> Medicine and Palliative Medicine, RUSH<br />
University Medical Center, Chicago, IL.<br />
Purpose: To recognize complications especially tumor lysis<br />
which can be associated with multiple myeloma ( MM) in an elderly<br />
patient.<br />
Case Report: An 83 year old woman with history of coronary artery<br />
disease presented with fatigue, weakness and unintentional 15<br />
lbs weight loss over 3 months. She denied fever/chills, night sweats,<br />
bladder/bowel complaints, bleeding from any site. Physical exam revealed<br />
normal vital signs and unremarkable systemic exam. Laboratory<br />
analysis revealed Hb 6 g/dL with normal MCV, Platelet count<br />
48,000/dL creatinine 3.7 mg/dL, total protein 12.1g/dL with albumin<br />
2.4 g/dL, Calcium 10.6 mg/dL, LDH 346 U/dL. Serum protein electrophoresis<br />
showed monoclonal band. She was hydrated and transfused<br />
packed RBCs and a bone marrow biopsy showed sheets of<br />
plasma cells consisting of 70% of marrow cellularity. Bone survey revealed<br />
multiple lytic lesions in skull, humerus, mandible. Chemotherapy<br />
was being planned but in the interim the symptoms worsened and<br />
laboratory analysis showed worsening creatinine 4.8 mg/dL, uric acid<br />
13.9 meq/dL, phosphorus 6 meq/dL and potassium 5.3 meq/dL. She<br />
was started on aggressive hydration and rasburicase for presumed<br />
tumor lysis syndrome, which resulted in improvement in symptoms<br />
and laboratory parameters. Dexamethasone was added for MM. Further<br />
therapy is being planned as outpatient with bortezomib with<br />
very close follow-up.<br />
Discussion: The incidence of MM increases considerably with<br />
age. The number of geriatric patients with MM is expected to increase<br />
over time as a consequence of the increased life expectancy of the<br />
normal population, and management of these patients is likely to become<br />
particularly pertinent in coming years. MM in the elderly can be<br />
a therapeutic challenge. Acute tumor lysis syndrome is rarely observed<br />
in MM. The incidence is probably less than 1% of patients who<br />
are treated with intermediate or high-dose chemotherapy. It is only<br />
occasionally observed with dexamethasone or prednisone treatment.<br />
Few case reports exist of the same. Spontaneous tumor lysis syndrome,<br />
on the other hand, has not been reported in untreated<br />
myeloma. Our case is unique with spontaneous tumor lysis in a very<br />
elderly patient with new diagnosis of MM, rapidly declining performance<br />
status with co-morbidities, presenting a therapeutic challenge.<br />
A6<br />
A case of atypical Gastro-intestinal bleeding (GIB) in an elderly; not<br />
just diverticulosis.<br />
H. Chataut, 1 M. Bednarczyk, 1 M. Gorbien, 1 M. Leiding, 1 J. Olson, 1<br />
C. Teodoro, 1 R. Arora. 2 1. Department of Geriatric Medicine, RUSH<br />
university medical center, Chicago, IL; 2. Gastroenterology, Rush<br />
University Medical Center, Chicago, IL.<br />
Purpose: GIB may present with vague symptoms and can be fatal.<br />
Background: GIB that required multiple procedures along with<br />
octreotide.<br />
Method: Case report<br />
Case report: A 85 year old man with receiving aspirin and<br />
coumadin presented with confusion, hypotension, tachycardia, guaiac<br />
positive and Hgb 5 gm/dl, INR 2.2. After resuscitation emergent<br />
colonoscopy revealed diverticulosis, non bleeding angiodysplasia<br />
(AVMs) and colon full of blood up to cecum with no blood in the terminal<br />
ileum, suggesting colonic source for bleeding. EGD up to duodenum<br />
showed no evidence of recent or active bleeding. Patient’s<br />
Hgb continues to drop requiring 17 units of Packed RBC transfusion<br />
in 2 days. Technetium labeled RBC scan localized the bleeding to<br />
duodenum and jejunum. Enterescopy showed bleeding site in the<br />
duodenum at junction of bulb and second portion of duodenum along<br />
with non bleeding AVMs in small bowel. Bleeding site was treated<br />
with epinephrine and cauterization. This temporarily stopped the<br />
bleeding; however bleeding recurred in the following day. Then patient<br />
underwent visceral arteriogram and empiric embolization of<br />
gastroduodenal artery (GDA), superior rectal artery of inferior<br />
mesenteric artery (IMA). In the setting worsening GIB, patient had a<br />
trial of octreotide infusion along with pantoprazole intravenously.<br />
Octreotide inhibits gastric acid secretion and decreases splanchnic<br />
blood flow due to its vasoconstrictive effect. Thereafter, hemoglobin<br />
stabilized and patient recovered.<br />
Discussion: This is a complex case of GIB from multiple angiodysplasia<br />
concurrent with diverticulosis. Patient presented with<br />
hypovolemic shock from GI bleed, requiring multiple blood transfusions.<br />
Thus we can initially assume that GIB from a large and readily<br />
visible source. However, this was not the case. This presented a diagnostic<br />
dilemma, which necessitated multiple procedures. To conclude,<br />
a trial of octreotide was given in the context of worsening GIB. In this<br />
case, looking and targeting a specific lesion may not be the best therapeutic<br />
option. Thus we step back and treat the GI system with a<br />
medication that affects it at all levels. This clinical scenario is not uncommon<br />
since both occur in elderly patients. Octreotide has been<br />
shown to halt bleeding in cases of angiodysplasia and was successful<br />
in our patient.<br />
A7<br />
The four-year mystery diagnosis.<br />
M. Walker, D. A. Pasquale. UPMC, Pittsburgh, PA.<br />
Background:<br />
S18<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
Achalasia is a rare, elusive, and progressive disease that is usually<br />
diagnosed only once it has reached advance stages. Described is a<br />
case of an older adult who after four years of extensive testing received<br />
therapeutic treatment for symptoms of episodic hypersalivation,<br />
vomiting, and weight loss.<br />
Case description:<br />
A 79 yo female with a history of Alzheimer’s Disease, atrial fibrillation,<br />
and osteoporosis was first seen in the office in 2006 with the<br />
complaint of episodic hypersalivation, vomiting, and weight loss. Initial<br />
EGD was significant for H.pylori, pre-pyloric edema and ulcer,<br />
gastric antrum thickening, and antral erosion. Laboratory tests, CT of<br />
the abdomen, and ultrasound of the abdomen were negative. Her<br />
symptoms persisted, however, after eradication of the H. pylori and<br />
PPI therapy. Further investigations in 2009 involved obtaining a<br />
colonoscopy and a non-air contrast barium enema; both revealed diverticulosis.<br />
Transglutaminase and small bowel biopsy were subsequently<br />
negative for celiac disease. In April 2010 she was diagnosed<br />
with lymphoma and was started on Rituxan therapy; she completed 4<br />
treatments. She then underwent psychiatric evaluation and was<br />
treated for apparent paranoia.<br />
In 2010 she again presented to the office with similar complaints.<br />
She now stated that she regurgitated what she ate after approximately<br />
15 minutes. She was given a trial of applesauce to verify<br />
her statement and after 10 minutes she regurgitated the applesauce.<br />
She was immediately admitted to the hospital for a barium swallow<br />
study that resulted in retained barium confirming the diagnosis of<br />
achalasia. The diagnosis of achalasia came with great relief to the patient.<br />
Today, her symptoms have resolved with the use of botulinum<br />
toxin injections.<br />
diagnosis which often times diverts clinicians from less common and<br />
treatable causes. This is a case of failure to thrive with chronic abdominal<br />
pain suggestive of an underlying malignancy but found to<br />
have a benign cause.<br />
The patient is a 78 year old female, cognitively intact with no<br />
past medical or surgical history, from Senegal, presented with a progressive<br />
2- year history of intermittent, mild, lower abdominal pain<br />
with normal soft bowel movements and 30-lb weight loss. Symptoms<br />
worsened for the past 2 months. She reports bright red blood per rectum<br />
but denies diarrhea, constipation, hematemesis,vaginal bleeding<br />
or fever.<br />
On physical examination, her abdomen was soft, non-distended<br />
with mild bilateral lower quadrant tenderness, without guarding or<br />
rebound. Rectal exam showed no hemorrhoids or masses with brown,<br />
Guiac positive stools. CT scan of the abdomen revealed significant<br />
circumferential thickening at the lower anus and rectum suspicious<br />
for malignancy.<br />
Colonoscopy failed to show any discrete mass but found irregularity<br />
and bogginess of anal mucosa along with severe diverticulosis<br />
of entire colonic mucosa. Biopsies were sent and were negative for<br />
malignancy. Ova and parasite screen revealed Ascaris lumbricoides.<br />
Patient was started on mebendazole. A three-week follow-up<br />
was significant for improved appetite with relief of abdominal pain<br />
and diarrhea.<br />
Discussion:<br />
Dealing with immigrants, parasitic causes of failure to thrive<br />
should be considered. Most of the literature describes Ascariasis in<br />
tropical and subtropical areas affecting mostly children without mentioning<br />
any case in the Geriatric population. Adults with ascariasis<br />
are more likely to present with biliary complications. However, significant<br />
nutritional deficiencies can be seen due to malabsorption, as in<br />
this case. Hence in an immigrant with failure to thrive, parasitic<br />
causes should be entertained.<br />
Barium Swallow<br />
A8 Encore Presentation<br />
Worming Through a Case of Failure to Thrive.<br />
M. A. Rashad, 1 J. Angeles, 1 H. Arabelo, 1 B. Matti-Orozco. 1,2 1.<br />
Geriatric medicine, St Lukes Roosevelt Hospital, New York, NY; 2.<br />
Medicine, Columbia Univeristy College of Physicians and Surgeon,<br />
New york, NY.<br />
Failure to thrive is a common diagnosis in the elderly consisting<br />
of physical frailty, cognitive impairment and functional disability.<br />
Weight loss more than 5% within 1 year is considered as the key component<br />
and usually attributed to poor oral intake, medications, depression,<br />
stroke and dementia. Malignancy is also a major differential<br />
A9<br />
Arteriovenous malformations in End Stage Renal disease.<br />
N. Maheshwari, 1 R. Varma, 1 S. Kulkarni, 1 D. Kumari, 2 E. Ong, 1<br />
E. Roffe, 2 S. Chaudhari. 2 1. Internal Medicine, New York Medical<br />
College Metropolitan Hospital Centre, Manhattan, New York, NY; 2.<br />
<strong>Geriatrics</strong>, New York Medical College Metropolitan Hospital Center,<br />
New York, NY.<br />
Introduction: Angiodysplasias can cause upper and lower gastrointestinal<br />
(GI) bleeding in small percentage of patients with an increased<br />
prevalence in patients like ESRD. We present a case of a<br />
ESRD patient with recurrent GI bleeding secondary to AVM that ultimately<br />
required a life saving surgical intervention.<br />
Case presentation: A 68 year old African <strong>American</strong> male patient<br />
with ESRD on maintenance hemodialysis was referred from Dialysis<br />
Center for evaluation of severe anemia with hemoglobin (Hb) of<br />
5.1gm/dl. He was managed in the medical intensive care unit and stabilized<br />
with multiple blood transfusions. EGD, colonoscopy and capsule<br />
endoscopy were inconclusive except an AVM in the proximal jejunum<br />
which was photocoagulated. Patient was discharged but<br />
presented again after a repeat fall in Hb from 8.7 to 4.3 gm/dl and was<br />
readmitted to MICU. A small bowel endoscopy did not demonstrate<br />
any lesion this time, tagged RBC scan showed abnormal activity from<br />
hepatic flexure till the sigmoid colon. Colonoscopy showed multiple<br />
erythematous mucosal lesions in the cecum, ascending colon and a<br />
solitary lesion in the left colon resembling AVM which was photocoagulated.<br />
Patient continued to drop his Hb despite repeated blood<br />
transfusion. A repeat colonoscopy showed fresh red blood throughout<br />
the colon up till the cecum and no clear bleeding site identified.<br />
Angiography of the celiac axis and superior mesenteric artery failed<br />
to identify clear focus of bleeding. Finally patient underwent Right<br />
hemicolectomy and distal ileal resection as a life saving procedure.<br />
Patient remained stable postoperatively and made an uneventful recovery.<br />
AGS 2012 ANNUAL MEETING<br />
S19
P OSTER<br />
A BSTRACTS<br />
Discussion: Angiodysplasia are cause of recurrent and chronic<br />
GI bleeding with marked acute bleeding in a small minority of patients.<br />
The reason for increased prevalence among patients with<br />
ESRD is unknown. Angiodysplasia are usually diagnosed by endoscopy.Angiography<br />
is gold standard for the diagnosis but it has low<br />
sensitivity. Radionulide scanning is more sensitive than angiography<br />
but lacks specificity. Bleeding angiodysplasia is commonly treated endoscopically.<br />
Surgery and angiography are alternatives for patients in<br />
whom endoscopic therapy has failed. Physician should aware of angiodysplaisa<br />
as cause of GI bleeding in old age patient, especially<br />
with ESRD.<br />
A10<br />
Old habits die hard.<br />
Q. Syed. <strong>Geriatrics</strong>, Cleveland Clinic, Cleveland, OH.<br />
Supported By: no financial disclosures<br />
86 year old female is brought to the ER after being found by<br />
daughter unresponsive in her house, with a needle in her arm. Patient<br />
was not arousable by narcan IV 2mg administered by EMT. Past history<br />
significant for hypertension, hepatitis B and hepatitis C. Social<br />
history is significant for IV heroin abuse since age 25, along with inconsistent<br />
use of marijuana and cocaine. She was enrolled in opioid<br />
detoxification programs multiple times with no benefit. She received<br />
detoxification therapy with methadone in 2002 and 2006, and with<br />
buprenorphine and naloxone in 2009. She initially did well on<br />
buprenorphine and naloxone but had a relapse during the time period<br />
when close friends passed away. On arrival in ED, vital signs indicated<br />
bp=186/102,p=81, T=98.6, =20, spo2=99% RA. On exam pt<br />
was noted to be nonverbal, opening her eyes on painful stimulus only.<br />
Pupils were reactive to light bilaterally, corneal reflex intact. Patient<br />
was able to move all extremities in response to painful stimuli. CT<br />
showed new acute subdural hematoma over the left cerebral hemisphere<br />
measuring up to 1.4 cm at the level of the left frontal lobe with<br />
1 cm midline shift. Patient underwent urgent craniectomy for evacuation<br />
of left acute subdural hematoma. Urine toxicology screen was<br />
positive for opiates. Patient was transferred to ICU and received mechanical<br />
ventilation for supportive care. Neurological status improved<br />
gradually within 1 week, patient became awake and alert, was<br />
able to follow commands and verbally communicate. Muscular<br />
strength was noted to be 3/5 bilat extremities. She was extubated day<br />
10th. She was cleared by speech therapist for oral pureed diet. Rehab<br />
team evaluated her and she was noted to require complete assistance<br />
in moving from one side to another, and transfer. She was discharged<br />
to skilled rehab 2 weeks after admission.<br />
Heroin is the second most frequently cited primary substance of<br />
abuse, after alcohol, for all admissions to substance abuse treatment<br />
by adults over the age of 50. Analyses of the Treatment Episodes<br />
Data Set (TEDS) identified that in 2005, 1 in 5.3 substance abuse admissions<br />
of 50–54 year old were for heroin abuse. Review of literature<br />
supports the need for practitioners within substance abuse settings to<br />
be sensitive to the physical limitations of older adult clients. Reduced<br />
mobility and stamina along with cognitive impairments associated<br />
with aging and decades of substance abuse will require adaptations<br />
within the treatment setting.<br />
A11 Encore Presentation<br />
Case Report: Immune Thrombocytopenic Purpura (ITP) Triggered<br />
by Allopurinol Refractory to Steroids and Intravenous<br />
Immunoglobulin (IVIG) Responded to Rituximab.<br />
R. Kothari. Internal Medicine, Coney Island Hospital, Brooklyn, NY.<br />
Background: ITP is an autoimmune disease that involves peripheral<br />
and central opsonization of platelets by auto-antibodies directed<br />
against different surface glycoproteins, leading to their premature<br />
destruction by the reticulo-endothelial system. Allopurinol is a<br />
xanthine oxidase inhibitor commonly used for the prevention of<br />
gouty arthritis. Less than 1% of patients develop significant adverse<br />
reaction including thrombocytopenia and vasculitis.<br />
Case: An 89 year old lady with hypertension, chronic systolic<br />
heart failure, stage 2 chronic kidney disease, gouty arthritis and peptic<br />
ulcer disease was admitted with generalized petechial rash all over<br />
her body after taking allopurinol for one week. On admission,<br />
platelet counts were 127,000. She received intravenous steroids, Benadryl<br />
and was discharged with a tapering dose of oral steroids. Her<br />
platelet count was 73,000 upon discharge.<br />
She was readmitted after 2 days due to development of oral ulcers<br />
and odynophagia; platelet count was noted to be 52,000. Abdominal<br />
sonogram did not show splenomegaly. She received high dose intravenous<br />
steroids. Oral ulcers resolved, but there was no significant<br />
improvement in rash and platelet counts. Platelet counts decreased to<br />
14,000 after a total of 21 days of intravenous plus oral steroids, then<br />
she received IVIG. She completed 5 days of IVIG but platelet count<br />
decreased further to 7,000. Direct anticoagulation test was positive<br />
and due to refractory thrombocytopenia she was given Rituximab.<br />
After two doses of Rituximab, platelet counts increased to<br />
25,000 and she was discharged home with oral steroids. On subsequent<br />
clinic follow up visits, platelet counts improved to 100,000. She<br />
completed tapered steroid treatment and after 7 days the platelet<br />
count was within normal range. She was followed up in the clinic for<br />
next 2 months and there was no thrombocytopenia noted.<br />
Discussion: The principal therapeutic options for elderly patients<br />
are similar to that of young adults. Age influences the response<br />
and adverse effect of conventional ITP therapies. The duration of disease<br />
before treatment with Rituximab did not affect responsiveness<br />
to therapy.<br />
A12<br />
Case of nephrogenic diabetes inspidus due to chronic Lithium use.<br />
R. Otsuka, S. Rahgoshay, T. V. Caprio. the University of Rochester<br />
Medical Center, Rochester, NY.<br />
Background: Lithium continues to be the mainstay for treatment<br />
in many older adult patients with chronic psychiatric illness.<br />
Lithium also has the potential for toxicity, drug-drug interactions and<br />
life threatening side effects. Nephrogenic diabetes inspidus is one of<br />
major concerns, causing hypernatremia and dehydration which may<br />
be amplified in at-risk older adults. We present a case of acute lithium<br />
induced nephrogenic diabetes.<br />
Case Presentation: A 66 year old male with schizoaffective disorder<br />
and intellectual disability was prescribed lithium for many<br />
years and he presented to the hospital with lethargy for a few days.<br />
He had been noted to be drinking several times from the faucet and<br />
had increased nocturia prior to presentation. However due to his intellectual<br />
disability, he was not able to communicate effectively to<br />
make his needs known. Initial blood work revealed a serum sodium<br />
of 154 meq/L. His renal function and other electrolytes were normal.<br />
Lithium level was within a therapeutic range. He underwent desmopressin<br />
stimulation test and was diagnosed with nephrogenic diabetes<br />
inspidus. His Lithium was discontinued.<br />
Discussion: This case highlights several challenges with the use<br />
of lithium in older adults with chronic illness, impaired cognition, and<br />
limitations in communicative abilities. Chronic lithium use is associated<br />
with nephrogenic diabetic inspidus (resistance to ADH), resulting<br />
in polyuria and polydipsia in up to 20 to 40 percent of patients receiving<br />
therapy. Acute onset of nocturia is an important clue to<br />
diagnose this condition, however nocturia can be a common symptom<br />
in older adults which makes recognition challenging. Furthermore,<br />
older adults are more susceptible to salt and water imbalance, including<br />
dehydration and hypernatremia which can be life-threatening. In<br />
addition, impaired sensation of thirst occurs with aging and may exacerbate<br />
this condition. Another important consideration in this case is<br />
that people with intellectual disabilities or chronic psychiatric illness<br />
may have difficulty expressing their needs and obtaining access to hy-<br />
S20<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
dration. Therefore, careful clinical monitoring by facility staff or families<br />
and laboratory assessments are essential for patients receiving<br />
lithium. Finally, there should be a consideration of changing therapy<br />
to other medications if appropriate, especially for those at highest<br />
risk for lithium-induced complications.<br />
A13<br />
Clinical Challenge of diagnosing Amyotrophic Lateral Sclerosis<br />
(ALS) in Elderly Patients.<br />
S. Rana, 1,2 N. Manov, 2 S. S. Rana. 3 1. <strong>Geriatrics</strong>, University of<br />
Pittsburgh School of Medicine, Pittsburgh, PA; 2. <strong>Geriatrics</strong>, UPMC-<br />
St Margaret Hospital, Pittsburgh, PA; 3. Neurology, Allegheny<br />
General Hospital, Pittsburgh, PA.<br />
Amyotrophic Lateral Sclerosis (ALS) occurs in 2 to 3 per 100<br />
thousand population and predominantly affects elderly.Diagnosis is<br />
made on clinical examination and ruling out other possible disorders.<br />
Since the elderly patients commonly have other confounding comorbidities,<br />
ALS is often misdiagnosed. We present two cases of ALS that<br />
underwent spine surgery with misdiagnosis of weakness secondary to<br />
degenerative spine disease.<br />
Methods: Chart review of two patients<br />
Case studies<br />
Case 1: 78 year male with history of prostate and lung cancers<br />
treated with chemotherapy in 2008, developed footdrop in fall of<br />
2009. Initial EMG studies showed denervating process involving legs<br />
which were felt to be secondary to peripheral neuropathy.Based on<br />
imaging studies he underwent decompressive surgery at L4-5 level<br />
with presumed diagnosis of radiculopathy. Patient continued to<br />
worsen and developed diffuse weakness, progressive weight loss, and<br />
respiratory failure for which he required tracheostomy and ventilator<br />
support. Follow up EMG studies revealed widespread denervating<br />
process, consistent with ALS.<br />
Case 2: 71 year female with history of hypertension, coronary artery<br />
disease, presented with weakness in legs, recurrent falls and “sciatic<br />
pain”. She underwent imaging studies of spine and was diagnosed<br />
with scoliosis. She underwent surgery at the thoracic level. She continued<br />
to get weaker in her extremities and then developed<br />
dysarthria. EMG studies showed widespread denervating process and<br />
she was diagnosed with ALS.<br />
Conclusion: Early ALS can be difficult to diagnose as there is no<br />
diagnostic test available. In elderly patients, initial presentation of<br />
ALS is commonly attributed to radiculopathies secondary to degenerative<br />
spine disease. Better diagnostic tools are needed to help diagnose<br />
patients with ALS. In the interim, patients with painless onset of<br />
weakness, absence of sensory symptoms and presence of fasciculations,<br />
should raise suspicion for ALS. In these patients, judicious approach<br />
ie EMG studies by experienced electromyographers, and<br />
carefully correlating the results to imaging studies are warranted. Increased<br />
awareness, and multidisciplinary approach can prevent unnecessary<br />
spine surgeries in these patients.<br />
A14<br />
A Stuttering Discovery of Lithium Toxicity.<br />
S. Sabillo, 1 R. V. Samala, 2 J. O. Ciocon. 1 1. <strong>Geriatrics</strong>, Cleveland Clinic<br />
Florida, Weston, OH; 2. The Harry R. Horvitz Center for Palliative<br />
Medicine, Cleveland Clinic, Cleveland, OH.<br />
Objectives<br />
1. Describe a case of lithium toxicity presenting as stuttering<br />
2. Enumerate the medications that may cause stuttering<br />
3. Discuss the mechanisms and management of drug-induced<br />
stuttering<br />
Case<br />
An 86-year-old female nursing home resident was typically described<br />
by the care staff as alert, pleasant, and conversant, though disoriented<br />
to time and place at times. She was frequently seen in the<br />
hallways, interacting with personnel and patients, and often breaking<br />
into song with her melodious voice. Her past medical history was significant<br />
for dementia, epilepsy, and bipolar disorder. Chronic medications<br />
included donepezil, risperidone, primidone, and lithium carbonate.<br />
One day, she complained to her nurse that she had been<br />
stuttering, finding it difficult to complete a sentence, as well as sing.<br />
She grew increasingly bothered by her faltering speech as the days<br />
wore on, and also pointed out that her grip on objects was becoming<br />
weak. Her attending physician was subsequently informed of these<br />
new symptoms. Physical and neurological examinations were unremarkable<br />
aside from her obvious stutter. She was able to talk straight<br />
for a few words, and then would begin to repeat syllables and words<br />
until she became obviously frustrated and abruptly terminate her<br />
sentence. A CT scan of her head was done which was similarly unremarkable.<br />
Her stuttering persisted for 3 more months until a lithium<br />
level was checked, and came back elevated at 2.0 mmol/L (0.6 to 1.2<br />
mmol/L). Lithium carbonate was promptly stopped and after about 2<br />
weeks, her level was back to normal, and her stuttering had completely<br />
resolved.<br />
Discussion<br />
A broad array of drugs has been shown to cause stuttering. Included<br />
in the list are phenothiazines, tricyclic antidepressants, benzodiazepines,<br />
selective serotonin reuptake inhibitors, theophylline,<br />
phenytoin, carbamazepine, and clozapine. Proposed mechanisms involve<br />
different drug-receptor systems: cholinergic, dopaminergic, noradrenergic,<br />
and serotonergic. In all previously reported cases, stuttering<br />
stopped when the offending agent was discontinued. We find<br />
great interest in this case since there has been a scarcity of literature<br />
implicating lithium. Clinicians should, therefore, be aware of stuttering<br />
as a potential sign of drug toxicity.<br />
A15<br />
Elderly Female with Hypercalcemia: Hodgkin Lymphoma<br />
Masquerading as Relapsed Breast Cancer.<br />
S. Lee, Y. Ang, S. Bellantonio. Internal Medicine, Baystate Medical<br />
Center, Springfield, MA.<br />
INTRO<br />
Malignancy-associated hypercalcemia is common in metastatic<br />
breast and prostate cancers as well as multiple myeloma. Hodgkin<br />
Lymphoma(HL) infrequently causes hypercalcemia. In the elderly, it<br />
can present as delirium and fatigue. We report a septuagenarian female<br />
breast cancer survivor with hypercalcemia who was found to<br />
have stage IVA HL.<br />
CASE<br />
A 76-year-old lady with history of right breast cancer status post<br />
mastectomy and type 2 diabetes presented to her PCP with a 5 day<br />
history of generalized malaise, intermittent confusion, nausea, vomiting,<br />
diarrhea, and epigastric pain. An enlarged right supraclavicular<br />
lymph node was found. Due to concern for cancer relapse, she was<br />
sent to the hospital for evaluation. She was found to be hypercalcemic(iCa<br />
1.6mmol/L) with normal phosphorous(3.4mg/dL),<br />
PTH(52pg/ml), and PTHrP(0.74pmol/L) levels. Renal function was<br />
good, and she had not been on vitamin D supplementation. CT scans<br />
show multiple splenic masses, a liver lesion, and an enlarged right<br />
subclavicular lymph node. Bone scan revealed no osseous involvement.<br />
She was treated with IV fluids, zoledronic acid, and glucocorticoids<br />
with normalization of serum calcium and resolved symptoms.<br />
Eventually, a supraclavicular lymph node biopsy confirmed HL,<br />
nodular sclerosing type. She was discharged with prednisone and<br />
plans for outpatient chemotherapy.<br />
DISCUSSION<br />
Malignancy-associated hypercalcemia affects 20% of cancer patients.<br />
This is most often PTHrP mediated. Also common is osteolytic<br />
hypercalcemia due to cancer metastasis to bone. Overproduction of<br />
calcitriol is a rare cause of hypercalcemia in malignancy(1% of cases).<br />
Incidence of this complication in HL is about 5%[1]. HL can produce<br />
AGS 2012 ANNUAL MEETING<br />
S21
P OSTER<br />
A BSTRACTS<br />
calcitriol via 1alpha-hydroxylase activity. This syndrome is characterized<br />
by normal phosphate levels, normal or suppressed PTH and<br />
PTHrP concentrations, and no osseous involvement. As with our patient,<br />
glucocorticoids can reduce extrarenal calcitriol production and<br />
inhibit osteoclastic bone resorption.<br />
CONCLUSION<br />
Advanced age is a cancer risk factor. The elderly account for<br />
60% of newly diagnosed malignancies. Hypercalcemia is a common<br />
cancer complication that can present in the frail elder with subtle<br />
symptoms and oftentimes, delirium. This, in setting of a possible neoplasia,<br />
should be entertained.<br />
REFERENCE<br />
1.Seymour JF, Gagel RF.Calcitriol:the major humoral mediator<br />
of hypercalcemia in Hodgkin disease and nonHodgkin<br />
lymphoma.Blood 1993;82:1383–94<br />
A16<br />
Describing an atypical variant of Guillain-Barré syndrome.<br />
S. Gulati, S. Gupta, G. Gulati. Internal Medicine, The Reading<br />
Hospital and Medical Center, West Reading, PA.<br />
CASE:62-year-old Asian male, presented to the hospital with bilateral<br />
extremity weakness after a trip to India 3 weeks ago, at which<br />
time he had developed severe gastroenteritis. Weakness had started<br />
in his upper extremities, followed by the lower. During hospitalization<br />
he experienced wide fluctuations in his blood pressure and heart<br />
rate (systolic blood pressure of 100-190 mm of Hg and heart rate<br />
ranging from 60-130 bpm). On neurologic, he had 3/5 motor strength<br />
of bilateral upper extremities, 4/5 of lower extremities, areflexia in<br />
upper with normal reflexes in the lower extremities. Gait was normal,<br />
so was the sensory and cranial nerve exam. Routine laboratory studies<br />
including a CBC, basic metabolic panel, thyroid panel, vitamin<br />
B12, folate levels and autoimmune markers were normal. ESR was<br />
elevated at 48 mm/hour (normal: 0-15mm/hour). CSF analysis revealed<br />
an elevated protein of 86 mg/dL (normal: 20-45mg/dL), with<br />
normal glucose level and zero WBC’s. This suggested albuminocytologic<br />
dissociation. Nerve conduction studies showed evidence of demyelination.<br />
Despite his atypical presentation, he was diagnosed with<br />
Guillain-Barré syndrome(GBS) and started on IVIGg for five days.<br />
His respiratory status remained stable with an improved neurologic<br />
exam. The patient was discharged on prednisone to an acute rehabilitation<br />
facility.<br />
DISCUSSION: GBS, a post infectious immune mediated disease,<br />
manifests as an acute inflammatory ascending polyradiculoneuropathy<br />
(with weakness and diminished reflexes). It has an annual incidence<br />
in US of 1.2-3 per 100,000, making it the most common cause<br />
of acute flaccid paralysis. The disease has a bimodal distribution, with<br />
peaks in age 15-35 years and a second, higher peak in elderly patients<br />
aged 50-75 years. There is a history of an antecedent illness (GI or<br />
upper respiratory), 1-3 weeks prior to the onset.<br />
Many clinical variants have been well documented. These include<br />
acute inflammatory demyelinating polyneuropathy (AIDP),<br />
acute motor axonal neuropathy (AMAN), acute motor-sensory axonal<br />
neuropathy (AMSAN), Miller-Fisher syndrome, a pure sensory<br />
variant of GBS.<br />
CONCLUSION: A disease not fitting the typical definition of<br />
GBS should not dissuade physicians from complete work up and<br />
treatment. This becomes especially important in the elderly population,<br />
because there is a 6-fold increase in the rate of death in patients<br />
aged 60 years or older compared to persons aged 40-59 years.<br />
A17<br />
Recognize the likely association between herpes encephalitis and<br />
cardiac arrhythmias.<br />
S. Gulati, G. Gulati, R. Alweis. Internal Medicine, The Reading<br />
Hospital and Medical Center, West Reading, PA.<br />
CASE: A 73 year old male with past medical history of hypertension<br />
and coronary artery disease on beta blocker therapy presented<br />
to the hospital with an acute change in mental status following<br />
an episode of witnessed tonic-clonic seizure-like activity. The patient<br />
had recently flown and had developed low grade intermittent fever<br />
since. Examination revealed obtundation with an otherwise non-focal<br />
neurological exam. He was intubated for airway protection and transferred<br />
to the ICU. Laboratory evaluation revealed only mild leukocytosis<br />
with a normal differential. Blood chemistries were normal with<br />
negative toxicology screening. Lumbar puncture revealed clear appearance<br />
of the CSF, normal glucose of 76 mg/dl, elevated protein of<br />
64 mg/dl (nl 20-45 mg/dl), elevated white cell count of 304 cmm (nl 0-<br />
5 cmm), with 80% lymphocytes (nl 0-50%) and 1% neutrophils. Herpes<br />
Simplex type 1 DNA was detected by PCR. A diagnosis of herpes<br />
encephalitis was made and the patient was started on intravenous<br />
acyclovir. After transfer out of the unit, he was noted to have sinus<br />
bradycardia with heart rate ranging from 40-60 beats per minute. Review<br />
of his rhythm revealed a first degree heart block. The patient<br />
was evaluated and, for unclear reasons, restarted on his home dose of<br />
metoprolol. This was followed by development of complete heart<br />
block which necessitated implantation of a dual-chamber pacemaker.<br />
DISCUSSION: Herpes simplex virus is the most common cause<br />
of acute, sporadic viral encephalitis, accounts for 10% to 20% of all<br />
cases. Of these more than 95% are caused by subtype I virus. The clinical<br />
hallmark of HSV encephalitis is acute onset of fever accompanied<br />
by focal neurologic signs (most commonly involving the temporal<br />
lobes). There have been isolated case reports in literature<br />
connecting cases of herpes encephalitis with development of cardiac<br />
arrhythmias. Hence patients with encephalitis need close cardiac<br />
monitoring. Literature search reveals that these patients spontaneously<br />
recover with treatment of the underlying infection and have<br />
not needed pacemakers.<br />
Physicians taking care of patients need to recognize the association<br />
of cardiac arrhythmias with non-cardiac causes like viral infection.<br />
This can help avoid catastrophic sequelae.<br />
A18<br />
An unusual presentation of deep vein thrombosis due to May-<br />
Thurner syndrome in an elderly man.<br />
S. Nakagawa, 1 A. Fischman, 2 J. Farber, 1 F. Ko. 1 1. Department of<br />
<strong>Geriatrics</strong> and Palliative Medicine, Mount Sinai School of Medicine,<br />
New York, NY; 2. Departments of Radiology and Surgery, Mount<br />
Sinai School of Medicine, New York, NY.<br />
Case<br />
A 79 year-old man presented with 2 weeks of progressive left<br />
lower extremity (LLE) swelling with pain precluding ambulation. He<br />
had significant unilateral non-pitting edema with skin discoloration<br />
in the entire LLE and a positive Homans’ sign. A Doppler ultrasound<br />
showed acute deep vein thrombosis (DVT). Despite starting anticoagulation,<br />
swelling and pain worsened. A subsequent CT venogram<br />
showed an extensive occlusive DVT from the left common iliac vein<br />
to the popliteal vein. Endovascular Catheter Directed Thrombolysis<br />
(CDT) and pharmacomechanical thrombectomy was performed with<br />
successful clot removal. An intravascular ultrasound (IVUS) showed<br />
focal narrowing of the left common iliac vein due to a crossing right<br />
common iliac artery consistent with May-Thurner syndrome (MTS).<br />
A self-expanding iliac stent restored iliofemoral venous system patency<br />
and resolved LLE swelling. A small post-procedure hematoma<br />
was seen which subsequently resolved. The patient remained stable<br />
on enoxaparin with a patent stent 5 weeks after treatment.<br />
Discussion<br />
MTS typically occurs in women of childbearing age. The right<br />
common iliac artery causes chronic external compression of the left<br />
common iliac vein and predisposes patients to LLE proximal DVT.<br />
Iliac vein compression needs aggressive management because it results<br />
in recurrent thrombosis and post-thrombotic syndrome (PTS)<br />
on anticoagulation therapy alone. Venography with IVUS is a superior<br />
modality for diagnosis. CDT and stent placement followed by anticoagulation<br />
is the most effective treatment. Due to its rarity in eld-<br />
S22<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
erly men, index of suspicion for MTS was low in our patient. His striking<br />
initial presentation and worsening symptoms after anticoagulation<br />
prompted further evaluation, leading to the diagnosis of MTS.<br />
Although CDT is associated with a higher risk of bleeding compared<br />
to anticoagulation alone, its benefits outweigh risks in highly active<br />
patients.<br />
Conclusion<br />
In acute proximal lower extremity DVT with severe symptoms,<br />
diagnostic work-up with CT venogram and aggressive catheter-based<br />
intervention should be pursued if indicated. Although DVT due to<br />
MTS is very rare in older adults, failure to recognize can result in serious<br />
vascular sequelae, particularly PTS, and thus appropriate clinical<br />
suspicion should be maintained.<br />
A19<br />
The Importance of Goals of Care in Elders with Mild Dementia.<br />
S. Arora, S. Khosla, M. J. Brennan. Internal Medicine, Baystate<br />
Medical Center/Tufts Univ. School of Medicine, Springfield, MA.<br />
Background:<br />
Existing literature regarding goals of care for dementia patients<br />
focuses on those with advanced disease facing end of life decisions<br />
due to aspiration, infections and debility. Little attention has been<br />
paid to those with early impairment. The authors present a case of an<br />
elderly man with mild dementia for whom a lack of clarity around<br />
goals prevented optimal care.<br />
Case Report:<br />
Mr. S. was an 88 year old with DM and CKD. A geriatrician diagnosed<br />
a mild dementia while he was admitted for an RCA STEMI<br />
with shock requiring vasopressors and intubation. Six weeks later he<br />
was readmitted with syncope and bradycardia secondary to hypovolemia.<br />
An echo documented an EF of 30-35%. AICD or pacer placement<br />
for sinus node dysfunction was discussed; an EP consultant<br />
opted for conservative treatment noting that Mr. S. had dementia.<br />
There was no discussion with the patient or family about possible device<br />
therapies. Within a week, Mr. S. returned to the ER unresponsive,<br />
hyperkalemic and bradycardic with a heart rate in the 20s. He improved<br />
with atropine but bradycardia recurred and attempts to place<br />
a pacer failed. Mr. S. required prolonged CPR for PEA, asystole and<br />
VT but was resuscitated and reintubated. At that point, his family<br />
chose a DNR order. After a lengthy CCU stay and placement of a<br />
dual chamber pacemaker, he was discharged for rehabilitation with<br />
cognitive abilities near his baseline.<br />
Discussion and Conclusions:<br />
Would earlier pacemaker placement have saved Mr. S. suffering<br />
and a long hospital stay? Was the decision not to place a pacemaker<br />
influenced by his diagnosis of dementia? Potentially life-sustaining<br />
therapies should not be foregone due to mild, cognitive deficits especially<br />
if prognosis and goals of care have not been discussed. To avoid<br />
unconscious paternalism, providers must not make judgments about<br />
a patient’s quality of life without input from the patient and family. It<br />
is best to clarify understanding and goals in the outpatient setting<br />
when families are not overwhelmed and patients can participate. This<br />
case was medically complex; elders like Mr. S. have largely been excluded<br />
from the clinical trials of post MI devices. Improved communication<br />
among primary care MDs, geriatricians, cardiologists and patients/families<br />
is essential. Research on communication strategies to<br />
enhance advanced care planning and to clarify clinical outcomes for<br />
vulnerable geriatric cardiology patients are both sorely needed.<br />
A20<br />
Femoral Spontaneous fracture Associated with Bisphosphonate<br />
Therapy.<br />
S. Rahgoshay, S. M. Friedman, S. V. Bukata, T. V. Caprio. Division of<br />
<strong>Geriatrics</strong> and Aging, University of Rochester, Rochester, NY.<br />
BACKGROUND: Hip fractures are important because they are<br />
associated with an increased rate of morbidity, substantial costs, and<br />
overwhelming effects on quality of life. Bisphosphonates(BPPs) are<br />
widely used for treatment of postmenopausal osteoporosis. BPPs<br />
have proven efficacy in reducing the incidence of vertebral and nonvertebral<br />
fractures. Although short term efficacy, safety and tolerability<br />
of these drugs have been documented, an increasing number of recent<br />
case reports suggest that some subtrochanteric hip fractures<br />
might occur in patients who have been treated on a long-term with<br />
BPPs due to suppressed bone turn over.<br />
CASE SUMMARY: A 58 year old female with known osteoporosis<br />
presented to the hospital after hearing an “audible creak”<br />
while going up stairs, followed by a spontaneous right-sided subtrochanteric<br />
hip fracture. Two weeks before the fracture she had prodromal<br />
pain in the right thigh with walking difficulty and came to the<br />
emergency department. Xrays of the right leg and hip did not show<br />
any sign of fracture at that time and she was therefore treated with<br />
analgesics. Five years previously, the patient had started taking alendronate<br />
and after 2 years was switched to zoledronic acid with calcium<br />
and vitamin D. At presentation again to the emergency department<br />
she had severe pain, acute tenderness in the right thigh, and her<br />
lower extremity was shortened with external rotation. The subthrochanteric<br />
fracture was treated with an intramedullary gamma<br />
nail and the patient recovered from surgery successfully. Routine<br />
blood tests; including bone profile, viamin D, thyroid function tests<br />
were normal. She was taken off her BPPs, and was discharged on calcium,<br />
and vitamin D. Outpatient arrangements were made to repeat<br />
her DEXA and to consider an alternative like teraparatide treatment<br />
for osteoporosis.<br />
CONCLUSION:<br />
Bisphosphonates have proven efficacy in reducing the incidence<br />
of vertebral and non-vertebral fractures. The literature suggests the<br />
existence of BPP-related atypical fractures, with unique clinical and<br />
radiographic features in patients on long-term BPP therapy as observed<br />
in this case study. Continued use of BPPs beyond a treatment<br />
period of 3 to 5 years should be reevaluated annually.<br />
A21<br />
A Doggone Cough-an unusual complication of pet ownership-a case<br />
report. Nathan S, Gorbien M, Olson J, Leiding M, Bednarzcyk M.<br />
S. N. Nathan. Department of Geriatric Medicine, Rush University<br />
Medical Center, Chicago, IL.<br />
Purpose: Discuss an unusual health consequence of pet ownership.<br />
Background: Kennel Cough is an infectious tracheobronchitis. It<br />
is a canine respiratory syndrome, often contagious in high density<br />
areas-pet shops, kennels, etc. The most frequent bacterial isolate is<br />
Bordetella bronchiseptica (B.b.)[i]. B.b. is a recognized respiratory<br />
tract pathogen of mammals since 1910. Evidence suggests that it colonizes<br />
human respiratory tract and causes infection in compromised<br />
hosts[ii]. Old age is an immunocompromised state[iii]. Snakes are<br />
also prone to pneumonia, which is contagious between species.This is<br />
an 82 year old woman with Herpes Zoster, URI & systemic symptoms<br />
after her dog was diagnosed with Kennel Cough, after exposure to<br />
the neighbor’s dog. The neighbors illegally bred dogs, snakes & mice.<br />
Method: Case report.<br />
Case Report: Ms. C is an 82 year old woman with Herpes Zoster<br />
seen in clinic for 2-3 days of URI & systemic complaints. The whole<br />
family had been ill for weeks, they think from their dog. The dog was<br />
diagnosed with Kennel Cough. The neighbor would sneak over & try<br />
to get the family’s dog to impregnate his dog. The neighbor had 2 pitbulls<br />
who died 4 weeks prior, whose bodies were dumped in the family’s<br />
garbage. The neighbors also had an illegal snake farm, with 200 of<br />
the snakes dying shortly before this visit.<br />
Discussion: There is benefit to pet ownership in the elderly<br />
[iv][v]. However, pets can transmit illness. This case shows an unusual<br />
situation that put the patient, family & dog at risk for an unexpected<br />
illness.<br />
i J Vet Med Sci Vol 70: 563-569.(2008). “Etiologic Study of<br />
Upper Respiratory Infections of Household Dogs”. Mochizuki M,<br />
Yachi A, Ohshima T, Ohuchi A, Ishida T.<br />
AGS 2012 ANNUAL MEETING<br />
S23
P OSTER<br />
A BSTRACTS<br />
ii J Clin Micrbiol. 1995 Aug; 33(8):2002-6. Human Bordetella<br />
bronchiseptica infection related to contact with infected animals: persistence<br />
of bacteria in host. Gueirard P, Weber C, Le Coustumier A,<br />
Guiso N.<br />
iii Trnspl Int. 2009 Nov;22(11):1041-50. Epub 2009 Jul 16. The<br />
aging of the immune system. Weiskopf D, Weinberger B, Grubeck-<br />
Loebenstein B.<br />
iv J Am Geriatr Soc. 1999 Mar;47(3):323-9. Influence of companion<br />
animals on the physical and psychological health of older people:<br />
an analysis of a one-year longitudinal study. Raina P, Waltner-<br />
Toews D, Bonnett B, Woodward C, Abernathy T.<br />
v J Nutr Elder. 1996;15(3):15-31. Pet ownership may be a factor<br />
in improved health of the elderly. Dembicki D, Anderson J.<br />
A22<br />
Aphasia vs. Dementia: A Case of Primary Progressive Aphasia.<br />
S. S. Naqvi, C. D. Furman. Family & Geriatric Medicine, University of<br />
Louisville, Louisville, KY.<br />
Introduction: Primary Progressive Aphasia (PPA) presents with<br />
dysnomia and impaired speech. Language dysfunction remains the<br />
most salient feature and deteriorates most rapidly during the illness.<br />
Impairments in other cognitive functions, including dementia, may<br />
also emerge.<br />
Case Report: A 70 y/o white male with h/o bipolar disorder, hallucinations,<br />
hyperlipidemia, and PPA presented with his wife and son<br />
to determine if he had dementia. Patient also had a h/o stuttering as a<br />
child and alcoholism. Patient had memory problems the past 2 years<br />
with a rapid decline over past 2-3 weeks. Patient did not recognize his<br />
own home or wife and often wore wife’s clothes. He had difficulty<br />
swallowing and eating. He developed poor coordination skills and<br />
found it hard to place food into his mouth. In 2003, he retired as an attorney.<br />
His symptoms began in 1999 with speech problems. He had<br />
difficulty with expression of language, incomplete sentences, spelling<br />
errors and word loss without compensation. In 2003, he was diagnosed<br />
with PPA and was seen by multiple local and national neurologists<br />
and neuropsychologists who unanimously agreed on a diagnosis<br />
of PPA. Brain PET scans, done in 2006 and 2010, showed hypometabolism<br />
in the left temporoparietal region, compatible with a neurodegenerative<br />
disorder, most likely Alzheimer’s type. The patient was on<br />
donepezil and memantine with no improvement and received speech<br />
therapy with some improvement. At the current presentation, dementia<br />
was diagnosed based on his memory loss and functional decline.<br />
He was admitted to hospice because of dysphagia and his overall<br />
decline.<br />
Discussion:This case exemplifies affluent type PPA,a rare neurodegenerative<br />
disorder in which symptoms start with language difficulty. Patients<br />
with PPA can become mute and may eventually lose the ability to<br />
understand written or spoken language. PPA is considered a form of dementia<br />
because it causes a gradual cognitive decline to the point where<br />
activities of daily living become compromised. Approximately 30% of<br />
patients have shown the microscopic pathology of Alzheimer’s disease,<br />
presumably with an atypical distribution of lesions. 70% of PPA is known<br />
to be a type of frontotemporal lobar degeneration. Currently, there is no<br />
effective pharmacologic treatment. However, evaluation by a speech<br />
therapist is useful. When PPA is diagnosed, the patient and family should<br />
be informed that PPA is a type of progressive dementia.<br />
A23<br />
Aspergilloma: association with chronic bronchiectasis and IgG2<br />
deficiency.<br />
T. T. Suh, 1,2 T. Efeovbokhan, 1,2 M. R. Hosler. 3 1. Family &<br />
Community Medicine, UT Health Science Center in San Antonio, San<br />
Antonio, TX; 2. ACE Unit, Christus Santa Rosa Hospital-City Centre,<br />
San Antonio, TX; 3. Allergy, Asthma & Immunology Associates of<br />
South Texas, San Antonio, TX.<br />
BACKGROUND: Aspergilloma is fungal lung infection that<br />
often causes cavitary lung lesions and the characteristic “fungus ball”<br />
or mycetoma on CT scan. Up to 10% of patients with bronchiectasis<br />
eventually become infected with aspergillus. It is thought that high<br />
levels of complement found in patients with bronchiectasis prevent<br />
the killing of aspergillus, allowing this fungal infection to occur. Up to<br />
half of patients with idiopathic bronchiectasis have deficiency of either<br />
IgA or IgG2 antibodies. Aspergilloma can also be a very rare<br />
complication of etanercept for rheumatologic conditions like<br />
rheumatoid arthritis, affecting about 0.01% of patients reporting side<br />
effects with this drug.<br />
CASE: A 75 year old Caucasian woman with multiple drug allergies,<br />
BMI of 19.5, chronic bronchiectasis, rheumatoid arthritis<br />
(being treated with etanercept and prednisone 5mg daily), an IgG2<br />
subclass deficiency (being treated with monthly IVIg) and a functional<br />
humoral immunodeficiency (with poor response to Pneumovax)<br />
presented to her allergist with hemoptysis for one week. A<br />
contrast-enhanced CT scan of the chest revealed a cavitary right<br />
upper lobe lung lesion. The patient was hospitalized, and bronchoscopy<br />
was performed. Tuberculosis and cancer were ruled out<br />
from bronchial washings and biopsies, but results were suggestive for<br />
aspergilloma. Because the patient was not thought to be a good surgical<br />
candidate, she was placed on IV voriconazole for 4 weeks. After<br />
completing this course of antifungal therapy, her hemoptysis resolved<br />
and overall respiratory status improved.<br />
DISCUSSION: Aspergilloma is a generally rare fungal infection<br />
that can be seen in patients who are immunosuppressed. It is important<br />
for geriatricians to be aware that aspergilloma is associated with<br />
chronic bronchiectasis. In turn, chronic bronchiectasis is associated<br />
with IgG2 deficiency that can be treated with IVIg. In particular,<br />
geriatricians should also note that non-CF-related bronchiectasis is<br />
more common and more severe in underweight Caucasian women<br />
over the age of 60 years.<br />
A24<br />
CADASIL Disease: a case report of a rare, genetic early onset<br />
dementia.<br />
T. Leucker, 1 B. Setters. 2 1. Internal Medicine, University of Louisville,<br />
Louisville, KY; 2. Family & Geriatric Medicine, University of<br />
Louisville, Louisville, KY.<br />
INTRODUCTION: Cerebral autosomal dominant arteriopathy<br />
with subcortical infarcts and leukoencephalopathy (CADASIL), a<br />
genetically determined arteriopathy involving the NOTCH 3 gene on<br />
chromosome 19, is a rare cause of vascular dementia affecting only a<br />
few hundred families worldwide. Clinical progression involves the sequential<br />
development of migraine with aura at age 30, followed by ischemic<br />
strokes, mood disorders then dementia at 50 yo and gait difficulty<br />
at 60.<br />
CASE REPORT: A 60 y/o AAF with a 40 year history of recurrent<br />
headaches with nausea/vomiting, light sensitivity, worsening<br />
memory loss and depression presented to the hospital 2 years ago<br />
with a blurry vision, a lazy eye and left sided weakness. Exam on admission<br />
did not reveal any neurological deficits, but given her extensive<br />
family history of stroke and personal history of persistent symptoms<br />
over the past few months, a full evaluation was completed. A<br />
head CT demonstrated subtle areas of abnormal attenuation. Follow<br />
up MRI identified diffuse hyper-intensities, heaviest in the temporal<br />
lobes in a subcortical location involving white matter, which was very<br />
concerning for a possible diagnosis of CADASIL disease given the<br />
patient’s history. The remaining clinical workup, including lumbar<br />
puncture was negative. The patient was offered genetic testing for<br />
CADASIL disease, but due to lack of insurance no further testing was<br />
done. Since this initial evaluation the patient had two more admission<br />
for stroke like symptoms. She has shown progressive decline in cognitive<br />
function including memory loss, aphasia, apraxia and a disturbance<br />
in executive functioning resulting in a loss of her job and dependence<br />
on her family for care with her daily activities.<br />
CONCLUSION: CADASIL disease is a rare genetic cause of<br />
dementia that can affect people of all ages and as such is not part of<br />
S24<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
most physicians’ differential diagnosis when working up cognitive<br />
disorders even in younger patients. Given that the presenting symptoms<br />
may be vague and individually common with a routine evaluation<br />
that is usually non-diagnostic, the clinical and family history can<br />
be crucial in making the diagnosis. To establish the diagnosis a<br />
NOTCH3 mutation by genetic analysis or a skin biopsy showing ultra<br />
structural deposits within small blood vessels is needed.<br />
A25<br />
Space Occupying Lesions of the Brain Presenting with<br />
Neuropsychiatric Symptoms.<br />
T. Beben, M. F. Assal, D. D. Sewell, J. Reichstadt, J. W. Daly. UC San<br />
Diego, San Diego, CA.<br />
Supported By: No funders provided support for this research.<br />
Introduction: Cognitive and behavioral problems are often attributable<br />
to underlying degenerative or psychiatric processes. <strong>Here</strong><br />
we present two atypical cases.<br />
Case 1: An 86-year-old man with a history of CAD and TIAs developed<br />
memory and executive function deficits three years prior to<br />
his presentation at our institution. Brain imaging and labs were normal<br />
and he was eventually diagnosed with frontotemporal dementia.<br />
Five months prior, his decline accelerated prompting placement in a<br />
residential care facility. He was noted to have acutely worsening behavioral<br />
symptoms, including wandering, disorganization, agitation,<br />
and impulsivity leading to falls, which led to his admission to our behavioral<br />
unit. Basic labs were normal. A head CT, ordered due to a recent<br />
fall, unexpectedly demonstrated a large mass. Subsequent MRI<br />
delineated a 7x4cm right temporal lobe mass with ring enhancement<br />
and central necrosis, most consistent with glioblastoma multiforme,<br />
which was felt to account for his accelerated decline. The patient was<br />
treated symptomatically with divalproex, olanzapine, and dexamethasone.<br />
After a family meeting, he was referred to hospice.<br />
Case 2: A 60-year-old woman with a history of hypertension and<br />
depression was brought to our geriatric assessment clinic by her<br />
daughter to investigate the cause of her personality changes and decline<br />
in executive function. She had worked as a lab technician until<br />
six years prior, when she became unable to perform work on time or<br />
learn new tasks. She had since been unemployed and could not manage<br />
her finances. At times, she was withdrawn in her cluttered apartment<br />
and neglected her personal hygiene. She also showed poor impulse<br />
control and judgment through inappropriate actions with<br />
strangers and debt accrual. Our initial evaluation revealed a score of<br />
28/30 on the MoCA, but difficulty with attention. A routine brain<br />
MRI was obtained, revealing a 7.2 cm extraaxial right frontal lobe<br />
mass. She was admitted to neurosurgery. Upon successful resection of<br />
the mass, a diagnosis of meningioma was confirmed. After a post-operative<br />
course that was complicated by hydrocephalus requiring a VP<br />
shut, her former personality began to re-emerge.<br />
Conclusions: Brain masses should not be overlooked as a potential<br />
cause of neuropsychiatric symptoms. An accurate diagnosis can<br />
help define prognosis and may guide treatment options.<br />
A26<br />
Clinical significance of measuring Blood Pressures in bilateral arms<br />
in patients with dizziness.<br />
T. Gyurmey, P. Coll, K. Singh. <strong>Geriatrics</strong>, University of Connecticut<br />
Health Center, Farmington, CT.<br />
82 y/o lady with DM type 2, CAD, HTN, TIA, lumbar stenosis,<br />
anemia of chronic disease, depression, GERD and PVD presents<br />
with left arm easy fatigability and episodic dizziness for 1 year. She<br />
was evaluated for dizziness and medications were reviewed with discontinuation<br />
of betablockers and the left arm fatigue was presumed<br />
by the patient to be as a result of the left shoulder replacement.She<br />
was symptom free for a few months until they returned. Past surgical<br />
history is significant for left shoulder joint replacement and left<br />
carotid artery stenting. Medications include morphine, bupropion,<br />
pravastatin, amlodipine, alendronate, epoetin alfa injections and lorazepam<br />
prn.She is afebrile, BP Rt arm 142/48, BP Lt arm 102/40, PR<br />
88 regular with diminished left radial artery pulsations, RR 12, orhtostatics<br />
negative. EOMI, exams of the HEENT, lungs, heart, abdomen<br />
and CNS were unremarkable. No peripheral edema. B/L Lower limb<br />
pulses are equal and symmetric. Based on the difference in systolic<br />
blood pressures and the symptoms, a presumptive diagnosis of Subclavian<br />
artery stenosis with steal syndrome was made.<br />
Management included prompt percutaneous transluminal angiography<br />
followed by angioplasty involving tandem stents being<br />
placed at two proximal left subclavian stenosed sites before the origin<br />
of the vertebral artery without any complications. She was on clopidogrel<br />
for a month and currently takes aspirin 325 mg daily and is<br />
symptom free.<br />
Discussion: Dizziness is a very common symptom in the elderly<br />
and can lead to decreased quality of life and predispose to falls and<br />
subsequent morbidity and mortality.Blood pressures, pulse rates and<br />
orthostatics are routinely measured but not often in both arms which<br />
could lead to missing the diagnosis of subclavian stenosis and steal<br />
syndrome that this patient presented with. On the other hand a<br />
falsely normal blood pressure reading in the arm affected by a stenosis<br />
could delay a diagnosis of Hypertension and subsequently lead to<br />
avoidable and sometimes devastating short term complications and<br />
long term end organ damages. Measuring blood pressure and pulses<br />
in both arms is a very simple but invaluable step that should be done<br />
routinely.<br />
A27<br />
Closed head injury with multisensory loss in a 74 year old athlete<br />
while playing senior league basketball.<br />
U. Kakwan, 1 N. Miller, 3 U. Braun. 2,1 1. <strong>Geriatrics</strong>, Baylor College of<br />
Medicine, Houston,TX; 2. <strong>Geriatrics</strong>, Michael E. DeBakey VAMC,<br />
Houston,TX; 3. Brazos-Valley Community Agency Action, Bryan,TX.<br />
Supported By: Nothing to disclose.<br />
INTRODUCTION<br />
Seniors are becoming more involved in competitive sports, and<br />
injuries in this age group are not well described. We report a patient<br />
who suffered traumatic brain injury with multisensory loss.<br />
CASE PRESENTATION<br />
A 74 year old Caucasian clinic nurse presented to the ER after<br />
she was bumped into, fell backwards, and struck her head on the hard<br />
court while playing basketball. She had brief LOC, bled from her<br />
right ear canal, and reported hearing loss and severe dizziness.<br />
Past medical history was significant for breast cancer in remission,<br />
treated with an aromatase inhibitor, and severe osteoporosis,<br />
treated with Calcium, Vitamin D, and alendronate. Head CT showed<br />
bilateral temporal bone fractures, bleeding in both mastoids, contracoup<br />
injury to the left frontal lobe, and subdural hematoma/subarachnoid<br />
hemorrhage.<br />
She was treated nonsurgically and discharged after 72 hours.<br />
Dizziness was severe but responded to Eppley’s maneuver, followed<br />
by vestibular home exercises. She had moderate symmetrical bilateral<br />
sensorineural hearing loss of 40-50 dbl with minimal improvement<br />
over 6 months.<br />
She also suffers from complete anosmia and dysgeusia. The patient<br />
returned to work after 8 weeks but struggled with patients’<br />
names and short-term memory. Electronic records and her high preinjury<br />
skills and medical knowledge acquired over many years compensated<br />
for her losses.<br />
This patient quit all her athletic activities except walking and expressed<br />
that her losses are worse than when she faced cancer.<br />
DISCUSSION<br />
With the baby-boomers now turning 60, a more active generation<br />
of elderly who may still actively participate in competitive sports<br />
AGS 2012 ANNUAL MEETING<br />
S25
P OSTER<br />
A BSTRACTS<br />
is on the rise. Thus, more severe and complicated sports-related injuries<br />
are likely to be encountered by emergency room physicians in<br />
the near future.<br />
These “fit” elderly are often still employed and despite being<br />
high-performing, sports injuries sustained in this older group may be<br />
more devastating and potentially disabling.<br />
A28<br />
Hands Tell All.<br />
V. Nurpeisov, 1 A. Akintan, 1 N. Holland. 2 1. geriatric medicine, VA<br />
Medical Center, Decatur, GA; 2. Geriatric medicine, Emory University<br />
School of Medicine, Atlanta, GA.<br />
An 85 year old gentleman with a history of hypertension, hyperlipidemia,<br />
and tobacco use presented to the geriatric clinic with a history<br />
of craving ice chips for several months and a twenty pound<br />
weight loss over the previous six months. He denied any noticeable<br />
change in stool habits, hematemesis, abdominal pain, or vomiting. He<br />
did not use alcohol and had smoked cigarettes for the past 60 years.<br />
His medications were: Lisinopril 5 mg daily, Aspirin 81mg daily, and<br />
Hydrochlorothiazide 12.5 mg daily.<br />
On exam he was a thin and cachectic. His vitals were stable.<br />
There was no noticeable jaundice. His lungs were clear and heart<br />
exam was unremarkable. His abdominal exam didn’t reveal any palpable<br />
masses but revealed an enlarged liver.<br />
His nails revealed spooning, evidence of nicotine staining and<br />
changes consisitent with Terry’s nails. His labs showed normal<br />
chemistries and urinalysis. TSH and vitamin B12 levels were normal.<br />
He had a microcytic anemia, hemoglobin of 9 g/dl.<br />
This patient was admitted and by CT colonoscopy, diagnosed<br />
with colon cancer with metastasis to the liver. He and his family<br />
elected for him to receive hospice care.<br />
His Terry’s nail changes were consistent with hepatic disease.<br />
These are usually seen with cirrhosis but in this case we felt these<br />
changes were the result of hepatic metastasis. His nails also revealed<br />
spooning consistent with an iron deficiency anemia as well as nicotine<br />
staining on the second and third finger nails.<br />
Based only on this gentelman’s history and nail changes as described,<br />
colon cancer with liver metastasis was a leading diagnosis before<br />
getting any diagnostic studies. Subsequent CT colonoscopy confirmed<br />
this diagnosis. To our knowledge, this is the first case of<br />
association of Terry’s nails with hepatic metastasis without hepatic<br />
cirrhosis.<br />
In this age of growing technology getting back to the bedside<br />
and taking the time to listen, as well as look for subtle but important<br />
physical exam findings still remains an important art and skill which<br />
should not be overlooked.<br />
Nail changes are easy to observe and often are associated with<br />
important clues to underlying systemic illness in older patients.<br />
This case report emphasizes Sir William Osler’s quote that “<br />
every patient you see is a lesson in much more than the malady from<br />
which he suffers.”<br />
This poster will show pictures of this gentelman’s hands and nail<br />
findings as well as other diagnostic nail changes in systemic disease.<br />
A29 Encore Presentation<br />
Metformin-associated severe hypomagnesemia; A Case report.<br />
V. Kaushik. <strong>Geriatrics</strong>, UTMB, Galveston, Galveston, TX.<br />
Supported By: UTMB<br />
Introduction<br />
Metformin is a oral hypoglycemic agent which decreases hepatic<br />
glucose production, decreases intestinal absorption of glucose, and<br />
improves insulin sensitivity by increasing peripheral glucose uptake<br />
and utilization. The main use for metformin is in the treatment of diabetes<br />
mellitus type 2, especially in overweight patients. Metformin reduces<br />
diabetes complications and overall mortality. Hypomagnesemia<br />
is not referred to as a side effect in the drug’s summary of product<br />
characteristics information, but diarrhea is an important side effect<br />
of metformin and various degree of hypomagnesemia and other<br />
electrolyte imbalance from diarrhea have been reported in the literature.<br />
One report describes a patient on metformin who developed diarrhea<br />
and symptomatic hypomagnesemia (1).<br />
Case presentation<br />
Patient is an 78 year old Caucasian female with h/o diabetes<br />
type II for more than 15 years, hypertension, hyperlipidemia and osteoarthritis.<br />
Her diabetes was fairly controlled by glipizide and metformin.<br />
Metformin was added to her medications three years ago for<br />
better control of her diabetes. Her other medications include<br />
enalapril, Felodipine, Clopidogrel (Plavix), Rosuvastatin (Crestor),<br />
Hydrocodone-acetaminophen and Temazepam (Restoril). Patient<br />
had normal serum magnesium levels prior to adding metformin. Two<br />
months after adding metformin, her routine evaluation showed an<br />
unexplained hypomagnesemia (1.0 mg/dl). Serum calcium, phosphorus,<br />
potassium and renal function were normal. She did not report any<br />
diarrhea. She continued to have chronic moderate to severe hypomagnesemia,<br />
mostly in 0.9 -1.4 mg/dl range. Oral magnesium supplementation<br />
was not very helpful . Her Metformin was discontinued six<br />
months ago and since then her serum magnesium level is improving<br />
slowly, now mostly in 1.5 -1.8 mg/dl range.<br />
Conclusion<br />
The lab findings in this case suggest severe hypomagnesemia,<br />
without any evidence of diarrhea. Hypomagnesemia resolved with<br />
discontinuation of metformin. Based on this association with metformin<br />
and the lack of other clear precipitating causes, the most probable<br />
cause of hypomagnesemia in this patient appears to be metformin.<br />
Clinician should consider the possibility of<br />
metformin-associated hypomagnesemia in patients with otherwise<br />
unexplained hypomagnesemia.<br />
References:<br />
(1) A patient presenting with symptomatic hypomagnesemia<br />
caused by metformin-induced diarrhea: a case report. Svare A. Cases<br />
J. 2009 Oct 16;2:156.<br />
A30<br />
Birds Don’t Make the Best Companions: Hypersensitivity<br />
Pneumonitis In The Elderly.<br />
W. Ooi, S. Dahiya. Internal Medicine, Baystate Medical Center, West<br />
Springfield, MA.<br />
Hypersensitivity pneumonitis, also known as extrinsic allergic<br />
alveolitis, represents a spectrum of immunologic-driven response to a<br />
variety of inhaled allergens. The diagnosis requires a known exposure<br />
to the offending agent along with compatible clinical, radiological<br />
and laboratory studies.<br />
A 67 year old lady with a history of bilateral pulmonary embolisms<br />
presented with progressive dyspnea associated with productive<br />
cough over one month. Patient denied fever, chills or night<br />
sweats. No hemoptysis or lower extremity swelling. Past medical history<br />
includes schizoaffective disorder, morbid obesity and osteoarthritis.<br />
Physical exam was significant for hypoxia requiring 5L of<br />
oxygen supplementation by nasal cannula. Lung and cardiac exam<br />
were otherwise unrevealing. Laboratory studies were significant for<br />
chronic anemia with hemoglobin of 9.8 gm/dL and elevated N-terminal<br />
pro-brain natriuretic peptide of 826 pg/mL. Patient underwent a<br />
computed tomography (CT) angiogram of the chest which revealed<br />
mosaic pattern of lung attenuation bilaterally and mediastinal lymphadenopathy.<br />
She was started on ceftriaxone and azithromycin for<br />
treatment of atypical community-acquired pneumonia. Collateral history<br />
from patient’s family later during her hospitalization revealed<br />
that patient keeps 17 birds; parrots and macaws for the past 15 years.<br />
Her house was revealed to be in an unhygienic condition with animal<br />
excreta and clutter in her bedroom. Pulmonary recommended a<br />
serum precipitin panel which revealed a positive qualitative titer of<br />
S26<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
pigeon serum antibody. Inpatient pulmonary function test showed a<br />
restrictive pattern with significant reduction in her lung diffusing capacity.<br />
Patient was initiated on intravenous methylprednisolone for<br />
five days. Repeat CT scan of her chest 6 days from admission showed<br />
a significant improvement of her lung parenchymal disease and lymphadenopathy.<br />
There are limitations to several proposed diagnostic criteria especially<br />
in the setting of sub-acute or chronic disease. Misdiagnosis<br />
and delays occur in the absence of a comprehensive review of environmental<br />
exposure. This provides a diagnostic challenge in the elderly<br />
and psychiatric population. Serum precipitins have poor sensitivity<br />
and specificity. The risks of invasive diagnostic workup including<br />
bronchoscopic lavage and lung biopsy may outweigh its benefits in<br />
advanced disease. The treatment involves removal of the offending<br />
agent and glucocorticoids.<br />
A31<br />
Lipedema, a frequently misdiagnosed problem in elderly patient.<br />
Y. Ye, U. T. Efeovbokhan, R. W. Parker. UTHSCSA, San Antonio, TX.<br />
Background: Lipedema was first described in 1940 as a bilateral,<br />
gradual accumulation of fatty deposition in the lower extremities and<br />
buttocks. The feet are usually spared which is difference from lymphedema.<br />
This condition is found exclusively in females. It develops<br />
insidiously after puberty and progresses gradually. This condition is<br />
frequently misdiagnosed as lymphedema which is due to accumulation<br />
of protein-rich interstitial fluid with the skin and subcutaneous<br />
tissue caused by lymphatic dysfunction. We describe an elderly patient<br />
with gradually enlargement of bilateral lower extremities for<br />
five years complicated with recurrent skin infection and ulcers.<br />
Methods: This case report describes the presentation of lipedema<br />
in a 68 yr old female patient in which the lipedema is complicated<br />
with lymphedema and skin infection.<br />
Results: Case Presentation: A 68 yr old Caucasian female was<br />
admitted for pain and smelling in bilateral lower extremities. The patient<br />
noticed her both legs gradually becoming swelling for five years.<br />
The swelling becomes worse when sitting for a long time and alleviated<br />
when both legs are elevated. This condition made her confined<br />
to wheelchair. One month ago, patient felt the swelling was getting<br />
worse and she has severe pain in both calves. One course of clindamycin<br />
did not improve the symptom. Physical examination revealed<br />
massive bilateral lower extremity non-pitting edema. There<br />
were firm subcutaneous, cobblestone like nodules and papules with<br />
hyperpigmentation on both legs, especially in the lower one third of<br />
the legs. There was noticeable bilateral erythema up to knees. The<br />
skin was warm to touch. There is a 5x3cm open, foul smelling ulcer on<br />
the left lower extremity. Bilateral ankles and feet were spared. Stemmer’s<br />
sign was negative. Skin biopsy revealed benign polypoid skin<br />
with dermal myxedematous-like change.<br />
Conclusion: Although lipedema is not a rare condition, it is frequently<br />
missed because clinicians lack familiarity with lipedema. Patient’s<br />
history and physical examination are usually sufficient to differentiate<br />
lipedema from lymphedema. However, patient with long<br />
–standing lipedema may eventually develop mechanical insufficiency<br />
of the lymphatic system, producing “lipolymphedema”. The discoloration<br />
and epidermal change of the legs, as well as the skin infection<br />
in this patient is probably due to the dysfunction of lymphatic system.<br />
A32<br />
“We need an interpreter!”<br />
Y. Ang, S. Lee, M. Brennan. Internal Medicine, Baystate Medical<br />
Center/ Tufts University School of Medicine, Springfield, MA.<br />
Intro:<br />
A growing number of immigrant elders in the US are at risk of<br />
poorer health due to cultural and language barriers that limit access<br />
to care.<br />
Case:<br />
A 65 year old Somali man (Mr. K) with dementia presented for<br />
geriatric evaluation after years of cognitive decline. He was disoriented,<br />
disinhibited, impulsive and had decreased speech and repetitive<br />
vocalization. He responded “ I don’t know” to most queries. History<br />
was difficult as the Somali interpreter did not arrive and family<br />
members’ English was limited. Mr. K. was diagnosed with frontotemporal<br />
dementia. Organizing medical care was complex. The language<br />
barrier, poor health literacy and cultural beliefs (e.g. a reluctance to<br />
allow “outsiders” into the home, views about the appropriate role of<br />
women in the family and fears of “official paperwork”) presented<br />
challenges. Medication adherence was frequently problematic as<br />
even simple instructions were “lost in translation”. Appropriate documentation<br />
for exemption from a citizenship interview exam required<br />
significant time and a multidisciplinary effort.<br />
Discussion:<br />
37 million foreign-born immigrants lived in the US in 2006; 12-<br />
15% were aged 65 or older. By 2050, elders will be 61% non-Hispanic<br />
whites, 18% Hispanic, 12% black, 8% Asian, and 2.7%<br />
“other”(1). Geriatric immigrants receive much less health care than<br />
native-born seniors and are far more likely to be uninsured (33.2%<br />
vs 12.7% in 2007)(2). Reasons include a dearth of culturally competent<br />
services along with geographic and economic factors. However,<br />
low English proficiency remains the major risk for poor access to<br />
care. Communication is critical for effective and equitable health<br />
care for ethnic elders.<br />
Conclusion:<br />
Care of older immigrants is challenging given current limitations<br />
in culturally and linguistically sensitive services. Physicians must<br />
consider potential obstacles to care for older immigrants and pay attention<br />
to communication barriers and cultural values as well as clinical<br />
symptoms. It is crucial for institutions to develop system wide<br />
policies and practices that welcoming the diversity of our patient<br />
populations.<br />
References:<br />
1. McBride M. (2010). Ethnogeriatrics and Cultural Competence<br />
for Nursing Practice. Hartford Instutute for Geriatric Nursing<br />
2010. Retrieved Nov 25, 2011, from http://consultgerirn.org.<br />
2. Steven A. (2009, Aug). Facts on Immigration and Health Insurance.<br />
Center for Immigration Studies. Retrieved Nov 25, 2011,<br />
from http://www.cis.org/HealthCare-Immigration<br />
A33<br />
Heart failure in hospitalized elderly subjects in geriatric department:<br />
poor and unusual clinical signs.<br />
Y. Wolmark, 1 M. Gaubert-Dahan, 1 F. Tubach, 2,3 T. Zerah. 1 1. Hôpital<br />
Bretonneau, Paris, France; 2. Hôpital Bichat, Paris, France; 3.<br />
Université Paris Diderot, Paris, France.<br />
Background: Heart failure is a frequent and serious disease in<br />
the elderly. The purpose of the present study was to analyse the characteristics<br />
of the patients with acute heart failure and to compare the<br />
frequency of these characteristics between systolic heart failure (left<br />
ventricular ejection fraction ≤ 50%) and diastolic heart failure. Methods:<br />
The present study was an observational and prospective study<br />
about the clinical features and the radiology, biology and echocardiography<br />
results of 53 patients (mean age 87.8 years) hospitalized in<br />
geriatric care units at Bretonneau hospital in Paris. The Fisher’s exact<br />
test was used to compare 2 nominal variables and the Mann-Whitney<br />
test to compare 2 ordinal variables. Results: The majority of the patients<br />
had hypertension (83%), malnutrition (81%) and anaemia<br />
(62%). Thirty eight percents experienced a first episode of heart failure.<br />
Before the current episode of acute heart failure, 55% of patients<br />
were treated with diuretic agents, 55 % with angiotensin-converting<br />
enzyme inhibitors or angiotensin receptor blockers and 51% with<br />
beta-blockers. The patients had 3 clinical signs or symptoms of heart<br />
failure on average. The most frequent were: pulmonary rales (68%),<br />
dyspnea (60%), crepitant rales (55%), weight gain (64%), peripheral<br />
AGS 2012 ANNUAL MEETING<br />
S27
P OSTER<br />
A BSTRACTS<br />
edema (60%), and weakness (32%). Thirty six percents of the patients<br />
reported a fall in the few days before the current episode of<br />
heart failure. Fifteen percents of the patients had a delirium. The patients<br />
with systolic heart failure had more cardiovascular diseases<br />
(atrial fibrillation (28% versus 19%, p=0.028), angina (21% versus<br />
4%, p=0.001), diabetes (9% versus 2%, p=0.074), and hypercholesterolemia<br />
(15% versus 6%, p=0.041)) than the patients with diastolic<br />
heart failure. Conclusions: Whether the heart failure is systolic or diastolic,<br />
the clinical profile of old patients is poor and unusual, the<br />
prevalence of malnutrition and anaemia is high and their treatment is<br />
inadequate. Cardiovascular diseases are more frequent in patients<br />
with systolic heart failure. Echocardiography enables the comprehensive<br />
diagnosis of heart failure.<br />
A34 Encore Presentation<br />
Age Analysis of Long-Term Safety of Diclofenac Sodium 1% Gel<br />
for Patients With Osteoarthritis of the Knee.<br />
J. H. Peniston, 1 M. S. Gold, 2 M. S. Wieman, 3 L. K. Alwine. 4 1.<br />
Feasterville Family Health Care Center, Feasterville, PA; 2. Novartis<br />
Consumer Health, Inc., Parsippany, NJ; 3. Endo Pharmaceuticals<br />
Inc., Chadds Ford, PA; 4. Downingtown Family Medicine,<br />
Downingtown, PA.<br />
Supported By: Novartis Consumer Health, Parsippany, NJ, and<br />
Endo Pharmaceuticals, Inc., Chadds Ford, PA.<br />
Background: Oral nonsteroidal anti-inflammatory drugs should<br />
be used with caution in the elderly. This study evaluated the safety of<br />
topical diclofenac sodium 1% gel (DSG) in an open-label extension<br />
of 2 double-blind, randomized, 3-month trials of DSG in patients ≥35<br />
years with a ≥6-month history of symptomatic Kellgren-Lawrence<br />
grade 1–3 knee OA.<br />
Methods: Patients applied 4 g DSG to 1 or both knees 4 times<br />
daily for 9 (continuing patients) or 12 (new patients) months; use of<br />
rescue acetaminophen (≤4 g/d) was allowed. AEs were monitored<br />
throughout the study and the Western Ontario and McMaster Universities<br />
Osteoarthritis Index (WOMAC) pain, stiffness, and physical<br />
function subscales were assessed at baseline and 3, 6, 9, and 12<br />
months.<br />
Results: The safety population (947 patients; 575
P OSTER<br />
A BSTRACTS<br />
increased LOS. There were no gender differences, but <strong>American</strong> Indians<br />
had shorter LOS than Whites or African <strong>American</strong>s. History of<br />
cigarette smoking, advanced age, and unclear diagnosis were also associated<br />
with longer LOS.<br />
Conclusion: The severity of the stroke, co-morbidities, and prestroke<br />
status of a stroke survivor may contribute to the LOS of stroke<br />
patients and affect their overall post-stroke outcome. Although biological<br />
factors are most influential, social and psychological factors<br />
also played a role.<br />
A37<br />
Correlation of health professional (KPS) and patient-rated (pKPS)<br />
Karnofsky Performance Status and associations with measures of<br />
geriatric assessment (GA) domains.<br />
T. Jolly, 1 A. Deal, 1 G. Williams, 1 S. Alston, 1 B. Gordon, 1 J. Pan, 1<br />
S. Moore, 2 W. Taylor, 3 H. Muss. 1 1. University of North Carolina,<br />
Chapel Hill, NC; 2. Rex Hematology Oncology Associates, Raleigh,<br />
NC; 3. New Bern Cancer Care, New Bern, NC.<br />
Supported By: Supported in part by the University Cancer Research<br />
Fund, Lineberger Comprehensive Cancer Center, Chapel Hill, NC<br />
BACKGROUND: KPS is frequently used to assess function in<br />
older patients; however, it is prone to observer bias and has limited<br />
ability to detect abnormalities in other GA domains. This study explores<br />
the relationship between KPS and pKPS and their association<br />
with measures of GA domains.<br />
METHODS: Data from the Carolina Senior registry which includes<br />
the North Carolina Cancer Hospital and community affiliates<br />
for patients ≥65 years were analyzed using Fisher’s Exact and<br />
weighted kappa (κ) statistics. Patients completed a predominantly<br />
self administered GA (Hurria et al, Cancer 2005) which included rating<br />
scales for both KPS and pKPS.<br />
RESULTS: The 386 evaluable enrollees had median age: 73<br />
(range 65-97); and were 81% female; 89% white; 55% married; 83%<br />
retired; 72% at least some college education; 97% a cancer diagnoses.<br />
There was fair agreement [κ=0.26 (95% CI 0.18-0.33)] between<br />
KPS and pKPS for patients with scores ≥ 40% (Fig. 1). There<br />
were statistically significant associations between KPS and pKPS<br />
scores
P OSTER<br />
A BSTRACTS<br />
categories based on Mini-Mental State Examination (MMSE) scores:<br />
>23 and those < 23.<br />
Results: The following differences were found between dementia(D)<br />
and non-dementia(ND) patients: Proportion with of twice<br />
daily brushings or more: Annual dental visits: 36% (D) vs. 54% (ND);<br />
flosses teeth: 11% (D) vs. 25% (ND); 51% (D) vs. 54% (ND); problems<br />
with teeth:16%(D) vs. 26%(ND); complaining of dental pain:<br />
20% (D) vs.21% (ND); wear dentures: 57% (D) vs. 58% (ND); problems<br />
with dentures: 25% (D) vs. 30% (ND); Two of the comparisons<br />
attained statistical significance(p< .05): annual dental visits(r=.18)<br />
and flossing teeth (r=.18). There were no significant correlations between<br />
the dichotomized MMSE score and the dental variables. In the<br />
dementia group, having at least an annual visit to dentist was significantly<br />
associated with stage of dementia; 71% and 22% had annual<br />
visits among person with mild and moderate or severe stages, respectively<br />
(χ2 = 6.62, df=1, p=.01). However, no other sociodemographic,<br />
cognitive, or neuropsychiatric variables were associated with annual<br />
dental visits.<br />
Conclusion: Although both groups showed substandard levels of<br />
care, persons with dementia had significantly lower levels of dental<br />
care, and this worsened with the stage of the dementia. The study confirms<br />
that need for education of caregivers and increased accessibility<br />
to oral health care in older adults with dementia.<br />
Key Words:<br />
Dental care; <strong>Geriatrics</strong>; Dementia<br />
A40<br />
Counting Pop-Drops: Emergency Department Re-Visits by Persons<br />
with Dementia.<br />
C. Clevenger, 1,2 D. Khalili, 2 Z. Yang. 3 1. Birmingham/Atlanta<br />
GRECC, Department of Veterans’ Affairs Medical Center, Grayson,<br />
GA; 2. Nell Hodgson Woodruff School of Nursing, Emory University,<br />
Atlanta, GA; 3. Rollins School of Public Health, Emory University,<br />
Atlanta, GA.<br />
BACKGROUND: Twenty-six to forty percent of older emergency<br />
department (ED) patients are estimated to have dementia. We<br />
conducted a pilot study in which persons with dementia (PwD) had<br />
twice the number of ED visits over a one-year period compared to<br />
those without dementia. The purpose of this study is to compare the<br />
pattern of ED use, discharges, and hospital admissions between older<br />
ED re-visitors with and without dementia.<br />
METHODS: The study employed retrospective chart review of<br />
persons over the age of 70 who accessed the ED of an urban academic<br />
medical center ≥ 2 times in 2009 with chief complaints of moderate<br />
severity. We reviewed clinical notes from the ED visit as well as<br />
inpatient and outpatient records for documentation of dementia.<br />
Dates and outcomes of ED visits (admission to hospital or discharge<br />
from ED) were used to calculate interval between visits and variables<br />
of events occurring within 7, 30, 60 and 90 days. We asked the following<br />
research questions: What is the mean number of days between<br />
ED visits for PwD? How likely are PwD to re-visit the ED within 30<br />
days compared to those without dementia? Is there a delay in hospital<br />
admission for PwD as shown by multiple ED discharges prior to<br />
hospital admission?<br />
RESULTS: The study sampled 540 ED visits made by 154 persons;<br />
54 were PwD (35.1%). The mean number of days between ED<br />
visits was 41.5 for those without dementia and 33.7 for PwD<br />
(p=0.160). Persons with dementia made 207 of the 540 total ED visits<br />
(38.3%); 154 of the 386 re-visits (39.9%); and 95 of the 219 30-day revisits<br />
(43.4%). The likelihood ratio of an ED re-visit in = 65 years with at least 1 ED visit<br />
between 1/1/00 and 9/30/07 (N = 4,964). Latent class analysis models<br />
were estimated to identify groups (or classes) with similar numbers of<br />
(1) primary care (PC) visits; (2) outpatient ED visits (i.e. treated and<br />
released); and (3) hospital days within 12 months preceding the index<br />
S30<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
ED visit. A multinomial logistic regression model was used to compare<br />
health care utilization measures in each class to the overall sample<br />
mean.<br />
Results: 5 groups with distinct patterns of health service use in<br />
the year preceding an index ED visit emerged. Two groups, dubbed<br />
“Wellderly,” had fewer chronic conditions than the population mean.<br />
The 1st group [“Wellderly with PC”, 39%] used less ED and hospital<br />
care, but had higher PC visits compared to the overall mean (6.2 vs 4).<br />
Members of this group were more likely to be female, live alone and<br />
have higher income (P
P OSTER<br />
A BSTRACTS<br />
Methods: A longitudinal, retrospective database analysis included<br />
outpatient data from the Veterans Health Administration<br />
(VHA). The study sample included veterans age 65 years or older<br />
with at least one outpatient primary care visit or one inpatient visit<br />
between fiscal year 2003 to 2005. We identified veterans with an ICD-<br />
9 diagnosis of insomnia, anxiety, PTSD, depression or chronic pain<br />
and potentially inappropriate prescriptions of antihistamines, psychotropics,<br />
musculoskeletal relaxants and opioids. We examined demographic<br />
data, Selim index comorbidities, total number of medications<br />
prescribed, and utilization of geriatric primary care. All analysis<br />
was conducted using SPSS-14. We obtained IRB approval.<br />
Results: Of the 41, 432 veterans identified, 21.8% (9,086) received<br />
a HRME. Only 7.9% of veterans older than 85 years of age received<br />
a HRME. More minorities received a HRME than whites<br />
(10.7% vs. 74.8%).Veterans exempted from a medication co-payment<br />
received more HRME than those not exempt (76% vs. 23.5%). Of<br />
those veterans with a HRME, 44.6% received 12 or more medications.<br />
Utilizing geriatric care in 2005 resulted in fewer HRME prescriptions<br />
(3.5% vs. 4.8) whereas more than 33% of veterans with 5 or more primary<br />
care visits received a HRME. Veterans with 0 to 1 physical conditions,<br />
but >2 mental health conditions received fewer HRME.<br />
Conclusion: HRME are common in the older adult veteran population.<br />
Geriatric primary care and older veterans age are protective<br />
characteristics, which are similar to other studies. Future studies<br />
should focus on interventions to reduce the number of HRME older<br />
adults receive.<br />
References: 1. Zhan C, Sangl J, Bierman AS et al. Potentially inappropriate<br />
medication use in the community-dwelling elderly: findings<br />
from the 1996 Medical Expenditure Panel Survey. JAMA<br />
2001;286:2823-2829.<br />
A46<br />
Differences in Vitamin D Deficiency by Ethnic/Racial Background<br />
in a Geriatric Clinic, Houston, TX.<br />
N. Rianon, 3 K. Murphy, 1 C. Dyer, 2 B. Selwyn. 4 1. Family and<br />
Community Medicine, University of Texas Medical School at<br />
Houston, Houston, TX; 2. Integrative Nursing Care, University of<br />
Texas Houston Health Science Center- School of Nursing, Houston,<br />
TX; 3. Internal Medicine, University of Texas Medical School at<br />
Houston, Houston, TX; 4. Epidemiology, University of Texas Houston<br />
Health Science Center- School of Public Health, Houston, TX.<br />
Supported By: The project was supported by funding from the<br />
Herzstein Foundation<br />
Background: Vitamin D deficiency documented in a national<br />
study (NHANES 2001-2004) in more than 70% of older patients at<br />
risk of age related bone loss or osteoporosis occurred in a higher percentage<br />
of African <strong>American</strong>s (AA) (97%) and Hispanics (90%)<br />
than in Caucasians (72%). Under- recognition of vitamin D deficiency<br />
led to under-treatment in patients needing prevention of, and<br />
treatment for osteoporosis. This cross sectional pilot study describes<br />
variations in Vitamin D testing and deficiency by ethnic/racial background<br />
among at risk patients in Houston, Texas.<br />
Methods:<br />
Electronic chart review recorded the ethnic/racial background<br />
for 72 patients receiving treatment for menopausal symptoms, osteoporosis<br />
and related fractures in a geriatric clinic in Houston, Texas<br />
from January 2009 to December 2010. Orders for serum 25 hydroxy<br />
vitamin D indicated vitamin D testing, and serum vitamin D levels<br />
recorded as less than 30 ng/ml indicated deficiency in this study.<br />
Results:<br />
The patient group was mostly women (93%) and had a mean<br />
age of 79±9 years (range 57 – 97 years). Most of the patients were<br />
Caucasians (64%), while 25% were AA and 11% were of “Other”<br />
ethnicities (7 Hispanics, 1 Asian). About half (49%) were not tested<br />
for Vitamin D levels. Of those tested (N=37), 68% were Caucasians,<br />
24% were AA and 8% were of “Other” ethnicities. About 46% of<br />
those tested had Vitamin D deficiency. Vitamin D deficient patients<br />
(N=17) were 65% Caucasians, 23% AA and 12% were of “Other”<br />
ethnicities.<br />
Conclusions:<br />
We report a lower prevalence of vitamin D deficiency among<br />
African <strong>American</strong> and Hispanic patients in Houston, Texas compared<br />
to the NHANES data. Our results may be reflective of the dietary<br />
and environmental differences in the population served in this region.<br />
Further studies that outline vitamin D deficiency in diverse ethnic<br />
and racial groups will help to improve osteoporosis management<br />
in older patients.<br />
A47<br />
Impact of race on cognitive assessment among hospitalized elders.<br />
B. Benizry, 1 N. Campbell, 2,3 S. L. Hui, 1,3 T. Perkins, 3 B. A. Khan, 1,3<br />
M. O. Farber, 1 W. Ely, 4,5 M. A. Boustani. 1,3 1. School of Medicine,<br />
Indiana University, Indianapolis, IN; 2. Pharmacy Practice, Purdue<br />
University, Indianapolis, IN; 3. Regenstrief Institute, Inc., Indianapolis,<br />
IN; 4. School of Medicine, Vanderbilt University, Nashville, TN; 5.<br />
Geriatric Research Education Clinical Center (GRECC), VA<br />
Tennessee Valley, Nashville, TN.<br />
Supported By: This work was supported by grants K23AG26770-01<br />
and R01AG034205-01A1 from the National Institute on Aging<br />
(NIA); the Hartford Foundation; the Atlantic Philanthropy; and the<br />
<strong>American</strong> Federation for Aging Research (AFAR). Additionally,<br />
Braca Benizry was supported by a Medical Student Training in<br />
Aging Research (MSTAR) award administered by the AFAR and<br />
the NIA. The sponsor had no role in the study design, evaluation, or<br />
manuscript development.<br />
Background: Racial disparities in health care quality and outcomes<br />
have been studied and well characterized for various medical<br />
conditions. African <strong>American</strong>s have been suggested to have a higher<br />
likelihood of developing chronic forms of cognitive impairment such<br />
as dementia, however little information exists regarding racial disparities<br />
in acute cognitive impairment or delirium. Our objective was to<br />
evaluate the association between Race and diagnosis and recognition<br />
of cognitive impairment and delirium.<br />
Methods: This study was an observational cohort study taking<br />
place at Wishard Hospital, an urban public hospital in Indianapolis.<br />
Participants included 991 patients aged 65 years and older admitted<br />
to general inpatient medical services between July 2006 and March<br />
2008. Cognitive impairment was identified using the Short Portable<br />
Mental Status Questionnaire and delirium was identified using the<br />
Confusion Assessment Method. Recognition of cognitive impairment<br />
and delirium was determined by examining ICD-9 codes in the Regenstrief<br />
Medical Record System (RMRS) within one year prior to<br />
hospitalization through discharge or hospital admission through discharge,<br />
respectively.<br />
Results: 424 patients (43%) screened positive for cognitive<br />
impairment and 173 patients (17%) screened positive for delirium.<br />
Sixty-seven percent of those with recognized cognitive impairment<br />
and 68% of those with recognized delirium were African<br />
<strong>American</strong>. After adjusting for potential confounders, the odds<br />
ratio for the relationship between race and recognition of cognitive<br />
impairment was 1.61 (95% confidence interval = 0.98, 2.64)<br />
and recognition of delirium was 1.51 (95% confidence interval =<br />
0.64-3.57).<br />
Conclusion: Among hospitalized older adults, neither the diagnosis<br />
nor recognition of cognitive impairment and delirium differed<br />
between races; however, a trend towards better recognition<br />
of cognitive impairment and delirium among African <strong>American</strong>s<br />
may exist.<br />
S32<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
A48<br />
Ninety-Day Mortality Among Older Adults Following Hospital<br />
Admission for Pneumonia.<br />
O. E. Abreu Lanfranco, 1,2 H. Rahbar, 1,2 C. Biedron, 1,2 A. Singh, 2<br />
M. Tims, 2 B. Ramasamy, 2 T. Chopra, 1,2 K. S. Kaye. 2,1 1. Infectious<br />
Disease, Wayne State University, Detroit, MI; 2. Infectious Disease,<br />
Detriot Medical Center, Detroit, MI.<br />
Background: Pneumonia is one of the leading causes for acute<br />
hospitalization in the US. In older adults, pneumonia is associated<br />
with increased morbidity, functional status deterioration, resources<br />
and mortality. We aimed to identify factors associated with an increased<br />
risk for 90-day mortality after hospitalization for pneumonia<br />
in older adults and to define the impact of hospital readmission on<br />
mortality.<br />
Methods: Study conducted at the Detroit Medical Center. Retrospective<br />
chart review in patients over 65 years of age who had a primary<br />
diagnosis of pneumonia from January to March 2011. Data abstracted<br />
from medical records. Cases were defined as patients who<br />
died within 90 days following hospital discharge and controls were<br />
patients who did not die during the 90-day period following hospital<br />
discharge. Controls were matched by hospital and calendar time of<br />
admission.<br />
Results: A total of 160 patients were studied with a mean age of<br />
77.7 years +/-8.2, 54% were men. Thirty-four patients (21%) died<br />
within 90 days after the initial discharge (21%). Cases were more<br />
likely to be readmitted within 30 days of the index hospitalization<br />
(85.3% and 40.9%; OR 8.33, 95% CI 3.3-25), need assistance with 3 or<br />
more ADLs (64.7% and 38.9%, OR 2.88(95% CI 1.3-6.3), have a<br />
Braden score < 16 (55.9% and 29.4%; OR 3.1, 95% CI 1.4-6.6), have a<br />
pleural effusion on radiography (50% and 25.3%; OR 2.9, 95% CI<br />
1.3-6.4), be treated for healthcare-associated pneumonia(58.8% and<br />
30.2%; OR 3.3, 95% CI 1.5-7.2), more likely to have a higher Charlson’s<br />
Score (OR 3.05, 95% CI 1.28-7.25) and Pneumonia Severity<br />
Index(OR 0.14, 95% CI 0.24-0.78). In multivariate analysis, independent<br />
predictors of 90-day mortality included readmission within<br />
30 days (OR 6.8, 95% CI 2.4-19.6), Pneumonia Severity Index > 4<br />
(OR 3.29, 95% CI 1.32-8.19), and having been treated for HCAP (OR<br />
2.32, 95% CI 1.01-5.35).<br />
Conclusions: Among older adults discharged from the hospital<br />
with pneumonia, mortality rates exceeded 20%. Readmission within 30<br />
days was associated with a greater than 7-fold increase in 90-day mortality,<br />
patients treated for HCAP during their initial pneumonia admission<br />
had a greater than 2.5-fold increased risk for 90-day mortality.<br />
A49<br />
DRIVING CESSATION: NOT A ONE WAY DECISION.<br />
R. A. Marottoli, 1,2 K. Araujo, 1 P. Peduzzi. 1 1. Yale University School<br />
of Medicine, New Haven, CT; 2. VA CT, West Haven, CT.<br />
Background: While it is often assumed that driving cessation is a<br />
final decision, it is likely that many individuals return to driving after<br />
temporarily stopping. The purpose of this study was to determine the<br />
frequency of occurrence and factors associated with the resumption<br />
of driving after initial cessation.<br />
Methods: Participants were community-living active drivers age<br />
70 years and older recruited from general medical clinics and community<br />
sources. Participants were assessed in-person at baseline and<br />
followed prospectively for two years with phone contacts every six<br />
months that included questions on driving status.<br />
Results: 615 drivers had a mean age of 78.8 (+/-4.9) years, 12%<br />
were women, mean MMSE score was 27.4 (± 2.1) points, average<br />
mileage was 129 (± 109) miles per week, and 72% drove daily. 68 drivers<br />
(11%) stopped driving at some point during two years of followup.<br />
Of these, 25 (37%) had resumed driving by the end of two years of<br />
follow up. Compared to drivers who stopped permanently, those who<br />
returned to driving had higher weekly mileage (153 v. 90, p=.01),<br />
fewer chronic conditions (64 v. 84% w/≥3, p=.06), higher self-rated<br />
health (80 v. 58% excellent/good, p=.07), higher MMSE scores (64%<br />
v. 40% scored ≥ 28, p=.05), drove more often (92 v. 53% daily, p=.001),<br />
and faster gait speed (75 v. 47% ≤ 7 sec, p=.02).<br />
Conclusion: The decision to stop driving is not always final. In<br />
this cohort a substantial proportion of older people returned to driving<br />
after temporarily stopping. Identifying these individuals and the<br />
factors contributing to their decisions to both stop and return to driving<br />
may help clinicians counsel other drivers and families facing this<br />
transition.<br />
A50<br />
Differential impact of hypertension and diabetes on cognitive tests<br />
over 4 years.<br />
R. M. Allman, 1,2 P. Sawyer, 2 M. Crowe, 3 R. E. Kennedy, 4 R. V. Sims. 1<br />
1. Birmingham/Atlanta VA GRECC, Birmingham, AL; 2.<br />
Gerontology, <strong>Geriatrics</strong>, and Palliative Care, University of Alabama at<br />
Birmingham, Birmingham, AL; 3. Psychology, University of Alabama<br />
at Birmingham, Birmingham, AL; 4. Biostatistics,<br />
Birmingham/Atlanta VA GRECC, Birmingham, AL.<br />
Supported By: National Institute on Aging<br />
Purpose: To understand predictors of changes in cognitive<br />
screening tests over four years in community-dwelling older adults.<br />
Methods: This is a prospective, observational study of community-dwelling<br />
Medicare beneficiaries aged 65 years and older that<br />
completed a comprehensive baseline in-home assessment (1999-<br />
2001) and a repeat in-home assessment in 2004. Data included sociodemographics,<br />
medical conditions diagnosed by a physician and<br />
health behaviors. Cognitive tests included drawing a clock (CLOXI),<br />
copying a clock (CLOX2), and a 30-point multi-item cognitive assessment<br />
(MICA). Multivariable linear regression models controlling for<br />
age, race, sex, education, and income were used to test the independence<br />
and significance of associations between baseline diabetes, hypertension,<br />
arrhythmia, coronary artery disease, geriatric depression<br />
score (GDS), smoking pack years, BMI>30, unintentional weight loss,<br />
vision, leisure time physical activity, and incident stroke or dementia<br />
diagnoses on changes in the three cognitive tests over 4 years.<br />
Results: Mean age of the sample (N=580) at baseline was 73.6<br />
(53% female; 46% African <strong>American</strong>). Mean (SD) baseline cognitive<br />
scores were 10.9 (2.8) for CLOX1, 12.9 (1.9) for CLOX2, and 26.5<br />
(3.5) for MICA. Mean declines (SD) in the cognitive test scores were<br />
0.6 (3.4), 0.5 (2.3), and 0.9 (3.0), respectively (p
P OSTER<br />
A BSTRACTS<br />
Design. CaMos is an ongoing 10 year prospective cohort study.<br />
Population. Age and sex matched Canadian population who are<br />
non-institutionalized individuals and reside in nine CaMos study<br />
centers.<br />
Methods. Data from 2819 men and 6444 women were classified<br />
as current GC users and non-users. New fractures based on self-reports<br />
from an annually completed questionnaire included vertebral,<br />
hip, other (excluding hip, vertebral, toes, fingers, skull fractures) and<br />
any fracture (excluding toes, fingers, skull fractures). Multivariable<br />
survival analyses were conducted to examine the association between<br />
the time to new fracture and GC use. Hazard ratios and 95% confidence<br />
intervals (CI) were calculated.<br />
Results. The mean age, femoral neck T-score (standard deviation)<br />
and GC use at baseline of the cohort was 62.0 (13.3), -1.07<br />
(1.03) and 128 (1. 4%), respectively. During the 10 year period, 130<br />
(1.4%), 157 (1.7%), 869 (9.7%) and 1102 (11.9%) individuals developed<br />
a new osteoporotic vertebral, hip, other and any fracture. Ever<br />
taking GC for a minimum of one month in both men and women had<br />
a hazard ratio of 1.4 (95% CI: 1.0 -1.8), 1.9 (95% CI: 1.0-3.6), 0.97<br />
(95% CI: 0.4-2.2),1.2 (95% CI: 0.9-1.6) for developing a new nonspine,<br />
hip, spine and any fracture as compared to those who never<br />
took GC, respectively.<br />
Conclusions. CaMos is the first prospective long-term study with<br />
data over 10 years showing that GC use is associated with higher incident<br />
fragility fractures.<br />
Key Words: glucocorticoids, fractures, bone mineral density<br />
A52<br />
Unsteadiness in Post-acute Care (PAC): Prevalence and Associated<br />
Characteristics.<br />
S. Bangalore, S. E. Hardy. Medicine/<strong>Geriatrics</strong>, University of<br />
Pittsburgh, Pittsburgh, PA.<br />
Supported By: NIA, Hartford Foundation<br />
Background-Unsteadiness is a subjective sense of loss of equilibrium<br />
or balance in regard to the environment. Patients in PAC frequently<br />
complain of unsteadiness, requiring a detailed evaluation.<br />
The purpose of this study is to describe the prevalence of unsteadiness<br />
and the characteristics associated with it.<br />
Methods-We performed cross-sectional analysis of baseline data<br />
on previously community-dwelling older adults admitted to skilled<br />
nursing facilities for PAC (age 81±8, 85% white, 71% female) obtained<br />
by in-person assessment and review of hospital records. Of the<br />
125 participants, 35 (28%) had no unsteadiness, 18 (14.4%) had mild,<br />
50 (40%) had moderate, and 22 (17.6%) had severe unsteadiness. The<br />
characteristics of participants with and without unsteadiness were<br />
compared using Chi-Square, Fisher’s exact, and t-tests.<br />
Results-Characteristics significantly associated with any unsteadiness<br />
are presented in the table (values represent % or<br />
mean±SD). Age, sex, race, pain, systolic BP
P OSTER<br />
A BSTRACTS<br />
351,874 visits to the ED, out of which 63,278 (18%) were of adults<br />
aged 60 and over (A60), while 17,593 (5%) were aged 80 years or<br />
older (A80). There was an increase in 83.2% of elderly visits throughout<br />
the years. It was additionally verified that of the total number of<br />
A60 and A80, respectively 46.1% and 51% were female; 24.5% and<br />
31.9% were admitted to hospital wards (versus 5.4% among patients<br />
aged from 18 to 59 years); and 1.4% and 2.8% died still at the ED or<br />
subsequently during hospital stay (versus 0.4%). The median length<br />
of stay for A60 was 3.1 days at the ED, and 5 days at the hospital<br />
wards (versus 2.5 and 3 days). Injuries and their consequences<br />
(17.8%), symptoms and signs involving the digestive system and abdomen<br />
such as abdominal pain, nausea and vomiting (8.4%), general<br />
symptoms and signs such as fever, syncope and collapse, malaise and<br />
fatigue (5.5%), specific medical procedures and health care actions<br />
(4.7%), acute upper respiratory infections (4.4%) and dorsopathies<br />
(3.5%) were the most common diagnoses, as defined using the ICD-<br />
10 blocks of codes. Conclusion: Older adults are increasingly seeking<br />
care in the ED. They are more frequently hospitalized and have<br />
higher mortality than younger patients who seek care in the same setting.<br />
Injuries and digestive system complaints are the most frequent<br />
motivations for their visits. The high frequency of non-specific symptoms<br />
like malaise, fatigue and fever indicate the need of an expert<br />
team to make the correct diagnoses in this setting.<br />
A55<br />
Nonagenarians: an increasing reality in the emergency room.<br />
T. J. Avelino-Silva, L. A. Gil, A. L. Bierrenbach, C. Toscano, W. Jacob-<br />
Filho, F. Ganem. Hospital Sirio-Libanes, Sao Paulo, SP, Brazil.<br />
Supported By: None of the authors reported a potential, real, or<br />
perceived conflict of interest or financial disclosure. No sponsors<br />
participated in or funded this research.<br />
Background: In Brazil, as in more developed countries, the<br />
strongest growth of the older population shall be in the age bracket<br />
above 80. How does one guarantee an efficient health system and<br />
quality of life for this new mass of older citizens? It was our objective<br />
to better understand the characteristics of the patients over 90 years<br />
of age who seek care in the emergency room. Methods: We retrospectively<br />
reviewed a database containing information of all the patients<br />
who visited the emergency department (ED) of a 350-bed private tertiary<br />
care general hospital in São Paulo, Brazil, from January 2003 to<br />
December 2010. Data pertaining to the patients who were 90 years of<br />
age or older were searched for the following: age; gender; principal<br />
diagnosis (ICD-10 codes); hospital admission; length of stay; and outcome.<br />
Results: Over the 8-year study period, there were 351,874 visits<br />
to the ED, out of which 63,278 (18%) were of adults aged 60 and over<br />
(A60), while 4,099 (1.1%) were aged 90 or older (A90). There was an<br />
expressive growth of the number of older adult visits to the ED<br />
throughout the years (83.2%), but it was the age group over 90 that<br />
showed the most remarkable expansion (95.6%). Of the total number<br />
of A90, 58.1% were female, while only 46.1% were so if one considered<br />
A60. A90 were admitted to hospital wards in 35.1% of the cases<br />
(versus 24.5% for A60), and 4.1% died at the ED or subsequently<br />
during their hospital stay (versus 1.4%). The median length of stay<br />
was 3.1 days at the ED, and 5 days at the hospital wards, which was<br />
similar to younger geriatric patients. Injuries and consequences accounted<br />
for 17.9% of A90 visits. Other important reason for their visits<br />
were specific medical procedures and health care actions (7%).<br />
These were mostly related to surgical and orthopedic follow-up care,<br />
attention to artificial openings, like colonostomy and others and issue<br />
of repeat prescriptions. General symptoms and signs such as fever,<br />
syncope and collapse, malaise and fatigue (6.9%), symptoms and<br />
signs involving the digestive system and abdomen (6.9%), influenza<br />
and pneumonia (6%), and heart diseases (5.4%) followed in frequency.<br />
Conclusion: ED visits by patients over 90 had the greatest increase<br />
among older adults. The primary motivations for their visits<br />
were injuries, specific medical procedures and health care actions.<br />
Further discussion of adequate settings to provide care for these patients<br />
is needed.<br />
A56<br />
Cause of Death among Older Adults with Cognitive Impairment<br />
with and without Dementia: The Aging, Demographics, and<br />
Memory Study.<br />
T. Okura, 1 K. M. Langa. 2 1. Bajikoen Clinic, Tokyo, Japan; 2.<br />
University of Michigan, Ann Arbor, MI.<br />
(Background) Hypothesizing that older individuals with dementia<br />
die from different causes compared to those with the milder levels<br />
of cognitive impairment, we compared the cause of death for those<br />
with dementia to those with normal cognition or cognitive impairment<br />
without dementia (CIND) using longitudinal data from a nationally<br />
representative sample of older adults in the United States.<br />
(Methods) We used data from the Aging, Demographics, and<br />
Memory Study (ADAMS), a sub-study of the Health and Retirement<br />
Study (HRS) focused on cognitive impairment and dementia. We<br />
identified individuals aged 71 or older diagnosed as normal, CIND, or<br />
demented by the ADAMS consensus diagnosis panel. Date and cause<br />
of death during the 9-year study period were obtained from the HRS.<br />
(Results) 91.3% of those with dementia died during the followup<br />
period compared to 67.5% and 28.1% of those with CIND and<br />
normal cognition, respectively. Heart disease was the most common<br />
cause of death across all cognitive categories, accounting for about<br />
25% of deaths in each group. Those with dementia were more likely<br />
to die from stroke (13.5% vs. 4.3% for CIND, 4.6% for normal cognition,<br />
p
P OSTER<br />
A BSTRACTS<br />
incidents (64%) regardless of age or the presence of alcohol.The odds<br />
of an injury being due to a fall or motor vehicle accident in BAL+ patients<br />
compared to BAL- patients can be seen the table below.<br />
When controlling for the selected demographic factors and the<br />
presence of alcohol, the odds of an injury being the result of a fall increased<br />
significantly as patient age increased. Conversely, the odds of<br />
an injury being from a motor vehicle accident decreased significantly<br />
as the patient age increased.<br />
Conclusions: Age as well as alcohol does influence the odds of<br />
an injury being due to a fall or a motor vehicle accident in older<br />
adults. Our findings suggest that alcohol related injury prevention<br />
programs should be tailored to the age group targeted.<br />
Unadjusted odds of injury being due to falls or motor vehicle accident<br />
by age group<br />
A58<br />
Long term treatment with metformin in patients with type 2 diabetes<br />
and risk of vitamin B-12 deficiency.<br />
V. Nurpeisov. Emory, Dunwoody, GA.<br />
Background: Identification of risk factors for metformin-related<br />
vitamin B12 deficiency has major potential implications regarding the<br />
management of DM.<br />
Methods: A case-control study was conducted from a database<br />
in which the source population consisted of subjects who had levels of<br />
both serum vitamin B12 and hemoglobin A1C checked in a laboratory.<br />
63 cases of diabetes mellitus (HbA1C>7) and vitamin B12 deficiency<br />
secondary to metformin treatment were identified. 73 controls<br />
which were identified as HbA1C>7 with normal vitamin B12 greater<br />
than 200pmol/L served as the comparison group.<br />
Results: After adjusting for confounders, we found a clinically<br />
important and statistically significant association of vitamin B12 deficiency<br />
with duration of metformin use. After adjusting for confounders,<br />
we found a clinically important and statistically significant<br />
association of vitamin B12 deficiency with duration of metformin use.<br />
Among those using metformin for 1 year or more compared with<br />
those receiving metformin for less than 1 year, the adjusted odds ratio<br />
was 8.91 with a CI(4.1; 19.4),(P
P OSTER<br />
A BSTRACTS<br />
cancer (84%), liver cirrhosis (2%), end stage renal disease (2%),<br />
and AIDS (2%). Overall, 38% of the patients seen by palliative<br />
care died at home, 24% in the hospital, 5% in a nursing home, and<br />
4% at an inpatient hospice. Sixty percent of patients who received a<br />
palliative care consult went on to choose hospice for EOL care. In<br />
multivariable analyses, patients with cancer (AOR: 2.23, 95% CI:<br />
1.88, 2.65), those who had a social work assessment (1.39, 1.20,<br />
1.62), and those with an advance directive (1.72, 1.41, 2.08) or DNR<br />
order (2.11, 1.59, 2.80) were more likely to use hospice. Race and<br />
ethnicity were not statistically significant predictors of hospice use<br />
in this cohort.<br />
Conclusion: In this cohort, once patients received a palliative<br />
care consult, there were no racial and ethnic disparities in hospice<br />
use. This suggests that despite being historically underutilized, palliative<br />
care and hospice services are viable EOL care options for<br />
URMs and persons of low SES. Though cancer sufferers often receive<br />
palliative care consultation, continued efforts should be<br />
made to encourage consultation for patients with other life-limiting<br />
illnesses.<br />
A61<br />
Physical Restraints of Home-dwelling Elders: Perception by Home<br />
Care Providers.<br />
S. Kurata. Gerontological Nursing, Hamamatsu University School of<br />
Medicine, Hamamatsu, Japan.<br />
Supported By: Grant-in-Aid for Research Activity Start-up from<br />
the Ministry of Education, Culture, Sports, Science and Technology<br />
of Japan<br />
Background: Family caregivers may unconsciously use physical<br />
restraints on home-dwelling elders, which could include or lead to<br />
abuse. Home care providers need to grasp the conditions and specificities<br />
of physical restraints in home care and to support family caregivers.<br />
I investigated how the home care providers perceive physical<br />
restraints.<br />
Methods: A self-administered questionnaire survey was conducted<br />
for home care providers (home helpers, visiting nurses, visiting<br />
physicians, and care managers) of home-dwelling elders: the Japanese<br />
version of the perceptions of Physical Restraint Use Questionnaire;<br />
whether or how they recognize 12 physical restraints prohibited in institutions<br />
and 10 harmful effects of physical restraints; and whether<br />
they have taken courses of physical restraints.<br />
Results: Total 568 home care providers responded: 201 home<br />
helpers, 78 visiting nurses, 131 visiting physicians, and 158 care managers.<br />
The number of physical restraints recognized as prohibited was<br />
significantly different among visiting physicians (5.2±2.9), visiting<br />
nurses (5.9±3.2), home helpers (6.3±3.3), and care managers (8.4±2.6;<br />
p
P OSTER<br />
A BSTRACTS<br />
TNF-R1 levels were compared across tertiles of IL-6 levels using a<br />
Hodges-Lehmann non-parametric K-sample median test.<br />
Results: The analytic sample included 1429 participants with<br />
available data for both inflammatory markers and all adjusted covariates,<br />
among whom 408 were HIV-infected and 1021 were HIV-uninfected.<br />
In an adjusted model, a one log increase in ln(IL-6) was associated<br />
with a 0.123 (95% confidence interval [CI] =0.102-0.145, p <<br />
.001) log increase in ln(TNF-R1). This association was further<br />
demonstrated by a 0.115 log increase in ln(TNF-R1) for every one<br />
standard deviation change in ln(IL-6) (95% CI =0.095-0.135, p <<br />
.001). Moreover, higher median TNF-R1 levels were observed in the<br />
top tertile of IL-6 levels (1753 versus 1404 pg/ml, p < .001), regardless<br />
of HIV status and changes in CRP.<br />
Conclusions: IL-6 and TNF-R1 levels were positively associated<br />
in the ALIVE study. These findings provide initial insight into the relationship<br />
between IL-6 and TNF-R1 in this unique population and<br />
suggest further investigations into potential mechanisms leading to<br />
generalized inflammation and immune activation in HIV infection<br />
and aging.<br />
A64<br />
Care of the Vulnerable Elder Practice Improvement Module: Chart<br />
Review Alone as a Valuable Educational Experience.<br />
E. Oleson, S. McGee, M. Zanetti, S. Barrett, M. Pugnaire,<br />
J. Gurwitz, C. DuBeau. University of Massachusetts Medical School,<br />
Worcester, MA.<br />
Supported By: Supported by the Donald W. Reynolds Foundation<br />
Background: The Care of the Vulnerable Elder Practice Improvement<br />
Module (COVE-PIM) was developed by the <strong>American</strong><br />
Board of Internal Medicine for maintenance of board certification<br />
and has been adapted for residency programs. The COVE-PIM includes<br />
chart review of geriatric care to identify any gap in care, evaluation<br />
of the care system, and a quality improvement (QI) project to<br />
address the gap. We included COVE-PIM into a new required Ambulatory<br />
Care Block rotation for Medicine residents at UMass Memorial<br />
Medical Center as part of the geriatric medicine curriculum. Care<br />
system review and QI projects were not feasible in our setting, therefore,<br />
we adapted COVE-PIM as a formative exercise with chart review<br />
and a reflective evaluation on changes the residents would make<br />
make in the care of their older patients as a result of the exercise.<br />
Methods: Residents were asked to complete chart reviews on<br />
five patients > 60 years in their continuity clinic using the standard<br />
COVE-PIM review of documented chronic medical conditions,<br />
health habits, screening measures, physical exam, and advanced directive<br />
discussions. The reflective evaluation consisted of the resident’s<br />
anticipated changes in care of the elderly in screening for geriatric<br />
syndromes, such as cognitive impairment and falls, and documenting<br />
surrogate decision makers and advanced directives by completing the<br />
COVE-PIM chart review.<br />
Results: A total of 31 PG1 and PG2 Medicine residents completed<br />
112 chart reviews across 9 different clinical sites. Ninety percent<br />
of residents reported that the formative experience was useful<br />
and 100% of the residents felt the exercise increased the likelihood<br />
they would screen for common geriatric conditions. In the chart review,<br />
34% of residents reported documentation of wishes for life-sustaining<br />
care and 39% had recorded surrogate decision makers. In the<br />
reflective evaluation, 90% of residents felt that the exercise would<br />
improve their likelihood of documenting surrogate decision makers<br />
and discussions regarding end-of-life care.<br />
Conclusions: COVE-PIM chart review alone with added reflective<br />
evaluation helped residents identify gaps of care among their<br />
older patients and was considered a valuable educational experience<br />
that residents anticipated would impact future care. This modification<br />
may be more suitable for shorter ambulatory rotations.<br />
A65<br />
Integration of Geriatric Medicine into a Multi-Year Ambulatory<br />
Care Block Curriculum.<br />
E. Oleson, S. McGee, E. Murphy, G. Manchester, C. DuBeau.<br />
University of Massachusetts Medical School, Worcester, MA.<br />
Supported By: Supported by the Donald W. Reynolds Foundation<br />
Background: We describe the successful transition of a PGY1<br />
geriatric medicine block rotation for Medicine residents into an integrated,<br />
multi-year PGY1-3 Ambulatory Care Block (ACB) curriculum.<br />
The ACB was developed as a yearly, one-month required rotation<br />
incorporating elements of geriatric medicine, gender medicine, a<br />
primary care core curriculum and intensive continuity clinic experience,<br />
with a 3-year cyclical curriculum.<br />
Methods: A review of literature, online geriatric modules, and<br />
previous geriatric medicine curriculum was done to expand the ACB<br />
geriatric medicine educational content. Required GeriaSims modules,<br />
didactics, and an Evidence-Based Medicine (EBM) exercise<br />
were adapted from the previous PGY1 experience. We designed a<br />
progressive curriculum with PGY-specific objectives in the context of<br />
a specific theme (Curriculum Year 1 - geriatric assessment; Year 2 -<br />
transitions in care). Geriatric clinical experiences were PGY-specific<br />
(e.g., PGY1 - skilled nursing facility, PGY2 - geriatric clinic, PGY3 -<br />
home visit and Elder Services). A PGY4 chief resident designed a<br />
geriatric morning report as his CRIT project. Residents also completed<br />
a formative COVE-PIM chart review of their continuity clinic<br />
patients. These were added to primary care didactics, quality improvement<br />
project, and continuity and subspecialty clinics. An online<br />
Wiki was created as a resource for schedules, lectures, and independent<br />
assignments.<br />
Results: The ACB pilot year included 28 PGY1 and 29 PGY2<br />
residents. Feedback from residents and faculty was quite positive and<br />
90.5% of the residents agreed or strongly agreed that the integrated<br />
ACB was a better learning experience than the previous separate<br />
components. Feedback led to changes in clinical site scheduling, required<br />
online modules, and structure of the EBM session in the second<br />
year of this rotation.<br />
Conclusions: A geriatric medicine curriculum was successfully<br />
integrated into an ambulatory block rotation for Medicine residents.<br />
Now in its second year the block has been expanded to include PGY3<br />
residents and a new set of didactic sessions and home care clinical experiences<br />
for what will eventually be a three year rotating curriculum.<br />
Overall, we found a valuable geriatric medicine experience may be<br />
incorporated into the ambulatory curriculum for Medicine residents.<br />
A66<br />
Development and Validation of a Novel Geriatric Skills Assessment<br />
Tool (GSAT) to Identify Training Needs of Internal Medicine<br />
Residents and Faculty.<br />
N. Jamshed, 1 P. Zeballos, 1 S. Sinha. 2 1. Internal Medicine,<br />
WHC/Georgetown University School of Medicine, Washington, DC; 2.<br />
University of Toronto, toronto, ON, Canada.<br />
Purpose: This study reports the pilot data and preliminary validation<br />
of a novel, learner-focused, Geriactic Skills Assessment Tool<br />
(GSAT), in assessing training needs in geriatrics at a large academic<br />
community hospital. Methods: A voluntary survey was conducted<br />
amongst the IM faculty and residents using the GSAT. GSAT was developed<br />
based on 15 basic competencies identified by the <strong>American</strong><br />
Board of Internal Medicine (ABIM) for IM trainees. Faculty and residents<br />
were each asked to rate their confidence in performing, confidence<br />
in teaching and interest in further training, in each skill set. We<br />
assessed the cronback alpha coefficient for reliability of the GSAT.<br />
Fisher’s exact test was used to evaluate the participant confidence in<br />
performing and teaching particular skills, as well as their interest in<br />
pursuing further training around them. Results: 27 faculty and 27 residents<br />
completed the survey. The cronback alpha coefficient for the<br />
S38<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
reliability of the GSAT was 0.96. 70% participants identified high<br />
need for training in medication management and in differentiating<br />
delirium, dementia and depression (p〈0.05). Residents were significantly<br />
more likely to report interest in training in differentiating<br />
delirium, dementia and depression (p〈0.05) when compared to faculty.62%<br />
of all participants reported low confidence in performing<br />
fall risk assessment with no statistically significant difference between<br />
the groups (p〈0.05). Lowest confidence in teaching was in modifying<br />
management, assessing fall risk, and use of antipsychotics (p〈<br />
0.05). There was no statistically significant difference between the<br />
groups. Residents with high interest of training in medication management,<br />
fall assessment, differentiating delirium, dementia and depression,<br />
and end of life care discussions also had high confidence in<br />
teaching and performing these skills (p〈0.05). It appears that residents’<br />
further interest in training was independent of their confidence.<br />
IM Faculty had no statistically significant interest in further<br />
training in any geriatric skill set.Conclusion: GSAT is reliable at identifying<br />
training needs in geriatric competencies. In this cohort the<br />
need was greater amongst the residents than the faculty. This pilot<br />
data supports the reliability and validity of this tool for curriculum<br />
development in geriatrics.<br />
A67<br />
An Alternative to the Geriatric Physical Diagnosis Lab for Second<br />
Year Medical Students.<br />
N. A. Kayani, S. Hazelett. Summa Health System, Akron, OH.<br />
Background: Previous physical diagnosis labs (PDL) in our institution<br />
involved mock physical exams of community-dwelling elderly<br />
volunteers and were not found to be valuable teaching tools for<br />
second year medical students. Building on an idea from an AGS education<br />
swap in 2009, we developed a new format to teach the important<br />
aspects of basic geriatric care within a limited 2 hour timeframe.<br />
Purpose: To describe a novel interdisciplinary curriculum for<br />
second year medical students that allow students to practice, visualize<br />
and experience for themselves some of the material they have<br />
learned in the classroom setting prior to exposure to real patients.<br />
Methods: During the PDL, the students rotate through a series<br />
of 5 stations each of which is precepted by one of the following Geriatric<br />
Medicine specialists: a physician, a pharmacist, a Fellow in training,<br />
a Clinical Nurse Specialist, Social Worker and an Occupational<br />
Therapist. Six students attend 20 minute sessions at each of the following<br />
stations:<br />
1) Cognitive assessment tools<br />
2) Pharmacology of aging<br />
3) Role of PT and OT<br />
4) Problems with transitions of care using an investigator generated<br />
“price is right” (sources of payment) interactive game<br />
5) Sensory changes with aging<br />
A survey was administered at the end of the PDL where students<br />
were asked to rate from 1-5 the value of the information<br />
gained.<br />
Results: The PDLs have been offered for the last 3 years, with<br />
120 students participating per year. When asked to rank how well<br />
each session helped them become more prepared for assessments or<br />
gain insights into geriatric issues on a scale of 1-5 with 5 being the<br />
best, the average for the cognitive assessments for years 1, 2 and 3<br />
were 4.4, 4.4 and 4.3, respectively. For pharmacology of aging/sources<br />
of payment averages were 4.1, 4.5 and 4.4. For the role of PT and OT<br />
averages were 4.4, 4.5 and 4.4. For transitions of care averages were<br />
4.5 and 4.3, measured in years 2 and 3 only. For sensory changes the<br />
average score was 4.4, measured in year 3 only. Overall value of the<br />
PDL as a learning experience averaged 4.5 each year.<br />
Conclusion: We have combined some standard PDL sessions<br />
with some sessions unique to our program (e.g., the “price is right”<br />
game for the transitions session) which has resulted in a highly valuable<br />
learning experience as reported by students.<br />
A68<br />
Image Atlas of Aging: Highlighting Normal Age-Related Gross and<br />
Histologic Changes.<br />
P. J. Bonavitacola, G. P. Blanchard, S. McGee, K. Johansen,<br />
V. Vanguri, K. Cornejo, A. Khan, C. Burnham, J. Gurwitz,<br />
M. Pugnaire. Division of Geriatric Medicine, University of<br />
Massachusetts Medical School, Worcester, MA.<br />
OBJECTIVE: The Image Atlas of Aging is an original UMMS<br />
educational product developed to highlight normal age-related<br />
anatomic and histologic changes within the renal system. Our goal<br />
was to integrate the Image Atlas into the existing MS1 “Disease,<br />
Structure, and Function” (DSF) curriculum, emphasizing: 1) Normal<br />
anatomic, physiologic, and histologic differences between the young<br />
and aged kidney; 2) The principle of homeostenosis, illustrating how<br />
the renal system becomes more susceptible to acute injury with the<br />
loss of age-related functional reserve (but that disease is not inevitable<br />
with normal aging).<br />
BACKGROUND: There is a dearth of existing educational resources<br />
that pictorially contrast normal age-related anatomic and histologic<br />
organ system changes. Most available resources demonstrate<br />
normal versus pathologic.<br />
METHODS: Pivotal to Image Atlas completion was developing<br />
partnerships with the UMMS Pathology Department and UMMS Division<br />
of Anatomy and Cell Biology. UMMS’ Advancing <strong>Geriatrics</strong><br />
Education (AGE)/Reynolds summer student forged new working relationships<br />
with two pathology chief residents and the co-DSF course<br />
director.<br />
Drawing from existing histological and anatomic images generated<br />
by the UMMS Department of Pathology (histologic slides,<br />
culled from recent autopsies and a legacy slide collection) and the<br />
UMMS Division of Anatomy and Cell Biology (dissection images),<br />
and online textbooks, a MS2 student compiled, annotated, and produced<br />
an online module to be used by anatomy students/faculty and<br />
geriatricians.<br />
After discussions with UMMS’ AGE team, the DSF course directors<br />
agreed to integrate the Image Atlas into the DSF curriculum.<br />
The Atlas served as the student prep material both for two UMMS<br />
geriatrician visits to the anatomy lab during abdominal cavity dissections<br />
and an introductory lecture given by an academic geriatrician.<br />
EVALUATION: All MS1s (n=125) will complete an end-ofcourse<br />
evaluation for DSF that will encompass the Image Atlas<br />
module.<br />
CONCLUSIONS: The Image Atlas was successfully incorporated<br />
into the existing DSF curriculum, introducing the concepts of<br />
normal aging and homeostenosis to first year medical students. Our<br />
goal is to have the Image Atlas serve as a prototype to illustrate normal<br />
aging in other organ systems that will also be integrated within<br />
the DSF curriculum.<br />
A69<br />
The Effects of a Pre-Clinical <strong>Geriatrics</strong> Curriculum on Attitudes<br />
Towards and Interest in Geriatric Medicine.<br />
P. Borker, A. Talati, E. O’Toole, P. DeGolia. Case Western Reserve<br />
University School of Medicine, Cleveland, OH.<br />
Supported By: MacGregor Foundation and the Health Resources<br />
Services Administration, Bureau of Health Professions Geriatric<br />
Education Centers Program<br />
BACKGROUND: It is projected that by 2030, 20% of the U.S.<br />
population will be over age 65. Since 1978, the IOM has called for improvements<br />
in geriatric education for health care providers, most recently<br />
re-addressing this issue in 2008. In this study, we assessed the<br />
effects of a multi-year, pre-clinical geriatrics curriculum on student’s<br />
interest in and knowledge of care for geriatric patients.<br />
METHODS: Cohort study of fourteen volunteering medical<br />
students during their second years immersed in a six-week geriatrics<br />
AGS 2012 ANNUAL MEETING<br />
S39
P OSTER<br />
A BSTRACTS<br />
curriculum between 2010–11 and 2011–12. Students met twice per<br />
week for the following activities: (1) focus group sessions discussing<br />
clinical and personal experiences with older adults; (2) interactive<br />
group sessions with geriatric specialists; and (3) shadowing activities<br />
with volunteering physicians and geriatric patients. Students participating<br />
in 2011 – 2012 also participated in a first year introductory<br />
course to geriatric patients and self-selected to participate during the<br />
second year curriculum. Students are surveyed regarding interest in<br />
geriatrics and examined using a geriatrics knowledge test pre and<br />
post intervention. Weekly focus group sessions are recorded and analyzed<br />
using grounded theory methodology.<br />
RESULTS: Pre-intervention geriatric interest survey for<br />
2011–12 show that 60% of students ‘strongly agree’ with the statement<br />
“I understand the unique issues involved in care for the elderly,<br />
compared to 22% of students from 2010–11. Furthermore, 20% of<br />
participating students reported that they are interested in pursuing a<br />
career in geriatrics during the 2011–12 curriculum; by contrast only<br />
11% of students reported interest in geriatrics from 2010–11. Pre-Intervention<br />
use of the <strong>Geriatrics</strong> Knowledge Test showed mean score<br />
of 50% (sd = 11%) during 2011–12; no significant change from<br />
2010–11 in which mean score was 48% (sd= 9%).<br />
CONCLUSION: Current data suggests longer exposure<br />
through a focused curriculum may improve interest and comfort with<br />
older adults, both within geriatrics or other medical fields, although<br />
study lacks power to comment on significance. Data collection, including<br />
career interest surveys for the class of 2010-11 and post intervention<br />
surveys for 2011–12, is in progress. Further investigation, including<br />
use of a 2:1 matched comparison control group is also<br />
pending, but may help eliminate selection bias and further validate<br />
study results.<br />
A70<br />
Fulfilling an ACGME Competency: Impact of a Novel<br />
Communication Skills Curriculum.<br />
R. Ramaswamy, 1,2 A. Williams, 1,2 A. S. Kelley, 1 E. M. Clark. 2,1 1.<br />
Brookdale Department of <strong>Geriatrics</strong> and Palliative Medicine, Mount<br />
Sinai School of Medicine, New York, NY; 2. GRECC, James J. Peters<br />
VA Medical Center, Bronx, NY.<br />
Introduction: Effective communication is essential to health<br />
care delivery, especially in care of the elderly, and is associated with<br />
increased adherence to treatment and patient satisfaction. The<br />
ACGME has designated communication skills as a core competency.<br />
Following a needs assessment, we developed an evidence-based communication<br />
skills curriculum with the objective to increase confidence<br />
and expertise among Internal Medicine interns in communicating<br />
with older patients.<br />
Methods: The communication skills curriculum was integrated<br />
in the 4-week <strong>Geriatrics</strong> block in the first year of Internal Medicine<br />
residency training at the Bronx VA. Developed and facilitated by 2<br />
geriatrics fellows, the curriculum consists of 2 small group sessions,<br />
1.5 hours each, involving 2 interns at a time. The sessions include didactic<br />
learning, discussion, role-play and self-study. Skills taught include<br />
Active Listening, Ask-Tell-Ask and SPIKES [1]. Participants<br />
complete questionnaires at baseline, after the course and at 3 months.<br />
Baseline data include demographics, past training in communication<br />
and self-identified communication challenges. Self-reported confidence<br />
with specific communication tasks is also measured on a 4-<br />
point Likert scale (1= minimal confidence, 4= high confidence).<br />
Results: To date, 9 interns have completed the curriculum. Five<br />
were ≥ 30 years old and 5 had medical school training in English.<br />
Only 3 reported any prior training in communication skills. Respondents<br />
found developing rapport and building trust with older patients<br />
most challenging. Compared to baseline, the interns’ average overall<br />
confidence in communicating with older patients increased by 25%<br />
(from 3.0 to 3.75); comfort level in delivering bad news to an older patient<br />
increased by 50% (from 2.0 to 3.0); comfort level in discussing<br />
advance care planning with an older patient and in conducting a family<br />
meeting both increased by 48% (from 2.11 to 3.13). SPIKES was<br />
felt to be the most useful skill and 71% respondents preferred the<br />
small group format as a safe way to learn and practice the skills.<br />
Conclusion: Implementation of a structured, standardized communication<br />
skills curriculum in Internal Medicine internship has<br />
been effective in improving confidence and comfort in communicating<br />
with older adults.<br />
[1] Baile WF, et al., Oncologist 2000; 5:302–311.<br />
A71<br />
An Intervention to Improve Medical Students’ Interprofessional<br />
Acumen.<br />
R. M. Wright, 1 J. H. Lingler, 2 J. P. Pschirer, 3 J. F. Mahoney, 4<br />
D. A. Nace. 1 1. Medicine/Division of <strong>Geriatrics</strong>, University of<br />
Pittsburgh, Pittsburgh, PA; 2. School of Nursing, University of<br />
Pittsburgh, Pittsburgh, PA; 3. School of Pharmacy, University of<br />
Pittsburgh, Pittsburgh, PA; 4. School of Medicine, University of<br />
Pittsburgh, Pittsburgh, PA.<br />
Supported By: Josiah P. Macy Foundation<br />
Health Resources and Services Administration (GACA)<br />
Background: Teamwork and interdisciplinary collaboration are<br />
essential to providing the best geriatric care but are challenging to<br />
teach medical students. We compared pre- and post-course knowledge,<br />
skills, and attitudes toward interprofessional (IP) teamwork<br />
among medical students who underwent a multimodal, IP team education<br />
intervention and among students who did not.<br />
Methods: 197 3rd-year medical students, nurse practitioner<br />
(NP)students, and pharmacy students, were divided into 6 IP teams<br />
(intervention group) and 10 non-IP, medical student-only teams (controls).<br />
Each IP team consisted of 4 or 5 self-selected medical students,<br />
4 or 5 NP and 1 or 2 pharmacy students. All teams received a lecture<br />
on transitions of care (TOC) and participated in a geriatric case TOC<br />
simulation and debriefing session. IP team instruction included a lecture<br />
on effective teamwork and IP competencies, a video demonstration<br />
of ineffective IP teamwork, and self-assessment of videorecorded<br />
teamwork. Before-and-after team performance surveys<br />
assessed students on perceived IP teamwork knowledge, skills, and<br />
attitudes. Paired t-test analyses assessed within-group pre- and posttest<br />
differences.<br />
Results: 18 (67%) IP and 83 (61%) non-IP medical students returned<br />
both 28-item surveys. Both groups demonstrated significant<br />
improvement on multiple items. Knowledge items that improved only<br />
within the IP group were “teams are more responsive to the complex<br />
needs of geriatric patients;” “team approach makes the delivery of<br />
care more efficient;” and “I see caring for older patients as a unique<br />
challenge.” Despite having lower pre-test ratings on 9 teamwork<br />
skills items, IP students rated post-test skills on average as “very<br />
good” or better for 10 of 11 skill items while non-IP students rated<br />
their post-test skills as “very good” or better on only 4 out of 11 items.<br />
Conclusion: Medical students generally considered themselves<br />
knowledgeable but not skillful at working in teams. A multimodal, experiential<br />
IP curriculum effectively improved knowledge, skills and<br />
attitudes toward IP teamwork. Additional analyses from this rich<br />
dataset will be presented. Future directions include testing for retention<br />
and transfer of IP team concepts.<br />
A72<br />
Teaching Fall Risk Assessment to Medical Students Using Meals on<br />
Wheels.<br />
S. Chenna, K. M. Sink, K. Callahan, J. Demons, H. Atkinson.<br />
<strong>Geriatrics</strong>, Wake Forest University, Winston Salem, NC.<br />
BACKGROUND: The AAMC and John A. Hartford Foundation<br />
have recommended a set of minimum geriatric competencies for<br />
S40<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
medical students, which include fall risk assessment. We describe an<br />
innovative method of teaching fall risk assessment using the Meals on<br />
Wheels (MOW) community program.<br />
METHODS: During an intense one week geriatric rotation, 3rd<br />
year students perform a fall risk assessment on a MOW client in their<br />
home. The evaluation includes: history of falls, fear of falling, medication<br />
review, visual acuity, Get-up and Go test, Mini-Cog, and brief<br />
home safety evaluation. ADLs and IADLs are also obtained. 4 of the<br />
8 recommended competency domains are covered in this experience.<br />
A <strong>Geriatrics</strong> attending reviews the assessment and provides relevant<br />
teaching. Students provided anonymous feedback on the MOW fall<br />
risk assessment on a scale of 1-10 (10=best). Using a retrospective prepost<br />
survey we assessed the self-reported change in the students’ confidence<br />
and perceived competence in elements of fall risk assessment.<br />
RESULTS: In the class of 2012, 110/124 completed the in-home<br />
fall risk assessment. 14 students did not complete it due to logistical<br />
problems. Students rated the MOW fall risk assessment highly (mean<br />
of 7.26 (of 10)). Students commented that it was a unique, “eye opening<br />
experience” to see the depth of need and the services available<br />
and enjoyed the novel opportunity for learning outside of the typical<br />
hospital setting. 60/110 (54%) completed the retrospective survey.<br />
Results on confidence in performing individual tasks are presented in<br />
the Table. 51% of students also report having assessed fall history<br />
since this rotation.<br />
CONCLUSION: The innovative MOW fall risk assessment experience<br />
efficiently teaches 4 of 8 competency domains with minimal<br />
faculty effort, was well received by medical students, and resulted in<br />
much improved confidence in elements of fall risk assessment. Our<br />
MOW falls risk assessment could easily be adopted by most medical<br />
schools.<br />
Percentage of students who reported moderate to very high confidence/competence<br />
BEFORE and AFTER the MOW fall risk<br />
assessment<br />
A73<br />
Evaluation of Medical Student Training and Attitudes towards<br />
<strong>Geriatrics</strong> at Wuhan Medical School.<br />
S. M. Shi, R. Sherer, I. Morgan, H. Dong, B. Cooper. University of<br />
Chicago - Pritzker School of Medicine, Chicago, IL.<br />
Supported By: Pritzker School of Medicine via Summer Research<br />
Program<br />
<strong>Geriatrics</strong> is an emerging field in China, with no national certification<br />
or formal specialty training presently. In the past decade,<br />
China has prioritized shifting the delivery of primary care for urban<br />
populations to community health centers (CHCs) rather than larger<br />
public hospitals. The ease of access, closer proximity, and lower outof-pocket<br />
costs make CHC care a more favorable alternative over<br />
sub-specialty care in tertiary hospitals for many elderly. Thus geriatrics<br />
training has become an increasing imperative to effective delivery<br />
of primary care in CHCs. We evaluated faculty and student attitudes<br />
towards geriatrics, and investigated whether a new CHC<br />
Clerkship experience at Wuhan University affected student opinions.<br />
We also explored the delivery of health care in local community settings,<br />
particularly to the elderly.<br />
Students at Wuhan University Medical School were surveyed, as<br />
well as elder care givers at the QingShan Community Health Center.<br />
A total of 18 pilot CHC clerkship students (‘Pilot’) were surveyed,<br />
with questions regarding their perceptions of geriatrics as well as<br />
judgment on current exposure to geriatrics during clinical and preclinical<br />
training. Parallel surveys were administered to 41 fourth year<br />
medical students who did not participate in the pilot (Control). ‘Elderly<br />
patients’ were defined as age over 60 years.<br />
In general, more CHC students reported that their medical<br />
school training, both courses and clinical, prepared them for work<br />
with the elderly. None of these differences were statistically significant<br />
(Mann-Whitney test, no P values
P OSTER<br />
A BSTRACTS<br />
A75<br />
<strong>Geriatrics</strong> and Aging through Transitional Environments (GATE):<br />
A Longitudinal, Competency-Based Medical Student Curriculum.<br />
S. Limaye, S. Williams, S. G. Smith, A. Baron. Medicine, University of<br />
Chicago, Chicago, IL.<br />
Supported By: Pritzker School of Medicine Dean’s Award,<br />
University of Chicago<br />
Background:<br />
The AAMC requires medical schools to address 26 minimum<br />
geriatric competencies. GATE targets 17 of these in a 4 year, systemsbased<br />
curriculum focused on geriatric assessment and transitions of<br />
care. Goals of the GATE curriculum are to improve medical students’<br />
geriatric assessment skills, develop competency-based evaluation<br />
tools, and integrate nationally recognized geriatrics curricula into<br />
existing ones.<br />
Methods:<br />
In a 2 year pilot integrated longitudinally into existing medical<br />
school courses from MS1-4, the GATE curriculum teaches geriatric<br />
assessment skills pertinent to different care settings: in-home geriatric<br />
functional history and home safety assessments; outpatient geriatric<br />
assessments (e.g. MMSE) and clinical skills (e.g. advance directives);<br />
hazards of hospitalization and transitions of care; and nursing<br />
home assessment and interdisciplinary care planning.<br />
Teaching methods include: lectures, in-home interviews with<br />
trained patients; reflective essays; skills-based practice workshop;<br />
simulated patient experiences; pocket cards; inpatient teaching<br />
rounds; podcast, and; geriatrician-led nursing home rounds.<br />
GATE evaluation is curriculum year specific and longitudinal,<br />
with periodic assessments of students’ knowledge of ADLs/IADLs,<br />
attitudes towards older adults, and confidence in skills in select competency<br />
domains.<br />
Results:<br />
Students’ knowledge of ADLs/IADLs improved after GATE<br />
intervention. Pre GATE-1 mean score = 5.58 (14 possible correct).<br />
Post GATE-2 mean score =11.70; t(121) =-6.9, p
P OSTER<br />
A BSTRACTS<br />
RESULTS:To date 20 IM residents have completed the rotation<br />
and 85% have completed an evaluation. The average overall<br />
score was 4.6/5. The case presentation and transitional care clinic received<br />
the highest scores of 4.75. Resident feedback has been positive<br />
and constructive, and the module has been modified in response.<br />
Example comments include, “more experiences like this<br />
week would be helpful,” and “great experience and rotation definitely<br />
helps me understand what to focus on and recognize in the<br />
care of elderly patients.”<br />
CONCLUSION:Medical residents express a strong need to<br />
learn about systems-based practice. A geriatrics rotation designed to<br />
underscore competency in systems-based practice has been well received<br />
and helped to address attitudes and gaps in knowledge about<br />
the care of older adults.<br />
A78<br />
Health professional students’ perceived need for interprofessional<br />
geriatric education.<br />
S. B. Bhattacharya, 1 M. Rosso, 1 V. Villareal, 1 C. Obering, 2 M. Eng, 3<br />
M. Peterson, 1 D. Ebbert, 1 R. Bhattacharya. 4 1. Family Medicine,<br />
Division of Geriatric Medicine, Univ of Kansas Medical Ctr, Kansas<br />
City, KS; 2. Pharmacy Practice, Univ of Missouri Kansas City, Kansas<br />
City, MO; 3. Pharmacy Practice, Univ of Kansas Medical Ctr, Kansas<br />
City, KS; 4. Internal Medicine, Univ of Kansas Medical Ctr, Kansas<br />
City, KS.<br />
Background<br />
An Institute of Medicine core competency for all healthcare<br />
professions is the ability “to work in interdisciplinary teams”. In addition,<br />
the Cochrane Library asserts that delivery of care will require<br />
the involvement of multiple health professions due to an aging<br />
population and a shift from acute to chronic care. Consequently,<br />
good interprofessional collaboration to coordinate patient care is<br />
critical.<br />
The <strong>Geriatrics</strong> Champions Program began in the Fall of 2011 at<br />
the University of Kansas Medical Center to build interprofessional<br />
collaboration in geriatric care utilizing a Team-Based Learning<br />
(TBL) format. This 8 session program was based on the “Minimum<br />
<strong>Geriatrics</strong> Competencies for IM-FM Residents” (released 6/09). Targeted<br />
audiences were family medicine residents and nurse practitioner,<br />
pharmacy and social work students. Prior to Session 1, we assessed<br />
their perception of the need for interprofessional education<br />
(IPE) in geriatric care and their familiarity with TBL. <strong>Here</strong>, we present<br />
our results.<br />
Methods<br />
Prior to Session 1, learners completed 2 voluntary and confidential<br />
electronic surveys. The 1st 6 item survey asked about their school<br />
and source of program knowledge. The 2nd 11 item Likert scale survey<br />
asked about their interest and expectations in learning geriatrics<br />
in an IPE and TBL format, as well as their prior experience and perceived<br />
benefit of IPE and TBL.<br />
Results<br />
Eighty-seven of 133 completed the survey including 47 Nursing<br />
(54% of total), 30 Pharmacy (34%), 9 Resident (10%), and 1 Social<br />
Work (1%) student. Most (72%) heard about this program from faculty<br />
and 91% were glad to participate in the program. Despite 53%<br />
and 68% knowing about IPE and TBL, this was the first IPE opportunity<br />
for 87%. Eighty-five (97%) anticipated learning something<br />
new. Most (95%) felt that IPE, and 78% and 76% felt that TBL, was<br />
useful and necessary, respectively.<br />
Discussion<br />
The majority were new to the IPE format, yet anticipated a good<br />
experience. Most felt that IPE was useful, but were less optimistic about<br />
TBL.This data shows learner willingness to engage in IPE and TBL for<br />
geriatric education, in concert with national recommendations.<br />
A79<br />
<strong>Geriatrics</strong> and Aging through Transitional Environments (GATE)<br />
MS2 Curriculum: Introduction to Geriatric Assessments.<br />
S. Williams, S. Limaye, S. G. Smith, A. Baron. Medicine, University of<br />
Chicago, Chicago, IL.<br />
Supported By: Pritzker School of Medicine Dean’s Award,<br />
University of Chicago<br />
Background:<br />
The GATE curriculum is a 4 year, systems-based curriculum<br />
teaching geriatrics across the spectrum of care settings to medical students.<br />
GATE-2 focuses on outpatient geriatric assessment and communication<br />
skills. Goals are to enhance skills in targeted AAMC<br />
competency domains (falls/balance/gait, health care planning and<br />
promotion, and cognitive and behavioral), and to develop competency-based<br />
evaluation tools and methods.<br />
Methods:<br />
GATE-2 includes a lecture on geriatric assessments and strategies<br />
for: communicating with patients with dementia and caregivers;<br />
conducting advance directive discussions; addressing health literacy,<br />
and; administering geriatric screening tests for depression, physical<br />
function, and cognition. A two hour skills based workshop facilitated<br />
by inter-disciplinary faculty allows role play and skills assessment.<br />
Geriatric SP encounters present challenges assessing patient’s cognition,<br />
depression, and physical function, addressing advance directives<br />
and health literacy, and jointly interviewing patients with dementia<br />
and collateral historian. Encounters are videotaped. Student’s performance<br />
is evaluated verbally by preceptor and SP. Student, SP and<br />
preceptor complete a written, competency-based evaluation of student’s<br />
clinical and interviewing skills.<br />
Results:<br />
Eighty-seven Pritzker MS2 participated in geriatric SP encounters.<br />
In a 360 degree evaluation of geriatric interviewing skills across<br />
cases, there was no difference in self, preceptor and SP evaluations for<br />
Depression, Health literacy and Dementia cases. SP scores were<br />
lower than both preceptor and student self-evaluations for MMSE<br />
and Physical Function cases. Student self-evaluation was lower than<br />
SP evaluation for Advance Directives case. In evaluation of case specific<br />
clinical skills, there was no difference in self, preceptor and SP<br />
evaluations for Depression, Health literacy, Dementia and Advance<br />
Directives cases. For Physical Function and MMSE cases, SP evaluation<br />
was lower than both preceptor and student self-evaluation.<br />
Conclusions:<br />
A 360 degree criterion-based assessment tool provides variable<br />
perspectives of student competencies in discrete assessment and communication<br />
skills. Future work will focus on inter-rater reliability in<br />
assessments via training students, preceptors and simulated patients<br />
on use of instrument.<br />
A80<br />
Increasing Residency Training of Goal-oriented Treatment Options<br />
in Patients with Life-Limiting Illnesses.<br />
T. Lee, 1 Q. Cao, 1 S. Hayes, 2 P. Austin, 1 M. Zafar, 1 R. Newman. 1 1.<br />
Family Medicine, East Carolina University, Greenville, NC; 2. Family<br />
Medicine, Naval Hospital, Jacksonville, FL.<br />
Supported By: HRSA:K01 HP20471, Geriatric Academic Career<br />
Award<br />
Objectives: For many patients with life-limiting illnesses, defining<br />
and discussing goals of future medical care (advance care planning)<br />
are very important. This study measures the effects of education<br />
to the in-training residents of family medicine (FM) and internal<br />
medicine (IM) residency programs at East Carolina University<br />
(ECU).<br />
AGS 2012 ANNUAL MEETING<br />
S43
P OSTER<br />
A BSTRACTS<br />
Design: Based on the results of the informal assessment of need<br />
from the residents and faculty, educational materials were developed.<br />
These included discussion of advance care planning, MOST (POLST)<br />
form, FIVE WISHES, healthcare power of attorney, and living will. A<br />
2-hour education and discussion session was given to all in-training<br />
FM and IM residents at ECU. Pre- and post-tests were administered<br />
to measure their medical knowledge as well as attitudes toward advance<br />
care planning.<br />
Results: A total of 70 pre-test and 53 post-test scores were analyzed.<br />
Overall knowledge improved with the educational sessions<br />
(74.9% vs 90.5% correctly answered pre- and post-test, respectively).<br />
Also, the residents’ own attitude toward advance care planning<br />
changed favoring less aggressive care at the end-of-life (EOL).<br />
Conclusions: Educational sessions significantly impacted residents’<br />
knowledge and attitude about advance care planning and<br />
EOL care.<br />
Knowledge and attitude scores<br />
EOL = end of life<br />
A81<br />
Implementing the Objective Structured Clinical Examination<br />
(OSCE) in a <strong>Geriatrics</strong> Fellowship Program – a three-year<br />
experience.<br />
T. J. Avelino-Silva, L. A. Gil, S. M. Lin, L. L. Farias, E. L. Kikuchi,<br />
C. K. Suemoto, W. Jacob-Filho. <strong>Geriatrics</strong> Division, Department of<br />
Internal Medicine, University of Sao Paulo Medical School, São<br />
Paulo, SP, Brazil.<br />
Supported By: None of the authors reported a potential, real, or<br />
perceived conflict of interest or financial disclosure. No sponsors<br />
participated in or funded this research.<br />
Background: The Objective Structured Clinical Examination<br />
(OSCE) appears to be an effective alternative for assessing not only<br />
medical knowledge, but also clinical skills, including effective communication<br />
and physical examination skills. Our purpose was to implement<br />
an OSCE model in a <strong>Geriatrics</strong> fellowship program and to compare<br />
the instrument with traditional essay examination.<br />
Methods: Seventy first- and second-year geriatric fellows were<br />
initially submitted to a traditional essay examination and scored from<br />
0 to 10 by a faculty member. Subsequently, the same fellows underwent<br />
an OSCE with eight ten-minute stations, covering a wide range<br />
of essential aspects of geriatric knowledge. Each OSCE station had<br />
an examiner responsible for its evaluation according to a predefined<br />
checklist. Checklist items were classified for analysis purposes as clinical<br />
knowledge items (CKI) and communication skills items (CSI);<br />
student responses were scored 0-10.<br />
Results: While essay exams took from 30 to 45 minutes to complete,<br />
180 to 200 minutes were required to evaluate students using the<br />
proposed OSCE method. Students scored an average of 6.2±1.2 on<br />
the traditional essay examination versus 6.6±1.0 on the OSCE<br />
(p
P OSTER<br />
A BSTRACTS<br />
A83<br />
Preparing to Care for an Aging Population: Medical Student<br />
Reflections on their Clinical Mentors within a New <strong>Geriatrics</strong><br />
Curriculum.<br />
T. W. Farrell, 1 R. R. Shield, 3 A. Nanda, 2 S. Campbell, 3 T. Wetle. 4 1.<br />
Division of <strong>Geriatrics</strong>, University of Utah School of Medicine, Salt<br />
Lake City, UT; 2. Division of <strong>Geriatrics</strong>, Warren Alpert Medical<br />
School of Brown University, Providence, RI; 3. Center for<br />
Gerontology and Healthcare Research, Warren Alpert Medical School<br />
of Brown University, Providence, RI; 4. Public Health Program,<br />
Warren Alpert Medical School of Brown University, Providence, RI.<br />
Supported By: This work was supported by a grant from the Donald<br />
W. Reynolds Foundation.<br />
Background:<br />
Mentoring relationships between faculty and medical students<br />
are increasingly recognized as key contributors to medical students’<br />
developing clinical expertise and approaches to specific patient populations.<br />
Reflective writing techniques such as journaling help provide<br />
insights into the process by which medical students are mentored in<br />
clinical settings and develop into practicing physicians. However,<br />
medical students’ reflections about their experiences with physician<br />
mentors have rarely been studied.<br />
Methods:<br />
From 2007 to 2010, we collected and analyzed 405 medical student<br />
journal entries regarding students’ experiences with a new geriatrics<br />
curriculum at the Warren Alpert Medical School of Brown University,<br />
including both formal and informal mentored experiences in<br />
community and hospital settings. Thirty preclinical and clinical volunteer<br />
medical student journalers from all class years participated in<br />
this journaling project. We employed qualitative analytic techniques<br />
in which rigor and saturation of categories were achieved. Using an iterative<br />
interdisciplinary team process, key themes were identified relating<br />
to students’ experiences with their clinical mentors.<br />
Results:<br />
Three major themes regarding mentoring emerged from the<br />
journals: (1) Exposure to clinical mentors challenged students’ preconceptions<br />
regarding older adults and geriatric medicine; (2) Students<br />
learned new subject matter and techniques from observing<br />
their mentors; and (3) Students provided both positive and negative<br />
assessments of their mentors.<br />
Conclusions:<br />
Opportunities exist to improve current approaches to clinical<br />
mentoring of medical students learning to care for older adults. Such<br />
mentorship may be particularly relevant to promoting medical students’<br />
interest in older persons and geriatrics. Reflective journaling<br />
provides important insights into the process by which medical students<br />
draw upon mentored clinical experiences during their training.<br />
A84<br />
A New Strategy for Teaching Residents Roles of<br />
Interprofessional Teams.<br />
T. C. James, 1 G. R. Westmoreland, 1 C. Arenson, 2 S. R. Counsell. 1 1.<br />
Section of <strong>Geriatrics</strong>, Indiana University School of Medicine,<br />
Indianapolis, IN; 2. Family and Community Medicine, Thomas<br />
Jefferson University, Philadelphia, PA.<br />
Supported By: HRSA GACA<br />
Background: New models of interprofessional care have been<br />
shown to improve outcomes for seniors at high risk for functional decline.<br />
However, Internal Medicine (IM) residents have few opportunities<br />
to learn the roles of interprofessional teams (IPTs). The Minnesota<br />
Complexity Assessment Method (MCAM) tool evaluates<br />
person-specific factors that interfere with usual decision-making and<br />
can highlight roles for IPTs.<br />
Methods: For this mini-course, IM residents completed an online<br />
audio PowerPoint lecture describing the MCAM tool and roles of<br />
the IPT. IM residents met with the geriatrician faculty member who<br />
demonstrated how to use the MCAM tool. Residents practiced using<br />
the MCAM tool on a case scenario then were given a real patient to<br />
assess using the MCAM tool. During the IPT conference the MCAM<br />
tool was applied to a patient the resident had researched in preparation<br />
for the meeting. Evaluation included pre- and post-tests assessing<br />
attitudes about IPTs and qualitative responses to questions pertaining<br />
to usefulness of the mini-course.<br />
Results: Twenty IM residents completed the mini-course. Results<br />
comparing pre- and post-tests demonstrate movement towards<br />
greater understanding of IPT care. There were higher average agreement<br />
ratings in the post-test compared to the pre-test for: “interdisciplinary<br />
health professionals know each other’s roles,” “I know when<br />
my patient needs an interdisciplinary team” and “interdisciplinary information<br />
tells us about disease progression;” and lower average<br />
agreement for items “working with colleagues in my own profession<br />
is more efficient” and “the goal of interdisciplinary teams is to support<br />
physician care plans.” Residents agreed that the mini-course was<br />
useful to their practice (40% agreed and 60% strongly agreed) and<br />
that MCAM was a useful tool (70% agreed, 25% strongly agreed and<br />
5% undecided). Residents stated they will look for opportunities to<br />
collaborate with IPTs.<br />
Conclusions: For IM residents, using the MCAM tool for evaluation<br />
of patient complexity in an IPT setting appears to be a successful<br />
strategy to highlight the roles of IPT care. Response to this minicourse<br />
suggests that residents may be receptive to additional<br />
opportunities for learning about, from, and with other health professionals<br />
to improve outcomes for at risk seniors.<br />
A85<br />
Quality Improvement Curriculum for <strong>Geriatrics</strong> Fellows Using Lean<br />
Methodology.<br />
G. Gupte, 1 J. A. Eng, 2,1 M. Young, 2 R. M. Zitnay, 2 K. James, 2<br />
M. Sissoko, 2 W. Suen. 2 1. Boston University School of Public Health,<br />
Boston, MA; 2. Section of <strong>Geriatrics</strong>, Boston University Medical<br />
Center , Boston, MA.<br />
Supported By: HRSA: Geriatric Academic Career Award<br />
John A. Hartford Foundation<br />
BACKGROUND: Practice-based learning and improvement<br />
(PBLI) and systems-based practice (SBP) are two out of the six competencies<br />
required by the Accreditation Council for Graduate Medical<br />
Education. However, few curricula exist as examples of how to<br />
teach and evaluate PBLI and SBP. “Lean” is a quality improvement<br />
philosophy replicated in many industries that focuses on maximizing<br />
customer value while minimizing waste throughout a system, using<br />
tools such as process mapping and identification of waste. The authors<br />
describe a curriculum that uses Lean techniques as a framework<br />
to teach and evaluate fellows in PBLI and SBP.<br />
METHODS. Five Geriatric medicine fellows chose to participate<br />
in a project aimed at improving the routine laboratory ordering<br />
process in their home care practice. The fellows met monthly with the<br />
QI mentors to discuss the ongoing project. The interactive sessions included<br />
introducing and applying the Lean tools of process mapping<br />
and identification of waste, identifying stakeholders, designing a pilot<br />
data collection process, brainstorming solutions, and pilot-testing the<br />
solution. Post-curriculum survey and reflection pieces were administered<br />
and analyzed.<br />
RESULTS. All five fellows worked together to complete a QI<br />
project. The fellows enjoyed the interactive curriculum, gained experience<br />
in systematically performing a QI project, identified challenges<br />
involved in the process, and had an increased understanding of the<br />
stakeholders and the system in which they work. The project was<br />
completed within the year-long geriatric fellowship curriculum.<br />
CONCLUSIONS.The year-long QI project using Lean management<br />
principles and tools allowed for a hands-on, interactive QI experience<br />
that fulfilled the PBLI and SBP competencies for Geriatric<br />
AGS 2012 ANNUAL MEETING<br />
S45
P OSTER<br />
A BSTRACTS<br />
medicine fellows. Future plans include expanding the project to increase<br />
the Geriatric section’s interdisciplinary staff involvement in QI<br />
endeavors and sharing the curriculum with other training programs.<br />
A86<br />
Incremental Value of Cardiovascular Assessment in Patients with<br />
Unexplained Non-Accidental Falls: The Faint and Fall Clinic<br />
Experience.<br />
N. Sanders, 1 T. Jetter, 2 S. L. Wasmund, 2 C. F. Pacchia, 2 M. Brignole, 2<br />
M. Hamdan. 3 1. <strong>Geriatrics</strong> Division, University of Utah, Salt Lake<br />
City, UT; 2. Cardiology Division, University of Utah, Salt Lake City,<br />
UT; 3. Ospedali del Tigullio, Lavagna, Italy.<br />
Background: Falls cause significant morbidity and mortality.<br />
Due to amnesia and lack of witnesses, some falls may be due to syncope.<br />
We sought to identify the incremental value of cardiovascular<br />
assessment in patients with unexplained non-accidental (NA) falls.<br />
Methods: Patients with NA-falls and no history of syncope underwent<br />
a standardized fall assessment (SA) by a geriatrician. Tilt<br />
Table Testing (TTT) and/or carotid sinus massage (CSM) were recommended<br />
in patients with unexplained falls after the initial evaluation.<br />
If a cause was still not found, insertion of an implantable loop<br />
recorder (ILR) was recommended. The rate of diagnosis was assessed<br />
as a percent of explained NA-falls following each step of the<br />
evaluation.<br />
Results: 51 patients were included in the analysis. Mean age was<br />
73. The number of NA-falls explained after initial SA was 27 (53%).<br />
The use of TTT and CSM identified the cause of falls in 10 more patients<br />
(n=37; 73%). 5 patients consented to insertion of an ILR. After<br />
an 11-month follow up period (mean 5.3 ± 4.8), the diagnosis was<br />
made in 1 additional patient (n=38; 75%)(Figure).<br />
Conclusion: The addition of CSM and/or TTT followed by the<br />
insertion of an ILR to a SA of patients with NA-falls leads to a sequential<br />
increase in the percent of explained falls. These tests should<br />
be considered in the evaluation of patients with unexplained falls.<br />
A87<br />
Matrix Metalloproteinase-9 and the Geriatric Syndrome of Frailty.<br />
N. Guo, D. Halade, M. L. Lindsey, S. Espinoza. Barshop Institute for<br />
Longevity and Aging Studies, UT Health Science Center, San<br />
Antonio, TX.<br />
Supported By: NIA, AFAR, UT Health Science Center at San<br />
Antonio<br />
Background: Aging of the US population comes with an increase<br />
in the incidence of frailty, a geriatric syndrome associated with<br />
adverse health outcomes that can be regarded as an exacerbation of<br />
the normal aging process. Frailty status shows a strong association<br />
with a number of inflammatory molecules, including interleukin-6, C-<br />
reactive protein, and D-dimer. Interestingly, these inflammatory components<br />
of frailty also serve as biomarkers for cardiovascular disease<br />
(CVD), suggesting a correlation between frailty and CVD. Matrix<br />
Metalloproteinase-9 (MMP-9) is secreted by inflammatory cells and<br />
is a known biomarker of CVD. Due to the knowledge of existing<br />
shared inflammatory biomarkers between frailty and CVD, we studied<br />
MMP-9 as a possible frailty biomarker and hypothesized that increased<br />
plasma MMP-9 concentration would be associated with<br />
frailty.<br />
Methods: Subjects were 65 community-dwelling older adults in<br />
San Antonio, TX (mean age= 81 years; range=66-93 years). Frailty<br />
was determined by standardized criteria. Chronic diseases were ascertained<br />
by self-report of physician-diagnosed disease. MMP-9<br />
serum concentrations for each sample were determined by ELISA.<br />
Characteristics by frailty status were analyzed using ANOVA for continuous<br />
measures and chi-squared test for categorical measures<br />
(STATA).<br />
Results: Mean age of the patients was 80.6 ±6.4 years. Of these,<br />
33.8% were non-frail, 47.7% were pre-frail, and 18.5% were frail.<br />
MMP-9 concentrations (ng/mL) were 27.2±8.6, 28.7±11.5, and<br />
33.8±10.2 in non-frail, pre-frail, and frail, respectively (p=.202).<br />
Discussion: Matrix Metalloproteinase-9 (MMP-9), an inflammatory<br />
protein and CVD biomarker, may be increased in frailty; however,<br />
perhaps due to small sample size, the trend of increasing MMP-<br />
9 by increasing frailty status did not reach significance in this study.<br />
Prior studies have shown an association between CVD and frailty;<br />
however, future longitudinal studies will be useful to examine the role<br />
that CVD may play in the development of frailty in older adults.<br />
A88<br />
Interventions and barriers to medication adherence in cognitively<br />
impaired older adults: a systematic review.<br />
N. Campbell, 1,2 M. A. Boustani, 2,3 E. Skopeljia, 3 S. Gao, 2,3<br />
F. Unverzagt, 2,3 M. D. Murray. 1,2 1. Pharmacy Practice, Purdue<br />
University, Indianapolis, IN; 2. Regenstrief Institute, Inc., Indianapolis,<br />
IN, IN; 3. School of Medicine, Indiana University, Indianapolis, IN.<br />
Background: The existence of known cognitive impairment<br />
challenges the ability to adhere to the complex medication regimens<br />
often required to treat the multitude of diagnoses common to older<br />
adults. This report describes a systematic evidence-based review to<br />
accomplish two objectives: 1) identify barriers to medication adherence<br />
in cognitively impaired adults, and 2) identify interventions<br />
aimed at improving medication adherence in adults with cognitive<br />
impairment.<br />
Methods: We searched PubMed, Medline, PsycINFO, Google-<br />
Docs and CINAHL between 1966 and November 1, 2010. Target participants<br />
for both study objectives included adults ≥ 45 years of age<br />
with a diagnosis of cognitive impairment of any degree (mild cognitive<br />
impairment or dementia of any type). Inclusion criteria for the<br />
first objective consisted of any observational study describing risk<br />
factors or barriers to medication non-adherence. Inclusion criteria for<br />
the second objective consisted of any clinical trial with an intervention<br />
targeting medication adherence in cognitively impaired adults.<br />
Studies were excluded if they were not specific to a cognitively impaired<br />
population, lacked a measure of medication adherence, or described<br />
case reports, reviews, or psychiatric or infectious disease populations.<br />
Results: A total of 584 articles were retrieved through the initial<br />
search. Eight studies met inclusion criteria for objective one and<br />
three studies met inclusion criteria for objective two. Two studies<br />
evaluated reminder systems and did not show a benefit in a small<br />
group of participants with cognitive impairment. One study improved<br />
adherence through telephone and televideo reminders at each dosing<br />
S46<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
interval. Results are limited to published articles and articles with at<br />
least an abstract published in English.<br />
Conclusions: This review identified that few barriers to medication<br />
adherence have been addressed in the cognitively impaired population.<br />
Future interventions should better address reported barriers<br />
to medication adherence, as well as evaluate the impact on disease<br />
markers and cognitive function as clinical endpoints.<br />
A89 Encore Presentation<br />
Atypical presentation is common in Late Onset Rheumatoid<br />
Arthritis.<br />
P. Chatterjee, A. B. Dey. <strong>Geriatrics</strong>, AIIMS, New delhi, India.<br />
Background-Presentation of rheumatoid arthritis (onset after<br />
60 years of age) is varied and atypical, posing diagnostic uncertainties.<br />
Objective- To examine the mode of presentation of late onset<br />
rheumatoid arthritis (LORA) and to identify baseline clinical and<br />
laboratory features that would contribute to diagnosis and prognostication.<br />
Methodology- 31 cases of inflammatory arthritis were diagnosed<br />
as RA among the patients attending Geriatric OPD of AIIMS,<br />
using revised <strong>American</strong> Rheumatology Association criteria for RA<br />
or with clinical (atypical presentation), laboratory and radiologic evidence<br />
of RA. Patients were followed 2 weeks, 3 months then 6<br />
months to see the response to DMARDs by Disease activity score<br />
and development of disability using Stanford Health Assessment<br />
Questionnaire disability index (HAQ DI).<br />
Result- Mean age of presentation 66.32 ± 4.24 years, mean duration<br />
of presentation 20.74 ±30.23 months. Female to male ratio was<br />
1.8. 51.61% had both large and small joint involvement, 29.35% had<br />
exclusive small joint involvement, 19.35% had exclusive large joint<br />
disease, 58.6% had peri-arthritis of shoulder joint and 51.6% had<br />
polymyalgic symptoms on presentation. 67.7% has bilaterally symmetrical<br />
presentation. 74.2% had RA factor positivity; 41.9% had x-<br />
ray features suggestive of RA; 25.8% had anti-CCP antibody positivity;<br />
and 61.3% had ADL impairment on diagnosis. 61.3% of the<br />
LORA patients had more than 3 co-morbidities. 80.6% patient responded<br />
to methotrexate and 19.4% developed deformity during follow-up.<br />
ADL impairment was significantly (p=0.001) associated with<br />
large joint involvement and RA factor positive group had significant<br />
XRAY changes (p=0.02) and ADL impairement(p=0.03)<br />
Conclusion- LORA is associated with female predominance as<br />
in young age. But due to late and atypical presentations, ADL impairment<br />
is common. Response to DMARD is satisfactory. Multiple comorbidities<br />
and early disability compromises the quality of life.<br />
Larger scale prospective studies are required to provide better diagnostic<br />
criteria and treatment recommendations.<br />
A90 Encore Presentation<br />
Factors Associated with Geriatric Syndromes in Older Homeless<br />
Adults.<br />
R. T. Brown, 1,2 D. K. Kiely, 3 M. Bharel, 4 S. L. Mitchell. 3,5 1. Division<br />
of <strong>Geriatrics</strong>, University of California, San Francisco, San Francisco,<br />
CA; 2. San Francisco Veterans Affairs Medical Center, San Francisco,<br />
CA; 3. Hebrew SeniorLife Institute for Aging Research, Boston, MA;<br />
4. Boston Healthcare for the Homeless Program, Boston, MA; 5.<br />
Division of Gerontology, Beth Israel Deaconess Medical Center,<br />
Boston, MA.<br />
Supported By: 1. NIH-NIA T32 AG000212<br />
2. NIH-NIA K24 AG033640<br />
Background: Although older homeless adults have high rates of<br />
geriatric syndromes, little is known about the risk factors for these<br />
syndromes. We sought to identify factors associated with geriatric<br />
syndromes in 250 homeless adults ≥50 years old recruited from eight<br />
homeless shelters in Boston, Massachusetts.<br />
Methods: Multivariate regression models were used to estimate<br />
the association of subject characteristics with the following outcomes:<br />
1) total number of geriatric syndromes; 2) cognitive impairment<br />
(Mini-Mental State Examination (MMSE) score and Trail Making<br />
Test Part B (TMT-B) duration); 3) fall in the past year; 4) frailty; and<br />
5) major depression.<br />
Results: Total number of geriatric syndromes was associated<br />
with < high school education, diabetes, binge-drinking, drug use problem,<br />
and impairment in Activities of Daily Living (ADL). Lower<br />
MMSE score (worse cognition) was associated with older age, < high<br />
school education, non-English primary language, binge-drinking, and<br />
longer duration of homelessness. Longer TMT-B duration (worse executive<br />
function) was associated with older age, non-White race, <<br />
high school education, non-English primary language and stroke.<br />
Falling was associated with arthritis, binge-drinking, ADL impairment<br />
and depression. Frailty was associated with diabetes and depression.<br />
Finally, depression was associated with younger age, < high<br />
school education, drug use problem, traumatic brain injury, and ADL<br />
impairment.<br />
Conclusions: This study identifies modifiable factors associated<br />
with geriatric syndromes in older homeless adults. This knowledge<br />
can help health care providers identify and assess homeless patients<br />
who may have geriatric syndromes, and may provide targets for interventions<br />
to improve the health of older homeless adults.<br />
A91<br />
A Mystery of Vision & Thrombosis.<br />
S. Hodroge, R. Lands, B. Pearman. Internal Medicine, University of<br />
Tennessee Medical Center, Knoxville, TN.<br />
Introduction:<br />
Unilateral orbital pain, swelling, limitations in ocular motion<br />
and diplopia, are concerning in any patient. This usually signals the<br />
presence of pathology within the orbit or paranasal sinuses. We present<br />
a patient with these symptoms who was found to have a right<br />
spontaneous superior ophthalmic vein thrombosis (SOVT) and a<br />
lupus anticoagulant.<br />
Case Report:<br />
A 56-year-old white female presented to University of Tennessee<br />
Medical Center with a 2-month history of progressive right<br />
sided periorbital redness, swelling, pain and finally opthalmoplegia.<br />
CT scanning revealed periorbital cellulitis. She was treated with several<br />
rounds of antibiotics, steroids, and NSAIDs without improvement.<br />
Upon presentation to our hospital, she had noted worsening of<br />
right-sided headache, photophobia, and vision deterioration with decreased<br />
red color discrimination. She reported no purulent nasal discharge<br />
or fever. She fell three months prior to admission, but denied<br />
loss of consciousness or neurologic symptoms. Risk factors for thrombosis<br />
included the use of estradiol. She had no family history of<br />
thrombophilia. Physical exam revealed right periorbital swelling with<br />
erythema, proptosis, ptosis and a lateral rectus palsy of the right eye.<br />
Dilated fundoscopic exam showed 1+ disc edema as well as abnormally<br />
engorged retinal veins. Pupils were reactive to light but the<br />
right pupil was smaller than the left. Right intraocular pressure was<br />
mildly elevated at 25mm Hg. Lab findings included a normal white<br />
blood cell count and ESR. Magnetic resonance angiography demonstrated<br />
a right superior ophthalmic vein thrombosis. The patient was<br />
anticoagulated with heparin and treated with IV antibiotics pending<br />
return of negative blood cultures. After ruling out carotid cavernous<br />
fistula, arteriovenous malformation, and intracranial aneurysm, she<br />
had a cerebrovascular angiogram that was normal. The patient’s<br />
symptoms improved after the angiogram. Evaluation for acquired hypercoagulable<br />
states demonstrated the presence of a lupus anticoagulant,<br />
which was still present three months later. She remains on Warfarin<br />
and will require anticoagulation indefinitely.<br />
Discussion:<br />
SOVT is a rare condition usually related to inflammation of the<br />
orbit or paranasal sinuses, clinically similar to periorbital cellulitis.<br />
AGS 2012 ANNUAL MEETING<br />
S47
P OSTER<br />
A BSTRACTS<br />
While we were not able to find another reported case of SOVT associated<br />
with the presence of a lupus anticoagulant, evaluation for hypercoagulation<br />
syndromes is probably warranted.<br />
A92<br />
Spontaneous Retroperitoneal Bleed Presenting as Right leg pain:<br />
Psoas sign.<br />
T. Hashim, A. H. Chaudhry. Hospitalist, Highline Medical Center,<br />
Burien, WA.<br />
We report case of 88year old man with past medical history of<br />
atrial fibrillation on anti- coagulation with Coumadin for chronic<br />
atrial fibrillation. Patient presented to our emergency room with 1<br />
day history of right leg pain and inability to walk secondary to severe<br />
pain and leg weakness. Patient denied any trauma. The pain was in<br />
right groin which was made worse with extension of the hip and was<br />
relieved with hip flexion. All other review of systems were negative.<br />
His medical problems included diabetes, hypertension and history of<br />
CHF.His home medications included Coumadin, Lisinopril, simvastatin<br />
and Carvidelol.<br />
On physical examination, his blood pressure was 122/65 heart<br />
rate 110/min irregular, respiratory rate 22 /min and temperature of<br />
98.7F. His cardio-pulmonary exam was unremarkable. Abdominal<br />
exam was benign. Patient however was constantly keeping his right<br />
thigh flexed. When patient was turned on his left side and an attempt<br />
was made to extend his right leg at the thigh; it resulted in severe pain<br />
(positive psoas sign). He also had sensory loss on the anterior upper<br />
thigh and also has significant weakness of the right Quadriceps<br />
Femoris Muscle.<br />
Laboratory data showed hematocrit of 28 which was a drop<br />
from his baseline hematocrit of 35. The INR was 4.6 and rest of the<br />
chemistry panel was with in normal limits.<br />
A CT scan of the abdomen and pelvis without contrast showed<br />
huge 13cmx5cmx6.5cm complex fluid collection close to the right iliacus<br />
muscle consistent with retroperitoneal bleed. Patient was admitted<br />
to ICU for close monitoring. He was transfused 4 units of Fresh<br />
frozen plasma along with 2 units of PRBCS and 10mg of IV vitamin<br />
K. Surgery recommended conservative management and complete<br />
reversal of anticoagulation and frequent hemoglobin checks.<br />
Over the next couple of days the patient’s condition improved<br />
and his hematocrit stabilized.<br />
On the 5th day of hospitalization, patient was discharged home<br />
with home health for physical therapy.<br />
Conclusion:<br />
Retroperitoneal bleed is a Known complication of anticoagulation<br />
which usually presents with abdominal pain and back pain. However,<br />
sometimes it presents as isolated Psoas sign. Clinicians taking<br />
care of patients on anti- coagulation should have low threshold for<br />
imaging the abdomen (CT or MRI) for patient who present with<br />
groin pain or leg pain.<br />
A93<br />
The Functional Performance Predictors of Adverse Health Outcomes<br />
in Community-Dwelling Older Adults: A preliminary study.<br />
T. J. Tseng, 1 P. S. Lin, 1 H. S. Cheng, 2 B. H. Gi. 1 1. Department of<br />
Physical Therapy, Graduate Institute of Rehabilitation Science, Chang<br />
Gung University, Taoyuan, Taiwan; 2. Internal Medicine, Chang Gung<br />
Memorial Hospital, LinKou Branch, Taoyuan, Taiwan.<br />
Background and Purpose: The number of older adults keeps increasing<br />
in Taiwan. “Frailty” is a newly defined syndrome, the declined<br />
physiologic reserve capacities will make older people highly<br />
vulnerable to adverse health outcomes, such as hospitalization and<br />
mortality. Finding predictors is one of the solutions to prevent or<br />
defer those adverse health outcomes. There are two purposes of this<br />
study: (1) To examine the differences of the occurrence of the adverse<br />
health outcomes in different levels of frailty for 2-year period. (2) To<br />
examine the functional performance predictors of older adults’ adverse<br />
health outcomes after 2-year period. Method: A convenient<br />
sample of 337 older adults, aged 65 years and older, living in the community<br />
participated in this study. The baseline evaluation included<br />
demographic and health status, functional tests, mental and depressive<br />
status. The subjects will be followed up annually and finally, medical<br />
record confirms of the occurrence of adverse health outcomes, including<br />
hospitalization, emergency visit, and fall. Results: Among the<br />
337 enrolled, 96 of whom were “non-frail”, 191 were “pre-frail”, and<br />
50 were “frail”. Results of preliminary analyses showed, at baseline,<br />
the three groups were significantly different in height, weight, comorbidity,<br />
GDS, MMSE and all functional tests. The frail older adults<br />
have significantly higher percentage of falls (X2= 13.305, p=0.01). The<br />
5-meter gait speed test, functional reach (FR) and 6-min walking test<br />
(6 MWT) were the tests that could significantly predict older adults’<br />
hospitalization, emergency visit and falls 2 years later, respectively.<br />
Conclusion: The 5-meter gait speed test, FR and 6 MWT were recommended<br />
for use to identify community-dwelling older adults who are<br />
at risk of future adverse health outcomes.<br />
A94<br />
Older Minority Persons Living with HIV/AIDS (PLWHA) The<br />
Influence of Social Support on Willingness to Participate in HIV<br />
Clinical Trials.<br />
R. Arakawa, 1,2 G. Corbie-Smith. 2,3 1. University of Hawaii John A<br />
Burns School of Medicine, Honolulu, HI; 2. The Program on Health<br />
Disparities Cecil G. Sheps Center for Health Services Research, The<br />
University of North Carolina Chapel Hill, Chapel Hill, NC; 3. School<br />
of Medicine, The University of North Carolina Chapel Hill, Chapel<br />
Hill, NC.<br />
Background: Racial and ethnic minorities are disproportionately<br />
affected by the AIDS epidemic, yet have been underrepresented<br />
in HIV research, including clinical trials. Older adults are increasingly<br />
infected, and the population over 50 years old living with<br />
AIDS is expected to grow. The unique experience of being an older<br />
minority person living with HIV/AIDS (PLWHA), in the context of<br />
clinical trial participation, is poorly understood. This study looked for<br />
age-related differences in willingness to participate in a clinical trial<br />
and specific facilitators of participation.<br />
Methods: A cross-sectional, stratified analysis of baseline survey<br />
data was conducted as an aspect of Project EAST (Education and<br />
Access to Services and Testing), a community-based research project<br />
devoted to increasing rural minority participation in research in<br />
North Carolina. Textual data from interviews with PLWHA was<br />
queried for qualitative support of the findings.<br />
Results: Age was not associated with willingness to participate<br />
(WTP), and study participants demonstrated a high level of baseline<br />
willingness. Older age was associated with high levels of perceived social<br />
support from church & religious faith, but lower levels of perceived<br />
support from friends. Older participants had lower perceived<br />
pressure from their doctors to participate, but most believed their<br />
doctor would support their decision to enroll. Both age groups received<br />
a higher frequency of support from other resources, including<br />
their spouse/partner and other family.<br />
Discussion: This study provides no empiric basis for excluding<br />
older minority PLWHA from clinical trials research. The high baseline<br />
willingness demonstrated by the survey participants is encouraging,<br />
but social desirability should be examined as a possible con-<br />
S48<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
founder. Future efforts to maintain participation should include engagement<br />
of faith leaders and doctors to lead discussions about HIV.<br />
Additionally, peer-lead interventions to increase knowledge amongst<br />
friends may increase subsistence-type support associated with better<br />
engagement in care.<br />
A95 Encore Presentation<br />
Hypertension Control in all Age Groups – a VA 10 Year Multicenter<br />
Analysis.<br />
R. Fletcher, 1,3 V. Papademetriou, 1 R. Kheirbek, 1,2 R. Amdur, 1,2<br />
C. Faselis, 1,2 R. Jones. 1 1. Veterans Affairs Medical Center, Washington<br />
DC, DC; 2. George Washington University Medical Center,<br />
Washington DC, DC; 3. Georgetown University Medical Center,<br />
Washington DC, DC.<br />
Introduction: While the benefits of blood pressure (BP) control<br />
are well known, BP control is rarely studied in large populations.<br />
Elderly patients have been considered difficult to control. We reviewed<br />
blood pressure control in a large cohort of VA patients.<br />
Methods: From September 2000 to August 2010, we assessed<br />
BP control in 582,851 hypertensive patients from 15 VA hospitals<br />
in various geographic locations around the United States. Patients<br />
were divided in 4 groups based on age: G1:
P OSTER<br />
A BSTRACTS<br />
and knowledge promoted advance care planning. Illness awareness,<br />
perceived barriers about advanced care planning, knowledge, access<br />
to medical care (esp palliative) influenced decisions about EOL and<br />
hospice, not one’s ethnicity. Patient & family education by health professionals<br />
led to increased awareness of disease and better EOL decision<br />
making. The international studies revealed the following: In a<br />
Korea study most subjects viewed advance directives positively which<br />
was not influenced by information disclosure, ICU experience, prognosis<br />
or gender. In a Taiwan study, knowledge of palliative care &<br />
hospice increased willingness to execute advance directives & many<br />
elderly cancer patients preferred to die at home with hospice care in<br />
their last year. In a China study, less awareness of prognosis increased<br />
anxiety and communication difficulties with family members.A survey<br />
of Chinese medical interns felt they had received insufficient palliative<br />
care education in medical school. Both individualistic and family<br />
autonomy models were observed in the US and International<br />
studies.<br />
Conclusion: Ethnicity or geography did not influence decisions<br />
regarding EOL, hospice, palliative care and advance directives.<br />
Rather, education and awareness improved outcomes. Asian populations<br />
both in the US and internationally could benefit by having active<br />
dialogue among health care professionals, patients and families.<br />
Clinicians should be more culturally sensitive in accepting a familycentered<br />
decision making process along with the autonomy model<br />
A98<br />
Neighborhood Socioeconomic Disadvantage and Walking: the<br />
Cardiovascular Health Study.<br />
T. Yan, 1 M. Cheung, 2 L. Liang, 3 S. D. Vassar, 1 W. T. Longstreth, 4<br />
S. S. Merkin, 5 J. J. Escarce, 3 A. F. Brown. 3 1. Department of<br />
Neurology, University of California, Los Angeles, Los Angeles, CA; 2.<br />
John A Burns School of Medicine, Honolulu, HI; 3. Division of GIM<br />
& HSR, University of California, Los Angeles, Los Angeles, CA; 4.<br />
Departments of Neurology and Epidemiology, University of<br />
Washington, Seattle, WA; 5. David Geffen School of Medicine,<br />
University of California, Los Angeles, Los Angeles, CA.<br />
Background: We examined the association between neighborhood<br />
socioeconomic status (NSES) and walking in older adults and<br />
assessed variation in the relationship by race and gender.<br />
Methods: We used data from the Cardiovascular Health Study, a<br />
multicenter study of cardiovascular disease in older adults 65 years<br />
and older, to examine the association between NSES (the summed z-<br />
scores of census variables representing income, wealth, education and<br />
employment) and self-reported blocks walked in the prior week. We<br />
constructed race- and gender-stratified multilevel binomial models<br />
adjusted for clustering by NSES quartile, sociodemographic, behavioral,<br />
and clinical characteristics.<br />
Results: The sample included 4005 whites (57% female) and 844<br />
African <strong>American</strong>s (62% women). Overall, adjusted mean blocks<br />
walked was higher among whites than African <strong>American</strong>s and among<br />
men than women (p
P OSTER<br />
A BSTRACTS<br />
patients (age ≥65) in outpatient settings in the USA using the<br />
NAMCS data from 2000 to 2007.<br />
Methods: Patients 65 years or older who visited outpatient clinics<br />
for non-malignant pain management were identified by one of the<br />
following methods: i) documented either by patients’ self-report of<br />
reason for visit; or ii) ICD-9 code for assessments recorded by physician<br />
for that visit or iii) prescription received for pain management<br />
during that visit.<br />
Results: A total of 206,879,848 weighted (5968 un-weighted)<br />
outpatient visits for older patients with non-malignant pain from<br />
2000-2007 were analyzed. About 89% of these visits recorded<br />
NSAIDs prescriptions. The mean age for the NSAIDs prescription<br />
receivers was 75.4 years and majority of these patients were women<br />
(68%) and Whites (87.6%). Half (50.6%) of the NSAIDs prescriptions<br />
were given by primary care providers. A large percentage of the<br />
NSAIDs users had Medicare (75%) while 15% had private insurance.<br />
Most patients (68.8%) received a total of 4 prescriptions during the<br />
outpatient visit and only 0.9% of the NSAIDs users had a diagnosis<br />
of kidney disease.<br />
Conclusions: A large percentage of older adults were prescribed<br />
NSAIDs for non-malignant pain management in outpatient<br />
settings. While pain severity and length of treatment are not reported<br />
in NAMCS to fully determine appropriate use of NSAIDS in older<br />
adults, it is imperative to further explore if appropriate guidelines<br />
are used for pain management in these patients who are at higher<br />
risk of ADRs.<br />
A101<br />
Effect of “as needed” dosing of antipsychotics and benzodiazepines<br />
for delirium on hospital length of stay and readmissions N.<br />
Rodgers,1 K.Young 1, V. Argento, Department of Medicine<br />
Bridgeport Hospital, Bridgeport, CT.<br />
N. Rodgers, K.Young,V.Argento. Bridgeport Hospital, Bridgeport, CT.<br />
Background: Despite the initial 2005 FDA advisory against antipsychotics,<br />
conventional and atypical antipsychotics as well as benzodiazepines<br />
continue to be used for the treatment of acute agitation/delirium<br />
in demented seniors. Few studies have explored the<br />
effect of cumulative as needed dosing of these medications on patient<br />
outcomes. This study seeks to determine if PRN dosing of antipsychotics<br />
and benzodiazepines is associated with increased hospital<br />
length of stay and more frequent 30 day hospital readmissions.<br />
Methods:<br />
Retrospective database review was performed on seniors (n=<br />
245, average age: 85) with baseline dementia who were admitted to<br />
the Bridgeport Hospital Inpatient Medical Units between 2006-2010<br />
with a diagnosis of delirium. Controls were matched for age, gender,<br />
and co-morbidities stratified using the Charleson index. Subjects<br />
were grouped into 5 categories based on prn medication given: typical<br />
antipsychotics, atypical antipsychotics, benzodiazepines, combinations<br />
of typical and atypical antipsychotics, any combination of the<br />
above, and no prn doses. Length of hospital stay and 30 day re-admission<br />
rates were compared.<br />
Results:<br />
The average length of hospitalization in patients with no prn<br />
medications was 14.1 days. Those receiving prn atypical antipsychotics<br />
had an average stay of 24.7 days (CI 4.0-17.3 p=0.0018). Dual<br />
antipsychotic administration had a stay of 24.0 days (CI 2.8-17.1<br />
p=0.0068). Mean hospital stay was longest for patients receiving combinations<br />
of benzodiazepines and antipsychotics with a mean stay of<br />
28.2 days (CI: 7.9-20.3 p= 0.0001). Comparison of 30 day readmission<br />
rates did not meet statistical significance, except for the prn benzodiazepines<br />
group having an 11 fold greater readmission rate (OR=<br />
11.3; CI: 1.6-64.8). Cumulative data for all prn medications showed a<br />
non-significant trend toward increased re-admissions (OR=2.1; CI:<br />
0.8-5.5).<br />
Conclusion:<br />
Hospital length of stay and readmissions may be adversely impacted<br />
by cumulative prn dosing of: atypical antipsychotics, dual antipsychotics,<br />
and triple combinations of antipsychotics with benzodiazepines.<br />
In addition to non-pharmacological management of<br />
agitation whenever possible; this study reinforces the need for more<br />
standardized prn administration practices among geriatricians and<br />
nurses.<br />
A102<br />
A Retrospective Study of Basal Insulin Analogs in Elderly Nursing<br />
Home Residents with Type-2 Diabetes.<br />
K. L. Davis, 1 W. Wei, 2 J. Meyers, 1 B. S. Kilpatrick, 3 N. Pandya. 4 1. RTI<br />
Health Solutions, Triangle Research Park, NC; 2. sanofi-aventis U.S.,<br />
Bridgewater, NJ; 3. AnalytiCare, San Francisco, FL; 4. Nova<br />
Southeastern University, Davie, FL.<br />
Supported By: This study was funded by sanofi-aventis U.S.<br />
Background: Guidelines recommend long acting basal insulin<br />
use when oral agents fail to control type 2 diabetes (T2DM) in elderly<br />
patients.<br />
Methods: This retrospective, cross-sectional study examined the<br />
use of basal insulin analogs in long term care (LTC) facilities and the<br />
associated outcomes. Data were extracted from medical charts and<br />
the Minimum Data Set (MDS). Treatment regimens of patients receiving<br />
insulin glargine (IGlar) or detemir (IDet) were investigated<br />
and indices of glycemic control and other outcomes compared descriptively<br />
between groups. Patients with T2DM were included if they<br />
were resident in LTC for ≥3 months, had ≥1 full MDS assessment and<br />
≥2 records of insulin dispensing. Patients using insulin pumps, receiving<br />
hospice care, or in a comatose state were excluded.<br />
Results: 2,096 patients were identified from 117 facilities, >50%<br />
received basal insulin (N=1142, mean [SD] age 73.5 [11.9], female<br />
60%). The majority (82.5%, N=942) were treated with IGlar. Baseline<br />
characteristics were generally similar between groups. Co-administration<br />
of sliding scale insulin (SSI) was common (IGlar: 53.3%; IDet:<br />
54.5%), either with basal alone (IGlar: 45.3%; IDet: 49.5%) or with<br />
basal-bolus regimens. Treatment with basal-only (23.1%), basal-bolus<br />
(10.6%) and multiple insulin regimens also occurred. Twice daily injections<br />
(BID) were less common in the IGlar group (5.5% vs 22.0%,<br />
P
P OSTER<br />
A BSTRACTS<br />
made more eye contact during anxiety-provoking visits, patients<br />
made more eye contact during routine visits. Given the rising prevalence<br />
of prostate cancer (PCa) in the aging population, the likelihood<br />
of PCa communication being anxiety-provoking, and the role of anxiety<br />
in decision-making about PCa, we compared eye contact during<br />
PCa communication with other clinical interactions.<br />
Methods: We analyzed NIA videotapes of older men and male<br />
physician interactions (n=26) during three different types of clinical<br />
visits involving: 1) PCa (n=9), 2) other anxiety-provoking situations<br />
(depression/suicidal ideation, behavioral issues, and acute medical issues;<br />
n=9), and routine situations (n=8). Using NVivo 9 Qualitative<br />
Software, history-taking segments were time-stamped and transcribed<br />
for each tape, enabling simultaneous independent assessment<br />
of eye contact—in terms of length, frequency and quality—and<br />
speech of both physicians and patients.<br />
Results: Compared to other situations, the length and frequency<br />
of physician eye contact was lowest during PCa interactions. The<br />
quality of eye-contact during PCa communication was characterized<br />
by the lowest number of sustained eye contact episodes per visit (1.5),<br />
followed by slightly higher number in routine visits (2), and the highest<br />
during anxiety-provoking visits (3). In contrast, patients made the<br />
most eye contact in PCa and routine visits, and least in other anxietyprovoking<br />
visits. The amount of verbal communication between<br />
physicians and patients was similar. The frequency of eye contact of<br />
physicians and patients was about twice that of verbal speech.<br />
Conclusions: Physicians and patients display different eye contact<br />
patterns during discussions of PCa when compared with other<br />
anxiety-provoking and routine care discussions. While the frequency<br />
of verbal utterances was similar, physicians display least eye contact<br />
while patients display most eye contact during PCa discussions. Understanding<br />
nonverbal communication patterns and designing interventions<br />
to improve eye contact can help enhance patient-centered<br />
communication for this preference-sensitive disease.<br />
A104<br />
QI Reducing 25 OH Vitamin D Ordering.<br />
R. Aminbakhsh, 1 Z. Aung, 1 G. Guo, 1 D. Chau, 1 S. Leong. 2 1. Internal<br />
Medicine, University of Nevada School of Medicine, Reno, NV; 2. Lab<br />
and Pathology, Veteran Affairs, Reno, Reno, NV.<br />
There has been an increase in the 25 OH Vitamin D lab orders<br />
to our VA healthcare system without any clear evidence based data to<br />
document appropriateness, need for general testing, and guidance.<br />
Recently, The IOM [Institute of Medicine]concluded that there’s evidence<br />
of vitamin D benefits for bone, but there is not enough on nonbone<br />
outcomes. Target blood level of 25OH vitamin D- 20 ng/mL<br />
cover the needs of at least 97.5% of the population. Labs for vit. D<br />
have variable ranges & these ranges can mislabel patients. At our Veteran<br />
Affairs approx. 1500 tests are sent per month at a cost of $18 per<br />
test. PARTICIPANTS of the QI project consisted of all ambulatory<br />
and hospital care providers who ordered 25 OH Vitamin D from August<br />
to November of 2011. # 25OHD Labs ordered by provider was<br />
reviewed (2011):August 982;September 1531;October 1078. INTER-<br />
VENTION: The QI team sent an educational letter September 2011<br />
based upon the IOM report, possible unneccessary testing to the VA<br />
primary care providers. This letter provided providers with the education,<br />
guidance, and recs on appropriate 25 OH Vitamin D lab testing.<br />
Following the letter, the team reviewed the lab orders for vitamin D<br />
and provided 1:1 education based on IOM directed towards PCPs<br />
who ordered high #s of tests. 2/10 PCPs ordered 20% of vit.D lab,5x<br />
more # of tests than by endocrinologist. In addition to education, a<br />
new in house lab for vitamin D testing was implemented standardizing<br />
D ranges of lab reported. MEASUREMENTS: We reviewed the<br />
lab orders for vitamin D prior to the quality improvement education<br />
process, the cost of the lab testing pre and post education. RESULTS:<br />
Of the 3591 tests ordered of 25 OHD from August - October only 8%<br />
had abnormal 25 OH vitamin D values, including deficient and insufficient<br />
vitamin D status. After the preliminary intervention, the 25 vitamin<br />
D lab test ordered was reduced from 1531 in the month of September<br />
to 1078 in the month of October a drop of 29.59%.CONCLU-<br />
SION: A QI project using educational email plus 1:1 education to<br />
outlying providers, and internally standardizing 25 OH lab reports<br />
lowered the number of vitamin D testing and abnormal reporting. We<br />
have also proposed to provide more education for primary care<br />
physicians through additional 1:1 and team education.<br />
A105<br />
Does Low Social Support Predict Hospitalization and Outcomes<br />
among Aging Veterans with and without HIV?<br />
R. Greysen, 1 L. I. Horwitz, 2 K. E. Covinksy, 1 R. Desai, 2 M. E. Ohl, 3<br />
M. Duggal, 2 A. C. Justice. 2 1. Dept of Medicine, University of<br />
California, San Francisco, CA; 2. Dept of Medicine,Yale University,<br />
New Haven, CT; 3. Dept of Medicine, University of Iowa, Iowa City, IA.<br />
BACKGROUND: Social isolation is common among aging Veterans,<br />
especially those infected with HIV, and may affect healthcare<br />
utilization and outcomes of care. Our objectives were to compare levels<br />
of social support in aging Veterans with and without HIV and determine<br />
associations between social support and hospital admission,<br />
length of stay, and disposition.<br />
METHODS: Using the Veterans Aging Cohort Study we created a<br />
10-point scale for social support using survey responses about: marital<br />
status, housing status, food security, number of friends/family and frequency<br />
of visits,and involvement in volunteer work,religious or self-help<br />
groups, or other community activities. We stratified data by HIV status<br />
and used multivariable regression to assess effects of social support on<br />
admission, length of stay, and skilled nursing facility (SNF) placement.<br />
RESULTS: Data were available for 1,836 Veterans: age 55-91<br />
(mean=61), 98% male, 68% non-white, 76% annual income
P OSTER<br />
A BSTRACTS<br />
be more reluctant to do so. However, they do value incorporation of<br />
their concerns and wishes into clinical decisions. Therefore, we developed<br />
a method for discussing goals with frail older people. <strong>Here</strong>, we<br />
describe primary care professionals’ first experiences with this<br />
method.<br />
Methods: We developed a two-step method for discussing goals<br />
with community-dwelling frail older people. It consists of an openended<br />
question: If there is one thing we can do for you to improve<br />
your situation, what would you like?; followed by an agenda-setting<br />
chart. Primary care nurses and gerontological social workers then<br />
used this method to discuss goals with community-dwelling frail older<br />
people of ≥ 70 years. The research team reviewed the goals elaborated<br />
and studied professionals’ experiences with the method using a<br />
survey. This included questions concerning time spent on discussing<br />
goals; reasons for not formulating goals; and perceived value of the<br />
method.<br />
Results: 140 frail older people described a total of 175 goals.<br />
These most frequently concerned mobility (n=43; 24.6%), well-being<br />
(n=52; 29.7%), and social context (n=58; 33.1%). Professionals (n=18)<br />
were positive about the method, which took about 16 minutes for<br />
each step. 17 (94.4%) agreed with the statement that it had helped<br />
them determine what the frail older person valued and 15 (83.3%)<br />
agreed that it had helped them to put the wishes of frail older persons<br />
first. Goals were not always formulated, frequently mentioned reasons<br />
for this were the frail older person being comfortable with the<br />
current situation; not being accustomed to discussing goals; or not<br />
being able to formulate goals due to cognitive problems.<br />
Conclusions: The first experiences with this brief two-step goalsetting<br />
method have shown that discussing goals with frail older people<br />
helps professionals to gain insight into what a frail older person<br />
values. This can assist professionals, and possibly frail older people, in<br />
choosing the most appropriate treatment or care option, thus increasing<br />
frail older people’s involvement in decision making.<br />
A107<br />
The Relationships between the Type of Long-Term Care Benefits<br />
and Cognitive Function among Long-Term Care Insurance<br />
Beneficiaries with Dementia in Korea, 2008-2010.<br />
T. Lee, 1 J. Chung, 2 E. Cho. 1 1. Dept. of Nursing Environments &<br />
Systems, Yonsei University College of Nursing, Seoul, Republic of<br />
Korea; 2. Dept. of Biobehavioral Nursing & Health Systems,<br />
University of Washington School of Nursing, Seattle, WA.<br />
Supported By: Korean National Health Insurance Corporation<br />
Background: In Korea, the population over age 65 is expected to<br />
double by 2020, and the prevalence of dementia among those will rise<br />
up to about 10%. The Act on Long-term Care Insurance for Senior<br />
Citizens (LTCI) was enacted in 2008 in an effort to fulfill the care<br />
needs of the elderly with chronic diseases, and the number of beneficiaries<br />
with dementia has reached approximately 80,000. In this<br />
paper, we aimed to examine the relationships between the type of<br />
LTC benefits and the level of cognitive function among LTCI beneficiaries<br />
with dementia.<br />
Methods: We assembled a national sample of all LTCI beneficiaries<br />
with dementia aged ≥ 65 years (N=80,293), examined for LTC<br />
rating in 2008 and followed through 2010. A standardized 10-item<br />
scale was used to assess cognitive function, with higher scores indicating<br />
lower cognitive function. Linear mixed models were used to investigate<br />
whether the LTC benefit type (fixed effects) was a significant<br />
predictor for cognitive function improvement over time<br />
(random effects).<br />
Results: There are three benefit types: in-home services (HS, a<br />
physician/nurse visits the homes of beneficiaries and provides services),<br />
aged care facility services (FS, the LTC facility provides services),<br />
and a combined type of in-home services and aged-care facility<br />
services (CS). From 2008 to 2010, there was a decrease in the mean<br />
cognitive function scores (CFS) for HS beneficiaries from 6.25 to 6.20<br />
(p < .001) and for FS beneficiaries from 7.19 to 6.86 (p < .001). However,<br />
the mean CFS of CS beneficiaries increased from 6.25 to 6.58<br />
during the same period (p < .001) (Table).<br />
Conclusion: Older adults with dementia showed an improvement<br />
in their cognitive function after receiving LTC services delivered<br />
at their home or aged care facilities.<br />
Mean Cognitive Function Scores of Long-Term Care Beneficiaries<br />
with Dementia by Benefit Type and Year<br />
A108<br />
Lower Cost of Care for Serious Chronic Disease by Increasing<br />
Services Not Restrictions.<br />
T. Edes, 1 S. Shreve, 2 L. Klepac, 1 B. Kinosian. 3 1. Dept Veterans Affairs,<br />
Washington, DC; 2. Dept of Veterans Affairs, Lebanon, PA; 3. Dept of<br />
Veterans Affairs and Univ of PA, Philadelphia, PA.<br />
Supported By: No research funding support.<br />
Purpose: To demonstrate that systems can increase access, improve<br />
quality and lower total cost of care by adding services rather<br />
than restricting services.<br />
Background: Congressional Budget Office report (2007) noted<br />
the cost per patient per year in the 7 years from 1998 to 2005 rose<br />
29% in Medicare, while costs rose only 1.7% in Department of Veterans<br />
Affairs (VA). The highest cost patients were those with multiple<br />
serious chronic diseases, many of whom were homebound. One factor<br />
attributed for VA’s cost containment was that VA has programs in<br />
place specifically for persons with serious chronic disease. VA has<br />
continued to expand programs specifically for Veterans with serious<br />
advanced chronic disease to receive patient-centered care in the least<br />
restrictive setting. We report an economic impact analysis of two such<br />
VA programs: Hospice & Palliative Care (HPC), and Home Based<br />
Primary Care (HBPC).<br />
Methods: VA databases were used to determine Veterans’ use of<br />
HBPC, use of HPC in all settings, and location of death. Utilization<br />
and costs of care were determined for 2003 and 2010.<br />
Results: Between 2003 and 2010, while the number of VA enrollee<br />
deaths decreased 11% and the number ofVA inpatient deaths decreased<br />
15%,the number of deaths inVA acute medical hospital decreased 36%,<br />
the number in VA inpatient hospice beds increased 179% and the number<br />
of Veterans in VA-paid home hospice increased 592%. 4582 fewer<br />
deaths occurred in acute medical plus ICU, and 5731 more Veterans received<br />
VA-paid home hospice per day. With the cost difference, the net<br />
cost reduction was over $8 million for each day 4500 Veterans received<br />
care in home hospice rather than VA acute medical inpatient care. The<br />
number of Veterans receiving HBPC increased 190%. Total net cost<br />
avoidance for 24,957 HBPC patients was over $70 million, at $2900 per<br />
patient per year largely by reducing avoidable inpatient days.<br />
Conclusion: Increasing access to inpatient hospice care, to VA-paid<br />
home hospice care and toVA-provided HBPC resulted in net reductions<br />
in total VA costs of care, without imposing any restrictions of services.<br />
A109 Encore Presentation<br />
Geriatric Surgery: The Association between Adherence to Processbased<br />
Quality Indicators and Postoperative Complications.<br />
V. Martelli, 3 S. A. Fraser, 1 V. Isabelle, 3 M. Deban, 3 C. Holcroft, 3<br />
M. Monette, 3 J. Monette, 2 S. Bergman. 1 1. Surgery, Jewish General<br />
Hospital, Montreal, QC, Canada; 2. Geriatric Medicine, Jewish<br />
General Hospital, Montreal, QC, Canada; 3. Lady Davis Institute for<br />
Medical Research, Jewish General Hospital, Montreal, QC, Canada.<br />
Supported By: Canadian Institutes of Health Research<br />
Background:<br />
AGS 2012 ANNUAL MEETING<br />
S53
P OSTER<br />
A BSTRACTS<br />
This study’s purpose was to understand the association between<br />
process- and outcome-based quality of care measurement in elderly<br />
surgical patients. Process measures describe the care that patients receive.<br />
Outcome measures are the result of care.<br />
Methods:<br />
This was a retrospective review of 143 patients over the age of<br />
65, who underwent elective general surgery between November 2009<br />
and July 2010. Adherence to 9 surgical Quality Indicators (QIs) (antibiotic<br />
and anti-thrombotic prophylaxis, euglycemia, early withdrawal<br />
of urinary catheter, central line inspection, early mobilization,<br />
malnutrition screening, medication list, surgical safety checklist) and<br />
6 geriatric QIs (delirium screening, standard delirium work-up, cognitive<br />
assessment, complete discharge planning, level of care documentation,<br />
pressure ulcer prevention) was abstracted from medical<br />
records. Surgical and Geriatric Quality Scores were calculated for<br />
each patient (#QIs passed / #QIs eligible x100). The primary outcome<br />
was 1 or more postoperative complications, recorded by NSQIP. The<br />
association between the Quality Score and complications was determined<br />
using logistic regression analysis.<br />
Results:<br />
The median Surgical Quality Score was 66.7%; the median Geriatric<br />
Quality Score was 20.0%. Descriptive statistics of the Low and<br />
High Quality Groups, stratified by the median Quality Score, are<br />
summarized in Table 1. Multivariate logistic regression analysis, adjusting<br />
for age, gender, comorbidities and functional status, revealed a<br />
higher risk of complications in the High Geriatric Quality Group,<br />
compared to the Low Geriatric Quality Group (OR=2.99,<br />
95%CI=1.21-7.33, p=0.017).<br />
Conclusions:<br />
We have assessed quality of surgical care in elderly patients<br />
using a novel, process-based approach. Better geriatric care was associated<br />
with a higher likelihood of developing complications, although<br />
the latter probably drives the former.<br />
Comparison of Patient Characteristics and Outcome in High and<br />
Low Quality Groups<br />
A110<br />
Depressive symptoms and high levels of stress significantly lower<br />
PSA screening rates in men with long life-expectancies in a<br />
nationally-representative sample.<br />
A. A. Kotwal, 1 S. G. Mohile, 2 W. Dale. 1 1. Department of Medicine,<br />
Section of <strong>Geriatrics</strong> & Palliative Medicine, University of Chicago,<br />
Chicago, IL; 2. Department of Medicine, James Wilmot Cancer Center,<br />
University of Rochester, Rochester, NY.<br />
Supported By: The National Social Life, Health, and Aging Project<br />
(NSHAP) is supported by grants from the National Institutes of<br />
Health, including the National Institute on Aging, the Office of<br />
Research on Women’s Health, the Office of AIDS Research, and the<br />
Office of Behavioral and Social Sciences Research (5R01 AG021487),<br />
and by NORC, which was responsible for the data collection.<br />
Background: Guidelines recommend informed decision-making<br />
regarding prostate specific antigen (PSA) screening for men having<br />
10 years of remaining life expectancy (RLE), but there remains a high<br />
rate of non-RLE-based PSA screening. Few studies have specifically<br />
examined the relationship of psychological health to cancer screening<br />
behaviors in men. We therefore assessed whether RLE-based screening<br />
is related to men’s psychological health.<br />
Methods: A nationally-representative sample of men over 57<br />
without prostate cancer (N=1,032) was selected from the National<br />
Social life, Health and Aging Project (NSHAP) and stratified into<br />
two RLE categories: 0-9 years (inappropriate to screen) and 10+<br />
years (appropriate to screen). The relationship of PSA screening<br />
rates within these RLE categories with psychological health variables<br />
anxiety, depression, and stress was assessed using multivariable logistic<br />
regression analyses to control for various potential confounders.<br />
Results: Men with 10+ year RLE with moderate/severe depressive<br />
symptoms had a significantly decreased odds of having PSA<br />
screening (OR=0.55 p=0.02). Men with 10+ year RLE with high stress<br />
levels also had decreased odds of receiving PSA screening (OR=0.37<br />
p=0.02). There was no significant difference in PSA screening rates by<br />
psychological variables in the 0-9 year RLE.<br />
Conclusions: Depression and stress significantly lower PSA<br />
screening rates in men with long life-expectancies for whom an informed<br />
decision on screening would be appropriate. Psychological<br />
morbidity may therefore be a barrier to appropriate informed decision<br />
making on PSA screening in healthy men with long life expectancies.<br />
A111<br />
Elder Self-Neglect and Hospitalization: Findings from the Chicago<br />
Health and Aging Project.<br />
X. Dong. Rush University, Chicago, IL.<br />
Supported By: NIH<br />
Objective: The objective of this study is to quantify the relation<br />
between reported elder self-neglect and rate of hospitalization in a<br />
community population of older adults.<br />
Design: Prospective population-based study<br />
Setting: Geographically-defined community in Chicago.<br />
Participants: Community-dwelling older adults who participated<br />
in the Chicago Health and Aging Project. Of the 6,864 participants<br />
in the Chicago Health and Aging Project, a subset of 1,165 participants<br />
was reported to social services agency for suspected elder<br />
self-neglect.<br />
Measurements: The primary predictor was elder self-neglect reported<br />
to social services agency. Outcome of interest was the annual<br />
rate of hospitalization obtained from the Center for Medicare and<br />
Medicaid System. Poisson regression models were used to assess<br />
these longitudinal relationships.<br />
Results: The average annual rate of hospitalization for those<br />
without elder self-neglect was 0.6 (1.3) and for those with reported<br />
elder self-neglect was 1.8 (3.2). After adjusting for sociodemographic,<br />
socioeconomic, medical commorbidities, cognitive function and physical<br />
function, elders who self-neglect had significantly higher rate of<br />
hospital utilization (RR, 1.47, 95% CI, 1.39-1.55). Greater self-neglect<br />
severity (Mild: PE=0.24, SE=0.05, p
P OSTER<br />
A BSTRACTS<br />
charge summaries at the time of transfer and high readmission rates<br />
for older patients within 30 days of discharge. Methods: Facility leadership<br />
chartered a multidisciplinary “Transition Redesign Team”<br />
(TRT) to examine factors contributing to patient and provider dissatisfaction<br />
after handovers from hospital to the subacute rehabilitation<br />
unit (rehab) at one VA Medical Center. Patients and families cited<br />
lack of advance information about the transfer. Rehab providers reported<br />
discharge summaries were often lacking at the time of transfer<br />
and also cited late times of transfer. Results: The TRT determined<br />
that despite the existence of adequate policies, hospital and rehab<br />
providers frequently lacked important information about factors pertaining<br />
to transfer specifics (e.g. patient information and ideal timing.)<br />
After discussion with the TRT, the rehab charge nurse joined the<br />
hospital team each morning for their “discharge huddle”. Information<br />
was exchanged about bed availability, prospective patient transfers,<br />
and feedback on past transfers. TRT realized that until the attending<br />
physician co-signed the discharge summaries, they were not<br />
visible in the EMR. The hospital team increased their verbal communication<br />
around transition planning, including negotiating time of<br />
transfer directly with the rehab charge nurse, reminding attending<br />
physicians to co-sign discharge summaries promptly, and talking with<br />
patients and families about possible transfer plans in advance. A dramatic<br />
improvement in provider satisfaction with the transition<br />
process occurred over the subsequent 9 months. Upon EMR review<br />
100% (76/76) of discharge summaries and 99% of patient discharge<br />
instructions were complete on the day of transfer to rehab. Patients<br />
and families reported moderately increased satisfaction with timeliness<br />
of information about transfer, and the TRT continues to work<br />
with hospital case managers to improve this communication process.<br />
Conclusion: Direct communication in the form of a discharge huddle<br />
appears to be important in improving provider and patient satisfaction<br />
with handovers from hospital to rehab.<br />
A113<br />
<strong>Geriatrics</strong> in Primary Care: Integrating Comprehensive Geriatric<br />
Care into the Medical Home.<br />
P. A. Engel, 1,3 A. Morgan, 1 J. Spencer. 2,3 1. Geriatric Research,<br />
Education and Clinical Center, VA Boston Healthcare System,<br />
Boston, MA; 2. Medicine, VA Boston Healthcare System, Boston, MA;<br />
3. Medicine, Harvard Medical School, Boston, MA.<br />
Supported By: This project is funded by the Department of Veterans<br />
Affairs<br />
Background: Most elderly patients are cared for by primary care<br />
physicians rather than geriatricians. In New England 48% of Veterans<br />
are aged ≥65 including 69,000 ≥85, a group in which cognitive and<br />
functional disabilities are endemic. The current healthcare system is<br />
not specifically designed to care for this vulnerable group. As a result<br />
frail aged Veterans may experience care that is fragmented, inefficient,<br />
costly and potentially harmful.<br />
Methods: <strong>Geriatrics</strong> in Primary Care (GPC), a clinical demonstration<br />
project addresses this problem by integrating geriatric clinicians<br />
and services directly into two large VA primary care practices<br />
that serve nearly 1,800 Veterans aged ≥85.At the heart of the program<br />
is the on-site presence of a consulting geriatrician and geriatric nurse<br />
care manager who combine forces with existing interdisciplinary<br />
teams to offer comprehensive geriatric care within the evolving VA<br />
medical home model known as PACT (Patient Aligned Care Team).<br />
The program promotes recognition of patients at risk, enhanced patient<br />
access, targeted care management, efficient resource use and a<br />
shift in care focus from multiple subspecialty sites to the PACT.<br />
Results: 175 patients have been evaluated and care managed<br />
since project initiation, August, 2010. 37 referrals to GPC versus 15 to<br />
a traditional stand alone interdisciplinary geriatric clinic (August-October<br />
2011) reflects a shift in geriatric consultation site to GPC. Complex,<br />
fragmented care seen in the first 50 patients (aged 82±7) referred<br />
to GPC indicates a need for this service. In the year prior to<br />
referral these patients made 15±14 total clinic visits with 34% attending<br />
≥5 subspecialty clinics. 74% were cognitively impaired, 18%<br />
lacked family caregivers and 40% received care in ≥2 health systems.<br />
Prorated 12 month follow-up of this original sample indicates a shift<br />
in locus of care with reduced total and mean subspecialty visits, (372<br />
to 269, 7.4±8.0 to 5.4±5.0, NS), significantly increased PACT visits<br />
(3.1±1.5 to 3.7±1.6, p=0.038) and use of phone contact by GPC<br />
(2.3±2.0) for follow-up care.<br />
Conclusion: Preliminary data suggests that GPC improves access<br />
to comprehensive geriatric care, reduces subspecialty service use<br />
and embraces clinical efficiencies by effectively creating interdisciplinary<br />
geriatric teams within PACT.<br />
A114<br />
Subset analysis of antidepressant medication utilization among<br />
geriatric patients with depression: Comparison between usual care<br />
and collaborative care using care managers.<br />
R. DeJesus. Mayo Clinic, Rochester, MN.<br />
Supported By: Nothing to disclose<br />
Depression poses significant economic and health burden yet<br />
remained under-diagnosed and inadequately treated. This is particularly<br />
true among geriatric patients. The STAR*D trial under the National<br />
Institute of Mental Health showed that more than one antidepressant<br />
medication is often necessary to achieve disease remission<br />
among patients seen in both psychiatric and primary care settings.<br />
The collaborative care model (CCM), using care managers, has been<br />
showed in numerous studies to be effective in achieving sustained<br />
outcomes in depression management compared to usual care. In<br />
March 2008, this model was implemented at Mayo Family Clinics<br />
Northwest in Rochester, Minnesota and was subsequently rolled out<br />
to other primary care sites. We hypothesized that utilization of antidepressant<br />
medications among patients with depression managed<br />
under the collaborative care management (CCM) model would be<br />
different from usual care even among geriatric patients.<br />
Records of patients who have been enrolled in CCM from<br />
March 2008 until March 2009 were reviewed and compared to those<br />
under usual care. Pattern of antidepressant medications utilization<br />
were compared between patients with depression enrolled in the<br />
CCM model and those under usual care. Sub-analysis was done on<br />
geriatric patients defined as those aged 65 and older.<br />
Those who were followed under CCM had significantly greater<br />
number of antidepressant medication utilization when compared to<br />
those under usual care. After 6 months, mean PHQ-9 score of patients<br />
under CCM was statistically lower than those in usual care.Subset<br />
analysis of patients aged 65 years and older (N=35) showed no statistically<br />
significant difference in mean PHQ-9 score at 6 months (p<br />
value: 0.59) and anti-depressant medications utilization (p value:<br />
0.29) between the two groups. This observation may reflect correlation<br />
between medication utilization and treatment response; however,<br />
sample number is small to account for any statistical difference.<br />
The collaborative care model for depression management is associated<br />
with greater anti-depression medication utilization with increased<br />
response rate compared to usual care. Future similar analysis<br />
on a larger sample of geriatric patients is needed to evaluate the true<br />
impact of CCM on antidepressant medication utilization and response<br />
rate.<br />
A115<br />
Incorporating INTERACT II Tools In Daily NH Practice,<br />
Recognizing Areas of Improvement.<br />
R. Madan, 1,2 F. Washington, 2 Y. Ye, 1 S. Oakes. 1,2 1. <strong>Geriatrics</strong>, UTH-<br />
SCSA, San Antonio, TX; 2. Buena Vida Nursing Home, San<br />
Antonio, TX.<br />
Background: Hospitalizations of frail nursing home residents<br />
can result in higher costs, complications and death. Research suggests<br />
AGS 2012 ANNUAL MEETING<br />
S55
P OSTER<br />
A BSTRACTS<br />
that a substantial proportion of these hospitalizations may be avoidable.<br />
INTERACT II(Interventions to Reduce Acute Care Transfers)<br />
has shown to address these issues from the nursing home perspective.<br />
Objective: Decrease the number of inappropriate transfers by<br />
using INTERACT II tools. Recognize areas for future improvement<br />
and cultural change.<br />
Design and Intervention: Quality improvement. IDT was<br />
formed and monthly sessions done by all lead members “on line”<br />
using INTERACT II modules. Cases following care pathways implemented<br />
for staff education. Physicians trained by attending medical<br />
executive committee. Using tools given through INTERACT II, all<br />
transfers that took place from May to September were evaluated.<br />
One preventable and one non-preventable transfer from each month<br />
evaluated in detail. In September there were no preventable transfers<br />
so 2 non preventable transfers evaluated in detail.<br />
Results: 31 transfers took place from May to September. 4<br />
deemed to be preventable and 27 non-preventable. 100% of patients<br />
transferred to the ED were admitted to the hospital. 70% of the patients<br />
transfer came from the hospital in the prior admission. None of<br />
the preventable and 33% non-preventable transfers had end of life<br />
planning. In the preventable transfers 75% used the “stop and watch”<br />
tool, 75% used the “SBAR” tool, 25% followed the “care pathways”<br />
and 75% used the “change in condition cards”. In the non-preventable<br />
transfers 83% used the “stop and watch” tool, 83% used the<br />
“SBAR” tool, 67% followed the “care pathways” and 100% used the<br />
“change in condition cards”.<br />
Discussion: Comprehensive advance care planning will likely<br />
improve number of transfers. Following the INTREACT II tools requires<br />
ongoing commitment and training in all levels of care.<br />
Lessons learned: 1.Ongoing education is needed for physician<br />
and non-physician staff due to turnover and cross coverage issues.<br />
Reinforcing standardized tools and approaches such as care pathways<br />
is needed. 2. Quality improvement projects need to work in<br />
identifying residents that are at increased risk for transfers. 3. Increased<br />
awareness to complete comprehensive end of life planning<br />
(POLST) should be undertaken in all residents, and especially those<br />
who are at increased risk of transfers.<br />
A116<br />
Geriatric Medicine Transfer-of-Care for Older Surgical Inpatients:<br />
Our Experience and Current Trends (2006-2009).<br />
R. Gonzales, A. Khoo, D. Basic. Geriatric Medicine, Liverpool<br />
Hospital, Liverpool, NSW, Australia.<br />
Supported By: No outside funding was used for this project.<br />
OBJECTIVE: To examine statistical trends regarding transferof-care<br />
to Geriatric Medicine for older patients admitted under surgical<br />
teams.<br />
BACKGROUND: Liverpool Hospital, Australia is a 700-bed<br />
teaching hospital in southwest Sydney and is the major surgical and<br />
trauma centre for the region. With older surgical patients having a<br />
longer length of stay and worse overall prognosis than younger patients,<br />
there has been an increasing need for geriatrician involvement<br />
in their care. In reviewing models of care, the literature suggests a<br />
transfer-of-care model improves functional capacity and decreases<br />
likelihood of placement compared with usual consultative care.<br />
METHODS: The Department of Geriatric Medicine, Liverpool<br />
Hospital has been maintaining a comprehensive database of consultation<br />
requests and outcomes since 2001. Statistical tests of trends in<br />
proportions were applied to transfer-of -care cases.<br />
RESULTS: A review of surgical consultations (n=741) to Geriatric<br />
Medicine (2006-2009) showed the majority were from neurosurgery<br />
(25.1% of surgical team consults) followed by orthopaedics<br />
(21.9%). The majority of the consultations were for medical assessment<br />
(39.2%), followed by high-level residential facility placement<br />
(30.1%). Geriatrician response times to surgical consultation remained<br />
similar over the four-year period. The proportion of surgical<br />
consultations leading to transfer-of-care ranged from 13.2-31.7%<br />
over 2006-2009, with neurosurgical patients highest among transfers<br />
(25.2% of all transfers). However, the proportion of all (medical and<br />
surgical) consultation patients whose care was transferred decreased<br />
significantly by year (2006-2009, Mantel-Haenszel trend test,<br />
p
P OSTER<br />
A BSTRACTS<br />
ratory failure become chronically critically ill, requiring prolonged<br />
mechanical ventilation (PMV). Older adults who are ventilator dependent<br />
and admitted to long-term care hospitals (LTCH) have a<br />
~50% mortality rate at 1 year, are at high risk for hospital and ICU<br />
readmission. But there is scant data about older adults who receive<br />
care at long-term care skilled nursing facilities (LTC-SNF). This study<br />
examines outcomes of adults on PMV, who were not able to be<br />
weaned, 1 year after their admission to a LTC-SNF.<br />
Methods: A retrospective chart review of mechanically ventilated<br />
adults, admitted to a 60-bed ventilator unit at Silvercrest Center<br />
for Nursing and Rehabilitation (SCNR) from 1/1/2009 to 12/31/2009<br />
and their outcomes at 1 year follow up. Demographic and clinical<br />
data were collected at the time of admission. At 1 year follow up, possible<br />
outcomes included: 1) Alive, 2) Dead, and 3) Lost to follow up.<br />
Also examined was number of readmissions.<br />
Results: During the 1 year time frame, there were a total of 167<br />
subjects on PMV. Of these, 98 were excluded (38 were ventilator liberated<br />
and 60 were admitted prior to 1/1/2009); 69 were admitted for<br />
the first time in 2009 and were included in this study. For these 69 subjects,<br />
the average age was 75 (19-104), with 39 female and 30 male.<br />
The ethnic composition was 37.7% White, 23.2% Black, 24.6% Hispanic,<br />
10% Asian and 4% other. The primary reasons for respiratory<br />
failure were: pneumonia (23.2%), CVA (20.3%), sepsis (15.9%),<br />
COPD (14.5%), anoxic brain injury (10%) and other (16%). At 1<br />
year follow up, 40 (58%) subjects died on the ventilator; 16 (23%)<br />
were alive with 15 in SNF and 1 in the hospital; and 13 (19%) were<br />
lost to follow up due to readmission. On average, subjects experienced<br />
3.3 readmissions (range 0-11). For subjects who were alive at 1<br />
year, readmission rate was 4.7 (range 1-8).<br />
Conclusions: Older adults who require prolonged mechanical<br />
ventilation have a high risk of mortality at 1 year and experience multiple<br />
transitions of care, with many resulting in loss to follow up. Subjects<br />
who survive at 1 year follow up have a higher readmission rate<br />
and none were able to go home.<br />
A119<br />
Improving Transitions to Home in Older Veterans after<br />
Hospitalization.<br />
M. Mather, 1,2 T. Patel, 1,2 S. Espinoza. 1,2 1. GRECC, South Texas<br />
Veterans Healthcare System, San Antonio, TX; 2. UT Health Science<br />
Center, San Antonio, TX.<br />
Supported By: GRECC, Veterans Administration<br />
Background: Approximately 20% of Medicare beneficiaries experience<br />
readmission after hospital discharge (DC). Follow-up (FU)<br />
is usually scheduled 7-10 days after DC, although the high risk time<br />
for post-DC complications, such as falls, is 24-72 hrs after DC. The<br />
goal of this quality improvement project was to improve transitions<br />
to home by contacting patients during this time window in order to<br />
increase safety awareness, improve medication compliance, and prevent<br />
readmission.<br />
Methods: Patients were outpatients enrolled in the Geriatric<br />
Evaluation and Management (GEM) clinic at Audie Murphy VA<br />
Hospital. Scripted follow up calls were made 24-72 hrs post-DC over<br />
a 15-month period by a clinical nurse leader (CNL), who asked about<br />
new disability, new medications, social work (SW) concerns, capacity<br />
for self-care, and whether FU was scheduled. All actions resulting<br />
from the call made by the GEM interdisciplinary team (CNL, MD,<br />
SW, clinical pharmacist) were documented. A standardized retrospective<br />
chart review was performed for data collection, and the information<br />
was summarized using descriptive statistics.<br />
Results: 96 patients were called: mean age was 77.3 ±11.5 yrs,<br />
93.8% were male, 53.1% were Non-Hispanic White, and 30.2% were<br />
Hispanic. Medical comorbidity was common: 65.4% had 2 or more of<br />
diabetes, congestive heart failure, chronic obstructive pulmonary disease,<br />
and hypertension. 73.9% had received new medications upon<br />
DC, and 16.7% had a new disability. While most (88.1%) were taking<br />
medications appropriately, 4.8% were taking the wrong medication<br />
or dose, and required medication reconciliation. 12.1% of calls lead to<br />
intervention by the MD, and readmission was prompted by the call in<br />
15.3% of patients. 4.8% experienced a fall after DC and 15.3% were<br />
readmitted within 30 days. Neither falls nor readmission were associated<br />
with any specific chronic disease.<br />
Conclusion: The GEM team identified the need for post DC FU<br />
calls to improve communication with patients and address unmet<br />
needs. Anecdotally, patients reported increased satisfaction and reduced<br />
anxiety transitioning to home post DC as a result of this intervention,<br />
although this was not formally evaluated. Patients and their<br />
families should receive disease and safety education, particularly with<br />
regard to falls, at every encounter.<br />
A120<br />
Improving Care of the Geriatric Trauma Patient.<br />
S. Hobgood, L. Scheider, P. Boling. <strong>Geriatrics</strong>/Internal Medicine,<br />
Virginia Commonwealth University, Richmond, VA.<br />
Background: Trauma from falls, motor vehicle crashes, and other<br />
mechanisms causes much morbidity, hospital use and mortality. Patients<br />
over age 65 now account for 12% of trauma admissions, rising<br />
to 40% by 2050. While studies have shown benefit from linking <strong>Geriatrics</strong><br />
and Orthopedic Surgery services, little evidence exists regarding<br />
outcome impacts by <strong>Geriatrics</strong> in other surgical areas. VCU Medical<br />
Center admits hundreds of trauma patients aged 65 and older<br />
each year. Every weekday, the Geriatric Consult Service (GCS) sees<br />
and follows Trauma patients on request. We assert that the VCU GCS<br />
intervention benefits trauma patients.<br />
Methods: We conducted a detailed structured electronic record<br />
review of all patients age 65 or older, seen by the GCS at VCU Medical<br />
Center in 2010, including 73 of 251 (29%) geriatric Trauma Surgery<br />
admissions. We studied patient characteristics, financial data, disposition,<br />
and mortality.<br />
Results: The table shows the main results. There were no differences<br />
in sex, race, zip code, or other demographic characteristics.<br />
Conclusions: Trauma patients seen by GCS were older, and were<br />
sicker than other elderly trauma patients based on a significant difference<br />
in DRG weights, and ICU days. GCS patients more often<br />
went to nursing homes which may reflect acuity or GCS intervention<br />
effects, and though the sicker GCS patients stayed longer and cost<br />
more, they had a better financial outcome for the hospital. Despite<br />
the acuity, in-hospital mortality was lower although not statistically<br />
significant in this small sample, an encouraging finding that we continue<br />
to study.<br />
Geriatric trauma patients seen by GCS versus those not seen by GCS<br />
A121<br />
Transition Coaching to Reduce Hospitalization and Emergency<br />
Department Use.<br />
S. Pandey, 1,2 D. Ifon, 2 L. Williams, 2 K. Blackstone, 1,2 E. L. Cobbs. 1,2 1.<br />
Medicine, George Washington University, Washington, DC; 2.<br />
<strong>Geriatrics</strong>, Extended Care and Palliative Care, Washington DC VA<br />
Medical Center, Washington DC, DC.<br />
Background: Transition Coaching (TC) is a short term program<br />
to help patients with functional decline. TC provides short term case<br />
management using home visits and person- and family-centered care.<br />
TC comprehensively assesses the patient and caregiver situation, provides<br />
meaningful education, improves medication management, and<br />
identifies needed resources. Goals are to achieve a comprehensive assessment,<br />
improve patient and family understanding of the disease,<br />
AGS 2012 ANNUAL MEETING<br />
S57
P OSTER<br />
A BSTRACTS<br />
articulate goals of care, reduce inefficiencies of care, and reduce caregiver<br />
burden.<br />
Methods: The TC program started in 10/10 and was fully operational<br />
in 2/11. Two nurse practitioners (NP) deliver short term transition<br />
coaching in response to consultation requests. Outcome measures<br />
include patient and family satisfaction, referring provider<br />
satisfaction, hospital and emergency department utilization, advance<br />
care planning documentation (ACP) and additional resources accessed.<br />
Initial funding was obtained with grant support for two NP<br />
salaries. NPs were embedded into an existing geriatric clinic team.<br />
Revenues from the home visits will sustain the TC program.<br />
Results: 63 patients were served by the TC program from 10/10<br />
to 10/11. 52 completed the program. The most common reasons for<br />
TC consult were medication use, averting functional decline, and alleviating<br />
caregiver burden. The mean age was 83, and all were men.<br />
Most were living with a caregiver. The two most common diagnoses<br />
were heart failure and dementia. 100% underwent comprehensive<br />
assessment, 96% had patient-centered medication management, and<br />
83% had ACP documentation. 37% were linked to new resources,<br />
38% received social worker consultation, 75% received durable<br />
medical equipment, 15% enrolled in home hospice, and 13% enrolled<br />
in home-based primary care. To date, hospital and emergency<br />
department use have been reduced by half, when compared with the<br />
year prior to TC. Patient, family and provider satisfaction has been<br />
excellent.<br />
Conclusion: TC appears to add an important piece to the array<br />
of interventions to help patients remain at home. TC helps optimize<br />
medical management, document ACP, and access resources to decrease<br />
hospital and emergency department use.<br />
A122<br />
Use of the Frailty Index to evaluate the risk of death in older<br />
patients presenting to hospital.<br />
S. Evans, 1 A. Mitnitski, 2 K. Rockwood. 2 1. Medicine, Mercy Hospital<br />
of Buffalo, Buffalo, NY; 2. Medicine, Dalhousie University, Halifax,<br />
NS, Canada.<br />
Supported By: Mercy Hospital of Buffalo, NY<br />
Community Health Foundation of Western and Central New York<br />
Dalhousie Medical Research Foundation<br />
QEII Fountain Innovation Fund<br />
Background: The frailty index can identify groups at increased<br />
risk of deathy in older adults, as reported by ours and other groups. In<br />
hospitals, a Frailty Index (FI) based on a Comprehsnive Geriatric assessment<br />
(CGA) can be built from routinely collected data. The objectives<br />
of our study were: 1. To test the predictive validity of the FI-<br />
CGA in relation to length of stay (LOS) and mortality. 2. To compare<br />
the impact of change in health status over a two week period on outcomes.<br />
Methods: This is a prospective cohort study of 754 patients age ≥<br />
75 admitted to a medical unit at Mercy Hospital, Buffalo NY.. Main<br />
outcome measures were mortality and hospital LOS. Kaplan-Meier<br />
survival analysis was performed separately in men and women.The logrank<br />
test was used to assess differences between survival curves. Cox<br />
proportional hazard regression model was applied to analyse the association<br />
of the FI-CGA with mortality, adjusted for age and sex. Multivariate<br />
logistic regression was used to analyse the association of the FI-<br />
CGA with 30-day and 90-day mortality.A generalized linear model was<br />
usedtoanalyseLOSinrelationtotheFI-CGAandotherfactors.<br />
Results: 754 older adults were enrolled, of whom complete data<br />
are available on 751. These patients were older (mean age 84.0<br />
(SD=5.5) and most (480; 60.7%) were women. Their mean length of<br />
stay in hospital was 5.2 (SD=5.1) days. 30-day mortality rate was<br />
11.5% (91/751) which increased to 16.4% (130/751) by 90 days. On<br />
average, patients were moderately frail at baseline (median FI-<br />
CGA=0.35), but their health status had worsened significantly in the<br />
two weeks prior to admission, at which time their median FI-CGA<br />
was 0.46. In Cox regression analysis, age, sex and the FI-CGA score<br />
were significantly associated with mortality (e.g., for the FI-CGA, the<br />
HR=1.04 (95%CI=1.03, 1.05) for each 1% FI-CGA increment. Multivariate<br />
logistic regression also showed the age and sex adjusted risk<br />
of death was highly associated with the FI-CGA (OR=1.06 (1.04,<br />
1.08) for 30-day mortality and OR=1.05 (1.03, 1.07) for 90-day mortality..<br />
Likewise, a higher FI-CGA was significantly associated with<br />
LOS (R2=0.3).<br />
Conclusion: <strong>Here</strong>, the FI-CGA stratified the risk of death and<br />
long LOS in older adults admitted to hospital.<br />
A123<br />
GHEST-3D: Greenwich Hospital Executive Screening Tool for<br />
Delirium, Depression and Executive Dysfunction. Report on an<br />
observational quality improvement study.<br />
S. Buslovich, 1 G. J. Kennedy. 2 1. Internal Medicine, Greenwich<br />
Hospital-Yale New Haven Health, Greenwich, CT; 2. Geriatric<br />
Psychiatry, Einstein-Montefiore Medical Center, Bronx, NY.<br />
Supported By: Greenwich Hospital funded the part time salary of a<br />
geriatric screening nurse to administer the survey instruments.<br />
Cognitive decline is omnipresent in the geriatric patient population.<br />
The risk of cognitive impairment increases with age and is further<br />
enhanced after hospitalization as supported in the literature.<br />
Screening patients for cognitive impairment during hospital admission<br />
could be the first step in early identification of cognitive impairment,<br />
allowing for implementation of appropriate interventions. Several<br />
conditions that significantly impact functionality and<br />
independence may be subtle and undiagnosed.<br />
We evaluated patients considered to be at high-risk for hospital<br />
re-admissions, such as patients admitted with CHF exacerbations,<br />
acute myocardial infarctions, pneumonia and COPD exacerbations<br />
for delirium, depression and executive dysfunction. A screening tool<br />
was designed utilizing evidence based tools, such as, the Confusion<br />
Assessment Method (CAM), Patient Health Questionnaire (PHQ-9),<br />
Controlled Oral Word Association Test (COWAT), and Oral Trail<br />
Making Test (OTMT) to conduct an oral interview and identify patients<br />
with delirium, depression and executive dysfunction.<br />
The original sample size consisted of 43 case patients and 27 control<br />
patients. Control patients were age, and sex matched surgical floor<br />
patients without history of the high-risk diagnoses. 91.3% (21) of the<br />
23 readmitted (within one year) case patients tested positive for executive<br />
dysfunction; 50% (3/6) original study subjects that tested positive<br />
for depression were readmitted with one year; 75% (3/4) original study<br />
subjects tested positive for delirium were readmitted in the same time<br />
period. The subject pool was inadequate to identify a reliable time to<br />
readmission for each specific diagnosis in this observational study.<br />
This study illustrates the potential value of systemic screening for<br />
cognitive impairment in acute stay hospitalized elderly patients and possible<br />
implications of all-cause readmission rates. Further cohort studies<br />
are needed to evaluate whether recognition and targeted interventions<br />
could contribute to positive outcomes, specifically, follow through with<br />
the discharge plan of care, medication regimen adherence, reduction in<br />
nursing home admissions, depressive symptom remission, hospital readmissions,<br />
mortality and improvements in the patients’ quality of life.<br />
A124<br />
Safety in Transitions of Care; Identifying Needs Among Key<br />
Providers in an Urban Academic Hospital.<br />
U. K. Ohuabunwa, 1,2 S. Shah, 1 Q. Jordan, 2 K. Johnson, 1 C.Tai, 1<br />
J. Flacker. 1 1. Division of <strong>Geriatrics</strong>, Dept of Medicine, Emory<br />
University,Atlanta, GA; 2. Senior Services, Grady Hospital,Atlanta, GA.<br />
Supported By: HRSA - Geriatric Academic Career Award<br />
Hartford Center of Excellence Clinician Educator Award<br />
Background: Medication errors, poor communication, and poor<br />
coordination between providers are major contributory factors to<br />
failure in transitions of care.<br />
S58<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
Objectives: 1. To determine the knowledge, attitude and care<br />
transitions practices of key inter professional providers involved in<br />
the discharge process.<br />
2. To determine their perceived patient, provider and system related<br />
factors contributing to failure in transitions of care<br />
Design: Mixed methods approach using surveys and focus group<br />
sessions<br />
Setting: A 953 bed academically affiliated inner city hospital<br />
Participants: Key providers involved in the discharge process including<br />
physicians, nurses, social workers and case managers.<br />
Procedure: We administered questionnaires to these key<br />
providers exploring their knowledge of care transitions best practices,<br />
attitudes and practices. Focus group sessions were held to further explore<br />
their perceived patient needs; and patient, provider and system<br />
related barriers to safe transitions of care.<br />
Results: 108 participants including 74 medical residents, 12 medical<br />
students, 7 social workers, 5 nurse case managers and 6 inpatient<br />
unit nursing directors /charge nurses completed the questionnaires.<br />
21% of the participants had received no formal training on care transitions<br />
best practices at anytime. Up to 61% reported no training on<br />
effective communication and patient education strategies. The areas<br />
of least training were on determination of patient - appropriate settings<br />
of care (27%) and communication and coordination of care with<br />
outside care facilities (18%). Medication reconciliation and scheduling<br />
of appointments were the most common provider practices reported.<br />
The following themes emerged during the focus group sessions<br />
as provider related factors contributing to failure in care<br />
transitions: 1) Poor communication between members of the healthcare<br />
team.2)Poor understanding of roles of members of the healthcare<br />
team.3) Poor patient education by providers and poor knowledge<br />
as to patient education best practices.4) Poor understanding of<br />
the care transitions process and recommended best practices. Conclusion:<br />
Determination of provider related deficiencies in the knowledge<br />
and practice of care transitions will form a basis for educational interventions<br />
to reduce provider related errors.<br />
A125<br />
Understanding the Southern Arizona Dual-Eligible Special Needs<br />
Patient (SNP) population.<br />
V. Nagaraja, 1 H. Goel, 1 A. Gilligan, 2 J. Mohler, 1 T. Ball, 3 I. Abraham, 2<br />
M. Fain. 1 1. Arizona Center on Aging, University of Arizona, Tucson,<br />
AZ; 2. HOPE Center, University of Arizona, Tucson, AZ; 3. University<br />
of Arizona Health Network, Tucson, AZ.<br />
Background: The dual-eligible population (Medicare and Medicaid<br />
eligible) represents a group of patients with disproportionally<br />
large healthcare expenditures and multiple chronic conditions. They<br />
are likely to have multiple inpatient stays and emergency room visits.<br />
New innovative chronic care models are needed for this population.<br />
The primary objective of this study was to characterize and analyze<br />
the most costly dual-eligible enrollees in a Special Needs Program<br />
(SNP) within a southern Arizona academic medical center and understand<br />
patterns of suboptimal utilization and barriers to coordination.<br />
Methods: This study was retrospective, with data consisting of<br />
patient chart reviews and administrative cost data. Information regarding<br />
socio-demographics, general health status health resource<br />
utilization (HRU), and total cost of care (TCoC) of the top 10%<br />
(n=30) of the most costly dual eligible enrollees assigned to providers<br />
within the hospital’s outpatient programs were collected.<br />
Results: Sixty percent of the sample was female (n = 18). Mean<br />
age was 60 years (SD=13). Mean body mass index (BMI) was 31.9<br />
(SD=9.2), and 14 patients (46.7%) were clinically obese (BMI >30).<br />
Nearly 50% were diabetic. Seventy-five percent had four or more<br />
chronic conditions, with 75% having one or more concomitant psychiatric<br />
illness. The average number of PCP visits was 7.7 per six<br />
months (SD=5.9; 95%CI: 0-23). Average number of hospitalizations<br />
per six months was 1.4 (SD=1.5; 95%CI: 0-6). Thirty-day re-admission<br />
rates averaged 27% (SD=0.45). TCoC averaged $15,955/six months<br />
(SD=$10,890; 95%CI: $6,570-$59,068). Hospital admissions were a<br />
statistically significant contributor to TCoC (p = 0.001). The top 5%<br />
of this population accounted for nearly 50% of total spending.<br />
Conclusion: Finding effective, efficient and high quality means<br />
for coordinating the care of the dual-eligibles could help to assure the<br />
fiscal sustainability of the Medicare and Medicaid programs in the future.<br />
Findings will be used to create inter-professional chronic care<br />
models in collaboration with patients and their families, which address<br />
suboptimal utilization and barriers to coordination and incorporate<br />
value-based, high-touch, high-tech care.<br />
A126 Encore Presentation<br />
Improving quality of care for older veterans through a RHIOenhanced<br />
Care Transitions Intervention (CTI).<br />
W. W. Hung, 1,2 C. M. Dunn, 1 N. E. Moodhe, 1 E. M. Gottesman, 1<br />
B. Morano, 1,2 K. S. Boockvar. 1,2 1. GRECC, James J Peters VA<br />
Medical Center, Bronx, NY; 2. <strong>Geriatrics</strong>, Mount Sinai School of<br />
Medicine, New York, NY.<br />
Supported By: VA GEC T21 grant<br />
Background: Older veterans who transition from acute care to<br />
home are at risk for adverse outcomes such as readmissions and medication<br />
errors. This is especially true for veterans who use both VA<br />
and non-VA services, which is common in the Medicare-eligible population.<br />
The Bronx Regional Health Information Organization<br />
(RHIO), a regional electronic health information network, provides<br />
an opportunity to improve care coordination between VA and non-<br />
VA systems by providing a platform for sharing clinical data. The objective<br />
of this project was to implement a CTI that used real time<br />
RHIO notification of hospitalization events.<br />
Methods: Our CTI was based on the Coleman model, which had<br />
components of patient education, medication management, tools for<br />
self-management, and patient and caregiver empowerment. Referrals<br />
and case finding were used to identify appropriate older adults aged<br />
60+ discharged from our VAMC. For veterans who agreed to be monitored<br />
through the Bronx RHIO, the CTI team received electronic<br />
notifications from the Bronx RHIO informing them of hospitalization<br />
events at non-VA hospitals in the Bronx. The care transitions coordinator<br />
delivered the intervention with a visit in the hospital, with a<br />
home visit 2 days after discharge, and with 3 follow-up phone calls.<br />
Results: We modified the CTI to adjust education material for<br />
health literacy level and to make additional calls or visits as needed.<br />
Also, for some with poor health literacy, our coordinator needed to<br />
follow up clinical issues with providers. The CTI was associated with a<br />
lower 30-day rehospitalization rate of 17.8% among those served by<br />
the CTI as compared with 24.4% among those referred but not<br />
served. 91% of veterans served had a follow up visit within 30 days at<br />
the VA Medical Center and on average 1.1 unmet needs (such as<br />
medication discrepancy or mishaps) addressed. Projected cost reduction<br />
was $103000 annually which can be used to support the salary of<br />
the coordinator.<br />
Conclusion: Quality of care for veterans across health systems<br />
can be improved through care transitions activities enhanced by the<br />
use of a RHIO, with the potential for cost neutrality or cost savings.<br />
A127<br />
Access to Primary Care Using a Care Transitions Program: a<br />
Cohort Study.<br />
Y. Chen, 1 H. Syed, 1 J. M. Naessens, 2 N. D. Shah, 2 A. S. Rahman, 2<br />
K. M. Swanson, 2 P. Y. Takahashi. 1 1. Internal Medicine, Mayo<br />
Clinic, Rochester, MN; 2. Health Science Research, Mayo Clinic,<br />
Rochester, MN.<br />
Background: Care transitions involve a smooth handoff from<br />
the hospital to the home environment. One important aspect of care<br />
AGS 2012 ANNUAL MEETING<br />
S59
P OSTER<br />
A BSTRACTS<br />
transitions involves access to primary care which may provide better<br />
care coordination. Our clinical practice has initiated a care transitions<br />
program (CTP) with nurse practitioners after hospital stay in<br />
high risk elders. The aim of this study is to evaluate the number of<br />
primary care visits 60 days prior to enrollment and 60 days after enrollment<br />
in CTP.<br />
Methods: This was a retrospective cohort study of older adults<br />
enrolled in CTP from March 2011 till September 2011. CTP was initiated<br />
after hospital dismissal in high-risk adults over 60. Data was<br />
collected using administrative billing data on primary care (PC) visits<br />
prior to enrollment and after enrollment. Primary outcomes included<br />
the percentage of people with at least one visit to the PC<br />
team and average number of PC visits. Secondary outcomes included<br />
visits to specialists. Analysis used McNemar test and paired t-<br />
test respectively.<br />
Results: 95 patients were identified who had enrolled in CTP in<br />
mid 2011. Subjects visited their PC team 84.2% of the time before enrollment<br />
compared to 94.74% after enrollment (p-value
P OSTER<br />
A BSTRACTS<br />
A130<br />
The effect of Thai traditional music on cognitive function,<br />
psychological health and quality of sleep among older Thai<br />
individuals with dementia.<br />
P. Sithinamsuwan, 1 S. Saengwanitch, 1 A. Pinidbunjerdkool, 1<br />
S. Ukritchon, 2 M. Mungthin. 3 1. Division of Neurology, Department<br />
of Medicine, Phramongkutklao Hospital, Bangkok, Thailand; 2.<br />
Office of Research Development, Phramongkutklao College of<br />
Medicine, Bangkok, Thailand; 3. Department of Parasitology,<br />
Phramongkutklao College of Medicine, Bangkok, Thailand.<br />
Supported By: 1.Phramongkutklao College of Medicine<br />
2.Department of Medicine, Phramongkutklao Hospital<br />
Background: This study was designed to investigate the effects<br />
of Thai traditional music on cognitive function, activities of daily living,<br />
mood, behavior and sleep quality in demented Thai elderly.<br />
Methods: An 8-week, interventional, controlled, cross-over<br />
study was undertaken in 67 patients with dementia. We randomly allocated<br />
patients into 2 groups; group-1 [intervention (4-week) followed<br />
by control (4-week)], group-2 [control followed by intervention].<br />
During the interventional period, care givers played the music<br />
CD for each patient for at least 30minutes daily. Cognitive function<br />
[Mini-Mental State examination (MMSE)], activities of daily living,<br />
mood, behavior [Behavioral Pathology in Alzheimer’s Disease Rating<br />
Scale (BEHAVE-AD)] and sleep quality [Pittsburgh Sleep Quality<br />
Index (PSQI)], were assessed at 1stvisit (baseline), 2nd and 3rdvisit.<br />
Results: The mean age was 77.6 years and mean initial MMSE<br />
17.5. Average daily listening time was 51.2 minutes. Music significantly<br />
improved scores in MMSE (p = 0.009), 2-domain of BEHAVE-<br />
AD [Diurnal rhythm disturbance (p = 0.021) and Anxiety/phobia (p =<br />
0.025)] as well as the summation of behavioral symptomatology (p =<br />
0.008) and one sleep index [Daytime dysfunction (p = 0.005)]. Also,<br />
there was a trend to improvement in 2 more domains of BEHAVE-<br />
AD [Paranoid/delusion and Aggressiveness], ADL and global sleep<br />
quality index. Median visual analog scale of satisfaction this intervention<br />
was 80. The optimal duration of music exposure to improve cognitive<br />
and neuropsychiatric functions was 15minutes/day.<br />
Conclusions: Thai traditional music is an effective tool for addressing<br />
neuro-psychological symptoms, especially in cognitive function,<br />
behavioral and sleep problems, in elderly Thai with dementia.<br />
This study suggests that regularly scheduled listening to music more<br />
than 15 minute/day promotes a positive short-term effect on emotional<br />
memory.<br />
A131 Encore Presentation<br />
Systemic inflammation inhibits low-density lipoprotein receptorrelated<br />
protein-1 mediated clearance of amyloid-β from blood:<br />
implications for Alzheimer’s disease.<br />
P. E. Hartvigson, 1,2 M. A. Erickson, 2,3 W. A. Banks. 1,2 1. University of<br />
Washington School of Medicine, Seattle, WA; 2. GRECC-VA Puget<br />
Sound Health Care System, Seattle, WA; 3. Saint Louis University,<br />
Saint Louis, MO.<br />
Supported By: Medical Student Training in Aging Research<br />
Program; National Institute on Aging (T35AG026736); National<br />
Institute on Aging (R01AG029839); John A. Hartford Foundation<br />
MetLife Foundation; Lillian R. Gleitsman Foundation; VA Merit<br />
Review (WAB)<br />
Background: Alzheimer’s disease (AD) is a neurodegenerative<br />
disease characterized by the formation of amyloid plaques containing<br />
amyloid-β (Aβ) in brain parenchyma. Neurons produce Aβ constitutively.<br />
In normal physiology low density lipoprotein receptor-related<br />
protein-1 (LRP-1) transports Aβ from brain across the blood-brain<br />
barrier (BBB) into blood (efflux). Aβ is then taken up by peripheral<br />
organs (primarily liver) for degradation. LRP-1 mediates liver uptake<br />
of Aβ from blood. It has been proposed that Aβ in blood may also<br />
contribute to Aβ accumulation in brain, thus liver uptake may play a<br />
significant role in maintaining brain Aβ homeostasis. Lipopolysaccharide<br />
(LPS) -induced inflammation recapitulates many components of<br />
this aspect of the AD phenotype, and evidence suggests oxidative<br />
modification (adding 3-nitrotyrosine (3-NT) and 4-hydroxy-2-nonenal<br />
(4-HNE)) inhibits BBB LRP-1. We tested whether systemic inflammation<br />
inhibits liver LRP-1 and peripheral Aβ uptake by the<br />
same proposed mechanism.<br />
Methods: We injected young CD-1 mice with intraperitoneal<br />
LPS (control: saline) to induce inflammation, and then injected radiolabeled<br />
albumin and Aβ intravenously. Blood, liver and kidney were<br />
collected at various time points. Aβ/albumin uptake and serum clearance<br />
were assessed by gamma counting. Exposure time was calculated<br />
with multiple-time regression analysis. Liver LRP-1 expression<br />
and liver protein carbonyl were determined by dot blot. 3-NT and 4-<br />
HNE modifications on liver LRP-1 were assayed with Western blot.<br />
Results: LPS treatment significantly increased liver protein carbonyl,<br />
liver LRP-1 expression and 4-HNE modification on liver LRP-<br />
1. 3-NT modification on liver LRP-1 increased 38.8%. LPS significantly<br />
inhibited serum Aβ clearance as well as the rate of liver and<br />
kidney Aβ uptake.<br />
Conclusions: These findings support the hypothesis that oxidative<br />
modification on LRP-1 in liver increases circulating Aβ, which<br />
has been shown to increase brain Aβ concentration and contribute to<br />
amyloid plaque formation, hallmarks of AD pathology.<br />
A132<br />
Age, gender and blood pressure predict cerebral cortical thickness in<br />
normotensive and prehypertensive middle-aged adults.<br />
S. Wo,A. Heim, L.Yadlosky, J. Owens, J. R. Jennings. Department of<br />
Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA.<br />
Supported By: National Heart, Lung, and Blood Institute<br />
Thickness of the human cerebral cortex decreases with normal<br />
aging, and accelerated cortical thinning has been demonstrated in<br />
several pathologies, including Alzheimer’s disease. Previous studies<br />
have shown that subclinical levels of cerebrovascular risk factors such<br />
as high blood pressure are associated with decreased regional cortical<br />
thickness in community-dwelling elderly adults. In this study, we examine<br />
the relationship between cortical thickness and blood pressure<br />
in normo- and prehypertensive middle-aged adults. Our sample consists<br />
of 89 adults aged 35-60 years without neurological, cerebrovascular<br />
or cardiovascular histories whose blood pressures were normal<br />
to prehypertensive (systolic BP
P OSTER<br />
A BSTRACTS<br />
findings suggest that early control of elevated blood pressure may<br />
promote successful brain aging.<br />
A133 Encore Presentation<br />
A Driving Assessment Clinic: Structure and Statistics.<br />
S. Suraj, G. Madero, M. Shawn, N. Shirley. <strong>Geriatrics</strong> Department,<br />
Marshall University, Huntington, WV.<br />
OBJECTIVE: The decision whether a patient of advanced age<br />
or with a diagnosis of dementia should stop driving is a complex one,<br />
as there are no firm guidelines. Clinicians do not generally provide<br />
uniform assessments; indeed they rarely do any formal assessment to<br />
decide the answer for each patient. At the Hanshaw Geriatric Center<br />
we reviewed records of the patients from our Driving Assessment<br />
clinic to find whether any general recommendations can be made for<br />
Primary Care Physicians to assist them in planning for driving assessments<br />
for their patients.<br />
PATIENTS AND METHODS: Records where reviewed from<br />
all patients evaluated at our Driving Assessment Clinic at the Hanshaw<br />
Geriatric Center from August 2007 to mid 2010. We first assessed<br />
patterns of appointments themselves (kept/cancelled/“noshowed”),<br />
and subsequently reviewed actual assessment results.<br />
RESULTS: Out of 144 appointment slots available, 109 (76%)<br />
were filled. 26 (24%) of 109 appointments were Cancelled out of<br />
which 16 (62%) rescheduled and were evaluated. 14 (13%) of 109<br />
were “No Shows” out of which 1 (7%) rescheduled and was evaluated.<br />
A total of 49 patients (29 men and 19 women) where evaluated,<br />
3 of whom underwent the testing twice, for a total of 52 evaluations.<br />
Mean age was 75.4. The prevalence of CNS disorders was high<br />
among those tested. In 27 evaluations (52%), the patient had the diagnosis<br />
of dementia at the time of the assessment. Eleven (21%) had<br />
suffered head trauma, four of whom also had a dementia diagnosis.<br />
Nine (17%) had strokes. In two cases, all three diagnoses coexisted,<br />
yet the patients were still driving.<br />
CONCLUSIONS: In spite of the value of having objective data<br />
about our patients’ driving skills, in is difficult to obtain such data.<br />
Formal driving assessment is labor intensive and cancellation and noshow<br />
rates are quite high. We conclude that this is not a process which<br />
can be accomplished in the primary care office, nor even in many<br />
larger institutions. Regional assessment clinics are a possible approach,<br />
but would likely have to be supported by funds other than<br />
fee-for-service.<br />
A134<br />
Identifying the malady of synaptic plasticity-related genes in human<br />
Alzheimer’s Disease.<br />
S. M. Harvey, J. Knebl, J. Simpkins, S. Sarkar. University of North<br />
Texas Health Science Center, Fort Worth, TX.<br />
Early Alzheimer’s disease (AD) pathophysiology is characterized<br />
by synaptic changes induced by degradation products of amyloid<br />
precursor protein (APP). Although there is evidence for synaptic dysfunction<br />
induced by soluble oligomeric Aβ, the pre- or postsynaptic<br />
sites of action and the specific mechanisms responsible for such dysfunction<br />
have not been established. We reasoned that by measuring<br />
pre-and postsynaptic plasticity related gene expression in different<br />
brain regions from age matched control (AMC) and AD patients,<br />
candidate defective gene(s) by the criteria of severe loss of expression<br />
in AD could be identified. Preliminary results from western blot<br />
analysis show region specific severe loss of expression of pre-synaptic<br />
proteins AP-180, synaptogamin and dynamin in AD compared to<br />
AMC. These losses were most profound in the occipital and temporal<br />
cortices, but not significant in the cerebellum. The loss of expression<br />
of pre-synaptic protein molecule could lead to defects in synaptic<br />
function and ultimately to synapse loss that underlies the memory impairment<br />
evident in the early phase of AD.<br />
A135<br />
Defining Dementia Multimorbidity in a National Sample.<br />
T. Sadak, J. Katon, S. Borson. University of Washington, Seattle, WA.<br />
Supported By: JAHF Atlantic Philanthropies Claire Fagin<br />
Fellowship<br />
National Alzheimer’s Diseases Coordinating Center<br />
Background: Clinicians cite clinical complexity as a major challenge<br />
in caring for dementia patients, and no general model of care<br />
has found wide acceptance. Quantifying clinical complexity is a first<br />
step toward developing the necessary infrastructure for populationbased<br />
dementia care. Our goal was to describe dementia multimorbidity,<br />
using prevalence estimates for single and complex dementia<br />
etiologies, neuropsychiatric symptoms (NPS), and co-morbid chronic<br />
psychiatric and medical conditions in a large, systematically diagnosed<br />
national sample.<br />
Methods: Baseline visit data in the National Alzheimer’s Coordinating<br />
Center repository [U01 AG016976] were analyzed for 3851<br />
persons enrolled in an Alzheimer’s Disease Research Center<br />
(ADRC) and diagnosed with one of the four most common primary<br />
dementias (Alzheimer’s (AD), Lewy Body (DLB), behavioral variant<br />
Frontotemporal (BvFTD), and Vascular (VaD)). ‘Complex dementia’<br />
was defined as >1 concurrent etiologic diagnoses; severity<br />
was indexed by the clinical dementia rating (CDR). Co-morbid conditions<br />
(present or absent) included cardiovascular disease (CVD),<br />
cerebrovascular disease (CVAD), diabetes, hypertension (HTN), hypercholesterolemia<br />
(HCL), and primary psychiatric disorders. NPS<br />
were rated using the total NPI-Q score (prevalence X severity<br />
summed across 12 symptoms). Results: The sample prevalence of primary<br />
dementia diagnoses was 3338 for AD, 241 for DLB, 189 for<br />
bvFTD, and 83 for VaD. Overall, 202 persons (5%) had >1 etiology.<br />
Dementia was mild (CDR 1) in 64% of the sample. Almost all patients<br />
(93%) had at least one additional clinical problem; 89% had a<br />
comorbid chronic medical condition and 27% had ≥3. 41% had a psychiatric<br />
diagnosis (nearly all depression), and 88% had at least one<br />
current NPS, with total NPIQ scores varying by dementia etiology<br />
(AD 5.4, DLB 8.7, bvFTD 9.3, VaD 7.0). Severe dementia (CDR 3+)<br />
was more prevalent among persons with complex etiologies (17%)<br />
compared to those with a single etiology (11%, p < 0.05) and mean<br />
NPIQ scores were higher (7.5 vs. 5.8, p < 0.05).<br />
Conclusions: Multimorbidity is part of the reality of dementia,<br />
even among participants in ADRC’s, where the prevalence of ‘pure’<br />
AD is higher and overall clinical complexity is expected to be lower<br />
than in an unselected population. This study points to the need for<br />
conceptual and pragmatic approaches to care that incorporate complexity<br />
and its impact on clinical outcomes.<br />
A136<br />
Reliability of the Rey Complex Figure Test for Identifying Mild<br />
Cognitive Impairment.<br />
T. V. De Beritto, 1 K. D. Tingus, 2 P. H. Lu, 2 E. Teng. 2,3 1. University of<br />
Utah School of Medicine, Salt Lake City, UT; 2. Neurology, UCLA,<br />
Los Angeles, CA; 3. VA Healthcare System, Los Angeles, CA.<br />
Supported By: MSTAR (Medical Student Training in Aging<br />
Research Grant)<br />
Background: Individuals meeting criteria for mild cognitive impairment<br />
(MCI) progress to dementia at higher rates than agematched<br />
controls. However, the optimal operationalization of the<br />
MCI criteria remains uncertain. The Rey Complex Figure Test<br />
(RCFT) is widely used to assess memory and visuospatial functioning.<br />
Previous work indicates that the RCFT has good sensitivity for<br />
identifying cognitive impairment, but RCFT deficits are unstable.<br />
This study explores potential factors limiting the utility of the RCFT<br />
for identifying MCI.<br />
Methods: We identified 182 participants who met criteria for<br />
MCI (n=106) or normal cognition (NC; n=76) and had been assessed<br />
S62<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
with the copy and 3 minute delayed recall portions of the RCFT using<br />
the Meyers & Meyers (1995) scoring criteria and normative data (impairment<br />
defined as performance ≤-1.5 SD below normative means).<br />
We evaluated the effects of different scoring criteria and normative<br />
data on diagnostic classification. A rater blinded to prior diagnoses<br />
rescored RCFT figures using Taylor (1969) criteria, and participants<br />
were reclassified as impaired or unimpaired using Boone et al. (1993)<br />
and Van Gorp et al. (1990) norms. Concordances between different<br />
diagnostic classifications were calculated using Cohen’s κ.<br />
Results: The proportion of participants defined as having impaired<br />
RCFT performance was dependent on which scoring criteria<br />
and normative data were used. RCFT analyses using Taylor criteria<br />
yielded higher rates of impairment with the Boone norms (copy:<br />
31.8%; recall: 27.4%) than with the Van Gorp norms (copy: 17.0%; recall:<br />
8.2%). Concordance between norms was moderate for RCFTcopy<br />
(κ=0.47) and fair for RCFT-recall (κ=0.38). Use of the Meyers &<br />
Meyers criteria and norms yielded intermediate rates of impairment<br />
on the RCFT-copy (25.8%) and recall (21.9%) subtests.<br />
Conclusions: Although the RCFT may be sensitive to cognitive<br />
impairment, the use of different normative means yielded different<br />
proportions of impaired participants. Differences seen with different<br />
normative data sets were greater than differences seen with different<br />
scoring criteria and may reflect subjective differences in scoring between<br />
studies. Investigations of inter-rater reliability with this data set<br />
are ongoing. These findings suggest that the RCFT may have limited<br />
reliability when used in isolation to identify MCI.<br />
A137<br />
Normal aging, neuroinflammation, and the brain-a sheep in wolf’s<br />
clothing?<br />
T. Harris. University of Nebraska Medical Center, Omaha, NE.<br />
Neuroinflammation is known to occur in clinically significant<br />
neurodegenerative processes including Parkinson’s and Alzheimer’s<br />
disease. Moreover, prior studies of aging and CNS transcriptome expression<br />
have implicated neuroinflammation as a potential process<br />
observed in normal CNS aging. Our earlier work has shown that<br />
overexpression of immunne/defense-related gene transcripts may be<br />
associated with age-related loss of important functional behaviors.<br />
Since many of the gene trascripts showing age-related changes in expression<br />
are well-known molecules used by the immune system (e.g.<br />
complement, class I histocompatibility molecules, cytokines,<br />
chemokines), this process has been assumed to be neuroinflammatory<br />
as well. However, no studies have been performed to specifically<br />
localize these molecules in the microglia-the resident immune cell-of<br />
the aging brain. In the current study, I extracted and purified microglia<br />
from the hypothalamus and cerebellum of C57BL/6 and<br />
BALB/cBy mice in a minimally stressful manner. Using RT-qPCR, I<br />
measured and analyzed the expression of several inflammatory genes<br />
in microglia. I found that the expression of these genes remained similar<br />
between young, middle-aged, and aged mice, with a few genes<br />
even decreasing in expression. This finding suggests that even though<br />
CNS aging is characterized by increased expression of multiple immune<br />
transcripts, neuroinflammation is not the underlying etiology.<br />
A138<br />
Effects of Multimedia Fall Prevention Training in Persons with<br />
Dementia.<br />
V. Panzer, 1,2 J. Burleson, 1 F. Into, 2 H. Waite, 2 P. Atwood. 3 1.<br />
Community Medicine & Health Care, University of Connecticut<br />
Health Center, Farmington, CT; 2. Brookside Research &<br />
Development, North Salem, NY; 3. Dementia Care, Hebrew Health<br />
Care, West Hartford, CT.<br />
Supported By: University of Connecticut TRIPP Center<br />
Background: Persons with dementia (PwD) in long-term care<br />
(LTC) experience 4.05 falls/year compared to 2.33 for those without<br />
dementia. Falls are attributed to the lack of safety awareness and patient<br />
education is the most common intervention attempted by LTC<br />
nursing staff. We examined the influence of multimedia fall prevention<br />
(MFP) training on safety awareness in PwD as demonstrated by<br />
recognition of circumstances that could result in falls.<br />
Methods: Ten LTC residents (age 77-95,mean(M)=88;MMSE<br />
10-20,M=15; Katz ADL 1-4,M=2) with a history of falls were asked to<br />
identify ‘Fall Threats’ that could make someone fall in 5 video clips.<br />
Participants received 3-4 once-weekly 15 minute standardized MFP<br />
training sessions, incorporating a total of 3-5 multimedia vignettes<br />
which concerned daily activities and included common Fall Threats.<br />
In post-tests 3-5 weeks AFTER the last training session, participants<br />
were asked to identify Fall Threats in 5 novel video clips that did<br />
NOT include circumstances featured in pre-test clips OR in the training<br />
vignettes. Usual care nurses who were not involved in study procedures<br />
recorded falls per state regulations. Repeated-measures<br />
ANOVA was used to compare pre and post-test results and assess<br />
awareness. Fall records were examined for 2 month periods prior to,<br />
during (including the 3-5 week period before post-testing) and after<br />
the study.<br />
Results: Participants recognition of Fall Threats in 5 novel video<br />
clips improved dramatically, (p
P OSTER<br />
A BSTRACTS<br />
and its sum of boxes. DLB patients without Capgras were able to tolerate<br />
and continue taking cholinesterase inhibitors (p=0.03) without<br />
other significant differences in medication management.<br />
Conclusions<br />
We found that DLB-C patients had more visual hallucinations,<br />
and that caregivers of DLB-C patients endorse greater caregiver burden.<br />
We were unable to discern specific patient characteristics or psychometric<br />
performance data to help us predict who may be at greater<br />
risk of developing Capgras syndrome. Future research is needed to<br />
evaluate management and treatment options for the clinically challenging<br />
behavioral sequelae of DLB and Capgras syndrome.<br />
A140<br />
Computational Modeling of Aging in Cardiac Myocytes.<br />
P. Dalal, E. Sobie. Pharmacology and Systems Therapeutics, Mt. Sinai<br />
School of Medicine, New York, NY.<br />
Supported By: This research is supported by the Medical Student<br />
Training in Aging Research (MSTAR) at Mount Sinai School of<br />
Medicine.<br />
BACKGROUND: The risk of susceptibility to more serious<br />
forms of cardiac arrhythmia rises significantly with normal aging.<br />
These forms of arrhythmia can manifest as palpitations, fibrillation,<br />
and even sudden death. One indicator of arrhythmia risk is action potential<br />
duration in cardiac myocytes. Specifically, the prolongation of<br />
action potential leads to a larger vulnerability period towards after<br />
depolarization. Such rogue depolarization can result in dangerous,<br />
self-sustaining circular currents. Animal studies in the past have<br />
shown that age associated molecular changes in cardiac myocytes include:<br />
a 40% reduction in SERCA pump protein, a 20% reduction in<br />
the transient outward current, a 59% increase in the peak L-Type calcium<br />
channel current, and a 142% increase in the inactivation time<br />
constant of the L-Type calcium channel. Additionally, the action potential<br />
is prolonged by 92% in older rats when compared with<br />
younger rats and the calcium transient decay is slower in aged rats<br />
while its amplitude remains the same.<br />
HYPOTHESIS: Implementing the molecular changes in rat myocytes<br />
into the computational models of Hund (2004), et al and Ten<br />
Tusscher (2004), et al will prolong the action potentials and slow the<br />
calcium transient decay of these models, creating a computational<br />
tool to study age associated arrhythmia risk.<br />
RESULTS: After implementing the four major molecular<br />
changes associated with cardiac aging, the action potential was prolonged<br />
by 4% in the Hund (2004) model and by 77% in the Ten Tusscher<br />
(2004) model. The calcium transient decay was slower in both<br />
models while the calcium transient amplitude was only unchanged in<br />
the Ten Tusscher (2004) model. In the Hund (2004) model, the amplitude<br />
was increased.<br />
CONCLUSIONS: It is possible to generate a computational<br />
model that replicates the age associated changes seen in cardiac myocytes.<br />
The Ten Tusscher (2004) model more accurately replicates<br />
these changes than the Hund (2004) model.<br />
A141<br />
Isolated CNS Post-transplant Lymphoproliferative Disorder in a<br />
Kidney Transplant Recipient.<br />
S. Dahiya, W. Ooi, A. Asik. Internal Medicine/Division of Hematology<br />
and Oncology, Baystate Medical Center, Springfield, MA.<br />
Introduction<br />
Post-transplantation lymphoproliferative disorder(PTLD)is a<br />
very well recognized complication of solid organ transplantation. Its<br />
incidence varies, depending on the graft recipient’s age,the type and<br />
intensity of immunosuppression, and the organ type transplanted.<br />
Extranodal involvement is common in PTLD, although the central<br />
nervous system (CNS) is an uncommon site of disease, especially in<br />
isolation. Literature review suggests less than handful of cases in geriatric<br />
population.<br />
Case<br />
65 year old female presented with complaints of intermittent expressive<br />
aphasia. Her medical history was remarkable for polycystic<br />
kidney disease leading to kidney failure and thus requiring transplant.<br />
Her transplant history includes, failed first transplant in 1995<br />
from a deceased donor and subsequent living-related donor transplant<br />
in 2005 from her son with unrelated blood type requiring heavy<br />
immunosuppresion. She was on mycophenolate, tacrolimus and prednisone<br />
for immunosuppressive regimen. Her neurological exam was<br />
significant for word finding difficulty and left eye ptosis. Rest of the<br />
physical exam was within normal limits. A spinal tap showed slight elevation<br />
of proteins to 149mg/dl and decreased glucose to 36mg/dl,<br />
raising a question of ongoing infectious process. An urgent MRI was<br />
obtained which showed multiple discrete enhancing lesions throughout<br />
the supratentorial and infratentorial white matter with leptomeningeal<br />
involvement. An extensive infectious workup looking<br />
for various causes of enhancing lesion in this severely immunosuppressed<br />
patient was negative. A brain biopsy was eventually performed,<br />
which showed monomorphic PTLD, categorized as EBV-associated<br />
diffuse large B-cell lymphoma. Given her kidney disease, she<br />
was started on a rather unconventional regimen with weekly rituximab<br />
for 8 weeks and 4 cycles of monthly intrathecal cytarabine. Her<br />
immunosuppresive regimen was changed to sirolimus only. She has<br />
been in remission since last 1 year, but unfortunately developed allograft<br />
rejection because of reduction in immunosuppressive regimen.<br />
Discussion<br />
Isolated CNS-PTLD following kidney transplant is exceedingly<br />
rare. However, it must be considered as a differential in transplant patients<br />
with CNS symptoms to avoid delay in diagnosis. Advanced age<br />
is considered as a poor prognostic factor, but this elderly patient did<br />
rather well with the unconventional regimen as outlined above.<br />
A142<br />
Deep Vein Thrombosis and Pulmonary Embolism (DVT/PE) with<br />
JAK2 positive Polycythemia Vera (PCV) and mild hematologic<br />
findings.<br />
R. Lands, S. Kelley. Department of Medicine, University of Tennessee,<br />
Knoxville, TN.<br />
An 81-year-old man came to the emergency room after becoming<br />
suddenly short of breath while taking a shower. Any exertion<br />
after that exacerbated his dyspnea but was relieved by lying down. He<br />
did not have chest pain, pleuritic or otherwise. He had no preceding<br />
illness, immobilization or prolonged travel. He was previously<br />
healthy with a history of hypertension and gout, but he was on no<br />
meds at the time of admission. Physical examination showed him to<br />
be in no distress at rest while wearing oxygen. Lungs were without<br />
rales or rhonci and his respiratory effort was normal. There was no<br />
edema of either lower extremity. High sensitivity D-Dimer was<br />
greater than 5000 ng/ml. EKG demonstrated right heart strain. Chest<br />
x-ray demonstrated elevation of the hemidiaphragm. Creatinine was<br />
1.9 mg/dl. Ventilation perfusion scan of the lungs was interpreted as<br />
high probability for left and right lower lobe pulmonary emboli.<br />
Doppler venous studies demonstrated bilateral deep vein thromboses<br />
of the lower extremities.<br />
Hgb was 17 g/dl and Hct 53%. WBC was 32,000 without basophilia<br />
or eosinophilia. Cells containing JAK-2 V617F mutation<br />
were present. BCR/ABL was absent. Erythropoietin was 1 mIU/ml.<br />
No further imaging was performed given his marginal renal function.<br />
Review of his old records demonstrated a very mild leukocytosis and<br />
upper normal hemoglobin levels for several years prior to this admission.<br />
One month after discharge, he followed up in the hematology<br />
clinic where his WBC was 15x103 and his hemoglobin 15.8mg/dL.<br />
Discussion: JAK2 is a gain of function mutation with tyrosine kinase<br />
activity that is present in 90% of patients with PCV. While it is<br />
primarily a diagnostic marker now, there is evidence that it might<br />
S64<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
have inherent procoagulant effect by itself. Prior to this admission,<br />
our patient’s blood findings were only mildly abnormal. When he was<br />
stable and on treatment for the DVT/PE, his blood findings reverted<br />
to their previous levels. We believe this case demonstrates that even<br />
mild elevations of blood elements should be investigated to rule out a<br />
myeloproliferative syndrome in the context of thrombosis, and further<br />
molecular testing might be warranted in some patients whose<br />
blood counts are mildly, but consistently abnormal. Myeloproliferative<br />
disorders, especially those that are JAK2 positive, should be considered<br />
in the differential diagnosis of acquired hypercoagulation<br />
syndromes.<br />
A143<br />
JAK2 positive Polycythemia Vera in a patient with sleep apnea.<br />
Competing causes for erythrocytosis.<br />
R. Lands, S. Y. Bae. Department of Medicine, University of Tennessee,<br />
Knoxville, TN.<br />
In the course of having blood work in her health maintenance, a<br />
75-year-old woman was found to have an elevated hemoglobin. She<br />
was not hypertensive, but had been treated for hyperlipidemia for<br />
several years. She had a left body stroke about a year prior to the<br />
clinic visit from which there was no residual and for which she was<br />
taking aspirin. She had never smoked cigarettes. She complained of<br />
fatigue and daytime sleepiness. Her husband noted that she snored,<br />
but he had not observed apnea. She did not complain of restless legs.<br />
Oxygen saturation was 98% on room air. The tongue was of normal<br />
size. There was no abdominal organomegaly.<br />
CBC demonstrated a hemoglobin of 17mg/dL and hematocrit of<br />
50%. The white blood cell count and platelet counts were normal although<br />
the platelets were quite large. The bone marrow demonstrated<br />
panhyperplasia. Megakaryocytes were increased with prominent<br />
pleomorphism. There was no increase in reticulin. JAK-2 V617F<br />
was found to be present in a population of cells tested. BCR/ABL<br />
was absent. Erythropoietin was 31mIU/ML (4.2-27.8), and the CT abdomen<br />
demonstrated an enlarged spleen. She was placed on hydroxyurea<br />
and one phlebotomy was performed.<br />
In the interim, she reluctantly accepted a referral to a sleep specialist.<br />
Sleep studies demonstrated mild to moderate sleep apnea. She<br />
was prescribed C-PAP and quickly noted a remarkable improvement<br />
in her fatigue and in her daytime somnolence. Furthermore, her hemoglobin<br />
dropped into the low normal range, more than expected<br />
from just one phlebotomy. The hydroxyurea and the phlebotomies<br />
were discontinued. She has been compliant with her C-PAP has not<br />
required resumption of hydroxyurea or phlebotomy in one year.<br />
Discussion: With a hemoglobin greater than 16.5mg/dL and the<br />
presence of JAK2, the patient met WHO diagnostic criteria for Polycythemia<br />
Vera. The history of cerebrovascular accident and<br />
splenomegaly further support a diagnosis of the myeloproliferative<br />
syndrome. The inappropriately high normal erythropoietin level together<br />
with the rapid improvement in her hemoglobin after treatment<br />
for sleep apnea suggest that the predominate cause of her erythrocytosis<br />
at the time of diagnosis was due to her sleep apnea. Myeloproliferative<br />
syndromes may be quite subtle in their presentation and may<br />
accompany other diseases that mask and delay their diagnosis.<br />
A144<br />
Calcium Supplement May be Associated with Optimal Responses to<br />
Vitamin D Supplementation in Adults.<br />
V. Heh, 1 C. Forman, 2 J. Gau. 2 1. Office of Research and Grants, Ohio<br />
University Heritage College of Osteopathic Medicine, Athens, OH; 2.<br />
Geriatric Medicine, OU-HCOM, Athens, OH.<br />
Background: Deficiency of vitamin D is a common problem in<br />
adult patients. There are efforts in aggressively treating these patients<br />
as benefits have been shown in reducing the risk of falls and fractures.<br />
Clinical observation suggests that some patients receiving a high-dose<br />
supplement may not have achieved an optimal serum 25-hydroxy<br />
(OH) vitamin D levels with months of therapy. The objective of this<br />
study is to characterize factors that may be associated with patients’<br />
responses to vitamin D supplementation. This characterization is<br />
based on the existence of possible unobserved groups, also called latent<br />
classes.<br />
Methods: Medical records of a geriatric clinic population who<br />
had baseline and follow-up serum 25(OH)D levels during the period<br />
of January 2007 and June 2011 were reviewed. All patients received<br />
vitamin D supplements to achieve levels above 30 ng/mL. Forty-one<br />
adults receiving an average daily dose more than 3,300 IU per day.<br />
These patients were sub-divided into two groups reflecting ideal (i.e.,<br />
> 40 ng/mL; N=24) and suboptimal levels (N=17) of serum 25(OH)D<br />
on the follow-up measurements.A cut-off value of 40 ng/mL was used.<br />
Results: The two groups, ideal respondents and suboptimal respondents<br />
to high dose regimens, were similar in age, gender, weight,<br />
BMI measures, baseline 25(OH)D and serum calcium levels, average<br />
daily dose (5,500 [1,800] vs. 5,100 [1,200] IU; p=0.44), and duration of<br />
therapy (11.9 [7.3] vs. 8.6 [5.3] months; p=0.11). However, those patients<br />
who had ideal levels of follow-up 25(OH)D had significantly<br />
higher baseline serum albumin levels (mean =4.1 gm/dL, SD=0.4 vs.<br />
mean =3.7 gm/dL, SD=0.4, p=0.026); were about 6 times more likely<br />
to be on calcium supplements (12 [50%] vs. 2 [12%], p=0.018, Fisher’s<br />
exact test). The suboptimal respondents were about 3 times more<br />
likely to use oral laxatives; 9(64%) vs. 5(21%), p=0.048. After adjusting<br />
for height, weight, and use of oral laxatives, calcium supplement<br />
was associated with a better response to high dose supplementation.<br />
Limitations of this study: small sample size, unknown compliance<br />
with supplements, and not a controlled clinical trial study.<br />
CONCLUSIONS: Calcium supplement may be associated with<br />
patients’ responses to vitamin D regimens. Nutrition status and better<br />
study design will need to be included in the future study.<br />
A145 Encore Presentation<br />
Nontuberculous mycobacterial infections in elderly patients with<br />
rheumatological diseases.<br />
V. Nagaraja, 1 J. Terriquez, 2 J. Lisse, 3 S. Hoover. 2 1. Arizona Center on<br />
Aging, University of Arizona, Tucson, AZ; 2. Infectious Diseases,<br />
University of Arizona, Tucson, AZ; 3. Rheumatology, University of<br />
Arizona, Tucson, AZ.<br />
Background: Non-tuberculous mycobacterial (NTM) infections<br />
are frequently identified in elderly patients with rheumatologic disease.<br />
Management of these infections can be challenging. The aim of<br />
this study was to describe the management and outcomes of cases of<br />
NTM infections in patients with any form of rheumatologic disease.<br />
Methods: A retrospective chart review of inpatient and outpatient<br />
records was performed at two health-care facilities. ICD-9 diagnostic<br />
codes were used to identify patients with NTM infection. Patients<br />
with any pre-existent rheumatologic disease were included in<br />
the study. The review focused on rheumatologic disease, its treatment,<br />
other co-morbidities, the NTM infection and its treatment, and impact<br />
of the infection on the rheumatologic disease management.<br />
Results: Of 339 patients with NTM infection, 11 with rheumatologic<br />
disease were identified. Ten were females. The median age at the<br />
time of diagnosis of the infection was 67 years. Eight cases were pulmonary<br />
and 3 were extrapulmonary. 5/11 patients had radiologically<br />
pre-existent bronchiectasis. There were patients with rheumatoid<br />
arthritis(5), systemic lupus erythematosus(2), polymyalgia rheumatic(1),<br />
scleroderma(1), polymyositis(1) and sarcoidosis(1). Patients<br />
were on one of the following medications for a significant period of<br />
time: prednisone, methotrexate, and anti-tumor necrosis factor (TNF)<br />
agents. In 4/9 cases who were on immunosuppressive therapy, the implicated<br />
medication was discontinued. In 3/9 it was continued, and in<br />
2/9 it was restarted after a brief discontinuation. Mycobacterium<br />
avium complex was the commonest species isolated. Treatment for<br />
AGS 2012 ANNUAL MEETING<br />
S65
P OSTER<br />
A BSTRACTS<br />
NTM infection was started in 8/11 patients. 2/8 patients had recurrence<br />
of the infection. 3/11 patients died, with no death directly related<br />
to NTM infection.<br />
Conclusions: This is the first study to describe the natural history<br />
of NTM infections in an older rheumatologic disease patient cohort.<br />
As in the general population with NTM infection, patients tended to<br />
be female with pre-existing bronchiectasis. The infection could often<br />
be successfully treated, but there appeared to be some risk of recurrence<br />
in patients who are continued on immunosuppressive therapy.<br />
Such cases will likely continue to be identified and more studies on<br />
the optimal management is needed.<br />
A146<br />
Lack of Effort Towards Removal of Foley Catheters Before<br />
Transferring Patients For Rehabilitation (Rehab).<br />
M. S. Ashraf, 1 N. Sheikh, 1 V. Kinzie, 2 K. Cochran, 2 C. Faulk, 1<br />
K. Ramsey. 1,2 1. East Carolina University, Greenville, NC; 2. Pitt<br />
County Memorial Hospital, Greenville, NC.<br />
Supported By: Study was supported in part by Centers for Disease<br />
Control and Prevention<br />
Background: Geriatricians commonly admit patients who are<br />
discharged with indwelling foley catheters from the hospitals to subacute<br />
care settings, and often these foleys are no longer indicated. We<br />
designed a study to review the effort of various health care providers<br />
towards removing foleys before discharging patients for rehab.<br />
Methods: A retrospective chart review of hospital and rehab admissions<br />
was performed on all adult patients admitted with an indwelling<br />
foley to a 75 bed rehab facility over a period of 1 year (9/09 to<br />
10/10). Data analysis was primarily descriptive to obtain the frequency<br />
of appropriate documentation for presence of the foley, plan for its<br />
discontinuation, timing of its removal and demographic information.<br />
Results: Total of 114 patients (Median age 65 year, 51% Male)<br />
were admitted in the facility with indwelling foleys and 103 hospital<br />
charts were available for review. A majority (n=61) of them were discharged<br />
by surgical teams as opposed to medical teams (n=42) and all<br />
were evaluated by the rehab service. Rehab providers mentioned<br />
presence of foley in their exams only 30% of the time. Similarly surgery<br />
and medical teams recognized the presence of foleys in less than<br />
half of the cases within 2 days before the discharge (38% & 31% respectively).<br />
In many cases (n=64, 62%) rehab service did not make<br />
recommendation to remove foley during hospitalization. Interestingly,<br />
a third of these patients (n=24, 37.5%) had their foley removed<br />
within 2 days of rehab admission. Even though the rehab providers<br />
recommended removing foleys in 39 (38%) cases, the primary team<br />
did not respond. Eventually 60% (n=23) of these foleys were also removed<br />
within 2 days of rehab admission. Surgical and Medical teams<br />
provided reasons for continuing foley in their final notes in only a<br />
third of cases (34% & 33% respectively).<br />
Conclusions: 1) We have identified that health care providers<br />
frequently under-recognize the presence of foleys in patients who are<br />
being transferred for rehab. 2) When they do identify, efforts are lacking<br />
to remove it in a timely fashion. 3) There is a need for improved<br />
communication among consulting rehab service, primary inpatient<br />
teams and physicians at accepting facilities to promote timely removal<br />
of foleys which should reduce the incidence of subsequent<br />
catheter associated urinary tract infections in this patient population.<br />
A147<br />
Hyponatremia and falls in the elderly in hospital setting Neychelle<br />
Fernandes MD,Mary Musuku MD, Arnold Eiser Md,FACP.<br />
N. Fernandes. Internal Medicine, Mercy Catholic Medical<br />
Center,Drexel university, Darby, PA.<br />
Background:Falls are the most frequently reported adverse<br />
events in inpatient settings.Mild chronic hyponatremia may appear to<br />
be asymptomatic and remain unnoticed by both physician and patient<br />
but has been associated with gait unsteadiness and attention deficits<br />
in the elderly<br />
Methods: The study objective was to determine the incidence of<br />
hyponatremia in patients above 65 years who experienced a fall and<br />
associated risk factors for falls<br />
During a twelve month period from Sept 2009- Sept2010 serum<br />
sodium levels were evaluated in 60 cases of falls in patients aged<br />
65years and older and in 60 randomly selected non fall patients aged<br />
65years and older seen in acute inpatient setting. The following data<br />
were extracted for all patients: age, gender, medical morbidities, and<br />
number of medications, details of medications, serum sodium level<br />
and length of hospital stay. Initial blood chemistry on day of fall was<br />
used for evaluation of hyponatremia. Non-fall group blood chemistry<br />
on day of admission was used. Hyponatremia was classified as Serum<br />
Na level less then 136mmol/l. Fall/nonfall groups who had a glucose<br />
level on chemistry above 200 mg/dl were excluded from study. Use of<br />
medication including drugs potentially associated with hyponatremia<br />
- SSRI, diuretics, antihypertensive, benzodiazepines,psycholeptics<br />
was also analyzed in both groups.<br />
Results:Majority of fallers were female (75%) and mean age of<br />
fall and non-fall groups were 78±8 and 79±7 respectively. Hyponatremia<br />
was detected in 18 (30%) of fall group, compared to 5(18%) in<br />
nonfall group (P value 0.0004). Mean sodium level was 131±3meq/l<br />
and lowest level of serum sodium was 124meql/l in fall group. In fall<br />
group when controlling for other independent risk factors hyponatremic<br />
patients were four times more likely to fall (Pvalue0.004). .<br />
Those in the fall group had a longer length of stay and were more<br />
likely to be nursing home residents. A greater proportion of fallers<br />
had multiple medical co-morbidities (HTN, CHF, AF) and were on<br />
more likely to be on four or more medications at presentation than<br />
non-fallers.<br />
Conclusion:Hyponatremia is an independent risk factor for falls<br />
in elderly acute inpatient setting and should be added to the list of<br />
common conditions causing falls. Screening for low serum sodium<br />
level,finding the etiology and treating it when present may be a step<br />
forward to prevent falls and related injuries.<br />
A148<br />
Osteoporosis awareness in men at risk for fragility fracture and<br />
osteoporosis.<br />
S. Kashan, N. Lecea, G. Bachuwa. Hurley Medical Center, Flint, MI.<br />
Supported By: No author received funding related to this research<br />
project.<br />
Background: Osteoporosis is a major public health problem. Its<br />
hallmark is fragility fractures and increased risk of morbidity and<br />
mortality which are known to be higher in men than in women. In<br />
2001, the direct cost of osteoporosis was $17 billion for <strong>American</strong>s<br />
and $3.4 billion of which was related to the care for men. The number<br />
of men age 50 and older with osteoporosis (and osteopenia) in the US<br />
was predicted to increase from greater than 14 million in 2002, to over<br />
17 million in 2010, and to well over 20 million in 2020.<br />
Aim: Evaluate the awareness and knowledge of osteoporosis in<br />
men. Estimate the proportion of men at risk for osteoporosis who received<br />
appropriate screening. Estimate the proportion of men at high<br />
risk for osteoporosis who received appropriate Calcium and Vitamin<br />
D supplements.<br />
Method: Our participants in this study were recruited by consecutive<br />
sampling from the Hurley Medical Center Senior Ambulatory<br />
Clinic. We included only Males who are greater than or equal to 54<br />
years old. Participants were asked to fill a self-administered survey.<br />
The questionnaire included questions about demographic data, Osteoporosis<br />
awareness, diagnosis and treatment, Co-morbid medical<br />
conditions and medications list including OTC and supplements. This<br />
study was approved by the Hurley Medical Center Institutional Review<br />
Board.<br />
S66<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
Results: We distributed 250 questionnaires and 105 were returned.<br />
Ninety-seven questionnaires were included based on our inclusion<br />
criteria. On a 13-question examination, subjects with risk factors<br />
correctly answered 5.3 (40.7%) questions correctly, compared to<br />
4.1 (31.5%) by subjects without risk factors. Of subjects with risk factors,<br />
only 15% believed that they were at risk for osteoporosis. Only<br />
6% of subjects with risk factors had a Dexa scan done. Among patients<br />
with a risk factor for osteoporosis, only 27% reported taking a<br />
vitamin D or calcium supplement.<br />
Conclusion: A good proportion of participants were aware of<br />
the term osteoporosis, however many were not knowledgeable of the<br />
disease itself. Having a risk factor for osteoporosis did not increase<br />
the awareness of condition by itself. Only one fourth of patients with<br />
risk factors have been taking Vitamin D or Calcium. A very small<br />
number of patients, regardless of risk factors, had Dexa scan done.<br />
Health care provides must do more to increase awareness of this<br />
common and costly health problem.<br />
A149<br />
The Effects of Aerobic Exercise and Stretching on Self-Reported<br />
Sleep Quality in Community Dwelling Older Adults with Cognitive<br />
Complaints: A Randomized, Controlled Trial.<br />
W. Goodson, 1,2 A. Bloch, 3 W. Santos-Modesitt, 1,2 K. Yaffe, 1,2<br />
A. C. King, 4 D. E. Barnes. 1,2 1. University of California, San Francisco,<br />
San Francisco, CA; 2. San Francisco Veterans Affairs Medical Center,<br />
San Francisco, CA; 3. Alliant University, San Francisco, CA; 4.<br />
Stanford University, Palo Alto, CA.<br />
Supported By: This work was supported by the Alzheimer’s<br />
Association (IIRG-06-27306), the National Institutes of Health<br />
(K01-AG024069, KL2 RR024130), and an AFAR MSTAR Summer<br />
Research Stipend.<br />
Background: Sleeping difficulties are common in older adults<br />
and are linked to poor health outcomes. Sedative use in older adults is<br />
problematic because sedatives have been linked to an increase in<br />
falls. There is an imperative for identifying effective, non-pharmacological<br />
strategies for improving sleep in older adults. Exercise is an<br />
appealing intervention because it is relatively low cost, does not require<br />
a health professional and has potential health benefits beyond<br />
sleep improvement. Few studies have directly compared aerobic exercise<br />
and stretching effects on self-reported sleep quality in older<br />
adults with cognitive complaints.<br />
Methods: Participants were randomized into aerobic exercise<br />
(n=63) and stretching groups (n=63) and completed 12-week interventions.<br />
The primary outcome was a total sleep quality score derived<br />
from 7 questions on the Sleep Disorders Questionnaire of the 2005-<br />
2006 NHANES (Range: 0-28 with higher scores reflecting worse<br />
sleep quality). Baseline characteristics of study participants were assessed<br />
using analysis of variance, chi-square analysis, and Fisher<br />
Exact Tests. Analyses of sleep quality change within groups and between<br />
groups were conducted intent-to-treat and per protocol analyses,<br />
which yielded similar results. Nearly half of participants did not<br />
report any sleep problems at baseline and, therefore, could not improve.<br />
As such, all analyses were repeated in the subgroup that reported<br />
at least some sleep difficulties at baseline.<br />
Results: Sleep quality did not change significantly within or between<br />
the groups when the entire participant population was considered<br />
(n=126). In the subgroup of participants who reported sleep<br />
problems at baseline (n=72), there was a significant different between<br />
the groups (p=.02) in which sleep quality improved within the stretching<br />
group (12.0 to 8.8, p
P OSTER<br />
A BSTRACTS<br />
death because “nobody told me”. Retrospectively, some families suspected<br />
that the healthcare providers knew death was approaching because<br />
the older adult was moved to the comfort care hospital room or<br />
the palliative care team was brought in, but the rationale for the action<br />
was never disclosed or conferred to the family up front. In some<br />
cases, family members knew death was approaching without being<br />
told and sought out healthcare providers to arrange end-of-life care.<br />
Providers who may or may not be perceptive to approaching death<br />
either disagreed with the family and resisted, or agreed and facilitated<br />
arrangements. In addition, there were inconsistent messages regarding<br />
the end-of-life stage of life by providers.<br />
Conclusions: From family’s perspective, healthcare providers do<br />
not openly communicate about approaching death, do not provide<br />
enough explanation how current condition may lead to death, and<br />
there are variations in healthcare providers’ readiness to communicate<br />
about end of life with patient and families.<br />
A152<br />
Adjustment to Aging: A Validation for Adjustment to Aging<br />
Schedule (ATAS-33).<br />
S. von Humboldt, I. Leal. Research Unit in Psychology and Health,<br />
Instituto Superior Psicologia Aplicada, Lisbon, Lisbon, Portugal.<br />
Supported By: This work was supported by a grant of the<br />
Portuguese Science and Technology Foundation (FCT) [grant number<br />
SFRH/BD/44544/2008].<br />
Background: There has been little attention in the research literature<br />
on adjustment to aging. This research aims at examining the relationships<br />
between older adults’ adjustment and aging.<br />
Methods: The measures used to in the study were selected to assess<br />
the reliability and validity of one new instrument, Adjustment to<br />
Aging Schedule (ATAS-33). Measures were completed using a variety<br />
of culturally appropriate methods, including mail-outs, self-administration<br />
and interviews. For the purposes of this study, the Health<br />
Survey Questionnaire (SF-6D), one measure of cognitive functioning<br />
- the Mini-Mental State Examination (MMSE) and demographics,<br />
were included. All variables had fewer than 1% missing values and<br />
there complete data were available for 709 older adults (mean age<br />
82.4, SD = 6.45, (range 74-102)) from eight different nationalities. Exploratory<br />
factor analyses were run for data reduction and for exploring<br />
theoretical structure. Controlling for age, gender and country of<br />
origin, we assessed the level of adjustment of elderly people, and its<br />
effect on aging.<br />
Results: The sampling adequacy was confirmed by the Kaiser-<br />
Meyer-Olkin test (KMO=0.775) and the total variance explained by<br />
this eight-factor structure is 75.09%. Adjustment to aging appears to<br />
be a catalyst to attitudinal markers of maturity and internal development<br />
which in turn impact quality of life and aging, across cultures.<br />
All estimates were statistically significant (p
P OSTER<br />
A BSTRACTS<br />
A155<br />
Intensity and Impact of Pain in Military Veterans Following Cancer<br />
Treatment.<br />
W. L. Mills, 1,2 A. June, 3 J. Moye, 3 B. Mulligan, 3 A. Jahn, 3 K. King, 3<br />
J. Gosian, 3 L. Herman, 1,2 A. Walder, 1 A. D. Naik. 1,2 1. Health Services<br />
Research & Development Center of Excellence, Michael E. DeBakey<br />
VA Medical Center, Houston, TX; 2. Baylor College of Medicine,<br />
Houston, TX; 3. VA Boston Healthcare System, Brockton, MA.<br />
Supported By: Veterans Administration, Rehabilitation Research<br />
and Development IIR Grant VA I01 RX000104<br />
Background: According to the National Cancer Institute, more<br />
than 60% of individuals with a cancer diagnosis will survive beyond 5<br />
years, extending the time survivors must contend with cancer-related<br />
complications and treatment, including pain. Poorly controlled pain<br />
can negatively impact quality of life, increasing depression, anxiety,<br />
and sleep disturbance. The purpose of this study was to improve care<br />
provided to cancer survivors through increasing knowledge of the intensity<br />
and impact of pain experienced in the post-treatment period.<br />
Methods: Participants for this study were 120 adults (M age =<br />
65) included in the Veterans Cancer Rehabilitation Study, which assesses<br />
psychological and rehabilitation needs 6 and 12 months after<br />
diagnosis of oral-digestive cancers. The participants, mostly white<br />
(81%) and male (100%), were treated for head and neck cancers<br />
(44%), esophageal (11%), stomach (3%), and colorectal (42%) cancers.<br />
From the larger battery, the current study examines outcomes<br />
from the Patient Reported outcomes Measurement Information System-29,<br />
a self-report measure of quality of life and pain intensity.<br />
Results: At 6 months, 22% of participants reported no pain, 39%<br />
reported mild pain, 31% reported moderate pain, and 8% reported<br />
severe pain. Survivors of stomach cancer reported higher levels of<br />
pain (M=6.0) compared to head and neck (M=3.9), esophageal<br />
(M=4.0), and colorectal (M=3.0) cancers, with differences approaching<br />
statistical significance (p=.07). Participants endorsed interference<br />
from pain, including daily activities (56%), work around the home<br />
(52%), enjoyment of life (51%), and social activities (46%). Intensity<br />
of pain was related to (all p values
P OSTER<br />
A BSTRACTS<br />
A158<br />
Curved Path Walking Predicts 12-Month Physical Function in Older<br />
Adults without Mobility Limited Physical Function.<br />
R. M. Hibbs, 1 J. M. VanSwearingen, 1 S. A. Studenski, 2 J. S. Brach. 1 1.<br />
Physical Therapy, University of Pittsburgh, Pittsburgh, PA; 2.<br />
Geriatric Medicine, University of Pittsburgh, Pittsburgh, PA.<br />
Supported By: Research/Grant Support: Pittsburgh Older<br />
<strong>American</strong>’s Independence Center, 1 P30 AG024827; Pitt Clinical<br />
Research Training- <strong>Geriatrics</strong>/Gerontology T32 AG021885; K23<br />
AG026766<br />
Background: Daily activities involve walking curves to navigate<br />
and participate in the environment, particularly among older adults<br />
who function within their home and community. We examined the<br />
usefulness of measures of curved path and straight path walking to<br />
predict future physical function in community-dwelling older adults<br />
without mobility limited physical function.<br />
Methods: Older adults (n=73, mean age, 77.1±6.0 years) independent<br />
in ambulation and without mobility limited physical function<br />
(Late Life Function and Disability Instrument, LLFDI, function ><br />
mobility limited mean, 48.2) performed curved path walking (Figure<br />
of 8 Walk test, time) and straight path walking (gait speed) at baseline.<br />
Self-reported physical function, (LLFDI function, 0-100) was<br />
recorded at baseline and 12 months. Receiver Operator Characteristic<br />
curves were used to determine a cutoff value that optimized sensitivity,<br />
specificity, and area under the curve (AUC) of the Figure of 8<br />
Walk test time and gait speed for good physical function (LLFDI<br />
function > non-mobility limited mean, 59.8) one year later.<br />
Results: Curved path and straight path walking predicted physical<br />
function at 12 months. Figure of 8 Walk time at an optimal cutoff<br />
of 8.72s, sensitivity, 65.8%, specificity, 65.2%, and AUC=.704, p=.008<br />
predicted LLFDI functioning. Gait speed at an optimal cutoff of<br />
1.12m/s, sensitivity, 65.8%, specificity, 56.5%, and AUC=.667, p=.030<br />
predicted LLFDI functioning.<br />
Conclusion: Curved path walking was a little better than gait<br />
speed in identifying individuals who did not have good physical function<br />
one year later among older adults without mobility limited physical<br />
function. Curved compared to straight path walking may better<br />
represent the complexity of walking in daily life characteristic of activities<br />
of well functioning, community-dwelling older adults.<br />
A159<br />
Dementia, Delirium, and Capacity to Consent to Research among<br />
Older Post-acute Care Recipients.<br />
S. E. Hardy, S. A. Studenski. Medicine/<strong>Geriatrics</strong>, University of<br />
Pittsburgh, Pittsburgh, PA.<br />
Supported By: NIA, Hartford Foundation<br />
Background: Dementia and delirium present particular challenges<br />
for research in post-acute care (PAC). We examine the relationship<br />
between cognitive function, delirium, and the capacity to<br />
consent to participation in an observational study of older adults<br />
newly admitted to skilled nursing facilities for PAC.<br />
Methods: We assessed capacity to consent with a 5-item instrument<br />
measuring understanding of the study procedures, risks, and<br />
benefits; cognitive function with the Montreal Cognitive Assessment<br />
(MoCA), delirium with the CAM. Among those with significant cognitive<br />
impairment, we assessed pre-hospital cognition via proxy using<br />
the IQCODE. ADL function was assessed on a scale of 0-14 with<br />
higher scores representing greater impairment and depressive symptoms<br />
were assessed with the PHQ-9.<br />
Results: Of the 179 participants assessed for capacity, 138 (77%)<br />
were deemed able to provide consent to participate. Of those able to<br />
consent, 1 declined to consent, 8 were ineligible to participate (for<br />
reasons unrelated to cognition), and 8 withdrew prior to the baseline<br />
assessment. Of the 41 without capacity, 8 were excluded because no<br />
surrogate was available and 2 because the surrogate declined to consent,<br />
2 were ineligible, and 1 withdrew prior to baseline assessment.<br />
The characteristics of the remaining 149 participants by capacity to<br />
consent are presented in the table. Regardless of capacity to consent,<br />
the 51 participants with significant cognitive impairment (MoCA
P OSTER<br />
A BSTRACTS<br />
A161<br />
Discharge to subacute rehabilitation as a predictor of 30 day<br />
readmission in elderly patients with acute decompensated heart<br />
failure.<br />
W. Qureshi, 1 F. Khalid, 1 Z. Alirhayim, 1 M. Al-Mallah. 2,3 1. Internal<br />
Medicine, Henry Ford Health Systems, Detroit, MI; 2. Department of<br />
Cardiology, King Abdul-Aziz Hospital, Riyadh, Saudi Arabia; 3.<br />
Wayne State University, Detroit, MI.<br />
Background: Acute decompensated heart failure is the admission<br />
diagnosis in 1/10th of all the hospitalization in US. Many of these<br />
patients may be discharged to rehabilitation centers or home with<br />
physical therapy. It is not known if the patient’s discharge disposition<br />
is a predictor for 30 - day readmission. The aim of the study was to determine<br />
if there was a difference in readmissions in patients discharged<br />
to home with physical therapy compared to subacute rehabilitation<br />
center.<br />
Methods: This is a single-center retrospective parallel group cohort<br />
study. Chart reviews of all the patients from 2009 - 2010 with primary<br />
DRG of acute decompensated heart failure was carried out.<br />
Primary outcome was 30-day all cause readmission. Secondary outcome<br />
was 1-year mortality. The baseline characteristic differences<br />
were evaluated by chi-square test and t-test. Logistic regression was<br />
used to adjust for baseline variables hypertension, diabetes, dysplipidemia,<br />
presence of coronary artery disease, age, gender to predict the<br />
binary outcome as readmission versus no readmission based on the<br />
discharge disposition.<br />
Results<br />
Out of 1543 total admissions, 542 were discharged to either<br />
home with home physical therapy or subacute rehabilitation center.<br />
The mean age was 75.3 +/- 7.0 years and females were 61%. Out of<br />
these, 324 (59.8%) were discharged to subacute rehabilitation center<br />
and ischemic cardiomyopathy was present in 335 (61.8%) of the patients.<br />
There were 256 (47%) 30 day readmissions to the hospital.<br />
About 66 (12.2%) of the patients died within 1 - year. Discharge to<br />
subacute rehabilitation was associated with higher readmission rates<br />
(adjusted OR 1.84; 95% CI, 1.19 – 2.83) p = 0.005 while, there was no<br />
difference in the secondary outcomes. There was no significant difference<br />
in the all-cause mortality (adjusted OR 1.56; 95% CI, 0.84 – 2.9)<br />
p = 0.16.<br />
Conclusion<br />
This study shows that even after adjustment for baseline characteristics,<br />
discharge to subacute rehabilitation was a weak but independent<br />
predictor of 30 – day readmission. This might be because of<br />
early detection of an exacerbation of acute decompensated heart failure<br />
at subacute rehabilitation center as compared to at home; however<br />
there was no significant association of mortality with the discharge<br />
disposition.<br />
A162 Encore Presentation<br />
Fighting the weekend trend: increased mortality in older adult TBI<br />
patients admitted on weekends.<br />
S. A. Hirani, 1,2 E. B. Schneider, 2 H. L. Hambridge, 2 E. R. Haut, 2<br />
A. R. Carlini, 2 R. C. Castillo, 2 D. T. Efron, 2 A. H. Haider. 2 1.<br />
University of Texas Southwestern Medical School, Dallas, TX; 2.<br />
Surgery, Johns Hopkins School of Medicine, Baltimore, MD.<br />
Background: Weekend admission is associated with mortality in<br />
cardiovascular emergencies and stroke. We sought to determine<br />
whether weekend vs. weekday differences exist for older adults with<br />
substantial head trauma.<br />
Methods: Data from the 2006-2008 Nationwide Inpatient Sample<br />
were combined and head trauma admissions were isolated. Abbreviated<br />
Injury Scale (AIS) scores were calculated for using ID-<br />
CMAP. Individuals aged 65 to 89 years with head AIS = 3 or 4 and no<br />
other region score > 3 were included. Individuals with missing mortality,<br />
gender or insurance data were excluded. Wilcoxon rank sum<br />
and Student t-tests compared LOS, demographic, and total charge<br />
data. Chi-square tests compared gender and head injury severity. Logistic<br />
regression modeled mortality adjusting for age, gender, injury<br />
severity, comorbidity and insurance status.<br />
Results: Of the 39,728 patients meeting criteria, 10,189 (25.6%)<br />
were admitted on weekends. Mean age was similar but more weekend<br />
admissions were female (51.5% vs. 50.0%, p = 0.011). Weekend<br />
patients demonstrated slightly lower comorbidity (mean Charlson =<br />
1.09 vs. 1.15, p < 0.001) and head injury severity (58.5% vs. 60.9%<br />
AIS=4, p < 0.001). Median weekend LOS was shorter (4 vs. 5 days, p <<br />
0.001), but total charges did not differ. Proportional mortality was<br />
higher among weekend patients (9.4% vs. 8.4%, p = 0.001). After adjustment,<br />
weekend patients demonstrated 17% increased odds of<br />
mortality (O.R. 1.17, 95% CI: 1.08-1.26).<br />
Conclusions: Older adults with traumatic brain injury admitted<br />
on weekends are less severely injured, carry less comorbidity and<br />
generate similar total charges compared to those admitted weekdays.<br />
However, weekend patients demonstrated 17% greater odds of<br />
mortality.<br />
A163<br />
Postoperative Cognitive Complications in the Elderly: Risks and<br />
Outcomes.<br />
S. J. Agarwal, M. G. Erslon, S. D. Kelley. Covidien, Mansfield, MA.<br />
Supported By: Covidien<br />
Background: Cognitive complications occur in elderly patients<br />
following surgery. The burden of postoperative cognitive complications<br />
(POCC) is difficult to assess due to differences in determining<br />
and documenting POCC. We utilized a large administrative database<br />
to assess the incidence, risk factors and patient outcomes associated<br />
with POCC in elderly patients across the top 5 major diagnostic categories<br />
(MDC).<br />
Methods: Inpatient surgical discharges in the top five MDCs for<br />
patients older than 50 years from the Premier Perspective® Database<br />
(Premier, Inc.) for CY2010 were selected. POCC was identified by<br />
ICD9 codes 780.09 and 293.0. We determined incidence and used<br />
multivariate logistic regression to estimate the adjusted risk of POCC<br />
based on age (reference: 50-64 years old), admitting status, general<br />
anesthesia (GA), ICU stay, comorbidity and MDC type (reference:<br />
circulatory system surgeries). We compared mortality, length of stay<br />
(LOS), costs and discharge disposition between patients with and<br />
without POCC.<br />
Results: 576821 discharges were selected, and 6553 (1.1%) were<br />
coded for POCC. The risk of POCC increased with age (85+ years:<br />
311% increased risk), ICU stay (183% increased risk), non-elective<br />
admission (94%), and GA (19%). Compared to circulatory system<br />
surgeries, other surgeries increased risk of POCC: musculoskeletal<br />
(158% increase), digestive system (86%), nervous system (48%) and<br />
hepatobiliary/pancreatic (46%). Patients with POCC had increased<br />
inpatient resource utilization and compromised outcomes (Table 1).<br />
Conclusion: Although the incidence of POCC based upon ICD9<br />
coding was limited, the reported cases were associated with significantly<br />
increased inpatient mortality, facility discharge, LOS and costs<br />
AGS 2012 ANNUAL MEETING<br />
S71
P OSTER<br />
A BSTRACTS<br />
compared to patients without POCC. Age, emergency admissions,<br />
ICU stay and GA independently increased risk for POCC. Large administrative<br />
databases and coded definitions of POCC should facilitate<br />
studies to determine whether preventing or managing POCC in<br />
elderly surgical patients improves outcomes.<br />
Table1: Outcomes for patients with and without POCC<br />
All comparisons are significant at p < 0.001<br />
A164<br />
Can a simple frailty score predict outcomes in elderly patients<br />
undergoing cardiac surgery?<br />
S. Kim, 1 J. Chikwe, 2 L. Croft. 1 1. Cardiology, Mount Sinai School of<br />
Medicine, New York, NY; 2. Cardiothoracic surgery, Mount Sinai<br />
School of Medicine, New York, NY.<br />
Supported By: MSTAR<br />
Elderly patients tend to have more postoperative complications<br />
and longer lengths of stay following cardiac surgery.They also display<br />
a range of biological statuses that varies from robust to frail, which<br />
makes predicting their surgical outcomes difficult. Frailty is an emerging<br />
concept in geriatrics that can account for a patient’s physiological<br />
reserve, and therefore useful in predicting outcome following cardiac<br />
surgery. As such, the two objectives that were investigated include:<br />
1. Are there easily assessable preoperative variables that can<br />
measure frailty in elderly patients undergoing cardiac surgery?<br />
2. Can such variables be used to predict clinical outcomes in elderly<br />
patients following cardiac surgery?<br />
Data was collected from the New York State Cardiac Surgery<br />
Database and EPIC/EDR for patients ≥ 70 years. Categories of preoperative<br />
variables collected to determine frailty included nutritional<br />
status, functional status, mental status, and social support status. An<br />
unweighted frailty score was calculated with these variables, and patients<br />
with a score ≥ 3 determined as frail. Univariate and multivariate<br />
logistic regression models were used to determine independent<br />
predictors of the major outcomes (Early postoperative mortality &<br />
morbidity; Prolonged length of stay; Discharge to institution). Statistical<br />
analysis was performed using IBM SPSS Statistics for Mac 19.0.<br />
The frailty score was significantly related to whether or not patients<br />
were institutionalized following cardiac surgery (P=.003). Although<br />
the frailty score did not predict any major outcomes, individual<br />
variables used to calculate frailty did predict them. Impaired<br />
mental status significantly predicted early postoperative morbidity &<br />
mortality (OR=8.5, 95% CI: 1.2-58.2), while being dependent in activities<br />
of daily living significantly predicted receiving institutionalized<br />
care (OR=3.2; 95% CI: 1.3-8.1).<br />
The unweighted frailty score by itself does not predict any major<br />
outcomes, but individual variables like impaired pre-operative mental<br />
state and lower Katz index do predict them. These can be used to<br />
identify at risk frail patients early, for whom providers of surgical care<br />
may intervene more aggressively to prevent poor clinical outcomes.<br />
A165<br />
Functional capacity as possible predictor of outcome in older<br />
patients who are undergoing surgery for urological malignancies.<br />
S. Sun, 1,2 V. Shklar, 1 H. Yulico, 1 B. Korc-Grodzicki . 1,2 1. Medicine,<br />
MSKCC, New York, NY; 2. Medicine, Weill Cornell Medical College,<br />
New York, NY.<br />
Background<br />
Urological cancers are disease of the older persons and many<br />
geriatric patients undergo major urological surgeries to achieve curative<br />
treatment. In order to understand their unique physiologic vulnerabilities,<br />
it has become very important to recognize the factors<br />
which lead to poor outcomes in these geriatric patients. Previously,<br />
pre-existing cognitive dysfunction has been shown to predict delirium<br />
and markers of frailty have been shown to predict 6 month mortality.<br />
Method:<br />
This is a retrospective review of patients who are 75 years of age<br />
or older in whom geriatric specific assessment has been performed<br />
prior to major urological cancer surgery in a tertiary cancer center.<br />
Geriatric preoperative assessments were performed by 4 geriatricians<br />
over the course of one year (January 1, 2010 to Decmber 31, 2010).<br />
The evaluation included, independence in basic activities of daily living(ADLs)<br />
and instrumental ADLs(iADLs), Charlson comorbidity<br />
index, albumin, Mini-Cog test, Hb, and falls within last 6 months. Outcome<br />
measures included presence of postoperative delirium, 30 day<br />
and 90 day postoperative mortality.<br />
Results:<br />
Forty seven patients(age 78.3±3.4) underwent geriatric preoperative<br />
assessment prior to major urological surgeries. Fourteen patients(30%)<br />
were female and 41 patients(87%) identified themselves<br />
as caucasians. Twenty six patients (55%) were identified as having<br />
bladder cancer or urothelial carcinoma. Thirty day mortality was 0%<br />
and 6 month mortality was 4.3% (2/47). Fifteen percent(7/47) of the<br />
patients developed delirium postoperatively. Of those seven, 1 patient<br />
died within 90 days of the surgery and both of the 6 month mortality<br />
cases had delirium postoperatively. Three out of 7 patients who<br />
developed delirium were dependent on ADLs or iADLs. More than<br />
91% of the patients who did not develop delirium were independent<br />
of ADLs and iADLs. There were no difference in Hemoglobin level,<br />
albumin level, and Charlson comorbidity index score between the<br />
two groups of patients who developed delirium and who did not. History<br />
of falls and Mini-cog test did not seem to be associated with postoperative<br />
delirium.<br />
Conclusions:<br />
Dependency in basic and/or instrumental activities of daily living<br />
seems to be a candidate for predictor of postoperative delirium.<br />
Patients who developed delirium had greater risk of dying within 6<br />
months of surgery.<br />
A166<br />
Relationship between age and incidence of chronic pain developing<br />
after cardiothoracic surgery.<br />
A. Raju, 1 M. Eckmann, 1,2 M. B. Little. 1,2 1. The University of Texas<br />
Health Science Center San Antonio, San Antonio, TX; 2. University<br />
Health System, San Antonio, TX.<br />
Supported By: AFAR- MSTAR Program<br />
Background:<br />
The effect of age on the development of chronic pain has been<br />
considered, but these studies have been on a limited population. In<br />
addition, studies have indicated that the occurrence of other outcomes<br />
such as depression/anxiety, neurological/cognitive problems,<br />
and sleep disturbances increase post-CT surgery, but these outcomes<br />
have not been quantified, nor have they been analyzed by age. Most<br />
of the existing studies have been in the form of patient questionnaires.<br />
Objective:<br />
To determine if age affects the incidence of post-surgery outcomes<br />
such as chronic pain, depression/anxiety, neurological problems,<br />
and sleep disturbances.<br />
Methods:<br />
A retrospective medical record review at University Health System,<br />
San Antonio was performed for CT surgery patients between<br />
5/15/2006 to 5/15/2009 (n= 412). Post surgery medical records were<br />
analyzed to determine if the patient developed any outcomes of interest<br />
and the date of onset. A Fisher test with a 2x2 contingency table<br />
using p < 0.05 as significant was used to analyze results.<br />
Results:<br />
S72<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
The incidence of the high occurrence outcomes were chronic<br />
pain (22.3%), neurological problems (20.4%), and depression/anxiety<br />
(14.1%). Patients above 60 years of age had significantly lower incidence<br />
of chronic pain (p = 0.0129), depression/anxiety (p = 0.0017),<br />
and neurological problems (p = 0.015).<br />
Conclusions:<br />
Patients above 60 years of age had lower incidences of all outcomes,<br />
possibly because of their retired lifestyle being less stressful<br />
and less physically demanding. Another contributing factor is older<br />
patients having more severe health problems such that these outcomes<br />
go unrecognized. In addition, cultural differences between<br />
generations may mean that the older generation is more tolerant of<br />
pain and less likely to seek care for these symptoms.<br />
Presidential Poster Session B<br />
Thursday, May 3<br />
4:30 pm – 6:00 pm<br />
B1<br />
Are osteosarcopenia, sarcopenia and osteoporosis different<br />
syndromes? Results from the Women’s Health and Aging Study<br />
(WHAS) II.<br />
A. Frisoli, 1,2 A. Diniz, 1 J. Diniz, 1 S. Inghan, 1 P. Chaves. 2 1. Cardiology<br />
Division, Federal University of São Paulo, Sao Paulo, Brazil; 2. Center<br />
on Aging and Health, Johns Hopkins University, Baltimore, MD.<br />
Substantial heterogeneity is observed among sarcopenic and osteoporotic<br />
patients, however, the concomitant occurrence of these<br />
two syndromes has not been evaluated. The goal of this study was to<br />
examine the body composition and muscle strength profile among osteoporosis,<br />
sarcopenia and osteosarcopenia in community-dwelling<br />
older women.<br />
Methods: Cross-sectional analysis of data from WHAS 2, an observational<br />
study of the epidemiology of disability onset in community-dwelling<br />
older women, Baltimore, USA. The analytic sample for<br />
this study included all women who underwent DEXA evaluation and<br />
had available data on fat, muscle and bone mass (n=248). Osteoporosis<br />
was defined as a bone mineral density (BMD) t-score
P OSTER<br />
A BSTRACTS<br />
Methods: We are conducting a 6-week, randomized, 3-arm clinical<br />
trial to compare the efficacy of 2 tailored, multi-component exercise<br />
programs for improving physical performance of older PCa patients<br />
on ADT. Men, aged 70 and older, were randomly assigned to<br />
either an established progressive resistance and walking program<br />
(EXCAP), a similar home-based computer-generated exercise program<br />
utilizing Nintendo’s Wii-Fit technology (Wii), or a usual care<br />
arm (UC). Assessments were completed at baseline and post-intervention.<br />
Primary outcome was a comparison of change scores on the<br />
Short Physical Performance Battery (SPPB) (0-12). Secondary outcomes<br />
were comparisons of changes in lean muscle mass (DEXA),<br />
chest press repetition maximum (CPRM), handgrip strength (HG),<br />
and total body weigh (TBW). T-tests were used to compare change<br />
scores between arms.<br />
Results: Sixteen (of 30 projected) men have completed post-intervention<br />
assessments (7 in Wii, 4 in EXCAP, and 5 in UC). The<br />
mean age of participants at enrollment was 76.9 years (70-87) and<br />
mean SPPB score was 7.6 (4-11). Mean duration of ADT was 57<br />
months. Mean SPPB scores improved by 1.25 in Wii vs UC (p=0.054),<br />
while mean scores improved by 1.33 in Wii vs EXCAP (p=0.061).<br />
There was no significant difference in change of scores between<br />
EXCAP and UC (p=0.903). Mean total body weight decreased by 4<br />
kg in Wii vs UC (p=0.092) and mean handgrip strength increased by<br />
4.37 kg in Wii vs UC (p=0.0274), and mean CPRM increased by 12.9<br />
reps in Wii vs UC (p=0.092). Lean muscle mass improved by 820<br />
grams in Wii compared to UC, although this was not statistically significant<br />
(p=0.42).<br />
Conclusions: Change scores were improved in all measures for<br />
Wii arm, while there were no changes in UC arm. This pilot study<br />
demonstrates the potential of Wii Fit technology to improve physical<br />
performance in older men on ADT over 6 weeks.<br />
B4<br />
REDD in the elderly.<br />
A. Chakka, A. Garrido, T. Iloabuchi, F. Perez. <strong>Geriatrics</strong>, Indiana<br />
University, Indianapolis, IN.<br />
81 y/o AAF with h/o Dementia, HTN, Gout, Hypothyroidism,<br />
DVT s/p IVC filter and GI bleed was admitted for decreased PO intake<br />
and weakness. She had B/L leg pain and progressive edema. Patient<br />
was only on Levothyroxine as all her medications were stopped<br />
for drug induced hepatitis. On exam- lethargy; Tmax-39.4’ C, BP-<br />
76/40, HR-94. Oral mucous membrane hyperemia; RS- clear; CVS-<br />
RRR; ABD- soft, BS+; CNS- confusion; BLE- 2+ edema; Skin- diffuse<br />
macular erythema. Labs: Wbc- 11.5, Eos- 15, Pl.let- 29, BUN/Cr-<br />
25/1.39 (baseline cr- 0.49), UC+ staph.aureus, BC+ MSSA. TEE, CT<br />
chest/abdomen, and vasculitis work up were negative. Patient was admitted<br />
to ICU with sepsis and treated with cephazolin for 3 weeks.<br />
Patient was stable in a week, erythema resolved but a week later developed<br />
generalized desquamation involving palms and soles with<br />
itching, which resolved in 2 weeks. Ten days later she was re-admitted<br />
for abdominal pain, hypotension and hypothermia. She had a similar<br />
clinical picture associated with myositis and the same diffuse erythema<br />
followed by diffuse desquamation, which continued over 4<br />
weeks till she was discharged.<br />
DISCUSSION:<br />
The Differential Diagnosis consisted of Staphylococcal Toxic<br />
shock syndrome (TSS), Stevens - Johnson syndrome, Toxic Epidermal<br />
Necrolysis, Kawasaki disease, Mercury Poisoning and Syphilis. Patient<br />
was diagnosed with a TSS variant, recalcitrant erythematous<br />
desquamating disorder (REDD)[1]. It is a toxin-mediated illness[2],<br />
usually precipitated by infection with Staphylococcus aureus. REDD<br />
is a presumed variant of TSS and is distinguished from classic TSS by<br />
its subacute presentation and recalcitrant course. Although the majority<br />
of patients described to date have had acquired immunodeficiency<br />
syndrome (AIDS), some cases without AIDS have been reported.<br />
Our patient did not have any risk factors for HIV. The<br />
diagnostic criteria met by our case are: Temp > 38.9 ‘C, SBP < 90<br />
mmHg, Diffuse macular erythema with subsequent desquamation involving<br />
palms and soles and multiorgan involvement. To our knowledge<br />
this is the first case report of REDD in an elderly patient.<br />
REFERENCES:<br />
1. Verbon, A. and C.J. Fisher, Jr., Severe recalcitrant erythematous<br />
desquamating disorder associated with fatal recurrent toxic<br />
shock syndrome in a patient without AIDS. Clin Infect Dis, 1997.<br />
24(6): p. 1274-5.<br />
2. Manders, S.M.,Toxin-mediated streptococcal and staphylococcal<br />
disease. J Am Acad Dermatol, 1998. 39(3): p. 383-98; quiz 399-400.<br />
B5<br />
Fever of Unknown Origin in women with osteoporosis.<br />
B. Peddagovindu, E. Oleson, C. DuBeau. <strong>Geriatrics</strong>, UMass Med<br />
School, Worcester, MA.<br />
Introduction:<br />
Recognition of atypical presentation of disease and prescribing<br />
cascades from adverse drug effects (ADEs) are tenets of geriatric<br />
care. We present 2 cases of an ADE and the costly investigative cascade<br />
that followed it due to non-recognition of the uncommon pattern<br />
of the ADE.<br />
Case 1:<br />
A 63yo woman with osteoporosis, hypertension, diabetes,<br />
COPD, pneumonitis and anxiety who was a poor historian was hospitalized<br />
due to fever 101.3, malaise, myalgia, nausea/vomiting, cough<br />
and dyspnea of one-day duration. Initial work up for infectious<br />
causes was negative. She received zoledronic acid (ZA) for treatment<br />
of osteoporosis 2 days prior, but it was not on her medication list and<br />
not discovered until 5 days into her stay. She continued to have fevers<br />
spikes to 101F and dyspnea. Empiric antibiotics for pneumonia were<br />
given for 5 days and repeat fever work up was negative. She was discharged<br />
after 1 week with diagnosis of fever from ZA ADE upon exclusion<br />
of other causes.<br />
Case 2:<br />
A 71yo woman with history of non-hodgkin’s lymphoma, cirrhosis,<br />
anxiety, osteoporosis, and nephrolithiasis was hospitalized due to<br />
fever 101F, and nausea/vomiting 1 day after ZA infusion and discharged<br />
in 24h after symptom control and negative infectious work<br />
up. She then developed a rash on her neck thought to be shingles and<br />
was given valcyclovir. She was seen by ID and given doxycycline for<br />
suspected tick borne illness. Due to daily fevers to 101F and worsening<br />
cough she was readmitted 12 days after original d/c. Per ID and<br />
oncology, pertussis titers, serology for tick-borne illnesses and CT<br />
chest/abdomen/pelvis for possible lymphoma recurrence done were<br />
negative. After 20 days, diagnosis of exclusion of fever from ZA was<br />
made. Total duration of fever was more than 20 days.<br />
Discussion:<br />
Fever is the most common ADE of ZA, likely from an increase<br />
in TNF-a and IL-6. In cases presented, patients had extended hospital<br />
stays and costly work ups because 1) ZA use was initially missed, and<br />
2) duration of fever > 72 hrs (usual for this ADE), “atypical presentation”<br />
of ZA ADEs, was not recognized. ZA fever may last 14+ days<br />
with rash and cough. These cases demonstrate the need to keep ZA<br />
on active med lists, understanding and informing patients about ZA<br />
ADEs, and using careful follow-up rather than costly evaluations for<br />
even prolonged fever after ZA. Prevention with acetaminophen or<br />
ibuprofen following ZA infusion can decrease this common ADE.<br />
B6<br />
81 year old man hospitalized with hypercalcemia - of course its<br />
cancer!<br />
C. Hathaway, D. Bynum. Division of Geriatric Medicine and Center<br />
for Aging and Health, University of North Carolina, Chapel Hill, NC.<br />
Supported By: University of North Carolina Division of Geriatric<br />
Medicine and Center for Aging and Health<br />
Introduction: It is very unusual for patients in the geriatric population<br />
to present with sarcoidosis as a new diagnosis, and thus there<br />
S74<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
is a paucity of literature about this unique subgroup of patients. Sarcoidosis<br />
is a systemic illness that typically presents in younger populations;<br />
peak incidence is between the ages of 20-40. Typical symptoms<br />
on presentation are systemic malaise, fever, and pulmonary<br />
complaints. There is a gender predilection with women being affected<br />
more often than men, and a racial predilection with African <strong>American</strong>s<br />
affected more so than Caucasian populations.<br />
Case: An 81 year old Caucasian man with a medical history of<br />
coronary artery disease, chronic obstructive pulmonary disease, and<br />
laryngeal cancer status post resection presented with a three week<br />
history of decline characterized by weakness, confusion, and frequent<br />
falls. Upon admission the patient was found to have an elevated calcium<br />
level of 13.5 mg/dL. Chest roentogram was unremarkable, but<br />
computed tomography of the chest with contrast revealed mediastinal<br />
lymphadenopathy. Lab results demonstrated parathyroid hormone<br />
(PTH) 20. The captopril challenge test confirmed<br />
the results in 2 patients, while Case 2 had an elevated ratio twice. CT<br />
scans of the abdomen were performed in 2 cases, revealing normal adrenal<br />
glands. All 3 patients were diagnosed with primary aldosteronism<br />
(PA) and were treated medically with spironolactone. In Case 1<br />
and 2, all BP medications were discontinued with the exception of<br />
spironolactone (50 mg daily in Case 1 and 125 mg daily in Case 2). In<br />
Case 3, BP improved with the addition of spironolactone 125 mg daily.<br />
Discussion: Idiopathic PA peaks in the sixth decade of life. PA<br />
has a prevalence of 5-15%. These 3 cases were found within a small<br />
primary care clinic panel of 215 patients. PA can commonly be found<br />
in a community-based primary care geriatric clinic setting (not just in<br />
specialized HTN referral centers). These cases had been treated as essential<br />
HTN for 1-2 years before diagnosis. The diagnosis may frequently<br />
be missed if not considered, including in HTN patients without<br />
hypokalemia. The Endocrine <strong>Society</strong> recommends that patients<br />
who have BP>160/100, or drug-resistant HTN, or HTN with spontaneous<br />
or drug-induced hypokalemia be screened for PA. In Case 1<br />
and 2, polypharmacy was markedly reduced. In Case 3, although BP<br />
improved, polypharmacy was not reduced, perhaps suggesting PA<br />
plus essential HTN. Even if the diagnosis of PA was a false positive,<br />
spironolactone is an effective BP medication to be considered in<br />
drug-resistant HTN. More importantly, there is now evidence to suggest<br />
that aldosterone excess in PA leads to adverse cardiovascular<br />
and renal outcomes independent of its effects on BP. Treatment<br />
specifically directed against aldosterone excess protects against the<br />
development of these complications more effectively than non specific<br />
BP medications, further emphasizing the importance of not missing<br />
the diagnosis of PA.<br />
B9 Encore Presentation<br />
Bilateral popliteal vein aneurysms: a rare cause of leg pain.<br />
F. Cardona, 1 T. T. Suh, 1 M. Sideman. 2 1. Division of Community<br />
<strong>Geriatrics</strong>, Department of Family and Community Medicine, UTH-<br />
SCSA, San Antonio, TX; 2. Division of Vascular & Endovascular<br />
Surgery,Department of Surgery, UTHSCSA, San Antonio, TX.<br />
BACKGROUND: Although popliteal vein aneurysms (PVAs)<br />
are the most common reported venous aneurysms, they are still rare<br />
AGS 2012 ANNUAL MEETING<br />
S75
P OSTER<br />
A BSTRACTS<br />
with only about 125 cases published in the literature. When encountered,<br />
PVAs are usually unilateral, with only 7 reported cases of bilateral<br />
PVAs. The causes of PVA are unclear, but are thought to result<br />
from congenital vascular malformation, inflammation, trauma or degenerative<br />
changes. Age at presentation is variable, ranging from 27<br />
to 79 years. We describe the oldest case of PVAs to date.<br />
CASE: An 81 year old retired mail carrier presented with burning<br />
sensation in his lower extremities and discomfort after prolonged<br />
standing, which began to limit his activities. Physical examination revealed<br />
bilateral lower extremity varicose veins along the greater<br />
saphenous vein and pain on palpation of the right leg. Duplex ultrasonography<br />
showed bilateral PVAs without any evidence of thrombosis.<br />
Three months later, his leg pain became more persistent, with<br />
worsening pain at night. Serial resections of the PVAs were performed,<br />
leading to complete resolution of the leg pain and return to<br />
his previous activity level and independent functional status.<br />
DISCUSSION: First described by Sir William Osler in 1915,<br />
PVAs are uncommon and the exact incidence is unknown. The clinical<br />
presentation of PVAs is widely variable; however, over 50% of the<br />
reported cases present as thromboembolic disease, with pulmonary<br />
embolism being the most common presentation (47% of cases vs. 7%<br />
for deep venous thrombosis). Diagnosisof PVAs because of leg pain<br />
has been reported in only 12% of cases, while 20% have been associated<br />
with the presence of varicose veins. Since only 5% of reported<br />
cases have been bilateral, this case represents an unusual presentation<br />
of PVAs. Duplex ultrasonography remains the diagnostic test of<br />
choice, although newer techniques have emerged such as CT angiography<br />
and MRI. Surgery is indicated whenever thromboembolic disease<br />
is present regardless of PVA size or if the PVA size is greater<br />
than 20mm. Anticoagulation for six months is generally recommended<br />
during the post-operative period. Geriatricians need to be<br />
aware of this condition since it can present in older adults.<br />
B10<br />
Challenges in diagnosing Creutzfeldt - Jakob disease.<br />
G. K. Penmetsa, 1 E. Zamrini. 2 1. <strong>Geriatrics</strong>, University of Utah hospital,<br />
Salt lake city, UT; 2. Center for Alzheimer’s Care, Imaging and<br />
Research, University of Utah, Salt Lake City, UT.<br />
Background:The rate of progression of cognitive impairment<br />
provides important insight into the differential diagnosis of dementia.<br />
Creutzfeldt-Jakob disease (CJD) is a rare neuro-degenerative disorder<br />
characterised by very rapid decline in cognitive and motor function.<br />
Diagnosis can be challenging<br />
Case history: A 65 year old previously healthy and fully functional<br />
man with no significant past medical problems was admitted to<br />
an outside hospital for sub-acute change in alertness and cognitive<br />
function over a period of 2 weeks. He could no longer engage in any<br />
family activities, communicate fluently or name family members, and<br />
required moderate assistance with all activities of daily living<br />
(ADLs). Extensive inpatient work-up included blood work, CSF<br />
studies and brain MRI, but the patient remained without a specific diagnosis<br />
at discharge on a tapering burst of prednisone. When referred<br />
to the University of Utah neuro-cognitive disorders clinic four weeks<br />
later, he was doubly incontinent and fully dependent in all ADLs. He<br />
also had personality changes, myoclonic jerks, ataxia and falls. CJD<br />
was suspected by the consultant and review of the outside hospital<br />
MRI with adjustment of the contrast windows revealed cortical ribbons<br />
and increased signal in the basal ganglia on diffusion weighed<br />
images (DWI) and FLAIR. The family was counselled. The patient<br />
was placed in hospice and died shortly afterwards.<br />
Discussion: CJD is a fatally progressive prion disease characterized<br />
by rapidly deteriorating dementia. The diagnosis of CJD may be<br />
made by performing an EEG, brain MRI or CSF studies for 14.3.3<br />
protein. MRI findings of cortical ribbons on DWI windows have<br />
higher sensitivity and specificity for CJD. The brain MRI was initially<br />
reported as inconclusive,but further review of the same images by the<br />
cognitive neurologist and a neuro-radiologist demonstrated cortical<br />
ribbons. This case highlights the need to consider CJD in patients<br />
with rapidly progressing dementia. It also offers insight towards the<br />
utility of expediting clinical consultation and expert review of imaging<br />
studies in diagnosing CJD.<br />
B11<br />
Encephalopathy Responsive to Zolpidem.<br />
M. Howard, 1 D. Rye, 2 J. Greene, 2 A. I. Levey. 2 1. <strong>Geriatrics</strong>, Emory<br />
University, Atlanta, GA; 2. Neurology, Emory University, Atlanta, GA.<br />
Encephalopathy has a wide variety of etiologies and presentations<br />
as in this case of sub acute persistent altered mental status.<br />
Zolpidem is FDA approved for treatment of primary insomnia. A<br />
newer active area of research is exploring its activity in patients with<br />
altered levels of consciousness.<br />
A 64 year old Caucasian woman was referred to a university<br />
neurology memory clinic with sub acute onset of altered mental status<br />
over the preceding 3 months. Shortly following a European vacation,<br />
the previously healthy woman became progressively more paranoid,<br />
anxious, confused, insomnic, and dependent in activities of daily<br />
living. Previous evaluation included brain imaging and lumbar puncture<br />
without definitive diagnosis. She was given empiric treatments<br />
including benzodiazepines, antipsychotics, and antidepressants which<br />
had no effect except for zolpidem which her husband noticed caused<br />
normalization of her behaviors and functional and cognitive abilities<br />
for a few hours following the dose. In clinic, exam showed marked<br />
anxiety with prominent deficits in attention and concentration as well<br />
as problems with memory and language (particularly fluency), increased<br />
rigidity, and frontal release signs.<br />
Upon hospital admission, workup included neurologic examination<br />
on and off of zolpidem, placebo, lorazepam and flumazenil. Objective<br />
improvement in neuropsychological function was noted only<br />
with zolpidem and worsening with flumazenil. Continuous EEG<br />
monitoring was normal. On functional MRI she was unable to do<br />
tasks before medication but after 24 hours on zolpidem she was able<br />
to do tasks and had normal activation of expected areas. FDG-PET<br />
imaging showed improvement in hypometabolism of multiple brain<br />
regions on zolpidem. Whole body imaging, cerebrospinal fluid, and<br />
serum studies were negative for infection, occult malignancy and<br />
paraneoplastic antibodies. Lumbar puncture before and after continuous<br />
zolpidem administration showed a small decrease in protein<br />
level from 60 to 46 mg/dL, and was otherwise unremarkable. She was<br />
discharged on zolpidem CR 12.5 mg three times a day with some improvement<br />
maintained at follow up several weeks later.<br />
The activating effects of zolpidem in the setting of altered levels<br />
of consciousness have been described in a few studies, mainly in the<br />
setting of persistent vegetative and minimally conscious states. This<br />
case appears to represent a case of encephalopathy of unknown etiology<br />
that responds to zolpidem.<br />
B12<br />
ATRIAL TACHYARRHYTHMIA PRESENTING AS<br />
POLYURIA.<br />
N. Maheshwari, 1 S. Anand, 1 D. Kumari, 2 J. Hanoi, 1 E. Ong, 1 E. Roffe, 2<br />
S. Mushiyev, 3 S. Chaudhari. 2 1. Internal Medicine, New York Medical<br />
College Metropolitan Hospital Centre, Manhattan, New York, NY; 2.<br />
<strong>Geriatrics</strong>, New York Medical College Metropolitan Hospital Center,<br />
New York, NY; 3. Cardiology, New York Medical College<br />
Metropolitan Hospital Center, New York, NY.<br />
INTRODUCTION: Polyuria is associated with atrial flutter and<br />
atrial fibrillation and excessive urine formation associated with any<br />
abnormal atrial rhythm or activity has been seen in few case reports.<br />
We report an unusual case of atrial tachyarrhythmia presenting as<br />
polyuria.<br />
CASE REPORT: 87 years-old female with history of blindness<br />
in left eye presented to the emergency department with complains of<br />
S76<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
urinary frequency of more than 10 episodes daily for last 10 days; review<br />
of systems was negative except for polyuria, On physical examination<br />
(PE) revealed tachycardia of 200 beats/min, Cardiovascular<br />
examination revealed tachycardia with irregular pulse, left eye blindness,<br />
rest of PE including genitourinary examination was normal.<br />
Electrocardiogram (EKG) showed atrial flutter and repeat EKG<br />
showed atrial fibrillation (AF), Troponin of 0.17ng/mL, normal renal<br />
bladder ultrasound. She was started on diltiazem drip and subsequently<br />
switched to oral long acting beta blocker (BB) and her urinary<br />
frequency and tachycardia resolved, started on Coumadin for<br />
AF. Echocardiogram showed ejection fraction of less than 25%. Next<br />
day patient again have tachycardia and urinary frequency and BB<br />
dose was increased and she improved. During the hospital stay patient<br />
developed multiple episodes of tachycardia and urinary frequency<br />
until BB dose titrated to achieve a controlled heart rate with<br />
normal sinus rhythm and urinary frequency resolved.<br />
DISCUSSION: Polyuria associated with abnormal atrial activity<br />
like atrial flutter or atrial fibrillation has been reported in few<br />
cases in past, but no exact mechanism is known. Wood suggested that<br />
polyuria is secondary to anti diuretic hormone inhibition; later<br />
Michael J et al speculate that human atrial hyperactivity from an<br />
atrial arrhythmia represents a natural experiment in man simulating<br />
volume expansion, and signaling the kidney to decrease renal tubular<br />
sodium and water reabsorption. The diuresis begins at once and becomes<br />
manifest in few minutes, stops immediately when the attack<br />
ends, as seen in our case. Physicians should keep polyuria as one of the<br />
rare presentation or differential diagnosis of atrial tachyarrhythmia.<br />
B13<br />
Diffuse Lewy Body Dementia (DLBD): Missed diagnosis can be life<br />
threatening.<br />
N. Bansal, D. Manocha, S. Brangman. SUNY Upstate Medical<br />
University, Syracuse, NY.<br />
Background: DLBD accounts for around 20% cases of adults<br />
with dementia. Clinical features include cognitive impairment with<br />
fluctuating course, neuropsychiatric manifestations, motor and autonomic<br />
dysfunction. Heightened sensitivity to neuroleptics is a grievous<br />
complication.<br />
Case Report: We present a unique learning case of a 65 year old<br />
lady with past medical history of remitting relapsing multiple sclerosis(MS)<br />
on betasetron prophylaxis. She had two recent hospitalizations<br />
for worsening agitation and hallucinations at an outside facility<br />
which were interpreted as manifestations of MS flare. Escalating<br />
doses of antipsychotics (19 mg of haloperidol intravenously over 24<br />
hours) were administered besides the therapy for MS. Subsequently,<br />
she was transferred to our institution for need of neuro ICU management<br />
of MS. She was dehydrated, febrile(102 F), had rigidity and myoclonus<br />
on initial evaluation. Her metabolic profile revealed elevated<br />
creatine kinase levels(9812 IU/ L) and acute kidney injury. A diagnosis<br />
of neuroleptic malignant syndrome was made. She responded well<br />
to medical management. After resolution of acute complications, patient<br />
started re experiencing visual hallucinations, depressive symptoms<br />
and memory lapses to create a diagnostic and management<br />
dilemma for the primary team. A detailed geriatric assessment was<br />
then performed. It revealed history of worsening short term memory<br />
loss with fluctuations over the past 1year, complicated by bradykinesia<br />
and depression for 7 months and visual hallucinations for 4<br />
months. The mental status testing revealed impaired visuospatial orientation,<br />
recall and execution. Work up for reversible causes (including<br />
Vitamin B12/ TSH/RPR-VDRL) and brain imaging were noncontributory.<br />
Thus a diagnosis of Diffuse Lewy Body Dementia with<br />
sensitivity to neuroleptics with neuroleptic malignant syndrome was<br />
made. The patient was started on donapezil for cognition, citalopram<br />
for depression and valproic acid for other secondary behavior problems<br />
with partial stabilization of her symptoms. Discussion: Use of<br />
neuroleptics has been associated significant adverse reactions in 54-<br />
81% patients with DLBD. Studies have shown increased mortality<br />
and shortened survival times in affected patients. Compromised nigrostriatal<br />
dopaminergic transmission predisposes to neuroleptic sensitivity<br />
even at modest doses.Co-existing medical conditions may<br />
delay the diagnosis and appropriate management as was the case in<br />
our patient.<br />
B14 Encore Presentation<br />
Getting the Patient Out of the Woods - Near Death from Babesiosis<br />
in an Elder.<br />
R. Jaber, M. Brennan. Internal Medicine, Baystate Medical Center,<br />
Springfield, MA.<br />
Supported By: Baystate Medical Center/Tufts Univ. School of<br />
Medicine<br />
Introduction<br />
Babesiosis is a tick-borne disease common in the Northeast and<br />
Midwest. The parasite, Babesia microti, infects red blood cells and can<br />
cause serious illness. The authors report a case of life threatening infection<br />
in an elder who recovered after prompt diagnosis and aggressive<br />
treatment.<br />
Case summary<br />
An 85-year-old man had 5 days of malaise, lethargy, and fever.<br />
PMH included ischemic stroke, hyperlipidemia and possible<br />
myelodysplastia. He lived in Monson, Massachusetts and had recently<br />
been gardening in a wooded area.<br />
On physical examination he appeared ill, was diaphoretic,<br />
slightly confused and febrile (101.7 F). He had a regular tachycardia<br />
(115 bpm). His bp was 137/75, RR was 20 and his O2 saturation was<br />
93% on 3 ls; there was no rash or lymphadenopathy. He had a few<br />
coarse crackles at the left base but his exam was otherwise normal.<br />
His wbc count was 3.9 K and left shifted with 13% bands. His hemoglobin<br />
was 9.7 gm/dl and the platelet count was 40 K. Most notably,<br />
he had an RBC parasitemia of 10 % classic for Babesiosis.<br />
Chest X-ray revealed left lower lobe atelectasis. Azithromycin and<br />
atovaquone were begun and he was tested for anaplasmosis (Human<br />
Monocytic Ehrlichiosis) since patients often have concomitant infections<br />
and this requires adjusting antibiotics. This was positive, so<br />
doxycycline was added. On hospital day 4, he developed severe hemolysis;<br />
his hemoglobin dropped to 6 and his parasitemia rose to 19<br />
%. Red blood cell exchange was performed; antibiotics were switched<br />
to clindamycin and quinine. The patient improved; at discharge the<br />
parasitemia was under 1 %.<br />
Discussion:<br />
Life-threatening Babesiosis occurs most often in elders (age> 75<br />
yrs) and those who are immunosuppressed or asplenic. Most deaths<br />
are due to hemolysis, thrombocytopenia, DIC, or multi-organ failure.<br />
Early recognition is critical. This patient’s life likely was saved by<br />
prompt diagnosis in a community hospital. This resulted in rapid<br />
transfer to tertiary care thereby facilitating immediate response to<br />
subsequent massive hemolysis. The case also highlights the importance<br />
of assessing for co-infection with Ehrlichia. Failing to identify<br />
all major infections would probably have proved fatal. Geriatricians<br />
often care for immunocompromised, frail elders. To prevent unnecessary<br />
deaths they must be aware of the presentation, natural history,<br />
treatments and complications of Babesiosis and screen promptly for<br />
co-infections.<br />
B15<br />
An Unusual Case of a Prosthetic Joint Infection with Lactobacillus.<br />
R. Zitnay, S. Chao. Section of <strong>Geriatrics</strong>, Boston University Medical<br />
Center, Boston, MA.<br />
Background: Lactobacillus is a Gram positive organism found<br />
as normal flora in the oral cavity, genital, and gastrointestinal tract. It<br />
is classically a nonpathogenic organism, found in fermented food<br />
products and probiotic supplements. Serious infections are very rare,<br />
AGS 2012 ANNUAL MEETING<br />
S77
P OSTER<br />
A BSTRACTS<br />
with typical risk factors being an immunocompromised state, malignancy,<br />
or translocation after invasive gastrointestinal procedures. We<br />
describe a patient with a subacute presentation of prosthetic joint infection<br />
with Lactobacillus as the culprit organism. Case: A 95 year old<br />
female with a history of dementia, a left hip fracture with hemiarthroplasty<br />
one year prior, and a clostridium difficile infection now on probiotic<br />
supplementation, developed a new complaint of left leg pain.<br />
The pain was worse with weight bearing, but did not compromise her<br />
walking. Physical examination was remarkable only for superficial<br />
tenderness to palpation of the distal anterio-lateral quadriceps muscle.<br />
Left hip and femur Xrays were normal with her prosthesis in<br />
anatomic alignment. Six months later she developed new difficulty in<br />
transferring from bed to stand, requiring one person assist and skin<br />
breakdown over the left lateral hip. A CT scan showed femoral diaphyseal<br />
cortical defects and subcutaneous and intramuscular enhancing<br />
collections concerning for infected hip prosthesis with sinus tract.<br />
Intra-operative cultures revealed lactobacillus casei/paracasei. Multiple<br />
peripheral blood cultures were negative. She completed a fourweek<br />
course of intravenous penicillin and then was placed on oral dicloxacillin<br />
for long term suppressive therapy. Discussion: This case<br />
demonstrates the subtle history and physical examination findings<br />
that can accompany subacute prosthetic hip infections in advanced<br />
age. The index of suspicion should remain high despite the reassuring<br />
lack of classic local or systemic infectious signs or symptoms. In the<br />
face of suspicion, the history should consider a broad range of potential<br />
pathogens. Current research argues against a link between systemic<br />
disease and probiotic therapy, but this case suggests such a link.<br />
B16<br />
POEMS Syndrome: A Rare Cause of Gait Imbalance.<br />
S. Arshad, J. Angeles, H. A. Arabelo. <strong>Geriatrics</strong>, St. Luke’s-Roosevelt<br />
Hospital, Academic Affiliate of Columbia University College of<br />
Physicians & Surgeons, New York, NY.<br />
Gait imbalance is very common in the elderly and could result<br />
from multiple causes, some of which are treatable. Loss of balance<br />
can be very debilitating.<br />
An 87 year old patient presented with bilateral leg weakness<br />
and imbalance. He reported trouble walking for the past year accompanied<br />
with ankle edema. Upon admission he was found on the floor<br />
and unable to ambulate. He complained of tingling in his feet &<br />
hands bilaterally. On physical exam he had no fasciculations, normal<br />
muscle tone, mild finger abductor weakness & 1+ bicep reflexes. He<br />
had weakness in both legs, markedly diminished pinprick in the legs<br />
to the mid thigh bilaterally, absent vibratory sensation in his feet, absent<br />
position sense in the toes, absent Achilles reflexes, and cautious<br />
gait with increased base. MRI of the spine showed DJD and mild<br />
compression fracture of T12 with no nerve impingement or cord lesions.<br />
TSH, B12 levels, and the Lyme Antibody were unremarkable.<br />
An EMG showed moderate to severe peripheral neuropathy with significant<br />
slowing in the right tibial and peroneal nerves, consistent<br />
with acquired demyelination. An IgG lambda spike on protein and<br />
immune fixation electrophoresis was noted. The skeletal survey was<br />
without lytic or blastic lesions. The patient had gait ataxia from severe<br />
peripheral neuropathy with monoclonal gammopathy as the etiology.<br />
Our patient has features of POEMS with sensory motor<br />
polyneuropathy, endocrinopathy with recent diabetes mellitus, edema<br />
and IgG lambda protein monoclonal gammopathy. He will follow up<br />
with his Hematologist & Neurologist for treatment and also have<br />
physical therapy.<br />
POEMS is a multisystemic syndrome that occurs in the setting<br />
of plasma cell dyscrasia. It is rare and can be underdiagnosed leading<br />
to recurrent falls. POEMS syndrome occurs because of the growth of<br />
certain clonal plasma cells that produce an abnormal amount of<br />
blood proteins, which damage body organs & result in this acronym<br />
for the syndrome’s most common features consisting of polyneuropathy,<br />
organomegaly, endocrinopathy or edema, monoclonal protein<br />
and skin changes. Not all features of the disease are required to make<br />
the diagnosis. POEMS syndrome begins around age fifty and affects<br />
twice as many men as women. If untreated it is progressive and often<br />
fatal. Only 60% survive five years after onset. However, the symptoms<br />
can improve if the blood disorder is diagnosed and treated.<br />
B17 Encore Presentation<br />
A Rare Etiology of Acute Cardiomyopathy and Respiratory Failure.<br />
S. Lee, S. Bellantonio, D. Joseph. Internal Medicine, Baystate Medical<br />
Center, Springfield, MA.<br />
INTRO<br />
Adult-onset Still’s Disease(AOSD) is a rare systemic inflammatory<br />
disorder of unknown etiology, commonly presenting with fever,<br />
rash, and arthritis/arthralgias. It more commonly affects women; median<br />
age of onset is 25. We report an atypical presentation of an<br />
AOSD flare with possible Macrophage Activation Syndrome(MAS)<br />
associated with extreme hyperferritinemia in a 60 year old male.<br />
CASE<br />
A 60-year-old high-functioning male with history of AOSD presented<br />
with subacute fever, rigors, and diarrhea. His exam was unremarkable,<br />
with no evidence of rash, synovitis or lymphadenopathy.<br />
Labs revealed mild leukocytosis and creatinine of 3.2mg/dL. He was<br />
admitted for acute renal failure and treated supportively with IV fluids.<br />
The next day, he developed acute, progressively worsening respiratory<br />
distress. CXR showed multifocal atelectasis without pulmonary<br />
congestion. There were no ischemic EKG changes, but<br />
troponinT was elevated(0.37). Echocardiogram revealed new diffuse<br />
hypokinesis with depressed systolic function(EF 30%). Serum ferritin<br />
was markedly elevated(103,670). He was transferred to the ICU and<br />
put on noninvasive ventilation. High dose IV steroids were initiated<br />
with impressive improvement in respiratory status. He was transitioned<br />
to PO steroids, and a week later initiated on an IL1 antagonist(anakinra)<br />
and discharged with normal renal function. Hypoxemia<br />
and dyspnea resolved over the ensuing weeks with ferritin<br />
returning to normal. Repeat echo showed normal cardiac function.<br />
Steroids were eventually tapered and anakinra continued.<br />
DISCUSSION<br />
Besides AOSD and MAS, there are few, if any conditions presenting<br />
with this extraordinary degree of hyperferritinemia. MAS,<br />
commonly associated with rheumatologic conditions, is caused by<br />
overwhelming macrophage activation resulting in phagocytosis of<br />
erythrocytic precursors in bone marrow. Both AOSD flare and MAS<br />
can be triggered by infection, and similarly managed with immunosuppression,<br />
as in our patient. The absence of cytopenias and hypofibrinogenemia<br />
militate against MAS. MAS is only confirmed with bone<br />
marrow biopsy, but with high false negative rates.<br />
CONCLUSION<br />
AOSD flare and MAS are rapidly fatal conditions that can<br />
occur in older adults. Both mimic sepsis with multiorgan dysfunction,<br />
and diagnosis is often delayed. Quick recognition and treatment is<br />
vital for favorable outcome.<br />
B18<br />
Dysphagia with a Large Goiter: What You See Is Not Necessarily<br />
What You Get.<br />
S. McCullough, 1 J. Reckrey, 1,2 B. Shah. 1,2 1. Mount Sinai School of<br />
Medicine, New York, NY; 2. Department of <strong>Geriatrics</strong>, Mount Sinai<br />
Hospital, New York, NY.<br />
Dysphagia commonly accompanies acute presentations of the<br />
elderly. This case illuminates the importance of maintaining a broad<br />
differential for dysphagia and highlights the phenomenon of<br />
pseudoachalasia.<br />
A 90 year old woman with a history of GERD, dysphagia, hyperthyroidism<br />
with a 7-cm multinodular goiter and atrial fibrillation<br />
with rapid ventricular response was transferred from her nursing<br />
S78<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
home for altered mental status and percutaneuous endoscopy gastrostomy<br />
(PEG) placement. The patient had dysphagia presumed to<br />
be caused by compression from her goiter. In the month prior to admission<br />
her daughter reported worsening dysphagia with the patient<br />
now unable to tolerate medications. Due to the dysphagia, the patient<br />
planned for ambulatory PEG placement; however, the patient became<br />
delirious and was transferred. Initial evaluation revealed a right<br />
lower lobe pneumonia and an E coli UTI which were treated with antibiotics.<br />
A goals of care (GOC) discussion with family confirmed the<br />
decision for PEG placement. A neck CT done to evaluate for airway<br />
compression showed no change in goiter size. Esophagogastroduodenoscopy<br />
(EGD) revealed stricturing and a fungating mass at the<br />
gastric cardia, identified pathologically as an invasive poorly differentiated<br />
adenocarcinoma. After the procedure the patient remained<br />
somnolent and GOC were readdressed. In accordance with the family’s<br />
wishes, the patient was transferred to the palliative care unit<br />
where she passed away with her family at bedside. In evaluating this<br />
patient’s dysphagia, our premature diagnostic closure attributed her<br />
dysphagia to external compression and failed to consider gastric cancer<br />
with resulting pseduoachalsia. Older age, sudden onset, and<br />
weight loss are clues to differentiating pseudoachalasia from achalasia.<br />
Pseudoachalsia is most commonly due to adenocarcinoma of the<br />
gastric cardia and can result from mechanical compression of the<br />
lower esophageal sphincter or myenteric plexus infiltration. The case<br />
makes clear that the less common causes of dysphagia such as<br />
pseudoachalasia should be considered when evaluating an elderly patient.<br />
The patient’s prior treatment decisions along with GOC discussions<br />
helped the daughter make end of life decisions. This case highlights<br />
a common problem in the elderly and reminds clinicans to<br />
maintain a broad differential, be knowledgable about the causes of<br />
dysphagia, and discuss GOC frequently.<br />
B19<br />
Transitioning into the Weekend, Staffing Constraints and Delayed Care.<br />
W. Colon Cartagena, M. Brennan. Internal Medicine, Baystate<br />
Medical Center/Tufts Univ. School of Medicine, Springfield, MA.<br />
Background<br />
Hospital staffing and specialty care is often reduced on weekends;<br />
studies suggest that certain types of patients have excess mortality<br />
if they are hospitalized on a weekend as compared to a weekday<br />
(1). However, little is known about the impact of delayed<br />
assessments for frail elders in acute care settings. The authors report a<br />
case of one man who was subjected to a lengthy hospitalization and<br />
much suffering due to delays in care over a weekend.<br />
Case<br />
Mr. R. was a 94 year old man with sub-acute, progressing leg<br />
pain and weakness. He arrived on a Friday evening for evaluation<br />
after an MRI showed a mass at L5. He was alert and oriented to person,<br />
place and time and had no motor or sensory deficits. His major<br />
complaint was pain. A CT showed bilateral pulmonary masses and<br />
suspicious lesions in his pelvis; cancer was high in the differential. A<br />
PSA and CEA were unremarkable. A CT-guided mass biopsy was ordered<br />
to identify the pathology and clarify the suitability of palliative<br />
radiation. The procedure was scheduled for Monday due to a lack of<br />
interventional radiology personnel over the weekend. However, Mr.<br />
R. became delirious on Sunday night and was discharged to a nursing<br />
home with ongoing delirium about a week later. His agitation resulted<br />
in an 11 day delay in obtaining the biopsy which eventually revealed<br />
multiple myeloma.<br />
Discussion<br />
Much attention has been paid to transitions of care between different<br />
institutions but the transition through a hospital’s weekly<br />
staffing cycle creates similar challenges. In this case, timely intervention<br />
would have identified multiple myeloma earlier allowing targeted<br />
treatment to improve pain and stabilize function. Hospitalizations<br />
have a disproportionately detrimental effect on older adults,<br />
leading to complications such as delirium and functional decline.<br />
These prolong hospital stay, increase costs and decrease patients’<br />
quality of life. However, it is unclear if these adverse outcomes are<br />
more common for elders admitted during a weekend. This is an important<br />
question for future research by geriatricians, hospitalists, and<br />
health care quality experts.<br />
Bibliography<br />
1. The association between night or weekend admission and hospitalization-relevant<br />
patient outcomes. Khana, R, et al., et al. Jan<br />
2011, Journal of Hospital Medicine, pp. 6(1):10-4.<br />
B20<br />
Understanding Surrogate Decision-makers’ Perceptions of Feeding<br />
Options for Patients with Dementia.<br />
E. A. Snyder, 1 R. Gilliam, 3 A. Caprio, 2 L. . Hanson. 2 1. School of<br />
Medicine, University of North Carolina, Chapel Hill, NC; 2. Division<br />
of Geriatric Medicine, University of North Carolina, Chapel Hill, NC;<br />
3. Cecil G. Sheps Center for Health Services Research, University of<br />
North Carolina, Chapel Hill, NC.<br />
Supported By: Funder: NIH-NINR 1R01 NR009826<br />
Background: Feeding problems are common in advanced dementia<br />
patients, requiring surrogates to make decisions about feeding<br />
options. Little is known about surrogates’ understanding of tube<br />
feeding and assisted oral feeding. Our study explores surrogate perception<br />
of these feeding options and assesses the impact of a decision<br />
aid on their perspectives, knowledge and decisional certainty.<br />
Methods: The study was conducted in 24 skilled nursing facilities<br />
in North Carolina as a part of a larger, randomized controlled trial.<br />
Study population included surrogate decision-makers for nursing<br />
home residents with advanced dementia and feeding problems<br />
(n=255). The intervention group viewed a decision aid about tube<br />
feeding and assisted oral feeding. Baseline interviews included items<br />
measuring knowledge, expectation of benefit from tube feeding and<br />
open-ended questions about the advantages and disadvantages of<br />
feeding options. Answers were compared before and after viewing<br />
the interventional decision aid.<br />
Results: Surrogates varied in their understanding of feeding options,<br />
yet commonly cited maintaining enjoyment, independence and<br />
dignity as major areas of importance. Surrogates provided conflicting<br />
responses regarding the effect of tube feeding vs. oral feeding on prolonging<br />
life and were uncertain of the effects on nutrition. Exposure<br />
to a structured decision aid modified surrogate understanding of<br />
feeding options. Surrogates were more likely to provide responses<br />
consistent with those presented in the decision aid. Detailed interviews<br />
with surrogates following exposure to the decision aid revealed<br />
increased knowledge (15.5 vs. 16.8; p
P OSTER<br />
A BSTRACTS<br />
The aim of this study was to determine if osteoarthritis (OA)-related<br />
biomarker levels were associated with hand symptoms severity<br />
and functional disability as reported by the Australian/Canadian<br />
Hand Osteoarthritis Index (AUSCAN) among middle- and olderaged<br />
adults.<br />
Methods<br />
AUSCAN total scores and biomarker measurements were<br />
available for 661 participants from the Johnston County Osteoarthritis<br />
Project. AUSCAN is a 15-item self-report measure of hand pain,<br />
stiffness, and function that has been previously validated among individuals<br />
with hand OA. Higher AUSCAN scores indicate worse pain<br />
or function in the hand. Commercially-available kits were used to<br />
measure levels of: serum hyaluronic acid (HA), serum carboxy-terminal<br />
propeptide of type II collagen (sCPII), serum type II collagen<br />
degradation product (C2C), urinary C-terminal crosslinked telopeptide<br />
of type II collagen (CTX-II) , and urinary N-terminal crosslinked<br />
telopeptide (NTX); serum cartilage oligomeric matrix protein<br />
(sCOMP) was measured with an in-house sandwich enzyme linked<br />
immunosorbent assay. The ratio of sC2C:sCPII was calculated. Spearman<br />
correlation coefficients were computed between AUSCAN and<br />
each biomarker. Linear regression models were used to estimate associations<br />
between AUSCAN total score and a biomarker, adjusting<br />
for age, race, current smoking status (yes/no), BMI, current alcohol<br />
usage, and radiographic hip, knee, and hand OA, each defined by<br />
Kellgren-Lawrence grade 2-4 in at least one joint in that joint group.<br />
Results<br />
After adjusting for possible confounders, AUSCAN total score<br />
was positively associated with uNTX-1, sCOMP, and negatively associated<br />
with C2C, CPII, and their ratio. The adjusted associations between<br />
AUSCAN scores and uCTX-II and HA were not statistically<br />
significant.<br />
Conclusion<br />
Even after adjusting for other factors and concomitant radiographic<br />
hip, knee, and hand OA, the AUSCAN index for hand symptoms<br />
and function was independently associated with biomarkers related<br />
to type 1 collagen resorption, non-collagenous matrix protein<br />
degradation, and decreased type II collagen synthesis. These findings<br />
suggest that biological processes related to these biomarkers are important<br />
in hand OA and its symptomatic consequences.<br />
B22<br />
Does antipsychotic dose reduction result in worsening behavior<br />
among nursing home residents with dementia: a systematic review of<br />
the literature.<br />
J. Tjia, A. Kanaan, J. Donovan. <strong>Geriatrics</strong>, University of Massachusetts<br />
Medical School, Worcester, MA.<br />
Supported By: This study was supported by a grant from the Agency<br />
for Healthcare Quality and Research.<br />
Background: While federal regulations require gradual dose reduction<br />
trials of antipsychotics prescribed for behavior management<br />
in nursing home (NH) residents with dementia, widespread concern<br />
about precipitating behavioral disturbances limits implementation.<br />
We conducted a systematic review of the literature to identify clinical<br />
trials of antipsychotic dose reductions. The study aim was to describe<br />
dose reduction practices and evidence for risk of behavior escalation.<br />
Methods: A comprehensive literature search was conducted in<br />
MEDLINE, EMBASE, and International Pharmaceutical Abstracts<br />
between January 1970 and October 2011 using the terms “antipsychotic<br />
agent or neuroleptic agent,” “dementia,” “nursing homes,” and<br />
“withdrawal.” One investigator reviewed abstracts for inclusion<br />
based on: English-language, human subjects, clinical trial, nursing<br />
home site, and reported reduction in antipsychotic medications. We<br />
excluded review articles, commentaries and secondary analysis of<br />
main trial results. The remaining articles were reviewed by 2 investigators<br />
for final inclusion, resulting in 9 articles.<br />
Results: The nine articles meeting inclusion criteria included<br />
randomized controlled trials of both typical and atypical antipsychotics.<br />
Study populations ranged in size from 55 to 183 NH residents<br />
with dementia and dose reductions typically targeted patients who<br />
were not psychotic and did not have a history of violent behavior.<br />
Gradual dose reduction protocols typically followed a strategy of<br />
50% dose reduction per week for 2-3 sequential weeks. Outcomes<br />
measured included behavioral problems, cognitive function, and resumption<br />
of antipsychotic medications. All 9 studies reported that the<br />
majority of residents randomized to gradual dose reductions of antipsychotics<br />
had no overall detrimental effect on functional and cognitive<br />
status, or exacerbation of behavioral symptoms.<br />
Conclusions: Clinical trials evaluating the withdrawal of antipsychotic<br />
medications from NH residents with dementia do not<br />
show evidence of rebound behavioral escalation after gradual dose<br />
reductions.<br />
B23<br />
Is Fracture Risk Assessment Index (HFRAI), an Electronic Medical<br />
Database Derived Tool, comparable to Femur neck Bone Mineral<br />
Density (FNBMD)?<br />
M. Albaba, S. S. Cha, P. Y. Takahashi. Mayo Clinic, Rochester, MN.<br />
BACKGROUND<br />
Femur neck bone mineral density (FNBMD) is the cornerstone of<br />
hip fracture risk stratification in current clinical practice. Other risk stratification<br />
tools use FNBMD with other selected risk factors. We have derived<br />
and validated the Hip Fracture Risk Assessment Index (HFRAI)<br />
(score range 0, 32) that uses electronic medical records data to predict<br />
risk for hip fracture in community-dwelling older adults. Using appropriate<br />
computer program,HFRAI is computed automatically to provide the<br />
clinician with a readily available score that assesses patient’s risk for sustaining<br />
hip fracture, without the need to manually calculate a score, perform<br />
a physical examination or obtain a radiology test.It is unknown how<br />
HFRAI compares to FNBMD and to other FNBMD based risk stratification<br />
tools.The goal of this study was to compare HFRAI to FNBMD.<br />
METHODS<br />
This was a retrospective cohort study. All community-dwelling<br />
subjects over 60 years of age in a primary care panel in Olmsted<br />
County, MN on January 1st, 2005 were enrolled.<br />
Since HFRAI uses electronic medical records data of the previous<br />
two years, we excluded all subjects that did not have a FNBMD<br />
tested during the two-year time frame (01/01/2003, 01/01/2005).<br />
We created two receiver-operating curves (ROC), one ROC<br />
using the HFRAI scores as of 01/01/2005, and the other using the lowest<br />
recent FNBMD T-score. The primary outcome was incident hip<br />
fracture in the subsequent four years (2005, 2008). We computed the<br />
area under the curve (AUC) for each ROC. We used Z statistics to<br />
compare AUC between the two ROCs. We evaluated each of<br />
FNBMD and HFRAI for sensitivity and specificity.<br />
RESULTS<br />
On 01/01/2005 13,457 subjects over 60 years were empanelled in<br />
the practice. 12,650 subjects (94%) consented to the study, among<br />
which 1953 subjects had FNBMD-DXA (dual-energy X-ray absorptiometry)<br />
scan within the previous two years. 83 subjects (4.3%) sustained<br />
a hip fracture between 01/01/2005 and 12/31/2008. AUC for<br />
HFRAI was 0.79, slightly larger than AUC for FNBMD of 0.74<br />
(Z=1.82, p=0.09). The best combined sensitivity and specificity for<br />
HFRAI tool was at a score of >12 (84% sensitive and 55% specific),<br />
and for FNBMD tool was at a T-score of
P OSTER<br />
A BSTRACTS<br />
Femur neck bone mineral density (FNBMD) is the cornerstone<br />
of hip fracture risk stratification in current clinical practice. Other<br />
risk stratification tools use FNBMD with other selected risk factors.<br />
It is unknown whether electronically derived available patient information<br />
is useful in predicting hip fracture. The goal of this study was<br />
to demonstrate the use of electronic medical records to create an<br />
index which is able to risk-stratify heterogeneous older population.<br />
METHODS<br />
This was a retrospective cohort study. All community-dwelling<br />
patients over 60 years in a primary care panel in Olmsted County,<br />
MN on January 1st, 2005 were enrolled (N=12,650).<br />
Subjects were randomly assigned to two groups, a development<br />
cohort (N=8,387) and a validation cohort (N=4,263).<br />
Using the development cohort’s electronic medical records<br />
(EMR), risk factors over the previous two years including demographic<br />
characteristics and comorbidities were evaluated for significance<br />
in univariate and multivariate logistic regression. The primary<br />
outcome was incident hip fracture in the subsequent four years. Risk<br />
factors were assigned a score based on their regression coefficient estimate<br />
and a total risk score was created. We used EMR of the validation<br />
cohort to evaluate the total risk score for sensitivity and specificity<br />
and create a receiver-operating curve.<br />
RESULTS<br />
288 (3.43%) subjects in the development cohort sustained a new<br />
hip fracture. The final model included age ≥75 (odds ratio (OR) 10,<br />
95% CI 4.4, 23), age 70-74 (OR 7.7, 95% CI 3.3, 18.1), age 65-70 (OR<br />
3.8, 95% CI 1.6, 9.4), white race (OR 2.5, 95% CI 1.2, 5.5), female gender<br />
(OR 1.5, 95% CI 1.1, 1.9), prior hip fracture (OR 5.3, 95% CI 3.8,<br />
7.4), liver cirrhosis (OR 2.7, 95% CI 1, 7.6), malnutrition (OR 2.6,<br />
95% CI 1.6, 4.5), peripheral arterial disease (OR 1.7, 95% CI 1.2, 2.3),<br />
Parkinson’s disease (OR 1.6, 95% CI 1.2, 2.1), prior nursing home<br />
stay (OR 1.7, 95% CI 1.2, 2.3), and prior hospitalization (OR 1.4, 95%<br />
CI 1.1, 1.8). Area under receiver-operating curve (AUC) was 0.818,<br />
SE 0.017. Subjects with the highest 10% of the total risk score had<br />
(OR 9.1, 95% CI 6.5,12.6); thus a 9 fold increased risk for acquired<br />
hip fracture versus the rest of the cohort.<br />
CONCLUSION<br />
Electronically obtained, readily available patient information<br />
can be utilized for hip fracture risk stratification, without the need for<br />
further patient evaluation or FNBMD testing.<br />
B25<br />
Comparative impact of continence promotion interventions<br />
targeting older women reluctant to seek care for urinary<br />
incontinence.<br />
R. Agnew, 1,2 E. van den Heuvel, 2 C. Tannenbaum. 1 1. Université de<br />
Montreal, Montreal, QC, Canada; 2. Brunel University, Uxbridge,<br />
United Kingdom.<br />
Supported By: This work was funded by a partnership grant between<br />
the Canadian Institutes of Health Research and the United<br />
Kingdom New Dynamics on Aging Program.<br />
Surveys suggest that only 13% to 50% of older women with urinary<br />
incontinence (UI) talk to a health care practitioner about their<br />
condition or implement evidence-based treatment. Continence<br />
awareness programs exist, but their effectiveness remains unknown.<br />
We sought to determine the comparative impact of a constructivist<br />
learning workshop on UI, an evidence-based self-management tool<br />
for UI, or both, compared to the effects of a sham workshop, on incontinent<br />
women’s perceived improvement in their UI condition.<br />
Methods: a 2x2 factorial open-label cluster randomized controlled<br />
trial testing is currently being conducted in the United Kingdom.<br />
The cluster (unit of randomization) is at the level of each local<br />
community senior’s group, from whence participants are recruited for<br />
the workshops. One of four interventions (3 experimental and 1 sham<br />
intervention) is randomly assigned to each community group, with<br />
randomization achieved by computer-generated random digits, balanced<br />
in block groups of four. Eligible participants are communitydwelling<br />
women 60 years of age or older, who have not sought medical<br />
advice for incontinence symptoms in the last 5 years, and who experience<br />
urinary incontinence with a frequency no less than twice<br />
weekly. One outcome for the trial is an improvement in UI at three<br />
months post-intervention, measured by a rating of improvement on<br />
the Patient’s Global Impression of Improvement questionnaire.<br />
Results: Five-hundred and twenty-four women attended the<br />
workshops and 200 (mean age 70 + 7 years) met eligibility criteria<br />
and were recruited to the trial. At 3-month follow-up, 47% of women<br />
in the combined group reported that their UI condition was very<br />
much or much better, compared to 35% of the constructivist workshop<br />
group alone, 28% of the self-management group, and 14% of<br />
the sham control group (p=0.013). Less than 5% of participants were<br />
lost to follow-up.<br />
Conclusion: Results of this interim analysis suggest that a continence<br />
promotion intervention combining constructivist learning theory<br />
debunking myths about UI being a normal part of aging and use<br />
of a self-management tool has the greatest impact on improvements<br />
in UI in older women with incontinence.<br />
B26<br />
The effects of life review writing on depressive symptoms: A<br />
randomized control trial.<br />
T. Chippendale. Occupational Therapy, Tufts University,<br />
Somerville, MA.<br />
Supported By: <strong>American</strong> Occupational Therapy Foundation<br />
Background:The purpose of this RCT was to evaluate the effectiveness<br />
of life review through writing with respect to decreasing depressive<br />
symptoms in older adults residing in senior residences. Life<br />
review is an important developmental task and therapeutic intervention.<br />
When executed through writing, the benefits may be multiplied.<br />
This study sought to provide support for this psychosocial intervention<br />
for older adults. Although meta-analysis reveals a number of<br />
studies that have examined the effectiveness of life review as an intervention<br />
for decreasing depressive symptoms (1), some have called for<br />
a refinement and validation of intervention protocols. The intervention<br />
used in this study, the “Share you Life Story” Workshop (2), includes<br />
the added therapeutic benefits of writing. Life review through<br />
writing, as opposed to life review through the oral method, has not<br />
been well studied (3) and may be a more beneficial approach (4).<br />
Methods: Participants: 45 older adults 65 years and older, who<br />
spoke English and who had a negative screen for probable dementia<br />
on the Mini-Cog.Setting:4 senior residences in NYC. Design: A randomized<br />
control trial with participants assigned to the treatment or<br />
wait list control group. Randomized was within each site using randomization<br />
with forced equal sample size. Data was analyzed using<br />
an RMANOVA and SPSS version 17 with a .05 significance level. The<br />
Geriatric Depression Scale was the primary outcome measure. Results:<br />
A statistically significant decrease in depressive symptoms was<br />
found for the treatment group as compared to the control group<br />
(N=45, p=.03, effect size d=.7). Conclusions: The results support the<br />
“Share your life story” writing workshop as an effective intervention<br />
for addressing depressive symptoms in older adults.<br />
(1)Bohlmeijer, E., Smit, F. & Cuijpers, P. (2003). Effects of life review<br />
on late life depression: A meta-analysis. International Journal of<br />
Geriatric Psychiatry, 18(12), 1088-1094.<br />
(2)Sierpina, M. (2002). Share your life story workshops. Galveston:<br />
University of Texas Medical Branch.<br />
(3)Richeson, N. & Thorson, J. A. (2002). The effect of autobiographical<br />
writing on the subjective well-being of older adults. North<br />
<strong>American</strong> Journal of Psychology, 4, 395-404.<br />
(4)Sherman, E. (1995). Differential effects of oral and written<br />
reminiscence in the elderly. In B. H. Haight, & Webster, J. D. (Eds.),<br />
The art and science of reminiscing (pp. 255-264). Washington: Taylor<br />
& Francis.<br />
AGS 2012 ANNUAL MEETING<br />
S81
P OSTER<br />
A BSTRACTS<br />
B27<br />
Shared Decision Making in the Selection of Outpatient Analgesics<br />
for Older Emergency Department Patients.<br />
C. G. Isaacs, C. E. Kistler, K. Hunold, G. Pereira, M. Buchbinder,<br />
S. A. McLean, T. F. Platts-Mills. University of North Carolina at<br />
Chapel Hill, Chapel Hill, NC.<br />
Supported By: This study was supported by a Medical Student<br />
Training in Aging Research grant (Isaacs), a National Center for<br />
Research Resources grant KL2 RR025746 (Platts-Mills), an Agency<br />
for Healthcare Research and Quality K12 HS19468-01 (Kistler), and<br />
institutional resources.<br />
Background: Shared decision making has been shown to improve<br />
patient satisfaction and clinical outcomes for chronic disease<br />
management. Given the presence of individual variations in the effectiveness<br />
and side effects of commonly used analgesics in older adults,<br />
shared decision making might also improve clinical outcomes in this<br />
setting. We sought to characterize shared decision making regarding<br />
the selection of an outpatient analgesic for older ED patients with<br />
acute musculoskeletal pain and to examine associations with outcomes.<br />
Methods: We conducted a prospective observational study with<br />
consecutive enrollment of patients age 65 or older discharged from<br />
the ED following evaluation for moderate or severe musculoskeletal<br />
pain. Two essential components of shared decision making, 1) information<br />
provided to the patient and 2) patient participation in the decision,<br />
were assessed via patient interview at one week using fourlevel<br />
Likert scales.<br />
Results: Of 233 eligible patients, 110 were reached by phone and<br />
87 completed the survey. Only 25% (21/87) of patients reported receiving<br />
‘a lot’ of information about pain medications, and only 21%<br />
(18/87) reported participating ‘a lot’ in the selection of the analgesic.<br />
There were trends towards white patients (p=.06) and patients with<br />
higher educational attainment (p=.07) reporting more participation<br />
in the decision. After adjusting for gender, race, and initial pain severity,<br />
patients who reported receiving ‘a lot’ of information were more<br />
likely to report optimal satisfaction with the analgesic than those receiving<br />
less information (78% vs. 47%, p
P OSTER<br />
A BSTRACTS<br />
the use of instruments validated for this particular environment is not<br />
yet widespread. The ideal timing of or interval during which a delirium<br />
screening process should take place has yet to be determined. Future<br />
research in the ED will be needed to both validate delirium<br />
screening instruments that are currently used for investigation and<br />
clinical care as well as to define the ideal timing and form of the delirium<br />
assessment process for older adults.<br />
B30<br />
Pain Care in the Emergency Department: Is it Satisfactory?<br />
M. Barlow, U. Hwang. Department of Emergency Medicine;<br />
Department of <strong>Geriatrics</strong> and Palliative Medicine, Mount Sinai<br />
School of Medicine, New York, NY.<br />
Supported By: Michelle Barlow was funded by an AFAR grant<br />
through the 2011 MSTAR program.<br />
Ula Hwang is supported by a K23 award from the NIA.<br />
BACKGROUND: Pain is a common reason for emergency department<br />
(ED) visits by older adults. There is evidence that older<br />
adults receive poorer ED pain care than younger patients, but many<br />
of these studies used retrospective data and were unable to assess patient<br />
satisfaction. The objective of this study is to compare the quality<br />
of ED pain care received with patient satisfaction.<br />
METHODS: This is a prospective observational study at an academic,<br />
tertiary care medical center that has been ongoing since July<br />
2011. Adult patients (≥ 20 years), who present to the ED with severe<br />
abdominal pain (pain score 10 out of 10) are surveyed at the end of<br />
their ED visit regarding their pain, care received, and satisfaction levels.<br />
Quality metrics of pain care received as well as covariates (age,<br />
gender, ethnicity, Charlson comorbidity score, etc.) are abstracted<br />
from the medical record.<br />
RESULTS: Between July 7 and November 14, 2011, 90 subjects<br />
meeting inclusion criteria were surveyed. There were no significant<br />
differences between older adults (65+ years, 16%) and younger<br />
adults (20-64 years, 84%) in their surveyed pain scores, time to first<br />
analgesic administration, nor overall receipt of analgesics. There was<br />
also no difference in pain care satisfaction. When comparing the 69%<br />
of patients satisfied with pain care versus the 31% who were unsatisfied,<br />
those who were satisfied had lower surveyed pain scores (5.64 vs.<br />
8.88, p < 0.0001) and were less likely to want more analgesics (37% vs.<br />
86%, p < 0.0001). Unsatisfied patients waited longer for administration<br />
of first analgesic (trend, p = 0.09). There was, however, no significant<br />
difference in analgesic administration (86% of unsatisfied received<br />
analgesics vs. 85% of satisfied).<br />
CONCLUSIONS: Pain care satisfaction is associated with lower<br />
pain scores and decreased desire for additional analgesics. Contrary<br />
to growing evidence of poorer ED pain care for older adults, subjects<br />
in this cohort appear to receive equivalent care to their younger<br />
counterparts. Older and younger adults received and had analgesics<br />
administered in similar time frames; they also had similar pain scores<br />
and levels of satisfaction. This is the opposite of recent studies and<br />
may indicate that both the type (abdominal versus other pain) and<br />
severity of pain described as well as the quality indicators used to define<br />
appropriate care may impact the level of discrepancy observed.<br />
B31<br />
Functional Impairment and Disability during the Last Two Years<br />
of Life.<br />
A. K. Smith,Y. Miao,W. Boscardin, K. Covinsky. Medicine, Division of<br />
<strong>Geriatrics</strong>, University of California, San Francisco, San Francisco, CA.<br />
Supported By: NIA, NCRR.<br />
Background: We know little about the national prevalence of<br />
disability at varying points across the last years of life.<br />
Methods: Data are from participants ages 50+ who died in the<br />
Health and Retirement Study (HRS) between the years 1995 and<br />
2008. Each participant was interviewed once in the last 24 months of<br />
life. We used the HRS interview closest to death to reconstruct national<br />
estimates of the monthly prevalence of functional impairment<br />
and disability in the two years prior to death. Measures of functional<br />
impairment and disability included: IADL difficulty (Difficulty with<br />
cooking, shopping, using telephone, taking medications, managing<br />
money); ADL dependence (requires assistance with dressing,<br />
bathing, eating, transferring, walking across the room, and toileting).<br />
We estimated the predicted probability of functional impairment or<br />
disability by age at death and gender, adjusting for race or ethnicity,<br />
educational level, net worth, and proxy status.<br />
Results: There were 7624 decedents (mean age at death 80,<br />
52%% women, 84% White, 10% African-<strong>American</strong>, 4% Latino, 27%<br />
proxy interview). The unadjusted prevalence of all forms of functional<br />
impairment rose linearly over the last two years of life (Table).<br />
The predicted prevalence of disability prior to death rose with advancing<br />
age. After adjustment for gender, race/ethnicity, educational<br />
level, net worth, and proxy status, the predicted prevalence of any<br />
ADL dependency for elders ages 50-69 12 months prior to death was<br />
24% (95% CI 18-29), compared to 29% (24-34) for ages 70 to 79, 37%<br />
(31-44) for ages 80 to 89, and 47% (41-54) for ages 90 and older (p for<br />
trend
P OSTER<br />
A BSTRACTS<br />
SES, adiposity and memory and executive function factor scores were<br />
assessed with multiple regression analyses (with age, sex, and race as<br />
covariates).<br />
Results: Higher levels of education and income were associated<br />
with higher memory (high vs. low education B = .41*** and income B<br />
= .28***) and executive function scores (high vs. low education B =<br />
.82*** and income B = .51***), and lower levels of adiposity. Small, but<br />
significant negative associations were found between adiposity indicators<br />
and cognitive function scores. However, coefficients for SES predictors<br />
remained relatively unchanged with the inclusion of adiposity<br />
indicators into analytic models, suggesting that adiposity indicators did<br />
not mediate observed SES variations in levels of cognitive functioning.<br />
Conclusion: Both lower SES and greater adiposity are associated<br />
with lower levels of cognitive functioning. Those of lower SES<br />
also have significantly greater levels of adiposity. However, results do<br />
not support adiposity as a mediator of SES variations in cognitive<br />
function. An important objective for future research is the identification<br />
of other biomedical and behavioral variables that may underlie<br />
SES disparities in cognitive function.<br />
B33<br />
Prediction of 5-Year Risk of Becoming Dependent in Activities of<br />
Daily Living in Community-Dwelling Older Adults.<br />
D. H. Kim, 1,3 E. Newton, 2 L. A. Lipsitz. 1,2 1. Gerontology, Beth Israel<br />
Deaconess Medical Center, Boston, MA; 2. Institute for Aging<br />
Research, Hebrew SeniorLife, Boston, MA; 3. Epidemiology, Harvard<br />
School of Public Health, Boston, MA.<br />
Supported By: Dr. Kim is supported by John A. Hartford Center of<br />
Excellence Award.<br />
Background: Several risk factors have been identified for activity<br />
of daily living (ADL) dependence, but it remains unclear how to<br />
optimally combine them into a simple clinical prediction model.<br />
Methods: Using data from the Established Populations for Epidemiologic<br />
Studies of the Elderly, a prospective cohort of community-dwelling<br />
older adults, we developed and validated a prediction<br />
model of ADL dependence, based on self-reported information and<br />
brief examination. In the derivation set (n=7,982), we used Cox proportional<br />
hazards regression to develop a risk score that predicted<br />
the 5-year risk of becoming dependent in 3 or more ADLs for at least<br />
2 consecutive years, or at 1 year followed by death in the subsequent<br />
year. We tested the score in the validation set (n=3,993), and examined<br />
its relations to hospitalizations and mortality within 5 years.<br />
Results: During 5 years, the incidence rate of ADL dependence<br />
was 2% in both derivation set (663/34,382 person-years) and validation<br />
set (359/17,128 person-years). A risk score calculated using age,<br />
income, visual impairment, self-rated health, diabetes mellitus, stroke,<br />
cognitive function, and self-reported upper and lower extremity function,<br />
showed good agreement between expected and observed absolute<br />
risks and excellent discrimination (C statistic, 0.80 in the derivation<br />
set and 0.77 in the validation set). The score predicted<br />
mortality as well as recurrent hospitalizations for myocardial infarction,<br />
stroke, cancer, and fracture within 5 years.<br />
Conclusions: A simple risk score based on self-reported information<br />
and brief cognitive assessment can accurately predict a persistent,<br />
severe form of disability within 5 years.<br />
B34<br />
The Utilization of HEDIS High-Risk Medications in Veteran’s<br />
Administration Nursing Homes.<br />
D. M. Dosa, 2,1 O. Intrator, 2,1 S. Hyde. 2 1. Research Enhancement<br />
Award Program, Providence VA Medical Center, Providence, RI; 2.<br />
Medicine, Brown University, Providence, RI.<br />
Supported By: Veteran’s Administration-(Dosa-Career<br />
Development Award)<br />
Background: Nursing homes (or Community Living Centers as<br />
they are referred to within the Veteran’s Administration) have been<br />
identified by the Institute of Medicine (2000) as the most common<br />
site for Adverse Drug Events (ADE) with over 800,000 estimated<br />
prescription related errors annually. Such errors in the long term care<br />
environment have been associated with a high degree of morbidity<br />
and mortality. A common error described in the literature is the utilization<br />
of high risk medications in the elderly—a population most<br />
likely to experience morbidity relative to ADEs. The purpose of this<br />
study was therefore to evaluate the use of prescriptions classified by<br />
the Healthcare Effectiveness Data Information Set (HEDIS) as high<br />
risk medications over time in VA Community Living Centers (CLCs)<br />
and assess variability by region and institution.<br />
Methods: Nursing home Minimum Data Set records from calendar<br />
year 2004-2009 were merged with VA Decision Support System<br />
Pharmacy Data to identify residents of Community Living Centers<br />
who received at least one medication on the HEDIS high risk list for<br />
the elderly.<br />
Results: Between 2004 and 2009, a total of 25,105 out of 186,986<br />
(Average=13.81%, SD=5.93%) veterans admitted to a CLC received<br />
at least one HEDIS high risk medication. Annual proportion of CLC<br />
veterans using HEDIS medications varied among CLCs from 3.6%<br />
to 44.2% and among VISNs from 7.2% (VISN22) to 22.6%<br />
(VISN10). Steady reduction in the use of high risk medications was<br />
noted, however, between 2004 and 2009. In 2004, the average proportion<br />
of veterans using HEDIS medications in any CLC was 15.0%<br />
(SD=7.2, Min= 2.9%, Max=47.1%); by 2009 the average rate was<br />
6.4% (SD=4.6; Min= 0.3%, Max=30.6%).<br />
Conclusions: The utilization of high risk medications at VA<br />
CLCs has improved over time but significant variation exists between<br />
homes. More work needs to be conducted to determine if patient specific<br />
and/or facility factors predict utilization of HEDIS medications<br />
amongst elderly nursing home veterans at high risk for ADEs.<br />
B35<br />
Risk Factors for Readmissions in Patients 65 or Older Admitted For<br />
Pneumonia.<br />
H. Rahbar, 1,2 O. Abreu-Lanfrranco, 1,2 A. Singh, 2,4 M. Tims, 2<br />
B. Ramasamy, 2 C. Biedron, 1,2 L. Mody, 3 K. S. Kaye. 1,2 1. Wayne State<br />
Medical School, Detroit, MI; 2. Detroit Medical Center, Detroit, MI; 3.<br />
University Of Michigan, Ann Arbor, MI; 4. Fuqua School of Business,<br />
Duke University, Durham, NC.<br />
Supported By: MSTAR Grant<br />
Background: Pneumonia is one of the most common infections<br />
leading to inpatient visits and is an important cause of morbidity and<br />
mortality, particularly in older adults. Recently Medicare began decreasing<br />
coverage for all-cause readmissions within the 30-day discharge<br />
period for patients who were admitted with a primary diagnosis<br />
of pneumonia. This study aimed to identify risk factors for hospital<br />
readmission within a 30-day period following hospitalization for<br />
pneumonia in adults > 65 years of age.<br />
Methods: This study was conducted at Detroit Medical Center,<br />
an 8-hosital tertiary care health system. Retrospective chart review<br />
was conducted for patients > 65 years old with primary diagnosis of<br />
pneumonia from January 2010 to March 2011, and data pertaining to<br />
demographics, comorbid conditions, functional status and medications<br />
were abstracted. “Cases” who experienced readmission within<br />
30 days of discharge for any reason were identified; and were compared<br />
to “controls” who were matched to cases by hospital and calendar<br />
time of initial admission.<br />
Results: Eighty cases who were readmitted within 30 days were<br />
compared to 80 controls that were readmitted after an initial pneumonia<br />
diagnosis, after matching a total of 160 patients were analyzed.<br />
Cases and controls had similar demographics (Mean Age of 77.7 +8.2,<br />
54.4% were female; and 55% were African <strong>American</strong>) and functional<br />
status. Cases were more likely to have diabetes than controls (50%<br />
and 30%, p=.015) and a were more likely to have a Braden Score < 16<br />
(36% and 20%, p=.013). Cases also had a greater severity of illness as<br />
S84<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
measured by CURB65, Pneumonia Severity Index [PSI] and Charlson’s<br />
Comorbid Index. Cases also had significantly more discharge<br />
medications than controls (median of 12.36 and 10.53, p=. 009) and<br />
were more likely to have received influenza vaccination in the year<br />
prior to initial hospital admission (59% and 41%, p=.009).<br />
Discussion: Among older adults, Braden Score was an objective,<br />
strong predictor of readmission following pneumonia hospitalization.<br />
The association between prior receipt of influenza vaccination and<br />
increased likelihood of readmission was unexpected and warrants<br />
further investigation.<br />
B36<br />
IS LENS TRANSPARENCY ASSOCIATED WITH<br />
CARDIOVASCULAR OR METABOLIC DISEASE OR<br />
COGNITIVE FUNCTION IN OLDER WOMEN? DEFINING A<br />
NEW BIOMARKER OF AGING.<br />
J. Sanders, A. Nau, Y. Conley, R. Boudreau, L. Niedernhofer,<br />
L. Kuller, A. Newman. University of Pittsburgh, Pittsburgh, PA.<br />
Background: Few primary markers of aging are validated in<br />
human population studies. The lens is of interest because transparency<br />
can be measured accurately, noninvasively, and repeatedly<br />
throughout life. To evaluate the lens as a biomarker of aging we<br />
tested the association of lens transparency and cataract surgery to<br />
markers of aging and disease including risk factors for coronary atherosclerosis,<br />
coronary artery calcium (CAC), fasting plasma glucose<br />
or insulin, cognitive function and ApoE genotype. Methods: We<br />
measured lens transparency with Scheimpflug photography (N=136)<br />
and cataract surgery with self-report (N=231) in participants of the<br />
Healthy Women Study (mean (SD) age 73.3 (1.7) years). Atherosclerosis<br />
risk factors (age, smoking, waist circumference, BMI, lipids,<br />
blood pressure, fasting glucose and insulin, medication use) were<br />
measured concurrently with lens transparency and 13 years previously.<br />
CAC was measured with electron beam tomography at the<br />
time of lens measurements and ~7, 10, and 13 years previously. Cognitive<br />
indicators included the Modified Mini Mental Status Exam and<br />
ApoE genotype. Results: Cross-sectionally, cataract surgery was associated<br />
with larger waist circumference and diabetes (P
P OSTER<br />
A BSTRACTS<br />
care (OR 1.93, 95% CI, 1.67-2.24 for high-risk antihistamines; OR<br />
5.97, 95% CI 0.76-47.03 for high-risk cardiac drugs; OR 1.99, 95% CI<br />
1.29-3.07 for psychotropics). Index exposure to high-risk cardiac<br />
drugs also significantly increased musculoskeletal adverse outcomes<br />
(OR 2.28, 95% CI 1.76-2.96) but incident exposure to psychotropics<br />
did not significantly increase gastrointestinal adverse outcomes (OR<br />
1.14, 95% CI 0.75-1.72). Conclusion: Incident exposure to HRME is<br />
associated with adverse outcomes within one year following index<br />
day in senior veterans with chronic pain. Further research is needed<br />
to develop intervention measures to limit such exposure.<br />
B39<br />
Novel predictors of new antibiotic resistant organism (ARO)<br />
colonization in nursing home (NH) residents.<br />
L. Min, 1,2 L. Mody. 1,2 1. Medicine, University of Michigan, Ann Arbor,<br />
MI; 2. GRECC, VA Health Care Systems, Ann Arbor, MI.<br />
Supported By: Agency for Healthcare Quality and Research (Min),<br />
VA Healthcare System Geriatric Research Clinical Care Center<br />
(GRECC, Min and Mody), Hartford Foundation (Min), NIA-<br />
Pepper Center (Min, Mody), NIH (K23AG028943 and<br />
R01AG032298 Mody), NIH-LRP (Min), T Franklin Williams<br />
(Mody).<br />
Objective: NH residents with functional disability are at risk for<br />
ARO colonization. We tested (1) whether function predicts AROs independent<br />
of clinical risk factors (co-morbidities, wounds, hospitalization)<br />
& (2) whether specific activities of daily living (ADLs) are<br />
associated with higher risk due to greater nursing contact time (e.g.<br />
feeding) or bodily exposure (e.g. toiling).<br />
Methods: Longitudinal surveillance of 178 NH residents, half<br />
with indwelling device, actively cultured at multiple anatomic sites at<br />
baseline and every 30 days until discharge or 1 yr.<br />
Outcomes: Time to new colonization for methicillin-resistant<br />
Staphylococcus aureus (MRSA), vancomycin-resistant enterococci<br />
(VRE), and resistant gram-negative bacteria (GNB-R). A new ARO<br />
was defined as a positive culture following a negative previous culture<br />
for that ARO. A patient could have multiple new colonizations if<br />
negative cultures were collected in between positive ARO cultures.<br />
Control variables (baseline): device, functional impairment (overall<br />
vs 6 ADLs [Table]), co-morbidity (Charlson index [CCI] vs conditions<br />
from CCI). Time-varying predictors: interval hospitalization or<br />
wound/pressure ulcer. We modeled time to new ARO using multiplefailure<br />
Cox proportional hazard models to allow for fluctuation in<br />
colonization status.<br />
Results: 111 had ≥2 visits (729 follow-up visits total). 76 had at<br />
least 1 new ARO colonization, with multiple new colonizations occurring<br />
in 51 residents.<br />
Conclusions: Besides known risk factors such as hospitalization,<br />
indwelling devices, and wounds, we identified contact-intense ADLs<br />
such as assistance in feeding and walking & chronic conditions such<br />
as heart failure and hemiparesis that predict new ARO colonization<br />
in NH residents.<br />
* p
P OSTER<br />
A BSTRACTS<br />
of all ACS hospitalized in 1 year in the Florence area, Italy, patients<br />
aged 75+ years with ST-segment or non-ST-segment elevation myocardial<br />
infarction (STEMI, NSTEMI) were selected. Background<br />
risk was assessed with the Silver Code (SC), a validated tool based on<br />
administrative data, which predicts mortality in subjects aged 75+<br />
hospitalized for medical reasons. Multivariable odds ratio with 95%<br />
confidence interval (CI) for PCI application, and hazard ratio (HR)<br />
for 1-year mortality by PCI utilization were calculated. RESULTS: In<br />
698 patients (358 women, mean age 83 years, STEMI=176), for each<br />
point increase in the SC score the odds for the use of PCI decreased<br />
by 11%, while the hazard of 1-year mortality increased by 10%, adjusting<br />
for comorbidity, STEMI vs. NSTEMI, Killip class, low<br />
glomerular filtration rate, anaemia, low platelets and peak troponin<br />
tertile. PCI reduced 1-year mortality progressively more with increasing<br />
SC score, with HR (95% CI) of 0.8 (0.19-1.21), 0.41 (0.18-0.45),<br />
0.41 (0.23-0.74), and 0.26 (0.14-0.48) for SC scores of 0-3, 4-6, 7-10,<br />
and 11+. CONCLUSIONS: Exclusion of older ACS patients from<br />
PCI increases with increasing background risk. This procedure, conversely,<br />
appears to be more effective in older patients with more severe<br />
background risk, as indicated by the SC score.<br />
B42<br />
A meta-analysis of mortality rates associated with comorbid<br />
depression among older adults with diabetes.<br />
M. Park, W. Katon. University of Washington, Seattle, WA.<br />
Supported By: NIMH 2 T32 MH 73553-6<br />
Background: Comorbid depression has shown a strong association<br />
with increased negative health outcomes among those with medical<br />
illness.<br />
Objectives: To examine mortality rates associated with comorbid<br />
depression among the older adults with diabetes.<br />
Methods: A systematic literature search, appraisal, and metaanalysis<br />
were conducted. Using various combinations of keywords<br />
(depression, diabetes, mortality), we searched five databases: Medline,<br />
CINAHL, Cochrane Library, Embase, and Science Direct. Selection<br />
criteria include English-language, peer-reviewed articles published<br />
between January 2000-June 2011, reporting hazard ratio for<br />
mortality from longitudinal and prospective epidemiological studies,<br />
and study of older adults.<br />
From 769 potentially relevant articles, we found four articles<br />
that met the selection criteria. The studies reported outcomes of<br />
29312 elderly persons.<br />
Findings: The weighted hazard ratios were 1.38 (95% CI: 1.24,<br />
1.52). The older adults with comorbid depression and diabetes experience<br />
approximately 38% elevated risk for death from all cause compared<br />
to those with only diabetes.<br />
Conclusion: Screening and treating depression among older<br />
adults with diabetes is important for better health outcomes in older<br />
adults populations<br />
Forest Plot<br />
B43<br />
Epidemiology of Restricting Fatigue in Older Adults.<br />
N. de Rekeneire, L. Leo-Summers, T. Gill. Yale University School of<br />
Medicine, New Haven, CT.<br />
Supported By: No Financial Disclosure<br />
Background: Fatigue is a frequent complaint among older adults<br />
and has been linked to functional decline and disability. Longitudinal<br />
data on fatigue leading to restricted activity are sparse. Our objectives<br />
were to estimate the rate of restricting fatigue among community-living<br />
older adults and to determine whether the rates differ according<br />
to age, sex, race and physical frailty.<br />
Methods: Participants were members of the Precipitation<br />
Events Project (PEP), a longitudinal study of 754 nondisabled community-living<br />
older adults aged 70+ years who were evaluated<br />
monthly for over 10 years. Restricting fatigue was defined as staying<br />
in bed for at least ½ a day and/or cutting down on one’s usual activities<br />
because of fatigue for 3+ consecutive months. Physical frailty was<br />
defined on the basis of slow gait speed.<br />
Results: The mean age of our study sample was 78.4 years; 64.6%<br />
were women, 90.5% were white and 42.7% had physical frailty. During a<br />
median follow-up of 111 months,66 (24.7%) of the men and 171 (35.1%)<br />
of the women developed an episode of restricting fatigue (p= 0.003).<br />
Among the 237 (31.4%) participants with restricting fatigue, the median<br />
(interquartile range) number of episodes was 1.0 (1.0-2.0).The mean duration<br />
of the 459 episodes of restricting fatigue was 3 months (3-4) and<br />
did not differ according to age, sex, race or physical frailty. The overall<br />
rate of restricting fatigue was 6.7 per 1000 person-months. As shown in<br />
the Table, rates were higher in women than men (p< 0.001), participants<br />
80+ yrs than those 70-79 yrs (p=0.045) and participants who were physically<br />
frail vs. not frail (p< 0.001), but did not differ according to race.<br />
Conclusions: Among community-living older adults, restricting<br />
fatigue is common. Women, the oldest old and those with physical<br />
frailty had higher rates of restricting fatigue. Additional research is<br />
warranted to better understand the characteristics associated with the<br />
development and recurrence of restricting fatigue in older persons.<br />
B44 Encore Presentation<br />
Trajectories of Positive Aging: Observations from the Women’s<br />
Health Initiative Study.<br />
O. Zaslavsky, 1 N. F. Woods, 1 B. Cochrane, 1,2 A. LaCroix . 1,2 1.<br />
University of Washington, Seattle, WA; 2. Fred Hutchinson Cancer<br />
Reserach Institute, Seattle, WA.<br />
Background: Our analyses of data from the Women’s Health<br />
Initiative (WHI) participants yielded a two-factor index of positive<br />
aging: physical-social functioning and emotional functioning. These<br />
two factors predicted years of healthy living, years of independent living<br />
and mortality. Based on these findings, we then described trajectories<br />
of positive aging indicators over time and identified those baseline<br />
characteristics that predict trajectory group membership.<br />
Methods: Women ages 65 years and older who enrolled in one<br />
or more WHI clinical trials and had data available on the positive<br />
aging indicators at baseline and years 1, 3, 6 and 9 were included in<br />
these analyses (N=2,281). We used Group-Based Trajectory Modeling<br />
to identify distinct subgroups of individuals, following a similar pattern<br />
of change over time on the two factors of positive aging. Then,<br />
multinomial logistic regression was conducted to identify baseline<br />
predictors of membership in these positive aging trajectories.<br />
Results: A 5-trajectory model was chosen to best represent the<br />
data. These trajectories included Low Maintainer (8.3%), Low Improver<br />
(11%) Moderate Decliner (12.5%), Moderate Maintainer<br />
(29.7%) and High Maintainer (38.6%) groups for Physical-Social<br />
Functioning and Low Maintainer (3.1%), High Improver (8.7%),<br />
Moderate Decliner (8.6%), Moderate Maintainer (29.7%), High<br />
Maintainer (55.8%) groups for Emotional Functioning. Using the<br />
Low Maintainer group as the reference category for Physical-Social<br />
Functioning, the High Maintainer group was younger, predominantly<br />
white, and more physically active. High Maintainers also had lower<br />
BMI, less pain and depression, fewer somatic symptoms, fewer chronic<br />
conditions, higher optimism, and either mild or moderate alcohol consumption.<br />
Similarly, odds ratios using the Low Maintainer group as the<br />
reference category for Emotional Functioning showed that High<br />
Maintainers had less pain and depression, fewer somatic symptoms,<br />
fewer negative life events, higher optimism, and greater social support.<br />
AGS 2012 ANNUAL MEETING<br />
S87
P OSTER<br />
A BSTRACTS<br />
Conclusion: Aging women are heterogeneous in terms of positive<br />
aging indicators over time. Somatic experiences (i.e., pain, symptoms)<br />
and number of chronic conditions were the strongest predictors<br />
of membership in non-robust trajectories for Physical-Social<br />
Functioning and depression was the strongest predictor of Emotional<br />
Functioning.<br />
B45<br />
Patterns of Comorbid Chronic Diseases and Geriatric Conditions<br />
Associated with Greater Severity of Chronic Obstructive Pulmonary<br />
Disease in Older Adults.<br />
S. S. Chang, T. M. Gill. <strong>Geriatrics</strong>/Internal Medicine, Yale School of<br />
Medicine, New Haven, CT.<br />
Supported By: This research was funded in part by the John A.<br />
Hartford Foundation for Excellence in Geriatric Medicine at Yale<br />
University (Grant 2007-0009), the Yale Claude D. Pepper Older<br />
<strong>American</strong>s Independence Center (National Institute on Aging P30<br />
AG021342), and Clinical Translational Science Award (Grant UL1<br />
RR024139/ KL2 RR024138) from the National Center for Research<br />
Resources (NCRR), a component of the National Institutes of<br />
Health (NIH), and NIH roadmap for Medical Research.<br />
Background:<br />
Chronic obstructive pulmonary disease (COPD) is the third<br />
leading cause of death in the U.S. and increases in prevalence with<br />
advancing age. Extrapulmonary diseases, which occur throughout all<br />
stages of COPD, can complicate its management and negatively impact<br />
long-term prognosis, especially as COPD worsens. Geriatric<br />
conditions, which confer high risk of adverse health outcomes, add to<br />
the complexity of effectively managing COPD in older adults. Identifying<br />
patterns of comorbid chronic diseases and geriatric conditions<br />
which are associated with greater COPD severity will provide<br />
insight into enhanced approaches to optimize outcomes in older<br />
adults with COPD.<br />
Methods:<br />
Data were drawn from the Cardiovascular Health Study, a<br />
prospective multi-center cohort of U.S. community-dwelling adults<br />
aged 65-80 who completed baseline spirometry (N=3583). COPD was<br />
established by spirometric criteria for airflow limitation, using the<br />
Lambda-Mu-Sigma (LMS) method, an approach which accounts for<br />
age-related changes in lung function. We performed ordinal logistic<br />
regression to evaluate the relationships between patterns of comorbidities<br />
and COPD severity, staged according to LMS-derived spirometric<br />
Z scores (mild, moderate, and severe) and the <strong>American</strong> Thoracic<br />
<strong>Society</strong> (ATS-DLD-78) dyspnea scale (grades 1-5). Models<br />
were adjusted for age, gender, education, and smoking.<br />
Results:<br />
Of the participants with COPD (13.8%), comorbid hypertension<br />
(HTN) and arthritis (28.0%), atherosclerotic vascular disease<br />
(AVD) and HTN (24.3%), and HTN and polypharmacy (11.1%)<br />
were among the most frequent comorbidity patterns. Individuals with<br />
COPD who had comorbid HTN and arthritis (adjusted OR=1.60,<br />
95%CI=1.08-2.38), AVD and HTN (1.55, 1.03-2.32), and HTN and<br />
polypharmacy (1.95, 1.09-3.46) were more likely than those without<br />
these respective comorbidities to have greater COPD severity, assessed<br />
by spirometry. Similarly, having comorbid HTN and arthritis<br />
(adjusted OR=1.63, 95%CI=1.11-2.39), AVD and HTN (1.65, 1.11-<br />
2.44), and HTN and polypharmacy (2.70, 1.57-4.63) was significantly<br />
associated with worsening dyspnea.<br />
Conclusions:<br />
Specific patterns of comorbid chronic diseases and geriatric conditions<br />
are associated with worsening COPD. These findings could inform<br />
the design of interventions to improve outcomes in older adults<br />
with COPD.<br />
B46<br />
Cognitive Status and Care-seeking Behavior in Elderly Patients with<br />
Acute Heart Failure.<br />
S. N. Levin, 1 A. Hajduk, 2 D. M. Lessard, 2 F. A. Spencer, 3<br />
J. H. Gurwitz, 1,2 R. J. Goldberg, 1 J. S. Saczynski. 1,2 1. Meyers Primary<br />
Care Institute and Division of Geriatric Medicine, UMASS Medical<br />
School, Worcester, MA; 2. Department of Quantitative Health<br />
Sciences, UMASS Medical School, Worcester, MA; 3. Department of<br />
Medicine, McMaster University, Hamilton, ON, Canada.<br />
Background: Heart failure (HF) is a chronic disease characterized<br />
by acute exacerbations and high rates of rehospitalization.<br />
In response to worsening symptoms, patients are advised to<br />
promptly seek medical care. Cognitive impairment (CI) is highly<br />
prevalent in patients with HF and may impact their decision or<br />
ability to seek treatment for an acute exacerbation. We examined<br />
the association of impairment in specific cognitive domains and<br />
time to emergency department (ED) presentation following acute<br />
HF symptom onset.<br />
Methods: The sample included 564 patients hospitalized with<br />
acute HF (mean age = 72 years, 45% female) between 2007 and 2010<br />
at several tertiary care and community medical centers. CI was assessed<br />
in 3 domains (memory, processing speed, executive function)<br />
using standardized measures. Time to ED presentation was collected<br />
from a structured interview during hospitalization. The time interval<br />
between the patient’s latest reported symptoms of HF and ED presentation<br />
was assessed.<br />
Results: More than three quarters (78.2%) of patients were impaired<br />
in at least one cognitive domain. The average pre-hospital<br />
delay for patients who experienced acute symptoms of decompensated<br />
HF was 4.2 days (100 ± 12 hr) while their median delay time<br />
was 14 hours. Over two fifths (43%) of all participants waited at<br />
least one day before presenting to the ED. Compared to patients<br />
with intact cognitive function, those with CI had a longer delay to<br />
ED presentation following symptom onset (median delays: 15.0 hr<br />
vs. 8.6 hr; p = 0.03). Pre-hospital delay times varied according to specific<br />
cognitive domains. Patients with deficits in memory or processing<br />
speed had longer median delay times than unimpaired patients<br />
(memory: 23.2 hr vs. 11.4 hr, p = 0.02; Speed: 19.4 hr vs. 11.3 hr, p =<br />
0.05). Executive function was not associated with duration of prehospital<br />
delay.<br />
Conclusion: Cognitive impairment is common among patients<br />
hospitalized for HF and is associated with delays in seeking emergency<br />
care. Interventions to enhance the care of patients with acute<br />
heart failure should take into consideration the important impact of<br />
cognitive status.<br />
S88<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
B47<br />
The Impact of Cognitive Impairment on Mortality in Older Adults<br />
with Heart Failure.<br />
T. Gure, 1 C. Blaum, 1,3 J. Ha, 1 S. Hummel, 4 L. Min, 1,3 C. Cigolle, 6,3<br />
A. Galecki, 1 K. Langa. 2,5 1. Geriatric & Palliative Medicine, University<br />
of Michigan, Ann Arbor, MI; 2. General Internal Medicine, University<br />
of Michigan, Ann Arbor, MI; 3. GRECC, VA Healthcare System, Ann<br />
Arbor, MI; 4. Cardiovascular Medicine, University of Michigan, Ann<br />
Arbor, MI; 5. VA Center for Practice Management & Outcomes<br />
Research, VA Healthcare System, Ann Arbor, MI; 6. Family Medicine,<br />
University of Michigan, Ann Arbor, MI.<br />
Supported By: The National Institute on Aging (NIA) provides<br />
funding for the Health and Retirement Study (U01 AG09740)<br />
which is performed at the Institute for Social Research, University<br />
of Michigan; NIA grants R01 AG027010 and R01 AG030155<br />
(Langa); Ann Arbor VA Geriatric Research, Clinical and Education<br />
Center (Blaum, Cigolle, and Min); NHLBI grant K23 HL109176<br />
(Hummel); AHRQ grants R21 HS017621 and R21 HS 019459<br />
(Min); NIA grant K08 AG031837 (Cigolle); NIA Diversity<br />
Supplement award R01 AG027010-02S1 (Gure); John A. Hartford<br />
Foundation Center of Excellence (Cigolle, Gure, and Min); the NIA<br />
Claude D. Pepper Center Research Career Development Core<br />
(Cigolle, Gure, and Min); National Center for Research Resources<br />
UL1 RR024986 (Gure).<br />
Background: Cognitive impairment (CI) is highly prevalent in<br />
older adults with heart failure (HF), yet our understanding of the impact<br />
of CI on mortality in this population is limited. We aimed to estimate<br />
the risk of death over 4 yrs of follow-up in older adults with<br />
HF, stratified by cognitive function. Methods: We used the 2004 wave<br />
of the Health and Retirement Study (HRS) linked to Medicare<br />
claims. A HF case-finding algorithm identified HRS respondents<br />
with highest likelihood of a HF diagnosis (“HF patients”). CI was assessed<br />
using previously published HRS population-based screening<br />
measures. Death was identified using the HRS data verified by National<br />
Death Index. We tested the relationship between cognitive<br />
function and mortality in HF patients using unweighted Kaplan-<br />
Meier survival curves and Cox proportional hazard models. Results:<br />
Of 707 HF patients identified, 286 (42%) died over the 4 yr-period.<br />
Survival of older HF patients was significantly influenced by their<br />
cognitive status (p
P OSTER<br />
A BSTRACTS<br />
B49<br />
Prevalence and Correlates of Self-Reported Medication Non-<br />
Adherence among Older Adults with Diabetes Mellitus, Coronary<br />
Heart Disease, and/or Hypertension.<br />
Z. A. Marcum, 1 Y. Zheng, 1 S. Perera, 1 E. Strotmeyer, 1 A. Newman, 1<br />
E. Simonsick, 2 R. Shorr, 3 D. C. Bauer, 4 J. M. Donohue, 1 J. T. Hanlon. 1<br />
1. University of Pittsburgh, Pittsburgh, PA; 2. NIA Intramural<br />
Research Program, Baltimore, MD; 3. VA GRECC, Gainesville, FL; 4.<br />
UCSF, San Francisco, CA.<br />
Supported By: Supported in part by National Institute on Aging<br />
grants and contracts (R56AG 0207017, P30AG024827, T32 AG021885,<br />
K07AG033174, R01AG034056, 3U01 AG012553, N01-AG-6-2101,<br />
N01-AG-6-2103, and N01-AG-6-2106), a National Institute of Mental<br />
Health grant (R34 MH082682), a National Institute of Nursing<br />
Research grant (R01 NR010135), Agency for Healthcare Research<br />
and Quality grants (R01 HS017695, K12 HS019461, R01HS018721),<br />
and a VA Health Services Research grant (IIR-06-062). This research<br />
was also supported in part by the Intramural Research program of the<br />
NIH, National Institute on Aging.<br />
Background: Medication non-adherence is common among<br />
older adults with chronic co-morbidity, but the underlying factors are<br />
largely unexplored. This study examines the prevalence and correlates<br />
of self-reported medication non-adherence among communitydwelling<br />
older adults with chronic cardiovascular conditions (i.e., diabetes<br />
mellitus [DM], coronary heart disease [CHD], and/or<br />
hypertension [HTN]).<br />
Methods: The study sample (mean [SD] age 82.1 [2.8], 52.5% female,<br />
37.0% black) included 897 members from the Health Aging<br />
and Body Composition cohort (n=3075) with any DM (n=338;<br />
37.7%), CHD (n=381; 42.5%), or HTN (684; 76.3%) at year 10. Selfreported<br />
medication non-adherence was measured by the 4-item<br />
Morisky Medication Adherence Scale (MMAS) and 2-item Cost-Related<br />
Non-Adherence scale (CRN) at year 11; these scales separately<br />
assess different reasons for medication non-adherence. We used multivariable<br />
logistic regression models with backward selection to identify<br />
correlates (i.e., demographic, health status, and access to care factors)<br />
of non-adherence for each measure.<br />
Results: Non-adherence by MMAS and CRN was reported by<br />
40.7% and 7.7%, respectively. Non-adherence by MMAS was associated<br />
with black race (adjusted odds ratio=AOR=1.85, 95% interval=1.25-2.74)<br />
and hospitalization in the previous 6 months<br />
(AOR=1.97, 95% interval=1.22-3.17). Non-adherence by CRN was<br />
associated with marital status (married vs. unmarried; AOR=0.47,<br />
95% interval=0.23-0.98) and money-related delay in medical care<br />
(AOR=6.94, 95% interval=2.41-19.97). Age, gender, and the total<br />
number of regularly scheduled medications were not associated with<br />
non-adherence by either MMAS or CRN.<br />
Conclusions: Self-reported medication non-adherence is common<br />
in older adults with chronic cardiovascular conditions, and nonadherence<br />
measured by CRN is less prevalent than MMAS. No correlates<br />
for non-adherence were detected consistently across both<br />
measures. Future studies should evaluate targeted interventions<br />
based on patient-specific modifiable barriers to improve medication<br />
adherence.<br />
B50<br />
Health Care Proxy Involvement and Satisfaction in Decision-<br />
Making for the Treatment of Infections in Nursing Home Residents<br />
with Advanced Dementia.<br />
C. K. Ankuda, 1 J. L. Givens, 2,3 S. L. Mitchell. 2,3 1. University of<br />
Vermont College of Medicine, Burlington, VT; 2. Division of<br />
Gerontology, Beth Israel Deaconess Medical Center, Boston, MA; 3.<br />
Hebrew SeniorLife Institute for Aging Research, Boston, MA.<br />
Supported By: National Institutes of Health (NIH)<br />
Background: Infections are common in advanced dementia, and<br />
health care proxies (HCPs) are often called upon to make treatment<br />
decisions. This study describes the awareness, involvement, and satisfaction<br />
of HCPs in decision making regarding infectious episodes for<br />
a cohort of nursing home (NH) residents with advanced dementia.<br />
Methods: From 2010-2011, data were prospectively collected<br />
from 135 NH residents with advanced dementia and their HCPs at 22<br />
Boston area facilities. For each infectious episode, information was<br />
obtained on whether the HCP: 1. could be contacted by study staff; 2.<br />
was aware of the infection; and 3. was involved in decision making.<br />
Multivariable logistic regression was used to determine resident,<br />
HCP and episode characteristics associated with HCP awareness of<br />
the infectious episode.<br />
Results: Residents experienced 287 infectious episodes (82 respiratory,<br />
114 urinary tract infection, 37 skin and 53 fever). HCPs were<br />
able to be contacted by study staff for 217/287 episodes. Once contacted,<br />
HCPs were aware of 94/217 (43%) of episodes, and of these,<br />
were involved in decision-making for 57/94 (61%). HCP awareness of<br />
the episode was associated with the HCP being the child of the resident<br />
(vs. other relationship) [adjusted odds ratio (AOR) 2.34, 95% CI<br />
1.19 – 4.59], female (AOR 2.79, 1.37-5.66), and the episode being<br />
treated with antibiotics (AOR 3.68, 1.56-8.66).<br />
Conclusions: The majority of infectious episodes in NH residents<br />
with advanced dementia do not involve HCPs in decision-making.<br />
Awareness of infections among HCPs is more likely for episodes<br />
treated with antibiotics, and when the HCP is the resident’s child and<br />
is female. These factors may help target infectious episodes that require<br />
greater attention with respect to better informing HCPs of their<br />
loved one’s health status.<br />
B51<br />
Can a patient navigator get older patients and their oncologists on<br />
the same page?<br />
E. Vig, 1,2 C. Clark, 2 R. Engelberg. 2 1. <strong>Geriatrics</strong>, VAPSHCS, Seattle,<br />
WA; 2. Medicine, University of Washington, Seattle, WA.<br />
Supported By: <strong>American</strong> Cancer <strong>Society</strong><br />
Background Older patients may approach cancer management<br />
decisions differently than younger patients. Although older patients<br />
may be more concerned about quality of life than cure, oncologists do<br />
not routinely elicit patients’ quality of life concerns. As a result, older<br />
patients and their oncologist may not be on the same page during office<br />
visits.<br />
We undertook a two phase pilot study to test whether a patient<br />
navigator intervention could facilitate shared decision-making between<br />
older patients with cancer and their oncologists.<br />
Methods In the study’s first phase, we interviewed oncologists,<br />
older cancer patients, and their family members about their decisionmaking,<br />
and whether/how a patient navigator might help. Interviews<br />
were recorded, transcribed, and analyzed using grounded theory<br />
methods.<br />
In the second phase, the patient navigator met with an older patient<br />
prior to an oncology appointment to identify his/her quality of<br />
life and other concerns. The navigator then accompanied the patient<br />
to the oncology appointment and debriefed afterwards. Several days<br />
later, an investigator debriefed separately with the oncologist and the<br />
patient/family. Content analysis and descriptive statistics were used to<br />
analyze study data.<br />
Results In the first phase, we recruited 9 oncologists from 2 clinics,<br />
12 of their patients, and 3 of their family members. Oncologists<br />
and patients thought navigators could be helpful by clarifying understanding,<br />
taking notes, and helping patients ask questions.<br />
In the second phase, the 9 oncologists identified 9 additional patients.<br />
Prior to the navigated visits, patients identified their main concerns<br />
(mean 3 concerns, range 1-5). During the visits, the navigator reminded<br />
the patient of concerns in 4 visits, facilitated discussion about<br />
referral to a pain specialist in 1 visit, clarified referral to a cardiologist<br />
in 1 visit, and clarified the follow up plan with the oncologist in 2 visits.<br />
Patients described the navigator as helpful, reported that all their<br />
S90<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
concerns had been addressed during the visit, and wished that navigator<br />
involvement could be ongoing. Oncologists described the presence<br />
of the navigator as helpful and not burdensome or intrusive.<br />
Conclusion A patient navigator who identifies older patients’<br />
concerns before an oncology visit, accompanies them to a visit, and<br />
debriefs with them afterwards can help to ensure that their concerns<br />
are elicited and addressed.<br />
B52<br />
Association of Experience with Illness and End-of-life Care with<br />
Advance Care Planning.<br />
H. Amjad, 1 V. Towle, 1 T. Fried. 1,2 1. Yale University School of<br />
Medicine, New Haven, CT; 2. VA Connecticut Healthcare System, West<br />
Haven, CT.<br />
Background: Advance care planning (ACP) remains an underused<br />
tool in medical care, and identifying factors associated with increased<br />
participation in ACP is important for the promotion of this<br />
health behavior. This study examines the relationship between previous<br />
experiences with illness and end-of-life care with the stages of<br />
change for six ACP behaviors.<br />
Methods: 304 individuals aged 65 and older were recruited from<br />
physician practices and a senior center. Participants were asked<br />
whether they had ever faced a life-threatening illness or surgery. They<br />
were also asked whether they had ever made a medical decision for<br />
someone who was dying, whether they knew someone who they believe<br />
had a bad death due to receiving too much or too little medical<br />
care, and whether they had experienced the death of a loved one who<br />
made his or her wishes about end-of-life known. Stages of change<br />
were assessed for six ACP behaviors: completion of a living will and<br />
healthcare proxy, communication with loved ones regarding use of<br />
life-sustaining treatments and quantity versus quality of life, and communication<br />
with physicians about these same topics. Mantel-Haenszel<br />
chi-square analysis was used to examine the association between<br />
each life experience and stages of change for each ACP behavior.<br />
Results: 84% of participants had experiences with their own illness<br />
or end-of-life care for a loved one. Personal experience with lifethreatening<br />
illness was not associated with increased readiness to participate<br />
in ACP behaviors except for discussing life-sustaining<br />
treatments with loved ones (p
P OSTER<br />
A BSTRACTS<br />
Conclusions: The study demonstrated that MED-SAIL is a valid<br />
brief screening tool to identify older adults with impaired capacity for<br />
remaining safe and independent in their current living environment.<br />
The tool will be useful for health and social service professionals<br />
working in the community.<br />
B55<br />
Differential regulation of mitochondrial biogenesis with Losartan in<br />
the heart and liver of young and aged mice.<br />
B. R. Manwani, H. Yang, C. Lin, J. Walston, P. Abadir. <strong>Geriatrics</strong>,<br />
Johns Hopkins University, Baltimore, MD.<br />
Supported By: National Institute of Aging<br />
Background<br />
The renin-angiotensin system (RAS) regulates multiple physiological<br />
functions through angiotensin (Ang) II type 1 (AT1R) and<br />
type 2 (AT2R) receptors. We recently identified a functional mitochondrial<br />
RAS, with AT2R located in inner mitochondrial membrane<br />
that decreases in number with age and increases with AT1R blocker<br />
losartan. Given the known relationship between aging and mitochondrial<br />
biogenesis, and the emerging understanding of local mitochondrial<br />
RAS system, we hypothesized that blocking AT1R with losartan<br />
in vivo would increase mitochondrial biogenesis and survival gene<br />
production.<br />
Methods<br />
10 young (20 wks) mice were equally divided into control group<br />
or treated with Losartan for 20 wks. 10 old (50 wks) mice were treated<br />
similarly. All mice were sacrificed at the same time and RNA isolated<br />
from liver and heart. For biogenesis, quantitative PCR was used to<br />
calculate CytB (mitochondrial gene)/GAPDH (nuclear gene) ratio<br />
and to measure mitochondrial survival genes Sirt1, Sirt3, Nampt, and<br />
PGC-1α. All data were analyzed using the Pfaffl method<br />
Results<br />
AT1R blockade increased the CytB/GAPDH ratio in the heart<br />
of treated young and old mice (3.84 fold and 4.37 fold increase respectively)<br />
but significant reduction in mitochondrial level was observed<br />
in the liver where the ratio in treated young and old mice was<br />
only 1.5% and 2.3% as much as their respective controls.<br />
Mitochondrial survival gene expression in the heart was not increased<br />
and PGC-1α, one of the main regulators that drive biogenesis,<br />
was in fact down-regulated by 50% and 55% in young and old<br />
treated mice respectively.<br />
Conclusion<br />
Older mice treated for 20 weeks with Losartan, irrespective of<br />
age, have increased mitochondrial biogenesis in the heart but not in<br />
the liver despite the fact that mitochondrial survival genes were not<br />
up-regulated in the heart. Mitochondrial survival genes and especially<br />
PGC-1α might have been up-regulated in the earlier phases of<br />
the treatment. The role of the RAS system in maintaining mitochondrial<br />
levels might therefore be a key mechanism in promoting<br />
healthy aging.<br />
Effects of AT1R blockade on mitochondrial biogenesis and survival<br />
genes expression in young and aged mice<br />
B56 Encore Presentation<br />
Cellular Senescence in Patients with Barrett’s Esophagus: A Pilot Study.<br />
E. Gorospe, J. Penfield, K. Wang. Department of Medicine, Mayo<br />
Clinic, Rochester, MN.<br />
BACKGROUND: Cellular senescence is an irreversible mechanism<br />
whereby cells enter a non-mitotic state as a response to oncogenic<br />
stress. Barrett’s esophagus (BE) is the leading risk factor for the<br />
development of esophageal adenocarcinoma, one of the fastest growing<br />
cancers in middle-aged and elderly Caucasian men.<br />
AIM: To assess if cellular senescence is present in BE as a tumor<br />
suppressing mechanism<br />
METHODS: We examined esophageal tissue from a series of 11<br />
patients (age 67.3 ± 7.9 y.o) who underwent clinically-indicated endoscopic<br />
mucosal resection (EMR) for BE. Cellular senescence was determined<br />
using the Senescent Cell Histochemistry Kit (Sigma<br />
CS0030, St. Louis, MO) that determines SA B-galactosidase activity,<br />
which is the gold standard for senescence. In addition, we assessed the<br />
expression of cyclins B1, B2, C, D1, D2, E1, F, G1, G2, H, T1 and T2;<br />
CDK 1A, 1B, 2A (p16), 2B (p15), 3, MCM2, MCM3, MCM4, RB1,<br />
RBBPB, RBL1, RBL2, RPA3 in biopsies taken from the Barrett’s<br />
esophagus segment. The biopsies were stored in RNAlater (Qiagen,<br />
Valencia, California) at -80 degrees Celsius until RNA purification.<br />
Tissue was then disrupted and homogenized in buffer solution. The<br />
lysate was then purified using an RNAeasy spin column (Qiagen, Valencia,<br />
California) and rinsed twice with 50 ul of RNAase free water.<br />
The RNA was then used to prepare cDNA using the RT First Strand<br />
Kit (Superarray, Frederick, MD) as per manufacturer’s instructions.<br />
The cDNA was placed with the RT qPCR mastermix with SYBR<br />
green and a reference dye, the mixture was then aliquoted across an<br />
expression array, thermal cycling was performed with real time amplification.<br />
Changes in gene expression were noted while internal array<br />
controls for genomic DNA contamination, efficiency of the RT, and<br />
the efficiency of the PCR were all found to be within specified norms.<br />
RESULTS: We detected senescent cells in 9 (81.85%) patients.<br />
The 2 patients who did not have senescence had non-dysplastic BE.<br />
The presence of senescence was further confirmed by the decreased<br />
expression of cell regulatory genes including a decrease in RB -197<br />
fold, p
P OSTER<br />
A BSTRACTS<br />
ferent than previously reported to be occurring in aging mice, highlighting<br />
the importance of confirming animal model data in people.<br />
B58<br />
An Isocaloric Low Protein Diet in Rodents: an Experimental Model<br />
of Frailty and/or Sarcopenia.<br />
P. Ammann, R. Rizzoli. Department of rehabilitation and geriatrics,<br />
Division of bone diseases, Geneva, Geneva, Switzerland.<br />
Frailty and sarcopenia are very frequent in the oldest old. Even<br />
if clinical diagnosis criteria are becoming recognized for both conditions,<br />
these disorders are still missing an operational definition and<br />
their pathophysiology remains still unclear. This is partially due to the<br />
lack of experimental models of acquired frailty and/or sarcopenia.<br />
To better understand the pathophysiology and potential therapeutic<br />
strategies of frailty and/or sarcopenia, we set up an experimental<br />
model in adult rats or mice. Animals were pair fed with an<br />
isocaloric low protein diet (50 % of the minimal amount necessary to<br />
maintain sex hormone status) and compared to animals with a normal<br />
protein diet. Both diets differed only by the casein content as the<br />
source of protein, the same amount of calories being provided by carbohydrate<br />
addition.<br />
This dietary modulation resulted in both sexes in a rapid reduction<br />
of GH and IGF-I production and in a resistance to IGF-I action<br />
(somatotrop axis), in a lower sex hormones concentration or function<br />
(gonadotrop axis) and decreased calcitriol levels and higher circulating<br />
PTH independently of the 25OH vitamin D status (vitamin<br />
D/PTH axis). These alterations were associated with a rapid decrease<br />
in bone mass, in alterations in bone microstructure and material level<br />
properties, a reduction in bone strength, and a marked decrease in<br />
muscle mass. A spontaneous reduction of the food intake was also observed.<br />
Under the isocaloric low protein diet, the response to exogenous<br />
IGF-I, growth hormone or PTH was blunted. All the bone, muscle<br />
and hormones abnormalities were corrected by essential amino<br />
acids supplements.<br />
These features in rodents fed an isocaloric low protein diet are<br />
quite reminiscent of the situation in the frail oldest old. This model<br />
should be of help to further study the pathophysiology of frailty<br />
and/or sarcopenia, and to explore preventive or curative measures.<br />
B59<br />
Osteopontin, a marker of sleep disordered breathing in older<br />
individuals.<br />
S. Shah, N. Punjabi, A. Jain, N. Fedarko. Johns Hopkins University<br />
School of Medicine, Baltimore, MD.<br />
Background: Sleep-disordered breathing (SDB), characterized<br />
by recurrent arousals from sleep and intermittent hypoxemia, is common<br />
among older adults. Studies have linked SDB to hypertension,<br />
cardiovascular, cerebrovascular disease, and dementia. Osteopontin<br />
(OPN) is a secreted glycophosphoprotein that plays a role in a diverse<br />
set of processes involved in stress response and/or chronic immune<br />
activation. The levels of circulating OPN have not been studied<br />
in the context of aging or SDB. We hypothesize that OPN levels correlate<br />
with measures of SDB. Additionally we sought to determine<br />
the influences of the covariates of age, gender, race, and BMI on OPN<br />
values.<br />
Methods: The group under study comprised of 205 healthy individuals<br />
ranging from 20 to 82 years. Subjects free of medical comorbidity<br />
had fasting morning serum tested for OPN levels by competitive<br />
ELISA. Full night polysomnography was conducted and the<br />
apnea-hypopnea index (AHI) was calculated. Differences between<br />
groups were assessed by Mann-Whitney t-tests and associations between<br />
OPN and individual covariates by Spearman rank correlation.<br />
Additionally, OPN levels were modeled by multiple linear regression<br />
with covariates including age, BMI, gender, race, and AHI.<br />
Results: The median level of OPN in the total study population<br />
was 56.4 ng/ml with a range of 5.4 to 426.5 ng/ml. OPN levels were<br />
found to differ by race and gender significantly (p 5, Spearman<br />
r = 0.7, p < 0.0001. Multiple regression of OPN values as a function<br />
of age, race, gender, BMI and AHI values revealed that the association<br />
of OPN with AHI remained significant even after correcting<br />
for these covariates.<br />
Conclusions: The observed differences in circulating OPN<br />
levels may be reflecting underlying differences by race and gender<br />
in allostatic load. Because effective treatments for SDB exist,<br />
early identification and treatment in the elderly may represent a<br />
novel management strategy for reducing the morbidity and mortality<br />
burden associated with SDB and its associated comorbid<br />
diseases.<br />
B60<br />
A calcium channel blocker characteristically prevents endothelial<br />
senescence: Possible implication for atherosclerosis.<br />
T. Hayashi, K. Ina, T. Yamaguchi. <strong>Geriatrics</strong>, Nagoya University<br />
Graduate School of Medicine, Nagoya, Japan.<br />
Supported By: No funders support for this research.<br />
Background: Aging is one of strongest risk factor of atherosclerosis,<br />
and endothelial senescence has been reported to precede atherosclerosis<br />
in vivo. We have reported the important role of glucose and<br />
NO on the endothelial senescence (PNAS 2006, JPET2011). Although<br />
HMG-CoA reductase inhibitor is shown to prevent endothelial<br />
senescence, the effect of anti-hypertensive agents on senescence<br />
was not known enoughly.<br />
Methods: We measured senescence-associated-β-galactosidase<br />
activity, telomerase activity, and telomere length after the exposure of<br />
human endothelial cells(HUVECs) to glucose, oxidized LDL or angiotensin<br />
II for 2days. Anti-hypertensive agents (calcium channel<br />
blocker:CCB, angiotensin converting enzyme inhibitor:ACEI and β<br />
blocker:βB) were pre- or co-incubated with the stimulus as above<br />
(such as high glucose). The experiment using small-interfering-RNA<br />
targeting endothelial-NO-synthase (eNOSsiRNA) was done to investigate<br />
the mechanisms. Finally, streptozotocin-induced diabetes<br />
showed more senescent cells in aortic endothelium of aged rats and<br />
the effect of anti-hypertension agents was investigated.<br />
Results: After the exposure of HUVECs to glucose (22 mM),<br />
oxidized LDL or angiotensin II for 2 days, senescence-associated-βgalactosidase<br />
activity was increased and decreased telomerase activity,<br />
and the effect of glucose is strongest.<br />
Among various anti-hypertensive agents which pre- or co-incubated<br />
with the stimulus as above (such as high glucose), only CCB,<br />
but not ACEI or betaB, preserved telomere<br />
length and delayed endothelial senescence, which was associated<br />
with reduced reactive oxygen species and increased nitric oxide<br />
(NO). The experiment using eNOSsiRNA suggested the role of NO<br />
in the anti-senescence effects of physiological concentration of CCB.<br />
High glucose and oxidized LDL worked additively. Finally, streptozotocin-<br />
induced diabetes showed more senescent cells in aortic endothelium<br />
of aged rats and the effect of CCB was investigated.<br />
Nifedipine is used in this experiment.<br />
Conclusion: The regulatory effects of CCB on endothelial senescence<br />
is observed in high glucose, oxidized LDL or angiotensin II induced<br />
senescence. These interactions may help explain the pivotal<br />
roleof CCB in atherosclerosis in elderly.<br />
AGS 2012 ANNUAL MEETING<br />
S93
P OSTER<br />
A BSTRACTS<br />
B61<br />
Losartan increases mitochondrial biogenesis in human fibroblast cells.<br />
V. Cheng, 2,1 B. Manwani, 1 J. Walston, 1 P. Abadir. 1 1. Johns Hopkins<br />
University, Baltimore, MD; 2. University of Kansas Medical Center,<br />
Kansas City, KS.<br />
Supported By: <strong>American</strong> Federation for Aging Research<br />
Mitochondrial function declines with age and is thought to influence<br />
chronic disease and frailty. The renin-angiotensin system (RAS)<br />
acts through angiotensin (Ang) II type 1 (AT 1<br />
R) and type 2 (AT 2<br />
R)<br />
receptors. We recently found a mitochondrial RAS, with AT 2<br />
R located<br />
in inner mitochondrial membranes that decrease with age and<br />
increase with AT 1<br />
R blocker losartan. Given these results, we hypothesized<br />
that the RAS plays a key role in mitochondrial biogenesis.<br />
Human fetal lung fibroblast cells (MRC-5) were grown in culture<br />
and separated into a control and treatment groups with serially<br />
increasing concentrations of losartan and Ang II. Cells given 100nM<br />
Ang II were subjected to losartan (0.01nM to 100nM). After 48 hrs,<br />
we measured mitochondrial gene ND6 and nuclear gene TK2 with<br />
qPCR. A ratio to compare gene expression based on treatment was<br />
generated.<br />
Mitochondrial biogenesis increased with higher doses of losartan.<br />
Cells given Ang II showed an increased ratio with Ang II up to<br />
1nM and decreased fold change above 1nM. Cells with Ang II and<br />
losartan displayed a reversal of AT 1<br />
R effects and increased mitochondrial<br />
biogenesis with losartan up to 10nM.<br />
These results illustrate a potentially important role of the RAS<br />
on mitochondrial biogenesis. While higher concentrations of losartan<br />
increase fold change, our results suggest a level of losartan that maximizes<br />
AT 1<br />
R blocking efficacy. Optimizing mitochondrial biogenesis<br />
via losartan is a novel approach that warrants further study in frail,<br />
older adults.<br />
ND6/TK2 ratio<br />
Cells with higher doses of losartan showed a higher ratio. Cells<br />
given Ang II show an increased ratio up to 1nM. Cells with 100nM<br />
Ang II and losartan showed an initial increase in ratio.<br />
B62<br />
The Hospital to Home Program: A Window into Healthcare<br />
Transitions for Older Adults.<br />
A. Cornell, J. Speice, T. Caprio, R. McCann. University of Rochester,<br />
Rochester, NY.<br />
Supported By: Reynolds Foundation<br />
HRSA GTPD Grant# HP08792<br />
BACKGROUND: Hospital readmission rates and levels of patient<br />
satisfaction have increasingly become a focus of attention as<br />
federal reimbursement policies change. Although a few programs<br />
have increased the efficiency of the discharge process, most hospitals<br />
lack sufficient resources to support a comprehensive discharge planning<br />
program outside the hospital. Data accumulated from the University<br />
of Rochester’s medical resident education program provides<br />
insight into the older adult patient’s perception of the discharge<br />
process.<br />
METHODS: A retrospective analysis from data collected from<br />
20 patients, age >60 years old, who participated in Highland Hospital’s<br />
“Hospital to Home Program” between September 2009 and September<br />
2011. This program focuses on training medical residents to<br />
identify discharge concerns during an inpatient bedside interview<br />
which is videotaped. Residents follow up with the patient one week<br />
after discharge in another videotaped encounter to gather information<br />
about the patient’s discharge experience. Video footage was reviewed<br />
by a clinical psychologist and the medical resident to identify<br />
common themes that contributed to negative discharge experiences.<br />
Learning points are highlighted in a video compilation that is presented<br />
to a group of medical residents during a teaching noon conference<br />
at the hospital to create a shared learning experience.<br />
RESULTS: Five main themes were identified from the patient<br />
feedback obtained during the program: difficulty accessing pain medicine<br />
or medical equipment, unclear discharge instructions, failure to<br />
have barriers to a safe return to home identified, inadequate follow<br />
up from home health nursing services, and difficulty obtaining answers<br />
to medical questions after discharge. One unique theme that<br />
was also identified was an expressed wish by some patients for more<br />
time to recover in the hospital due to preexisting caregiver responsibilities<br />
at home.<br />
CONCLUSION: The Hospital to Home program provides valuable<br />
insight into the problems that older adult patients experience<br />
after discharge from the hospital. Besides the educational value of this<br />
program, the identified themes provide distinct areas of focus for institutions<br />
striving to prevent unnecessary readmissions to the hospital.<br />
B63<br />
Enhancing Access to Palliative Care: An Initiative to Improve<br />
Advance Care Planning Documentation.<br />
A. Beyea, 1 H. Laura, 1,2 A. Caprio, 1,2 G. Winzelberg, 1,2 K. Wessell, 3<br />
C. Rowe. 4 1. Division of Geriatric Medicine and Center for Aging and<br />
Health, University of North Carolina, Chapel Hill, NC; 2. Palliative<br />
Care Program, The University of North Carolina, Chapel Hill, NC; 3.<br />
Cecil G. Sheps Center for Health Services Research, The University of<br />
North Carolina, Chapel Hill, NC; 4. Division of Hematology and<br />
Oncology, The University of North Carolina, Chapel Hill, NC.<br />
Purpose: This prospective study focused on improving documentation<br />
of advance care planning discussions for patients aged 65<br />
and older admitted to an Acute Care for the Elderly (ACE) unit at a<br />
university hospital. The primary aim was to increase utilization of an<br />
Advance Care Planning (ACP) note, a hospital-specific documentation<br />
tool in the electronic medical record (EMR).<br />
Methods: A case-based education session was repeated nine<br />
times from August 2010 to June 2011 to reach all physicians and medical<br />
students providing care to patients admitted to an ACE unit. Education<br />
covered communication and documentation about decisionmaking<br />
and preferences for life-sustaining treatments (LST).<br />
Following education sessions, participants received group performance<br />
data feedback. A gift card incentive was also used to encourage<br />
ACP discussions and documentation. Weekly chart review of patients<br />
discharged was used to collect data on outcomes: frequency of documented<br />
discussions about patient preferences for LST, and frequency<br />
of documentation with the ACP note tool.<br />
Results: Baseline chart review (N=88) showed 27% of patients<br />
had documentation of LST preferences, while only 4% were documented<br />
in the ACP note. Of the 204 charts reviewed during the intervention<br />
phase, 49% had documentation of LST preferences and 14%<br />
had an ACP note. For patients with dementia (N=64), 53% had documented<br />
discussion of LST preferences in the EMR; 41% in an ACP<br />
note. Among patients confused, sedated, or nonverbal (N=95), 56%<br />
had documented LST preferences in the EMR; 32% in an ACP note.<br />
Discussion: ACP note utilization facilitates effective communication<br />
about changes in health status and patient preferences for LST<br />
across a continuum of care. This quality improvement intervention<br />
was associated with an overall increase in frequency of ACP note utilization.<br />
Documentation practices among patients with dementia and<br />
confusion suggest that providers engage in discussions about LST<br />
preferences at least 50% of the time with patients at risk for progressive<br />
decline, adverse outcomes, and death.<br />
S94<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
B64<br />
Residency Training in Optimizing Hospital to Nursing Home<br />
Transitions.<br />
A. Nazir, A. K. Chakka, M. Tegeler, A. D. Graves,<br />
G. R. Westmoreland. Medicine, Indiana University, Indianapolis, IN.<br />
Supported By: 1. Dr. Arif Nazir was funded by the Geriatric<br />
Academic Career Award sponsoerd by Health Resources and<br />
Services Adminsitration.<br />
Background: Selecting an appropriate Post-Acute Care (PAC)<br />
venue and ensuring a seamless transition are critical for the recovery<br />
of older hospitalized patients. We implemented a course for Internal<br />
Medicine and Medicine/Pediatrics residents on selection of PAC venues,<br />
best practices in transitional care, and PAC insurance coverage.<br />
Methods: A formal needs assessment helped structure the aims<br />
that included teaching: 1) various PAC options and Medicare and<br />
Medicaid coverage, 2) strategies to help patients and families select<br />
the most appropriate skilled nursing facility (SNF), and 3) best practices<br />
in transitional care. Course pre-work included an online self-efficacy<br />
survey, a pretest and assigned readings. Sessions 1 and 2 of the<br />
course were conducted by geriatricians in 2 local SNFs. Session 1 included<br />
case-based discussions and role-play in a mock family meeting<br />
focusing on description and insurance coverage of various PAC options,<br />
and the physician’s role in helping families select the most appropriate<br />
SNF. In session 2 residents used a formal tool to assess the<br />
quality of patient transitions and patient awareness of their diseases<br />
and PAC goals. The course concluded with residents repeating the online<br />
self-efficacy survey, a posttest and course evaluation.<br />
Results: Twelve residents have taken the course. Preliminary<br />
survey results show that after taking the course the residents who<br />
were ‘aware OR very much aware’ of ‘available PAC options’ increased<br />
from 3 to 12; those who were ‘knowledgeable OR very<br />
knowledgeable’ about PAC insurance coverage increased from 0 to 7;<br />
and those who were ‘familiar OR very familiar’ with ‘transitional care<br />
issues in elders increased from 2 to 11. Similarly, more residents felt<br />
‘confident OR very confident’ to ‘carry out a family meeting regarding<br />
appropriate PAC venue’, ‘facilitate successful transition for an<br />
older patient’, and ‘help a family to select the best SNF’. There was a<br />
16% mean gain in posttest vs. pretest scores and 85% would recommend<br />
this course to others. Most felt the course will impact their practice.<br />
One learner said, “I will check discharge summaries, look up<br />
(star) rating information on facilities and have early discussions<br />
about goals of care.”<br />
Conclusion: Early findings show that a structured course may<br />
improve residents’ knowledge, skills and attitudes about their role in<br />
patient selection of appropriate PAC options and transitional care.<br />
B65<br />
Inadequate Understanding of Code Status Improved by Case-Based<br />
Learning.<br />
A. Sangarlangkarn, M. Drickamer. <strong>Geriatrics</strong>, Yale School of<br />
Medicine, New Haven, CT.<br />
Multiple studies show continued deficiencies in education on<br />
end-of-life care. However, there is limited literature on whether<br />
providers have an adequate understanding of DNR/DNI, which is essential<br />
in end-of-life care. Our study evaluates the understanding of<br />
DNR/DNI among physicians in training and the efficacy of casebased<br />
learning in code status education.<br />
In Fall 2011, we surveyed medical students and residents at Yale<br />
School of Medicine before and after a course on challenging end-oflife<br />
cases. Constructed using the same standards as the nationally utilized<br />
Yale Office-Based Medicine Curriculum, the course focused on<br />
DNI/not DNR patients, reversibility of code status, and futility of<br />
care. Mcnemar test was used to evaluate changes in responses.<br />
Results from 44 surveys are shown in attached image. After the<br />
course, participants were 9 times more likely to correctly forego<br />
amiodarone in coding DNR patients (p=0.02), and 11 times more<br />
likely to correctly offer ambu-bag in DNI patients (p=0.01). When<br />
asked if participants possess adequate understanding of DNR/DNI<br />
on a scale of 1 (disagree) to 5 (agree), there was a 0.93 point increase<br />
after the course (before=3.26, after=4.19, p=0.00). Ninety-three percent<br />
would recommend the course to others.<br />
Surveys showed that many participants would provide contraindicated<br />
interventions to DNR patients while failing to offer appropriate<br />
interventions to DNI patients. After the course, more participants reported<br />
having an adequate understanding of DNR/DNI. A significant<br />
number appropriately offered manual lung inflation to DNI patients<br />
and correctly withheld antiarrhythmics in coding DNR patients. Our<br />
study showed that physicians in training may benefit from code status<br />
education, particularly case-based learning which may improve their<br />
understanding of DNR/DNI and the quality of end-of-life care.<br />
B66<br />
Development of an Ambulatory <strong>Geriatrics</strong> Exam for Internal<br />
Medicine Residents.<br />
J. L. Kalender-Rich, 1,2 J. D. Mahnken, 4 I. Dong, 4 A. M. Paolo, 3<br />
S. K. Rigler. 1,2 1. Internal Medicine, University of Kansas School of<br />
Medicine, Overland Park, KS; 2. Landon Center on Aging, University<br />
of Kansas School of Medicine, Overland Park, KS; 3. Office of<br />
Medical Education, University of Kansas School of Medicine,<br />
Overland Park, KS; 4. Department of Biostatistics, University of<br />
Kansas School of Medicine, Overland Park, KS.<br />
Background<br />
Internal Medicine residents must complete geriatric-specific<br />
training. Ambulatory care is now increasingly emphasized in Internal<br />
Medicine residency which has traditionally focused on inpatient care.<br />
Two widely used geriatrics knowledge exams focus mainly on nonambulatory<br />
topics. Our goal was to create a valid ambulatory-focused<br />
geriatrics knowledge exam for residents.<br />
Methods<br />
We created exam questions that cover common clinical topics<br />
likely to be tested on in-training and board exams. Questions were reviewed<br />
by experts in Internal Medicine, Geriatric Medicine, and<br />
Medical Education for content and structure. The exam was administered<br />
to 55 interns and residents after which item analysis was performed<br />
to assess discrimination and level of difficulty; five questions<br />
were discarded based on poor item performance, creating a final 25<br />
question exam. It was also completed by 20 fourth year medical students,<br />
11 general medicine faculty, and 10 geriatrics fellowshiptrained<br />
faculty. We compared the mean correct score for each group<br />
with one-way ANOVA, and also treated group as ordinal and tested<br />
for a trend using simple linear regression.<br />
Results<br />
The mean correct scores for the four groups were 65%, 59%,<br />
60%, 70% and 80% for students, interns, residents, general medicine<br />
faculty and geriatric medicine faculty, respectively. The test of equal<br />
mean scores across groups was rejected (p
P OSTER<br />
A BSTRACTS<br />
Conclusions<br />
Our overall results demonstrated a gradient of increasing scores<br />
from learners to generalist faculty to geriatrics faculty. Interns and<br />
residents did not score as well as the fourth year medical students;<br />
however, all fourth year medical students at our institution have completed<br />
a required third year geriatrics rotation. In contrast, interns<br />
and residents have a wide variety of backgrounds and many had not<br />
had previous dedicated geriatric exposure. We conclude that this new<br />
exam is an appropriate tool to assess knowledge gained by learners in<br />
an ambulatory geriatric rotation.<br />
B67<br />
A Comprehensive Curriculum to Train Internal Medicine Residents<br />
on Care Transitions.<br />
M. Eskildsen, C. Payne, J. Bonsall, A. Miller, E. Rimler,<br />
U. Ohuabunwa, M. Khosravanipour, A. M. Galvez, J. Stein.<br />
Department of Medicine, Emory University School of Medicine,<br />
Atlanta, GA.<br />
Supported By: John A. Hartford Foundation<br />
Background: Medically complex patients are at risk for complications<br />
during care transitions among providers and hospital units, as<br />
well as in the period after hospital discharge. To address this problem,<br />
Emory’s internal medicine residency program started a new care<br />
transitions curriculum.<br />
Methods: The curriculum, which was developed for medical interns,<br />
addressed patient handovers between providers during a hospital<br />
stay, as well as discharge practices. Components included a two-hour<br />
workshop during intern orientation, two plenary presentations, and a<br />
pocket card outlining preferred practices. A pilot initiative at one participating<br />
hospital also incorporated direct feedback of residents’ discharge<br />
summaries. 71 of 89 interns participated in the curriculum during<br />
the 2010-2011 academic year.We administered pre- and post-course<br />
surveys which addressed confidence in performing care transitions, and<br />
their fund of knowledge on the topic. In addition, the post-course survey<br />
asked about the role the course played in their ability to perform<br />
care transitions. The evaluation also included surveys assessing intern<br />
satisfaction with a pilot discharge summary training program.<br />
Results: Pre- and post-course surveys were completed by 71 and<br />
43 interns, respectively. 16 interns took part in the discharge summary<br />
training pilot and completed a separate questionnaire. Interns’ confidence<br />
in their ability to perform care transitions tasks improved from<br />
19.8 to 25.7 on a 30-point scale (p
P OSTER<br />
A BSTRACTS<br />
Using this scale, the average score improved from -6.25 pre-curriculum<br />
to -4.95 post-curriculum, p=.000.<br />
Conclusion: We have designed an effective curriculum that improves<br />
both knowledge and self efficacy for residents and medical<br />
students to learn and practice the principles of appropriate prescribing<br />
for older adults that is coordinated and patient-centered.<br />
B70<br />
Identifying the Training Needs of Internal Medicine Faculty in<br />
<strong>Geriatrics</strong> utilizing the <strong>Geriatrics</strong> Skills Assessment Tool (GSAT).<br />
P. Yin, 1 N. Jamshed, 2 H. Hu, 1 S. K. Sinha. 1 1. Faculty of Medicine,<br />
University of Toronto, Toronto, ON, Canada; 2. Faculty of Medicine,<br />
Georgetown University, Washington, DC.<br />
Supported By: Mount Sinai Hospital Department of Medicine<br />
Research Fund<br />
Background: As many internists have had no formal training in<br />
geriatrics, improving their geriatrics skills is becoming especially important<br />
given our ageing population. This study assessed the training<br />
needs in geriatrics of faculty across one of North America’s largest<br />
academic Departments of Medicine. Methods: The <strong>Geriatrics</strong> Skills<br />
Assessment Tool (GSAT) was developed around the 15 core geriatric<br />
skills competencies defined by the <strong>American</strong> Board of Internal Medicine<br />
(ABIM) for Internal Medicine (IM) residents. A GSAT Survey<br />
was distributed to all active IM faculty at the University of Toronto,<br />
asking each participant to rate each skill in regards to their confidence<br />
in performing, teaching and interest around acquiring further<br />
training in it while also providing some basic demographic information<br />
on training background, sub-specialty etc. Chi-squared, Kendall<br />
Tau-b, and ANOVA tests were used to evaluate associations between<br />
the responses and the demographic profiles of the respondents. Results:<br />
369/491 (75%) faculty members representing 12 sub-specialties<br />
completed the survey, with a minimum response rate of 60%<br />
achieved per specialty. Compared to all other subspecialists, Geriatricians<br />
consistently expressed the highest levels of confidence in performing<br />
and teaching all skills except for those related to end-of-life<br />
care (p
P OSTER<br />
A BSTRACTS<br />
Significant increases in the mean and variability of reaction time<br />
on the SART were significantly associated with both falls (p < 0.01)<br />
and reduced falls efficacy (p < 0.05) in older adults. An increase in<br />
omission errors was also associated with falls (p < 0.01) and reduced<br />
falls efficacy (p < 0.05). Upon controlling for age and gender affects,<br />
logistic regression modelling revealed that increasing variability reflective<br />
of the vigilance (top-down) aspect of sustained attention was<br />
a retrospective predictor of falling in the previous year (p < 0.01, OR<br />
= 1.14, 95% CI: 1.03 – 1.26) and was weakly correlated with reduced<br />
falls efficacy in non-fallers (p = 0.07).<br />
Conclusions<br />
Greater variability in sustained attention is strongly associated<br />
with retrospective falls and to a lesser degree with reduced falls efficacy.<br />
This cognitive measure may provide a novel and valuable biomarker<br />
for falls in older adults, potentially allowing for early detection<br />
and the implementation of preventative intervention strategies.<br />
B73<br />
Under-recognition of Weight Loss in Community-Dwelling Elders.<br />
A. Dobracki, 1,2 W. Zirker. 2 1. <strong>Geriatrics</strong>, Temple University,<br />
Philadelphia, PA; 2. <strong>Geriatrics</strong>, Crozer Chester Medical Center,<br />
Upland, PA.<br />
Background: Intentional and unintentional weight loss has been<br />
shown to produce negative outcomes in morbidity and mortality in<br />
older populations, even in the overweight. It has been associated with<br />
a decline in bone mineral density and an increase in fractures. Weight<br />
loss may herald impending Alzheimer’s dementia and earlier institutionalization.<br />
Because weight loss may portend adverse outcomes,<br />
recognition is clinically relevant. This study sought to identify the<br />
scope of under-recognition of weight loss using electronically generated<br />
patient records.<br />
Methods: The electronic database of a community-based health<br />
network was used to retrospectively identify patients age 70 and<br />
older who sustained a 5% weight loss during any 12-month time span<br />
occurring between May 2006 and September 2011. Data included age,<br />
gender, height and weights, documentation by the physician of weight<br />
loss and the number of missed opportunities to document weight loss.<br />
A missed opportunity was defined as an office visit in which weight<br />
loss went unrecognized. Patients were excluded if cancer was an active<br />
problem or if weights were not measured at least twice in a year.<br />
Descriptive statistics were used to analyze the results.<br />
Results: A total of 2387 charts were reviewed, 439 were excluded,<br />
and 1948 charts met inclusion criteria. These included charts<br />
from 143 different physicians. Weight loss occurred in 643 patients<br />
(33%), 237 (37%) were recognized, but 406 (63%) were not. Of those<br />
who lost weight, 133 (21%) were recognized at the first visit by 46 different<br />
physicians, and 95 (71%) of these were recognized by the same<br />
18 providers. If weight loss was initially unnoticed, there was an average<br />
of 2.3 missed opportunities and 4.7 months that elapsed before its<br />
recognition.<br />
Conclusions: In this sample, weight loss in elderly outpatients<br />
was unrecognized in the majority of cases. Only a small number of<br />
providers identified the majority of weight loss cases. Even with the<br />
use of an electronic medical record, most providers did not document<br />
the acknowledgement of weight loss. Given the problems associated<br />
with weight loss, its under-recognition could potentially have serious<br />
consequences in the elderly.<br />
B74<br />
Facilitating frailty identification in clinical practice: Comparison of<br />
two methods among community-dwelling older adults.<br />
A. Islam, 1,2 S. Muir, 2 M. Montero Odasso. 2,3 1. School of Kinesiology,<br />
University of Western Ontario, London, ON, Canada; 2. Geriatric<br />
Medicine, Parkwood Hospital, London, ON, Canada; 3. Lawson<br />
Health Research Institute, London, ON, Canada.<br />
Frailty is characterised by an increased vulnerability for adverse<br />
events such as falls, fractures, nursing home admission, and death.<br />
Several models for the identification of frailty have been developed,<br />
including Fried’s widely accepted Frailty Phenotype Index (FPI). Alternatively,<br />
the 9-category Clinical Frailty Scale (CFS) has been proposed<br />
based on its simplicity for retrieving information from clinical<br />
history and physical exams. The CFS evaluates energy level, mobility<br />
capabilities, comorbidities, self-reported physical activity and functionality.<br />
The CFS scores range from 1 (‘very fit’), to 9 (‘severely<br />
frail’). Each increment in the CFS score increases the risk of death or<br />
institutionalization by approximately 20% (within a six year time<br />
frame). To date, the CFS has not been validated against the FPI. Our<br />
aim was to test the agreement between the FPI and the CFS to identify<br />
community older adults with frailty. Methods: One hundred nine<br />
community-dwelling older adults, aged ≥75, were included in the<br />
study. Participants were first classified as robust, pre-frail or frail<br />
using the FPI. Subsequently, two clinicians blinded from the first assessment,<br />
determined frailty status by applying the CFS to our sample.<br />
Differences amongst assessments were resolved by consensus.<br />
Inter-rater reliability agreement was assessed using kappa statistics.<br />
Frailty status in the same individual by CFS was compared to the<br />
number of FPI components present using Pearson Correlation coefficients.<br />
Results: Analysis of kappa statistics showed a substantial<br />
agreement among raters in applying the CFS to the sample (κ= 0.76,<br />
95% CI (0.68, 0.84)). The CFS was also found to be positively correlated<br />
with an increasing number of frailty components of the FPI<br />
(r=0.69, p
P OSTER<br />
A BSTRACTS<br />
thus, 90% were considered non-adherent with at least one medication.<br />
The mean number of medications that individuals were non-adherent<br />
to was 3.4. None of the cognitive or physical function measures<br />
appeared to be associated with medication non-adherence in this<br />
study.<br />
Medication non-adherence is a very prevalent problem among<br />
elders who self-neglect. Physicians who find high rates of medication<br />
non-adherence should consider the possibility of elder self-neglect in<br />
their patents. Future efforts should focus on studying the underlying<br />
reasons for medication non-adherence in larger samples of elder selfneglecters.<br />
This would facilitate the development of interventions to<br />
reduce medication non-adherence in this population.<br />
B76<br />
Nocturia and overnight polysomnography outcomes among adults<br />
with Parkinson disease.<br />
C. P. Vaughan, 1,2 J. L. Juncos, 3 L. M. Trotti, 3 T. M. Johnson, II, 1,2<br />
D. L. Bliwise. 3 1. Birmingham/Atlanta VA GRECC, Decatur, GA; 2.<br />
Geriatric Medicine & Gerontology, Emory University, Atlanta, GA; 3.<br />
Neurology, Emory University, Atlanta, GA.<br />
Supported By: Supported by NINDS RO1 NS-050595 and PHS<br />
Grant UL1 RR025008 and KL2 RR025009 (Dr. Trotti) from the<br />
Clinical and Translational Science Award program, National<br />
Institutes of Health, National Center for Research Resources. Dr.<br />
Vaughan is supported by a VA Rehabilitation R&D career development<br />
award.<br />
Background: Epidemiologic studies have shown nocturia to be a<br />
frequent and bothersome complaint for patients with Parkinson disease<br />
(PD). Detailed clinical and sleep data have not been available<br />
for this population and may provide insight into the pathophysiology<br />
and bother related to nocturia in the setting of PD.<br />
Methods: PD patients were recruited from university-based<br />
movement disorders clinics for two consecutive nights of in-laboratory<br />
polysomnography regardless of any sleep or voiding complaints.<br />
Nocturia frequency and overall satisfaction related to urinary symptoms<br />
were assessed using the <strong>American</strong> Urological Association<br />
Symptom Index. Measured sleep characteristics included total sleep<br />
time (minutes) and sleep efficiency (percent). Differences between<br />
those with at least two episodes of nocturia and those with fewer<br />
were determined using chi-square, t-tests, or Wilcoxon signed rank<br />
tests. Linear and logistic regression techniques were used to assess<br />
factors associated with nocturia frequency.<br />
Results: Sixty-three adults (65% male, mean age 63, (range 32-<br />
83)) with PD completed the study. Fifty-nine (93%) participants had<br />
1 or more and 37 (61%) reported 2 or more nocturia episodes nightly.<br />
Unified Parkinson Disease Rating Scale motor score was a predictor<br />
of nocturia occurring at least twice nightly (p=0.02). This association<br />
persisted when controlling for age and gender (p=0.03). MMSE score<br />
did not predict nocturia frequency. Compared to participants with 2-3<br />
episodes of nocturia who were mostly satisfied with their urinary<br />
symptoms (n=13), participants with 2-3 episodes who reported being<br />
dissatisfied with their urinary symptoms (n=12) demonstrated significantly<br />
less total sleep time (372.5 ± 58.7 min vs. 280.5 ± 116.1 min,<br />
p=0.03) and worse sleep efficiency (75.9% ± 11.2 min vs. 59.2% ±<br />
22.7, p=0.04).<br />
Conclusions: Nocturia at least twice per night in adults with PD<br />
is predicted by motor symptom severity, but not cognitive impairment.<br />
PD patients with 2-3 episodes of nocturia and dissatisfaction<br />
related to urinary symptoms have significantly worse sleep compared<br />
to those reporting 2-3 episodes and no dissatisfaction with urinary<br />
symptoms. Improving sleep as part of a multicomponent treatment<br />
strategy for nocturia in PD patients might be an independent target<br />
for therapy.<br />
B77<br />
Consumer-Targeted Drug Information to Reduce Inappropriate<br />
Prescriptions: Feedback from Older Adults and Preliminary<br />
Effectiveness.<br />
C. Tannenbaum, 1 R. Tamblyn, 2 S. Ahmed. 2 1. Université de Montreal,<br />
Montreal, QC, Canada; 2. McGill University, Montreal, QC, Canada.<br />
Supported By: This research was supported by a grant from the<br />
Canadian Institutes of Health Research. There are no financial disclosures<br />
to report in relation to this work.<br />
Previous interventions have targeted physicians and pharmacists<br />
to reduce inappropriate prescriptions. We sought to ascertain<br />
older adults’ response to directly receiving a knowledge transfer intervention<br />
aimed at empowering them to discuss benzodiazepine discontinuation<br />
with their pharmacist and/or physician.<br />
Methods: A written knowledge transfer tool was validated by a<br />
panel of geriatric pharmacists and pilot tested with focus groups of<br />
adults aged 60+. The tool includes a self-assessment component, presentation<br />
of evidence-based risks associated with benzodiazepine use,<br />
knowledge statements designed to create cognitive dissonance about<br />
the safety of benzodiazepine use, education about drug interactions,<br />
peer-champion stories intended to augment self-efficacy, suggestions<br />
for equally or more effective therapeutic substitutes for insomnia and<br />
anxiety, and simple tapering recommendations. The tool was distributed<br />
to eligible participants recruited and randomized to the intervention<br />
group of an open-label cluster randomized controlled trial on<br />
inappropriate prescribing being conducted in Quebec, Canada. Participants<br />
consuming any benzodiazepine > 3 months were contacted<br />
one week after receiving the intervention to ascertain their initial reaction,<br />
change in knowledge with respect to the risks associated with<br />
benzodiazepines and their anticipated course of action.<br />
Results: 50 participants (75% female, mean age 75 + 7 years,<br />
mean duration of benzodiazepine use 11 + 9 years) were contacted<br />
for their feedback. Prior to receipt of the tool, less than 27% correctly<br />
answered questions about the long-term safety of benzodiazepine<br />
use. After receipt of the tool, the proportion increased to 66%<br />
(p
P OSTER<br />
A BSTRACTS<br />
frailty have increased prevalence and incidence of cognitive impairment,<br />
that those with cognitive impairment have increased prevalence<br />
and incidence of frailty, and that those with both have increased<br />
mortality.<br />
We used data from the 2004, 2006, and 2008 waves of the Health<br />
and Retirement Study (HRS), a nationally-representative longitudinal<br />
health interview survey. The study sample included adults >=65<br />
years who completed physical performance measures in 2004<br />
(n=2,111, representing 35.5 million). We operationalized the frailty<br />
phenotype model and used a performance-based cognitive measure.<br />
We determined prevalence in 2004 and 2- and 4-year cumulative incidence<br />
(2006, 2008) of pre-frailty and frailty and of mild cognitive impairment<br />
(MCI) and dementia. We examined mortality using Kaplan-<br />
Meier survival curves and Cox proportional hazards models.<br />
Prevalences in 2004 were: frailty only, 9%; MCI/dementia only,<br />
20%; frailty and MCI/dementia, 9%. The 2-year cumulative incidence<br />
of MCI/dementia was 16.7% (p=.0009) for the pre-frail and was<br />
18.6% (p=.013) for the frail. Of those with MCI/dementia, the 2-year<br />
cumulative incidences of pre-frailty and of frailty were 54.4%<br />
(p=.002) and 11.0% (p=.002). Both conditions impacted 4-year survival<br />
(Table, p
P OSTER<br />
A BSTRACTS<br />
B81<br />
Antihypertensive Drug Class Use Associated with Urinary<br />
Incontinence in Community-Dwelling Elderly Women?<br />
E. P. Peron, 1 Y. Zheng, 1 S. Perera, 1 A. B. Newman, 1 N. M. Resnick, 1<br />
R. I. Shorr, 2 D. C. Bauer, 3 E. M. Simonsick, 4,5 S. L. Gray, 6<br />
J. T. Hanlon, 1 C. M. Ruby. 1 1. University of Pittsburgh, Pittsburgh, PA;<br />
2. Gainesville VA Geriatric Research, Education and Clinical Center,<br />
Gainesville, FL; 3. University of California, San Francisco, CA; 4.<br />
Johns Hopkins University, Baltimore, MD; 5. National Institute on<br />
Aging Intramural Research Program, Baltimore, MD; 6. University of<br />
Washington, Seattle, WA.<br />
Supported By: This study was primarily supported by National<br />
Institute on Aging grants and contracts (P30 AG024827, T32<br />
AG021885, K07 AG033174, R56 AG027017, R01 AG034056), a<br />
National Institute of Nursing Research grant (R01 NR010135), and<br />
Agency for Healthcare Research and Quality grants (R01<br />
HS017695, R01 HS018721, K12 HS019461).<br />
Background: Medication use is a potentially reversible cause of<br />
urinary incontinence (UI). This cohort study evaluated whether the<br />
use of specific antihypertensive classes is associated with self-reported<br />
incident UI in community-dwelling older women.<br />
Methods: The sample consisted of 959 black and white women<br />
aged 72 to 81 years without baseline (Year 1) UI from the Health,<br />
Aging and Body Composition study. Use of any antihypertensive<br />
from 10 drug classes (i.e., alpha blockers [central], alpha blockers [peripheral],<br />
angiotensin-converting enzyme inhibitors, angiotensin-II<br />
receptor blockers, beta blockers, calcium channel blockers, diuretics<br />
[loop], diuretics [potassium-sparing], diuretics [thiazide], or vasodilators)<br />
was determined during Year 3 in-person interviews. Self-reported<br />
UI, operationally defined as leaking urine at least weekly during<br />
the previous 12 months, was assessed at Year 4 visits.<br />
Results: Overall, 197 women (20.5%) reported incident UI. Use<br />
of specific antihypertensive drug classes ranged from a high of 32.4%<br />
for diuretics (specifically, 8.1% for loop, 9.8% for potassium-sparing,<br />
and 24.3% for thiazide) to a low of 5.6% for peripheral alpha blockers.<br />
Use of nine of the 10 antihypertensive classes was not associated<br />
with incident UI (all p>0.05). Only peripheral alpha blocker use (i.e.,<br />
prazosin, doxazosin, terazosin) increased the risk of UI (adjusted<br />
odds ratio [AOR] 4.47; 95% confidence interval [CI] 1.79-11.21).<br />
There was an even greater increased risk of UI with peripheral alpha<br />
blockers when taken in combination with loop diuretics (AOR 8.81;<br />
95% CI 1.78-43.53).<br />
Conclusions: In elderly community-dwelling women, peripheral<br />
alpha blocker use was associated with incident UI, and this risk nearly<br />
doubled when used in combination with loop diuretics.<br />
B82<br />
Increased Rhythmic Gait Variability May Contribute to Falls Risk in<br />
Older Knee Osteoarthritis Patients.<br />
J. E. DeCaria, 1 R. J. Petrella, 1,2 M. Montero-Odasso. 2,3 1. Aging,<br />
Rehabilitation & Geriatric Care, Lawson Health Research Institute,<br />
London, ON, Canada; 2. Schulich Faculty of Medicine and Dentistry,<br />
The University of Western Ontario, London, ON, Canada; 3. Gait and<br />
Brain Lab, Parkwood Hospital, London, ON, Canada.<br />
BACKGROUND: Reduced joint motion and flexibility in knee<br />
osteoarthritis (OA) patients may impair gait consistency. Increased<br />
gait variability is associated with instability, and is a valid and strong<br />
predictor of falls. However, the role of gait variability as a contributor<br />
to falls in knee OA is unknown. Our objective was to determine if<br />
rhythmic and postural gait variability is elevated in a sample of older<br />
knee OA patients compared to healthy older adults.<br />
METHODS: Community-dwelling older adults without cognitive<br />
or neurological impairment were included. The gait characteristics<br />
of 30 older knee OA patients (Kellgren-Lawrence II-III) were<br />
compared to those of 23 healthy older adults. Gait characteristics<br />
during self-selected gait velocity were determined with a 10 metre<br />
electronic walkway (GAITRite). Rhythmic and postural gait variability<br />
was calculated as the coefficient of variation (CoV) for stride<br />
time (StrTM) and double-support time (DSTM) respectively. Significant<br />
differences between groups (p
P OSTER<br />
A BSTRACTS<br />
Conclusion: In this analysis of palliative care inpatients, we<br />
found that escalating ARS increases the odds of delirium. In an effort<br />
to minimize delirium, anticholinergic medications should be added<br />
with caution in this vulnerable cohort. Further prospective studies are<br />
needed to establish a directly causal relationship.<br />
B84<br />
Screening for osteoporosis in elderly patients admitted to post-acute<br />
rehabilitation.<br />
K. Major, 1 S. Monod, 1 C. Bula, 1 S. Rochat, 1 O. Lamy, 2 D. Hans, 2<br />
A. Laszlo, 3 M. Krieg. 2 1. Service of <strong>Geriatrics</strong> medicine and geriatric<br />
rehabilitation, University of Lausanne Medical center, Lausanne,<br />
Switzerland; 2. Center of Bone Diseases, Lausanne University<br />
Hospital, Lausanne, Switzerland; 3. Service of Geriatric medicine,<br />
Hospital of Fribourg, Fribourg, Switzerland.<br />
Background: Screening for osteoporosis is important in older<br />
patients admitted to post-acute rehabilitation. However, DXA measurement<br />
is sometimes difficult to perform because of difficulties in<br />
positioning the patient and artefacts (osteoarthritis, prosthesis). The<br />
objectives were to determine the prevalence of unknown clinical osteoporosis<br />
in rehab patients and to determine new strategies for identifying<br />
clinical osteoporosis in this population.<br />
Method: Over a 9-months period, patients consecutively admitted<br />
to post-acute rehabilitation were included in th stdy. Patients with<br />
osteoporosis diagnosis, and those with terminal illness or severe physical<br />
limitations were excluded. Patients underwent Bone Mineral<br />
Density (BMD) by DXA and Vertebral Fracture Assessment (VFA).<br />
Clinical osteoporosis was defined as BMD ≤-2.5 SD at any site (lumbar<br />
spine, femoral neck, total hip or distal radius), ≥1 vertebral fracture,<br />
≥1 hip fracture, or another fragility fracture and BMD ≤-2 SD.<br />
Results: Overall, 102 (17.0%) of the 600 patients admitted to<br />
rehab refused to participate in the study or were unable to consent.<br />
Among the 498 remaining patients, 99 (19.9%) were excluded because<br />
of already known diagnosis of osteoporosis, 101 (20.3%) were<br />
excluded because of terminal illness, severe physical limitations, and<br />
45 (9.0%) because of inability to perform DXA during the stay<br />
(death, hospital transfer). Overall, 253 patients were assessed with<br />
DXA and VFA (166 women, mean age 83±7 years, mean BMI 27±6<br />
kg/m2, and 87 men, mean age 82±6 yrs, mean BMI 27±5 kg/m2). Of<br />
these, 70% had history of fall during the last 6 months and 9.1% had<br />
hip fracture history. Prevalence of osteoporotic vertebral fracture was<br />
36% in women and 32% in men. Overall, 152 (60.1%) patients had<br />
clinical osteoporosis (women: 67%; men: 46%) according to above<br />
criteria. Hip fracture history and vertebral fracture assessment identified<br />
correctly 105 (69.1%) of these 152 patients.<br />
Conclusion: A high prevalence of osteoporosis was observed in<br />
this population of rehab patients. Osteoporosis status should be systematically<br />
assessed in these patients at high fall risk, at least with<br />
careful history of hip fracture and an assessment for vertebral fractures<br />
with spine X-ray.<br />
B85<br />
Reasons for not prescribing guideline-recommended medications to<br />
veterans with heart failure.<br />
L. Dimaano, 1 C. Peterson, 2 M.A. Steinman. 2 1. University of California,<br />
San Francisco, CA; 2.VA Medical Center, San Francisco, CA.<br />
Supported By: MSTAR Program Grant 2 T35 AG026736-06<br />
Department of Veteran Affairs Grant 06-080-02<br />
Background:<br />
ACE inhibitors and beta blockers reduce mortality among patients<br />
with heart failure, yet some patients are not prescribed these<br />
medications. While general barriers to prescribing have been previously<br />
described, little is known about the reasons for foregoing treatment<br />
in individual patients, and whether this represents appropriate<br />
or inappropriate care. In this study, we described the distribution of<br />
reasons for not prescribing guideline-recommended drugs to older<br />
adults with heart failure.<br />
Methods:<br />
We conducted a chart review of patients from 4 VA health care<br />
systems who had systolic heart failure but were not prescribed ACE<br />
inhibitors (or ARBs) or beta blockers. For each patient, we used a<br />
standardized chart abstraction tool to identify the clinician’s reasons<br />
for not prescribing these drugs. Because chart review may not fully<br />
capture reasons for non-prescribing, we interviewed 61 clinicians who<br />
cared for patients in our cohort and compared the reasons they cited<br />
in the interview with reasons found in chart review.<br />
Results:<br />
Among 2846 patients screened, 301 were included in the study.<br />
Mean age of subjects was 75 +/- 10 years and 98% were male. 70%<br />
were not prescribed ACE inhibitors or ARBs, 18% were not prescribed<br />
beta blockers, and 11% were not prescribed both drugs. Using<br />
chart review, we identified reasons for non-prescribing in 65% of patients.<br />
The most common reason was clinical contraindications (58%).<br />
We identified at least one non-biomedical reason in 18% of patients,<br />
including patient attitude, adherence, and misuse of drugs (10%), and<br />
co-management with another clinician (6%). Interviews with clinicians<br />
yielded substantially more reasons than chart review (1.6 vs 0.9<br />
reasons per patient, P < .001). While clinical contraindications remained<br />
the most common reason for non-prescribing (70%), clinicians<br />
described other reasons in 66% of patients. These included patient attitude,<br />
adherence and misuse; co-management with other clinicians;<br />
and believing that the drug was not indicated (21-27% each).<br />
Conclusion:<br />
Clinical contraindications are the most common reason for not<br />
prescribing guideline-recommended drugs to heart failure patients.<br />
While chart review indicates that clinical contraindication eclipses all<br />
other reasons in importance, clinician interviews suggest that nonbiomedical<br />
factors figure equally in the decision not to prescribe<br />
these medicines.<br />
B86<br />
Tai Chi training increases the complexity of standing postural<br />
control in frail older adults.<br />
M. Lough, 1 B. Manor, 2 M. Gagnon, 1 I. Iloputaife, 1 P. Wayne, 3<br />
L. Lipsitz. 1,2 1. Institute for Aging Research, Boston, MA; 2. Beth<br />
Israel Deaconess Medical Center, Harvard Medical School, Boston,<br />
MA; 3. Osher Center for Integrative Medicine, Boston, MA.<br />
Background: The development of frailty in old age is accompanied<br />
by a loss in the dynamic “complexity” of standing postural control.<br />
In this case, complexity refers to the multi-scale structure contained<br />
within postural sway fluctuations, which is believed to arise<br />
from the numerous processes that regulate the body’s movements<br />
over time. Tai Chi is a mind-body exercise with goals of targeting multiple<br />
physiological processes and integrating their dynamics. We<br />
therefore hypothesized that Tai Chi training would increase postural<br />
sway complexity in frail older adults.<br />
Methods: Subjects were recruited from supportive housing facilities<br />
and randomized into a Tai Chi group (11 women and 3 men;<br />
age=83±6yrs) or educational control group (12 women and 3 men;<br />
age=84±8yrs). Tai Chi and education interventions consisted of two,<br />
60min instructor-led group sessions per week for 12 weeks. To assess<br />
postural sway, center-of-pressure dynamics were recorded during<br />
standing with eyes-open and eyes-closed. Postural sway complexity<br />
was estimated by multi-scale entropy analysis. Average sway speed<br />
and area were also computed. Cognition (i.e., Trail Making Test,<br />
TMT) and physical function (i.e., gait speed, timed up-and-go, TUG)<br />
were evaluated.<br />
S102<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
Results: Groups were similar in age, height, body mass, and<br />
baseline metrics of postural sway, cognition and physical function.<br />
Following the intervention, the Tai Chi group increased postural sway<br />
complexity when standing with eyes open (p = 0.001) and eyes closed<br />
(p = 0.05) as compared to controls. No changes were observed in the<br />
traditional metrics of sway speed or area. As compared to controls,<br />
the Tai Chi group also exhibited improved performance in the TMT<br />
(Part A, p = 0.04), 4-meter walk time (p = 0.04) and TUG (p = 0.04).<br />
The percent increase in eyes-open postural sway complexity after Tai<br />
Chi training related to percent increases in 4-meter walk (r 2 =0.34,<br />
p=0.02) and TUG (r 2 =0.29, p=0.05) performance.<br />
Conclusion: Tai Chi training effectively increased postural sway<br />
complexity in a cohort of older frail adults. As 1) no changes were observed<br />
in average sway speed or area, and 2) increased complexity<br />
was associated with improved physical function, we contend that Tai<br />
Chi may combat frailty by targeting the complex dynamics of the<br />
human postural control system.<br />
B87<br />
Polypharmacy and Prescribing Quality in Older HIV-Infected<br />
Adults.<br />
M. Greene, M. Steinman, K. Nicolas, V. Valcour. University of<br />
California San Francisco, San Francisco, CA.<br />
Supported By: NIH [K23-AG032872(VV), P50-AG023501(BM)],<br />
UL1 RR024131(UCSF GCRC), P30-AI027763(UCSF CFAR)] and<br />
the UCSF AIDS Research Institute<br />
Background: Advances in antiretroviral therapy have led to an<br />
aging HIV-infected population, with many individuals suffering from<br />
multiple chronic diseases. The burden of HIV and non-HIV disease<br />
puts patients at high risk for polypharmacy and medication-related<br />
complications, yet little is known about the characteristics and burden<br />
of prescribing problems in this population. Our aim was to describe<br />
the frequency of polypharmacy and prescribing quality issues in an<br />
older HIV-infected population.<br />
Methods: We performed a retrospective chart review of subjects<br />
enrolled in a cohort study of HIV infected adults age 60 and older in<br />
San Francisco. Total number of medications, frequencies of inappropriate<br />
medications as defined by the modified Beers criteria, anticholinergic<br />
drug burden as defined by the Anticholinergic Risk Scale,<br />
and potential drug-drug interactions were examined. The Lexicomp<br />
drug interactions database was used to analyze drug-drug interactions<br />
with a focus on severity scores D (consider therapy modification)<br />
and X (contraindicated). Findings were compared to age and<br />
gender matched HIV-negative controls.<br />
Results: 89 HIV-infected subjects’ medications were reviewed.<br />
Most subjects were Caucasian (91%) and male (94%) with a mean<br />
age of 64 (range 60-82). Common co-morbidities included hyperlipidemia,<br />
hypertension, peripheral neuropathy, and depression. A total<br />
of 1,198 medications were prescribed, with a mean of 13 medications<br />
per subject (range 2-38). At least one inappropriate medication was<br />
prescribed in 34 subjects (38%), most commonly zolpidem, alprazolam,<br />
and fluoxetine. A majority of subjects had at least one potential<br />
drug-drug interaction, with 65 (73%) having a category D interaction<br />
and 7 (8%) having a category X interaction. 15 subjects (17%) had an<br />
anticholinergic risk scale score of ≥3. In contrast, HIV-negative controls<br />
had a mean of 6 medications per subject, 18% had at least one<br />
inappropriate medication, and 4% had an anticholinergic risk scale<br />
score of 3 (p-value
P OSTER<br />
A BSTRACTS<br />
BMI=28.4, mean PSQI=8.7 and mean PHQ-9=4.6. Previously unrecognized<br />
SA was common, with a mean AHI=19.5; 49.3% of participants<br />
had AHI ≥15 (suggesting moderate-severe SA). 14.2% of all<br />
participants were prescribed BzRAs, and 11.5% reported using the<br />
BzRA during the study period. Among participants with moderatesevere<br />
SA, 9.6% were prescribed BzRAs and 8.2% actually used the<br />
medication. There were no significant differences between participants<br />
with or without moderate-severe SA in BzRA prescription<br />
(Chi-square=2.504, p=.157) or BzRA use (Chi-square=1.513, p=.303).<br />
CONCLUSIONS: We found that half of community-dwelling<br />
older Veterans meeting diagnostic criteria for insomnia had objective<br />
evidence of unrecognized moderate-severe SA. Nearly 10% of these<br />
individuals were prescribed BzRAs, some of which may worsen SA<br />
and increase risk for adverse health outcomes. Further research is<br />
needed to address the recognition and management of coexisting insomnia<br />
and SA in older adults.<br />
B90<br />
Pyridostigmine Improves Orthostatic Tolerance and Symptoms in<br />
Patients with Orthostatic Hypotension and Supine Hypertension:<br />
The Faint and Fall Clinic Experience.<br />
N. Sanders, 1 T. Jetter, 2 S. Wasmund, 2 C. Pacchia, 2 M. Hamdan. 2 1.<br />
<strong>Geriatrics</strong> Division, University of Utah, Salt Lake City, UT; 2.<br />
Cardiology Division, University of Utah, Salt Lake City, UT.<br />
Background: Orthostatic Hypotension (OH) is a common problem<br />
in the elderly. While midodrine helps OH, its use is often limited<br />
by the presence of supine hypertension (HTN). Pyridostigmine is an<br />
acetylcholinesterase inhibitor that increases sympathetic tone by improving<br />
cholinergic neurotransmission. Its efficacy in patients with<br />
OH remains uncertain.<br />
Methods: All patients with symptomatic OH and supine HTN<br />
were included. Supine, 1-min and 3-min orthostatic BP measurements<br />
were obtained at baseline and following 30 days of pyridostigmine at<br />
60 mg PO TID. The decreases in SBP and DBP at 1 and 3 minutes<br />
were assessed at baseline and compared to the 30-day follow-up values.<br />
Clinical symptoms were also assessed and categorized as worsening,<br />
no change or improving.<br />
Results: A total of 10 patients were enrolled with 2 patients not<br />
tolerating the drug (Mean age=75). At baseline, the supine BP and<br />
HR were 139/82 mmHg and 74 bpm. The mean decrease in SBP/DBP<br />
at 1 minute and 3 minutes were 28/12 mmHg and 31/10 mmHg respectively.<br />
After 30 days of drug therapy, the baseline supine BP and<br />
HR were 132/78 and 73 bpm. The mean decrease in SBP/DBP at 1<br />
minute and 3 minutes were 16/7 mmHg (p=0.055 for SBP; p=NS for<br />
DBP when compared to baseline) and 13/9 mmHg (p=0.05 for SBP;<br />
p=NS for DBP when compared to baseline) respectively (see Figure).<br />
All patients reported improvement in their symptoms.<br />
Conclusion: Pyridostigmine improves orthostatic tolerance and<br />
symptoms in patients with OH and supine HTN at 30 days. Its longterm<br />
efficacy awaits additional studies.<br />
B91<br />
Cancer, Functional Decline, and the Vulnerable Elders Survey<br />
(VES-13) in Older Medicare Beneficiaries.<br />
P. Wroe, 1 A. Naeim, 2 W. Dale, 1 L. Fan, 3 S. Mohile. 3 1. University of<br />
Chicago, Chicago, IL; 2. University of California, Los Angeles, Los<br />
Angeles, CA; 3. University of Rochester, Rochester, NY.<br />
Supported By: The Medical Student Training in Aging Research<br />
Program, the National Institute on Aging (T35AG026736), the John<br />
A. Hartford Foundation, the MetLife Foundation, and the Lillian R.<br />
Gleitsman Foundation.<br />
University of Rochester John Hartford Foundation Center of<br />
Excellence Grant (to Mohile).<br />
Background: The US population is aging rapidly, cancer is more<br />
prevalent among older adults, and older adults account for a large<br />
and growing percentage of cancer cases and deaths. The longitudinal<br />
association between a cancer history and functional decline has not<br />
been determined, nor has the use of the Vulnerable Elders Survey<br />
(VES-13) as a screening tool for predicting decline or death in older<br />
cancer survivors.<br />
Methods: Using data from the 2003 and 2004 Medicare Current<br />
Beneficiary Survey, we compared older adults with and without a cancer<br />
history on functional status (Activities and Instrumental Activities<br />
of Daily Living, I/ADLs), geriatric syndromes, and vulnerability<br />
(VES-13 score 3 or higher) with chi-squared tests of proportion. We<br />
used receiver operating characteristic (ROC) curves to assess the<br />
ability of the VES-13 survey instrument (VES-13 score 3 or higher) to<br />
predict functional decline or death one year after baseline.We defined<br />
functional decline as one of the following: a one-year increase of 2 or<br />
more functional deficits, one or more functional deficits after one year<br />
if zero functional deficits at baseline, or a nursing home admission.<br />
Results: Older Medicare beneficiaries with a cancer history<br />
(n=1,210) were significantly more likely than those without a cancer<br />
history (n=5,278) to have functional limitations (56.2% vs. 49.3%,<br />
p
P OSTER<br />
A BSTRACTS<br />
who reported an MD diagnosis of arthritis were asked to identify the<br />
location of their arthritis as well as the presence of pain and stiffness<br />
in their joints. Life-space (LS) was measured by distance, frequency<br />
and independence of movement within four weeks of the interview<br />
(range 0-120; higher scores represent greater mobility). Linear regression<br />
was used to examine the association of arthritis with LS adjusting<br />
for age, race, gender, rural residence, comorbidity, BMI, depression<br />
and cognitive impairment. LS among participants reporting<br />
a diagnosis of arthritis was examined using ANOVA according to location,<br />
number of joint types involved and the presence of joint pain<br />
and/or stiffness.<br />
Results: Of 1000 participants (50% male; 50% African <strong>American</strong>;<br />
51% rural; mean age (SD)=75.3 (6.7)), 662 reported an MD diagnosis<br />
of arthritis. Elders with arthritis had a significantly lower mean<br />
(SD) LS than those without arthritis (60.8±24.9 vs. 70.6±23.7 respectively;<br />
p
P OSTER<br />
A BSTRACTS<br />
Each subject’s score was calculated as a sum of the points for the diseases<br />
and conditions they had.<br />
RESULTS: The variables retained in the model were congestive<br />
heart failure (2 pts), peptic ulcer (1 pt), dementia (1 pt), cerebrovascular<br />
disease (1 pt) and history of tumor (1 pt). Using these, we created<br />
a score more parsimonious and more predictive than the Charlson<br />
score. Scores given by our tool and Charlson scores were used as<br />
predictors in a Cox model, revealing our score’s statistically significant<br />
predictive value (p
P OSTER<br />
A BSTRACTS<br />
sess caregiver burden, the surviving spouse reported whether assistance<br />
was provided with 6 ADLs and 4 IADLs in the last 3 months of<br />
life. To assess change in depressive symptoms and health, we compared<br />
CES-D (≥2 symptoms from the 8-item version) and self-rated<br />
health (good or better) reported by the surviving spouse in the interview<br />
waves before and after death.<br />
Results: A total of 555 caregivers were women (mean age=70.6;<br />
mean age of their deceased husbands=70.9) and 190 caregivers were<br />
men (mean age=73.1; mean age of their deceased wives =75.1). Overall<br />
the sample was 85% white, 12% African <strong>American</strong>, and 5% Hispanic.<br />
For decedents, cancer was the leading reported cause of death<br />
(41%). A majority (55%) of caregiver spouses provided help with<br />
bathing, 53% with dressing, 43% with transferring, 38% with walking<br />
37% with toileting, and 29% with eating. Assistance with IADLs was<br />
also common: 54% helped with medications; 39% helped with meals;<br />
29% helped with shopping; and 23% helped with phone calls. Men<br />
and women did not differ in terms of the ADL tasks they performed,<br />
but gender differences were observed with IADL assistance. Men<br />
provided more help with meals (57% vs. 33%, p
P OSTER<br />
A BSTRACTS<br />
There is growing evidence that the broader process of advance care<br />
planning (ACP) benefits patients at the end of life (EOL). Most clinicians<br />
receive little training in ACP and medical institutions often lack<br />
effective documentation tools.<br />
Purpose: 1) To assess whether an educational intervention for<br />
health care providers improves the quality of ACP discussion documentation;<br />
and 2) to describe the preferences for EOL care of older<br />
veterans.<br />
Methods: Interventions included 1) a new template for ACP discussion<br />
documentation introduced in electronic medical record in<br />
February 2009; 2), educational trainings by 2 staff geriatricians (lectures<br />
and small group discussions) emphasizing importance of ACP<br />
documentation. Continuous 100 ACP discussion notes were selected<br />
for review from pre-education period (PRE) and post-education period<br />
(POST) respectively. Designation of desired surrogate decision<br />
maker, use of quotes from patients or family, description of<br />
goal/value, limitation of medical care, and EOL setting were compared<br />
between PRE and POST.<br />
Results: PRE was 2/09-6/09 with 97 patients and POST was 4/11-<br />
8/11 with 93 patients. Patients in POST were younger (79.2 ± 9.5 vs<br />
75.1 ± 12.3, p=0.012), and more patients in POST have 1 or more comorbidities<br />
(66% vs 80%, p=0.036), and lacked decision-making capacity<br />
(9.3% vs 20.4%, p=0.040). Descriptions of desired medical care<br />
did not differ significantly (75% vs 80%, p=0.40), and among those<br />
notes with descriptions, 91% expressed desires for certain limitations.<br />
Among those who had decision-making capacity, there was no difference<br />
of designation of desired surrogate decision maker (92 % vs 87<br />
%, p=0.44). Description of goals/values (36% vs 52%, p=0.02) and<br />
EOL setting (8% vs 18%, p=0.04) increased significantly in POST.<br />
Among those notes without descriptions of desired medical care, specific<br />
reasons were documented in significantly more notes (36% vs<br />
70%, p=0.02).<br />
Conclusion: The vast majority of older veterans expressed desired<br />
limitations of medical care at EOL. Educational sessions to<br />
health care providers led to improved quality of ACP documentation.<br />
B102<br />
Rehospitalization of Older Adults Discharged to Hospice Care.<br />
A. M. Goldenheim, 1 D. Oates, 1 V. Parker, 2 M. Russell, 1 M. Winter, 2<br />
R. Silliman. 1,2 1. Boston University School of Medicine, Boston, MA;<br />
2. Boston University School of Public Health, Boston, MA.<br />
Supported By: <strong>American</strong> Federation for Aging Research<br />
T 35AG038027-01 (MSTAR)<br />
Background: Hospital readmission of older adults receiving hospice<br />
care can be traumatic, costly, and often preventable; acute care is<br />
generally not aligned with the goals of hospice. We identified factors<br />
associated with 30-day readmission of older adults newly discharged<br />
to hospice from Boston Medical Center.<br />
Methods: A structured medical record review of 59 patients, 19<br />
readmitted within 30 days and 40 randomly selected controls who<br />
were not readmitted, from 206 subjects newly discharged to hospice<br />
between February 1, 2005 and January 31, 2010. We collected information<br />
about disease characteristics, hospital course, end-of-life planning<br />
and decision-making, and post-hospitalization follow-up. We calculated<br />
bivariate associations and used a Cox Proportional Hazards<br />
model to examine the relation between index admission characteristics<br />
and readmission.<br />
Results: Subjects had a mean age of 79.7 ± 8.4; 74.6% were female.<br />
Among those readmitted, 25% received a palliative care consultation,<br />
compared to 47.1% of those not readmitted (p = 0.06). Patients<br />
who did not have a surrogate involved in their hospice decision<br />
had 3.5 times the risk of readmission with 30 days, compared to patients<br />
who had a surrogate involved in the hospice decision (HR 3.53,<br />
CI 0.97, 12.82). Patients who had one or more telephone contacts with<br />
their primary care physician (PCP) during the first week after discharge<br />
had 2.4 times the risk of readmission with 30 days, compared<br />
to patients who had no telephone contacts with PCPs during this period<br />
(HR 2.35, CI 0.9, 6.1).<br />
Conclusions: Readmission within 30 days of initial discharge to<br />
hospice appears to be associated with a lack of education and communication<br />
about the goals and course of hospice care. There is a<br />
need for greater support for the patient and family during the transition<br />
from hospital to hospice.<br />
B103<br />
Analysis of patient and clinician complaints related to care<br />
transitions in a large, urban teaching hospital.<br />
A. Levenson, 1 O. Hasan. 2 1. Mount Sinai School of Medicine, New<br />
York, NY; 2. Center for Clinical Excellence, Brigham and Women’s<br />
Hospital, Boston, MA.<br />
Supported By: This research is supported by the Medical Student<br />
Training in Aging Research program (MSTAR).<br />
Many patients experience problems during transitions from one<br />
care setting to another. Although patient concerns regarding care<br />
transitions have been investigated in small, focused studies, a systematic<br />
review of hospital-wide patient and clinician complaints has not<br />
been published to date. To fill this gap, we aggregated and analyzed<br />
all patient and clinician complaints related to care transitions filed at<br />
an 800-bed urban, teaching hospital from January through June 2011.<br />
We reviewed all relevant free-text complaints from three hospital reporting<br />
databases: clinician-filed Patient Safety Reports tagged “Coordination<br />
of Care” (n=208), Press-Ganey patient survey comments<br />
in the “Discharge” section of the survey (n=698), and Patient & Family<br />
Relations complaints tagged “Continuity of Care” and “Discharge”<br />
(n=138). Reports unrelated to transitions into or out of the<br />
hospital and complimentary comments were excluded from further<br />
analysis. Of 1044 reports initially reviewed, 468 were found to be relevant<br />
and were coded and examined in further detail. On the Press-<br />
Ganey patient survey (n=347), 92 (26.5%) of complaints were about<br />
delays in discharge, 46 (18.4%) were about unclear discharge instructions,<br />
and 49 (14.1%) were about patient unreadiness for discharge.<br />
Of the patient-generated Patient & Family Relations complaints<br />
(n=84), 24 (28.6%) concerned patient confusion or discomfort with<br />
the plan of care, 21 (25%) were about patient unreadiness for discharge,<br />
and 14 (16.7%) were about insufficient care coordination. Of<br />
the clinician-filed Patient Safety Reports (n=37), 18 (48.6%) were<br />
about poor communication between providers, 4 (10.8%) concerned<br />
unclear discharge instructions, and 3 (8.1%) were about insufficient<br />
care coordination. Gaps in communication emerged as a dominant<br />
theme in this analysis. Patients were most concerned about insufficient<br />
communication of the discharge plan, while both patients and<br />
clinicians felt that there was insufficient communication between clinicians<br />
during transitions in care.<br />
B104<br />
Improving Documentation of Advance Care Planning in an<br />
Electronic Medical Record.<br />
B. Chauhan, C. Chang, A. Kelley. Department of <strong>Geriatrics</strong> and<br />
Palliative Care, Mount Sinai School of Medicine, New York, NY.<br />
Background: Advance care planning (ACP) is important to promote<br />
patient dignity and autonomy in the setting of serious illness.<br />
Electronic medical records (EMR) may help improve communication<br />
among providers about ACP. Since 2005, the <strong>Geriatrics</strong> Practice<br />
at Mount Sinai Hospital, a patient centered medical home, has used<br />
an EMR for all aspects of patient care. While providers may discuss<br />
ACP regularly, monthly quality measures of ACP documentation are<br />
low (27%, July 2011). Thus, we aimed to understand how providers<br />
document and retrieve ACP discussions in the EMR.<br />
Methods: Using mixed methods, we first surveyed providers regarding<br />
their current pattern of documenting ACP and areas they felt<br />
S108<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
need improvement. We then conducted and audio-recorded semistructured<br />
interviews with providers to better understand practice<br />
patterns and challenges in documenting and retrieving ACP.<br />
Results: Of 42 providers, 33 (79%) responded to the survey. Despite<br />
low observed rates of ACP documentation (27%), 42.5% report<br />
discussing ACP with patients yearly and 30% state they have documented<br />
a Health Care Proxy for >50% of their patients. Yet 46% did<br />
not know how to document DNR orders; 79% had never received<br />
training on documenting ACP in the EMR; and 97% stated they<br />
would benefit from such training. Of 28 providers (14 fellows & 14 attendings)<br />
completing qualitative interviews, 24 (85%) said the primary<br />
place they document ACP discussions is the progress note for<br />
that visit, while 4 (14 %) primarily document the discussion in a permanent<br />
section of the chart (e.g., demographic notes). When asked<br />
about locating ACP information on another provider’s patient, interviewees<br />
commented, “People are having the conversations but documenting<br />
it all over the place”; “When you can’t find the discussions, it<br />
can significantly impact the trust of patients. It is a big problem.” On a<br />
likert scale of 1-5 (5= absolutely certain), providers averaged 1.8 on<br />
certainty of finding ACP documentation: “I do not know where to<br />
start”.<br />
Conclusions: Despite a well established EMR, ACP documentation<br />
varies widely among providers thus making this important information<br />
difficult to find. A standardized ACP template in a labeled<br />
section of the EMR and training providers to document ACP uniformly<br />
may enhance high-quality patient centered care.<br />
B105<br />
Self-rated Health and Memory Impairment. A Connection?<br />
D. Peng, 1 K. Connor, 1 S. Vassar, 1 M. Lee, 1 B. Vickrey, 1,2 J. Chodosh. 1,2<br />
1. VA GLAHS / UCLA, Los Angeles, CA; 2. RAND Health, Santa<br />
Monica, CA.<br />
Supported By: SCAN Health Plan<br />
Veterans Administration<br />
Background: Dementia has high personal and societal costs. Diagnoses<br />
are often substantially delayed, yet those with dementia are<br />
at greater risk for functional decline than non-demented patients.<br />
Cognitive screening applied to all older patients may be too stigmatizing<br />
and burdensome due to false positives. Thus, screening those atrisk<br />
for dementia through self-reported general health ratings - a<br />
known predictor of functional decline –may be desirable.<br />
Methods: Randomly selected seniors ≥ 75 years enrolled in a<br />
Southern California “Medicare Advantage” HMO and seen in a primary<br />
care practice between 2003 and 2006 to yield an analytic sample<br />
of ~300 was drawn from administrative data; those with an ICD code<br />
for dementia or prescription for anti-dementia medication were excluded.<br />
For consented subjects, cognitive impairment was assessed<br />
using the Memory Impairment Screen for Telephone (MIS-T), a 4-<br />
item cue-recall test. Self-reported health was measured using a 5-<br />
point scale (excellent, very good, good, fair, or poor). Cut-points predictive<br />
of dementia (MIS-T of ≤ 4) provided prevalence estimates<br />
and were used to assess specificity of self-rated health for memory<br />
impairment. Association between MIS-T scores and self-rated health<br />
were assessed using multivariable regression, controlling for age, gender,<br />
ethnicity, and education.<br />
Results: Of 458 potential subjects, 60% (N=275) were interviewed,<br />
of which 30% were male; mean age was 82.1 years; 83% were<br />
Caucasian; and 89% had at least a high school education. Fifteen percent<br />
(N=40) had MIS-T scores predictive of dementia. Overall, 29%<br />
(N=81) rated their health as “fair” (N=57) or “poor (N=24),” including<br />
55% (22 of 40) of those with memory impairment versus 25% (59<br />
of 235) of those without impairment (p-value75 years old, 658 (61%)<br />
failed a screen for > 1 condition (mean 1.6 conditions) and triggered a<br />
mean 7.1 QIs. Charts were reviewed for a randomly selected 485 of<br />
these. Approximately half (237 (49%) were seen by a NP for co-management.<br />
Overall 53% of QIs were passed. Quality scores for those<br />
seen by a NP were higher for all conditions except depression<br />
(Table).<br />
In multivariate analyses, adjusting for gender, age of patient,<br />
number of conditions, site, and a NP estimate of physician management<br />
style, team care remained significant (p
P OSTER<br />
A BSTRACTS<br />
variation in utilization of screening mammography in women with<br />
limited life expectancy at the level of the usual care provider (UCP)<br />
and associated physician characteristics.<br />
Methods: We used 100% Texas Medicare claims data to select a<br />
cohort of Texas female Medicare beneficiaries aged 67-90 years, with<br />
a life expectancy based on age and comorbidity of less than 7 years,<br />
and with an identifiable UCP. The sample contains 103,385 women<br />
and 11,554 UCPs. Data were linked to the <strong>American</strong> Medical Association<br />
masterfile to obtain UCP characteristics. Each woman was followed<br />
up for two years to measure her screening mammography utilization.<br />
Descriptive statistics and multilevel modeling were used for<br />
the analyses.<br />
Results: 28.4% of women with
P OSTER<br />
A BSTRACTS<br />
life care. Application of this benefit to NH residents has come under<br />
increasing scrutiny due to dramatic expansion in recent years and increasing<br />
costs. We used a unique merged dataset to describe trends<br />
over time in NH patients who used hospice.<br />
Methods:Between 1999-2009, data was collected on 33,387 people<br />
over age 65 who had contact with a large, urban public hospital<br />
which serves a population that is largely poor, about 60% women and<br />
35% black. Clinical data from the local comprehensive electronic<br />
medical record was merged with Medicare claims, Indiana Medicaid<br />
claims, Minimum Data Set, and Outcome and Assessment Information<br />
Set. Patients with a hospice claim and the sub-group of hospice<br />
patients in NHs were identified. We present trends over time with descriptive<br />
statistics.<br />
Results: 4361 patients used hospice in the 10 year period; about<br />
1/3 of overall decedents enrolled in hospice. About 1/3 of the overall<br />
cohort had a nursing home stay. There were 1260 patients who used<br />
hospice and lived in NHs. In this NH-hospice cohort 62% of patients<br />
were female; 61% were white and 38% were black. Average age at<br />
hospice enrollment was 81 years and did not change appreciably over<br />
time. A trend of increased enrollment over time was evident. The proportion<br />
of NH-hospice patients with non-cancer diagnoses increased<br />
over time from 35% in 1999 to 79% in 2009. In 1999, the median<br />
length of stay on hospice was 93 days (mean 195 days) and remained<br />
high throughout the study period. The overall median for the 10 year<br />
period was 85 days (mean 161). For hospice patients not in NHs, the<br />
median length of stay was 16 days (mean 58).<br />
Conclusions: Consistent with national data, the use of hospice<br />
by nursing home patients and proportion with non-cancer diagnoses<br />
has risen over time. A striking difference from other studies is the<br />
much longer length of stay of NH-hospice patients throughout the 10<br />
year study period. In contrast to our results, NH-hospice patients<br />
were found to have a median length of stay of 46 days in 1999 and a<br />
steady increase over time in a national sample. Additional analyses<br />
will use this rich dataset to probe factors affecting length of stay and<br />
use of hospice in this population of vulnerable older adults.<br />
B111<br />
Can primary care providers estimate remaining life expectancy in<br />
older adults with chronic kidney disease and other comorbidities?<br />
K. H. Campbell, 1 S. G. Smith, 2 C. Fox, 3 J. W. Mold, 4 J. W. Shega, 1<br />
W. Dale. 1 1. Section of <strong>Geriatrics</strong> and Palliative Medicine, University<br />
of Chicago, Chicago, IL; 2. Pritzker School of Medicine, University of<br />
Chicago, Chicago, IL; 3. UNYNET, University at Buffalo, Buffalo,<br />
NY; 4. OKPRN, University of Oklahoma, Oklahoma City, OK.<br />
Supported By: Supported by the John A. Hartford Foundation<br />
Center of Excellence in <strong>Geriatrics</strong> at the University of Chicago Pilot<br />
Research Award.<br />
Background: Estimating remaining life expectancy (RLE) is<br />
considered preferable to using age to guide medical decision-making<br />
for older adults. We evaluated whether primary care providers<br />
(PCPs) were able to estimate RLE in older patients with chronic kidney<br />
disease (CKD) and various comorbidities with known RLE associations.<br />
Methods: Using a cross-sectional survey of PCPs in 2 practicebased<br />
regional networks designed to evaluate referral decisions for<br />
older adults with chronic kidney disease, we developed clinical vignettes<br />
of older adults. Vignettes randomly varied 6 factors dichotomously<br />
(age, race, gender, presence of stage III congestive heart failure<br />
(CHF), ability to ambulate, and presence of moderate dementia)<br />
in a block factorial design. PCPs were asked to estimate RLE of vignette<br />
patients. We categorized vignettes as: 1) no comorbidities; 2)<br />
presence of CHF; 3) presence of dementia; and 4) presence of both<br />
CHF and dementia. Each category was assigned an “expected” RLE<br />
using life tables, placing each group into upper, middle, and lower<br />
quartiles by age and gender. We compared the mean RLE estimated<br />
by the PCPs with the expected RLE from life tables using t-test.<br />
Results: Eighty-two PCPs answered RLE questions about 8 randomly-assigned<br />
vignettes. Providers significantly underestimated<br />
RLE of patients assigned to the “no comorbidities”: women age 67<br />
RLE estimate 12.4 years versus life table expected RLE 21.3 years;<br />
p
P OSTER<br />
A BSTRACTS<br />
complex elders should consider extra clinic visits and resources (e.g.,<br />
pharmacy to review additional medication burden).<br />
B113<br />
Defining Fever in Nursing Home Patients.<br />
P. D. Sloane, 1,2 C. Kistler, 2 C. Mitchell, 1 A. S. Beeber, 4 R. Bertrand, 5<br />
S. Zimmerman. 1,3 1. Sheps Ctr for Health Services Research, Univ. of<br />
North Carolina at Chapel Hill, Chapel Hill, NC; 2. Department of<br />
Family Medicine, Univ. of North Carolina at Chapel Hill, Chapel Hill,<br />
NC; 3. School of Social Work, Univ. of North Carolina at Chapel Hill,<br />
Chapel Hill, NC; 4. School of Nursing, Univ. of North Carolina at<br />
Chapel Hill, Chapel Hill, NC; 5. Abt Associates, Inc., Cambridge, MA.<br />
Supported By: Agency for Healthcare Research and Quality<br />
Background: Existence of fever is often identified as a criterion<br />
for determining the “appropriate” use of systemic antibiotics; however,<br />
several different criteria exist for determining what temperature<br />
in a nursing home patient constitutes a fever.Among the more popular<br />
fever guidelines are those of Loeb et al., who defined fever as either<br />
37.9°C [100°F] or 1.5°C [2.4°F] above average routine temperature.<br />
Methods: To develop a more empirical basis for definition of<br />
fever, we evaluated 257 residents of six North Carolina nursing<br />
homes who had been treated with antibiotics for a presumed infection<br />
during a two month observation period. Data collected included<br />
the temperature recorded on the day the treatment was started, and<br />
three prior routine temperatures recorded when the residents were<br />
not ill. We then proposed to redefine fever based on the temperature<br />
distribution in the sample, and used that standard to evaluate<br />
whether or not fever was present at the time of a suspected infection<br />
for each of the 257 residents using both the standard Loeb fever criteria<br />
and this new definition.<br />
Results: The mean routine temperature was 97.8°F, with a standard<br />
deviation of 0.59°F. Based on these routine temperatures, we derived<br />
two empirical definitions of fever in nursing home patients: (1)<br />
a temperature of 99.0° F or higher (i.e., above the 95th percentile for<br />
the sample); or (2) 1.2° F (i.e., two standard deviations) above the average<br />
temperature for an individual patient. Applying these criteria<br />
to the 257 episodes of antibiotic prescribing, we found that 21% of<br />
urinary tract infections, 22% of respiratory infections, and 15% of<br />
skin infections treated with systemic antibiotics were accompanied by<br />
a fever. In contrast, 13% of urinary infections, 14% of respiratory infections,<br />
and 6% of skin infections met the Loeb fever criteria.<br />
Conclusions: The presence or absence of fever should be assessed<br />
using different criteria in nursing home patients from that used<br />
with the general adult populations. Whether, when, and how often a<br />
fever should be present for antibiotic prescribing to be considered<br />
“appropriate” remains debatable.<br />
B114<br />
Reducing Potentially Inappropriate Antibiotic Prescribing in<br />
Nursing Homes.<br />
S. Zimmerman, 2,4 P. D. Sloane, 1,2 A. S. Beeber, 3 C. Kistler, 1<br />
R. Bertrand, 5 L. Haddon, 5 C. Mitchell. 2 1. Dept. of Family Medicine,<br />
Univ. of North Carolina, Chapel Hill, NC; 2. Sheps Ctr for Health<br />
Services Research, Univ. of North Carolina, Chapel Hill, NC; 3.<br />
School of Nursing, Univ. of North Carolina, Chapel Hill, NC; 4.<br />
School of Social Work, Univ. of North Carolina, Chapel Hill, NC; 5.<br />
Abt Associates Inc., Cambridge, MA.<br />
Supported By: Agency for Healthcare Research and Quality<br />
Background: As concern regarding antibiotic-resistant organisms<br />
has reached global proportions, attention has become focused<br />
on populations in which prescribing is high and may be inappropriate.<br />
Nursing home residents are one such population.<br />
Methods: To examine the extent of potentially inappropriate antibiotic<br />
prescribing and the ability of educational efforts to reduce<br />
such prescribing, we conducted and evaluated a quality improvement<br />
program in six North Carolina nursing homes. The program had four<br />
components: 1) training physicians in antibiotic prescribing criteria,<br />
especially criteria prescribed by Loeb and colleagues; 2) training<br />
nursing home (NH) nurses in the use of a Medical Care Referral<br />
Form (MCRF) to report the signs and symptoms of the Loeb criteria<br />
to physicians; 3) providing information to residents, their family<br />
members, and other NH staff about antibiotic prescribing; and 4)<br />
maintaining contact with physicians and NH staff during a six-month<br />
quality improvement program, providing information about prescribing<br />
rates, concurrence with the Loeb criteria, and use of the MCRF.<br />
Results: At baseline, the number of monthly antibiotic prescriptions<br />
(unadjusted) ranged from 26-52 across the six NHs. Within three<br />
months of initiating the program, five of the six settings evidenced reduced<br />
prescribing ranging from 19-41%. Adherence to the Loeb criteria<br />
for prescribing increased for urinary tract infections (8% at<br />
baseline to 12% at follow-up), respiratory infections (2% at baseline<br />
to 8% at follow-up) and especially for skin infections (41% at baseline<br />
to 82% at follow-up). The MCRF was used to report information<br />
for only a minority of treated infections (from 0 to 17%).<br />
Conclusions: Antibiotic prescribing may be reduced in nursing<br />
homes through concerted efforts including prescriber training, more<br />
detailed and focused staff-prescriber communication, and patient and<br />
family education. While not all treated infections should meet published<br />
criteria for appropriateness, some further reduction in prescribing<br />
that does not meet criteria would likely constitute optimal care.<br />
The MCRF may be a mechanism to improve prescribing practices.<br />
B115<br />
Where Heroes Meet Angels:the Medical Foster Home.<br />
T. Edes, 3 C. Levy, 4 D. Goedken, 3 B. kinosian. 2,1 1. Univ of PA,<br />
Philadelphia, PA; 2. CHERP, Philadelphia VAMC, Philadelphia, PA;<br />
3. Dept. Veterans Affairs, Washington DC, DC; 4. Denver VAMC,<br />
Denver, CO.<br />
Background: Medical Foster Home (MFH) merges care in a personal<br />
home with an interdisciplinary home care team (IDT), such as<br />
VA Home Based Primary Care (HBPC). MFH is for veterans who<br />
cannot live independently because of complex chronic medical, psychological<br />
and functional impairments and lack of adequate family<br />
support. The Department of Veterans Affairs (VA) has rapidly expanded<br />
the availability of MFHs, growing from 3 programs in 2008 to<br />
over 56, with 358 foster homes caring for 484 veterans. Over 1,245 veterans<br />
have been served since program inception. All Veterans in<br />
MFH meet nursing home level of care. MFH is intended to be the Veteran’s<br />
home often until the end of life. HBPC provides comprehensive<br />
care in the home, as well as caregiver training and support.Veterans<br />
pay the MFH caregiver, approximately $1800 to $2500 per month.<br />
Methods: All 56 MFH programs for FY 2011 were analyzed in<br />
terms of their expenses (administration, coordination, HBPC-IDT<br />
management of complex care needs) and their revenue, creating an<br />
internal, virtual firm. We operationalized revenue as the lowest-cost<br />
nursing facility care VA could provide to veterans who were eligible<br />
to have VA covered nursing home care (veterans in Priority Group<br />
1A), crediting monthly NH payments each month a P1A veteran was<br />
in MFH. In FY2011, the community NH rate VA paid was<br />
$7076/month, while HBPC and MFH administration cost<br />
$1520/month. We also examined savings if VA were to cover the<br />
MFH housing cost of $2400/mo for P1A veterans.<br />
Results: During FY 2011, census grew from 297 total and80 P1A<br />
to 454 total and 132 P1As at year end. Discharges averaged<br />
6%/month (240 for FY2011), with 13% to an assisted living facility,<br />
9% to a nursing home, 18% to their own or family’s home, and 49%<br />
due to death. With a total of 4459 MFH months/1217 months for<br />
P1As, expenses would be $6.372M with revenues of $8.61 M, or a net<br />
margin of $2.24M (35% ROI). Serving 27% P1A veterans, the program<br />
would still be slightly in the black ($6.4M in net revenue, or a<br />
S112<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
net margin of $48,980), if it covered the housing payment now made<br />
by the veteran.<br />
Conclusion: Medical Foster Home is a cost-saving alternative to<br />
nursing home care. When organized as a virtual “firm”, a MFH program<br />
can generate savings for further non-institutional care investment,<br />
improving the re-balancing of long term living dollars.<br />
B116<br />
Improving Care for Frail Elders: A Home-Visiting Provider<br />
Program for Medicare Advantage Members.<br />
J. M. McBride, 1 R. D. Laird, 2 L. C. Hanson. 1 1. Division of Geriatric<br />
Medicine and Center for Aging and Health, University of North<br />
Carolina at Chapel Hill, Chapel Hill, NC; 2. Health First Aging<br />
Institute, Melbourne, FL.<br />
Supported By: Health First Health Plan, Melbourne, Florida;<br />
INSPIRIS, Inc., Brentwood, Tennessee;<br />
Center for Aging and Health, University of North Carolina at<br />
Chapel Hill<br />
Background: A Medicare Advantage plan in Florida desired to<br />
improve the hospital readmission rate of members with repeated hospitalizations<br />
and multiple medical co-morbidities, many of whom had<br />
barriers to access. The plan partnered with a physician house call<br />
company in 2004 to implement a home visit program, and evaluated<br />
its effect on hospitalization rates.<br />
Program Description: Patients were eligible for the program if<br />
they had > 1 hospitalization in the previous 12 months and multiple<br />
chronic illnesses; participation was voluntary with no additional cost<br />
to the patient. Home visits were provided by physicians and nurse<br />
practitioners who were employed full-time by the program; participants<br />
maintained relationships with their primary care physicians.<br />
Home visits were provided as needed, but no less than monthly. A<br />
provider was always on call, making home visits on nights and weekends<br />
as necessary. Telephonic nurse case managers were an integral<br />
component of the program, coordinating and facilitating care.<br />
Results: The program served 997 patients during 2010. 59%<br />
were female, the mean age was 80.4 years, and the mean number of<br />
major chronic disease diagnoses (included in the Medicare Hierarchical<br />
Condition Categories model) was 2.96 per patient. The hospitalization<br />
rate in 2010 for program participants was 1,047 per thousand<br />
person- years, compared to an expected hospitalization rate of 2,611<br />
using actuarially adjusted baseline data. For the entire 23,000 member<br />
plan, the 30-day hospital readmission rate in 2010 was 15.2%,<br />
compared to a baseline readmission rate of 18.2%. The decrease in<br />
the 30-day readmission rate for the plan closely corresponded to the<br />
decrease in hospitalizations among the program participants.<br />
Conclusions:Implementation of a physician and nurse practitioner<br />
home visit program is associated with a reduced hospitalization rate for<br />
high risk geriatric patients. Clarification of the role of the home-visiting<br />
provider as a“house call specialist”co-managing the member collaboratively<br />
with the primary care physician was important in gaining acceptance<br />
from members as well as community physicians.Community physicians<br />
now see the program as an important resource for their most<br />
vulnerable patients, and regular referrals to the program continue.<br />
B117<br />
Patients Surviving 6 Months in Hospice Care: Who are they?<br />
L. Rothenberg, 1,5 G. Cordts, 2 L. Simon, 3 J. Gryczynski, 4<br />
D. Doberman. 3 1. Stony Brook School of Medicine, Port Jefferson,<br />
NY; 2. Geriatric Medicine and Gerontology, Johns Hopkins Bayview<br />
Center, Baltimore, MD; 3. Gilchrist Hospice Care, Hunt Valley, MD; 4.<br />
Friends Research Institute, Baltimore, MD; 5. Medical Student<br />
Training in Aging Research (MSTAR) Program, Johns Hopkins<br />
School of Medicine, Baltimore, MD.<br />
BACKGROUND: In 2011, CMS regulation required U.S. hospices<br />
to conduct a “face-to-face” (F2F) assessment of ongoing hospice<br />
eligibility for all patients entering their 3rd certification period.<br />
Using a cohort of patients enrolled in hospice we sought to characterize<br />
those requiring F2F assessment.<br />
METHODS: Retrospective program records were obtained for<br />
hospice patients enrolled 6 months prior to January 1, 2011 (N=375).<br />
Patients who remained in hospice on January 1, 2011 and received a<br />
F2F (n=140) were compared to patients who were no longer in hospice<br />
(n=235) on demographics, terminal condition, presence of comorbidity,<br />
length of stay, and hospice outcome using bivariate statistics.<br />
Predictors of F2F assessment were examined using a multivariable logistic<br />
regression model controlling for demographics, setting of care<br />
prior to admission, comorbidity, and primary terminal diagnosis.<br />
RESULTS: Patients with a F2F were older (p64 years of age and reside within 35 miles<br />
of the Durham, NC VA. Comprehensive in-home needs assessments<br />
are performed by the COACH RN and social worker, with subsequent<br />
case review by the full COACH team (geriatrician, geriatric<br />
psychiatrist, geriatric pharmacist, RN, geriatric social worker) and<br />
recommendations are made to PCP. Individualized follow-up plans<br />
are developed and monitored.<br />
Data from the 92 p-cd enrolled during the first 12 months of the<br />
program’s existence were analyzed. Rates of NHP were tracked and<br />
compared with historical controls. Health delivery was evaluated using<br />
percentage of caregivers receiving education on available resources,<br />
identification of patients with behavioral disturbance, and number of<br />
geriatric psychiatry referrals. Caregiver burden was measured at baseline<br />
and over time with the Caregiver Strain Index (CSI). Quality of life<br />
was evaluated by caregiver satisfaction survey. Costs, cost avoidance<br />
and savings were estimated and compared with accepted averages for<br />
similar community populations to determine cost-effectiveness.<br />
RESULTS<br />
Three COACH patients were placed in nursing homes as compared<br />
with the estimated average annual risk of NHP for COACH<br />
patients of 13%, or 6 patients (50% reduction). Average CSI score<br />
was reduced by one point, from 7 to 6. 90% of caregivers reported<br />
AGS 2012 ANNUAL MEETING<br />
S113
P OSTER<br />
A BSTRACTS<br />
satisfaction with the program. COACH is estimated to have saved the<br />
health care system $223,000 in a year by delaying NHP.<br />
CONCLUSIONS<br />
The COACH program reduced NHP in its first year of existence,<br />
while also improving dementia care delivery, caregiver burden<br />
and quality of life. These outcomes were achieved cost-effectively.<br />
The COACH program represents an innovative collaborative care<br />
model for patients with dementia.<br />
B119<br />
Knowledge-To-Action for Delirium Prevention: Diffusion of the<br />
Hospital Elder Life Program (HELP).<br />
T. T. Hshieh, 1 P. Chen, 1 S. Dowal, 2 S. K. Inouye. 1,2 1. Internal<br />
Medicine, Beth Israel Deaconess Medical Center, Boston, MA; 2.<br />
Hebrew SeniorLife, Harvard Medical School, Boston, MA.<br />
Background: Delirium is a common, increasingly prevalent condition<br />
among older hospitalized patients with significant morbidity<br />
and mortality. HELP has been a successful evidence-based model of<br />
care to prevent delirium and functional decline in hospitalized elders,<br />
which has been disseminated widely. Knowledge translation and diffusion<br />
in healthcare is important but often challenging, and theoretical<br />
frameworks to do so effectively are underutilized.<br />
Aim: To evaluate the effectiveness and scope of the HELP diffusion<br />
process (2000-2011), we applied the Knowledge-To-Action<br />
framework (Straus 2009) to determine adherence of HELP diffusion<br />
to best practices in translation and diffusion.<br />
Methods: The Knowledge-To-Action framework consists of 10<br />
phases (3 knowledge creation, 7 action phases), incorporating knowledge<br />
translation into a collaborative, multi-level, systems-based approach.<br />
The 3 knowledge creation phases are: inquiry, synthesis, products/tools.<br />
The 7 action phases are: identify problem/knowledge,<br />
adapt to local context, assess barriers, implement intervention, monitor<br />
use, evaluate outcomes, sustain use.<br />
Results: HELP adheres to all 10 phases of the Knowledge-To-<br />
Action framework (See Table). Many HELP diffusion steps were assignable<br />
to more than one feature.<br />
Conclusions: The HELP diffusion process followed best practices<br />
in translation of knowledge. The steps to evaluate efficacy, costeffectiveness,<br />
adaptations, barriers, and ongoing outcomes may have<br />
helped contribute to its success. We hope this case example may assist<br />
others in developing their own effective knowledge translation programs<br />
for innovations in geriatrics.<br />
HELP Diffusion Adheres To Knowledge-To-Action Framework<br />
B120<br />
Factors associated with Survival after Stroke among Elderly Women<br />
in the WHI.<br />
C. L. Bell, 1 A. LaCroix, 2 S. Smoller, 3 K. Masaki, 1 J. Curb, 1<br />
E. M. Hade, 4 T. Manini, 5 W. Mysiw. 6 1. Geriatric Medicine, University<br />
of Hawaii John A Burns School of Medicine, Honolulu, HI; 2. Fred<br />
Hutchinson Cancer Research Center, Seattle, WA; 3. Epidemiology &<br />
Social Medicine, Albert Einstein College of Medicine, Bronx, NY; 4.<br />
Center for Biostatistics, Ohio State University, Columbus, OH; 5.<br />
Aging and Geriatric Research, University of Florida, Gainesville, FL;<br />
6. Physical Medicine & Rehabilitation, Ohio State University,<br />
Columbus, OH.<br />
Supported By: National Heart, Lung and Blood Institute<br />
Background: Data are limited on factors affecting long-term<br />
post-stroke survival in older women.<br />
Methods: Women’s Health Initiative (clinical trials and observational<br />
study) data on women aged 50-79 and stroke-free at baseline,<br />
with incident stroke prior to 2005, were analyzed for survival through<br />
2010. Prestroke physical function used Rand-36 subscale scores<br />
(range 0-100, higher=better).<br />
Results: Of 3,173 women, 2,062 (65%) survived through 2010;<br />
1,111 (35%) died. On multivariable Cox models, prestroke factors associated<br />
with post-stroke mortality included: older age at stroke<br />
(HR=1.07, 95%CI= 1.05-1.08, p
P OSTER<br />
A BSTRACTS<br />
trolling for resident demographics, acuity, and facility characteristics,<br />
there was a 2.8% (Standard Error 0.01; p=0.004) increase in death at<br />
30 days and a 3.9% (Standard Error 0.01; p=0.008) increase in death<br />
at 90 days for residents with severe dementia who evacuated for Hurricane<br />
Gustav.<br />
Conclusions: Nationwide, of the approximately 1.6 million<br />
adults who live in nursing homes, an estimated 50% to 70% carry a<br />
diagnosis of Alzheimer’s disease or a related dementia. This research<br />
reveals the deleterious effects of evacuation on residents<br />
with severe dementia. Interventions need to be developed and<br />
tested to determine the best methods for protecting this at-risk<br />
population when there are no other options than to evacuate the<br />
facility.<br />
B122<br />
Proteinuria in Mid-Life and Cognitive Function in Late-Life: The<br />
Honolulu-Asia Aging Study.<br />
M. Higuchi, 1 R. Chen, 2 C. Bell, 1 L. Wongvarcharoen, 1 W. Ross, 3,1<br />
H. Petrovitch, 1,2 L. Launer, 4 R. Abbott, 1 K. Masaki. 1,2 1. Geriatric<br />
Medicine, University of Hawaii, Honolulu, HI; 2. Kuakini Medical<br />
Center, Honolulu, HI; 3. VA Pacific Islands Healthcare System,<br />
Honolulu, HI; 4. National Institute on Aging, Bethesda, MD.<br />
Supported By: The National Heart, Lung, and Blood Institute; the<br />
National Institute on Aging; Veterans Affairs Pacific Islands<br />
Healthcare Systems; John A. Hartford Foundation Center of<br />
Excellence in <strong>Geriatrics</strong>, University of Hawaii.<br />
Background: Impairment of renal function has been linked to<br />
cognitive impairment. There are few longitudinal studies of proteinuria<br />
and cognitive function. We assessed mid-life proteinuria and<br />
cognitive decline or incident dementia in an elderly Asian male population.<br />
Methods: The Honolulu Heart Program (HHP) is a prospective<br />
study that began in 1965 with 8,006 Japanese-<strong>American</strong> men ages 45-<br />
68 years. Mid-life proteinuria was detected by urine dipstick at exam<br />
3 (1971-74). Subjects were classified into 3 groups: no proteinuria,<br />
trace, and positive. The Honolulu-Asia Aging Study of dementia<br />
began 20 years later with HHP exam 4 (1991-93) with 3,734 men ages<br />
71-93 years. Global cognitive function was assessed by the Cognitive<br />
Abilities Screening Instrument (CASI) (score range 0-100). Cognitive<br />
decline was defined as drop in CASI score of >=1 SD (>=10<br />
points at 3 years, >=14 at 6 years, >=14 at 8 years). Standard criteria<br />
were used to classify 8-year incident dementia (DSM-IIIR),<br />
Alzheimer’s Disease (NINDS-ADRDA), and Vascular Dementia<br />
(California ADDTC).<br />
Results: No proteinuria was found in 97.2% of subjects, trace in<br />
1.7% and positive proteinuria in 1.1%. Age-adjusted incident dementia<br />
rates increased significantly from 13.8, to 22.8, to 39.7 per 1,000<br />
person years follow-up, among those with no, trace and positive proteinuria<br />
respectively, p=0.004. Using multiple logistic regression adjusting<br />
for age, education, apoE4, prevalent stroke, hypertension, diabetes,<br />
and baseline CASI, those with positive proteinuria were more<br />
likely to have cognitive decline (3-year decline OR=2.89, 95%<br />
CI=1.28-6.55, p=0.011; 6-year decline OR=3.46, 95% CI=1.15-10.4,<br />
p=0.027; 8-year decline OR=3.74, 95% CI=1.15-12.1, p=0.028), using<br />
no proteinuria as reference. Multivariate Cox regression found a significant<br />
association between positive proteinuria and all-cause incident<br />
dementia (RR=2.71, 95% CI=1.20-6.09, p=0.016) and incident<br />
Vascular Dementia (RR= 6.38, 95%CI=1.98-20.5, p=0.002), using no<br />
proteinuria as reference.<br />
Conclusion: Proteinuria in mid-life was an independent predictor<br />
for late-life incident dementia and cognitive decline over 8<br />
years. This association needs to be confirmed in other ethnic groups<br />
and women.<br />
B123<br />
Effect of rapamycin in a mouse model of synucleinopathy.<br />
M. Hughes, 1 M. Wey, 2 X. Bai, 2 A. Martinez, 2 E. Fernandez, 2,3<br />
R. Strong. 2,3 1. School of Medicine, UTHSCSA, San Antonio, TX; 2.<br />
Pharmacology, Barshop Institute for Longevity and Aging Studies,<br />
San Antonio, TX; 3. Geriatric Research, Education and Clinical<br />
Center, South Texas Veterans Health Care Network, San Antonio, TX.<br />
Supported By: MH was supported by the MSTAR program, the<br />
<strong>American</strong> Federation for Aging Research and the NIA. Support for<br />
this project also included PHS grants AG022307, AG036613 and<br />
AG13319 and by a grant from the Department of Veterans Affairs<br />
Medical Research Program (RS).<br />
Background: Synucleinopathies, including Parkinson’s disease<br />
(PD), multiple system atrophy and the Lewy body variant of<br />
Alzheimer’s disease (AD), are age-related neurodegenerative disorders<br />
characterized by expression of pathological intracellular inclusions<br />
containing α-synuclein. Mice transgenic for α-synuclein containing<br />
the human A53T mutation, expressed specifically in neurons,<br />
exhibit severe motor symptoms. Rapamycin has been shown to be<br />
neuroprotective in mouse models of several neurodegenerative disorders,<br />
including AD, Huntington’s disease and PD. However, it was<br />
unknown whether rapamycin would be effective in an animal model<br />
of synucleinopathy. The aim of this study was to determine whether<br />
rapamycin reduces accumulation of α-synuclein and attenuates<br />
motor deficits in A53T transgenic mice.<br />
Methods: Mouse diet containing microencapsulated rapamycin<br />
(14 ppm in diet; 2.25 mg/kg body weight/day) was fed to age-matched<br />
wild type and A53T transgenic mice from 13 to 41 weeks of age. The<br />
control diet contained the microencapsulation material. The mice<br />
were assessed on several tests of motor performance including the<br />
pole test, forepaw stepping adjustment test, accelerating rotarod, grip<br />
strength test, gait performance and the challenging beam traversal<br />
test. Expression of α-synuclein in midbrain, striatum, cerebellum, and<br />
spinal cord was tested by Western analysis.<br />
Results: Rapamycin significantly improved performance on the<br />
forepaw stepping adjustment test, the rotarod and the pole test in<br />
both genders of transgenic mice. Rapamycin significantly reduced<br />
error steps on the challenging beam traversal test in male, but not female,<br />
transgenic mice. Feeding rapamycin had no effect on grip<br />
strength or stride length or any effect in wild-type mice. Rapamycin<br />
significantly reduced expression of human α-synuclein in midbrain<br />
and spinal cord, but not in striatum or cerebellum.<br />
Conclusions: Rapamycin significantly attenuated motor deficits<br />
in the A53T mice by reducing human α-synuclein expression in midbrain<br />
and spinal cord. Further experiments will determine whether<br />
the effect of rapamycin is through enhancement of autophagy and<br />
whether rapamycin prevents neurodegeneration.<br />
B124<br />
Does Slow Reaction Time Predict Incident Parkinson’s Disease?:<br />
The Honolulu-Asia Aging Study.<br />
M. Inaba, 1 M. Kamal, 1,2 R. D. Abbott, 1 K. Fong, 2 C. Bell, 1<br />
H. Petrovitch, 1,2 C. Tanner, 4 W. G. Ross. 3,1 1. Geriatric Medicine,<br />
University of Hawaii, Honolulu, HI; 2. Kuakini Medical Center,<br />
Honolulu, HI; 3. Veterans Affairs Pacific Islands Healthcare System,<br />
Honolulu, HI; 4. The Parkinson’s Institute, Sunnyvale, CA.<br />
Supported By: National Parkinson Foundation; the National<br />
Institute on Aging; Veterans Affairs Pacific Islands Healthcare<br />
Systems; John A. Hartford Foundation Center of Excellence in<br />
<strong>Geriatrics</strong>, University of Hawaii.<br />
Introduction: Many studies have shown a deficit in reaction time<br />
(RT) in Parkinson’s disease (PD) patients. To date, there have been<br />
no longitudinal population-based studies of RT and incident PD. We<br />
studied whether RT may identify individuals at risk for PD among<br />
elderly Japanese-<strong>American</strong> men.<br />
AGS 2012 ANNUAL MEETING<br />
S115
P OSTER<br />
A BSTRACTS<br />
Methods: The Honolulu-Asia Aging Study (HAAS) is a longitudinal<br />
cohort study of aging, cognition and movement disorders in<br />
Japanese-<strong>American</strong> men in Hawaii, which began in 1991 among survivors<br />
of the Honolulu Heart Program cohort, followed since 1965.<br />
The fifth examination cycle was held in 1994-96, when 2,705 men ages<br />
74 to 95 years were examined. Subjects were administered simple RT<br />
(SRT) and choice RT (CRT) tests performed with a laptop computer.<br />
Subjects were divided into quartiles based on reaction time. Diagnosis<br />
of PD was based on consensus from at least 2 neurologists according<br />
to published criteria. Incident PD data were available for 7 years<br />
of follow-up, and those with prevalent PD were excluded. Separate<br />
analyses were performed for SRT and CRT, using the lowest quartile<br />
of each as reference.<br />
Results: There were 25 cases of incident PD during follow-up,<br />
and incidence rates increased by quartiles of SRT, from 5.7, to 20.0, to<br />
19.1, to 25.0 per 10,000 person-years follow up, p for trend=0.03.<br />
Using multivariate Cox regression, adjusting for age, education, baseline<br />
cognitive test score, prevalent stroke, handedness, handgrip<br />
strength, percent SRT error rate and amount of caffeine intake, men<br />
in the highest (slowest) quartile of SRT were significantly more likely<br />
to develop incident PD (RR=5.32, 95% CI=1.05-26.9, p=0.04). Analyses<br />
were repeated on men who were cognitively intact at baseline and<br />
without prevalent stroke, and those in the highest quartile of SRT still<br />
had higher incidence of PD (RR=5.03, 95% CI=0.96-26.2, p=0.055).<br />
We found no significant associations between CRT and incident PD.<br />
Conclusions: Men in the slowest quartile of SRT were significantly<br />
more likely to develop incident PD compared to those in the fastest<br />
quartile. Measurement of RT is a low-cost method that may help to<br />
identify those at risk for PD who may benefit from early intervention.<br />
B125<br />
Neuropsychological and Functional Performance in Adult<br />
Protective Services Clients.<br />
M. T. Le, D. J. Goldstein, J. E. Schillerstrom. University of Texas<br />
Health Science Center at San Antonio, San Antonio, TX.<br />
Supported By: The research reported on this abstract was supported<br />
by Hartford/AFAR Medical Student Training in Aging Research<br />
(MSTAR) Program.<br />
Background: In fiscal year of 2010, Texas Adult Protective<br />
Services (APS) validated 56,053 cases of neglect, abuse, or exploitation.<br />
The UTHSCSA Department of Psychiatry performs decisionalcapacity<br />
assessments across Region 8 which encompasses 29 Texas<br />
counties. In Texas, the legal definition of decisional capacity is heavily<br />
dependent on the functional status of the client. The purpose of this<br />
study was to determine which cognitive domains contribute independent<br />
variance to instrumental activities of daily living (IADL) in<br />
elderly APS referrals. Methods: We performed a retrospective<br />
medical record review of referrals (n=157 of which n=75 subjects<br />
completed all measures), calculated Spearman correlation coefficients<br />
between cognitive and functional scores, and regressed neuropsychological<br />
measures onto IADL to search for independent contributions.<br />
Results: There was no correlation between IADL and<br />
the Geriatric Depression Scale. IADL correlated significantly with<br />
the Executive Interview (r=0.68, p
P OSTER<br />
A BSTRACTS<br />
RESULTS: Participants had a mean age of 77.6 (SD=5.8, range<br />
69-98), 42% were African <strong>American</strong>, 50% were female, and 29% and<br />
20% had eGFR levels 45-59 and
P OSTER<br />
A BSTRACTS<br />
B130<br />
Early Discontinuation of Adjuvant Chemotherapy among Veterans<br />
with Colon Cancer.<br />
H. Riggs, 1,4 K. Lane, 1 S. Rawl, 3,4 P. Loehrer, 1,4 S. Hui, 1 M. Weiner. 1,2 1.<br />
Indiana University School of Medicine, Indpls, IN; 2. Center of<br />
Excellence on Implementing Evidence-Based Practice, VHA HSR&D<br />
HFP 04-148 at Richard L. Roudebush VA Medical Center, Indpls, IN;<br />
3. Indiana University School of Nursing, Indpls, IN; 4. Indiana<br />
University Melvin and Bren Simon Cancer Center, Indpls, IN.<br />
Supported By: John A. Hartford Foundation<br />
BACKGROUND: Standard therapy for patients (pts) with<br />
colon cancer and high-risk features or lymph node involvement is 6<br />
months (mos) of adjuvant chemotherapy (C) after surgical resection.<br />
Receipt of 5 mos or less of C may be a marker for inferior outcomes.<br />
Whether advanced age, regimen-specific or other clinical and demographic<br />
factors are associated with delivery of C is uncertain. We evaluated<br />
the association of baseline characteristics and planned C regimen<br />
with C delivery in pts with resected colon cancer.<br />
METHODS: We identified stage II or III colon cancer pts from<br />
our local VA tumor registry and assembled a cohort who initiated C<br />
at our VA between 2004 and 2010. C delivery was measured as the<br />
percentage of planned cumulative dose (PCD) of C that was actually<br />
delivered. Baseline characteristics were pts’ demographics, disease<br />
stage, travel distance to the treatment site, Adult Comorbidity Evaluation-27<br />
score (ACE), and lab results. We classified C as oral<br />
capecitabine- or intravenous 5-fluorouracil-based and as oxaliplatinor<br />
non-oxaliplatin-containing. Linear regression tested each association<br />
with PCD. Toxicities, hospitalization, and other reasons for modifying<br />
or discontinuing C were recorded.<br />
RESULTS: Fifty pts (98% male) initiated C for stage II (n=6)<br />
and III (n=44) disease. Median age was 63 years (range 41-82); median<br />
baseline estimated glomerular filtration rate (GFR) was 83<br />
mL/min/1.76 m 2 (range 26-171); 76% were white; 28% were married;<br />
52% had moderate or severe comorbidity; 74% received oxaliplatin;<br />
and 24% received oral capecitabine. The median travel distance was<br />
40 miles. The median PCD was 75%; median treatment duration was<br />
5 mos. Lower PCD was associated with older age (P=0.05), lower<br />
GFR (P=0.05), higher travel distance (P=0.02), and receipt of<br />
capecitabine (P
P OSTER<br />
A BSTRACTS<br />
ther studies should target the evaluation of connective tissue markers<br />
and pathological mechanisms linking low BMD and pelvic floor<br />
symptoms.<br />
B133<br />
Biomarkers of Joint Metabolism and the Severity of Radiographic<br />
Hand Osteoarthritis.<br />
I. Perjar, 1 A. Shi, 1 Y. Golightly, 1 J. Renner, 1 A. Nelson, 1 V. Kraus, 2<br />
J. Jordan. 1 1. Thurston Arthritis Research Center, UNC School of<br />
Medicine, Chapel Hill, NC; 2. Duke University School of Medicine,<br />
Durham, NC.<br />
Supported By: <strong>American</strong> Federation for Aging Research, <strong>American</strong><br />
College of Rheumatology<br />
Background: Osteoarthritis (OA) is a joint disorder traditionally<br />
diagnosed using physical examination and radiographic imaging.<br />
Focus has turned to the possibility of using biomarkers of joint metabolism<br />
to assess the extent of joint damage and understand the biological<br />
processes involved in OA. Most studies to date have examined<br />
biomarkers in relation to knee OA, but few have investigated biomarker<br />
patterns in hand OA (hOA) in diverse populations. We examine<br />
the association of two biomarkers with hOA in a bi-racial population-based<br />
study.<br />
Methods: The sample consisted of 667 African <strong>American</strong> (AA)<br />
and Caucasian adults (37% AA, 49% men, mean age 64 years, mean<br />
BMI 30 kg/m 2 ) with available hOA and biomarker data from the<br />
Johnston County Osteoarthritis Project, a prospective cohort of OA<br />
in a rural county in North Carolina. Radiographs were obtained for<br />
the DIP (distal interphalangeal), PIP (proximal interphalangeal),<br />
MCP (metacarpophalangeal), and CMC (carpometacarpal) joints, as<br />
well as the knees and hips. Radiographic OA in a joint was defined as<br />
a Kellgren-Lawrence score of ≥2. We examined urine C-terminal<br />
crosslinked telopeptide of type II collagen (CTX-II), a marker of collagen<br />
breakdown, and serum hyaluronic acid (HA), a component of<br />
cartilage and synovium, in relation to hOA defined by hand joint<br />
group affected and total number of hand joints affected. Separate<br />
multiple regression models were used to estimate the association between<br />
each hOA outcome and biomarker, adjusting for race, gender,<br />
age, BMI, and knee and hip OA status.<br />
Results: The prevalence of radiographic OA in the sample was<br />
26% for hand, 27% for hip, and 36% for knee. Looking at individual<br />
joint groups, CTX-II was associated with OA at the DIPs (p
P OSTER<br />
A BSTRACTS<br />
IgE antibodies in serum. Additional work is needed to test large numbers<br />
of samples for clinical application.<br />
B136<br />
Does this Patient have Benign Prostatic Hypertrophy with Bladder<br />
Outlet Obstruction?<br />
K. A. D’Silva , 1 P. Dahm, 2 C. L. Wong. 1 1. Geriatric Medicine,<br />
University of Toronto, Toronto, ON, Canada; 2. Urology, University of<br />
Florida, Gainesville, FL.<br />
Background: Although benign prostatic hyperplasia (BPH) is<br />
very common in older men, not all men with histologic BPH will develop<br />
the non-specific symptoms known as lower urinary tract symptoms<br />
(LUTS). Likewise, not all men with LUTS have histologic BPH.<br />
Bladder outlet obstruction (BOO) refers to the pressure gradient at<br />
the bladder neck/prostatic urethra which can be measured by invasive<br />
urodynamics. Accurate diagnosis of BOO is important because it<br />
can cause not only immediate symptoms including severe pain and<br />
urinary retention but also lead to complications, e.g.incontinence and<br />
renal insufficiency.<br />
Objective: To systematically review the evidence on the diagnostic<br />
accuracy of office-based tests for BPH with BOO in males<br />
with LUTS.<br />
Methods: Search of MEDLINE and EMBASE (from 1950 to<br />
August 12, 2010), Cochrane Central Register of Controlled Trials via<br />
Ovid, and references of retrieved articles, to identify diagnostic studies<br />
of patients with LUTS due to BPH with BOO.<br />
Data selection: Prospective studies comparing at least one diagnostic<br />
test, feasible in a clinical setting and readily available to a nonspecialist<br />
clinician, to the gold standard reference test, invasive urodynamic<br />
studies. Studies were excluded if they used pediatric patients<br />
or if participants had confounding medical conditions.<br />
There were 6692 unique citations identified with 9 prospectively<br />
conducted studies (N=1217 patients) meeting inclusion criteria and<br />
describing use of 2 symptom questionnaires as well as individual<br />
symptom(s). All tests were administered and scored based on international<br />
guidelines. The best constellation of symptoms that suggested<br />
BPH with BOO was ‘poor stream and frequency and/or nocturia’<br />
(positive LR, 1.76; 95% CI, 1.17- 2.64). The most useful<br />
symptom in which the absence made a diagnosis of BPH with BOO<br />
less likely, was nocturia (negative LR, 0.19, 95% CI, CI 0.05-0.79). The<br />
best symptom questionnaire to support or rule out a diagnosis of<br />
BPH with BOO was the International Prostatic Symptom Score (I-<br />
PSS) at a cut-off of 8 (summary positive LR, 1.34; 95% CI, 1.06-1.70;<br />
summary negative LR, 0.28, 95% CI, CI 0.12-0.70).<br />
Conclusions: Although urodynamic investigations are the gold<br />
standard for diagnosis of BPH with BOO, symptoms obtained<br />
through history may be useful for diagnosis. The best evidence supports<br />
asking the patient about nocuturia, stream and frequency.<br />
B137<br />
Predicting Mortality Following Clostridium difficile Infection.<br />
L. Archbald-Pannone, 1,2 R. Pinkerton, 1,3 R. Guerrant. 1,3 1. Internal<br />
Medicine, University of Virginia, Charlottesville, VA; 2. Division of<br />
General Medicine, <strong>Geriatrics</strong>, and Palliative Care, University of<br />
Virginia, Charlottesville, VA; 3. Division of Infectious Diseases and<br />
International Health, University of Virginia, Charlottesville, VA.<br />
Supported By: NIH/ NIAID 5K23AI074681-04<br />
Background: With increasing incidence & severity of Clostridium<br />
difficile (C. difficile) infection (CDI), there are no objective factors<br />
at diagnosis that have been proven to predict poor outcome. We<br />
evaluated demographics, co-morbidities, medications, & laboratory<br />
tests in a cohort of hospitalized patients to determine factors that<br />
could predict death following CDI diagnosis. Methods: After obtaining<br />
consent, adult inpatients with CDI diagnosed in our hospital<br />
(September 2008-May 2010, UVA HSR-IRB 13630) were followed 12<br />
months after C. difficile diagnosis to determine short-term mortality<br />
(STM, 1 month) & long-term (LTM, 12 months). Age & Charlson comorbidities<br />
score were calculated on day of CDI diagnosis. White<br />
blood cell count (WBC) & renal function (BUN, GFR, & Creatinine)<br />
were recorded on day of diagnosis; serum albumin recorded within 7<br />
days of diagnosis (mean, if multiple); & medications prior to diagnosis<br />
were recorded. Binary logistic regression (SPSS 19) determined a<br />
model to best predict mortality, using univariate predictors of mortality<br />
(student’s t-tests, chi-squared) & backward regression to eliminate<br />
non-significant factors. Significance set p ≤ 0.05. Results: 85 subjects;<br />
age 63.4 years (sd 16.9); Charlson score 5.8 (sd 4.0); time to death 2.4<br />
months (sd 3.6); STM rate 32.9% (n=28); LTM rate 52.9% (n=45).<br />
Factors associated with STM & LTM, respectively: age (both<br />
p
P OSTER<br />
A BSTRACTS<br />
Table 1. Multivariable Odds Ratios (95% Confidence Intervals) for<br />
Malignancy by Serum Ferritin Level<br />
B139<br />
IL-6 inhibits erythroid maturation in human TF-1<br />
erythroleukemia cells.<br />
N. M. Cruz, 1 B. J. McCranor, 1 F. Peña-Cruz, 1 A. E. Berger, 2<br />
C. Cheadle, 2 C. I. Civin, 3 C. N. Roy. 1,4 1. Division of Geriatric<br />
Medicine, Johns Hopkins University School of Medicine, Baltimore,<br />
MD; 2. Lowe Family Genomics Core, Johns Hopkins University<br />
School of Medicine, Baltimore, MD; 3. Center for Stem Cell Biology<br />
& Regenerative Medicine and Departments of Pediatrics and<br />
Physiology, University of Maryland School of Medicine, Baltimore,<br />
MD; 4. Division of Hematology, Johns Hopkins University School of<br />
Medicine, Baltimore, MD.<br />
Supported By: MSTAR/AFAR 5T35AG026758-07; <strong>American</strong><br />
<strong>Society</strong> for Hematology Scholars Award (CNR); R01 DK082722<br />
Background: Approximately 10% percent of adults over 65<br />
years of age are anemic. One-third of cases can be attributed to anemia<br />
of inflammation (AI). Aging, even in the absence of disease, can<br />
be considered a chronic pro-inflammatory state. Interleukin-6 (IL-6)<br />
increases with age and is elevated in the serum of patients with AI.<br />
We tested the hypothesis that IL-6 inhibits erythroid precursor maturation.<br />
To provide rationale for future studies in human volunteers,<br />
we used TF-1 human erythroleukemia cells as an in vitro model of<br />
human erythroid maturation and AI.<br />
Methods: We incubated TF-1 cells overnight in basal medium,<br />
and then treated the cells for 3-4 days with erythropoietin (Epo) to<br />
induce erythroid maturation in the presence or absence of 100 ng/mL<br />
of human IL-6. Erythroid maturation was assessed by staining with<br />
CD44 and glycophorin A (GYPA) monoclonal antibodies and flow<br />
cytometry. We performed quantitative RT-PCR to measure fold<br />
changes in expression of aminolevulinic acid synthase 2 (ALAS2)<br />
and band 3 (SLC4A1), which are markers of heme biosynthesis and<br />
erythroid maturation.<br />
Results: We found that Epo-treated TF-1 cells became phenotypically<br />
more mature, as measured by CD44 and GYPA. The mature<br />
population was 45 ± 11% of total cells, but this population was<br />
reduced to 33 ± 9% of total cells with IL-6 treatment. ALAS2 expression<br />
increased in Epo-treated cells to 10 times that of untreated<br />
cells (p
P OSTER<br />
A BSTRACTS<br />
contribution by heightened immune activation to age-associated accelerated<br />
HIV disease progression has not been delineated.<br />
Methods: Prospective, age-differentiated, multicenter cohort<br />
study of older (≥45 years) and younger (18-30 years) subjects who received<br />
192 weeks of a uniform ART regimen. Age-group differences<br />
in the time course of a diverse array of immunologic indices were assessed<br />
with adjustment for other correlates of T cell restoration in<br />
mixed-effects models.<br />
Results: 90 subjects enrolled in this cohort, including 45 younger<br />
(median age 26, range 18-30 yrs) and 45 older (median age 50, range<br />
45-79 yrs) subjects. The increases of naive, memory and total CD4<br />
cells, and naïve CD8 cells per week with ART did not differ significantly<br />
between the age-groups, but older subjects maintained significantly<br />
fewer circulating naive ( P
P OSTER<br />
A BSTRACTS<br />
ing decisions when patients develop dementia. The purpose of this<br />
study was to describe the perspectives of family caregivers toward<br />
forgoing or continuing cancer screening.<br />
We audio-taped and transcribed focus group sessions with a<br />
convenience sample of caregivers of patients with dementia attending<br />
4 local Alzheimer’s Association support groups. Session topics included<br />
recent experiences with screening decisions and preferences<br />
for patient-clinician communication. The interviews were coded independently<br />
by all investigators to identify key themes using methods<br />
of grounded theory.<br />
We conducted 4 focus group sessions with 32 caregivers of patients<br />
with dementia. Mean age was 65.5 (range 49-85), 25 were<br />
women, 7 were African <strong>American</strong>, 24 white, and 1 African <strong>American</strong>/Indian.<br />
Caregivers were 14 daughters, 13 were spouse, and 5<br />
other. The most important factor in making decisions about screening<br />
tests preserving the patient’s Quality of Life. One said, “I was concerned<br />
about her quality of life and making sure that she was very,<br />
very comfortable, and I think that means more than putting people<br />
through a lot of unnecessary, uncomfortable…procedures.” The second<br />
theme involved the Increasing Burdens and Decreasing Benefits<br />
of continued screening as dementia worsened. Specifically, the inability<br />
to understand procedures and patient agitation increased the test<br />
burdens. Caregivers noted their own Pivotal Role in Decision Making,<br />
often stepping in to stop invasive tests and deciding when to take<br />
over decision making from the patient. Caregivers noted variable levels<br />
of Physician Knowledge/Expertise, with some having limited<br />
knowledge of the course or challenges of dementia.<br />
Caregivers of patients with dementia consider cancer screening<br />
tests in light of their impact on quality of life. Given their perceptions<br />
of the changing balance of burdens and benefits as dementia worsens,<br />
many caregivers choose to forgo screening. The perspective of caregivers<br />
contrasts with prior research on patient perspectives, which<br />
finds that many patients plan to continue screening for themselves<br />
despite possible future declines in health.<br />
B145<br />
Older Adult Opinions of “Advanced Driving Directives”<br />
M. E. Betz, 1 S. Lowenstein, 1 R. Schwartz. 2 1. Emergency Medicine,<br />
University of Colorado School of Medicine, Aurora, CO; 2. Division<br />
of <strong>Geriatrics</strong>, University of Colorado School of Medicine, Aurora, CO.<br />
Supported By: Emergency Medicine Foundation and John A<br />
Hartford University of Colorado Denver Center of Excellence.<br />
BACKGROUND: Discussions and decisions about driving retirement<br />
are difficult. “Advanced driving directives” [ADDs], similar<br />
to advanced directives for end-of-life care, would allow drivers to designate<br />
a person to help make decisions about driving cessation when<br />
their driving skills decline. It is not known if older drivers support the<br />
idea of ADDs; we sought to describe older adults’ experiences and<br />
opinions about driving discussions and ADDs”.<br />
METHODS: A convenience sample of English-speaking adults<br />
(55+ years) at two independent living facilities and two community<br />
centers were invited to complete an anonymous survey.<br />
RESULTS: Of the 168 participants, 133 (80%) were female and<br />
the median age was 76.5 (range: 56-93) years. Most reported driving a<br />
motor vehicle at least occasionally (96%; 95%CI:92-98) and only<br />
29% (95CI:22-37) found driving somewhat or very stressful. Seven<br />
percent (95CI:4-12) reported a crash in the past year. Most participants<br />
(73%; 95CI:66-80) supported mandatory age-based driver testing;<br />
of these, half (50%; 95CI:40-59) though testing should begin at<br />
age 80 or higher. More thought that the driver (71%; 95CI65-78),<br />
family (61%; 95CI:53-68) or physician (59%; 95CI:51-66) should determine<br />
license revocation for an unsafe driver rather than the department<br />
of motor vehicles (32%; 95CI:25-39). A minority had spoken<br />
with someone about driving safety (5%; 95CI:2-10) or wishes<br />
when driving skills decline (21%; 95CI:15-28); of these, 83%<br />
(95CI:67-94) had spoken with a family member but only 17%<br />
(95CI:6-33) with a healthcare provider. However, older adults were<br />
open to discussions (table) and 54% (95CI:46-62) said they would<br />
complete an ADD if recommended. Of these, 79% (95CI:69-87) said<br />
it was likely or very likely they would follow the ADD in the future.<br />
CONCLUSION: Older drivers are open to driving discussions<br />
with physicians, supporting the important physician role in counseling<br />
and coordinating conversations about driving. Advanced planning<br />
with ADDs may facilitate future decisions about driving retirement.<br />
B146<br />
Walking Ability is Associated with Pain, Depression, and<br />
Overweight among Community Dwelling Older Adults.<br />
N. Satchidanand , 1 C. Fox, 1 K. Brunton, 2 G. S. Cherr . 2 1. Family<br />
Medicine, State University of New York at Buffalo, Buffalo, NY; 2.<br />
Surgery, State University of New York at Buffalo, Buffalo, NY.<br />
Supported By: <strong>American</strong> <strong>Geriatrics</strong> <strong>Society</strong>: Dennis W. Jahnigen<br />
Career Development Scholars Awards Program.<br />
BACKGROUND: Maintenance of mobility is an important goal<br />
for the elderly. Impaired physical function limits the ability of older<br />
adults to live independently and is strongly associated with declining<br />
health. The association between physical comorbidities and disability<br />
is well studied. However, less is known about the influence of modifiable<br />
factors on physical function. The study purpose was to examine<br />
the influence that select treatable factors have on walking ability<br />
among older adults.<br />
METHODS: A total of 200 subjects, age ≥65 were included<br />
(62.5% female). Depressive symptoms, psycho-social stress and<br />
chronic pain were assessed using literature validated questionnaires.<br />
Body mass index (BMI) was calculated. Physical function was assessed<br />
using the Six Minute Walk Test. Pre-existing medical conditions<br />
which may impact walking ability (i.e. PAD, COPD, CHF) were<br />
also assessed. Path analysis was performed to characterize the contribution<br />
of each predictor variable (depression, stress, chronic pain,<br />
BMI) on distance walked and to derive path coefficients, R 2 -values<br />
and probability values.<br />
RESULTS: The predictor variables demonstrated low to moderate<br />
correlations with one another, (0.27 to 0.54). Depressive symptoms,<br />
pain and BMI (but not psychosocial stress) were significant predictors<br />
of distance walked.The overall causal model accounted for about 30%<br />
of the variance in distance walked among all patients. After adjusting<br />
for pre-existing medical conditions, the proposed model still accounted<br />
for about 30% of the variance in distance walked.The strongest association<br />
with distance walked was with chronic pain for both the overall<br />
model (β = -.296, p < .01) and adjusted model (β = -.250, p < .01).<br />
CONCLUSIONS: Among community dwelling older adults,<br />
three treatable factors were significantly associated with impaired<br />
walking ability. These associations remained after adjusting for medical<br />
conditions that are also associated with impaired physical function.<br />
Further research is needed to determine the most efficacious interventions<br />
to treat depression, ameliorate chronic pain, and prevent weight<br />
gain in aging in order to preserve physical function and quality of life.<br />
B147<br />
“SERIOUSLY ILL OCTOGENARIANS &<br />
NONAGENARIANS”– ROLE OF PALLIATIVE CARE<br />
CONSULTS IN INITIATING “DO NOT ESCALATE CARE”<br />
PATHWAY AND DISCHARGE TO HOSPICE IN SERIOUSLY<br />
ILL OLDEST OLD PATIENTS ADMITTED TO A TERTIARY<br />
ACADEMIC MEDICAL CENTER.<br />
F. Kawai, V. Periyakoil. Stanford University School of Medicine,<br />
Stanford, CA.<br />
Supported By: Stanford University School of Medicine<br />
Background:<br />
AGS 2012 ANNUAL MEETING<br />
S123
P OSTER<br />
A BSTRACTS<br />
The oldest old (age>85yo) are the fastest growing segment of<br />
the US population<br />
About 27% of Medicare’s annual $426 billion budget goes to<br />
care for patients in their final year of life, with acute hospitalizations<br />
being a major cost.<br />
Evidence supports improved clinical and utilization outcomes<br />
with palliative care consults for seriously ill patients and increased<br />
patient and family satisfaction.<br />
The goal of this study was to assess the role of palliative care<br />
consults(PCC)in preventing futile escalation of care in a cohort of seriously<br />
ill oldest old inpatients.<br />
Methods:<br />
A retrospective chart review of palliative care consults in a tertiary<br />
academic medical center between August 2008 and June 2011<br />
yielded 314 patients >85 yo. Charts were reviewed to extract patient<br />
demographics,admitting diagnosis, inpatient mortality and disposition<br />
post PCC including initiation of “Do Not Escalate Care” pathway<br />
and facilitation of Hospice discharge.<br />
Results:<br />
-Of the 314 patients identified, there were 148 males (47%) and<br />
166 females (53%).153 patients (49%) were nonagenarians.<br />
-Admission diagnosis included Cancer: 25% (77), Stroke:15%<br />
(48), Cardiac:15% (47), Dementia: 12% (36), Pulmonary: 6% (8), and<br />
Other (including infection, falls, failure to thrive, Hepatic & Renal<br />
disease): 27% (86)<br />
-36% (113 patients) died during the course of hospitalization.<br />
-PCC resulted in the initiation of the “Do Not Escalate Care”<br />
pathway in 73% (229 patients) during the hospitalization.<br />
-Of the 201 patients who did not die during the hospitalization,hospice<br />
was initiated in 60% (113 patients): 32% home hospice,<br />
22% long term care facility with hospice, 6% inpatient hospice. Non<br />
hospice discharges: 17% SNF and 18% home. No discharge data<br />
available: 5%.<br />
Conclusions:<br />
-Oldest old inpatients had a high (36%) in hospital mortality.<br />
Most deaths were expected and due to serious illnesses including<br />
Cancer, Stroke, end stage cardiac, lung and renal disease.<br />
-PCC resulted in initiation of the “Do Not Escalate Care” pathway<br />
in 73% of the patients, thereby preventing ineffective interventions<br />
(such as CPR, invasive procedures, ICU care) in this seriously ill<br />
population of older adults;<br />
-PCC facilitated discharge to hospice in 60% of the survivors,<br />
thereby promoting comfort and quality of life while avoiding prolonged<br />
hospitalizations.<br />
B148<br />
Predicting Mortality in End Stage Dementia: A Retrospective<br />
comparison of Medicare Guidelines and Mitchell Criteria for<br />
Hospice Referral.<br />
J. Almeida, M. C. Galicia-Castillo. Internal Medicine/<strong>Geriatrics</strong>,<br />
Eastern Virginia Medical School, Norfolk, VA.<br />
Background: Dementia is the sixth-leading cause of death posing<br />
a significant cost of $183 billion annually(1). The progression of<br />
the disease is variable, with the end stage lasting as long as three<br />
years(2). Current guidelines for predicting six-month mortality have<br />
been under scrutiny; they are not evidenced-based and were never<br />
studied prior to implementation as hospice criteria(3,4). Mitchell et al<br />
derived a mortality risk index for six-month mortality using items<br />
from the minimum data set. The objective of this study was to compare<br />
the Mitchell risk index to Medicare guidelines in predicting sixmonth<br />
mortality in end-stage dementia(3).<br />
Methods: A retrospective chart review of patients who died<br />
from dementia in a nursing home facility from January 2004 through<br />
December of 2009 was performed. Data points from three, six and<br />
twelve months prior to death were collected from the minimum data<br />
set. At each point subjects were coded as eligible or ineligible for hospice<br />
according to Mitchell risk index and Medicare guidelines.<br />
Results: At six months prior to death, out of 24 subjects, the<br />
Mitchell risk index score identified 13 (54%) as eligible for hospice<br />
and Medicare guidelines identified six(25%; p =0.16). Three months<br />
prior to death, out of 24 subjects Mitchell risk index identified 19<br />
(79%); using Medicare guidelines identified nine(37.5%, p=0.118)<br />
Conclusion: Current guidelines for predicting six-month mortality<br />
for appropriate hospice referral for end-stage dementia are inaccurate.<br />
The Mitchell risk index may be a better tool to help clinicians<br />
better prognosticate six-month mortality and employ hospice services<br />
earlier.<br />
References<br />
1 Herbert, LE; Scherr, PA; Bienias, JL; Bennet, DA. Alzheimer<br />
Disease in the U.S. Population: Prevalence Estimates Using the 2000<br />
Census. Archives of Neurology August 2003:60(8)1119-1122.<br />
2 Shuster, J. Palliative Care for Advanced Dementia. Clinics in<br />
Geriatric Medicine 2000: 16(2).<br />
3 Mitchell, SL; Kiely, DK; Hamel, MB; Park, PS; Morriss, JN;<br />
Fries, BE. Estimating Prognosis for Nursing Home Residents with<br />
Advanced Dementia. JAMA2004:291 (22) 2734-2740.<br />
4 Schonwetter RS, Han B, Small BJ, Martin B, Tope K, Haley<br />
WE. Predictors of six-month survival among patients with dementia.<br />
<strong>American</strong> Journal of Hospice and Palliative Care 2003:(20):105-113.<br />
B149 Encore Presentation<br />
Pain is good for you? Non-cancer pain predicts improved 5-year<br />
survival.<br />
J. Shega, 1 M. Andrew, 2 D. Lau, 3 K. Herr, 4 M. Ersek, 5 D. Weiner, 6<br />
W. Dale. 1 1. Medicine, University of Chicago, Chicago, IL; 2.<br />
Medicine, Dalhousie University, Halifax, NS, Canada; 3. Pharmacy,<br />
University of Illinois, Chicago, IL; 4. Nursing, University of Iowa, Des<br />
Moines, IA; 5. Nursing, University of Pennsylvania, Philidelphia, PA;<br />
6. Medicine, University of Pittsburgh, Pittsburgh, PA.<br />
Supported By: NIA<br />
Background: Non-cancer pain is known to result in significant<br />
morbidity, but little is known about its impact on mortality. We assessed<br />
the relationship of self-reported non-cancer pain at baseline<br />
and subsequent 5-year mortality among community-dwelling older<br />
adults.<br />
Methods: We analyzed data from a large prospective cohort<br />
study, the 1996 wave of the Canadian Study of Health and Aging.<br />
Non-cancer pain was assessed using the 5-point verbal descriptor<br />
scale, dichotomized into “no/very mild” versus “moderate” or greater<br />
pain. Frailty was measured as the sum of self-reported health (1<br />
item), social support (1 item), co-morbidity (17 items), and functional<br />
abilities (14 items) with each item scored from 0 to 1, ranging from 0-<br />
33, with higher scores indicating greater frailty. Cognitive status was<br />
measured using the Modified Mini-Mental Status Exam, ranging<br />
from 0-100, with a score 11<br />
indicating depression. Multivariable logistic regression was used to<br />
analyze the relationship between pain and mortality, controlling for<br />
other factors.<br />
Results: Of the 5,703 participants, 4,694 (82.3%) had complete<br />
data for analysis. Of these, 35.4% reported moderate or greater pain<br />
and 28.6% had died at 5-year follow-up. The 5-year mortality odds<br />
increased by 1.12 (CI: 1.10, 1.13); p
P OSTER<br />
A BSTRACTS<br />
older adults are needed to better understand its trajectory, associated<br />
factors, and outcomes.<br />
B150<br />
Factors associated with enrollment in a randomized controlled trial<br />
of oxycodone vs acetaminophen for moderate or greater noncancer<br />
pain.<br />
J. Shega, C. Ogbevire, W. Dale. Medicine, University of Chicago,<br />
Chicago, IL.<br />
Supported By: NIA<br />
Background: Studies document the under-identification and<br />
treatment of non-cancer pain among older persons. In addition optimal<br />
pharmacologic management remains unclear.<br />
An obstacle of analgesic use in this setting is lack of high-quality<br />
comparative effectiveness data comparing acetaminophen to opioids<br />
in community-based populations, particularly African <strong>American</strong>s<br />
(AA). We sought to identify factors associated with the likelihood of<br />
older adults enrolling in a randomized control trial (RCT) of these<br />
therapies.<br />
Methods: A face-to-face screening questionnaire was completed<br />
for all referred older adults who were eligible for an analgesic intervention<br />
conducted in a predominantly AA, community-based geriatrics<br />
clinic. Information elicited from the screening questionnaire included<br />
basic demographics, pain intensity (verbal descriptor scale: 0<br />
[no pain] to 5 [excruciating pain], frequency of pain in the past week,<br />
number of painful sites, mobility difficulty, and presence of adequate<br />
social support.<br />
Results: Among the first 50 participants (46/50, 96%, AA) referred,<br />
15 (30%) elected to enroll in the RCT. The most commonly<br />
cited reasons for not enrolling were: 1) infrequency of pain (6%) and<br />
2) fear of opioid-related side effects (8%). Age was not associated<br />
with likelihood of enrollment, 82.2 ( SD=6.78) years versus 82.0<br />
(SD=6.72) years, p=0.94. Gender (female) 31% vs 69%, p=0.55, pain<br />
severity 2.87 ( SD=1.1) versus 3.18 ( SD=1.2), p=0.40, number of<br />
painful sites 2.6 (SD=1.6) versus 2.1 (SD=1.4), p=.53, mobility difficulty<br />
60% versus 40%, p=0.31, and availability of social support 93%<br />
versus 97%, p=1.00 were also not associated with study enrollment.<br />
Those who reported pain everyday, compared with those reporting<br />
pain 1-3 times per week were more likely to enroll, 100% versus<br />
31%., p=0.065.<br />
Conclusion: In this preliminary analysis, the number of older,<br />
primarily AA adults in a community setting enrolled in a RCT that<br />
included an opioid mirrored the rates from cancer clinical trials.<br />
Common stated reasons for not enrolling were concern for side effects<br />
and pain considered insufficient for treatment. The experience<br />
of pain everyday was positively associated with enrollment, while age,<br />
gender, pain intensity, number of pain sites, mobility difficulty, and social<br />
support were not associated with study enrollment. This is unique<br />
information on AA enrollment in RCT for pain management.<br />
B151<br />
Experiences of informal caregivers of older adults discharged from<br />
nursing homes to the community through the Money Follows the<br />
Person Demonstration Program.<br />
L. Kristof, C. Butler, J. Robison, R. Fortinsky. Center on Aging,<br />
University of Connecticut, Farmington, CT.<br />
Background: The multi-state Money Follows the Person (MFP)<br />
Demonstration Program enables Medicaid recipients residing in<br />
nursing homes to move back to their communities. Little is known<br />
about how family and other informal caregivers are affected by older<br />
adults returning to the community after what was considered longterm<br />
nursing home residence. We examined caregiver burden and the<br />
positive aspects of caregiving in caregivers of older adults (age >65)<br />
enrolled in Connecticut’s MFP who were discharged to the community<br />
after a nursing home stay of more than 3 months. Secondary outcomes<br />
evaluated were depressive symptoms and anxiety in caregivers.<br />
Methods: In this cross-sectional study, caregivers completed a<br />
self-administered questionnaire 6 months after their family members<br />
returned to the community. We asked caregivers about stress levels<br />
compared to previous time points. Caregiver burden was measured<br />
using the Modified Zarit Burden Interview. Positive aspects of caregiving<br />
were evaluated using the COPE index. We evaluated for symptoms<br />
of depression using the 2 question PRIME-MD screen. Statistical<br />
analysis was done using SPSS.<br />
Results: Preliminary results from 21 caregivers were analyzed<br />
(M age = 57, range 30-77; 81% female; 48% live with the MFP participant;<br />
32% work full time, 53% do not work). The mean Burden<br />
Index score was 5.38 (M=5.38, Range 0-12); mean score for the<br />
COPE index was 8.85 (M=8.85, Range 0-10). Compared to the time<br />
when the older adults resided in nursing homes, 75% of caregivers<br />
felt less stressed, 10% felt the same stress, and 15 % felt more<br />
stressed. Compared to the period before nursing home admission,<br />
61.1% of the caregivers felt less stress, 27.8% felt the same stress, 11.1<br />
% felt more stressed. Burden scores and COPE index scores were not<br />
significantly different whether caregiver lived with the MPF participant<br />
or not (Burden M=4.2 vs. M=6.45, p=0.081; COPE M=9.6 vs. M=<br />
8.18, p=0.234).<br />
Conclusions: Preliminary results suggest a decrease in caregiver<br />
stress and, compared to other studies of community-based caregivers,<br />
lower levels of caregiver burden and higher levels of positive aspects<br />
of caregiving for caregivers of older MFP participants in CT.<br />
B152<br />
FUNCTIONAL OUTCOMES AND HEALTH RELATED<br />
QUALITY OF LIFE AFTER TRANSCATHETER AORTIC<br />
VALVE IMPLANTATION IN ELDERLY PATIENTS WITH<br />
SEVERE AORTIC STENOSIS.<br />
M. G. Mendieta F., 1 N. F. Pereyra, 1 E. Sánchez G., 1 E. Gutierrez, 2<br />
F. Fernández Aviles, 2 H. Bueno, 2 M. Vidán A.. 1 1. Geriatry, Gregorio<br />
Marañón Hospital, Madrid, Madrid, Spain; 2. Cardiology Service,<br />
Gregorio Marañon Hospital, Madrid, Madrid, Spain.<br />
Background: Transcatheter aortic valve implantation (TAVI)<br />
improves survival in patients with aortic stenosis unelegible for surgery.<br />
The changes in patients functional performance and quality of<br />
life (QoL) after TAVI are not well known.<br />
Methods: The change in health related quality of life (SF-12<br />
questionnaire), autonomy for activities of daily living (ADL), mobility<br />
and social help was prospectively evaluated in a cohort of consecutive<br />
patients one month after TAVI. Demographic and clinical characteristics,<br />
in-hospital complications and clinical evolution were also<br />
evaluated.<br />
Results: Between January 2009 and November 2011, 57 patients<br />
were enrolled in the Cardiology Department, with a mean age of 82.2<br />
± 5.7 years. Thirty-day mortality was 12,2%. Among survivors, 58%<br />
improved cardiac symptoms, 26% improved mobility, and 15% improved<br />
autonomy for ADL but 30% increased dependency for ADL.<br />
In addition, 41% needed new social or private help for daily living.<br />
Baseline SF-12 physical summary was 36.3± 10 and baseline mental<br />
summary was 43±9.2. Both scores showed modest improvements<br />
after one month: 2.9±9.6 (p=0.04) and 2.7±11.6 (p=0.02), for physical<br />
and mental scores, respectively. The proportion of patients with relevant<br />
improvement (>2points) in physical health was 47.7%, and<br />
59.1% in mental health. No significant association between cardiac<br />
symptoms improvement and changes in quality of life was found.<br />
Conclusions: Most inoperable patients with severe aortic stenosis<br />
show improvements in symptoms and quality of life one month<br />
after TAVI but the changes are modest in absolute terms and not always<br />
associated with functional improvement. Longer-term follow-up<br />
is ongoing.<br />
AGS 2012 ANNUAL MEETING<br />
S125
P OSTER<br />
A BSTRACTS<br />
B153 Encore Presentation<br />
Too Many Finger Sticks for Nothing? A Study of Sliding Scale<br />
Insulin Use Among Elderly Nursing Home Residents With Type 2<br />
Diabetes.<br />
N. Pandya, 1 W. Wei, 2 B. S. Kilpatrick, 3 J. L. Meyers, 4 K. L. Davis. 4 1.<br />
Nova Southeastern University, Ft. Lauderdale, FL; 2. sanofi-aventis,<br />
Bridgewater, NJ; 3. AnalytiCare, LLC, Glenview, IL; 4. RTI Health<br />
Solutions, Research Triangle Park, NC.<br />
Supported By: This study was funded by sanofi-aventis U.S. The authors<br />
received editorial support in the preparation of the abstract,<br />
funded by sanofi-aventis U.S.<br />
Background: Type 2 diabetes mellitus (T2DM) patients in longterm<br />
care (LTC) often receive sliding scale insulin (SSI) therapy;<br />
however, this provides suboptimal glycemic control.<br />
Methods: This retrospective study assessed the burden associated<br />
with SSI use in older T2DM patients treated with insulin at US<br />
nursing homes, using merged medical chart data and the Minimum<br />
Data Set (MDS). Patients who were not comatose or receiving hospice<br />
care, residing in LTC facilities for ≥3 months were included if<br />
they had ≥1 full MDS assessment and ≥2 records of insulin dispensing<br />
with no insulin pump use.<br />
Results: A total of 2,096 patients (mean [SD] age = 74 [12.1]<br />
years) were identified with a median of 56 days of medical administration<br />
record sheet data available (range 6-424 days). Among these<br />
patients, 35.1% had ≥1 glycated hemoglobin AIC (A1C) value<br />
recorded (mean [SD] A1C = 7.2% [1.3]); 51.1% had A1C ≤7.0% and<br />
mean (SD) fasting blood glucose was 146.4 (43.6) mg/dL. Seventyfour<br />
percent of patients (n=1,550) were on SSI (either alone or as<br />
supplemental therapy with another regimen) for the entire follow-up;<br />
30.9% (n=648) were exclusively on SSI throughout follow-up. On average,<br />
patients received 19.9 SSI-related finger sticks per week, with<br />
12.5 (62.8%) of these showing blood glucose levels that did not necessitate<br />
subsequent insulin administration.<br />
Conclusions: Despite older T2DM patients maintaining relatively<br />
good glycemic control, SSI use was widespread in the LTC facilities<br />
examined and was associated with a high finger-stick burden.<br />
These findings question the need of prolonged SSI therapy among<br />
older T2DM patients in LTC.<br />
B154<br />
Attitudes of medical providers regarding the withdrawal of life<br />
sustaining interventions during end-of-life care.<br />
A. J. Shipley, 2 Q. Cao, 1 D. Cummings. 1 1. Family Medicine, East<br />
Carolina University, Greenville, NC; 2. Brody Medical School, East<br />
Carolina University, Greenville, NC.<br />
Supported By: HRSA:K01 HP20471, Geriatric Academic Career<br />
Award<br />
Background: Taking care of patients near the end of life is a<br />
daunting and delicate task. Interventions like pacemakers, implantable<br />
cardioverter defibrillators (ICDs), hemodialysis, artificial<br />
hydration and nutrition, and ventilator support all can prolong life,<br />
often without improving quality of life. The distinction between terminating<br />
a life sustaining treatment and physician assisted suicide<br />
(PAS) has been questioned and the decisions about withdrawal are<br />
challenging.<br />
Objective: A statewide cross-sectional survey was developed to<br />
assess the attitudes among medical providers in North Carolina related<br />
to withdrawal of life sustaining interventions.<br />
Methods: The survey was conducted online in November 2011.<br />
Participants were asked if withdrawal of a specific intervention constituted<br />
PAS and whether they would feel comfortable with the withdrawal<br />
if patient preference was known. Demographic questions include<br />
age, gender, race, the medical school, and the year of<br />
graduation, the residency program, and the specialty/subspecialty.<br />
Survey responses were based on a Likert scale and T-tests compared<br />
differences between groups.<br />
Results: n=888 medical providers participated in the survey; the<br />
vast majority of respondents were white, with a mean age of 53 ± 14<br />
years. The sample was 65% Male; 35% female. 64% of respondents<br />
were specialists and 36% were primary care providers. Over 79% of<br />
participants either strongly disagreed or disagreed that withdrawal of<br />
a specific intervention constituted PAS and the majority of them felt<br />
comfortable with the withdrawal of life-sustaining interventions.<br />
There were small but statistically significant differences by age with<br />
younger providers (< 48 yrs) expressing stronger disagreement with<br />
intervention withdrawal being equated with PAS and more comfort<br />
in withdrawing interventions (p
P OSTER<br />
A BSTRACTS<br />
B156<br />
The Impact of Testing Protocol on Recorded Gait Speed.<br />
A. Sustakoski, J. M. VanSwearingen, S. Perera, S. A. Studenski,<br />
J. S. Brach. University of Pittsburgh, Pittsburgh, PA.<br />
Supported By: T32 AG021885, K23 AG026766, P30 AG024827<br />
Background: Gait speed predicts disability, cognitive decline,<br />
hospitalization, nursing home admission and mortality. Although gait<br />
speed is often measured in clinical practice and research, testing protocols<br />
vary widely and its impact on recorded gait speed has yet to be<br />
explored. Our purpose is to describe and compare gait speeds obtained<br />
from different testing protocols in the same individuals.<br />
Methods: Subjects were 104 community-dwelling older adults<br />
who could ambulate household distances independently (mean<br />
age=77.2±6.1). Gait speed was recorded over 4 meters using the protocols:<br />
1) standing start, usual pace over ground, 2) walking start,<br />
usual pace over ground, 3) walking start, usual pace on a computerized<br />
walkway, and 4) walking start, fast pace on a computerized walkway.<br />
Paired t-tests were performed to compare gait speeds within individuals<br />
across different protocols. Linear regression was used to<br />
derive an equation to convert standing start usual pace to walking<br />
start usual pace gait speed.<br />
Results: Mean±SD gait speed for each condition was: standing<br />
start, usual pace over ground 0.97±0.23 m/s; walking start, usual pace<br />
over ground 1.14±0.25 m/s; walking start, usual pace on walkway<br />
1.01±0.26 m/s; and walking start, fast pace on walkway 1.31±0.34 m/s.<br />
On average, the determined gait speed was 0.17 m/s faster during the<br />
walking compared to the standing start (p=1 transition/year<br />
(aHR=3.70, 95%CI=2.23-6.14, p
P OSTER<br />
A BSTRACTS<br />
B159<br />
Accuracy of Formulas to Predict Resting Metabolic Rate in Elderly<br />
Admitted to a Recuperative Care Unit.<br />
D. H. Sullivan, 1,2 K. P. Padala, 1,2 K. K. Garner, 1,2 R. A. Dennis, 1,2<br />
M. Bopp, 1,2 P. R. Padala. 1,2 1. Geriatric Research Education and<br />
Clinical Center, VISN16/CAVHS, North Little Rock, AR; 2. <strong>Geriatrics</strong>,<br />
University of Arkansas for Medical Sciences, Little Rock, AR.<br />
Supported By: VA Health Services and Clinical Science Research<br />
and Development programs (HSR&D IIR-04-298 and CSR&D)<br />
and a University of Arkansas for Medical Sciences Tobacco<br />
Settlement award<br />
Background: There is a lack of validation studies of formulas for<br />
estimating resting metabolic rate (RMR) in elderly patients in the recuperative<br />
phase of illness. Given the importance of such formulas<br />
for estimating the nutrient requirements of older medically complex<br />
patients, this study was undertaken to explore this issue.<br />
Methods: This prospective study included 156 males over 64<br />
years of age admitted to a recuperative care and rehabilitation unit<br />
located within a Veterans Affairs hospital Community Living Center.<br />
RMR was measured (mRMR) within seven days after admission by<br />
indirect calorimetry in the fasted state prior to the subjects’ arising in<br />
the morning. Height and weight were measured at the same time.<br />
Results: The subjects had a mean age of 79 + 8 years and 85%<br />
were white. Although free of metastatic cancer and other terminal<br />
conditions, all were deconditioned and most were undernourished<br />
and frail. For all 10 published formulas evaluated, estimated RMR<br />
(eRMR) was highly correlated with mRMR (r = 0.70 to 0.74,<br />
p
P OSTER<br />
A BSTRACTS<br />
a different strategy than young adults to deal with a walking challenge<br />
may potentially inform interventions to improve motor skill in<br />
walking.<br />
B162<br />
Dual-Stiffness Flooring: Does it Reduce Fracture Rates Among<br />
Older Fallers ?<br />
F. Knoefel, 1 L. Patrick, 1 J. Taylor, 1 R. Goubran. 2,1 1. EBRI Research<br />
Institute, Ottawa, ON, Canada; 2. Engineering and Design, Carleton<br />
University, Ottawa, ON, Canada.<br />
Supported By: Satech Inc., Chehalis, WA, USA<br />
BACKGROUND: Fractures in older adults are associated with<br />
significant morbidity and mortality. Falls in this population lead to<br />
fractures approximately once every 20 falls. A number of bio-mechanical<br />
studies suggest that dual-stiffness flooring (DSF) diminishes<br />
the impact of contact with a floor, potentially reducing injuries associated<br />
with falls. To our knowledge however, there has never been a<br />
controlled study comparing fracture rates on regular flooring to that<br />
on DSF. METHODS: Mountain View Manor is a Skilled Nursing Facility<br />
in Prescott, Arizona where two resident bedrooms have DSF<br />
flooring (SmartCells flooring). Falls and related injuries were tracked<br />
during the period of July 1, 2008 to December 31, 2010. Injury rate<br />
comparisons, based on Chi-Square analyses, and prediction of room<br />
type allocation based on the number of injuries sustained, using Logistic<br />
Regression, were conducted. RESULTS: A total of 167 falls<br />
were reviewed. Fifty-five percent (55%) of falls resulted in an injury<br />
and 26% in a significant injury, defined as abrasion, cut, fracture or<br />
two or more injuries. There were 82 falls on the DSF and 85 falls on<br />
the regular floor. Patients in the dual-stiffness flooring rooms were<br />
significantly younger and took significantly fewer medications; these<br />
factors were thus treated as covariates in the analyses. There was a<br />
marked tendency for residents falling on DSF to have less bruising<br />
and abrasions, while having more redness and cuts. There were two<br />
fractures on regular flooring (2.4% fracture rate) and none on the<br />
DSF flooring (0% fracture rate). DISCUSSION: A 2.4% fracture<br />
rate (as noted on the regular floor) is consistent with numerous incidence<br />
reports in the literature; whereas a 0% rate (as noted on Smart-<br />
Cells DSF floor) is a clinically significant improvement over prior reported<br />
results. Both clinical findings and preliminary statistical trends<br />
analysis suggest a positive effect of dual-stiffness flooring. This suggests<br />
that DSF may be a practical approach for institutions and consumers<br />
to reduce fall-related injuries. In contrast to other solutions,<br />
like hip protectors, DSF requires no active client participation. A<br />
large scale study to achieve sufficient statistical power to statistically<br />
confirm these preliminary findings is warranted.<br />
B163<br />
Subcortical Hyperintensities and Outcomes of Targeted Gait<br />
Interventions for Mobility Impairment.<br />
N. K. Nadkarni, S. Perera, J. Brach, H. Aizenstein, C. Rosano,<br />
S. A. Studenski, J. M. Van Swearingen. University of Pittsburgh,<br />
Pittsburgh, PA.<br />
Supported By: Source of funding: Pittsburgh Claude D. Pepper<br />
Older <strong>American</strong>’s Independence Center grant (P30 AG024827)<br />
Background: Gait interventions that incorporate motor-skill acquisition<br />
are superior to standard therapy in improving mobility impairment<br />
in elderly. Subcortical hyperintensities (SH), commonly<br />
seen on brain MRI of older adults, are associated with impairments in<br />
gait and executive function.<br />
Objective: We examined whether regional SH volumes influence<br />
gait outcomes from two types of gait interventions.<br />
Methods: We analyzed data from a 12 week randomized trial of<br />
community-dwelling older adults with mobility impairment receiving<br />
two interventions: progressive strength, balance and endurance training<br />
(I) vs goal-directed motor learning, adaptive stepping, pattern<br />
walking and dual-tasking (M). A linear model was used to study the<br />
relationship between pre- to post-intervention change in outcomes<br />
(gait speed, double-support time, step-time, stance time variability)<br />
with baseline SH in regions associated with executive function (anterior<br />
prefrontal cortex (APC), dorsolateral prefrontal cortex<br />
(DLPFC), ventrolateral prefrontal cortex (VLPFC), anterior cingulate<br />
(AC), basal ganglia and posterior parietal cortex).<br />
Results: Significant interactions emerged between right APC<br />
SH and intervention on changes in gait speed (p=0.04), step-time<br />
(p=0.001) and double-support time (p=0.01). With respect to steptime<br />
change, significant interactions emerged for SH in left APC<br />
(p=0.02), right and left DLPFC (p=0.03 and 0.02), right VLPFC<br />
(p=0.04) and right AC (p=0.02) with intervention. In the I-group,<br />
greater right APC and right AC SH were associated with poorer<br />
changes in gait speed (p=0.005 and 0.02), double support time<br />
(p=0.002 and 0.001), step-time (p=0.002 and 0.001) and variability in<br />
stance-time (p=0.004 and 0.01). In the M-group, there were no significant<br />
associations between changes in outcomes and SH in any of the<br />
above brain regions.<br />
Conclusion: Gait interventions that incorporate motor-skill acquisition<br />
and dual-tasking may benefit older adults irrespective of SH<br />
severity in brain regions linked to executive function while benefits<br />
from impairment-based interventions may depend on SH burden in<br />
these regions.<br />
B164<br />
Mood and Neurocognitive Measures to Predict Intake and Function<br />
in Elderly in a Recuperative Care Unit.<br />
P. R. Padala, 1,3 P. Dubbert, 1,3 K. P. Padala, 1,2 K. Garner, 1,2<br />
R. A. Dennis, 1,2 M. Bopp, 1,2 D. H. Sullivan. 1,2 1. Geriatric Research<br />
Education and Clinical Center, VISN16/CAVHS, North Little Rock,<br />
AR; 2. <strong>Geriatrics</strong>, University of Arkansas for Medical Sciences, Little<br />
Rock, AR; 3. Psychiatry, University of Arkansas for Medical Sciences,<br />
Little Rock, AR.<br />
Supported By: VA Health Services and Clinical Science Research<br />
and Development programs (HSR&D IIR-04-298 and CSR&D)<br />
and a University of Arkansas for Medical Sciences Tobacco<br />
Settlement award<br />
Background: Among older patients hospitalized for recuperative<br />
care and rehabilitation, persistent anorexia and poor functional<br />
rehabilitation are associated with high levels of inflammatory markers<br />
and other indicators of illness severity at admission. It is not<br />
known whether cognitive dysfunction or depression also contribute<br />
to the persistent anorexia and poor functional outcomes.<br />
Methods: This prospective study included patients over 64 years<br />
admitted to a recuperative care and rehabilitation unit in a VA hospital<br />
Community Living Center. Each subject’s daily total nutrient intake<br />
from all sources was measured using a standardized protocol.<br />
Depression was measured by the Geriatric Depression Scale-15 items<br />
(GDS), apathy was derived from 3 items on the GDS related to motivation<br />
(GDS-apathy), and executive function was measured by verbal<br />
fluency, digit span and Florida praxis battery. Correlation analyses<br />
were performed between the dependent variables of energy and protein<br />
intake with independent variables of mood and neurocognitive<br />
measures followed by regression analyses. T-tests were performed on<br />
the neurocognitive measures based on if the subjects were apathetic<br />
or not.<br />
Results: 416 veterans were enrolled. Mean scores at baseline<br />
were 3.7 (± 2.7) for GDS, 1.5 (±0.9) for GDS-apathy, 5.9 (±3.7) for<br />
Verbal Fluency-F, 7.4 (±2.5) for Digit Span Forward, 4.6 (±2.2) for<br />
Digit Span Backwards, 14.6 (±1.4) for Florida Praxis Battery, 83.8<br />
(±35.7) and 59.7 (±23.6)for Average Energy and Protein Intake respectively.<br />
Baseline measures of apathy, depression, executive function<br />
did not predict either energy or protein intake. However baseline<br />
AGS 2012 ANNUAL MEETING<br />
S129
P OSTER<br />
A BSTRACTS<br />
GDS and GDS apathy were negatively correlated to change in walking<br />
and walking endurance. The impact of depression and apathy on<br />
changes in walking endurance persisted even after controlling for<br />
change in inflammatory markers. Apathetic patients when compared<br />
to those without apathy had lower scores on verbal fluency (p=0.01-<br />
0.04), and increased intake (0.02).<br />
Conclusions: Depression and apathy scores but not neurocognitive<br />
scores were strong correlates of change in measures of physical<br />
function.<br />
B165<br />
Three, Five or Seven Days: How Much is Enough When Measuring<br />
Physical Activity with an ActiGraph Accelerometer in Older<br />
Adults?<br />
S. J. Francois, S. A. Studenski, J. S. Brach. University of Pittsburgh,<br />
Pittsburgh, PA.<br />
Supported By: Research/Grant Support: K23 AG026766, P30<br />
AG024827, T32 AG021885<br />
Background/Aims: Accelerometers provide valid and reliable<br />
measures of physical activity but have primarily been studied in<br />
healthy, young adults. Little is known about the reliability or wear<br />
time of accelerometers for measuring physical activity in older adults.<br />
Current protocols suggest 7 days to provide the best estimates of<br />
daily activity. Therefore, our goal is to assess the test-retest reliability<br />
of the ActiGraph accelerometer in community-dwelling older adults<br />
and determine if the number of days worn (3, 5, or 7) impact the testretest<br />
reliability of the measure.<br />
Methods: Participants included 32 community-dwelling older<br />
adults (mean age 78.0 ± 5.5 years) who ambulated independently<br />
(mean gait speed 0.96 ± 0.28 m/s). Physical activity was measured using<br />
an ActiGraph GT1M accelerometer (ActiGraph LLC, Pensacola, FL)<br />
worn on the waist during waking hours for 7 days. Subjects recorded<br />
wear times of the accelerometer in a daily journal. Subjects wore the<br />
accelerometers for another 7 days approximately 1 week later. Physical<br />
activity was summarized for each time period as the mean counts<br />
per minute per day (cpm) averaged over all 7 days, the first 5 days, and<br />
the first 3 days. Paired t-tests were used to compare physical activity<br />
measures from time 1 and time 2 and intraclass correlation coefficients<br />
(ICCs) were calculated to estimate the test-retest reliability.<br />
Results: The mean physical activity was similar for time 1 and<br />
time 2 for 7 days (135.4 and 135.3 cpm), 5 days (127.6 and 133.1 cpm)<br />
and 3 days (121.1 and 133.7 cpm); all p>0.15. The ICCs (95% CI) for<br />
7, 5, and 3 days of wear were 0.93 (0.86, 0.97), 0.92 (0.83, 0.96), and<br />
0.87 (0.73, 0.94), respectively.<br />
Conclusions: Compared to previous research in communitydwelling<br />
older adults (70+), the older adults in this sample demonstrated<br />
slightly lower levels of physical activity. Test-retest reliability<br />
for the ActiGraph accelerometer indicates moderate (3 days) to high<br />
(5 and 7 days) agreement in this older adult population. Taking into<br />
consideration accuracy of measurement and participant burden, our<br />
initial recommendation is at least 5 days of wear. The impact of weekend<br />
versus weekdays on physical activity measurement needs to be<br />
examined in future studies of older adults.<br />
B166<br />
How Do Falls, Fear and Cognition Influence the Association<br />
between Physical Performance and Self-Reported Function in Older<br />
Adults?<br />
V. A. Hornyak, 1 J. VanSwearingen, 1 D. Wert, 1 S. Studenski, 2 J. Brach. 1<br />
1. Physical Therapy, University of Pittsburgh, Pittsburgh, PA; 2.<br />
Geriatric Medicine, University of Pittsburgh, Pittsburgh, PA.<br />
Supported By: Support: Pittsburgh Older <strong>American</strong>’s Independence<br />
Center, 1 P30AG024827; Geriatric Academic Career Award<br />
K01HP20478; K23 AG026766.<br />
Background: Fall history, fear of falling (FOF) and cognitive<br />
function associate with reported physical functioning but how they<br />
influence the relation between physical performance and self-reported<br />
physical function is not known. We examined the relation of<br />
fall history, fear and cognition to reported physical functioning, controlling<br />
for performance in older adults.<br />
Methods: Older adults, independent in ambulation (n=70, mean<br />
age, 77± 5.3 years) completed physical performance and self-reported<br />
measures of function and cognition. The Late Life Function and Disability<br />
Instrument (LLFDI) overall functioning was used to determine<br />
physical function in daily life. Gait speed a performance measure<br />
of physical function was determined from self-paced walking over<br />
an instrumented walkway. Fall history and FOF were determined<br />
from the participant’s report. Cognitive function was determined<br />
using the Digit Symbol Substitution Test (DSST) and Trail-Making<br />
Test B (Trails B), measures of executive cognitive functioning. Pearson<br />
bivariate correlations were used to determine the relation between<br />
age, gait and cognitive functioning with physical functioning<br />
and define the related variables to include in the regression model. A<br />
linear regression model was used to determine the relative association<br />
of falls, fear and cognition to physical functioning, controlling for<br />
age, gender and gait speed.<br />
Results: Self-reported functioning (LLFDI) was related to gait<br />
speed (r=.56, p
P OSTER<br />
A BSTRACTS<br />
ent effect of cardiopulmonary comorbidities on VTE. Secondarily, we<br />
analyzed functional status expressed in a summary physical component<br />
score (PCS) in a subset of patients for whom it was available.<br />
Results: There were 24,051 THR and TKR surgeries performed<br />
at the VA during the study period. COPD predicted a 24% increase in<br />
VTE (OR=1.24, 95% CI 1.06-1.45). Low values of PCS, which was<br />
available for 3256 patients, demonstrated a trend of increased risk of<br />
VTE (lowest quartile OR =1.65, 95% CI 0.96-2.85 compared with<br />
highest quartile).<br />
Conclusions: COPD predicted a small increase in VTE whereas<br />
low functional status appeared to increase the odds of VTE substantially.<br />
Our findings suggest that cardiopulmonary comorbidities<br />
should not be factored into decisions about prophylaxis but that functional<br />
status probably should be assessed. More definitive conclusions<br />
about the role of these comorbidities and functional status are<br />
limited by typical constraints of administrative data analysis.<br />
B168<br />
Psychoactive Medications as Predictors of Post-operative Delirium<br />
in Hip Fracture Patients.<br />
A. L. Gruber-Baldini, 1 E. R. Marcantonio, 2 D. Orwig, 1 E. Barr, 1<br />
N. Ma, 1 M. Terrin, 1 J. Magaziner, 1 J. L. Carson. 3 1. Epidemiology &<br />
Public Health, University of Maryland School of Medicine, Baltimore,<br />
MD; 2. Division of General Medicine and Primary Care, Beth Israel<br />
Deaconess Medical Center, Boston, MA; 3. . Division of General<br />
Internal Medicine, UMDNJ-Robert Wood Johnson Medical School,<br />
New Brunswick, NJ.<br />
Supported By: Supported in part by grants from the National Heart,<br />
Lung, & Blood Institute: R01 HL085706, U01 HL073958 and U01<br />
HL074815, by a National Institute on Aging training grant: T32<br />
AG00262, and by funds from the Claude D. Pepper Older<br />
<strong>American</strong>s Independence Center, National Institute on Aging, P30<br />
AG028747.Dr. Marcantonio is a recipient of a Mid-Career<br />
Investigator Award in Patient-Oriented Research (K24 AG035075)<br />
from the National Institute on Aging.<br />
Delirium is common after hip fracture and is associated with<br />
poor short- and long-term outcomes. Previous research suggests that<br />
psychoactive medications may increase risk of delirium, and it is hypothesized<br />
that anticholinergic medications may also increase delirium.<br />
In this paper we examine the association of psychoactive medications<br />
on delirium severity in 131 patients from the Transfusion<br />
Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing<br />
Surgical Hip Fracture Repair(FOCUS) Cognitive Ancillary<br />
Study, a randomized clinical trial examining the impact of blood<br />
transfusion strategy on delirium. Medication administration records<br />
24 hours before initial post-surgery assessment were coded by drug<br />
class, and also using 3 scales which summarize anticholinergic effects:<br />
Anticholinergic Drug Scale (ADS), Anticholinergic Risk Scale<br />
(ARS), and Anticholinergic Cognitive Burden Scale (ACBS). Delirium<br />
severity was measured 1-5 days post-surgery (Mean=1.8, SD=0.8)<br />
using the Memorial Delirium Assessment Scale (MDAS) and delirium<br />
presence using Confusion Assessment Method Diagnostic Algorithm<br />
(CAM). Average age was 81.8 (SD=9.0), 74.1% female, and<br />
90.8% white. The average number of psychoactive medications administered<br />
24-hours before initial post-operative assessment was 1.7<br />
(SD=1.8, range 0-8). Mean MDAS 7.1 (SD=5.3) and 29.8% CAM<br />
delirium. Percentage on medications by class: antipsychotics 2.3%,<br />
antidepressants 13.7%, opiates 0.8%, antihistamines 6.1%, analgesics<br />
62.6%, sedative-hypnotics 10.7%, anticholinergics 5.3%, ADS 57.3%,<br />
ARS 22.1%, ACBS 58.0%. The simple count of anticholinergic drugs<br />
was significantly associated with MDAS delirium severity (r=0.22,<br />
p=0.01), but none of the more complicated anticholinergic scales (all<br />
r0.10). Number of opiates, antihistamines, analgesics, antidepressants,<br />
and sedative-hypnotics was not associated with delirium<br />
severity or presence. Greater antipsychotic medication use was associated<br />
with worse MDAS delirium severity (r=0.18, p=0.03). Simple<br />
counts of antipsychotics and anticholinergics in prior 24 hours were<br />
associated with delirium after hip fracture surgery.<br />
B169<br />
Complications Following Cochlear Implantation in Older Adults.<br />
D. M. Clarrett, 1 L. Li, 2 F. R. Lin. 3 1. University of Cincinnati College<br />
of Medicine, Cincinnati, OH; 2. The Johns Hopkins Center on Aging<br />
and Health, Baltimore, MD; 3. Otolaryngology-Head and Neck<br />
Surgery, Johns Hopkins Hospital, Baltimore, MD.<br />
Supported By: Medical Student Training in Aging Research<br />
(MSTAR) program at Johns Hopkins University<br />
Background: Cochlear implantation (CI) is a hearing rehabilitative<br />
option for individuals with severe-to-profound sensorineural<br />
hearing loss. However, older adults with hearing loss are infrequently<br />
referred for CI, in part due to concerns about surgical risks and the<br />
potential for poor recovery among older adults. The objective of this<br />
study was to analyze the postoperative complications associated with<br />
CI surgery in a large, consecutive case series of older adults (≥60<br />
years) undergoing CI. Methods:The Johns Hopkins Listening Center,<br />
the largest provider of cochlear implants in North America, maintains<br />
a prospective database of all patients receiving cochlear implants at<br />
Johns Hopkins. We queried this database to ascertain all individuals<br />
≥60 years who underwent a first CI from 1999-2011. We then performed<br />
a retrospective chart review of the electronic patient record<br />
system at Johns Hopkins to abstract data on post-operative follow-up<br />
and complications. Abstracted data were coded and validated by randomly<br />
sampling 15% of the sample for repeat data abstraction. Statistical<br />
analyses comparing observed frequencies were performed<br />
using goodness-of-fit Fisher exact tests. Results: From 1999-2011, 445<br />
individuals ≥60 years received a first cochlear implant at Johns Hopkins.<br />
The mean age at implantation was 72.7 years (range 60-94.9<br />
years) and the median duration of follow-up was 4.8 years (range 0.1-<br />
12.5 years). There were a total of 42 minor complications (surgical<br />
site infection, balance problems, delayed transient facial weakness, facial<br />
nerve stimulation) in 41 patients (9.2%) and 36 major complications<br />
(device failure, skin flap dehiscence, surgical device removal) in<br />
21 patients (4.7%). There were no cases of meningitis or postoperative<br />
facial paralysis. Seventeen patients (3.8%) required surgical device<br />
removal. Complication rates did not differ between individuals<br />
P OSTER<br />
A BSTRACTS<br />
status, procedure complexity, and the presence or absence of major<br />
complications.<br />
Results: 100,831 patients were included for analysis. In general,<br />
advanced age was associated with increased preoperative comorbidities<br />
and postoperative complications. After adjustment for these associations,<br />
however, advanced patient remained an independent predictor<br />
of overall and diagnosis-specific mortality and for<br />
failure-to-rescue (mortality after the development of a major complication;<br />
see Table). Of the 32 variables included for risk adjustment,<br />
the strongest predictor of postoperative mortality for those patients<br />
aged ≥80 years was the development of a major postoperative complication<br />
(adjusted odds ratio 5.69, 95% CI 4.88-6.59).<br />
Conclusions: Advanced age is an indepedendent predictor of<br />
mortality after emergency general surgery, even after adjustment for<br />
other known perioperative predictors. Failure-to-rescue is identified<br />
as a primary reason for this increase in mortality. Efforts to improve<br />
the outcomes of elderly patients needing emergent surgery should<br />
focus on prevention of major postoperative morbidity.<br />
B171<br />
Age and Preoperative Geriatric Assessments in Predicting Surgical<br />
Outcomes in a Prospective Study of Patients Undergoing<br />
Pancreaticoduodenectomy.<br />
J. A. Hemmerich, 1 K. K. Roggin, 2 A. M. Kamm, 2 E. Melstrom, 1<br />
S. Wilson, 1 W. Dale. 1 1. Medicine, The University of Chicago, Chicago,<br />
IL; 2. Surgery, The University of Chicago, Chicago, IL.<br />
Supported By: The Michael Rolfe Foundation, Rita Meltzer, The<br />
John A. Hartford Foundation<br />
Drs. Hemmerich and Roggin are co-first authors.<br />
Objective: Older patients with pancreas cancer are often not<br />
considered for pancreaticoduodenectomy (PD) due to anticipated<br />
perioperative complications and prolonged recovery. Pre-operative<br />
geriatric assessment (GA) of vulnerability might better predict major<br />
complications, readmissions, discharge site, and hospital stays. We<br />
conducted a prospective study of GA in older patients who were undergoing<br />
PD.<br />
Methods: PD-eligible patients were enrolled into a single-site<br />
prospective observational study. Preoperative GA included components<br />
of Fried’s Model of Frailty (weight loss/weakness/self-reported<br />
exhaustion), the Vulnerable Elder Survey (VES-13), the short physical<br />
performance battery (SPPB). Socio-demographics, body mass<br />
index (BMI) clinical characteristics (including co-morbidities), and<br />
<strong>American</strong> <strong>Society</strong> of Anesthesiologist (ASA) scores were also collected<br />
at baseline. Outcomes included graded surgical complications<br />
(Clavien classification), length of hospital stay, discharge location<br />
(home vs rehab) and 30-day readmissions. Linear and logistic regressions<br />
were used to control for the influence of patient age, body mass<br />
BMI, preoperative ASA score, and co-morbid burden.<br />
Results: A total of n=76 had a PD (median age 68 years; range<br />
36-88). Significant preoperative vulnerability was identified in the<br />
sample: VES-13 >3 in 15.0%; SPPB
P OSTER<br />
A BSTRACTS<br />
80% show signs of this condition. The goals of treatment are pain reduction<br />
and preservation of functional status. Treatment is often multimodal<br />
including surgery and medications, such as NSAIDs and opioids.<br />
Many of these options pose a significant risk of adverse events.<br />
Therefore assessing the efficacy of noninvasive and “alternative”<br />
treatments, such as acupuncture, should be a primary focus of research.<br />
Acupuncture is a low risk and likely effective treatment for a<br />
number of chronic conditions. It is growing in popularity in the public<br />
consciousness. Ralph Gardner addressed this topic when writing in<br />
the Wall Street Journal (October 27, 2011) of his mother’s “willingness<br />
to undergo (this) treatment” for her neck pain. Given the suitability<br />
of the elderly as a target population for acupuncture, our objective<br />
was to determine if geriatric populations are represented in<br />
clinical studies on this subject.<br />
Methods: A PubMed search of the combined MESH terms<br />
“acupuncture and pain” and “acupuncture and osteoarthritis” for articles<br />
published between 1999 and 2011 found 4017 articles. Studies<br />
were excluded if they were not clinical trials or were in a language<br />
other than English. The final number of publications was 40, 37 of<br />
which were controlled trials. An analysis was carried out to determine<br />
how well the older population was represented.<br />
Results: Osteoarthritis was the primary indication for acupuncture<br />
treatment in 38% of all 40 trials, with the remainder of the studies<br />
evaluating other pain syndromes and insomnia. 78% of the studies<br />
identified fewer than 20% adverse events. Only 20% analyzed subjects<br />
who were 65 years of age or greater. No studies analyzed subjects<br />
of age greater than 85. 32% of the controlled studies reported an<br />
improvement in more than half the subjects<br />
Conclusions: The use of acupuncture has many advantages for<br />
the elderly because it is noninvasive, poses low risk of side effects, and<br />
frequently appears to be efficacious. In spite of these advantages,<br />
acupuncture is insufficiently studied in the elderly, the population for<br />
which it is likely most indicated.<br />
of paramount importance to consider CAA prior to thrombolysis for<br />
acute stroke in elderly.<br />
Multifocal hemorrhages<br />
C3<br />
Thrombolysis Related Intracerebral Hemorrhage due to Cerebral<br />
Amyloid Angiopathy.<br />
A. S. Danve, S. P. Kulkarni, M. Belal, S. Anand, S. Awasthi, E. Roffe.<br />
Internal Medicine, Metropolitan Hospital New York, New York, NY.<br />
INTRODUCTION-<br />
Intracerebral hemorrhage (ICH)is most feared complication of<br />
thrombolysis for acute stroke.Cerebral amyloid angiopathy (CAA) is<br />
a known risk factor for thrombolysis related ICH especially in elderly.<br />
CASE-<br />
A 90 year old woman developed acute onset right sided weakness<br />
45 minutes prior to arrival to ER. She had hypertension,<br />
Alzheimer’s dementia and mitral valve replacement. Her medications<br />
included Coumadin, Namenda and hydrochlorothiazide. On examination,<br />
patient had global aphasia and right hemiparesis. INR was<br />
1.12 with normal CBC and metabolic panel. CT Brain did not show<br />
any new infarct. Thrombolytic therapy was administered after neuro<br />
evaluation. One hour later, patient became unresponsive and developed<br />
decerebrate posturing. NIH score worsened from 13 to 36. Repeat<br />
CT Brain showed multifocal bilateral cerebral and cerebellar<br />
hemorrhages mainly at gray-white junction. Patient died 3 days after<br />
supportive care in ICU. Retrospectively, she was diagnosed to have<br />
underlying probable CAA (based on Boston Criteria) leading to<br />
thrombolysis related ICH.<br />
DISCUSSION-<br />
CAA is heterogeneous disorder characterized by deposition of<br />
Aβ fibrils in the walls of medium sized arteries in brain. Sporadic<br />
CAA is common in elderly, its incidence and severity increasing with<br />
age. It affects about 50 % of people above 80 years. In elderly, CAA is<br />
important risk factor for thrombolysis related ICH. It is typically multifocal,<br />
lobar, at corticosubcortical areas and associated with dementia.<br />
Currently, there is no specific therapy available for treatment. It is<br />
C4<br />
A Case Report Of Lung Cancer With Metastasis To Pancreas.<br />
A. Iraqi, T. Hughes. Syracuse VA medical center, Syracuse, NY.<br />
Introduction: Lung cancer is the leading cause of cancer deaths<br />
in the United States of America. It is broadly classified in two major<br />
histological entities, small cell lung (SCLC) and non-small cell lung<br />
cancer (NSCLC).SCLC is distinguished from NSCLC by its rapid<br />
doubling time and early development of widespread metastases with<br />
a propensity to spread to liver, adrenals, bone, bone marrow, and<br />
brain. However, it is rare for lung cancer including SCLC to metastasize<br />
to the pancreas. The usual histology of pancreatic cancer is adenocarcinoma<br />
and rare to have small cell.<br />
We describe a case of lung cancer which has metastasis to the<br />
pancreas.<br />
Case Description: A 77 year old male was hospitalized with<br />
painless jaundice. He had elevated bilirubin of 13.6 ( ref. 0.1 to<br />
1mg/dl ) with direct bilirubin of 10.4 ( ref. 0.0 to 0.5mg/dl) and alkaline<br />
phosphatase of 208 ( ref. 50-136 units/L ). His medical history included<br />
prior CVA, Atrial fibrillation, chronic kidney disease. Abdominal<br />
sonogram showed a 5.5cm mass in the region of pancreatic head<br />
with intra and extrahepatic biliary ductal dilation, no gall bladder<br />
wall thickening. Abdominal CT confirmed a 5 mm mass at pancreatic<br />
head with no evidence of masses outside the pancreatic head. He underwent<br />
ERCP with sphincterotomy, brushing with cytology and<br />
common bile duct (CBD) stenting. CBD and pancreatic duct brushings<br />
cytology were benign. Subsequently, he underwent endoscopic<br />
ultrasound with fine needle aspiration of the mass in the pancreatic<br />
head, and pathology showed small cell carcinoma, and special stains<br />
suggested against the diagnosis of lymphoma and melanoma. Following<br />
this, CT thorax showed a mediastinal mass, and CT brain negative<br />
for metastasis. Over time his condition declined and was complicated<br />
by pneumonia, GI bleed, infective endocarditis, worsening kidney<br />
function and intracranial bleed with metastasis to brain. With declining<br />
condition he opted for hospice care.<br />
AGS 2012 ANNUAL MEETING<br />
S133
P OSTER<br />
A BSTRACTS<br />
In this case it was thought that mediastinal mass is due to SCLC<br />
with metastasis to pancreas, and that he does not have a primary pancreatic<br />
cancer with metastasis to mediastinum or that he did not have<br />
two primary cancers.<br />
Conclusion: This case is un-usual as it is rare for lung cancer to<br />
have metastasis to pancreas and it is also rare for primary pancreatic<br />
cancer to be small cell.<br />
C5<br />
An Unusual Approach to Aggressive Behavior in Dementia<br />
Patients.<br />
A. I. Akintan, 1 V. Nurpeisov, 1 B. Patel, 2 N. Holland. 2 1. Geriatric medicine,<br />
Emory University, Atlanta, GA; 2. Geriatric medicine, VA<br />
Medical Center, Decatur, GA.<br />
We recently saw an 85 year old gentleman in the geriatric clinic<br />
with a past medical history of hypertension, osteoarthritis and dementia.<br />
He has had Alzheimer’s dementia for the past four years with<br />
increasing episodes of agitation. He was on the following medications;<br />
Aspirin, Metoprolol, Donepezil, Memantine, Allopurinol,<br />
Cyanocobalamin, Lisinopril, Furosemide and Acetaminophen.<br />
In an attempt to decrease his polypharmacy his Allopurinol was<br />
weaned off as he had no history of gout for the past five years. His aggressive<br />
behavior increased shortly after stopping the Allopurinol<br />
and this was subsequently restarted at the family’s request. His aggressive<br />
behavior stabilized after restarting Allopurinol.<br />
A review of the literature looking at Allopurinol in the treatment<br />
of aggression in dementia revealed two case reports.<br />
Allopurinol, a xanthine oxidase inhibitor decreases production<br />
of oxygen free radicals and promotes accumulation of purines and<br />
thus increases circulating pools of adenosine that may ultimately<br />
have antipsychotic and anxiolytics effects.<br />
We present this case as we feel that the possible association of<br />
using Allopurinol in treatment of aggressive behavior in patients with<br />
dementia is not well known.<br />
This may offer an alternative therapy for aggressive behavior in<br />
dementia patients who also have recurring gouty arthritis and may<br />
prove useful with more studies in other patients with dementia and<br />
aggressive behavior.<br />
C6<br />
Infection Associated Parasthesia: Case of “parasthesias gone wrong”<br />
A. Itticheria, B. Setters, R. Gopalraj. Family & Geriatric Medicine,<br />
University of Louisville, Louisville, KY.<br />
Introduction: Parasthesia is a main symptom of stroke, TIA’s,<br />
and other neurological conditions. Other underlying etiologies including<br />
the possibility of an infectious process should also be considered.<br />
Symptoms such as generalized or unilateral weakness, numbness<br />
and tingling of the extremities and sensory deficits have been<br />
seen in patients with acute infections.<br />
Case Report: A 64 yo female with history of a right middle cerebral<br />
artery stroke presented with acute left handed weakness that was<br />
gradually worsening. This was associated with asthenia and dysuria.<br />
Review of systems found stumbling and falls. Physical exam revealed<br />
mild left sided facial droop, decreased sensation of the left side, including<br />
face, arm and leg. Strengths were 5/5 and reflexes were 2+ bilaterally.<br />
She was dehydrated, with mild renal insufficiency and hypotension.<br />
A CT of the head was negative for any acute changes and<br />
brain MRI was unchanged showing a previous full occlusion of right<br />
cervical and intracranial internal carotid artery. EEG was also negative.<br />
A diagnosis of urosepsis was made and the patient was started on<br />
IV antibiotics and aggressive IVF hydration. With appropriate treatment<br />
in the next few days her symptoms fully resolved and the patient<br />
was discharged home.<br />
Three months later, she presented to the office with generalized<br />
weakness, tingling sensation in the fingertips of the right hand with<br />
numbness, blurred vision of the right eye, and sinusitis like symptoms.<br />
Again, her vital signs and exam were unremarkable, but given her history<br />
she was admitted to the hospital for further evaluation where<br />
MRI/A of the head showed no changes. She was diagnosed with acute<br />
sinusitis and treated with oral antibiotics. Her symptoms immediately<br />
improved and had resolved by the next day when she was discharged<br />
home at her baseline functional status. On both hospital visits the<br />
neurology consultant was not able to link any symptoms to a neurologic<br />
diagnosis.<br />
Conclusion: This case illustrates that paresthesias may not always<br />
be due to the typical neurological etiologies. As such other<br />
causes including infection must be considered and a comprehensive<br />
history and exam must be completed. Infectious processes may mimic<br />
such symptoms due to associated sepsis, fever, or dehydration.<br />
Recognition and treatment of potential infections might be the unusual<br />
but simple answer to a startling presentation of new onset<br />
paresthesias.<br />
C7<br />
Case Report of a Purple Rash and Gum Pain.<br />
A. Lum. Geriatric Medicine, University of Pittsburgh Medical Center,<br />
Pittsburgh, PA.<br />
Case Report<br />
Lum, Albert. University of Pittsburgh Medical Center Geriatric<br />
Fellow. Pittsburgh, PA<br />
A 68 years old Caucasian female with complaints of burning<br />
pain to her oral mucosa and gums off and on for 4 months seen at<br />
an outpatient clinic. She described the pain as burning type especially<br />
after eating hot spicy foods and worsened in the morning<br />
when she brushes her teeth. She also noticed purple pruritic rash to<br />
her hands started approximately same time as her gums. She had no<br />
previous history of similar symptoms. Her past medical history include<br />
GERD and borderline hypertension. She denies smoking, illicit<br />
drugs and alcohol use. She lives alone and is not sexually active.<br />
She is currently taking omeprazole 20mg daily for GERD and<br />
started on lisinopril 5mg daily approximately 5 months ago.On<br />
physical exam her vital signs were normal. Oral exam her buccal<br />
mucosa and gums had shallow, tender, erythematous small erosions<br />
P OSTER<br />
A BSTRACTS<br />
C8<br />
Blisters from my surgery: clinical history helped by internet pictures.<br />
A. I. Garrido, A. Chakka, T. Iloabuchi, F. Perez, A. Nazir.<br />
<strong>Geriatrics</strong>/Internal Medicine, Indiana University-<strong>Geriatrics</strong> fellowship,<br />
Indianapolis, IN.<br />
84 y/o WF admitted to a sub-acute rehab. to recover from complication<br />
from a total knee arthroplasty. PMHx. consists of DM, HTN,<br />
anemia, HLD, CAD, COPD, CKD, anxiety, and Hypothyroidism.<br />
After two weeks of successful rehabilitation, she developed blisters<br />
in her extremities and torso, with no other symptoms. When the<br />
blisters burst, they express a clear fluid, then crust and new blisters<br />
appear in other parts of her body.<br />
The patient was started on Prednisone while in the hospital but<br />
no documentation was found regarding the reason for it. With further<br />
interrogation, she stated that she had the blisters before and that<br />
steroids usually improved them. Until then, since no documentation<br />
found about her blisters, COPD exacerbations were the presumable<br />
cause for her steroid treatments.<br />
After reviewing and taking in consideration that the patient is a<br />
female older than 60, with previous episodes of non-complicated blistering,<br />
also that those blisters have responded to steroids treatment,<br />
and finally and foremost after comparing her lesions with the ones<br />
posted online in multiple sites Our patient was diagnosed with Bullous<br />
Pemphigoid and started on a long prednisone taper after which<br />
she improved and was successfully discharged home.<br />
Discussion:<br />
Bullous Pemphigoid is a fairly uncommon disease, but when<br />
present is usually in elderly females, it is one differential diagnosis we<br />
should think of when blisters are present in the elderly, followed by<br />
Pemphigus (similar but less common blistering disease). The difference<br />
between the two is auto antibodies to intradermal epitopes in<br />
the latter vs. sub dermal auto antibodies in the former. Both have<br />
been linked with higher risk of death, and this is why primary care<br />
geriatricians and anyone taking care of the elderly should be vigilant<br />
to diagnose and treat Bullous Pemphigoid, the treatment is mainly<br />
wound care (treat like a burn) and oral steroids. Recurrence is common<br />
and even longer steroid tapers might be required. Etiology is<br />
not well understood but an autoimmune response is known. The diagnosis<br />
is clinical. An association with some medications use is<br />
known (Furosemide, Penicillamine, and Captopril –among the most<br />
prominent-).<br />
References:<br />
1. Beth G Goldstein, MD, Bullous pemphigoid and other pemphigoid<br />
disorders. Topic review/Uptodate 2011<br />
2. González Ramírez A, Romero de Ávila AD, Mazoteras<br />
Muñoz V, Rev Esp Geriatr Gerontol. 2011 Nov 16.<br />
C9<br />
When Safe is Really Sad: Omeprazole Induced Depression with<br />
Psychotic Features.<br />
A. Tucker, B. Setters. Family and Geriatric Medicine, University of<br />
Louisville, Louisville, KY.<br />
Introduction: Omeprazole, a proton pump inhibitor, is used to<br />
reduce acid production and relieve symptoms associated with gastric<br />
reflux disease and is considered highly effective with relatively few<br />
side effects. As a result, it is considered a safe medication even for<br />
elderly patients and those sensitive to other medication classes.<br />
Case Report: A 70 yo female presented to the hospital with<br />
complaints of confusion. She had developed an acute change in her<br />
mentation with audio- visual hallucinations, delusions about her family<br />
and severe depression with vegetative type symptoms including<br />
anhedonia, anorexia and self-neglect which was very atypical for this<br />
active, fully independent woman. She had been recently diagnosed<br />
with Sjogren’s syndrome and had been referred for an endoscopy<br />
after persistent complaints of stomach discomfort. She was diagnosed<br />
with lower esophageal sphincter dysfunction and was started on<br />
omeprazole and fluconazole for oral thrush. Within the next two<br />
weeks, the patient’s mental status changed and she declined into a<br />
vegetative state. Examination found an unkempt, withdrawn, nonverbal<br />
woman fixated upon the death of her family and everyone around<br />
her. She was very bradykinesic and her mental status was equally<br />
slowed and impaired with a 20/30 MMSE score and a 2/4 clock drawing<br />
and she was hyponatremic (sodium 128). Her medications<br />
(omeprazole and losartan) save fluconazole were stopped for a medication<br />
washout. A complete work up ensured due to concern over<br />
acute mental changes; including CT and MRI of the head, EEG, lumbar<br />
puncture, cultures, toxicology and viral screens were all negative.<br />
Neuropsychological testing for dementia was also negative. As a result,<br />
she was started on olanzapine. Her symptoms persisted and she<br />
eventually required electroconvulsive therapy to restore her function<br />
and reverse her depression. She responded immediately to the ECT<br />
therapy and was able to return home to her active, independent,<br />
happy life.<br />
Conclusion: While cognitive changes and other psychological<br />
symptoms such as depression and hallucinations have been reported<br />
with proton pump inhibitors, they are very rare and often overlooked.<br />
This case illustrates the importance of considering unusual pharmacologic<br />
side effects as an underlying cause of acute psychotic and depressive<br />
symptoms, especially in the elderly patient. If overlooked,<br />
this patient may not have recovered.<br />
C10<br />
Follow the polypharmacy leader: medication induced heart block in<br />
a frail elderly female after failed cardio version.<br />
A. Burke, 1 B. Setters. 2 1. Internal Medicine, University of Louisville,<br />
Louisville, KY; 2. Family and Geriatric Medicine, University of<br />
Louisville, Louisville, KY.<br />
Introduction: Physicians continue to treat elderly patients with<br />
the same goals and protocols used for less complicated, younger patients.<br />
Slowed physiological responses, normal aging changes and<br />
often times frailty mean many elderly patients do not have the ability<br />
to appropriately respond to acute illness. Medical comorbidities and<br />
polypharmacy complicate this already convoluted treatment picture<br />
and lead to unexpected adverse events.<br />
Case Report: Mrs. M, a 71 year old female with a history of oxygen<br />
dependent COPD, diastolic dysfunction, paroxysmal atrial fibrillation<br />
(Afib) treated with cardioversion, obesity and diabetes, present<br />
to the emergency department with “trouble breathing” and palpations.<br />
EKG revealed Afib with a heart rate in the 120’s. She was admitted<br />
to the hospital for rate control, management of mild COPD<br />
exacerbation, and acute renal insufficiency (Cr 2.99; clearance 16<br />
ml/min). Mrs. M’s baseline rhythm on previous EKG was sinus bradycardia<br />
with a first degree AV block. Cardiology was consulted due to<br />
her complicated heart history and propafenone (225mg three times<br />
daily) and digoxin (0.125mg daily) were continued at home dosages<br />
with an increase dose of metoprolol (100mg twice daily from 75mg<br />
twice daily). Mrs. M then developed two episodes of unresponsiveness<br />
and subsequent code despite having a DNR code status. After<br />
the second episode of unresponsiveness, the continuous telemetry<br />
monitor revealed a wide irregular complex bradycardia without evidence<br />
of a p wave. The digoxin was held, a dig level checked and her<br />
beta blocker stopped as it was determined she was experiencing erratic<br />
complete heart block. She then has a pacemaker placed to control<br />
her bradycardia and heart block while the medications cleared<br />
her system. After her pacemaker placement, she did not experience<br />
any additional episodes of unresponsiveness and was discharged back<br />
to her nursing facility the following week after her renal function recovered<br />
and her medication effects wore off.<br />
Conclusion: In the elderly, medication titration and goals need<br />
to be adjusted from traditional protocols used in younger patients.<br />
With slower medication titration, reduction of polypharmacy, or decrease<br />
doses of home cardiac medications, Mrs. M may have avoided<br />
AGS 2012 ANNUAL MEETING<br />
S135
P OSTER<br />
A BSTRACTS<br />
the episodes of unresponsiveness, subsequent code and pacemaker<br />
placement.<br />
C11<br />
Unmasking PTSD in Dementia.<br />
A. H. Chodos, A. Moreno. <strong>Geriatrics</strong>, UCSF, San Francisco, CA.<br />
Introduction: A new presentation of posttraumatic stress disorder<br />
(PTSD) in the setting of cognitive impairment is increasingly diagnosed<br />
in patients with a history of prior trauma. The effect on caregivers<br />
is not well understood.<br />
Case: Mr. H is an 89-year-old male veteran with hypertension<br />
and glaucoma. At a primary care visit, he had a Montreal Cognitive<br />
Assessment score of 12/30 (normal ≥26) but reported no functional<br />
impairments. A social work and APS evaluation found his home to be<br />
safe and that he lived with his frail wife.<br />
Two months later he was seen by psychiatry, who noted a previous<br />
diagnosis of PTSD two years earlier and that he had since fallen<br />
out of psychiatric care. They documented a history of trauma during<br />
early childhood and WWII. Mr. H reported ongoing symptoms of<br />
nightmares, intrusive thoughts, insomnia and frequently checking the<br />
house at night. He refused any medication.<br />
A neuropsychological battery revealed impaired memory, language<br />
and attention,consistent with dementia.Laboratory tests showed<br />
a B12 of 196, and he was started on B12 supplement. A head MRI<br />
showed volume loss and subcortical white matter hyperintensities.<br />
A month later he presented three times to the ER for nonspecific<br />
symptoms and weight loss, and was admitted on the last visit. He<br />
was discharged home after his symptoms resolved without intervention.<br />
Several days later, he presented to his PMD endorsing severe<br />
anxiety, paranoia about his wife and suicidality. He was admitted to<br />
psychiatry. His suicidality resolved but he remained paranoid about<br />
his family. His providers discovered that prior to his presentation to<br />
his PMD, he had been alone for three days after exhibiting anxious<br />
and paranoid behavior that prompted a stepdaughter to remove his<br />
wife from the home. His family has refused to participate further in<br />
his care, and he awaiting guardianship in the hospital.<br />
Discussion: Mr. H was diagnosed late in life with PTSD in the<br />
setting of cognitive decline. His symptoms worsened as his dementia<br />
progressed and his social environment became strained. His case<br />
demonstrates that protective cognitive strategies may be affected in<br />
dementia, unmasking PTSD symptoms. Evidence also suggests traumatic<br />
memories are better encoded than others and may be preferentially<br />
recalled as dementia impairs recent memory. Older adults diagnosed<br />
with dementia require early social and psychiatric assessment<br />
to prevent harms of unaddressed psychiatric disease, caregiver stress<br />
and social vulnerability.<br />
C12<br />
Foot recognition following amputation.<br />
A. Gupta, 1,2 M. K. Bautista, 1,2 M. Izhar, 1,2 F. Aziz, 1,2 R. J. Beyth, 1,3<br />
K. M. Heilman. 1,4 1. GRECC, NF/SGVHS, Gainesville, FL; 2.<br />
Department of Aging and <strong>Geriatrics</strong>, University of Florida,<br />
Gainesville, FL; 3. Department of Medicine, University of Florida,<br />
Gainesville, FL; 4. Department of Neurology, University of Florida,<br />
Gainesville, FL.<br />
Background: Studies of body knowledge and imagery may help<br />
us understand disorders of the body schema such as phantom limbs<br />
and anosognosia. Following limb amputation there are alterations of<br />
a limb’s cortical representation. This case report attempted to learn if<br />
shortly after an above-knee amputation of the right leg this patient<br />
had a normal or impaired ability to recognize pictures of the right<br />
versus left foot taken from different angles.<br />
Methods: A 56-year right handed man with history of diabetes,<br />
peripheral vascular disease and remote history of right side stoke 10<br />
years ago without residual neurological deficits, developed a diabetic<br />
foot ulcer of the right lower leg and underwent an above-knee amputation<br />
of the right leg. Two weeks after surgery, the right-left foot<br />
recognition task was performed. The patient was shown, in a random<br />
order, a total of 24 images of either right or left foot at 12 different angles<br />
for each foot, and was asked to tell the examiner as rapidly, but as<br />
accurately as possible, if this picture was either the right or left foot.<br />
The subject made 44 errors recognizing the picture of the right foot<br />
and 44 errors recognizing the left foot. The mean reaction time for the<br />
right foot was 1.60±1.19 seconds, and the mean reaction time for the<br />
left foot was 1.52±1.28 seconds. There was no statistical difference in<br />
terms of the reaction time or accuracy in identifying images of the<br />
right foot compared to the left foot.<br />
Discussion: Previous studies using a limb recognition task with<br />
people who had a unilateral hand amputation and unilateral leg pain<br />
revealed increased reaction time and decreased accuracy in identifying<br />
images of the affected limb compared to the unaffected limb.<br />
Contrary to these prior reports this patient with right leg amputation<br />
revealed no difference in identifying images of the right compared to<br />
the left foot. Cortical reorganization occurs over a period of time and<br />
this patient was tested only two weeks after amputation. Further<br />
studies are needed to learn if patients such as this develop an alteration<br />
of their amputated limbs representation and if this interferes<br />
with recognition.<br />
C13<br />
Hip fractures in Elders Nearing End of Life: Is There a Role for<br />
Palliative Surgery?<br />
A. R. Atreya, S. Arora, M. J. Brennan. Medicine, Baystate Medical<br />
Center/Tufts Univ. School of Medicine, Springfield, MA.<br />
Background:<br />
There are 350,000 hip fractures in the US annually, with over<br />
90% of them in elders. Most patients benefit from rapid surgical repair<br />
but decision making can be complex near the end of life. The authors<br />
present a case of a frail dementia patient whose precarious situation<br />
and limited reserves posed a conundrum regarding surgical<br />
repair of his fracture.<br />
Case Report:<br />
An 88 year old retired pediatrician (Dr. R.) with advanced dementia<br />
was found lying on the nursing home bathroom floor. His history<br />
included CAD, a CABG and AVR, DM and HTN. He had lost<br />
weight due to dysphagia; his BMI was 15.6. He had an advanced dementia<br />
and was cachectic, incontinent of stool and urine; and he slept<br />
most of the day. Dr. R. needed assistance with all his ADLs. He still<br />
was able to speak a bit and could walk short distances unaided. An X-<br />
Ray confirmed an intertrochanteric fracture.<br />
In the ER, he was anemic, hypotensive, in rapid AF and had a<br />
creatinine of 1.5; he was admitted to the ICU. The critical care, medical<br />
consult and orthopedic teams were divided about whether to<br />
proceed to an ORIF. All agreed that Dr. R was high risk but some<br />
MDs felt he would have less pain after surgery and that the mortality<br />
risk was justified. <strong>Geriatrics</strong> was consulted to render an opinion regarding<br />
“palliative” surgery and to guide the family through this complex<br />
decision. The family reported that Dr. R. had always valued<br />
quality of life and function highly. He had chosen to have a CABG<br />
and AVR at an advanced age (despite the risks) to decrease symptoms<br />
and improve QOL. The family decided to proceed to surgery<br />
but overnight Dr. R. became stuporous, had an MI, developed pneumonia<br />
and worsening renal failure. Thoughts of surgery were abandoned,<br />
comfort measures intensified and Dr. R. died peacefully 3<br />
days after admission.<br />
Discussion and Conclusion:<br />
A search of the medical literature yields little data on the palliative<br />
outcomes of fracture repair for frail elders like Dr. R. High risk<br />
surgery is unjustified unless there is a real potential palliative benefit.<br />
If patients have better pain control, are able to transfer to chairs and<br />
have a lower requirement for opiates with fewer drug side effects,<br />
S136<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
then the palliative benefits may outweigh the medical risks. This glaring<br />
gap in the evidence calls for a multispecialty collaborative research<br />
effort involving geriatricians, palliative care physicians, hospitalists<br />
and orthopedists.<br />
C14<br />
End-of-life Care in Patients with Advanced Dementia or Severe<br />
Mental Retardation.<br />
B. D. Putnam, 2 Q. Cao, 1 D. Russo. 1 1. Family Medicine, East Carolina<br />
University, Greenville, NC; 2. Brody Medical School, East Carolina<br />
University, Greenville, NC.<br />
Objective 1:<br />
Understand that patients with dementia or mental retardation<br />
may not be able to make end-of-life decisions.<br />
Objective 2:<br />
Recognize the importance of a Health Power of Attorney<br />
(HPoA), and the role it plays in end-of-life decisions regarding a patient<br />
with dementia or mental retardation not capable of acting on his<br />
or her behalf.<br />
Objective 3:<br />
Discuss a particular case in which extraordinary measures were<br />
undertaken to preserve the life of such a patient and the ethical conflicts<br />
that present to health care and behavioral health providers in<br />
these situations.<br />
Abstract:<br />
End-of-life decisions for individuals with dementia or/and mental<br />
retardation may present more complications and uncertainties<br />
than for other patients. Patients who are severely mentally retarded<br />
or demented may have an inability to express themselves in spoken<br />
word or physical movements. Some have never had the mental capacity<br />
to understand what their options are as the end of life approaches.<br />
These decisions are often left up to the individuals named in their<br />
HPoA, often a family member or caregiver. In one particular case, a<br />
woman with severe cerebral palsy and mental retardation had been<br />
treated for eight of her last ten months of life in the hospital after a<br />
large portion of her bowel was resected secondary to obstruction. She<br />
required resuscitation in the medical intensive care unit multiple<br />
times, was maintained via Total Parenteral Nutrition for nine months,<br />
experiencing frequent complications which eventually led to septic<br />
shock and death. The patient’s caregiver, who held the HPoA, insisted<br />
all life-preserving measures be taken and refused hospice or palliative<br />
care despite the patient’s failing physical condition. Added to this<br />
was the concern of her health care providers secondary to the caregiver’s<br />
refusal to consider narcotic pain management for the patient.<br />
The health care team was faced with many moral and ethical issues<br />
including what it meant to “do no harm” or how to address decisions<br />
affecting the patient that they did not believe would improve her care<br />
or prognosis. Models for development of collaboration with medical<br />
and behavioral health team members and those with the HPoA need<br />
to be further developed to answer these difficult dilemmas.<br />
C15<br />
Acute heart failure in an elder with multimorbidities: the “nonlinear<br />
patient trap.”.<br />
B. Gao, 2,1 S. H. Gottlieb. 2 1. <strong>Geriatrics</strong>, Northeast Ohio Medical<br />
University, Rootstown, OH; 2. Medicine, Johns Hopkins University<br />
School of Medicine, Baltimore, MD.<br />
Introduction: Acute decompensated heart failure (HF) is one of<br />
the most frequent reasons for hospitalization among the elderly.<br />
Studies show that HF is often preceded by 2 weeks of worsening<br />
symptoms. Elderly patients may not seek timely treatment for their<br />
HF because they don’t sense or understand the import of premonitory<br />
symptoms. However, elderly patients often suffer from many interacting<br />
problems that cause symptoms to present in a nonlinear,<br />
rapidly evolving course that is difficult to anticipate.<br />
Case: A 73 year old woman with hypertension, hyperlipidemia,<br />
large B cell lymphoma treated with CHOP, right-sided pleural effusions<br />
with pleurodesis, and type 2 diabetes, stopped taking her medications,<br />
olmesartan and hydrochlorothiazide, 6 months before admission<br />
because she was exhausted taking care of her sister who had Lou<br />
Gehrig’s disease and because she ran out of money. Her symptoms of<br />
dyspnea and fatigue increased slowly until one week before admission<br />
when they became progressively worse; on the day of admission<br />
her symptoms became unbearable over 4 hours; when she thought<br />
that she was dying, she called 911 and was taken to the emergency<br />
room. On admission, her echocardiogram showed an ejection fraction<br />
of 20% and NT-ProBNP was 5,288 pg/ml. Troponin I was
P OSTER<br />
A BSTRACTS<br />
paralysis is seen for 36-48 hours then medical therapy is fully acceptable.<br />
In conclusion, the clinical presentation of epidural abscesses is<br />
often non-specific and should be investigated in atypical scenarios.<br />
C17<br />
Case Report: A primary mucinous adenocarcinoma with multiple<br />
recurrences and a 24 year survival.<br />
C. M. Espinal, 1,2 N. K. Patel, 1,2 R. W. Parker. 1,2 1. <strong>Geriatrics</strong>, University<br />
of Texas Health Science Center at SA, San Antonio, TX; 2. <strong>Geriatrics</strong>,<br />
Christus Santa Rosa, San Antonio, TX.<br />
INTRODUCTION: Advanced stage mucinous carcinoma of the<br />
ovary is very rare and is associated with poor overall survival. We report<br />
a case of a patient who has survived 24 years since her diagnosis<br />
of mucinous adenocarcinoma.<br />
CASE REPORT: A 70 year old (y/o) hispanic female with a 24<br />
year history of ovarian mucinous adenocarcinoma diagnosed at 46<br />
y/o in Mexico(1987). She underwent exploratory laparotomy due to<br />
recurrent abdominal discomfort, was diagnosed with mucinous adenocarcinoma<br />
of the left ovary. The patient was managed with<br />
oophorectomy and chemotherapy. Latter in the course of her disease<br />
she had about six laparotomies for removal of recurrent abdominal<br />
mucinous collections. The last recurrence was at the left pleural cavity.<br />
She has three fistulas on her left upper back draining serous fluid<br />
since 2009. The patient presented to our clinic with a desire for surgical<br />
evaluation for possible closure of fistulas, to regain her quality of<br />
life. She is limited in her socialization because of the fistulas and<br />
drainage. A CT of the chest demonstrated prior surgeries as well as<br />
lesions that extend beyond the pleura into the overlying chest wall.<br />
She was referred to a surgeon experienced with the geriatric population<br />
for management of the fistulas and also to an oncologist.<br />
DISCUSSION: Primary mucinous tumors are classified into benign,<br />
borderline, or malignant categories depending on their<br />
histopathology characteristics. For women with regional and distant<br />
disease, 5 year survival rates are 73% and 28%, respectively. These tumors<br />
usually develop in the third to fifth decades of life and typically<br />
cause vague symptoms, such as increasing abdominal girth, abdomino-pelvic<br />
pain, fatigue, constipation, and urinary incontinence.<br />
The patient started experiencing abdominal symptoms in her late<br />
40’s. Fortunately she had appropriate management with frequent interventions<br />
of her abdominal recurrence and pain management. Her<br />
wishes have always been to be able to live and enjoy her family.<br />
CONCLUSION: The survival rates for women with ovarian<br />
cancer and distant-recurrent disease is low, but considering the benefits<br />
versus the risk of cancer management, one should consider not<br />
only the comorbidities and life expectancy but quality of life. The patient<br />
and the family’s preferences should be an important part of the<br />
decision making for the plan of care.<br />
C18<br />
Thirteen courses of ECT over 4 years in an Alzheimer’s patient. Is it<br />
helping?<br />
C. D. Teodoro, M. Leiding, M. Gorbien, J. Olson, M. Bednarczyk.<br />
Section of Geriatric Medicine and Palliative Care, Rush University<br />
Medical Center, Chicago, IL.<br />
Purpose:<br />
To highlight the need for evidence-based practice guidelines in<br />
the use of ECT in persons with dementia and depression.<br />
Background:<br />
Electroconvulsive therapy (ECT) is a widely accepted treatment<br />
for older adults with medication refractory depression. Although<br />
evidence is limited, ECT is presumed to be effective in treating<br />
depression in older adults with dementia. Because patients with<br />
advanced dementia are difficult to interview, surrogate markers for<br />
depression must be used, such as function, oral intake, agitation or aggression.<br />
We present an extreme case of a woman with Alzheimer’s<br />
dementia, who has required repeated admissions for ECT to treat<br />
symptoms presumed to represent depression.<br />
Method: Case report<br />
Case Report:<br />
Mrs. G. is an 81 year-old female with Alzheimer’s dementia, who<br />
has been admitted to the gero-psychiatry unit thirteen times since<br />
Aug 2007 with symptoms of severe anxiety, insomnia and anorexia.<br />
Despite multiple pharmacologic therapies and use of outpatient<br />
maintenance ECT, her depression continues to relapse. She received<br />
a mean of 9 treatments per admission, a minimum of 7 and maximum<br />
of 15. Along with improved sleep and oral intake, one of the clearest<br />
indications ECT is helping Mrs. G. has been the condition of her knitting.<br />
A life-long knitter, she is always admitted with balls of yarn, her<br />
needles, and a hopelessly, tangled, knitted scarf. By discharge, her new<br />
scarf has few to no errors.<br />
Discussion:<br />
In the case of Mrs. G., ECT appears to relieve her depression, albeit<br />
temporarily. However, due to her dementia, ECT’s effect on cognition<br />
cannot be fully evaluated. In addition, observation of surrogate<br />
makers for depression by caregivers is subjective and difficult to standardize.<br />
A review of the literature reveals retrospective chart reviews<br />
and case reports describing ECT efficacy and purport its safe use in<br />
the treatment of depression with co-morbid dementia. However,<br />
these are limited in number, and descriptive in nature. While we acknowledge<br />
ECT’s therapeutic benefit in depressed patients, its use in<br />
those with underlying dementia still necessitates careful consideration<br />
and selection of the patients to be treated.<br />
C19<br />
Alzheimer’s Disease versus Hippocampal Sclerosis (HS): Is There a<br />
Clinical Imperative to Diagnose HS?<br />
D. M. Otero, K. Sharma. Division of <strong>Geriatrics</strong>, Albert Einstein<br />
College of Medicine, Montefiore Medical Center, Bronx, NY.<br />
Hippocampal sclerosis (HS) is a pathologic term used to describe<br />
severe loss of neurons and reactive gliosis in the hippocampus.<br />
HS is associated with hippocampal atrophy, severe amnesia, and<br />
slowly progressive dementia without clinical seizure activity. HS is<br />
found bilaterally in 50% of cases and 25% on the right or left side<br />
only. HS is difficult to distinguish clinically from Alzheimer’s disease<br />
(AD) and is often diagnosed postmortem. In autopsy series, HS is described<br />
in 1-5% of cases as an isolated diagnosis. However, HS has<br />
been described in up to 26% of cases when it occurs in combination<br />
with other vascular and neurodegenerative disorders.<br />
Case: A 78 year old woman was evaluated because the family<br />
had noticed changes in her behavior for 6 months. She had no significant<br />
PMH or toxic habits. The patient, a retired book-keeper with a<br />
high-school education, was no longer paying her bills, her house was<br />
disorganized and dirty and she could no longer use the computer.<br />
General PE: Unremarkable. Neurological: No focal signs. Psychiatric:<br />
No signs or symptoms of depression or personality change. Mental<br />
Status Testing: Clock Drawing Test: 3 (3 or > cognitive deficit); Mini-<br />
Mental State Examination: 21/30. Laboratory data revealed normal:<br />
chemistry, CBC, TSH, B12 and folate levels. Given the atypical presentation<br />
and rapid deterioration, the patient was referred for neuropsychological<br />
(NP) testing. NP testing revealed preserved insight.<br />
Memory was markedly impaired for both verbal and nonverbal material.<br />
However, she displayed a high level of nonverbal reasoning<br />
which was unexpected given her marked memory impairment. Verbal<br />
intelligence was near superior. The patient’s profound memory impairment<br />
in the context of well-preserved reasoning ability is an unusual<br />
profile for AD and HS was considered. MRI showed nonspecific<br />
vascular changes which is often seen in HS.<br />
Discussion: HS is distinguished from AD by the findings of preserved<br />
reasoning in the setting of profound memory loss early in the<br />
disease. HS is currently a pathological diagnosis however new research<br />
suggests that HS can be diagnosed with NS testing.This case il-<br />
S138<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
lustrates how HS and AD could potentially be differentiated clinically<br />
in the earliest stages with NP testing. The etiology and clinical significance<br />
of HS and its associated dementia has to be further elucidated.<br />
C20<br />
Looking Past the Dementia: Anxiety & Tachycardia Induced Seizure<br />
in a Patient with Dementia.<br />
D. Neamtu, L. Grooms, B. Setters. Family & Geriatric Medicine,<br />
University of Louisville, Louisville, KY.<br />
Introduction: Twenty five percent of new onset seizures occur in<br />
individuals over 65 years of age and approximately one fourth of all<br />
persons with epilepsy are elderly. Most seizures in elderly patients are<br />
partial onset, with or without secondary generalization, and are underdiagnosed<br />
especially in patients with dementia. Given the high<br />
quality of life burden seizures cause, it is important to diagnose and<br />
appropriately treat them even among frail elders.<br />
Case report: A 79 yo female with a history of advanced dementia,<br />
hypercholesterolemia, gastro-esophageal reflux disease, urinary<br />
incontinence and osteoarthritis, living in a long-term care facility, had<br />
a witnessed tonic-clonic seizure with no loss of consciousness while<br />
ambulating in the hallway. After the episode the patient had garbled<br />
speech and worsening confusion. By the time she was evaluated in the<br />
emergency department, the aphasia resolved and no neurological<br />
deficits were noted. Diagnostic studies including CMP, CBC, TSH,<br />
toxicology and head CT were normal; EEG showed normal activity<br />
save movement artifact. Telemetry during hospitalization, however,<br />
found the patient was experiencing episodes of sinus tachycardia to<br />
150 beats per minute during restful awake periods. She was unaware<br />
of these symptoms and additional cardiac evaluation including an<br />
echocardiogram was unremarkable. Careful investigation and observation<br />
suggested a relationship between the patient experiencing extreme<br />
anxiety or heightened awareness and resultant sinus tachycardia<br />
which were decreasing cerebral flow and resulting in seizure<br />
activity. The patient returned to the nursing facility with recommendations<br />
for anxiety treatment as a first measure.<br />
Discussion: Patients with dementia are at increased risk of<br />
seizures. Approximately 15% of patients with Alzheimer’s Dementia<br />
will develop seizures, a rate that is ten times higher than expected for<br />
age. No clear etiology was found for the tachycardia occurring during<br />
wakeful periods; this may be secondary to anxiety as postulated, but<br />
may also occur from uncontrolled pain or dementia associated psychosis.<br />
No signs of the latter etiologies were noted in this patient.<br />
Given the high burden of seizures on quality of life even among dementia<br />
patients and those with high comorbid diseases proper diagnosis<br />
and treatment is very important.<br />
C21<br />
Does Living in a Family Slow Cognitive Decline in Dementia?<br />
D. Basu, M. Brennan. Baystate Medical Center/Tufts Univ. School of<br />
Medicine, Springfield, MA.<br />
INTRODUCTION: Cultural norms and family structures may<br />
slow the progression of dementia or even delay its onset. The authors<br />
report a case of a Latino senior with dementia who remained cognitively<br />
stable longer than anticipated due in part to the devotion of his<br />
family.<br />
CASE: In 2008, a 85 year old man with CHF, atrial fibrillation,<br />
CKD, DM, PVD, gait impairment and memory loss for a year was<br />
seen by geriatrics and diagnosed with a moderate stage mixed<br />
Alzheimer’s and vascular dementia. As the years passed, occasional<br />
restlessness, insomnia and hallucinations occurred and he was treated<br />
for depression; occasionally low dose antipsychotics were prescribed.<br />
Overall, he has responded well to reorientation, cueing and cognitive/social<br />
stimulation by his devoted family who never leave him unattended.<br />
His dementia has progressed but he remains verbal, interactive,<br />
recognizes family and enjoys life despite many admissions and<br />
functional decline. He recently even made a trip back to Puerto Rico<br />
to visit relatives.<br />
DISCUSSION: Epidemiological data indicates the incidence<br />
and rate of dementia are higher for socially isolated elders. Studies of<br />
African and Italian patients indicate that social integration and networks<br />
and cognitively challenging leisure activities protect against<br />
dementia and some research suggests that occupational therapy approaches<br />
may slow cognitive decline for dementia sufferers. Emotional<br />
support maintains cognitive reserves and enhances recovery in<br />
stroke patients. However, a search of the literature using standard engines<br />
such as pubmed and google scholar, found no studies analyzing<br />
whether preserved family life can prevent or slow dementia’s inexorable<br />
course.<br />
CONCLUSION: Living with loving families provides personalized<br />
care for frail elders and will decrease the public costs of health<br />
care; strategies to support family-based care in the community thus<br />
may improve quality of life while decreasing the state’s financial burden.<br />
Additionally, elders living with families who involve them in decision<br />
making, problem solving and ongoing social interaction will be<br />
stimulated cognitively and may maintain intellectual reserves longer.<br />
There is a glaring gap in the literature; studies must be done to clarify<br />
whether family life delays the onset or progression of dementia. The<br />
role of families in slowing cognitive decline in dementia patients is<br />
critically important for the field of ethnogeriatrics.<br />
C22<br />
A Request by a Septuagenarian to Stay Young.<br />
D. Chen, 1,2 R. S. Tan. 2,1 1. Medicine/<strong>Geriatrics</strong>, Baylor College of<br />
Medicine, Houston, TX; 2. Houston VA, Houston, TX.<br />
A 77 yo female asked that her last years be of quality. She had<br />
no falls, incontinence, mood instability or memory loss. She requested<br />
hormones be checked due to fatigue, bruising and weakness. PMH:<br />
hysterectomy 40 years ago. She lives by herself, drives and walks 30<br />
minutes daily. She was using no meds.<br />
She had a weight of 125 pounds, height 5 feet 6 inches,<br />
BP:110/70, MMSE:30/30, senile purpura in forearms, mild kyphosis,<br />
genu varus of left knee. Cardio-respiratory exam normal. Body fat by<br />
impedance: 26%.<br />
Labs (with normal ranges): estradiol: pg/mL (>27); testosterone:<br />
11 ng/dL (2-40); undetectable progesterone; IGF-1: 56 ng/mL (34-245,<br />
Z score -1.1). CBC, glucose, cholesterol and TSH were normal. Mammogram<br />
was normal.<br />
After a lengthy discussion of safety and that we have no longterm<br />
data to guide us, and documenting informed consent for offlabel<br />
use, the decision was made to initiate hormone therapy. Reproductive<br />
hormone replacement was achieved through compounding of<br />
estradiol 1mg, testosterone 2 mg and progesterone 40 mg in a topical<br />
gel applied daily. Growth hormone replacement was administered<br />
subcutaneously, initially with 0.3 mg 3 times weekly, and later increased<br />
to 0.5 mg eod, after titrating IGF-1 levels. Therapy was to be<br />
combined with a supervised exercise regimen in the gym.<br />
The patient was followed up monthly. At month 4, she reported<br />
significant changes to her quality of life. Her bruising had disappeared.<br />
She was mentally sharper and felt physically stronger, and<br />
able to ambulate faster and longer. There was no numbness in the<br />
hands, hot flashes or virilism. Physical examination showed redistribution<br />
of body fat to lean body mass as evidenced by constant weight,<br />
but lowering of body fat from 26% to 25%. Her grip strength significantly<br />
improved for both hands (see table). Labs confirm elevation of<br />
estradiol to 32 pg/mL, testosterone to 58ng/dL and progesterone to<br />
1.3 ng/mL. IGF-1 levels remained the same, which may be reflective<br />
of the conservative dosing.<br />
This case illustrates that while considered non-mainstream by<br />
some, geriatricians can help selected septuagenarians improve quality<br />
of life with careful replacement of hormones with aging. Cost and<br />
ethical concerns must be considered.<br />
AGS 2012 ANNUAL MEETING<br />
S139
P OSTER<br />
A BSTRACTS<br />
grip strength change before and after treatment<br />
*p
P OSTER<br />
A BSTRACTS<br />
ratory symptoms such as stridor and airway compromise due to RA.<br />
The patient in this case presented with dysphagia and dysphonia<br />
without any other respiratory symptoms. Also, this case illustrates a<br />
unique presentation of RA in which dysphagia was not only caused<br />
by laryngeal dysfunction but also oropharyngeal dysfunction possibly<br />
related to striated muscle involvement, a phenomenon that has not<br />
been very well described. Further studies are needed to investigate<br />
pathophysiology and treatment of dysphagia and dysphonia in patients<br />
with RA.<br />
C26<br />
Stuck Between a Rock and a Bare Metal Stent: Triple<br />
Antithrombotic Therapy Resulting in a GI Bleed.<br />
F. Longenecker, 2 B. Setters. 1 1. Family & Geriatric Medicine,<br />
University of Louisville, Louisivlle, KY; 2. School of Medicine,<br />
University of Louisville, Louisville, KY.<br />
Introduction: Although the standard of care for PCI with stent<br />
placement and DVT prophylaxis for hip arthroplasty are individually<br />
well established, little evidence exists about what to do for patients<br />
requiring both treatments simultaneously. In such a situation the risk<br />
of bleeding vs. the risk of thrombosis must be used to determine the<br />
individual patient’s treatment course.<br />
Case Report: A 79 y/o WF was admitted with an L femoral neck<br />
fracture after being found down for 48 hours. Preoperative clearance<br />
determined she needed a cardiac catheterization which found a 90%<br />
occlusion of her LAD requiring placement of a bare metal stent. She<br />
was started on clopidogrel and aspirin therapy post stent for a minimum<br />
of 30 days. Discussion ensued with orthopedics and cardiology<br />
about the timing of the patient’s orthopedic procedure now that she<br />
was on anticoagulation. Orthopedics felt that the surgery could be<br />
safely performed on anticoagulants and performed the surgery 3 days<br />
post-stent. She was then started on fondaparinux for DVT prophylaxis<br />
post hip repair.<br />
The patient was discharged to a rehabilitation center four days<br />
post operatively with instructions to monitor for bleeding; Hemoglobin<br />
at discharge was 10.3. Nine days later, she returned to the hospital<br />
with dark, tarry stools worrisome for a GI bleed. Hemoglobin was 7.2<br />
and two units of blood were transfused and pantoprazole was started.<br />
Cardiology was consulted and it was decided the patient would remain<br />
on aspirin but fondaparinux were discontinued to allow for an<br />
upper endoscopic evaluation which was done the next day. She was<br />
diagnosed with antral erosive gastritis without active bleeding. Follow<br />
up Hemoglobin was 9.4 and without evidence of further bleeding,<br />
clopidogrel was resumed. She remained stable and was discharged<br />
back to her rehabilitation center with instructions for continued monitoring<br />
and has done well.<br />
Conclusion: Patients with indications for both DVT prophylaxis<br />
and dual antiplatelet therapy pose a great challenge. In approaching<br />
such cases, providers must assess each patient’s risk and benefit profile<br />
to determine appropriate treatment and monitor for increased<br />
risk of bleeding when combining multiple anticoagulants. Additional<br />
recommendation for treatment and bleeding risks in patients with<br />
bare metal stents who need DVT prophylaxis would be useful for<br />
these cases.<br />
C27<br />
Gastrointestinal Bleeding as a Consequence of Bisphosphonate-<br />
Induced Musculoskeletal Pain.<br />
J. Seguin, 1 F. Chang, 1 K. Yeung. 2 1. School of Pharmacy, University of<br />
Waterloo, Waterloo, ON, Canada; 2. Geriatric Medicine, North York<br />
General Hospital, Toronto, ON, Canada.<br />
Background:<br />
Non-steroidal anti-inflammatory drugs (NSAIDs) are common<br />
causes of gastrointestinal (GI) bleeds in older adults. Bisphosphonates<br />
are first line treatment for osteoporosis, a chronic disease with<br />
increased prevalence with aging. This case discusses how an uncommon<br />
adverse effect associated with bisphosphonate use can be an underlying<br />
cause to GI bleeds in older adults.<br />
Pertinent Case History:<br />
DA, a 79 year old community dwelling woman, was admitted<br />
through the emergency department with acute leg and knee pain and<br />
black stools. She was anemic with low hemoglobin (81 g/L or 8.1<br />
g/dL), but did not require a blood transfusion. Endoscopy revealed 4<br />
small gastric ulcers. Her pain started about 2.5 weeks prior to admission<br />
and she was prescribed naproxen 375mg twice daily as management.<br />
This was switched to diclofenac 75mg twice daily with rabeprazole<br />
5 days prior to admission; however, she did not discontinue<br />
naproxen. Upon investigation, the acute pain started with the initiation<br />
of risedronate 35mg weekly for osteoporosis. The NSAIDs were<br />
discontinued in hospital, and lansoprazole was initiated with acetaminophen,<br />
as well as ferrous gluconate. She was discharged home 4<br />
weeks later, followed by 3 months of outpatient physiotherapy.<br />
Conclusions:<br />
This case illustrates how missed identification of drug-related<br />
adverse events can be harmful for the patient. Potential drug-related<br />
causes should be investigated prior to symptomatic treatment for<br />
pain. Practitioners should consider bisphosphonates in addition to osteoporotic<br />
pain in their differential diagnosis for musculoskeletal<br />
pain in the elderly. While the cause and risk factors for musculoskeletal<br />
pain induced by bisphosphonates remain unclear, one study has<br />
suggested that the effect may be mitigated by starting patients on<br />
low-dose daily treatment before starting the once weekly dose. This<br />
case also reinforces the 2009 recommendation by the <strong>American</strong> <strong>Geriatrics</strong><br />
<strong>Society</strong> to avoid the use of nonselective NSAIDs and COX-2<br />
inhibitors in the elderly with persistent pain without a compelling<br />
reason, and to exercise extreme caution if used. In addition, patient<br />
education and reinforced understanding are pertinent to avoid therapeutic<br />
duplications particularly with switching between agents in the<br />
same high risk medication class.<br />
C28<br />
Terminal Suffering: the Complex Interplay of Pain and Delirium at<br />
End of Life.<br />
G. Sachdeva, 1 M. Brennan. 2 1. Internal Medicine, Baystate Medical<br />
Center / Tufts University School of Medicine, Springfield, MA; 2.<br />
Internal medicine/<strong>Geriatrics</strong> division, Baystate Medical Center/ Tufts<br />
University School of Medicine, Springfield, MA.<br />
A 70 year old man (Mr. F.) had a complex cardiopulmonary history,<br />
anxiety, chronic pain, dysphagia, recurrent pneumonias and a<br />
vascular dementia. Home medications included clonazepam (4 mg<br />
over the day) a 350 mcg fentanyl patch and methadone (15 mg total<br />
daily). He was admitted with lethargy, weakness and confusion and<br />
proved to have a new aspiration pneumonia. His two daughters were<br />
PAs and along with a wife and son were closely involved in decision<br />
making. When he aspirated yet again, all agreed to strictly comfort<br />
goals; family was deeply committed to relieving Mr. F.’s suffering. Despite<br />
explanations that much of his restlessness and moaning was due<br />
to a terminal delirium, the family worried he was in pain and often<br />
declined antipsychotic doses and requested changes in the analgesic<br />
regimen. House officers and covering hospitalists were uncomfortable<br />
with the doses and drugs being used but certainly did not want<br />
the patient to suffer. At times drugs (e.g. methadone) were inappropriately<br />
discontinued but sometimes they were increased too quickly.<br />
One day an escalation of morphine despite renal failure led to early<br />
signs of opioid toxicity and occasional myoclonus. On another occasion,<br />
opioids were switched because fentanyl “wasn’t working.” In<br />
fact, the patient’s restlessness was due to urinary retention and resolved<br />
with a catheter. With careful communication, education and<br />
frequent reassessment, symptoms were controlled and the family<br />
comforted. Mr. F. died calmly several days later.<br />
AGS 2012 ANNUAL MEETING<br />
S141
P OSTER<br />
A BSTRACTS<br />
Discussion/Conclusion<br />
Distress at the end of life may be from treatable factors such as<br />
urinary retention but often results from a complex interplay of delirium,<br />
pain and psychosocial factors. Effective palliation requires a<br />
multimodal approach targeting all sources of suffering. Geriatricians<br />
and palliative care experts have much to learn from each other and to<br />
teach trainees and hospitalists. To ease patients’ final hours and relieve<br />
the guilt of families, the <strong>American</strong> Academy of Hospice and Palliative<br />
Medicine and the <strong>American</strong> <strong>Geriatrics</strong> <strong>Society</strong> should collaborate<br />
on educational and clinical initiatives on end of life care<br />
C29<br />
Galantamine Induced Generalized Myoclonus.<br />
G. Luna, 1 N. Sharma, 2 J. Makela. 3 1. Geriatric, UIC, Chicago, IL; 2.<br />
Geriatric, UIC, Chicago, IL; 3. Geriatric, UIC, Chicago, IL.<br />
Supported By: No financial support provided<br />
Introduction: Myoclonus is a brief, involuntary twitching of a<br />
muscle or a group of muscles characterized by spastic-ballistic disabling<br />
jerking movements. It describes a medical sign and is not itself<br />
a diagnosis. While respiratory myoclonus associated with galantamine<br />
has been previously described, generalized myoclonus second to<br />
galantamine use has not been described before in the published geriatric<br />
literature.<br />
Case: A 87-year-old male with vascular dementia was started on<br />
galantamine for dementia. Four months later, at 16mg dosing, the<br />
caregiver reported that the patient started to experience a fine right<br />
hand tremor, but refused further work-up at the time. The patient<br />
continued on galantamine 16 mg. Nine months after galantamine<br />
therapy was started, the patient came to the clinic complaining of a<br />
new disabling movement disorder. The movements first started three<br />
months previous, as infrequent, short, brief jerks. These episodes did<br />
not follow a day cycle pattern or involve loss of consciousness. On<br />
clinical exam, high amplitude, frequent, multifocal myoclonus was observed.<br />
These jerks involved the whole body; however they were<br />
more prominent in the upper extremities. After discussion with a<br />
movement disorder specialist, who assisted in the assessment, galantamine<br />
was identified as a possible cause of myoclonus. Subsequent<br />
laboratory work-up for other causes was negative. Two weeks after<br />
stopping galantamine all movement symptoms had successfully disappeared,<br />
confirming the suspicion.<br />
Discussion:<br />
In the geriatric practice we see a number of conditions that can<br />
cause generalized myoclonus. Few of these conditions are reversible.<br />
This case report suggest that when we see a patient present with generalized<br />
myoclonus we should consider the possibility of galantamine<br />
induced myoclous, as it is easily reversible. It is important to note that<br />
the development of myoclonus was not abrupt, as might be expected<br />
in a drug reaction. Rather, the myoclonus worsened over the course<br />
of several months while on treatment. However, the rapid resolution<br />
of symptoms after galantamine withdrawal implicated it as a cause.<br />
The insidious onset and progression of myoclonus, as seen in this<br />
case, may hinder recognition of galantamine as a cause. We would encourage<br />
physicians treating generalized myoclonus to consider galantamine<br />
as a possible reversible cause.<br />
C30<br />
Bilateral pulmonary emboli in a patient with renal angiomyolipoma.<br />
G. Ratnarajah, D. Seminara, A. Szerszen . <strong>Geriatrics</strong>, Staten Island<br />
University Hospital, Staten Island, NY.<br />
Renal angiomyolipoma is a benign hamartoma that can rarely<br />
extend into the renal vasculature and subsequently into the inferior<br />
vena cava (IVC) . An even more rare occurrence is embolism of the<br />
tumor from the IVC into the pulmonary circulation<br />
A 72 year old lady with a history of hypertension was found to<br />
have renal insufficiency on routine evaluation by her private medical<br />
doctor. Her physical examination was unremarkable and workup of<br />
the renal insufficiency revealed a mass in the left kidney by ultrasound.<br />
Further inquiry of this renal mass was undertaken with abdominal<br />
computerized tomography ( CT ) scan which revealed a left<br />
sided renal mass with extension into the left renal vein; a preliminary<br />
diagnosis of renal angiomyolipoma was made. The scan also showed<br />
suspicion for a loculated effusion of the left lung. A chest CT scan was<br />
then performed to investigate the pleural effusion which incidentally<br />
revealed bilateral pulmonary emboli. In addition, the right sided embolus<br />
was seen to contain macroscopic fat.<br />
On admission to the hospital, the patient denied any chest pain,<br />
shortness of breath, abdominal pain, or hematuria. Her physical examination<br />
was unremarkable with no signs of tachycardia, fever, hypoxia,<br />
or petechiae. Her labs were significant for a glomerular filtration<br />
rate of 39 ml/min/1.73 m 2 . An echocardiogram was performed<br />
which revealed no signs of right ventricular strain pattern. The patient<br />
was started on intravenous heparin and the decision was made to<br />
bridge her with Coumadin therapy upon discharge. An open radical<br />
nephrectomy was planned on an outpatient basis.<br />
In conclusion, we present an asymptomatic elderly patient with<br />
bilateral pulmonary emboli from renal angiomyolipoma. The extension<br />
of renal angiomyolipoma into the renal vasculature is an uncommon<br />
entity. In these patients, clinicians should be aware of the complication<br />
of embolization and consider further workup to rule out<br />
pulmonary embolism.<br />
C31<br />
Cerebral Infarction: A Rare Presentation of Cryptococcal<br />
Meningoencephalitis in an Immunocompetent Patient.<br />
I. P. Resurreccion. Medicine, UAB Montgomery, Montgomery, AL.<br />
Cerebral cryptococcosis is common fungal opportunistic infection<br />
in immunocompromised, but a rare disease in immunocompetent<br />
patients. We report an unusual case of CNS cryptococcosis as<br />
cerebral infarction in an immunocompetent patient.<br />
A 78-year-old Caucasian male with hypertension, hyperlipidemia<br />
and osteoarthritis was admitted with confusion, left-sided<br />
weakness, dizziness, falls, headache and anorexia. No head trauma nor<br />
fever. On physical, he was disoriented to time and place and decreased<br />
strength on the left side with preserved sensation. Brain CT<br />
was negative. Brain MRI showed subacute infarct in anterior right<br />
middle cerebral territory. Lumbar puncture had normal opening pressure,<br />
showed 18 WBC with 100% mononuclears, high protein<br />
82.5mg/dL, low glucose 18mg/dL, positive India ink and cryptococcal<br />
antigen titer 1:1024. CSF culture grew Cryptococcus neoformans.<br />
HIV screening was negative. Induction therapy initiated with liposomal<br />
amphotericin and flucytosine. He continued to have altered mental<br />
status and headache. He was planned for another lumbar puncture<br />
every 2 weeks or earlier to relieve headaches. He continued to deteriorate<br />
with multi-organ failure and died.<br />
Cerebral infarction is an unusual presentation of CNS cryptococcosis.<br />
Rarely, cryptococcus can cause cerebral infection in immunocompetent<br />
patients. Manifestations include fever, headache, altered<br />
mental status, personality changes and memory loss. Lumbar<br />
puncture is useful for diagnostic and therapeutic. Opening pressure is<br />
elevated and CSF has elevated protein, low glucose with positive<br />
India ink stain, cryptococcal antigen titer and culture. Treatment includes<br />
induction therapy with amphotericin B and flucytosine. Duration<br />
in patients without neurological complications with a negative 2<br />
week CSF culture is 4 weeks and in patients with neurological complications<br />
is 6 weeks. Consolidation therapy with fluconazole is 8<br />
weeks. Maintenance therapy is 6-12 months. The incidence of cerebral<br />
infarction due to cryptococcal meningitis in HIV-negative patients is<br />
4%. Mechanisms include antigen-antibody complexes with vasculitis<br />
and direct toxic effects of viral antigen on vascular endothelium. Poor<br />
prognostic factors are cerebral infarcts, high opening pressure, CSF<br />
WBC
P OSTER<br />
A BSTRACTS<br />
antigen >1:32. Early diagnosis and appropriate management is crucial<br />
to reduce the high morbidity and mortality with CNS cryptococcosis.<br />
C32<br />
WEIGHT LOSS ASSOCIATED WITH SWITCHING<br />
CHOLINESTERASE INHIBITORS.<br />
J. T. Stewart, 1,4 I. Sheyner, 2,5 L. V. George, 3 K. M. Mattox, 3<br />
K. T. Stover. 2 1. Psychiatry, James A Haley VA Hospital, Tampa, FL; 2.<br />
<strong>Geriatrics</strong>, James A Haley VA Hospital, Tampa, FL; 3. Pharmacy,<br />
James A Haley VA Hospital, Tampa, FL; 4. Psychiatry, University of<br />
South Florida College of Medicine, Tampa, FL; 5. Geriatric Medicine,<br />
University of South Florida College of Medicine, Tampa, FL.<br />
Supported By: There was no funding or other support for this work.<br />
BACKGROUND: Weight loss is common in dementia, leading<br />
to poor quality of life and increased mortality. Weight loss is reported<br />
in up to 20% of patients receiving cholinesterase inhibitors. It is not<br />
known which of these agents are more likely to cause weight loss, nor<br />
whether patients who have lost weight on one agent can be treated<br />
with another.<br />
METHODS: Case report, literature review.<br />
RESULTS: An 86 year old man with vascular dementia had<br />
been treated with donepezil for six years; he had improved cognitively<br />
and had never experienced any nausea, anorexia or weight loss.<br />
Galantamine SR was substituted in 2010. Over the next 17 months he<br />
and his daughter reported poor appetite and a loss of 48 pounds.<br />
There was no nausea or vomiting. Ultimately donepezil was reinstated.<br />
His appetite returned and he regained 30 pounds over the<br />
next three months (Figure).<br />
CONCLUSIONS: Cholinesterase inhibitors have modest benefits<br />
in dementia but are not without risk. Weight loss in dementia can<br />
have catastrophic effects on health and quality of life and a reasoned<br />
risk-benefit analysis is essential in all prescribing. The literature does<br />
not guide the clinician when a patient has clear benefit from a<br />
cholinesterase inhibitor but also develops significant weight loss. This<br />
case suggests that weight loss from one agent does not necessarily<br />
predict weight loss from other agents in the class and that switching<br />
to a different agent may be a reasonable strategy. It is not known<br />
whether galantamine is more likely to cause weight loss than other<br />
agents, nor whether its secondary effect of modulating nicotinic receptors<br />
is salient; controlled studies will be necessary to examine<br />
these questions.<br />
C33<br />
A PILOT RANDOMIZED TRIAL OF A BEHAVIORAL SLOW-<br />
BREATHING INTERVENTION TO TREAT URGENCY<br />
INCONTINENCE IN WOMEN.<br />
A. Huang, D. Grady, A. Appa, S. Leslee. University of California, San<br />
Francisco, CA.<br />
Supported By: National Institutes of Health<br />
Background: Urgency urinary incontinence affects up to a quarter<br />
of middle-aged and older women and can have profound adverse<br />
effects on functioning and quality of life. Existing anti-cholinergic<br />
treatments for incontinence are associated with frequent side effects<br />
and high rates of discontinuation in the community. Multiple studies<br />
have indicated that urgency incontinence is associated with increased<br />
levels of perceived stress as well as abnormalities in autonomic nervous<br />
system activity, suggesting that behavioral relaxation interventions<br />
that reduce stress and improve autonomic balance may be helpful<br />
in alleviating this condition.<br />
Methods: Pilot feasibility randomized trial in 20 ambulatory<br />
women with ≥7 episodes of urgency incontinence per week and no<br />
major urologic or neurologic co-morbidities. Women were randomized<br />
to use a portable guided-breathing device (RESPeRATE) to<br />
slow their breathing to
P OSTER<br />
A BSTRACTS<br />
Results: Of 1401 subjects screened at 109 sites, 562 (40%) were<br />
eligible and enrolled. The most common reasons for exclusion were<br />
not meeting VE criteria (226; 27%), low creatinine clearance (114;<br />
14%), and/or too few UUI episodes (82; 10%). 446 subjects (79%)<br />
completed the trial; 116 (21%) discontinued (Table 1). Drop-outs related<br />
to study drug were 8%. Recruitment challenges included access<br />
to fesoterodine without trial participation and subject concerns about<br />
randomization to placebo.<br />
Conclusions: Enrolling/retaining VE in an AM trial is feasible,<br />
with a trial cost of ~$8M. Despite subject vulnerability, retention was<br />
good and drug-related withdrawals were low. Future improvements<br />
for VE trials include allowing assistance with questionnaire completion<br />
and use of home and phone visits for safety assessments and follow-up,<br />
making participation more convenient and less burdensome.<br />
Table 1. Reasons for Subject Discontinuations.<br />
C35 Encore Presentation<br />
Central Nervous System (CNS) Penetration and Memory Effect:<br />
Trospium Chloride vs Oxybutynin in Adults with Overactive<br />
Bladder and Age-Associated Memory Impairment.<br />
C. Tannenbaum, 1 D. Staskin, 2 G. Kay, 3 H. B. Goldman, 4 W. Tong, 5<br />
R. K. Patel. 5 1. Department of Geriatric Medicine, Institut<br />
Universitaire de Gériatrie de Montreal, Montreal, QC, Canada; 2.<br />
Department of Urology, Caritas St. Elizabeth’s Medical Center,<br />
Boston, MA; 3. Cognitive Research Corporation, St. Petersburg, FL; 4.<br />
Glickman Institute, The Cleveland Clinic, Cleveland, OH; 5. Allergan,<br />
Inc., Irvine, CA.<br />
Supported By: Funding for this work was received from Allergan, Inc.<br />
Background: Anticholinergic agents can affect memory due to<br />
CNS penetration, which allows for muscarinic receptor binding in the<br />
brain. Older adults with age-associated memory impairment may be<br />
especially vulnerable. Antimuscarinic agents most likely to cross the<br />
blood-brain barrier are lipophilic tertiary amines. Quaternary amines<br />
are far less lipophilic. This double-blind, placebo-controlled trial<br />
(SMART II) is the first to compare cerebrospinal fluid (CSF) permeation<br />
and memory effects of a quaternary (trospium) and tertiary<br />
(oxybutynin) amine in older adults with overactive bladder and ageassociated<br />
memory impairment.<br />
Methods: Adults ≥60 years were randomized to receive extended-release<br />
(XR) trospium 60 mg QD for 10 days (n=6), or immediate-release<br />
(IR) oxybutynin 5 mg TID for 2 days (n=10). Overactive<br />
bladder was defined by ≥8 voids/day with ≥1 associated with urgency.<br />
CSF was drawn at selected timepoints for bioanalysis. Memory was<br />
measured at baseline and at post-dose plasma steady state using the<br />
Hopkins Verbal Learning Test-Revised (HVLT-R) for total and delayed<br />
recall.<br />
Results: Oxybutynin was detected in the CSF in all oxybutynin<br />
IR subjects (mean age: 68 years; range: 60-76 years). Mean CSF<br />
AUC 0-tau<br />
values were 0.204 ± 0.089 and 1.68 ± 1.06 ng*hr/mL, for oxybutynin<br />
and desethyloxybutynin, respectively. CSF concentrations of<br />
trospium were below the lower limit of quantification of 40 pg/mL at<br />
all timepoints for all trospium XR subjects (mean age: 74 years;<br />
range: 67-84 years). Increased memory impairment on the HVLT-R<br />
delayed was seen with oxybutynin IR (mean baseline score, 9.4; mean<br />
change from baseline, -1.3; p=0.03). Trospium XR had no deleterious<br />
effect on memory (mean baseline score, 8.2; mean change from baseline,<br />
-1.2; p=0.11).<br />
Conclusions: In older adults with overactive bladder and age-associated<br />
memory impairment, oxybutynin and desethyloxybutynin,<br />
but not trospium, were detected in the CSF at steady state. Memory<br />
worsened in adults receiving oxybutynin IR, but not trospium XR.<br />
C36<br />
Falls Assessment In Older Patients Treated With Duloxetine.<br />
C. Nelson, 1 T. M. Oakes, 2 P. Liu, 2 J. Ahl, 2 M. E. Bangs, 2 J. Raskin, 3<br />
D. G. Perahia, 4,5 M. J. Robinson. 2 1. University of California, San<br />
Francisco, CA; 2. Eli Lilly and Company, Indianapolis, IN; 3. Eli Lilly<br />
Canada, Scarborough, ON, Canada; 4. Lilly Research Center,<br />
Windlesham, Surrey, United Kingdom; 5. The Gordon Hospital,<br />
London, United Kingdom.<br />
Supported By: Eli Lilly and Company and subsidiaries, Indianapolis,<br />
IN, USA<br />
Background: In an analysis of spontaneously reported treatment-emergent<br />
adverse events in older patients (≥65 years) (N=3278)<br />
from all placebo-controlled trials across indications, 1.1% of patients<br />
treated with duloxetine had one or more falls compared with 0.4% of<br />
patients treated with placebo. Methods: This was a secondary analysis<br />
of falls data collected at each study visit using a specific soliciting<br />
questionnaire during a 24-week, double-blind, randomized, placebocontrolled<br />
trial of duloxetine for treatment of major depressive disorder<br />
(MDD) in older patients. Patients were randomized to duloxetine<br />
60 mg/day (N=249) or placebo (N=121) for the first 12 weeks (acute<br />
phase), after which the duloxetine dose could be increased and<br />
placebo patients could be switched to duloxetine if not responding.<br />
The difference in frequency of falls with duloxetine treatment vs.<br />
placebo was compared by Fisher’s exact test. The exposure adjusted<br />
incidence rate (EAIR) of falls per patient-year was also estimated<br />
based on the patient’s actual duration of exposure to drug or placebo.<br />
Results: The percentage of patients with a fall in the acute phase was<br />
17.3% with duloxetine 60 mg vs. 11.6% with placebo (p=.170). Over<br />
24 weeks, the percentage of patients with a fall was significantly<br />
higher with duloxetine 60/120 mg (25.3%) vs. placebo (15.7%,<br />
p=.045), and the percentage of patients with a fall while taking duloxetine<br />
60 mg during the 24-week study was 24.1% vs. placebo (15.7%,<br />
p=.078). The EAIR of falls per patient-year during the acute phase<br />
was 0.95 with duloxetine 60 mg and was 0.69 with placebo. Over 24<br />
weeks, the EAIR was 0.79 with duloxetine 60 mg and was 0.54 with<br />
placebo. Between-treatment differences in EAIRs over 12 weeks<br />
(0.26; 95% confidence interval [CI]: -0.20 to 0.72) and over 24 weeks<br />
(0.24; 95% CI: -0.07 to 0.56) were not significant. Conclusions: Although<br />
the EAIR of falls per patient-year associated with duloxetine<br />
treatment was not significantly different than with placebo in this<br />
trial of elderly patients with MDD, the overall higher frequency of<br />
falls during treatment with duloxetine suggests that the increase in<br />
falls may be duloxetine-related.<br />
C37 Encore Presentation<br />
Factors Influencing Time to Resolution of Diarrhea in Patients with<br />
Clostridium difficile Infection Treated with Fidaxomicin or<br />
Vancomycin.<br />
D. Gerding, 1 D. Crook, 2 M. Miller, 3 T. Louie, 4 O. Cornely, 5 T. Peto, 2<br />
S. Gorbach. 6 1. VA Chicago Health Care System, Chicago, IL; 2.<br />
University of Oxford, Oxford, United Kingdom; 3. McGill University,<br />
Montreal, QC, Canada; 4. University of Calgary, Calgary, AB,<br />
Canada; 5. University Hospital of Cologne, Cologne, Germany; 6.<br />
Optimer Pharmaceuticals, Inc., San Diego, CA.<br />
Supported By: This study was funded by Optimer<br />
Pharmaceuticals, Inc.<br />
Background: TTROD, an important endpoint for patients, varies<br />
considerably among CDI patients even when treated with effective<br />
antibiotics. We sought to identify factors that influenced TTROD in a<br />
database of 1105 patients enrolled in two phase 3 studies and treated<br />
with FDX or VAN.<br />
Methods: Patients with CDI confirmed by positive stool toxin<br />
test were randomized to receive oral FDX (200 mg twice daily) or<br />
oral VAN (125 mg 4 times daily) for 10 days. TTROD was determined<br />
S144<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
in hours from first dose of study drug to the time of last unformed<br />
bowel movement. Survival functions were estimated by the Kaplan-<br />
Meier product-limit method with log-rank and Wilcoxon tests to test<br />
equality across strata for each parameter at α=0.05.<br />
Results: Diarrhea resolved 24 h later in patients infected with<br />
the REA type BI strain (median TTROD 78 h; [95% CI [61, 103])<br />
than non-BI strains (54 h, 95% CI [51, 57]); Kaplan-Meier analysis<br />
confirmed the difference (log-rank p24 h difference and<br />
log-rank P
P OSTER<br />
A BSTRACTS<br />
Results: Regional anesthesia as compared to general anesthesia<br />
did not carry excess mortality risk in elderly patients 90 and above (p<br />
= 0.43). There was no association between the type of anesthesia used<br />
and the rate of post-operative complications. The relationship of age<br />
and the type of anesthesia used were also considered. Within this age<br />
group, the choice of anesthesia did not seem to depend on a patient’s<br />
age (p = 0.51).<br />
Conclusion: The type of anesthesia, whether regional or general,<br />
does not affect outcomes in elderly patients undergoing surgery for<br />
hip fractures. Therefore, greater utilization of regional anesthesia in<br />
this population may be a cost effective option, as it deters the need<br />
for extensive preoperative evaluations.<br />
C41<br />
Translating Geriatric Assessment into Community Oncology Clinics:<br />
Comparative Results.<br />
G. R. Williams, 1 A. Deal, 2,3 T. Jolly, 4 S. Alston, 2 B. Gordon, 2 J. Pan, 2<br />
A. Caprio, 1 S. Moore, 5 W. Taylor, 6 H. Muss. 2,4 1. Division of Geriatric<br />
Medicine and Center for Aging and Health, University of North<br />
Carolina at Chapel Hill, Chapel Hill, NC; 2. Lineberger<br />
Comprehensive Cancer Center, University of North Carolina at<br />
Chapel Hill, Chapel Hill, NC; 3. Biostatistics Core Faculty, University<br />
of North Carolina at Chapel Hill, Chapel Hill, NC; 4. Division of<br />
Hematology / Oncology, University of North Carolina at Chapel Hill,<br />
Chapel Hill, NC; 5. Rex Hematology Oncology Associates, Raleigh,<br />
NC; 6. New Bern Cancer Care, New Bern, NC.<br />
Supported By: Supported by University Cancer Research Fund,<br />
Lineberger Comprehensive Cancer Center, Chapel Hill, NC<br />
Background: Emerging results support the value of geriatric assessment<br />
(GA) in determining the risk and benefits of cancer treatment<br />
in older adults. A brief GA tool consisting of valid and reliable<br />
measures has been developed (Hurria et al, J Clin Oncol 29:1290,<br />
2011), but little data exist on the GA of elderly patients in the community.<br />
This study compares the differences between geriatric oncology<br />
patients at academic versus community based oncology practices<br />
in North Carolina.<br />
Methods: From 2009 to 2011 a total of 386 patients were recruited.<br />
283 (73%) were from a tertiary care referral cancer center<br />
(UNC) and 103 (27%) were from community clinics. The two groups<br />
were compared using Fisher’s Exact and Wilcoxon rank sum tests.<br />
Results: Community clinics enrolled older patients (p= 0.004),<br />
with 52% being ≥ 75 years of age, compared to only 33% at UNC. The<br />
Karnofsky performance status as rated by medical staff was significantly<br />
lower at community clinics (60% vs 25% with a score ≤ 90%;<br />
p= 65 years of age hospitalized with pneumonia during fiscal<br />
years 2002 to 2007 in Department of Veterans Affairs hospitals.<br />
Our primary analyses were multilevel regression models that examined<br />
the association between cardiovascular medication classes and<br />
either 90-day mortality or cardiovascular events within 90-days after<br />
adjusting for potential confounders.<br />
Results: Our cohort included 50,064 patients with a mean age of<br />
77.3 years, 98% were male, 23% died within 90 days of admission, and<br />
38% had a cardiac event. Medications associated with decreased<br />
mortality include beta-blockers (OR 0.92, 95% CI 0.87-0.97), statins<br />
(OR 0.67, 95% CI 0.63-0.70), ACE inhibitors (OR 0.81, 95% CI 0.76-<br />
0.86), and ARBs (OR 0.61, 95% CI 0.53-0.70), but an increased number<br />
of cardiovascular events: beta-blockers (OR 1.15, 95% CI 1.10-<br />
1.21), statins (OR 1.02, 95% CI 0.98-1.07), ACE inhibitors (OR 1.14,<br />
95% CI 1.09-1.20), and ARBs (OR 1.20 95% CI 1.08-1.33).<br />
S146<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
Discussion: While cardiovascular medications were associated<br />
with decreased mortality, there was an association with increased<br />
with increased number of cardiovascular events. These results indicate<br />
that cardiovascular medications may have beneficial effects for<br />
the outcomes of patients admitted with pneumonia however not due<br />
only to cardioprotective effects.<br />
C44 Encore Presentation<br />
Lower diastolic blood pressure and increased heart rate are<br />
independent predictors of mortality for 1 year in elderly outpatients:<br />
Data from Frailty in elderly with cardiovascular disease.<br />
A. R. Diniz, A. Frisoli, E. T. Pinto, J. D. Majeski, M. Erlichman,<br />
A. C. Carvalho. UNIFESP- Escola Paulista de Medicina, São Paulo,<br />
Brazil.<br />
Introduction: Increased heart rate (HR) is risk factor for cardiovascular<br />
mortality. Elevated values of diastolic (DBP) and systolic<br />
blood pressure (SBP) have been associated with the same outcomes.<br />
The predict outcomes of low values of DBP and SBP with increased<br />
HF has been poor clarified in elderly.<br />
The goal of this study was to evaluate the association of increased<br />
HR, lower DBP and SBP with mortality for 1 year in elderly<br />
outpatients.<br />
Methods: cross sectional analysis of data from an observational<br />
study of epidemiology of frailty in elderly outpatients with cardiovascular<br />
diseases. DBS, SBP and HF were obtained with the median of<br />
three measures at the first visit. Diagnoses of Heart failure were<br />
made with ejection fraction higher (diastolic heart failure-DHF) or<br />
lower than 50% (systolic heart failure-SHF) and the presence of signs<br />
and symptoms of heart failure (NYHA). Mortality information was<br />
obtained by phone call at 6, 12, 18 and 24 months after.<br />
Results: On May, 2011, 103 patients reached 1 year or died.<br />
74.5% had heart failure, which 48.4% DHF and 51.6% SHF. Female<br />
was 60.2% (n=62) prevalent. The mean age of men was 76.05 (±5.0)<br />
and women 77.71 (±5.5) years old. 60% were Caucasian. Mortality<br />
rate was 8.7% (n=9), which 66.7% had heart failure and 50% DHF.<br />
Among patients who died SBP (119 vs 141mmHg; 0.028) and DBS<br />
(68 vs 88mmHg; 0.003) were significant lower, and HR (96 vs 69bpm;<br />
P OSTER<br />
A BSTRACTS<br />
Conclusions: Conclusions: The results indicate that there may be<br />
a single factor underlying the responses to OHIP-14 questions in<br />
these older adults. The ohip-14 seems not to represent seven separate<br />
dimensions of oral health as originally devised.<br />
C47<br />
Mexican-<strong>American</strong> Elder Post Hip Fracture Survival Study.<br />
D. V. Espino, 1,2 R. C. Wood, 1,2 C. C. Moore. 2,1 1. Family and<br />
Community Medicine, University of Texas Health Science Center at<br />
San Antonio, San Antonio, TX; 2. School of Medicine, University of<br />
Texas Health Science Center at San Antonio, San Antonio, TX.<br />
Supported By: National Institute of Health (NIH)<br />
<strong>American</strong> Federation for Aging Research (AFAR)<br />
University of Texas Health Science Center at San Antonio<br />
(UTHSCSA)<br />
As the world’s population is shifting to an older age due to advances<br />
in medical care, increased numbers of hospital visits, especially<br />
for geriatric hip fractures, are being documented. Despite the<br />
vast research conducted on hip fractures in general, little emphasis<br />
has been made on the effects of hip fractures on Mexican-<strong>American</strong>s.<br />
The Hispanic Established Populations for the Epidemiologic<br />
Study of the Elderly (H-EPESE) compiled data on risk factors for<br />
morbidity and mortality in Mexican-<strong>American</strong>s used to create a<br />
community-based survival analysis of geriatric hip fractures. The H-<br />
EPESE began in 1993 with a contingent of 3050 individuals and is<br />
currently on the seventh wave of the study. Using a Cox Model Regression<br />
Survival Analysis program, significance (p65), gender and presence or<br />
absence of Type II Diabetes Mellitus creating a drastic influence on<br />
mortality rates. Over a 7 year span after sustaining a hip fracture, a<br />
patient meeting the appropriate risk factors noted above had an approximate<br />
fifteen percent increased risk for mortality than a patient<br />
not meeting the criteria. Factors influencing the comorbidities,such<br />
as: osteoporosis in the elderly, post-menopausal hormone imbalances<br />
in women and peripheral neuropathy associated with Type II<br />
Diabetes Mellitus were investigated as contributors to the increased<br />
mortality rates. While this study does not cover the entire spectrum<br />
of comorbidities associated with increased geriatric hip fractures in<br />
the Mexican-<strong>American</strong> population, it does attempt to bridge the literature<br />
gap associated with the Mexican-<strong>American</strong> minority and<br />
create interest for expanding the literature for this subset of the<br />
population.<br />
C48<br />
Lifetime Manic Spectrum Syndromes and All-Cause Mortality: A<br />
26-year Follow-Up of the US National Epidemiological Catchment<br />
Area Study.<br />
C. Ramsey, 1 A. P. Spira, 1 W. W. Eaton, 1 H. B. Lee. 2,1 1. Mental Health,<br />
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD;<br />
2. Psychiatry, Yale University, New Haven, CT.<br />
Background: Increasing evidence suggests a high prevalence of<br />
bipolar spectrum disorders, associated morbidity and mortality.While<br />
research supports the association between depression and mortality,<br />
the role of mania has received less attention. This analysis evaluated<br />
the association between manic spectrum syndromes and risk of mortality<br />
in the community. Methods: Participants in the prospective US<br />
National Epidemiological Catchment Area Study were classified into<br />
mutually exclusive groups based on their responses to the Diagnostic<br />
Interview Schedule items assessing mania in 1981. Those with manic<br />
spectrum syndromes (n=133; mean age: 33.8 +/- 12.6; female: 29.2%)<br />
met one of the following criteria: mania (met DSM-III criteria for a<br />
manic episode; n=36), hypomania (met all DSM-III criteria for a<br />
manic episode except the severity requirement of causing impairment<br />
or help seeking; n=42) and subsyndromal mania (had a euphoric<br />
or irritable mood for a week or more and at least one other<br />
symptom, but did not meet criteria for mania or hypomania; n=55).<br />
Participants without manic spectrum syndromes (n=13,784; mean<br />
age: 48.6 +/- 20.2; female: 53.8%) comprised the control group. Vital<br />
status through the end of follow-up in 2007 was ascertained by<br />
matching individual identifying information with the National Death<br />
Index. Manic spectrum and control groups were compared in terms<br />
of demographics, depressive symptoms, and self-rated health in 1981<br />
using independent samples t-tests and chi-squared tests. To account<br />
for the age difference between groups, a propensity score was used.<br />
Risk of mortality was assessed using a Cox-proportional hazards<br />
model with age in 1981 as the time of entry and age at death or follow-up<br />
as the time of exit. Results: Estimated lifetime prevalence of<br />
manic spectrum syndromes was 0.98%. This group was older than the<br />
controls, had more symptoms of depression, was more likely to be<br />
married and to be Caucasian. After adjusting for these covariates in<br />
the hazard model, manic spectrum syndromes were not a significant<br />
risk factor for all-cause mortality (HR=1.3, p=0.270). Conclusions:<br />
History of manic spectrum syndromes did not increase risk of allcause<br />
mortality. Future studies should evaluate specific causes of<br />
mortality.<br />
C49<br />
Asymptomatic Bacteriuria and Antibiotic Use in Nursing Homes.<br />
D. R. Mehr, 1 C. D. Phillips, 2 L. Adepoju, 2 D. K. Moudouni, 2 N. Stone, 4<br />
O. Nwaiwu, 2 E. Frentzel, 3 S. Garfinkel. 3 1. Family and Community<br />
Medicine, University of Missouri, Columbia, MO; 2. Texas A&M<br />
Health Sciences Center, College Station, TX; 3. <strong>American</strong> Institutes for<br />
Research, Chapel Hill, NC; 4. Centers for Disease Control and<br />
Prevention, Atlanta, GA.<br />
Supported By: Supported by the Agency for Healthcare Research<br />
and Quality<br />
Background: Overuse of antibiotics is a longstanding concern in<br />
nursing homes. As part of a project on antibiotic stewardship, we investigated<br />
the use of antibiotics to treat asymptomatic bacteriuria<br />
(ASB) among nursing home residents with a suspected urinary tract<br />
infection (UTI).<br />
Methods: In 4 central Texas nursing homes, episodes of treatment<br />
for suspected UTI were identified from facility logs. Symptoms<br />
and resident characteristics were abstracted from residents’ records.<br />
Using a multi-level multivariate model, we evaluated resident and facility<br />
characteristics associated with antibiotic use despite the absence<br />
of symptoms and signs suggesting need to treat a UTI (criteria from<br />
Loeb, et al. Infect Control Hosp Epidemiol 2001).<br />
Results: Over 6 months, clinicians ordered antibiotics for suspected<br />
UTI 227 times among 167 residents; 89% had urine studies.<br />
Half (114) of the antibiotic prescriptions occurred in the absence of<br />
any symptoms or signs. In multivariate analyses, resident characteristics<br />
did not differentiate between treated residents with or without<br />
symptoms or signs; however, in the same model, 2 of the 4 facilities<br />
exhibited less treatment of asymptomatic residents (odd ratios and<br />
95% confidence intervals, 0.28 [0.09,0.88] and 0.34 [0.15,0.74]).<br />
Conclusions: This research confirms frequent use of antibiotics<br />
for ASB in nursing homes. Antibiotic stewardship in nursing homes<br />
must address treatment that seems to be based solely on urine findings.<br />
Clinicians’ prescribing behavior was clearly associated with the<br />
S148<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
nursing homes in which they practiced and may be related to, or may<br />
create, the facility’s clinical culture.<br />
C50<br />
Hospital acquired pressure ulcers and markedly decreased survival<br />
after a hip fracture.<br />
E. I. Vidal, 1 D. C. Moreira, 6 R. S. Pinheiro, 2 F. B. Fukushima, 4<br />
P. J. Villas Boas, 1 K. R. Camargo, 3 L. M. Almeida, 5 C. M. Coeli. 2 1.<br />
Internal Medicine Department, UNESP, Botucatu, Brazil; 2. IESC,<br />
UFJR, Rio de Janeiro, RJ, Brazil; 3. IMS, UERJ, Rio de Janeiro, RJ,<br />
Brazil; 4. Anesthesiology Department, UNESP, Botucatu, SP, Brazil;<br />
5. Epidemiology Division, INCA, Rio de Janeiro, RJ, Brazil; 6. Social<br />
and Preventive Medicine Department, UNICAMP, Campinas, SP,<br />
Brazil.<br />
Supported By: This study was funded by the Brazilian National<br />
Council for Scientific and Technological Development (CNPq).<br />
Background: There are few data examining the association between<br />
hospital acquired pressure ulcers and survival after a hip<br />
fracture.<br />
Methods: The medical records of all patients aged 60 years and<br />
older admitted to a public university hospital in the city of Rio de<br />
Janeiro with a primary diagnosis of hip fracture between 1995 and<br />
2000 were reviewed. Stage II or higher hospital acquired pressure ulcers<br />
were identified from medical records. Survival to hospital discharge<br />
and at 1 year was examined.<br />
Results: Among 343 patients included in the study, there were 18<br />
(5.3%) in-hospital deaths, and 297 (86.6%) patients remained alive 1<br />
year after surgery. A hospital acquired stage II or higher pressure<br />
ulcer was recorded in 36 (10.5%) of patients. Incident pressure ulcers<br />
were associated with markedly increased risk of reduced survival to<br />
hospital discharge (hazard ratio [HR] 4.25, 95% CI 1.35–13.36,<br />
p=0.013) and of reduced survival at 1 year after surgery (HR 4.15,<br />
95% CI 2.14–8.06, p
P OSTER<br />
A BSTRACTS<br />
2.47–25.96), and cancer history (RR 3.73, 95% CI 1.28–10.88) at baseline<br />
predicted disability in men only. Women with diabetes (RR 2.97,<br />
95% CI 1.66–5.32), stroke history (RR 2.89, 95% CI 1.07–7.85), and<br />
bodily pain (RR 1.95, 95% CI 1.11–3.41) had higher risk of incident<br />
disability.<br />
CONCLUSIONS: Older women and men with multimorbidity<br />
had different risk factors for incident disability. Among them, several<br />
factors were potentially modifiable. Early screening and targeted intervention<br />
among multimorbid older adults may prevent or delay<br />
disability.<br />
C53<br />
D as in Death - Dietary Vitamin D in Mid-Life and Total Mortality:<br />
The Honolulu Heart Program.<br />
G. Kojima, 1 F. Lui, 1 R. Chen, 2 C. Bell, 1 R. D. Abbott, 1 L. Launer, 4<br />
G. W. Ross, 3,1 J. D. Curb, 1,2 K. H. Masaki. 1,2 1. The John A. Hartford<br />
Foundation Center of Excellence in <strong>Geriatrics</strong>, Department of<br />
Geriatric Medicine, University of Hawaii, Honolulu, HI; 2. Kuakini<br />
Medical Center, Honolulu, HI; 3. Veterans Affairs Pacific Islands<br />
Healthcare System, Honolulu, HI; 4. National Institute on Aging,<br />
Bethesda, MD.<br />
Supported By: The National Heart, Lung, and Blood Institute; the<br />
National Institute on Aging; Veterans Affairs Pacific Islands<br />
Healthcare Systems; John A. Hartford Foundation Center of<br />
Excellence in <strong>Geriatrics</strong>, University of Hawaii.<br />
Background:<br />
Low serum vitamin D levels are associated with total mortality<br />
in previous epidemiological studies. Little is known about effects of<br />
dietary vitamin D intake on mortality. We examined the association<br />
between mid-life dietary vitamin D intake and 45-year total mortality<br />
in Japanese-<strong>American</strong> men.<br />
Methods<br />
The Honolulu Heart Program is a longitudinal cohort study of<br />
8,006 Japanese-<strong>American</strong> men in Hawaii aged 45-68 at baseline in<br />
1965-68. Mid-life dietary vitamin D intake was calculated from 24-<br />
hour dietary recall using the Nutritionist IV v3 software. Subjects<br />
were divided into quartiles of vitamin D intake. Data on total mortality<br />
were available for up to 45 years, through December 2010. Cox<br />
proportional hazards models were used, and analyses were also stratified<br />
for hypertension (HTN) status.<br />
Results<br />
There were 6,972 deaths during the 45 years of follow-up. Ageadjusted<br />
total mortality rates were higher in the lower 3 quartiles of<br />
dietary vitamin D intake compared to the highest (p for trend=0.011).<br />
In Cox regression models, there was a significant inverse association<br />
between dietary vitamin D quartiles and mortality; quartile (Q) 1<br />
hazard ratio (HR)=1.14, 95%CI=1.07-1.22, p30<br />
days, 90 days after last MDS, death, or end of study).<br />
Results: A total of 2144 VTE On Admission cases were identified,<br />
accounting for 3.7% of all admissions (95% CI: 3.5–3.9%). A<br />
total of 757 cases of VTE During Residence were identified (from an<br />
est. 20,586 person–years [PY] at risk), yielding an incidence of 3.68<br />
cases/100 PY During Residence (95% CI: 3.42–3.95). [See table for<br />
full results] Conclusions: VTE incidence during admission and residence<br />
was common in this population; the latter was higher than previously<br />
reported in LTC studies. Furthermore, this rate was 6 times<br />
higher than a similar-age community cohort.1 These incidence rates<br />
merit further investigation as diagnostic improvements may be driving<br />
greater recognition of VTE in LTC.<br />
1. White RH. Circulation 2003;107(23 suppl 1):I4-8.<br />
VTE Incidence by Age Group (95% CI)<br />
C55<br />
TITLE: Vitamin D Levels and Asssociation with Chronic Medical<br />
Conditions in Home Based Primary Care (HBPC).<br />
H. Moiduddin, 1,2 S. N. Imam, 1,2 A. Imran, 1,2 L. Medina Munoz, 1<br />
T. Lee, 1 Q. Syed, 1 P. Karumanchi. 1 1. <strong>Geriatrics</strong> and Extended Care,<br />
Edward Hines Veterans Hospital, Hines, IL; 2. Internal Medicine,<br />
Loyola University Medical Center, Maywood, IL.<br />
Background: Numerous studies suggest that Vitamin D deficiency<br />
is commonplace in the United States and the world at large.<br />
The homebound and frail elderly are at high risk for having Vitamin<br />
D deficiency. Recent research confirms that Vitamin D deficiency<br />
contributes to many common conditions other than the musculoskeletal<br />
system disorders to include falls, chronic pain, diabetes<br />
mellitus, hypertension, depression, cancer and increased overall mortality.<br />
Several studies have shown reduced fall risk with Vitamin D<br />
supplementation and also possible improvement in control of chronic<br />
pain, hypertension, diabetes mellitus, and depression. Despite all this<br />
S150<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
evidence there are currently no guidelines for screening for Vitamin<br />
D deficiency and it remains a largely under diagnosed and under<br />
treated problem. Treatment of Vitamin D deficiency has the potential<br />
to improve the health and thus the quality of life of the elderly.<br />
Purpose: To determine the prevalence of low Vitamin D levels in<br />
Veterans enrolled in a single HBPC program and to mark any association<br />
with depression, diabetes mellitus and cancer.<br />
Methods: This is a retrospective observational cohort study of<br />
Veterans enrolled in HBPC between January 2006 and December<br />
2008. We reviewed medical records of Veterans with documented Vitamin<br />
D levels during the specified time period to assess the following:<br />
Serum 25-hydroxy Vitamin D level, Vitamin D therapy regimen,<br />
length of time to repeat Vitamin D level, post-treatment Vitamin D<br />
level, and correlation with depression, diabetes mellitus and cancer.<br />
Results: Of 560 patients enrolled in HBPC during the study period,<br />
218 (39%) had a Vitamin D level measured. Among these 135<br />
patients (62%) had Vitamin D deficiency. In the Vitamin D deficient<br />
group, the incidence of depression was higher 46% versus 35%, the<br />
incidence of diabetes mellitus was also slightly higher 43% versus<br />
37% and incidence of cancer was lower 30% versus 36%.<br />
Conclusions: Vitamin D levels were measured infrequently in<br />
Veterans enrolled in HBPC program. Vitamin D deficiency is very<br />
common in this population and there is an association of depression<br />
with Vitamin D deficiency.<br />
C56<br />
Is the Geriatric Population Represented to an Appropriate Degree<br />
in Journals of Infectious Disease?<br />
H. Chawla, 1,2 K. Steel, 2 M. Parulekar, 1,2 L. Tank, 1,2 A. Sarkar, 1,2<br />
L. Mansour. 2 1. <strong>Geriatrics</strong>, UNDMJ, Newark, NJ; 2. <strong>Geriatrics</strong>,<br />
HUMC, Hackensack, NJ.<br />
Background: Although advances made in reducing complications<br />
related to infections have been a significant factor in increasing<br />
life expectancy, infections remain a major health care problem for<br />
people in the older age group. Therefore we reviewed the clinical<br />
studies in two infectious disease journals to determine how well the<br />
geriatric population is represented in these trials.<br />
Objective: To determine what percentage of clinical research articles<br />
published in two journals, Clinical Infectious Disease and the<br />
Journal of Infectious Diseases, report on a population with an age<br />
equal to or greater than 65 years of age.<br />
Method: We reviewed 100 consecutive clinical research articles<br />
in the Journal of Infectious Disease published between January, 2011<br />
and May, 2011 and 100 articles in a second journal, Clinical Infectious<br />
Diseases published between January, 2011 and July, 2011.We defined<br />
a geriatric population as individuals age 65 or older. If this information<br />
was not available then the best estimate was made using the median<br />
or mean age provided. A few studies did not provide information<br />
about median or mean age and were therefore considered<br />
“indeterminate”.<br />
Results: In the 200 articles that were reviewed, the site of infection<br />
under study was as follows: lung (25%), skin (11%), central nervous<br />
system (8%) and gastrointestinal tract (7%). The most commonly<br />
seen primary organism was HIV (20%) followed by influenza (17%).<br />
38% of the studies were undertaken in a hospital setting and in 5 %<br />
of studies the duration of stay in the hospital was more than 15 days.<br />
Sepsis was observed in about 6 % of the studies reviewed.<br />
Of the 200 articles published in these two journals during the<br />
time period noted, only 14.5 % focused on an age group 65 years of<br />
age or older. The percentage of death in the age group 65 and older<br />
was provided in only 1 % of the studies.<br />
Conclusion: The top 3 causes of death for the general population<br />
are heart disease, cancer, and stroke. This also holds true for the elderly<br />
population. But infectious diseases are the fourth leading cause<br />
of death in the older population. The data from both the Journal of<br />
Infectious<br />
Diseases and Clinical Infectious Diseases suggest that the geriatric<br />
population is strikingly underrepresented in clinical studies.<br />
Only 14.5 percent of research articles had a study population with a<br />
median age of 65 years or greater.<br />
C57<br />
Potential Barriers to Hospice Referral Among Internal Medicine<br />
Residents and Physicians.<br />
A. Marszalek-Litauska, 1 S. Pereira, 1 M. Kline, 2 A. Kozikowski, 1<br />
R. Pekmezaris, 1 C. Nouryan, 1 G. Wolf-Klein. 1 1. NSLIJ Health<br />
System, New Hyde Park, NY; 2. FIMR, Manhasset, NY.<br />
INTRODUCTION: Only 30% of terminally ill patients are<br />
under hospice care at time of death. We sought to identify physicians’<br />
perceived barriers and approaches to hospice referral.<br />
METHODS: Anonymous surveys were distributed in 5 hospitals<br />
of a large health system in New York. Comparisons across gender and<br />
training were performed using the chi-squared test or Fisher’s exact<br />
test as appropriate. Spearman correlations were calculated to determine<br />
if professional status and years in practice were correlated with<br />
degree of comfort discussing end of life topics with terminal patients.<br />
RESULTS: Of the 264 physicians who responded, 58.3% were<br />
males, and 45% were between the ages of 21-30 years; PGY1 (23%),<br />
PGY-2 (15.8%) and hospital attending /specialists (34%) accounted<br />
for more than half of the respondents. A full 71.4% of respondents<br />
had received palliative/hospice care training and of those, 90% asserted<br />
they had referred the terminally ill to hospice care. However,<br />
on questions that tap knowledge of hospice care, only 40% chose the<br />
correct answer to all three questions. Though 91% of all respondents<br />
stated that ascertaining patient preferences at end of life was important/very<br />
important, over half (53%) believed that the ER attending<br />
is actually responsible for “sorting out patient/family wishes”. Furthermore,<br />
27.3% stated that the palliative care team generally initiates<br />
hospice discussion. In addition, 45% of physicians incorrectly believed,<br />
or were not sure, that patients must have six months prognosis<br />
to be eligible for hospice. Most frequently identified barriers were<br />
fear of patient/family reactions (34.3%), lack of familiarity (23.2%)<br />
and time constraints (18.9%). Yet most physicians had never (21.1%)<br />
or rarely (38.5%) actually experienced anger from their patients<br />
when mentioning hospice. Physicians’ level of comfort discussing several<br />
end of life topics (e.g., prognosis, advanced directives, pain management)<br />
was significantly associated with increasing years of experience<br />
and increasing professional status.<br />
CONCLUSION: Despite palliative care training and experience,<br />
physicians relinquish end-of-life care to emergency room physicians<br />
and palliative care consultants. Exploring unfounded and preconceived<br />
fear of patient and/or family anger in reaction to hospice<br />
referral needs to be integrated into a palliative care curriculum.<br />
C58<br />
Advance Care Planning Documentation: from theory to practice at 2<br />
VA Medical Centers.<br />
E. Clark, 1,2 E. Lindenberger, 2,1 K. Blackstone, 3,4 R. Anderson-<br />
Malico, 1 S. Pandey, 3,4 E. L. Cobbs. 3,4 1. JJ Peters VA Medical Center,<br />
Bronx, NY; 2. Mt. Sinai School of Medicine, New York, NY; 3.<br />
Washington DC VAMC, Washington, DC; 4. George Washington<br />
University School of Medicine, Washington, DC.<br />
Background: Advance Care Planning (ACP) benefits patients<br />
with serious illness. Electronic medical records (EMR) offer promise<br />
for sharing meaningful information about ACP, but clinicians may<br />
lack familiarity with ACP methods or a standardized format for ACP<br />
documentation.<br />
Objective: Ongoing facility-wide implementation of EMR ACP<br />
documentation<br />
Setting: 2 urban VA Medical Centers<br />
AGS 2012 ANNUAL MEETING<br />
S151
P OSTER<br />
A BSTRACTS<br />
Methods:<br />
EMR ACP tool: VAMC 1 - 2000; VAMC 2 - 2009<br />
ACP champions: VAMC 1 - 6 physicians, 9 nurse practitioners;<br />
VAMC2 - 2 physicians, 1 advance practice nurse<br />
Settings for ACP: VAMC 1 - NH, geriatrics clinic, home based<br />
primary care, geriatrics & palliative care (PC)consults; VAMC 2 -<br />
geriatrics & PC consults<br />
Interventions: VAMC 1 - role modeling; monthly orientation for<br />
housestaff; noon conferences for faculty & housestaff; training for fellows<br />
& residents in geriatrics & PC; performance improvement initiatives.<br />
VAMC 2 - large group lectures; small group provider detailing;<br />
role modeling; noon conferences for housestaff; training of geriatrics<br />
& PC fellows<br />
Results: see table<br />
Discussion: Both VAMCs have adopted standardized EMR<br />
ACP documentation. At VAMC 1, where the EMR ACP tool was first<br />
developed in 2000, ACP documentation has grown steadily over a<br />
decade. At VAMC 2, the EMR ACP was introduced in 2009 and has<br />
slowly expanded. Growth factors include a critical mass of committed<br />
champions, ongoing recruitment of champions in other disciplines,<br />
and regular multi-modal education of trainees. The NH may be an important<br />
center of EMR ACP documentation since virtually all NH<br />
residents are living with a serious illness. VAMC 1 has had 100%<br />
EMR ACP documentation in its NH for the past 10 years. New initiatives<br />
at VAMC 2 likely to increase EMR ACP documentation include<br />
a required geriatrics rotation for medical interns; a needs assessment<br />
program in key outpatient clinics and its NH to identify barriers to<br />
ACP; and mentoring of individual providers.<br />
Results: ACP notes completed<br />
C59<br />
Role of Advance Directives in Determining Care for Older Nursing<br />
Home (NH) Residents.<br />
E. Manu, 1,2 S. McNamara, 1,2 B. Lansing, 1,2 L. Mody, 1,2 C. A. Vitale. 1,2<br />
1. Division of Geriatric & Palliative Medicine, Department of Internal<br />
Medicine, University of Michigan Healthcare System, Ann Arbor, MI;<br />
2. <strong>Geriatrics</strong> Research Education and Clinical Center, Veterans Affairs<br />
Ann Arbor Healthcare System, Ann Arbor, MI.<br />
Supported By: Funding source for the study was provided by NIA<br />
K23 AG028943, ASP/AGS T. Franklin Williams Research<br />
Scholarship, NIA R01AG032298 and The Claude D. Pepper Older<br />
<strong>American</strong>s Independence Center and Michigan Institute for Clinical<br />
& Health Research, University of Michigan Pilot Grant Program.<br />
Background:<br />
We aimed to study the effect of advance directives on treatments<br />
received including indwelling devices, hospital transfers, & antibiotics<br />
in NHs.<br />
Methods:<br />
A subgroup analysis of a prospective cohort study of 178 residents<br />
from 15 NHs in southeast MI. Demographic data, Charlson’s<br />
Comorbidity Index (CCI), Functional Score (PSMS, scores 6-30) &<br />
advance directives were obtained at enrollment. At 30 day intervals,<br />
presence of indwelling device, infection rate, antibiotic use & hospitalization<br />
were assessed. Advance directives were divided in 4 groups:<br />
1-comfort measures only, no transfer to hospital; 2- comfort focused<br />
care but may transfer to hospital & receive antibiotics, no CPR; 3-<br />
transfer to acute care hospital for assessment & treatment, no CPR or<br />
ICU admission, 4- full code. Poisson regression was used to calculate<br />
the incidence rate ratios (IRR) of new infections, antibiotic use &<br />
hospitalizations. Risk factors included in the analysis: PSMS, CCI, device<br />
use & advance directive.<br />
Result:<br />
161 (91%) residents had advance directives. 38 (24%) were in<br />
group 1 with comfort care only, 29 (18%) in Group 2, 43 (27%) in<br />
Group 3 & 51 (32%) in Group 4 desiring full code. While Group 4<br />
residents were younger (mean age 76.7 yrs., SD 11, p
P OSTER<br />
A BSTRACTS<br />
C61<br />
New Non-Invasive Technique to Assess Arterial Stiffness.<br />
F. M. Felice, A. K. Reddy, J. D. Taffet, C. J. Hartley, G. E. Taffet.<br />
Baylor College of Medicine, Houston, TX.<br />
Supported By: AFAR,NHLBI,Huffington Center on Aging<br />
Large arteries stiffen with age increasing the risk of cardiovascular<br />
disease. The stiffening causes increased systolic blood pressure,<br />
decreased diastolic blood pressure, and increased pulse wave velocity(PWV).<br />
Yet current techniques only measure PWV at diastolic<br />
pressure when the pulse wave velocity is lowest because the artery is<br />
not fully distended.<br />
Methods: We developed a new technique to measure stiffness<br />
looking at reversals in flow in the radial artery. Using 20 mHz<br />
Doppler probes to assess blood flow velocity in the proximal and distal<br />
radial arteries, sampling at both sites simultaneously to avoid beat<br />
to beat variations. Probes were custom made and interfaced with a<br />
multichannel Doppler Signal processing workstation (Indus Instrument).<br />
Pulse wave velocity was calculated at the start of flow and<br />
when forward flow started after each reversal.<br />
Results: We attempted to assess radial artery flow non-invasively<br />
in 8 subjects ranging in age from 18 to 64. We found that reversals<br />
in blood flow happened in all our subjects, providing timing signals<br />
for calculation. The quality of the signals needed to determine<br />
the second wave PWV was very high so we could not get interpretable<br />
data from 5 out of 8 subjects. We found within the range of<br />
diastolic to systolic blood pressure, PWV increases by 40-80% as<br />
blood pressure increased by 20 to 30 mmHg. Obtaining adequate signals<br />
required significant attention to detail, however with good data,<br />
it was then feasible to create a pressure versus PWV relationship.<br />
Conclusion: With this strategy, the slope of the pressure PWV<br />
relationship more directly defines stiffening and provides novel information<br />
to assess arterial stiffening with aging and perhaps direct risk<br />
reduction for cardiovascular disease for the elderly.<br />
C62<br />
Positive Effect of Restorative Sleep on IL6 and Fibrinogen in<br />
Post-Midlife.<br />
S. Song, 1 F. J. Prerost, 2 M. Sanders, 2 M. Barash, 2 A. Valone. 2 1.<br />
Biomedical Sciences, Midwestern University, Downers Grove, IL; 2.<br />
Family Medicine, Midwestern University, Downers Grove, IL.<br />
BACKGROUND: Treatment of medical illnesses that emphasizes<br />
hereditary and lifestyle etiological factors is often associated<br />
with diverse health outcomes. The research identifying converging<br />
bio-psychosocial pathways reflects this emphasis on disease risk. Proinflammatory<br />
markers are understood as indicative of chronic conditions<br />
including metabolic, autoimmune, and hematologic disorders.<br />
The objective of the current study is to examine the positive effect of<br />
restorative sleep on IL6 and fibrinogen as a protective factor that<br />
might mitigate the onset of aging related decline.<br />
METHODS/DESIGN: Longitudinal, secondary data<br />
SETTING: Midlife in the United States (MIDUS) national sample<br />
of independently dwelling middle-aged and older adults living in<br />
the United States<br />
PARTICIPANTS: Phase II of the MIDUS study comprised the<br />
biomarkers project; a subsample (n = 398) of the original group of<br />
participants between the ages of 35 and 84 underwent biological assessments<br />
over a two-day period<br />
MEASUREMENTS: Actiwatch sleep data collection and fasting<br />
blood specimens of IL6 and fibrinogen biomarkers<br />
RESULTS: Restorative sleep, measured as sleep efficiency, was<br />
inversely related to serum IL6 (r = -.14, p < .001) and blood fibrinogen<br />
(r = -.12, p = .01). Sleep efficiency was not significantly diminished<br />
by the presence of diabetes (84% of participants did not have<br />
diabetes) or physician diagnosed arthritis (F = .102, p >.05), blood<br />
clots (F = .056, p > .05), or bleeding diseases (F = .031, p > .05).<br />
CONCLUSIONS: Participants who exhibited higher amounts<br />
of restorative sleep had lower levels of inflammation measured by<br />
serum IL6 and blood fibrinogen. It was not the case that sleep efficiency<br />
was adversely affected by pre-existing illnesses typically associated<br />
with less healthy markers and subsequent disruptions to circadian<br />
rhythm. Researchers have found that chronic and acute stressors<br />
(i.e. childhood traumas, parental neglect, difficulties in adulthood,<br />
etc.) have generated profiles similar to those of older and oldest<br />
adults. Identifying possible mitigating factors of aged proinflammatory<br />
markers will contribute to the literature and broaden treatment<br />
options.<br />
C63<br />
Attitudes and Knowledge about Resuscitation Discussion in a<br />
Community Hospital: A Survey of Physicians and Nurses.<br />
C. X. Pan, 1 D. A. Acquista, 1 A. Bushan, 1 S. M. Constantine, 1<br />
I. Kariolis, 1 S. Sunday. 2 1. New York Hospital Queens, Flushing, NY; 2.<br />
North Shore- LIJ Health System, Manhasset, NY.<br />
Background: For patients with a serious illness, discussions with<br />
healthcare staff often include resuscitation preference or “code status”<br />
including DNR/DNI (do not resuscitate/do not intubate). This<br />
study assesses health care professionals’ attitudes and knowledge<br />
about resuscitation discussions at a community hospital. The objective<br />
is to examine if health care discipline and level of experience affect<br />
attitudes and knowledge about discussion about resuscitation decisions.<br />
Methods: A 34-question self administered survey was distributed<br />
to attending physicians, nurses and internal medicine residents.<br />
Questions included demographic information, religious beliefs, clinical<br />
vignettes with management options, scales assessing<br />
comfort/competency levels regarding treatment of symptoms in patients<br />
who are full code vs DNR, knowledge of hospice appropriateness,<br />
and perceived need for education about resuscitation discussions.<br />
Results: There were 135 respondents: 30 attendings, 50 nurses<br />
and 55 residents (M=37%; F=63%). Respondents were diverse in<br />
ethnic/racial background. One respondent reported having a religious<br />
reason that prevented discussing DNR/DNI. 83% of attendings,<br />
49% of residents and 52% of nurses felt it was the attendings’<br />
responsibility to discuss code status. When managing symptoms,<br />
>85% of nurses, >75% of attendings and >63% of residents felt “very<br />
comfortable,” while >89%, >63%, and >49% of nurses, attendings,<br />
and residents felt “very competent,” respectively; (p-value for “comfort<br />
level” NS; and “competence” p=0.0002). Attendings correctly<br />
identified hospice appropriate patients in different case scenarios;<br />
nurse and resident responses varied. Both nurses and residents<br />
(>84%) felt they would benefit from more training about resuscitation<br />
discussion. Conclusion: This study found differences in attitudes<br />
and knowledge about resuscitation decisions among health care disciplines<br />
with various levels of experience. Nurses felt more comfortable<br />
and competent in managing symptoms compared to attendings<br />
and residents; and only attendings consistently identified hospice appropriate<br />
patients. Next steps may include: 1) residents and nurses receive<br />
more education regarding resuscitation discussion and hospice<br />
appropriateness, and 2) attendings and residents may benefit from<br />
more training in symptom management.<br />
C64<br />
Weaving Aging Education Into The Surgery Clerkship: an<br />
opportunity to increase future physician awareness of unique issues<br />
in surgical care for the elderly.<br />
A. Macnow, 1 R. Kelz, 1,3 A. Corcoran. 1,2 1. Perelman School of<br />
Medicine, University of Pennsylvania, Philadelphia, PA; 2. Internal<br />
Medicine, University of Pennsylvania, Philadelphia, PA; 3. Surgery,<br />
University of Pennsylvania, Philadelphia, PA.<br />
Supported By: Donald W. Reynolds Foundation<br />
Background: Successful outcomes for geriatric surgical patients<br />
are dependent on a team well versed in the unique issues of the aging<br />
AGS 2012 ANNUAL MEETING<br />
S153
P OSTER<br />
A BSTRACTS<br />
patient population. We report the evaluation of a case-based educational<br />
session for surgical clerks focused on the peri-operative management<br />
of an elderly patient as part of an integrated aging theme<br />
initiative. Methods: Utilizing a clinical scenario involving an elderly<br />
patient with abdomen pain, a 55 minute case-based session was added<br />
into the required lecture schedule. Students were divided into learning<br />
teams and asked to provide group answers to open-ended questions<br />
incorporated as the case unfolded. An anonymous audience response<br />
system was employed to allow learners to assess their<br />
successes in comparison to their peers to voluntary 5 multiple choice<br />
knowledge questions and pre/post self-assessment survey using a<br />
four-point Likert scale (1=very good,4=poor). Descriptive statistics<br />
were performed comparing before and after the session using the<br />
Wilcoxen rank sum test. Results: Thirty students participated in the<br />
pilot. At the end of the case, students responded correctly 85% or<br />
more of the time to the multiple-choice questions. All self-assessment<br />
questions showed statistically significant improvement when responding<br />
to the following: (1) appreciate the unique problems of the<br />
increasing number of older adults undergoing abdominal surgery<br />
(median=3pre/2post,p
P OSTER<br />
A BSTRACTS<br />
other age group (Krisberg 2005). One way to prepare future physicians<br />
for increased demand may be to better integrate geriatrics education<br />
into medical school. The study’s objective was investigate<br />
whether taking a geriatrics elective class improves first-year medical<br />
students’ perceptions and knowledge of geriatrics.<br />
Subjects were 18 first-year medical students, 8 of whom had enrolled<br />
in a 4-month geriatric elective class. Surveys were administered<br />
to students within 1 month of the first class session. The surveys assessed<br />
students’ interest in and comfort level with elderly patients<br />
and included a modified version of Palmore’s Facts on Aging Quiz, a<br />
validated geriatrics knowledge assessment survey (Fabiano 2005).<br />
These surveys will be administered again to students within 1 month,<br />
and again 1 year after the completion of the elective.<br />
There was no significant difference between knowledge survey<br />
scores for geriatrics elective (GE) and non-geriatrics elective (non-<br />
GE) students; the average score was 13.9±0.5 out of 25. On a scale of<br />
1-10 (1 being least and 10 being most interested), GE students’ average<br />
geriatrics interest was 7.4±0.7, which was significantly higher than<br />
that of non-GE students, 4.3±0.4 (p
P OSTER<br />
A BSTRACTS<br />
C71<br />
Outpatient Anticoagulation Management in the Elderly Patients:<br />
Attitude and Knowledge Survey in Geriatric Fellows.<br />
A. S. Gangavati, L. Lipsitz. Gerontology, Beth Israel Deaconess<br />
Medical center, Harvard Medical School, Brookline, MA.<br />
Supported By: Geriatric Academic Career Award<br />
Background: Despite ongoing national initiatives to reduce the<br />
likelihood of patient harm associated with use of anticoagulant therapy,<br />
little or no formal curricula on anticoagulation management in<br />
the elderly are included in the majority of post-graduate training programs.<br />
Methods: Eleven geriatric fellows were sent knowledge and attitude<br />
survey questions in outpatient anticoagulation management in<br />
the elderly patients. Questions were designed based on expert advice<br />
and from comprehensive literature review.<br />
Results:<br />
Attitude Questions: Five out of eleven geriatric fellows (45.5%)<br />
felt that they were “quite often” comfortable with managing anticoagulation<br />
as compared to 54.5% (6/11) who felt that they were “very<br />
often” comfortable with anticoagulation management in the elderly<br />
patients. Seven out of the eleven fellows (63.6%) felt that they have<br />
enough knowledge regarding anticoagulation management as compared<br />
to 36.4% (4/11) who felt that they did not have enough knowledge<br />
regarding anticoagulation management.<br />
Knowledge questions: Table 1 shows results from knowledge<br />
questions that specifically addressed outpatient dose initiation and<br />
monitoring in elderly patients, drug interactions with Warfarin, cultural<br />
influences of diet on Warfarin and dosage/storage of Dabigatran.<br />
Conclusions: Most Geriatric fellows felt that they were comfortable<br />
managing anticoagulation in the elderly patients and only 36.4%<br />
felt that they don’t have adequate knowledge. Most fellows were able<br />
to answer only 50% or less of all the questions. Based on these results,<br />
formal education curriculum addressing the knowledge gaps is being<br />
developed.<br />
Table 1. Knowledge questions on anticoagulation management in<br />
geriatric patients. (n=11)<br />
C72<br />
“<strong>Geriatrics</strong> Fellows’ Most Difficult Case Conference”- Knowledge<br />
Sharing and Teaching through program networking: a one year<br />
experience.<br />
A. Khan, 1,2 T. Howell, 2 M. Malone, 1,2 P. Colon-Nieves, 1 K. Singh. 1,2 1.<br />
Aurora Health Care, Milwaukee, WI; 2. University Of Wisconsin<br />
School of Medicine and Public Health, Madison, WI.<br />
Background:<br />
A monthly “Most Difficult Case Conference” has emerged as a<br />
promising strategy to teach the bio-psycho-social approach to complex<br />
older adults.It has grown to involve 13 geriatrics fellowship programs<br />
in 7 states, networked by simple conference call. The fellowship<br />
teams rotate in selecting and presenting cases experienced as especially<br />
emotionally and cognitively taxing. Teams at the other sites take<br />
turns inquiring about the case, using the “Wisconsin Star Method” as<br />
a format. This involves mapping clinical data onto five domains: medications,<br />
medical, behavioral, personal, and social. Geriatric psychiatry<br />
and medicine faculty from other sites take turns with summary<br />
teaching points, and the discussions conclude with “the rest of the<br />
story” from the presenting team.<br />
Methods:<br />
This is an on-line survey of participants during the second year<br />
of the program. Data was compared to the survey of participants during<br />
the first year.<br />
Results:<br />
The survey was sent to 43 participants and 18 responded. Of<br />
these 56% were faculty, 33% fellows and 11% “other”.<br />
When compared to last year an increased number of respondents<br />
noted that the quality of program was good (72% current year<br />
vs. 59% last year), enjoyed collaborating with colleagues across the<br />
country (89% vs.74%), and would recommend it to their colleagues<br />
(78% vs.69%).<br />
As compared to last year more respondents noted learning<br />
practical strategies for addressing complexity (61% vs.36%) and that<br />
Wisconsin Star Method was effective in assessing complex cases<br />
(61% vs. 49%). Regular use of the Wisconsin Star Method in clinical<br />
practice did not change (18%). Similar to last year, responders found<br />
the discussions of the “hardest part of the case” and the “summary<br />
teaching points” to be most useful.<br />
Participants noted that the conference allows them to a feel part<br />
of a national interdisciplinary team (61%) and half noted that it has<br />
helped build their emotional and cognitive skills.<br />
Conclusion:<br />
“<strong>Geriatrics</strong> Fellows’ Most Difficult Case Conference” has<br />
demonstrated an improvement in participant satisfaction over the<br />
last 2 years. This assessment of the conference will assist in making<br />
the educational case for further dissemination to additional fellowship<br />
programs.<br />
C73<br />
Interprofessional Geriatric Clinical Skills Fair.<br />
B. Salzman, 1 L. Collins, 1 E. Hajjar, 2,1 A. Egras, 2,1 C. Hsieh, 1 L. Hersh, 1<br />
S. Fleegle, 1 D. Snyderman. 1 1. Family & Community Medicine,<br />
Thomas Jefferson University, Philadelphia, PA; 2. Jefferson School of<br />
Pharmacy, Thomas Jefferson University, Philadelphia, PA.<br />
Supported By: This project was supported by funds from the<br />
Department of Health and Human Services (DHHS), Health<br />
Resources and Services Administration (HRSA), Bureau of Health<br />
Professions (BHPr), under Geriatric Academic Career Award number<br />
5K01HP20486.<br />
Background: The need to expand geriatric education for health<br />
professionals at all levels of training has been well described (1). The<br />
purpose of this study was to evaluate the experience of participants in<br />
an Interprofessional Geriatric Clinical Skills Fair.<br />
Methods: The objective of the fair was for learners to gain practical,<br />
evidence-based skills and knowledge pertaining to the care of<br />
older adults. Six interactive stations included cognitive assessment,<br />
gait evaluation, older patient simulation, medication management,<br />
code status conversation, and disposition discussion. Each station ran<br />
for 15 minutes and the entire fair ran for 2 hours. The stations were<br />
led by interprofessional faculty including 4 geriatricians, 1 palliative<br />
care specialist, and 2 clinical pharmacists.<br />
A short survey was administered after the fair to assess learners’<br />
experience. Learners were asked to rate each station on a 5-point<br />
scale. They were asked if there was anything they would change to improve<br />
the fair and whether they learned something at the fair that<br />
would change their clinical practice.<br />
Results:<br />
A sign-in sheet demonstrated 34 participants, including 17 residents<br />
in Family Medicine (FM), 13 medical students on their 3rd-year<br />
S156<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
clerkship in FM, 2 medical students on their 4th-year sub-internship<br />
in Geriatric Medicine, and 2 second-year pharmacy students.<br />
Surveys were distributed to all participants (34), and 28/34<br />
(82%) completed surveys were returned.<br />
On a 5-point scale (ranging from 1=poor, 2=fair, 3=good, 4=very<br />
good, 5=excellent), the average rating for each station ranged from<br />
4.65 to 4.85, with a mean of 4.73.<br />
When asked if they would change anything to improve the program,<br />
2 learners responded that they would have liked more time.<br />
When asked if they learned anything at the fair that would<br />
change their clinical practice, 24 out of the 28 (86%) responders<br />
wrote, “Yes.”<br />
Conclusion:<br />
An Interprofessional Geriatric Clinical Skills Fair was highly<br />
rated by learners at various levels of training. The fair was a fun and<br />
effective method for providing education addressing geriatric competencies.<br />
Reference:<br />
Institute of Medicine of the National Academies. Retooling for<br />
an Aging America: Building the Health Care Workforce. Washington,<br />
DC: The National Academies Press; 2008.<br />
C74<br />
Improving Uptake of a Falls Educational Program by Focusing on<br />
Staff Interactions.<br />
C. Colon-Emeric, 1,2 S. Pinheiro, 1 K. M. Simpson, 2 K. Porter, 1<br />
K. Corazzini, 1 R. A. Anderson. 1 1. Duke University, Durham, NC; 2.<br />
GRECC, Durham VA Medical Center, Durham, NC.<br />
Supported By: VA HSR&D EDU 08-417<br />
NIH R56NR003178–09<br />
Background: Traditional educational programs for nursing<br />
home staff have not resulted in improvements in quality indicators or<br />
fall rates. One potential explanation is that staff lack sufficient connections<br />
with each other to effectively share information and problem<br />
solve.<br />
Methods: Eight nursing homes were block randomized to receive<br />
either a traditional falls education program (FALLS only), or a<br />
program teaching staff to improve their connections and interactions<br />
with co-workers, followed by the traditional falls program (CON-<br />
NECT+FALLS). The education programs were delivered by research<br />
assistants over 3 months, targeted all staff with direct resident<br />
contact (n=674), and used story-telling, role play, relationship mapping,<br />
and coaching. Focus groups (n=16) were conducted with staff<br />
who had participated in at least one intervention component (n=87).<br />
Qualitative analysis identified thematic differences in staff-reports of<br />
organization learning.<br />
Results: Both groups expressed that the FALLS content was familiar,<br />
reminded them about fall risk factors, and helped them engage<br />
in teamwork. However, the CONNECT groups additionally noted: 1)<br />
that relationship mapping sessions helped them identify and correct<br />
communication weaknesses; 2) that improved understanding about<br />
the roles of various disciplines led to a wider fall prevention network;<br />
and 3) that improved job attitudes and cooperation resulted in<br />
greater willingness to stick to interventions such as toileting programs.<br />
One CONNECT participant stated that “with the two, the<br />
CONNECT and the FALLS portion of it…it all flowed together, so it<br />
helped us to understand and learn better.” Participants also mentioned<br />
that the CONNECT intervention would be helpful for learning<br />
about other topics, such as behavior problems.<br />
Conclusions: An educational program focused on improving interactions<br />
among nursing home staff was highly acceptable, and was<br />
reported to enhance the uptake of a traditional falls education program.<br />
Measurement of its impact on resident fall indicators and outcomes<br />
is warranted.<br />
C75<br />
Community Based Advance Care Planning Education for Older<br />
Adults.<br />
C. W. Johnston. Betty Irene Moore School of Nursing, University of<br />
California at Davis, Sacramento, CA.<br />
Supported By: Betty Irene Moore School of Nursing, University of<br />
California at Davis<br />
Senior Citizens of Davis<br />
Background: Advance care planning (ACP) includes health education,<br />
anticipating future care, establishing a plan, choosing a<br />
spokesperson, documenting wishes, and communication. The objective<br />
of this pilot study was to determine whether a community based<br />
educational program for older adults would increase participation in<br />
ACP. Previous research has not shown whether community-based education<br />
improves participation in ACP. Methods: This pilot study targeted<br />
a population of older adults (>65 years), and was performed at<br />
a small public community center. A convenience sample was recruited<br />
and informed consent was obtained prior to the completion of<br />
a pre-education survey to determine baseline knowledge of ACP. A<br />
multi-component presentation was given by the researcher highlighting<br />
CPR survivability and both forms primarily used in ACP; the Advance<br />
Directive (AD) and Physicians Orders for Life Sustaining<br />
Treatment (POLST) form. Results: 23 of the 30 attendees participated<br />
in the survey, with a mean age of 72.9 years. 74% (n=17) were<br />
college educated, with 43% (n=10) reporting their highest level of education<br />
to be a Masters degree. 78% had an awareness of ACP and<br />
had talked with someone about their wishes. 91% had a spokesperson<br />
to make healthcare decisions on their behalf. 52% had a Durable<br />
Power of Attorney (DPOA), and 87% knew what a DPOA was. 74%<br />
(n=17) knew what an AD was and most (n=18, 78%) did not know<br />
what a POLST form was. Most had not filled out an AD and a<br />
POLST form. 96% reported knowing of CPR but 96% failed to correctly<br />
estimate survivability after CPR. Percentages of survival were<br />
on a Likert scale ranging from a score of 1 being equal to a survival<br />
rate of 81-100% to a score of 5 being equal to a rate of 0-20% survival.<br />
Conclusion: Participants were highly educated and indicated<br />
they have made attempts to learn about their health, communicate<br />
with others about their wishes for healthcare, know what CPR is, and<br />
are somewhat aware of the process of ACP. Conversely, most have<br />
not participated in ACP, are not aware of AD and POLST forms, and<br />
are unable to correctly estimate CPR survivability. This pilot study illustrated<br />
a need for more education about the benefits of ACP. More<br />
research is needed to improve participation in ACP among older<br />
adults and future studies should focus on community based ACP education.<br />
Awareness of ACP may improve the likelihood that healthcare<br />
wishes will be communicated and honored at the end of life.<br />
C76<br />
Effect of the Health Mentors Program on Student Attitudes toward<br />
Team Care.<br />
C. Arenson, C. Giordano, K. Lyons, L. Collins, E. Umland,<br />
L. Hewston, K. Smith, R. Antony, M. Rose. Thomas Jefferson<br />
University, Philadelphia, PA.<br />
Supported By: This research was wholly funded by Thomas<br />
Jefferson University, Jefferson InterProfessional Education Center<br />
and the Jefferson Office of Institutional Research.<br />
Background: Interprofessional education (IPE) is a key theme<br />
in preparing the future geriatric workforce, yet there is a lack of robust<br />
data documenting the benefits of IPE. Student attitudes toward<br />
AGS 2012 ANNUAL MEETING<br />
S157
P OSTER<br />
A BSTRACTS<br />
IPE are generally positive and show little change after IPE. Attitudes<br />
toward team care may be a more sensitive interim measure of IPE efficacy<br />
(Rose et al). The Health Mentors Program (HMP) is a 2-year<br />
longitudinal curriculum that brings entry-level interprofessional<br />
teams of students together with a Health Mentor (a person living<br />
with one or more chronic conditions) to learn patient-centered, teambased<br />
care. Nearly 3,000 students have participated; 52% of Health<br />
Mentors are age 60 or over.<br />
Methods: Students entering HMP in Fall 2009 completed the Attitudes<br />
Towards Interdisciplinary Teams scale (Heinemann et al) at<br />
matriculation and at program completion in Spring 2011.<br />
Results: A paired samples t test showed significant improvements<br />
in mean attitude scores (scale 0-5, higher = more positive attitude)<br />
between baseline and program completion in all disciplines<br />
with sufficient sample size. A paired samples t test for students in all<br />
programs (n=173) found significant improvements (p=.000) in attitudes<br />
(baseline mean 3.27 (.45) and 3.75 (.58). ANOVA showed no<br />
significant differences between groups.<br />
Conclusions: The gold standard for measuring impact of IPE is<br />
clearly improvement in patient outcomes. However, given the long<br />
time-delay from entry into health professions training to independent<br />
practice, interim measures to assess program outcomes are essential.<br />
Improved attitudes toward team-based care may be one important<br />
indicator of program success. A limitation of this study is lack of a<br />
control group of students not exposed to formal IPE. Next steps include<br />
measuring attitudes longitudinally during the remainder of<br />
training and into clinical practice.<br />
Rose M, et al. Attitudes of students in medicine, nursing, occupational<br />
and physical therapy toward interprofessional education. J<br />
Allied Health, 38:196-200, 2009.<br />
Heinemann GD, et al. Development of an Attitudes Toward<br />
Health Care Teams Scale. Eval & Health Professions, 22:123-42, 1999.<br />
Discipline Specific Changes in Attitudes to Team-based Care<br />
C77<br />
Do physicians in-training assess for falls among the elderly<br />
population in the outpatient setting?<br />
D. Soto, 1 J. F. Fogel. 2 1. Division of <strong>Geriatrics</strong>, Montefiore Medical<br />
Center Albert Einstein College of Medicine, Bronx, NY; 2. Dept of<br />
Medicine,Division of <strong>Geriatrics</strong>, Beth Israel Medical Center, New<br />
York, NY.<br />
Falls are one of the most common geriatric syndromes threatening<br />
independence and are one of the leading causes of injuries in the<br />
older population. Patients 65 and older account for 39% Internal<br />
Medicine (IM) ambulatory visits. There has been an impetus to incorporate<br />
education on geriatric syndromes into IM residents curriculum.<br />
This study aims to evaluate the assessment for falls and gait instability<br />
provided to vulnerable elders by IM residents in an<br />
ambulatory setting.<br />
A retrospective chart review of total 150 randomly selected patients<br />
followed by IM residents for one year period was conducted.<br />
Inclusion criteria: >65 years of age, attendance at ambulatory clinic<br />
for at least one year and treated only by in-training physicians. The<br />
electronic medical records of these patients were reviewed for any<br />
question regarding falls, past medical history including co-morbidities<br />
and gait abnormalities as a problem, number of falls and consequences,<br />
use of psychoactive medications. Physical exam was reviewed<br />
for evidence of gait assessment.<br />
Documentation of fall inquiry was noted in 25% (38) of records.<br />
Of the 38 records gait was recorded in 12 occasions (P
P OSTER<br />
A BSTRACTS<br />
C79<br />
Interprofessional, Evidence-Based Education to Reduce Falls.<br />
E. Eckstrom, 1 K. Lasater, 1 V. Cotrell, 2 W. Simonson, 3 M. Neal, 2<br />
T. Harvath. 1 1. Oregon Health & Science University, Portland, OR; 2.<br />
Portland State University, Portland, OR; 3. Oregon State University,<br />
Corvalis, OR.<br />
Supported By: Health Resources and Services Administration<br />
Fall prevention in older adults requires an interprofessional, evidence-based,<br />
systems-oriented approach. We implemented a fall prevention<br />
protocol for medical, nursing, social work, and pharmacy professionals.<br />
Methods: Interprofessional project faculty met monthly to develop<br />
the protocol and train ourselves in teamwork, motivational interviewing,<br />
and content expertise. Interprofessional workshops were<br />
offered onsite for ambulatory, long term care, hospital, and home<br />
health practices focused on: (1) screening patients over 75 for falls, (2)<br />
Vitamin D supplementation, (3) exercise prescription (tai chi), (4) environmental<br />
assessment, and (5) medication review and reduction.<br />
Study team members (“coaches”) partnered with each practice site to<br />
develop an individualized action plan to implement a fall prevention<br />
protocol. Outcomes data will be collected for one year at each site.<br />
The study is ongoing.<br />
Results: 1) Team members were reminded of the important roles<br />
all professions play in fall prevention (e.g., social workers are trained<br />
to reduce fear of falls but are rarely used for this role); 2) We needed<br />
a shared lexicon on motivational interviewing for use both in training<br />
of practice sites and in coaching individual teams, requiring multiple<br />
training sessions; 3) Team members can be cross trained to deliver<br />
content from other professions, enhancing the flexibility of the<br />
“coach”/practice team pairings; 4) Practice settings have varying degrees<br />
of “team-ness” and this impacts successful implementation of<br />
the protocol; 5) Solutions to implementing evidence-based action<br />
plans vary between practice sites, are innovative, and deserve further<br />
research, e.g., adapting tai chi exercises for use by CNAs; 6) “Champions”<br />
for practice change come from any profession; 7) Rural communities<br />
can coordinate efforts effectively across inpatient, outpatient,<br />
and long-term care settings, thereby facilitating culture change and<br />
setting a new community standard.<br />
Conclusions: Interprofessional education takes commitment<br />
and training but can lead to effective evidence-based practice adoption.<br />
Team member roles are often narrowly defined, and better identification<br />
of expertise can improve team effectiveness. Interprofessional<br />
teaching enhances everyone’s experience; the impact on<br />
patient outcomes remains to be determined.<br />
C80 Encore Presentation<br />
The effect of a delirium e-learning program on nurses’ knowledge of<br />
delirium.<br />
E. Detroyer, 1,2 D. Debonnaire, 1 F. Dobbels, 1 J. Gommers, 2 K. Irving, 3<br />
E. Joosten, 4 K. Milisen. 1,4 1. Center for Health Services and Nursing<br />
Research, Katholieke Universiteit Leuven, Leuven, Belgium; 2.<br />
Department of Health Service, Katholieke Hogeschool Limburg,<br />
Hasselt, Belgium; 3. Department of Nursing, Dublin City University,<br />
Dublin, Ireland; 4. Department of Geriatric Medicine, University<br />
Hospitals Leuven, Leuven, Belgium.<br />
BACKGROUND: Delirium is a common complication among<br />
hospitalized elderly patients, but remains frequently unrecognized by<br />
healthcare workers. Despite the evidence that educational packages<br />
can improve awareness and knowledge of delirium among nurses, no<br />
research testing e-learning in this area was found. This study determined<br />
the effect of a delirium e-learning program on nurses’ knowledge<br />
about delirium.<br />
METHODS: A convenience sample of 56 nurses from a university<br />
hospital (60% bachelor degree, all computer literate) were included,<br />
and completed two validated questionnaires to assess their<br />
knowledge about delirium and their ability to identify delirium before<br />
and after the educational intervention. The intervention consisted<br />
of (1) a one-hour information session with instructions on how<br />
to use the e-learning program and (2) a two-month learning period<br />
given access to the delirium e-learning program. This e-learning program<br />
is organized into 11 submodules of approximately 10 minutes<br />
each. It provides information about the epidemiology, the clinical<br />
presentation, the risk factors, the causes and the prevention, screening<br />
and treatment strategies of delirium in combination with case<br />
studies, videos and tests for self-assessment.<br />
RESULTS: Nurses’ knowledge about delirium was significantly<br />
improved in the after-education period compared to the before-education<br />
period (mean score (SD) of correct answers on the 23 items of<br />
the questionnaire = 19.68 (SD 2.08) versus 17.61 (SD 3.52); p
P OSTER<br />
A BSTRACTS<br />
the outpatient setting. Our ultimate goal is to enhance the abilities of<br />
medical students to work collaboratively with the disciplines of nursing<br />
and pharmacy to consider the needs of older adults using an interdisciplinary<br />
learning methodology.<br />
C82<br />
Geriatric Relocation Syndrome: A Marker for Frailty in Older<br />
Adults?<br />
A. Ahmed, S. Friedman, K. McCormick. University of Rochester,<br />
Rochester, NY.<br />
Background: Demographic changes have created a new dynamic<br />
which results in substantial late life geographic relocation<br />
within the United States. The aim of this study was firstly to assess if<br />
there was a difference between patients who relocated and patients<br />
who did not in terms of their overall health, and secondly to gauge<br />
whether relocation contributed to risk of mortality longitudinally.<br />
Methods: A convenience sample was obtained of 440 patients<br />
who were newly enrolled in a Geriatric outpatient practice attached<br />
to a university hospital in Rochester, NY. Subjects were identified as<br />
having moved at least 60 miles in the past year (n= 64) or not<br />
(n=376). Demographics, functional status, self-reported health, and<br />
comorbidities were recorded. Comparisons were made between “relocators”<br />
and “non-relocators” via Chi square and t-test analysis as<br />
appropriate. A Cox Proportional Hazard analysis was completed to<br />
assess impact of relocation status on mortality for the 429 subjects<br />
who had complete data on mortality and death date.<br />
Results: Subjects’ self report of health was more likely to be<br />
“fair” or “poor” for relocated patients (27.0% vs 19.1%, P
P OSTER<br />
A BSTRACTS<br />
Conclusions: Although participants with PD demonstrated a<br />
trend toward improved functional mobility after intensive training,<br />
no change occurred in the frequency of urinary symptoms and participants<br />
reported greater bother related to overactive bladder. Multicomponent<br />
strategies are needed to impact both motor and nonmotor<br />
symptoms of PD.<br />
C85 Encore Presentation<br />
Outcomes after Discontinuation of Proton Pump Inhibitor Therapy<br />
in Geriatric Outpatients.<br />
C. Eisenhower, 1 H. Sakely, 1,2 F. D’Amico, 1 S. Rana. 1,2 1. University of<br />
Pittsburgh Medical Center St. Margaret, Pittsburgh, PA; 2. University<br />
of Pittsburgh Medical Center St. Margaret Geriatric Care Center,<br />
Pittsburgh, PA.<br />
Chronic use of proton pump inhibitors (PPIs) in the geriatric<br />
population without a clear indication creates opportunities for longterm<br />
adverse events and drug interactions. A 2009 quality initiative at<br />
University of Pittsburgh Medical Center Geriatric Care Center enrolled<br />
eleven patients for a trial discontinuation of PPI therapy. Many<br />
of the patients did not have a documented indication for a PPI, and<br />
six patients were successfully discontinued. The purpose of this extension<br />
study was to evaluate geriatric patients after discontinuation of<br />
PPI therapy to determine rate of discontinuation and confirm that<br />
the intervention did not worsen gastrointestinal (GI) symptoms or<br />
quality of life.<br />
From 10/2010 to 3/2011, charts were reviewed at the Geriatric<br />
Care Center prior to routine appointments. Eligible patients were<br />
aged 60 years and older, currently taking a PPI, or a new patient potentially<br />
taking a PPI. Based on indication, current GI symptoms, and<br />
concomitant medications, physicians determined whether PPI use<br />
was still appropriate. Telephone follow-up was conducted by the<br />
pharmacy resident for three months with each enrolled patient. Patient<br />
charts were reviewed and pertinent demographic information<br />
analyzed. Rate of discontinuation was calculated with 95% confidence<br />
intervals using Poisson Distribution.<br />
A total of 175 patients were seen at the geriatric clinic. Nine patients<br />
were enrolled by their physician and five did not restart their<br />
PPI therapy at any time after discontinuation. The rate of discontinuation<br />
was estimated to be 0.076 (95% CI, 0.033-0.165). Duration of<br />
therapy was estimated for many enrolled patients to be less than 10<br />
years. GI symptoms continued after discontinuation for three patients,<br />
began anew for one patient, and resolved for three patients.<br />
Due to small sample size, a relationship could not be established between<br />
PPI therapy and long-term adverse events, although history of<br />
osteoporosis, B-12 deficiency, and hypomagnesmia were present in<br />
some patients.<br />
The majority of patients were successfully discontinued from<br />
their PPI therapy, and persisting GI symptoms were controlled by alternative<br />
treatments. While no significant adverse drug events occurred,<br />
it is unknown whether the use of step-down therapy would<br />
have resulted in a greater number of successful discontinuations.<br />
C86 Encore Presentation<br />
Factors associated with the care burden experienced by caregivers of<br />
older patients.<br />
C. Y. Yeo, 1 W. K. Ng, 2 W. Wong. 1 1. Geriatric Medicine, Tan Tock Seng<br />
Hospital, Singapore, Singapore; 2. Nursing Service, Tan Tock Seng<br />
Hospital, Singapore, Singapore.<br />
Supported By: Nil.<br />
Background: Caregiver burden experienced by caregivers of<br />
older adults is expected to increase with the aging population. The<br />
aim of this study was to determine the factors associated with caregiver<br />
burden experienced by caregivers of a cohort of elderly patients<br />
attending an outpatient geriatric clinic.<br />
Methods: This was a cross-sectional study of caregivers of patients<br />
referred to an outpatient geriatric clinic. Demographic information,<br />
medical history, functional and psychosocial status of patients<br />
were recorded. The relationship of the caregivers to the patients was<br />
also recorded. Caregiver burden was assessed using the short-form of<br />
the Zarit Burden Inventory (ZBI).<br />
Results: 240 caregivers were included in the study. 68.3% were<br />
female. 19.6% of the caregivers were spouses, 55.8% were children<br />
and children-in-law, 4.2% were other relatives and 20.4% were domestic<br />
helpers. Mean ZBI score was 16.15. Spousal caregivers had the<br />
highest ZBI score (mean 18.04), followed by other relatives (mean<br />
16.70), children and children-in-law (mean 16.56), and domestic<br />
helpers (mean 13.14). Using multivariate analysis, factors that were<br />
significantly associated with higher ZBI scores were male patients<br />
(Beta coefficient = 3.14, 95% CI 0.50 to 5.78), patients who were independent<br />
in feeding (Beta coefficient = 3.51, 95% CI 0.39 to 6.64),<br />
patients who were dependent in grocery shopping (Beta coefficient =<br />
2.11, 95% CI 0.23 to 4.00), patients with behavior problems (Beta coefficient<br />
= 2.85, 95% CI 0.37 to 5.33) and spousal relationship with<br />
patient (Beta coefficient = 1.70, 95% CI 0.57 to 2.83). There were no<br />
significant association between the ZBI score and patients’ diagnosis<br />
of dementia or depression, nor with caregivers’ gender.<br />
Conclusion: Patient factors that were associated with higher<br />
burden of care in our study include male gender, independence in<br />
feeding, dependence in grocery shopping and presence of behavioral<br />
problems. Familial relationship between caregivers and patients was<br />
also associated with higher care burden. Further research can be<br />
done to explore carer stress among spousal caregivers for elderly and<br />
their coping abilities and utilisation of family and community resources,<br />
given our aging population and low birthrate resulting in<br />
smaller families.<br />
C87<br />
Effects of Sub-acute Care on Hospital Acquired Anemia in the<br />
Elderly.<br />
C. Bocirnea, M. V. Corrigan, S. K. Sandhu. MetroHealth Medical<br />
Center, Cleveland, OH.<br />
OBJECTIVES: To determine if sub-acute care results in further<br />
hemoglobin decrease in elderly patients with hospital acquired anemia<br />
and if there is an association between development of anemia<br />
and patient demographic characteristics, medical conditions, medications,<br />
and length of stay.<br />
DESIGN: Retrospective observational study.<br />
SETTING: Academic medical center.<br />
PARTICIPANTS: Patients over the age of 65 admitted to an academic<br />
hospital based sub-acute care unit, post hospitalization for a<br />
medical illness from January 2007 to July 2011. Exclusion criteria: patients<br />
transferred from ICU, those who underwent surgical procedures,<br />
had documented blood loss, active leukemia or recent<br />
chemotherapy.<br />
MEASUREMENTS: Demographics; chronic medical conditions<br />
and medications; hemoglobin levels; number of blood tubes<br />
drawn; length of stay.<br />
RESULTS: Of 835 patients transferred to sub-acute care after a<br />
medical hospitalization between 01/2007-07/2011, 393 met the inclusion<br />
criteria. Median age was 78 years, 65% Caucasian, 65% female.<br />
Nearly half had heart disease, one third heart failure, and 85% hypertension.<br />
Median length of stay was 7 days for acute care and 13 days<br />
in sub-acute care. Anemia was present on hospital admission in 57%<br />
of patients, with 80% of patients anemic upon sub-acute care discharge.<br />
43% of patients did not have anemia on admission; at discharge<br />
from sub-acute care this group had a mean decrease in Hgb of<br />
1.9 g/dL, significantly greater compared with anemic patients. Factors<br />
predicting a significant drop in Hgb levels of more than 2.0 g/dl(25%<br />
of patients) were longer los in acute care (p 0.002), number of tests<br />
obtained during sub-acute stay (p 0.001), presence of cognitive<br />
deficits (p 0.009), coronary artery disease (p 0.02) and lower BMI (p<br />
AGS 2012 ANNUAL MEETING<br />
S161
P OSTER<br />
A BSTRACTS<br />
0.03). Age and subsequent admission to the sub-acute unit did not influence<br />
the presence of anemia.<br />
Conclusions: A high percentage of elderly patients were admitted<br />
to the sub-acute unit with anemia; nearly 30% of these patients<br />
acquired anemia during the hospitalization. However, subsequent<br />
blood draws during sub-acute care did not worsen underlying anemia.<br />
Patients admitted without anemia experienced more significant<br />
decrease in hemoglobin level during both acute and sub-acute stay.<br />
This finding warrants further investigation. Judicious testing, use of<br />
pediatric tubes and elimination of routine ordering may decrease the<br />
risk of anemia.<br />
Key words; anemia; elderly; sub-acute; hospitalization<br />
C88<br />
C-Reactive Protein Fails to Predict Geriatric Depression: The<br />
Cardiovascular Health Study.<br />
D. C. Hsu, 1,2 D. Tancredi, 3,4 C. Hirsch. 1,4 1. Internal Medicine,<br />
University of California, Davis, Sacramento, CA; 2. Psychiatry,<br />
University of California, Davis, Sacramento, CA; 3. Pediatrics,<br />
University of California, Davis, Sacramento, CA; 4. Center for<br />
Healthcare Policy and Research, University of California, Davis,<br />
Sacramento, CA.<br />
Background: Although depression and inflammation are associated<br />
with an increased risk of cardiovascular outcomes (CVO), the<br />
extent to which depression is in the causal pathway between inflammation<br />
and CVO is unknown. Our objective was to assess whether<br />
higher levels of C-reactive protein (CRP) are associated with greater<br />
increases in depressive symptoms among older persons up to eight<br />
years after baseline measurement.<br />
Methods: We performed a retrospective analysis of data from<br />
the Cardiovascular Health Study (CHS), a prospective cohort study<br />
of 5,888 persons 65 and older from four communities in the U.S. They<br />
included Forsyth County in North Carolina, Washington County in<br />
Maryland, Sacramento County in California, and Allegheny County<br />
in Pennsylvania. 5201 men and women aged 65 and older enrolled in<br />
the original cohort group of 1989, along with 687 African-<strong>American</strong><br />
participants in 1992 and 1993. Levels of CRP were obtained at baseline<br />
and year 5 of the study, and depression was evaluated with the 10-<br />
item Center for Epidemiologic Studies Depression Scale. Selected via<br />
directed acyclic graphs, variables for demographics, chronic medical<br />
diseases, medications, and life events were controlled in the multiple<br />
linear regression models for changes in depression score.<br />
Results: No statistically significant association between CRP<br />
and mean changes in depression score was found in this cohort. CRP<br />
levels showed only modest within-person correlation (r=0.25) from<br />
baseline to year 5.<br />
Conclusions: Infrequently assessed levels CRP cannot help predict<br />
geriatric depression up to eight years after initial measurement.<br />
Further study of the relationship between inflammatory markers and<br />
geriatric depression is needed.<br />
C89<br />
Under the radar - previously undocumented dementia among older<br />
veterans on an inpatient medical service.<br />
E. Clark, 1,2 J. Burns, 3,4 L. Leon, 5 E. Gottesman, 1 E. Livote. 1 1. JJ<br />
Peters VA Medical Center, Bronx, NY; 2. Mt. Sinai School of<br />
Medicine, New York, NY; 3. Union Square Family Health, Somerville,<br />
MA; 4. Harvard Medical School, Boston, MA; 5. Staywell Health<br />
Center, Waterbury, CT.<br />
Background: Dementia compromises individuals’ abilities to<br />
live independently and to manage their healthcare and thus often<br />
confounds safe hospital discharge. With advancing age, the incidence<br />
of dementia and the complexity of medical problems increase yet dementia<br />
frequently remains unrecognized.<br />
Objectives: Identify likely cases of previously undocumented<br />
dementia among inpatient older veterans at a VA medical center<br />
Methods:<br />
1) Brief battery of cognitive and functional assessment tools<br />
performed within 48 hours of admission to a general medical service,<br />
January – March 2009<br />
2) Chart review of the electronic medical record (EMR) for<br />
documentation of dementia, memory loss or cognitive impairment<br />
during the year prior to study enrollment<br />
Subjects:<br />
Convenience sample of 50 veterans: all male; median age 77.5<br />
(range 65-91);26.7% did not graduate from high school, 28.9% were<br />
high school graduates, and 44.4% had at least some college.<br />
Results:<br />
Of the 50 subjects, 32 (64%) had no EMR documentation of<br />
memory loss, dementia, or cognitive impairment during the prior<br />
year. Among these, 2 (6.7%) had a Mini Mental Status Exam score <<br />
20/30; 22 (71%) had an abnormal Clock; 8 (25%) named few than 12<br />
animals in 60 seconds. Only 9 (28%) of these 32 subjects had no abnormalities<br />
on cognitive testing. Of the 40 total subjects with at least<br />
1 abnormal cognitive test, 25 (62.5%) reported 2 or more deficits in<br />
IADLs.<br />
Of the 32 subjects with no prior documentation of cognitive impairment,<br />
only 2 had documentation of prior formal cognitive testing.<br />
Of the 18 subjects who did have prior diagnosis of cognitive impairment,<br />
15 (83%) had documentation of prior testing.<br />
Discussion: Cut offs for abnormal test values were chosen to be<br />
consistent with cognitive impairment independent of educational attainment.<br />
While this was a small pilot study, the high prevalence of<br />
abnormal results on cognitive testing coupled with self reported<br />
deficits in IADLs among hospitalized subjects with no prior documentation<br />
of memory loss, cognitive impairment or dementia, supports<br />
the contention that cognitive impairments often go unrecognized<br />
among older veterans. Further studies are needed to assess the<br />
true extent of dementia under-recognition in this population.<br />
C90<br />
Outpatient medication reconciliation: Does accuracy improve if<br />
patients “brown bag” their medications?<br />
E. Sarzynski, S. Zhou, C. Rios-Bedoya, C. Luz. Michigan State<br />
University, East Lansing, MI.<br />
Background: Most medication reconciliation research conducted<br />
in outpatient settings has focused on general medical patients,<br />
where average age is 50-60. Among this cohort, medication discrepancies<br />
are prevalent. Studies often rely on multiple methods to determine<br />
what medications patients are actually taking, including patient<br />
recall, “updated” medication lists, medication containers (“brown<br />
bag” review), and phone interviews. There is little data to suggest that<br />
lists generated by these methods are equivalent.<br />
Methods: A study was conducted to assess whether providerdocumented<br />
medication lists were more accurate among patients that<br />
bring their medications to outpatient appointments (“brown-baggers,”<br />
BBs) compared with patients who do not bring their medications<br />
to appointments (“non-brown-baggers,” NBBs). Subjects were<br />
patients at a community geriatric clinic. Three medication lists were<br />
generated for each subject: 1) a provider-documented list in the patient’s<br />
chart (recorded list); 2) an immediate post-appointment list<br />
(point-of-care list); and 3) a post-appointment telephone interview<br />
(reported list, gold standard). Investigators identified prescriptions<br />
from other providers, non-oral medications, and over-the-counter<br />
medications in order to generate the most robust lists. Completeness<br />
and correctness 1 among these lists were compared between BBs and<br />
NBBs.<br />
Results: The study enrolled 46 cognitively intact elders who<br />
managed their own medications. Average age was 79.8 and 33% were<br />
men. Overall, 89% of subjects self-reported that their physician reviewed<br />
medications during the office visit, although significantly<br />
S162<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
fewer NBBs (62%) reported the same. Subjects reported taking an<br />
average of 9.9 medications, of which 5.7 were prescription drugs. Of<br />
the 46 subjects, 34 brought at least 1 of their medications to their office<br />
visit (BBs). Among BBs, only 38% brought all of the medications<br />
they reported taking. Additional analyses are pending, including assessment<br />
of recorded lists for completeness, correctness, errors of inclusion/exclusion,<br />
and comparison of recorded list accuracy between<br />
BBs and NBBs.<br />
Conclusions: Among elderly patients who “brown bag” their<br />
medications for outpatient primary care visits, most do not bring all of<br />
the medications that they report taking. Additional conclusions are<br />
pending.<br />
1 Nassaralla et al. Qual Saf Health Care. 2007. 16: 90-94.<br />
C91 Encore Presentation<br />
Group Medical Visits for Alzheimer’s Dementia Patients and Their<br />
Caregivers.<br />
G. Fujikami, S. Lai. Santa Clara Valley Medical Center, San Jose, CA.<br />
Introduction: Alzheimer’s Dementia (AD) is a growing terminal<br />
disease that affects not only the patients but also their loved ones and<br />
caregivers. Caregiver burden is common and can manifest as mental,<br />
physical, social, and financial problems. Current outpatient models of<br />
care poorly address dementia-related issues. Outpatient group visits<br />
for a variety of chronic diseases have been studied. We applied a similar<br />
model to a group of AD patients and their caregivers. Our hypotheses<br />
were that patients’ behavioral problems and caregiver burden<br />
would be more adequately managed and improved with a<br />
structured group medical visit facilitated by a physician and social<br />
worker.<br />
Methods: 10 patients diagnosed with AD and their caregivers<br />
from a community geriatric clinic agreed to participate in this observational<br />
study. Participants met monthly for 1.5 hours for 1 year.<br />
Group medical visits began with an educational talk of interest to the<br />
group followed by a series of interval histories focused on one patient-caregiver<br />
dyad at a time facilitated by the physician and medical<br />
social worker. Caregivers filled out the Zarit Caregiver Burden Interview<br />
and Neuropsychiatric Inventory Questionnaire before and after<br />
the year-long intervention to assess caregiver stress and the severity<br />
of patient’s behavioral problems. Paired t-tests were employed.<br />
Results: 5 patient-caregiver dyads had complete data sets. There<br />
was a trend toward decrease in caregiver burden and stress as well as<br />
in severity of patients’ behavioral problems at the conclusion of the<br />
group meetings although the results were not statistically significant<br />
(p=0.43 and p=0.09, respectively). 4 of the 5 dyads experienced improvement<br />
in caregiver stress and patient’s neuropsychiatric score. If<br />
the remaining outlier dyad was excluded, scores became statistically<br />
significant (p=0.05 and p=0.02, respectively). Even though that particular<br />
dyad experienced worsening of behavior and caregiver stress, the<br />
caregiver expressed an appreciation for the support from the group.<br />
Caregivers also felt more knowledgeable about AD and about resources<br />
in the community.<br />
Conclusion: Outpatient group medical visits focusing on AD education<br />
and care may be beneficial for reducing both patient behavioral<br />
problems and caregiver stress. Future directions include focusing<br />
on specific ethnic groups and assessing for differences in health<br />
care usage and medical costs.<br />
C92<br />
Gait Speed in Older Patients Admitted to an Acute Care for Elders<br />
Hospital Unit.<br />
G. Ostir, I. Berges. UTMB, Galveston, TX.<br />
Supported By: (R01-AG031178) from the National Institute on Aging<br />
Background. Assessment of mobility on geriatric hospital units<br />
relies primarily on subjective observation or patient self-reports. We<br />
objectively examined the gait speeds of hospitalized older patients.<br />
Methods. Prospective study of 322 patients aged ≥65 years admitted<br />
to a geriatric hospital unit from the community between<br />
March, 2008 and October, 2009. Associations between gait speed<br />
(m/s) and ADLs on length of stay and home discharge were examined<br />
in multivariable logistic and generalized linear regression models.<br />
Results. About two-thirds (206/233) of older patients completed<br />
the walk with a mean gait speed of 0.53 m/s. A strong gradient of association<br />
was found between increasing gait speed and shorter hospital<br />
stays. Older patients unable to complete the walk or with gait<br />
speeds
P OSTER<br />
A BSTRACTS<br />
C94<br />
Exploring the Relationship between Computerized Measures of<br />
Gait and Lower Extremity Function, Balance and Fear of Falling.<br />
E. McGough, H. J. Thompson, T. Le, S. Chaudhuri, G. Demiris.<br />
University of Washington, Seattle, WA.<br />
Background: Up to 40% of elders experience a fall at least annually,<br />
and of those who fall, up to 10% have a significant injury. Even<br />
when no injury occurs, older adults may develop fear of falling, resulting<br />
in self-imposed activity restriction, increasing the risk of falling.<br />
The present study explored the extent to which features of gait measured<br />
by computerized gait analysis system were correlated to measures<br />
of lower extremity function, balance, and self-reported fear of<br />
falling. The goal was to determine if the system was feasible to implement<br />
and would be a useful addition to the clinical armamentarium.<br />
Methods: Community dwelling elders were observed during the<br />
completion of the Short Performance Battery (SPPB), and the Berg<br />
Balance Scale (BBS). Participants were asked to walk at 1) usual pace<br />
and 2) as quickly as possible on the GAITRite walkway. Measures<br />
obtained included gait velocity, cadence, double support time, swing<br />
time variability, and stride length variability. Subjects completed the<br />
Falls Efficacy Scale (FES). Correlations between measures were analyzed.<br />
Results: Mean age of subjects was 88.4 years, 37.5% were male<br />
(N=16). Average SPPB score was 8.06 (SD 2.95) and average BBS<br />
score was 43.75 (SD 11.7). The average FES score reported was 9 (SD<br />
0.97) indicating low concern about falls in this sample despite an average<br />
score on the BBS indicating balance impairment (
P OSTER<br />
A BSTRACTS<br />
C98<br />
Effect of level of education on regular physical activity in an elderly<br />
population within a Military Health System.<br />
H. Kumar, T. Combest, S. George. Internal Medicine, Walter Reed<br />
National Military Medical Center, Bethesda, MD.<br />
Supported By: No funding to disclose<br />
Background:Previous research has shown that those with higher<br />
levels of education are also more physically active.The effect of level<br />
of education and participation in regular physical activity is currently<br />
unknown among patients aged 60 and older in a military health system.We<br />
conducted a descriptive study utilizing survey data from participants<br />
of a fall prevention program to determine the effect of level<br />
of education on physical activity.<br />
Methods:The study involved surveys of 135 community dwelling<br />
older adults aged 60 and older who were falls clinic participants. The<br />
surveys were conducted over three years.Physical activity and exercise(Regular<br />
physical activity, consisting of 3 days a week for 30 minutes<br />
and at least 2 days with muscular conditioning) was self reported<br />
in the initial screening of all participants in the falls clinic.Demographic<br />
information was analyzed using means and simple frequencies.<br />
Univariate analysis was performed using chi square and the<br />
Fisher Exact test where appropriate, with the primary outcome being<br />
reported exercise.Groups were stratified according to level of education<br />
(high school or less, college education, and graduate level education).Results:135<br />
surveys were collected over the three year study period.<br />
There were almost equal proportions of males (43%) and<br />
females (57%). The average age was 80 years. About one third of the<br />
participants (33%, n=46) reported that were exercising. Of those surveyed,<br />
47% (n=63) reported a high school education, 39% (n=53) a<br />
college education, and 14% (n=19) a masters degree or above.<br />
Among those that reported a high school education, 25% (n=16)<br />
were exercising; those with a college education, 45% (n=24) were exercising;<br />
and those with a masters or higher, 37% (n=7) were exercising.<br />
Univariate analysis did not show a significant difference among<br />
those that reported exercising based on gender (p=0.92). This held<br />
true when analyzed according to exercise and gender among those<br />
with a high school education (p=1.0), college education (p=1.0), and<br />
masters education (p=0.47). Univariate analysis was significant<br />
among groups stratified by education (p=0.03).<br />
Conclusion: Level of Physical activity was positively associated<br />
with the level of education amongst those over sixty in this military<br />
medical system. Lowest level of physical activity was associated with<br />
the high school and lower level education from the three groups.<br />
C99<br />
Can a real-time checklist, automatically generated by the electronic<br />
medical record, predict 30-day readmissions in hospitalized elderly?<br />
A. Khan, 1,2 K. Padua, 1 M. Malone, 1,2 M. Volbrecht, 1 P. Pagel. 1 1.<br />
Aurora Health Care, Milwuakee, WI; 2. University Of Wisconsin<br />
School of Medicine and Public Health, Madison, WI.<br />
Background<br />
Approximately one-fifth of Medicare beneficiaries are readmitted<br />
within 30 days. A software called “ACE Tracker” enables the<br />
health care team to quickly view risk factors that may be correlated<br />
with readmission at the bedside and identify vulnerable seniors in the<br />
hospital.<br />
Research Question<br />
Can a real-time “ACE Tracker” tool embedded in the electronic<br />
medical record (EMR) predict 30-day readmissions?<br />
Description of ACE Tracker and readmission risk tool:<br />
The Acute Care for Elders (ACE) Tracker is a real-time report<br />
that captures relevant data from the electronic medical record of<br />
older patients including: readmission risk score, number of medications,<br />
Morse fall score, urinary catheter usage, functional status,<br />
Braden and pain score.<br />
The readmission risk score is generated from the electronic<br />
medical record ranging from 0-20 based on presence of following risk<br />
factors.<br />
1) Admitting diagnoses: congestive heart failure (CHF), psychosis,<br />
other vascular surgeries, chronic obstructive pulmonary disease<br />
(COPD), pneumonia, gastrointestinal problems 2) Chronic diseases:<br />
CHF, COPD, diabetes mellitus, shortness of breath, skin ulcers,<br />
cirrhosis, leukemia, peripheral vascular disease, stroke, metastatic<br />
cancer, malnutrition, acute respiratory failure, rheumatoid arthritis,<br />
hypertension. 3) Demographics: hospital admission in prior 6 months,<br />
length of stay. 4) Social factors: functional status, medicaid, living situation<br />
and educational barriers.<br />
Validation of readmission risk tool<br />
The readmit risk score was determined for 227 patients at four<br />
hospital on one day and those patients were followed for thirty days<br />
afterwards.<br />
Forty one percent had a value score of 7 or more. Using a cutoff<br />
value of 7, sensitivity was 61%, specificity= 22%, positive predictive<br />
value=12%, negative predictive value= 77%. The positive and negative<br />
likelihood ratios were 0.8 and 1.8.<br />
Univariate and multivariate analyses were performed on variable<br />
predictors available on “ACE Tracker”. The risk of readmission<br />
was correlated with number of medications (p=0.03).<br />
Conclusion<br />
The number of medications variable on “ACE Tracker” correlates<br />
with readmission. The readmission risk score is better in identifying<br />
those who are not at risk for readmission.<br />
C100<br />
Evaluation of a computerized physician order entry (CPOE) alert<br />
program on prescribing of selected drugs among the elderly.<br />
L. E. Rios Rojas, 1,2 I. H. Gomolin, 1,2 P. Lester. 1. Geriatric Medicine,<br />
Winthrop University Hospital, Mineola, NY; 2. Medicine, State<br />
University of New York, Stony Brook, NY.<br />
Background:<br />
Emphasis is placed on reducing adverse drug reactions<br />
(ADR)among elderly. Knowledge of predisposition to ADRs or poor<br />
efficacy may improve prescribing. Diphenhydramine is commonly<br />
prescribed to decrease transfusion reactions or as a hypnotic. Studies<br />
show no efficacy for these indications and use predisposes to ADRs 1 .<br />
Antipsychotics are commonly prescribed in the hospital with potential<br />
for continued treatment despite increased risk of death associated<br />
with their use.<br />
Methods:<br />
Winthrop Hospital is a community teaching institution. CPOE<br />
became operational by 2009. In January 2011, a series of alerts were<br />
built into CPOE for selected medications and include links to relevant<br />
papers. We evaluated the effect of alerts on prescribing frequency<br />
by comparing the number of patients for whom these medications<br />
were prescribed during second quarters of 2009 and 2010 to<br />
the second quarter of 2011. Alerts were created for diphenhydramine,<br />
metoclopramide and all antipsychotics. Prescribing patterns<br />
were evaluated by ascertaining the pharmacy database which contained<br />
all medication orders since the introduction of CPOE. Frequency<br />
was adjusted for total admissions among those over 65 years<br />
during each quarter of interest. Chi square was used to compare pre<br />
and post frequencies.<br />
Results:<br />
Diphenhydramine prescriptions were reduced when comparing<br />
2011 vs. 2010 (38% reduction, RR 0.63, 95% CI = 0.58 to 0.67) p<br />
P OSTER<br />
A BSTRACTS<br />
with the least efficacy and greatest potential for short term<br />
ADR(e.g.diphenhydramine) may be most amenable to this type of<br />
alert system. Follow up studies to test such systems are warranted.<br />
Ref:<br />
1. Kennedy LD et al. Double-blind trial of acetaminophen vs<br />
diphenhydramine pretransfusion. Transfusion 2008;48:2285-91.<br />
2011 vs 2010 and 2009<br />
C101<br />
Assessment of knowledge gaps relevant to antibiotic stewardship<br />
among health care workers in long term care facilities.<br />
A. Krishna, 1,2 C. Biedron, 2 L. Mody, 5 P. Lichtenberg, 3 R. Severson, 2<br />
C. Cassidy, 3 C. M. Pickney, 4 K. S. Kaye, 1,2 T. Chopra, 1,2 M. Johnson. 4 1.<br />
Infectious Disease, Detroit Medical Center, Detroit, MI; 2. Infectious<br />
Disease, Wayne State University, Detroit, MI; 3. Nexcare Health<br />
System, Westland, MI; 4. Dominican Life Center, Westland, MI; 5.<br />
University of Michigan, Ann Arbor, MI.<br />
Background: Long Term Care Facilities (LTCFs) provide a<br />
major reservoir for multi-drug resistant organisms (MDROs), however<br />
standard Antibiotic Stewardship Programs (ASPs) are lacking in<br />
most LTCFs. The objective of our survey was to identify knowledge<br />
gaps of health care workers [HCWs] relevant to antibiotic stewardship<br />
(AS) at LTCFs.<br />
Methods: A 71 item voluntary survey was completed by health<br />
care workers in August 2011 at two LTCFs (Dominican Life Center a<br />
174 bed facility and Nexcare Health System, a 111 bed facility) in<br />
South East Michigan.<br />
Results: 44 HCWs (36 nurses, 4 infection control professionals, 2<br />
physician assistants and 1 staff physician) responded to the survey.<br />
Mean age of respondents was 42 + 14 and 93% were females. 61% of<br />
respondents believed that over prescribing of antibiotics was a very<br />
important cause of antibiotic resistance. Most respondents believed<br />
that prescriber education [51%], institution specific guidelines [54%]<br />
or accessible advice from infectious disease physician [58%] were effective<br />
interventions in reducing antibiotic resistance.<br />
100% of the respondents were familiar with methicillin-resistant<br />
Staphylococcus aureus [MRSA], 73% were familiar with vancomycin-resistant<br />
enterococci [VRE], 34% were familiar with Klebsiella<br />
pneumoniae carbapenemase [KPC] and 27% were familiar with<br />
extended-spectrum beta lactamase [ESBL]. Percentage of respondents<br />
confident in caring for a patient with MRSA, VRE, KPC and<br />
ESBL were 98, 95, 56 and 47 respectively. 30% and 26% of the respondents<br />
were not familiar with differences between definitions of<br />
colonization and infection respectively.<br />
Conclusions: Significant knowledge gaps among HCWs remain,<br />
specifically related to treating infections with KPCs and ESBLs. Educating<br />
HCWs on the differences between colonization and true infection<br />
is crucial. Formal ASPs are urgently needed in LTCFs to optimize<br />
antibiotic use and decrease colonization pressure by MDROs.<br />
C102<br />
Staff Responses to Resident-to-Resident Elder Mistreatment in<br />
Nursing Homes: Results of a Multi-Site Survey.<br />
A. Rosen, 1,2 M. S. Lachs, 1 K. Pillemer, 3 J. Teresi. 4,5 1. Medicine,<br />
<strong>Geriatrics</strong>, Weill Cornell Medical College, New York, NY; 2. Emegency<br />
Medicine Residency, New York Presbyterian Hospital, New York, NY;<br />
3. Human Development, Cornell University, Ithaca, NY; 4. Research<br />
Division, Hebrew Home at Riverdale, Riverdale, NY; 5. Columbia<br />
University Stroud Center and New York State Psychiatric Institute,<br />
New York, NY.<br />
Background: Resident-to-resident elder mistreatment (RREM)<br />
in nursing homes is a likely frequent phenomenon that may lead to<br />
severe outcomes for victims and perpetrators. Nursing home staff actions<br />
in response to this behavior may significantly mitigate its impact,<br />
but little is known about prevention and management strategies.<br />
Objective:To identify the most common staff responses to RREM<br />
Methods: We conducted this study as part of a large, multisite<br />
NIA-funded study attempting to estimate the prevalence of RREM<br />
in long term care facilities. For this project, the behavior of 1,688 residents<br />
of 5 nursing homes in New York City was evaluated. Certified<br />
nursing assistants primarily responsible for the care of residents<br />
under study in the parent project were asked about their responses to<br />
RREM during the previous two weeks. A modification of a validated<br />
instrument initially created to measure behavioral problems in nursing<br />
home residents was used.<br />
Results: Staff reported taking some action for RREM incidents<br />
involving 277 residents (16.4%) during the previous two weeks, and<br />
22 different responses were described. Most common responses were:<br />
physically intervening / separating residents (84), talking calmly to<br />
settle residents down (65), and verbally intervening to defuse the situation<br />
(59). Not included among staff responses was requesting consultation<br />
of a physician or psychiatrist.<br />
Conclusion: RREM is a potentially common and dangerous occurrence,<br />
and nursing home staff report many varied responses to it.<br />
Despite this, physicians and psychiatrists are seldom called upon to<br />
assist in RREM prevention and management. The effectiveness of existing<br />
responses and the potential for physician contribution needs to<br />
be examined in greater detail, and comprehensive evidence-based interventions<br />
should be developed.<br />
C103<br />
Care Delivery Consequences of Poor Quality Hospital-to-Skilled<br />
Nursing Facility Transitions: A Qualitative Study.<br />
B. King, 1 A. Kind, 2 A. Gilmore, 1 R. Roiland, 1 K. Pecanac, 1<br />
M. Hovanes, 1 N. Husain, 2 B. Bowers. 1 1. Nursing, University of<br />
Wisconsin, Madison, WI; 2. Medicine, University of Wisconsin,<br />
Madison, WI.<br />
Supported By: This study is funded by a NIA Beeson K23 Award<br />
Background: Poorly executed, transitions from the hospital to<br />
home can result in care fragmentation and lapses in patient safety.<br />
Research has focused on transitions from hospital to home with few<br />
studies on the highly vulnerable population: older adults transferring<br />
from the hospital to a Skilled Nursing Facility (SNF). Nurses in SNFs<br />
design a resident’s plan of care based on orders/information received<br />
from the hospital physician and nursing staff. The purpose of this<br />
study is to explore how nurses in SNFs transition care of residents admitted<br />
from hospitals, the barriers they experience and their views of<br />
the consequences of poor quality care transitions.<br />
Methods: This qualitative study utilized Grounded Dimensional<br />
Analysis, a variant of Grounded Theory. Registered nurses (n=9) employed<br />
at 3 SNFs in Wisconsin participated in focus groups with indepth<br />
interviews. Constant comparisons were used to expand the<br />
richness of the data. Data was analyzed using open, axial and selective<br />
coding.<br />
Results: Nurses in SNFs engage in a complex process of getting<br />
prepared to transition residents from hospital-to-SNFs. Despite this<br />
complex preparation, the information SNF nurses receive from the<br />
hospital is often incorrect or incomplete. Nurses cited multiple inadequacies<br />
of hospital discharge information, including regular problems<br />
with medication orders (including the lack of opiod prescriptions for<br />
pain), little information on resident’s psychosocial/functional history,<br />
and inaccurate information regarding the resident’s current health<br />
status. These inadequacies necessitated repeated call backs to the discharging<br />
hospital, created delays in care delivery to SNF residents<br />
(including delays in pain control), increased SNF staff stress and frustrated<br />
patients/family members. SNF nurses identified a specific list<br />
of information/components that they need to initiate a high-quality<br />
SNF plan of care.<br />
S166<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
Conclusions: Nurses in SNFs identify multiple quality deficiencies<br />
in hospital-to-SNF transitions, which they feel impact care. Future<br />
qualitative work with SNF nurses will assist in designing interventions<br />
to improve hospital-to-SNF care transitions.<br />
C104<br />
Primary Care Providers’ Experiences of Assessing and Minimizing<br />
Treatment Burden of Multimorbid Older Adults.<br />
B. Limm, 1 T. B. Hughes, 2 C. Boyd, 2 C. Rand. 2 1. John A. Burns<br />
School of Medicine, University of Hawaii, Honolulu, HI; 2.<br />
Department of Medicine, Johns Hopkins University School of<br />
Medicine, Baltimore, MD.<br />
Supported By: The Robert Wood Johnson Foundation Physician<br />
Faculty Scholars Program, and the Paul Beeson Career<br />
Development Award Program (NIA K23 AG032910, AFAR, The<br />
John A. Hartford Foundation, The Atlantic Philanthropies, The Starr<br />
Foundation and an anonymous donor).<br />
Purpose: Comorbidity is associated with poor outcomes including<br />
worse quality of life, mortality, disability, and complications from<br />
treatment. Older patients with multiple chronic conditions present<br />
substantial challenges to delivering medical care that is both patientcentered<br />
and guideline-based. Patients are often overwhelmed by the<br />
aggregate weight of all the actions and resources that they must devote<br />
to maintain their health. To gain insight into the experience of<br />
managing and treating multimorbid older adults, focus groups were<br />
conducted with 20 primary care physicians. Methods: Participants<br />
were asked to discuss how treatment burden affected the treatment<br />
plans and adherence of older adults with multiple chronic conditions,<br />
and how they made decisions with these patients. Focus group sessions<br />
lasted one to two hours in duration, were audio-taped and transcribed.<br />
Content analysis of data was performed for emergent themes<br />
by two independent investigators utilizing Atlas.ti 5.2. Results: Nearly<br />
all respondents reported challenges in the treatment of patients with<br />
multiple chronic conditions, particularly among patients with complex<br />
medication regimens, financial constraints, inadequate social<br />
support, and those in need of prolonged visits. Findings revealed the<br />
following emergent themes: physicians prioritized treatment decisions<br />
based on patient preferences, level of motivation, finances, disease<br />
severity, and level of social support; system regulations were barriers<br />
to the provision of comprehensive care; and non-physician office<br />
staff was a link to better patient care. Conclusions: Treatment burden<br />
presented challenges by affecting decision-making, actual treatment<br />
plans, and adherence among primary care providers. Research findings<br />
will contribute to the development of a screening tool for health<br />
care providers to assess the burden of prescribed treatments and recommendations<br />
among patients, promote communication between patients<br />
and physicians, and guide medical decision-making regarding<br />
treatment regimens.<br />
C105<br />
For a seat at the table, bring the table: A transdisciplinary model for<br />
aging-related advocacy in non-health policy.<br />
B. Williams, 1 C. Ahalt, 1 D. Faigman. 2 1. UCSF, San Francisco, CA; 2.<br />
UC Hastings, San Francisco, CA.<br />
Supported By: The Langeloth Foundation and The UCSF Program<br />
for the Aging Century<br />
Background: Policy decisions that are not health-specific may<br />
increasingly cause unintended health consequences for older adults.<br />
As a result, broader reaching geriatrics advocacy is needed. Health<br />
Impact Assessment (HIA) is an emerging conceptual model for identifying<br />
the health consequences of policies and communicating that<br />
information to policymakers. Using the HIA transdisciplinary approach,<br />
we convened a roundtable of national experts in geriatrics,<br />
correctional health, and the law to assess “Realignment,” a new criminal<br />
justice policy in California that will redistribute thousands of<br />
older adults from prisons to jails and community corrections. We explored<br />
HIA as a platform for geriatrics advocacy to develop recommendations<br />
to minimize the adverse consequences of Realignment<br />
for older adults.<br />
Methods: The 26 Roundtable participants received a short crossdisciplinary<br />
lecture to convey basic knowledge in 3 areas: geriatrics,<br />
older prisoner health, and Realignment. Next, transdiscipline working<br />
groups brainstormed critical issues to address.Facilitators grouped highpriority<br />
issues into 4 “topic areas” and assigned each to a transdisciplinary<br />
group to develop recommendations. Each group then presented<br />
their policy recommendations to the Roundtable to achieve consensus.<br />
Results: 26 of 32 (81%) invitees participated: Correctional physical<br />
or mental health providers (4), Law professors (4), Public Defenders<br />
or District Attorneys (3), Pre-Trial Diversion or Probation officials<br />
(2), Community service providers for the formerly incarcerated (2),<br />
Criminal justice experts (4), and Academic physicians/geriatricians<br />
(7). Consensus was reached on 6 recommendations: Collect age-stratified<br />
data; Improve access to incarceration alternatives; Develop geriatric<br />
assessments for arrest and incarceration; Expand peer-mentoring<br />
for older inmates; Improve transitions of care; Expand geriatric training<br />
for professionals in contact with older correctional populations.<br />
Each recommendation incorporated the expertise of multiple disciplines.<br />
95% of participants would participate in a similar future event.<br />
Conclusion: While many policy changes could affect older<br />
adults’ health, policymakers in non-health related fields rarely reserve<br />
a “seat at the table” for geriatricians. Our findings show that the<br />
HIA approach works as a mechanism for achieving transdiciplinary<br />
geriatrics advocacy in non-health-specific policy.<br />
C106<br />
Knowledge of and perceived need for evidence-based educational<br />
materials about antipsychotic medication safety by nursing home staff.<br />
C. Lemay, S. Foy, K. Mazor, L. R. Harrold, J. Donovan, A. Kanaan,<br />
B. A. Briesacher, J. Gurwitz, J. Tjia. <strong>Geriatrics</strong>, University of<br />
Massachusetts Medical School, Worcester, MA.<br />
Supported By: This study was funded by the Agency for Healthcare<br />
Quality and Research.<br />
Background: Given the widespread overuse of antipsychotic<br />
medications among US nursing home (NH) residents, we sought to<br />
identify knowledge of and perceived need for the AHRQ Comparative<br />
Effectiveness Research Summary Guide (CERSG) “Off-Label<br />
Use of Atypical Antipsychotic Drugs”.<br />
Methods: We conducted a baseline needs assessment with 12<br />
NHs participating in a randomized controlled trial evaluating evidence<br />
dissemination strategies. Using a mixed-methods approach, we<br />
conducted in-depth assessments of knowledge, attitudes, and practice<br />
behavior using telephone interviews with NH leadership (administrators,<br />
directors of nursing [DONs], and medical directors), and questionnaires<br />
with NH leadership, consultant pharmacists and direct care<br />
staff. Interviews were transcribed and verbatim responses were coded<br />
independently by 2 project staff. The coding scheme was revised after<br />
each round until substantial agreement (85%) was reached.<br />
Results: Interviews revealed that 70% of medical directors and<br />
46% of DONs & administrators believed that antipsychotics decreased<br />
agitation and controlled harmful behavior; 50% of medical<br />
directors and 7% of DONs & administrators reported knowledge of<br />
the increased risk of morbidity amd mortality due to atypical antipsychotics.<br />
Half of administrators and DONs expressed interest in receiving<br />
information for NH staff pertaining to understanding dementia<br />
and dementia-related behaviors, and 42% believed families would<br />
benefit from information about antipsychotic use for dementia-related<br />
behaviors. Questionnaire results were similar. When leaders<br />
were asked to list any risks associated with antipsychotic use for residents<br />
with dementia, only 17% reported death as a possible adverse<br />
event; licensed nursing staff (RN and LPNs) reported death 5% of<br />
the time. Over half of consultant pharmacists reported that their<br />
biggest barrier to improving medication use in challenging NHs was<br />
AGS 2012 ANNUAL MEETING<br />
S167
P OSTER<br />
A BSTRACTS<br />
physician resistance to accepting prescribing recommendations, including<br />
gradual dose reductions.<br />
Conclusions: The responses of the NH leaders, staff and consultant<br />
pharmacists suggest widespread knowledge gaps regarding antipsychotic<br />
benefits and risks, and suggest a need for increase evidence<br />
dissemination and broad organizational change.<br />
C107<br />
A Discrete Choice Analysis of Older Adults’ Preferences for<br />
Colorectal Cancer Screening Tests.<br />
C. E. Kistler, 1 T. Hess, 2 M. Pignone, 1 S. Hawley, 3 C. Lewis. 1 1.<br />
University of North Carolina at Chapel Hill, Chapel Hill, NC; 2.<br />
North Carolina State University, Raleigh, NC; 3. University of<br />
Michigan, Ann Arbor, MI.<br />
Supported By: This study was supported by the Agency for<br />
Healthcare Research and Quality K12 HS19468-01 (Kistler) and institutional<br />
support from the University of North Carolina at Chapel<br />
Hill and North Carolina State University.<br />
Background: Tailoring colorectal cancer (CRC) screening tests<br />
to older adults’ preferences may improve adherence to CRC screening.<br />
Given the heterogeneity of health status among older adults, different<br />
attributes other than mortality reduction may be key factors<br />
when deciding upon a preferred CRC screening test. This study aims<br />
to describe older adults’ preferences for colorectal cancer screening<br />
test attributes via a discrete choice analysis.<br />
Methods: We conducted a discrete choice analysis among adults<br />
aged 70 and older who volunteered at either a local Family Medicine<br />
clinic or a local research site. Participants were first asked to rank<br />
four key attributes in order of importance: mortality reduction, risk of<br />
complications, test frequency, and testing procedure. Next, in 10 different<br />
scenarios, they were asked to choose between two hypothetical<br />
CRC screening tests. Each hypothetical test contained varying levels<br />
of the four key attributes. Responses were used to calculate the overall<br />
importance of these attributes. These results were then compared<br />
to the initial ranking exercise.<br />
Results: Preliminary results include 63 participants with a mean<br />
age of 76 years (range 70-90) of whom 51 were White, 11 African<br />
<strong>American</strong>, and 1 <strong>American</strong> Indian. All but 3 participants had been<br />
screened at least once for colorectal cancer. Initially, 44% of participants<br />
(28/63) ranked mortality reduction as the most important test<br />
attribute; 44% (28/63) ranked risk of complications second; 40%<br />
(25/63)ranked test frequency third; and 48% (30/63) ranked testing<br />
procedures as the least important attribute. A discrete choice analysis<br />
determined the attribute importance from most to least was: testing<br />
procedure (28%), test frequency (27%), risk of complications (23%),<br />
and mortality reduction (23%).<br />
Conclusion: Older adults appear to have differing preferences<br />
for CRC screening test attributes depending on how the information<br />
is presented. A discrete choice analysis appears to shift older adults’<br />
preference away from prioritizing mortality reduction and towards<br />
other test attributes.<br />
C108<br />
Qualitative Approach to Understanding Medication Challenges<br />
among Older Adults after Hospital Discharge.<br />
D. Liu, 1,2 S. Rennke, 1 H. Chi, 1 M. Steinman. 1,2 1. Internal Medicine,<br />
UCSF, San Francisco, CA; 2. <strong>Geriatrics</strong>, SF VA Medical Center, San<br />
Francisco, CA.<br />
Supported By: Supported in part by NIH grant 1K23-AG030999<br />
(PI: Steinman, M)<br />
Background: Patients age 65 years and older have a 19% risk of<br />
30 day readmission after hospital discharge, and medication safety<br />
plays an important role in reducing this risk. We piloted a telephonebased<br />
qualitative study to better understand the needs older adults<br />
have with medications after recent hospital discharge.<br />
Methods:The study population included patients 2-4 weeks after<br />
discharge from the general medicine service at an academic teaching<br />
hospital. Inclusion criteria were age ≥65 years, English-speaking, and<br />
discharged home with ≥ 5 medications. We used semi-structured,<br />
open-ended questions assessing problems with medication since discharge,<br />
resources patients have, and what additional help they need.<br />
Transcriptions were analyzed from a grounded theory approach.<br />
For participants who answered “no problems,” we used common scenarios<br />
based on the medical literature as prompts. Concurrent with<br />
our study, hospital discharge nurses attempted to reach all participants<br />
with a standard post-discharge telephone call that included 2<br />
medication questions (Did you fill your prescriptions? Did you understand<br />
your medication instructions?).<br />
Results: We have conducted 9 interviews. All interviewees endorsed<br />
some medication-related problem including adherence, titration,<br />
side effects, and financial difficulty. Three initially denied any<br />
problems, but in response to prompts did endorse at least one. Six of<br />
the participants received the standard post-discharge phone call, but<br />
none of these revealed any medication problems. Participants identified<br />
needs at discharge along themes of lack of communication (“I<br />
don’t think anyone has any time to discuss with me before I left”) and<br />
inclusion of family in discharge planning. Four participants denied<br />
needing any additional help at discharge with reasons being family<br />
support or confidence in self ability. The latter group, however, qualified<br />
their response by saying they did “not yet” need assistance.<br />
Conclusion: Our study suggests that the brief post-discharge<br />
phone call after discharge fails to identify common medication problems<br />
among older patients. The themes of family and communication<br />
suggest focal points for future study and design of discharge programs.<br />
Even participants who denied needing assistance still qualified<br />
their response with a “yet,” suggesting needs are a moving target.<br />
C109<br />
Effects of a randomized controlled trial comparing reimbursement<br />
of care coordination to pay-for-performance in primary care.<br />
D. A. Dorr, 1 G. S. Olsen, 1 M. Pierre-Jacques Williams, 1<br />
C. P. Brunker. 2,3 1. Medical Informatics & Clinical Epidemiology,<br />
OHSU, Portland, OR; 2. <strong>Geriatrics</strong>, Intermountain Healthcare, Salt<br />
Lake City, UT; 3. <strong>Geriatrics</strong>, University of Utah, Salt Lake City, UT.<br />
Supported By: The John A. Hartford Foundation, AHRQ<br />
Background:Addressing patients’ longitudinal coordination needs<br />
may reduce hospitalizations and improve quality while lowering costs,<br />
particularly for older adults with multiple chronic illnesses. Yet, most<br />
payment structures are fee-for-service or quality measure-based rather<br />
than coordination-based. We tested the hypothesis that incentives for<br />
care coordination would increase coordination activities and reduce utilization<br />
more than traditional quality measure-based pay-for-performance<br />
in a cluster randomized controlled trial of 6 primary care clinics.<br />
Methods: Clinics were randomized into two arms: 3 received payment<br />
for improvement on a self-selected set of 5 validated quality measures<br />
(quality) and 3 received payment for assessment, education, goal<br />
setting, motivational interviewing, and communication activities (coordination).<br />
All clinics had designated, trained care managers and health<br />
IT that provided interactive quality reports, tracked and reminded<br />
about services, and facilitated risk-based population management. Patients<br />
were eligible if seen twice during the 3 year study period. Patients<br />
were analyzed in two groups: 1) preselected based on risk of hospitalization<br />
and death; 2) enrolled by the care manager. Descriptive statistics<br />
were computed to compare quality and care coordination encounters.<br />
Results: 27,001 patients were eligible for the study; 18% were<br />
preselected as high risk; 15% were enrolled in care management. In<br />
all, 20% of patients were >65; however, they were 50% of high risk<br />
and 36% of referred patients. Coordination clinics performed 1.8<br />
times the coordination activities, including 4.3 times the education,<br />
3.1 times the communication, and 3.9 times the motivational interviewing<br />
as quality clinics. Quality clinics increased their absolute performance<br />
on selected quality measures by 10.8% vs 5.1%.<br />
S168<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
Conclusion: The focus of incentives motivated clinic activity, but<br />
the impact of care coordination incentives was greatest. Information<br />
about which had greater effect on utilization, patient outcomes, and<br />
clinic quality metrics is required to determine how to alter health policy.<br />
C110<br />
Person and Organizational Correlates of HEDIS High-Risk Drug<br />
Utilization within Veteran’s Administration Nursing Homes.<br />
D. M. Dosa, 2,1 O. Intrator, 2,1 G. Kochersberger, 3 P. Katz. 4 1. Medicine,<br />
Brown University, Providence, RI; 2. Providence Research<br />
Enhancement Award Program, Providence VA Medical Center,<br />
Providence, RI; 3. Canandaigua VAMC, Rochester, NY; 4. Baycrest<br />
Hospital, Toronto, ON, Canada.<br />
Supported By: Veteran’s Administration<br />
Objectives: A common error described in the literature is the<br />
utilization of high risk medications in the elderly—a population most<br />
likely to experience morbidity. This study evaluates the use of medications<br />
classified by the Healthcare Effectiveness Data Information<br />
Set (HEDIS) as high risk in VA Nursing Homes (NHs) and identifies<br />
any patient/organizational correlates of high use.<br />
Methods: Minimum Data Set (MDS) records from 2009 were<br />
merged with VA Pharmacy Data to identify residents of VA NHs who<br />
received at least one medication on the HEDIS high risk list. Utilizing<br />
HEDIS medication use as a quality indicator (QI), the MDS was<br />
then used to identify patient specific correlates of high use (e.g. demographics,<br />
cognitive status, and functional status.) Organizational<br />
practices within specific NHs were identified from a 2010 VA NH<br />
medical director survey. Descriptive statistics (Chi- Square, t-tests)<br />
were used to test associations between person level variables and a<br />
Poisson Regression analysis was conducted to test associations of organizational<br />
characteristics with the QI.<br />
Results: Of 43,577 veterans residing in any of 132 NHs, 2666<br />
(6.4%) received at least 1 HEDIS medication. Females were more<br />
likely to receive a HEDIS drug (10.5 versus 5.9%). Those with better<br />
cognition (7.1%) were more likely to receive a HEDIS drug compared<br />
to those with intermediate(4.6%) or severe cognitive status (4.0%).<br />
Conversely, residents were more likely to get a HEDIS medication as<br />
their functional status declined on a 28-point scale. Among organizational<br />
correlates, increased HEDIS medication use was noted at<br />
homes with increased hospice care, short stay rehabilitation, low cognitive<br />
impairment, and higher acuity. Decreased HEDIS use was associated<br />
with the perception of greater physician supervision by the medical<br />
director (Estimate: -0.69, 95% confidence interval (CI) -0.94 to<br />
-0.43) and by the perception of better NH leadership (Estimate: -0.47;<br />
95% CI: -0.73 to -0.21).All estimates were significant at less than 1%.<br />
Conclusions: The HEDIS QI appears to be important in targeting<br />
veterans receiving high risk medications in VA NHs. Certain subpopulations<br />
are at higher risk for receiving HEDIS medications and<br />
can be targeted for quality improvement efforts.<br />
C111<br />
Food Access in Aging Adults with Impaired Mobility.<br />
D. L. Huang, 1,2 D. E. Rosenberg, 3 S. D. Petz, 4 B. Belza. 4,5 1. Veterans<br />
Affairs Puget Sound Health Care System, Seattle, WA; 2. Division of<br />
Gerontology and Geriatric Medicine, University of Washington,<br />
Seattle, WA; 3. Group Health Research Institute, Seattle, WA; 4. School<br />
of Nursing, University of Washington, Seattle, WA; 5. Health<br />
Promotion Research Center, University of Washington, Seattle, WA.<br />
Supported By: FUNDING: CDC Prevention Research Centers<br />
Program, through a grant to the University of Washington Health<br />
Promotion Research Center (cooperative agreement #U48-DP001911).<br />
Dr. Huang receives salary support from the Department of Veterans<br />
Affairs Advanced Fellowship in <strong>Geriatrics</strong>.<br />
BACKGROUND: Food access is essential and may be difficult<br />
for aging adults, especially those with impaired mobility. Many aging<br />
adults may not live near locations where they can access food outside<br />
their residence, such as grocery stores. The purpose of this study was<br />
to determine where aging adults access food and built environment<br />
factors affecting their ability to access food.<br />
METHODS: Thirty-five older adults living in the Seattle, WA<br />
metropolitan area who used assistive mobility devices completed<br />
in-depth interviews focusing on built environment barriers and facilitators<br />
in their neighborhood and wore a Global Positioning System<br />
(GPS) device for 3 days. Qualitative data analysis of 20 interviews<br />
to date was completed to date by 2 researchers using Atlas.ti<br />
software.<br />
RESULTS: Participants’ mean age was 66.8 years (range 50-86<br />
years), 9 (25.7%) lived in low-income ( 80 years<br />
old, but evidence-based guidelines specific to the elderly are scarce.<br />
OBJECTIVES To correlate serious episodes of hypoglycemia<br />
(blood sugar < 65 with symptoms) with patient-specific factors and<br />
medication use. METHODS Prospectively designed retrospective<br />
explicit electronic chart review of 140 patients randomly selected out<br />
of a pool of 525 consecutive patients with diabetes that visited our<br />
clinic 8/1-10/30/2010. We excluded subjects as follows: age < 65<br />
(n=3), mislabeled as diabetics (n=6), no follow up visit<br />
4/1–10/30/2011 (n=6), or no follow up HbA1c after enrollment<br />
(n=8). Serious hypoglycemia was defined as blood sugar less than 65<br />
with reported symptoms. Chi 2 and logistic regression techniques<br />
were used to investigate the efficacy (levels of HbA1c, LDL) and<br />
safety (serious hypoglycemia) of chosen medication classes and<br />
achieved therapeutic goals. RESULTS The mean age was 78±8 years<br />
(range 65-100). Other baseline characteristics and univariate results<br />
are shown in table 1. 96% were on statins, yet only 32% had an LDL<br />
P OSTER<br />
A BSTRACTS<br />
Table 1. Effect of co-morbidities and medications on 1-year rate of<br />
hypoglycemia in elderly patients<br />
§ Comparison of hypoglycemia rates with vs. without factor<br />
C113<br />
Baby Boomers Caring for Aging Parents: Pilot Data from a<br />
Validated Survey Measuring Caregiving Effect on Attitudes,<br />
Expectations and Healthcare Practices of Caregivers.<br />
D. Kaplan, 1 L. Kaplowitz, 2 M. Reid, 1 E. Finkelstein. 1 1.<br />
Medicine/<strong>Geriatrics</strong>, Weill Cornell Medical College, New York, NY; 2.<br />
State University of New York, Buffalo, NY.<br />
Purpose: Over 45 million adult children provide informal care<br />
to aging parents. The effect of caregiving on caregiver’s health and<br />
well-being has been well documented. However, little information exists<br />
regarding how providing care for an aging parent affects caregivers’<br />
attitudes, expectations and behaviors toward their own aging.<br />
This study uses a novel, validated survey instrument that aims to expand<br />
our knowledge of caregiving and its effects in those particular<br />
domains. Pilot data are reported here.<br />
Methods: The Caregiver’s Aging Trajectory Survey (CATS) is a<br />
41-item instrument that measures respondents’ attitudes of and expectations<br />
for aging, plans for aging and healthcare practices of caregivers<br />
providing or who have provided care to aging parents. CATS<br />
also captures relevant data about caregivers and the quality and extent<br />
of the caregiving experience. Participants are being recruited at<br />
an urban academic geriatric practice, as well as at local caregiver support<br />
groups. Our target “n” is 100 caregivers and 100 non-caregiver<br />
controls.<br />
Results: As of 12/5/11, we have collected data from 58 adult<br />
child caregivers. Mean age is 56 (SD +/- 5), 82% female, 58% married,<br />
77% Caucasian. Time spent caregiving ranges from 40 hrs/wk.<br />
Participants are well-educated (64% college graduates), 58% rate<br />
their own health as excellent or very good; 40% report feeling depressed.<br />
Caregiver strain was reported as severe in 55% of participants<br />
using the Caregiver Strain Index (> or = 7 on a scale of 1-13).<br />
Caregiver’s expectations regarding aging (as per Expectations Regarding<br />
Aging Survey-12, which is on a scale of 0-100, 0=lowest) are<br />
low overall – mean of 34 for physical health and 36 for cognitive function.<br />
Though 78% reported having a routine check-up in the past<br />
year, only 10% reported having advanced directives, 24% a living<br />
will, and 29% a health care proxy. 24% of participants indicated that<br />
they had long-term care insurance, and of those who had not, only 18<br />
indicated that they may plan to in the future.<br />
Conclusions: The purpose of the present study is to gain a better<br />
understanding of the nuanced effects of caregiving on the aging<br />
child caregiver. This can in turn help the health care system provide<br />
better care to the growing number of baby boomers who are informal<br />
caregivers.<br />
C114<br />
How similar are Medicaid’s PACE payments to its outlays on<br />
alternative long-term care for comparable patients?<br />
G. D. Wieland, 1 B. Kinosian, 2 E. Stallard. 3 1. U South Carolina,<br />
Columbia, SC; 2. Department of Medicine, University of Pennsylvania<br />
School of Medicine, Philadelphia, PA; 3. Center for Population Health<br />
and Aging, Duke University, Durham, NC.<br />
Supported By: None to declare.<br />
Background. In rebalancing from nursing homes [NH], states<br />
are increasing access of NH-certified dual eligibles to aged/disabled<br />
waiver programs, and—in 29 states—PACE. Evaluations using community<br />
controls suggest Medicaid’s [MA] PACE capitation exceeds<br />
its spending for alternative fee-for-service [FFS] care. By design, these<br />
studies did not compare PACE payments to outlays for patients with<br />
equivalent health deficits/needs in both waiver and NH. <strong>Here</strong>, we develop<br />
a multiattribute model of PACE-eligible admissions to waiver,<br />
NHs and PACE to test whether MA PACE payments are lower than<br />
FFS outlays for equivalent controls. Methods. Using grade-of-membership<br />
methods, we model health deficits for duals >= 55 admitted<br />
from 1997 to 2005 (n=3,988) using SC data. Pure patient types, membership<br />
vectors, and program type prevalences are described. We calculate<br />
a PACE blend-—fitting PACE between waiver & NH entrants.<br />
FFS utilization was measured to 1-year from admission and converted<br />
to attrition-adjusted FY05$ outlays. The PACE blend locates<br />
FFS estimates for PACE entrants between mean waiver and NH payments,<br />
adding the waiver base cost. PACE’s capitation is then compared<br />
to the expenditure prediction. Results. Four clinical types describe<br />
population health deficits/service needs. The waiver cohort is<br />
most represented among the least impaired type (1: 47.1%), NH entrants<br />
in the most disabled (4: 38.5%). PACE’s highest prevalences<br />
were in Types 3 (32.7%) & 2 (32.3%). PACE’s blend probabilities are:<br />
Waiver—0.5602; 95% c.i., 0.5472, 0.5732, and NH—0.4398; 0.4268,<br />
0.4528. MA attrition-adjusted 1-year per capita payments for waiver<br />
& NH were $4,177 & $77,945. The PACE blend is 43.98% of the difference<br />
atop the waiver base, i.e., $36,620 (95% c.i.: $35,662, $37,580).<br />
PACE’s MA capitation was $27,648—28% below the lower limit of<br />
predicted FFS payments for the PACE cohort. Discussion. PACE entrants<br />
in SC comprise a 56/44% blend of the health deficits/service<br />
needs of waiver & NH patients. PACE’s capitation was well below<br />
outlays for equivalent patients in alternative placement—a substantial<br />
savings for the MA program. Further, our methods provide an element<br />
of PACE rate setting which states presently lack.<br />
C115<br />
Hospitalizations and Emergency Room Visits in Older Adults<br />
Receiving Care Transition: a Cohort Study.<br />
H. Syed, K. Swanson, A. Rahman, J. Naessens, N. Shah, G. Hanson,<br />
P. Takahashi . Mayo Clinic, Rochester, MN.<br />
Background: Management of care transitions from the hospital<br />
to home is an important area of need for older adults. It has been<br />
widely recognized that older adults are readmitted to the hospital at<br />
high rates which can potentially be reduced. Our clinical practice has<br />
initiated a nurse practitioner (NP) care transitions program (CTP) to<br />
help address the immediate needs of the patient after hospital stay.<br />
The aim of this study was to determine the change in number of hospitalizations<br />
from the 60 days prior to enrollment in CTP to 60 days<br />
after enrollment in CTP.<br />
Methods: This was retrospective cohort study of patients within<br />
CTP from March 2011-September 2011. Patients discharged from the<br />
hospital were selected for CTP based on risk stratification using the<br />
elder risk assessment index. The intervention included a home visit by<br />
the NP after discharge (within 7 days as goal). Primary outcomes included<br />
a within group comparison of average hospitalizations, number<br />
of hospital days and average emergency room visits for all subjects.<br />
McNemars test or paired t tests were used for analysis.<br />
Results: 95 subjects were enrolled in the cohort. The average<br />
number of hospitalizations prior to CTP enrollment was 1.03 (SD<br />
0.7) compared to 0.38 (SD 0.6) after enrollment (p value
P OSTER<br />
A BSTRACTS<br />
flect the natural course of healing for these individuals. This within<br />
group study points to a potentially better model of care for at-risk<br />
older adults.<br />
C116<br />
Discharge, Drugs, and Discrepancies: The Pharmacological<br />
Intervention in Late Life (PILL) Project.<br />
A. M. Paquin, 1,2 T. Kostas, 1,3 M. Salow, 1,2 J. L. Rudolph. 1,3 1. Geriatric<br />
Research Education and Clinical Center (GRECC), VA Boston<br />
Healthcare System, Boston, MA; 2. Pharmacy Department, VA<br />
Boston, Boston, MA; 3. Aging, Brigham and Women’s Hospital,<br />
Boston, MA.<br />
Supported By: Department of Veterans Affairs, Office of <strong>Geriatrics</strong><br />
and Extended Care (GEC) Patient-Centered Alternatives to<br />
Institutional Care Initiative<br />
Background: Hospital discharge, polypharmacy, and medication<br />
discrepancies pose risks for elders, especially when they occur simultaneously.<br />
The Pharmacological Intervention in Late Life (PILL)<br />
Project is a quality improvement program that provides proactive<br />
medication follow-up after a hospital stay. We aim to reduce acute<br />
care utilization by addressing medication discrepancies and difficulties<br />
in older patients.<br />
Methods: This project targeted veterans >65 years old with<br />
cognitive impairment, who were discharged home after an inpatient<br />
admission at VA Boston. Patients received PILL pharmacist followup<br />
after discharge which included: telephone medication review<br />
and evaluation of regimen for pharmaceutical care issues (i.e. dosing,<br />
drug interactions, etc.) and medication discrepancies. Medication<br />
discrepancies were collected by comparing discharge medication<br />
lists and actual medication orders. Patients were followed 60<br />
days after discharge for the primary outcome of acute care utilization<br />
(readmission, emergency department or urgent care visit) or<br />
death.<br />
Results: Of 285 eligible veterans, 242 patients with a mean age<br />
of 78.9 ± 8.0 were reached by PILL pharmacist after discharge. Patients<br />
with PILL follow-up were not significantly different than<br />
those without (n=43) with respect to age, number of medications,<br />
length of stay, or discrepancies. The mean number of discharge medications<br />
was 15.1 ± 5.8, with 2.9 ± 2.3 medication changes per patient.<br />
Among veterans receiving PILL intervention, fifty-nine percent<br />
(59%, n=143) had at least 1 medication discrepancy, with an<br />
average of 1.5 ± 2.1 discrepancies per patient. After adjustment for<br />
number of medications and discrepancies, patients with PILL follow-up<br />
had a 24% relative risk reduction in acute care utilization or<br />
death compared to those with usual care (RR 0.76, 95% CI 0.58-<br />
0.98).<br />
Conclusion: Cognitively-impaired elders were discharged<br />
home with medication lists characterized by polypharmacy, frequent<br />
medication changes, and discrepancies. The PILL Project<br />
demonstrated that pharmacist telephone medication review and<br />
reconciliation results in a significant reduction in acute care utilization<br />
or death after hospital discharge. Pharmacist post-discharge<br />
medication follow-up shows promise as a successful model<br />
of care.<br />
C117<br />
The VA Coordinated-Transitional Care (C-TraC) Program: A<br />
Registered Nurse Telephone-Based Initiative to Improve Transitions<br />
for Hospitalized Veterans with Dementia and Other High-Risk<br />
Conditions.<br />
A. J. Kind, 1,2 L. Jensen, 2 S. Barczi, 1,2 A. Bridges, 1,3 R. Kordahl, 3<br />
M. Smith, 1 S. Asthana. 1,2 1. Univ of Wisconsin, Madison, WI; 2.<br />
Madison VA Geriatric Research Education and Clinical Center<br />
(GRECC), Madison, WI; 3. William S Middleton VA Hospital,<br />
Madison, WI.<br />
Supported By: This project was supported by a VA Transformation-<br />
21 Grant and by a National Institute on Aging Beeson Career<br />
Development Award (K23AG034551, National Institute on Aging,<br />
The <strong>American</strong> Federation for Aging Research, The John A.<br />
Hartford Foundation, The Atlantic Philanthropies and The Starr<br />
Foundation). Additional support was provided by the University of<br />
Wisconsin School of Medicine and Public Health’s Health<br />
Innovation Program, and the Community-Academic Partnerships<br />
core of the University of Wisconsin Institute for Clinical and<br />
Translational Research (UW ICTR), grant 1UL1RR025011 from<br />
the Clinical and Translational Science Award (CTSA) program of<br />
the National Center for Research Resources, National Institutes of<br />
Health.<br />
Background: The Accountable Care Act encourages dissemination<br />
of evidence-based transitional care programs designed to improve<br />
patient safety and outcomes after hospital discharge, but no existing<br />
program fully addresses the challenges of distance, dementia<br />
and patient vulnerability common in a Veterans Affairs (VA) hospital<br />
setting. Our objective was to test the feasibility of C-TraC — a low-resource,<br />
nurse-led, telephone-based program which builds upon Coleman’s<br />
transitional care model and is designed to improve care coordination<br />
and outcomes in hospitalized veterans with dementia and<br />
other high-risk conditions.<br />
Methods: C-TraC launched at Madison VA Hospital in April<br />
2010. Hospitalized veterans discharged to community settings had<br />
to have dementia/delirium/cognitive impairment, or had to live<br />
alone or have prior hospitalizations and be >65 years to be eligible.<br />
Veteran characteristics, process measures and outcomes were<br />
abstracted from the medical record for all eligible patients during<br />
the 6 months prior to the intervention launch (N=144) and for patients<br />
enrolled in C-TraC during its first 6 months of operation<br />
(N=116).<br />
Results: In the first 6 months, C-TraC successfully enrolled 116<br />
veterans using 1.0 FTE nursing staff. No patients refused enrollment.<br />
52% of C-TraC veterans had medication discrepancies detected/rectified<br />
during the 48-72-hour post-discharge phone call, averaging 2 discrepancies/veteran<br />
(range 0-9). As compared to usual care, C-TraC<br />
veterans were more likely to leave the hospital with a scheduled follow-up<br />
appointment (85% vs 60%, p
P OSTER<br />
A BSTRACTS<br />
C118<br />
Patient and Family-Centered Rounds on a Geriatric Inpatient<br />
Service: Patient Perspectives.<br />
A. M. Stecher, 1 J. D. Schlaudecker. 1,2 1. University of Cincinnati,<br />
Cincinnati, OH; 2. Department of Geriatric Medicine, University of<br />
Cincinnati, Cincinnati, OH.<br />
Supported By: Funded with support from a Geriatric Academic<br />
Career Award and the <strong>American</strong> Federation of Aging Research<br />
Medical Student Training in Aging Research.<br />
Background: While well studied in the pediatric setting, little is<br />
known about the application of patient- and family-centered rounds<br />
(PFCR) to the geriatric population, but the potential for care improvement<br />
is great. PFCR is a model for empowering patients and<br />
families and improving communication and care in the hospital. In<br />
contrast to traditional rounding, PFCR occurs at the bedside and actively<br />
includes patients and families as well as other members of the<br />
healthcare team.<br />
Methods: Fourteen adults (mean = 68 years) admitted to the<br />
Christ Hospital received either traditional care (n=4) or PFCR<br />
(n=10) during their stay. Patients and their families were asked to<br />
participate in semi-structured interviews focused on:<br />
-communication with physicians<br />
-satisfaction<br />
-clarity of DC instructions<br />
Follow-up interviews via phone were performed two to four<br />
weeks following discharge.<br />
Results: Statistical comparison of the Likert ratings between patients<br />
receiving PFCR and traditional care were inconclusive due to<br />
small sample sizes; however, descriptive statistics found no apparent<br />
differences between these groups. During the interviews, patients expressed<br />
very positive opinions about care under PFCR.<br />
“I felt I wasn’t alone and someone was in my corner, trying to<br />
find out what was happening in my body. It was great to get an update<br />
on a daily basis…It was comforting, really, to have so many heads in<br />
on it.”<br />
Patient 514 - PFCR<br />
“In the past, you get one doctor and you feel like you are taking<br />
up their time, whereas when there are a lot of people here you feel<br />
like they are here as a group to answer questions…I really like that!”<br />
Daughter 511 - PFCR<br />
Conclusions: The positive responses of those receiving PFCR indicate<br />
that PFCR can lead to positive care experiences for geriatric<br />
patients and their families. The similar Likert ratings of care quality<br />
statements between those receiving PFCR and traditional care<br />
demonstrates that PFCR is at least as effective in providing quality<br />
care as traditional care. However, the positive interview responses of<br />
patients and families receiving PFCR suggest that PFCR may result<br />
in higher satisfaction among geriatric patients and their families.<br />
More research is needed with a larger sample to investigate how<br />
PFCR outcomes and satisfaction compare to traditional care.<br />
C119<br />
The PACE Approach to Keeping Older Adults with Dementia in<br />
Private Homes.<br />
A. Dunbar, 1,2 K. Ward, 1 A. Beeber. 1,3 1. Cecil G Sheps Center for<br />
Health Services Research, Chapel Hill, NC; 2. School of Medicine, The<br />
University of North Carolina at Chapel Hill, Chapel Hill, NC; 3.<br />
School of Nursing, The University of North Carolina at Chapel Hill,<br />
Chapel Hill, NC.<br />
Supported By: AFAR Medical Student Training in Aging Research<br />
Program 2010 (Recipient: Anne Dunbar), NC TraCS CTSA Pilot<br />
Award (Awardee: Dr. Beeber), Building Interdisciplinary Careers in<br />
Women’s Health K12 Career Development Award (Awardee: Dr.<br />
Beeber)<br />
Background: Evidence suggests that the multidisciplinary care<br />
provided by Programs of All-inclusive Care for the Elderly (PACE)<br />
can postpone or prevent nursing home placement for older adults.<br />
PACE participants with dementia are one of the most challenging<br />
subpopulations within PACE because they require complex care<br />
management. Thus, we aim to examine the challenges PACE sites<br />
face and the services they have found to be the most useful in successfully<br />
keeping PACE participants with dementia in private homes.<br />
Methods: This analysis examines the data from a web-based survey<br />
of 32 PACE sites from 19 different states. The survey respondents<br />
were composed of leadership personnel within the PACE sites. Three<br />
independent coders performed a qualitative content analysis, reviewing<br />
text responses from two questions: 1)What are the biggest challenges<br />
your program faces when trying to keep participants with dementia<br />
in a private home? and 2)What have you found to be the most<br />
useful for helping these participants stay at home? The text responses<br />
were coded for similarities and then were categorized. The research<br />
team met to discuss similarities and differences found during coding<br />
and reached consensus on the main categories for each question.<br />
Results: Survey respondents reported that issues relating to<br />
family caregiving are the biggest challenges faced when trying to<br />
keep participants with dementia in a private home. Availability and<br />
commitment of the family, stress and burden of caregiving, caregiver<br />
burnout, and PACE providing support for the family were all identified<br />
as challenges. Respondents identified safety concerns, behavioral<br />
changes, medication management, cost, staffing, PACE in-home services,<br />
importance of early enrollment, and care plan compliance as barriers<br />
to keeping these participants in private homes. Respondents reported<br />
that day center attendance was the most useful for helping<br />
participants with dementia stay at home as well as home health, family<br />
caregiver support, personal companions, dementia specific strategies,<br />
and respite services.<br />
Conclusions: The results from this work will provide information<br />
about the types of services used to provide care for PACE participants<br />
with dementia. Conclusions will include recommendations for<br />
future practice and research.<br />
C120<br />
Interventions to Prevent Hospitalizations of Elderly Patients:<br />
Quality Care with Cost Benefit.<br />
A. Kaul, M. Bansal, R. Bhandari. Wyckoff Heights Medical Center,<br />
Brooklyn, NY.<br />
Background:<br />
Repeated hospitalizations of geriatric patients stigmatize the<br />
quality of care and place an added strain on the economics of healthcare<br />
delivery. Over the past two years at Wyckoff Heights Medical<br />
Center (WHMC), we have established three different heath care delivery<br />
goals for our geriatric patients; 1) extend services to home<br />
bound patients, 2) carefully survey and manage nursing home (NH)<br />
residents, and 3) promote palliative care services and counseling.<br />
These agendas provide high quality care and have significant cost<br />
benefit in preventing futile hospitalizations and unnecessary aggressive<br />
treatment.<br />
Methods:<br />
1) HOPE Program: Conduct visits for home bound elderly patients<br />
by geriatric MD or NP, closely monitor functional decline and<br />
medication compliance, provide certain lab/radiology services and<br />
preventive management; and avoid progression to long term care facility.<br />
2) INTERACT II Program: Established modified clinical pathways<br />
for early recognition and management of patients at the NH to<br />
decrease ER transfers and subsequent inpatient admissions. Formed<br />
a partnership between healthcare providers at the NH and WHMC<br />
through coordinated care and communication, allowing for ER evaluation<br />
and management of certain acute care conditions (eg. PICC<br />
line, peg tube replacements) without admission. 3) Enhancing Palliative<br />
Care: Expanding palliative care service at WHMC by dedicating<br />
hospital beds and advocating physician accountability through policy<br />
changes and awareness.<br />
S172<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
Results:<br />
The HOPE program has 175 enrolled patients, showing 25% reduction<br />
in acute care hospitalizations, only 5% readmission rate, and<br />
a cost saving of $1.3million/year. The INTERACT II program has<br />
generated a saving of at least $500,000/year in avoided inpatient admissions.<br />
The Enhanced Palliative Care program is estimated to reflect<br />
a cost avoidance of $600,000 over the first two years by minimizing<br />
aggressive management.<br />
Discussion:<br />
In today’s climate of healthcare reform, our approach seeks to<br />
improve patient care quality with cost effective implications. We present<br />
a three pronged intervention of managing the most vulnerable<br />
geriatric population through patient centric home monitoring, integrated<br />
care of NH residents, and appropriate evaluation for terminal<br />
care needs. We hope to expand our pilot programs to suit the need of<br />
a managed or accountable care organization.<br />
C121<br />
Transitions Bundle: Ensuring smoother transitions at hospital<br />
discharge.<br />
A. Hayward, 1 R. Rastogi, 2 T. J. Hillstrom, 2 C. A. Barnes. 1 1. Care<br />
Management Institute, Kaiser Permanente, Portland, OR; 2. Sunnyside<br />
Medical Center, Kaiser Permanente, Clackamas, OR.<br />
Supported By: Project undertaken as quality improvement activity<br />
by Kaiser Permanente<br />
Background: Across the US one in five Medicare patients is<br />
readmitted to the hospital within 30 days after discharge. Some readmissions<br />
are preventable. After discharge, patients don’t always know<br />
whom to call with questions, what medicines to take, or how to obtain<br />
follow-up care. Those physicians and clinicians responsible for providing<br />
post-hospital care don’t always receive timely, accurate, and<br />
complete information about these patients.<br />
Methods: Kaiser Permanente’s Sunnyside Medical Center created<br />
a process to improve the transition for all patients discharged to<br />
post-hospital care. First, a diagnostic evaluation identified that 10 to<br />
40% of readmissions were preventable. Next, a design team including<br />
staff and patient input developed, tested and implemented a “transition<br />
bundle”, the aim of which was to improve care for every patient<br />
after hospital discharge. Thirty-day readmission rates were measured<br />
before and after implementation. Components of the “bundle” included<br />
the following:<br />
1. risk assessment and care tailored to likelihood of re-hospitalization<br />
2. standardized discharge summary completed on the day of discharge<br />
and available in the electronic medical record<br />
3. pharmacist’s review of medications, followed by a phone call<br />
to those patients at high risk, as well as review for all patients discharged<br />
to a skilled nursing facility<br />
4. first follow-up appointment scheduled before discharge for all<br />
patients: within five days for those identified at high risk, within 10<br />
days for those at medium risk, and within 30 days for all others<br />
5. follow-up RN phone call within 72 hours of discharge for all<br />
high risk patients<br />
6. discharge instruction sheet with dedicated phone number for<br />
all questions<br />
Results: Overall year-to-date readmission rates at Sunnyside<br />
Medical Center decreased from 12 to 9.8% in 2011 and rates for<br />
Medicare members from 14 to 13%. More than half of patients discharged<br />
were seen for a follow-up visit within five days. Ninety-two<br />
per cent of discharged patients reported that they received written<br />
information.<br />
Conclusions: A transitions bundle composed of six elements improved<br />
continuity of care for patients discharged from the hospital<br />
and has been associated with a decrease in readmission rate.<br />
C122<br />
Changing the norms for trainees to prevent inappropriate<br />
emergency room referrals.<br />
N. K. Patel, 1,2 C. M. Espinal, 1,2 U. T. Efoevobokhan, 1,2 R. W. Parker. 1,2<br />
1. <strong>Geriatrics</strong>, University of Texas Health Science Centera at SA, San<br />
Antonio, TX; 2. <strong>Geriatrics</strong>, Christus Santa Rosa, San Antonio, TX.<br />
Background: Transfers between settings of care are referred to<br />
as transitions. Emergency Room (ER) transfers of patients from<br />
nursing homes(NH) for inappropriate reasons is expensive, worsens<br />
patient outcomes, hastens functional decline and decreases the quality<br />
of life. The average wait time in an ER in San Antonio is 4-6 hours.<br />
The average local ER visit for a geriatric patient costs anywhere from<br />
$4,000-$6,000. This project done at the University of Texas Community<br />
<strong>Geriatrics</strong> directed nursing homes where residents in family<br />
medicine are the first called for the group. On reviewing call center<br />
calls it was noted that many residents from NH were being sent to the<br />
emergency room for inappropriate reasons, majority of the referrals<br />
were afterhours and by trainee residents who were unfamiliar with<br />
the patients, lacked the confidence, knowledge and skill of managing<br />
frail elders.<br />
Objectives:To sustain the norm of preventing inappropriate ER<br />
transfers of patients by trainees from UT Medicine nursing homes by<br />
100% in response to after hour calls. This project also sought to open<br />
a dialogue between the NH, clinical staff, the residents, and the after<br />
hour call center to facilitate better care for the residents in the nursing<br />
homes.<br />
Design: Quality improvement project.<br />
Metric: ER visits of NH patients obtained from call center logs,<br />
calls tracker and chart reviews.<br />
Study Period: July 2010 to June 2011.<br />
Intervention: The norm was changed. All residents in training<br />
could not send a patient to ER without discussing the patient with the<br />
attending on call. The on call team maintains a call tracker and the<br />
call center maintains a log.<br />
Results: Tracking the calls and following the intervention decreased<br />
the number of inappropriate ER visits to zero.The norm is sustained<br />
even beyond a year because of reinforcement and monitoring.<br />
Conclusions: Changing the norm of residents in training helped<br />
reduce the inappropriate ER visits. This also influenced the faculty<br />
behavior. Total number of calls reduced with the use of the SBAR<br />
tool and fact that calls were being tracked.<br />
Next Step: The call logs will continue to be collected from the<br />
clinical staff on call after hours. Complement with the Interact II<br />
program, track day time calls and education of families regarding<br />
ER transfers vs. treatment either in NH or direct admission to the<br />
ACE unit.<br />
C123<br />
Facilitating Geriatric-focused Primary Care Electronically: A<br />
Follow-up.<br />
C. Gardner. Elder Care, Kaiser Permanente, Atlanta, GA.<br />
Kaiser Permanente Georgia recognizes the importance of identifying<br />
and meeting older patients’ needs. In 2010 we developed and<br />
implemented interventions for non-geriatricians to easily address<br />
topics not routinely discussed with younger patients, leveraging our<br />
electronic medical record. A template is used at new patient and annual<br />
40-minute visits for patients 65 and older. This decision support<br />
tool prompts primary care physicians to assess, discuss, and appropriately<br />
document actions re: topics including functional status, incontinence,<br />
falls, cognition, and advance directives. It provides options for<br />
interventions and prompts ordering recommended screenings and referring<br />
to <strong>Geriatrics</strong>. Patient instructions important in older people<br />
(e.g., regarding screenings, fall prevention, incontinence) automatically<br />
print. The elder-focused review of systems and patient instructions<br />
are also available to all clinicians for use in patients not scheduled<br />
for a comprehensive primary care visit.<br />
AGS 2012 ANNUAL MEETING<br />
S173
P OSTER<br />
A BSTRACTS<br />
We monitor the template’s use and encourage physicians not<br />
using it to do so. Performance on quality measures such as HEDIS,<br />
which include topics addressed in the template, is measured annually<br />
and has improved. For example, glaucoma screening increased from<br />
54.84% in 2010 to 60.88% in 2011. For a sub-group of our population,<br />
metrics include annual discussion of advance directives, medication<br />
review, assessment of functional status and comprehensive pain<br />
screening. Along with other initiatives, template implementation was<br />
associated with improvements between 2010 and 2011: Advance Care<br />
Planning increased from 22.14% to 70.07%; Medication Review<br />
74.94% to 98.30%; Functional Status Assessment 13.63% to 91.48%;<br />
and Pain Screening from 39.42% to 95.13%. Referrals to our <strong>Geriatrics</strong><br />
team increased with template use, from 21 to 35 per month. Issues<br />
identified for referral included previously unrecognized cognitive<br />
disorder/dementia and gait problems/falls.<br />
Because our physicians are now familiar with the need to address<br />
these topics, we recently modified the template and developed<br />
and refined workflows to enable nursing staff to ask many of the<br />
screening questions. This will increase efficiency and better enable<br />
physicians to focus on evaluating and treating the problems identified.<br />
Overall, implementation of the tool appears to be an effective<br />
means of improving primary care physicians’ awareness of, attention<br />
to, and appropriate referral for, issues important in older patients.<br />
C124<br />
Care of the Older Adult Continuing at Home (COACH):<br />
Optimizing Medical Resident Understanding of the patient at home.<br />
D. C. Hayley, 1,2 J. Kalender-Rich, 1,2 B. Lowry, 1 M. Brimacombe. 3 1.<br />
Internal Medicine, University of Kansas, Kansas City, KS; 2. Landon<br />
Center on Aging, University of Kansas School of Medicine, Kansas<br />
City, KS; 3. Biostatistics, University of Kansas School of Medicine,<br />
Kansas City, KS.<br />
Supported By: Landon Center on Aging<br />
Purpose-To determine differences between what Internal Medicine<br />
residents expect to find and what they actually observe on posthospitalization<br />
home visits of frail elderly.<br />
Methods—Internal Medicine Residents on their month of <strong>Geriatrics</strong><br />
rotation make a home visit through COACH (Care of the<br />
Older Adult Continuing at Home) on an elderly patient discharged<br />
from the hospital in the last month. After chart review, the resident<br />
completes a pre-visit questionnaire with questions on discharge diagnosis,<br />
predicted functional status, number of medications and support<br />
at home. After the home visit and primary data collection in these<br />
same domains, a post-visit questionnaire is completed including<br />
quantitative and qualitative differences between what was expected<br />
and what was found.<br />
Results—Of the 12 residents who have completed this study<br />
thus far, 10 reported that there was NO difference between diagnosis<br />
on the hospital discharge summary and the patient/family report. In<br />
all cases, the patients had someone with them at all times and 4 residents<br />
reported that this was more supervision than expected. Patient<br />
functional status was different than expected in 5 of 12 cases. There<br />
were from 0 to 16 differences in number of medications at home as<br />
compared to expected and in only one case was it reported that there<br />
were no discrepancies. 10 of 12 residents reported the experience was<br />
superior. Qualitative responses regarding suggestions on discharge of<br />
elderly patients to home include attending to patient’s social support,<br />
functional status and medications. There were repeated requests for<br />
more of this experience in residency.<br />
Conclusions—Residents did a fair job of predicting discharged<br />
patient’s supervision and functional status but still missed many important<br />
issues at home, especially medications the patient is actually<br />
taking. Most residents acknowledged the importance of these aspects<br />
in elderly patients and request more of this geriatrics and home visit<br />
experience in residency. They found this was useful for their learning<br />
and improving optimal discharge practices in the frail elderly.<br />
C125<br />
Safety profile of high dose statin therapy in geriatric patients with<br />
stroke.<br />
D. Manocha, N. Bansal, Z. El Zammar, S. Brangman. SUNY Upstate<br />
Medical University, Syracuse, NY.<br />
Introduction: Use of high dose statins in patients with stroke has<br />
become a standard clinical practice after the SPARCL study in 2006.<br />
Although the mean age of population in SPARCL study was around<br />
63 years, scientific evidence derived from the same has been extrapolated<br />
to much older patients in clinical practice. Very little data is<br />
available on the magnitude of adverse effects of high dose statin therapy<br />
in geriatric patients. Methods: This single-center retrospective<br />
study was conducted at Upstate Medical University, Syracuse, NY.<br />
The goal was to define the magnitude of side effects of high dose<br />
statins in our selected geriatric study population. We reviewed<br />
records of 120 patients between the ages of 65-89 years to collect demographic,<br />
clinical, laboratory & adverse drug reaction data. Data<br />
were compared between patients on high dose statin therapy (cases)<br />
vs. those on regular doses (controls) using Chi square, Fisher exact<br />
test & Student T test. P value
P OSTER<br />
A BSTRACTS<br />
b) the frequency and number of emergency room visits, hospitalizations,<br />
readmissions, and nursing home placements, c) the presence of<br />
a health care proxy and the formulation of advanced directives, d) the<br />
types and extent of services the patient receives from DOROT and e)<br />
instruments to assess patient satisfaction with overall healthcare and<br />
perception of their quality of life. Data will also be collected on patients<br />
cared for under our house call program, using retrospective<br />
data going back to 2007 (n=251) and prospective data on patients currently<br />
being cared for (n=82).<br />
Results and Conclusion: To date, the collaboration has been involved<br />
in the care of 40 patients. In addition, data is being collected<br />
on all 82 patients currently cared for with our house call program and<br />
retrospectively on about 250 patients who had been cared for by our<br />
house call program since 2007. It is hoped that by comparing the information<br />
obtained on the two groups of patients that we can better<br />
understand the impact of providing a comprehensive care program<br />
offered by agencies like DOROT.<br />
C127<br />
A Qualitative Review of Exercise Interventions to Reduce Falls in<br />
Older Adults.<br />
E. Trieu, 1 V. Shier, 2 D. Ganz. 3,1 1. David Geffen School of Medicine at<br />
UCLA, Los Angeles, CA; 2. RAND, Santa Monica, CA; 3. Greater LA<br />
VAMC, Los Angeles, CA.<br />
Supported By: This project is funded by the Archstone<br />
Foundation/USC Fall Prevention Center of Excellence. DAG is supported<br />
by a VA HSR&D Career Development Award. ET was supported<br />
by the UCLA Medical Student Training in Aging Research<br />
program.<br />
Background<br />
Systematic reviews demonstrate that exercise containing balance<br />
training is particularly effective in reducing falls in communitydwelling<br />
elders. However, the best strategy for implementing a balance<br />
program is unknown.<br />
Methods<br />
Two reviewers independently screened 114 full text articles<br />
from 6 systematic reviews of RCTs to prevent falls. Fourteen RCTs of<br />
exercise programs in a medical setting and involving a balance training<br />
component were selected for further review. We identified related<br />
articles that provided experiential insight into the exercise program<br />
of each included RCT by searching the references in, and articles citing,<br />
the RCT. Two reviewers independently abstracted data from the<br />
14 RCTs and their related articles. Data were analyzed using qualitative<br />
data analysis software.<br />
Results<br />
Exercise programs were heterogeneous across target population<br />
and baseline risk of falling, program approach and setting, and exercise<br />
intensity and duration. Many programs were successful in improving<br />
strength, mobility, and/or endurance, in addition to balance.<br />
Facilitators to uptake of exercise programs reported in at least one<br />
study included involvement of health practitioners in the recruitment<br />
process, supervision of exercise (resulting in reduced feelings of isolation),<br />
and individualized training (resulting in recruitment of a<br />
broader participant group). Studies also reported factors that contributed<br />
towards a lack of success in reducing falls or falls risk factors<br />
including the population being too healthy or lacking balance problems,<br />
lack of supervised exercise, and low adherence due to an unhealthy<br />
population. Authors mentioned the positive effects of group<br />
training on promoting adherence and group cohesion. Convenient locations,<br />
opportunity for social interaction and pleasant environments,<br />
and overall enjoyment were also noted as factors that promote adherence.<br />
Several programs reported patient enjoyment but did not<br />
necessarily show high adherence.<br />
Conclusions<br />
Exercise programs to prevent falls are not “one-size-fits-all”<br />
programs. Because patient adherence is an important aspect of an exercise<br />
program’s success, special consideration to a patient population’s<br />
baseline health measures, needs, and interests improves participant<br />
enjoyment, potentially resulting in greater effectiveness.<br />
C128<br />
The high diagnostic yield of an outpatient geriatric clinic.<br />
F. Moret, H. Jaccard-Ruedin, C. Bula, S. Monod. Service of geriatrics<br />
medicine and geriatric rehabilitation, Epalinges, Switzerland.<br />
Background: Primary care physicians have limited time to perform<br />
comprehensive geriatric assessment. Interdisciplinary outpatient<br />
geriatric clinic might assist primary care physicians in early<br />
recognition and management of geriatric syndromes. The objectives<br />
of this study were 1) to determine characteristics of patients referred<br />
to an outpatient geriatric clinic; 2) to determine the prevalence of<br />
geriatric syndromes in this population; 3) to identify main recommendations<br />
made to primary care physicians.<br />
Method: Database from the outpatient clinic of the service of<br />
geriatric medicine was analyzed. It includes demographic, social,<br />
functional and medical data, as well as recommendations made for<br />
primary care physicians.<br />
Results: Subjects (N=146) were all community-dwelling older<br />
patients (79.1±7.4 years, 56.2% women, 50.7% living alone, 34.9% receiving<br />
home care), referred by a primary care physician, an hospitalist<br />
or a family member (79%, 15% and 6% respectively). Main reasons<br />
for referral were request for comprehensive assessment,<br />
cognitive evaluation, and mobility assessment (41.8%, 28.1%, and<br />
15.8%, respectively). Mean performances at Katz’s Basic ADL and<br />
Lawton’s instrumental ADL were 5.3±1.1 and 4.7±2.8, respectively,<br />
and 54.1% of patients reported a fall over the past year. Overall,<br />
74.7% of patients were newly diagnosed with gait and balance impairment,<br />
71.9% with cognitive impairment, 52.7% with affective disorder,<br />
52.1% with osteoporosis, 43.8% with urinary incontinence,<br />
32.2% with orthostatic hypotension, and 55.5% with polypharmacy<br />
(≥6 different drugs; median 6±3.9, IQR 1-11). A mean number of<br />
12.7±4.2 recommendations was made for each patient. Overall, 87.6<br />
% of patients were given recommendations about fall prevention:<br />
walking aid adaptation (54% of all patients), vitamine D prescription<br />
(53%), home hazards assessment (52%), and exercise prescription<br />
(46%). Half (51.7%) of the patients received a recommendation for<br />
referral to a memory clinic. Treatment modifications were proposed<br />
in 80.8% of patients with polypharmacy (mostly psychotropic drugs<br />
discontinuation).<br />
Conclusion: In this population of elderly outpatients, polypharmacy,<br />
mobility and cognitive impairments were highly prevalent. Outpatient<br />
geriatric consultation is a good opportunity to identify new<br />
geriatric syndromes and to propose interventions aiming at functional<br />
decline prevention.<br />
C129<br />
The Fracture Care and Prevention Program: an integrated model of<br />
care to prevent reoccurrence of minimal trauma fractures.<br />
G. Loza-Diaz, 1 E. Thembani, 1 O. Demontiero, 1,2 A. Sharma, 2<br />
G. Duque. 1,2 1. Ageing Bone Research Program, The University of<br />
Sydney, Penrith, NSW, Australia; 2. Geriatric Medicine, Nepean<br />
Hospital, Penrith, NSW, Australia.<br />
Supported By: Servier, Sanofi-Aventis, Novartis, Nepean Medical<br />
Research Foundation<br />
BACKGROUND: Patients that experience a minimal trauma<br />
fracture are at higher risk of experiencing another fracture. Yet, very<br />
few patients, especially the elderly, are identified and provided with<br />
an appropriate plan to prevent further fractures.<br />
OBJECTIVE: To describe the implementation and evaluation<br />
of an osteoporotic fracture prevention in a geriatric setting.<br />
AGS 2012 ANNUAL MEETING<br />
S175
P OSTER<br />
A BSTRACTS<br />
PROGRAM STRUCTURE AND PROCESS: The Fracture<br />
Care and Prevention Program is a model of care designed to intervene<br />
when the first minimal trauma fracture occurs. A nurse coordinator<br />
(attached to a geriatrics department) identifies patients with<br />
minimal trauma fractures in hospital wards, rehab department, emergency<br />
department and local health centres. This coordinator provides<br />
patients with educational materials about osteoporosis and fractures,<br />
provides recommendations for vitamin D and calcium supplementation,<br />
encourages exercise and explains the specific treatment for osteoporosis.<br />
Patients are also referred to bone density testing. The patients’<br />
family doctor is informed of the assessment to reiterate the<br />
recommendations provided to the patient, and for referral to a specialist<br />
at the Falls and Fractures Clinic.<br />
PROGRAM OUTCOMES: From January to August 2011, 82<br />
patients were registered with the Fracture Care and Prevention Program.<br />
At follow-up post-discharge from hospital (8 weeks), 51% of<br />
patients were referred to the Falls and Fractures Clinic (13% attended),<br />
32% started gentle exercise, and 40% read the educational<br />
materials provided. The number of patients taking vitamin D increased<br />
from 12% to 40%. The number of BMD tests increased 25%.<br />
In addition, 28% had a discussion with their physician about osteoporosis<br />
and treatments. Finally, the number of prescription for osteoporosis<br />
treatment increased in 32%.<br />
CONCLUSIONS: The Fracture Care and Prevention program<br />
is an effective model of intervention to increase awareness of the importance<br />
of falls and fractures prevention in older persons, not only<br />
to the patients but also to their physicians. This model, run by a nurse<br />
coordinator, is cost effective and easily implemented in a geriatric<br />
setting.<br />
C130<br />
Profiles and Characteristics Associated with Rehospitalization of<br />
Patients in a Sub-Acute Rehabilitation Facility.<br />
H. Guzik, 1 N. Sharma, 1 A. Gupta, 1 N. Arif, 1 C. Nouryan, 1<br />
R. Pekmezaris, 1 M. Lesser, 2 G. Wolf-Klein. 1 1. North Shore-LIJ<br />
Health System, New Hyde Park, NY; 2. Feinstein Institute for Medical<br />
Research, Manhasset, NY.<br />
Background: Reduction of unnecessary rehospitalization of patients<br />
has been identified as an important goal in geriatric medicine.<br />
We studied hospital readmission patterns of patients receiving care at<br />
a 258-bed sub acute rehabilitation facility.<br />
Methods: Retrospective chart review of 100 patients (50 rehospitalized<br />
[RH] and 50 not rehospitalized [NRH] within 60 days of admission),<br />
randomly selected between 1/2011 and 9/2011.<br />
Results: When comparing RH and NRH, demographic analysis<br />
revealed a significant difference with regard to age (80.6 vs 75.7 respectively,<br />
p
P OSTER<br />
A BSTRACTS<br />
medical assistant. We work closely with all community agencies to<br />
help maintain the patient in the community as long as possible.<br />
Methods: Home visit patients (N=590) were identified by a log<br />
maintained by home visit staff. The patients were linked to hospital<br />
information system data by medical record number to obtain demographic<br />
and hospital encounter information (N=539). Only patients<br />
with identifiable hospital admissions prior to or post 180 days to the<br />
program entry were included in the before and after comparison<br />
(N=387). A comparison group (N=1273) was defined as Medicare patients<br />
with 3 or more inpatient admissions in calendar year 2008 who<br />
were not enrolled in HV program. Primary outcome measures were<br />
ED visits, hospital admissions, and length of stay at 30 and 180 days<br />
pre- and post-home visit enrollment. Secondary measures were patient<br />
days in the HV program and discharge disposition.<br />
Results: Approximately 55% of the HV patients had death as<br />
their primary reason for discharge from our program. Average number<br />
of patient days in the HV program was 285 days.<br />
Patients had worse primary outcome measures prior to enrolling<br />
in the HV program. After entering the HV program, 30 day<br />
ED visits and inpatient admissions were reduced by 26% and 34% respectively.<br />
At the 180 day interval, this effect was still sustained with<br />
ED visits reduced by 9% and inpatient admissions by 28%. When<br />
compared to the non-HV comparison group, the HV outcomes were<br />
favorable as the comparison group had a 55% 180 day readmission<br />
rate. Of note, our case mix index (1.74) was higher than the comparison<br />
group (1.66).<br />
Length of stay for our cohort of patients prior to the HV program<br />
was 8.0 days. After enrollment, LOS was 6.2 days which again<br />
compares favorably to the non-HV comparison group with a LOS of<br />
7.5 days.<br />
Conclusion: A HV program is an effective model of care that reduces<br />
ED visits, readmission rates, and length of stay. Hospital systems<br />
looking to improve their transitions of care process should look<br />
to partner with HV programs to improve similar outcome measures.<br />
The average length of time a patient stays in our program is<br />
roughly 9.5 months. By serving such a frail population, a HV program<br />
can and should be viewed as an outpatient palliative care program.<br />
C133<br />
The Effect of Medication on Brain Size: Polypharmacy is Associated<br />
with Gray Matter Atrophy.<br />
A. Toussi, 1 O. V. Meulenbroek, 2 S. A. Studenski, 1 M. G. Olde<br />
Rikkert. 2 1. University of Pittsburgh School of Medicine, Pittsburgh,<br />
PA; 2. Alzheimer Centre Nijmegen, Radboud University Nijmegen<br />
Medical Centre, Nijmegen, Netherlands.<br />
Supported By: NIH Grant 5 T32 AG 021885-09<br />
Background: Cognitive decline is a frequent problem encountered<br />
in the geriatric population and it is associated with the use of<br />
polypharmacy. In addition, the elderly are more susceptible to adverse<br />
drug reactions, especially neuropsychiatric effects (e.g. delirium)<br />
due to aging changes in the neurochemistry of the brain, pharmacodynamics,<br />
and pharmacokinetics. The combined effect of aging<br />
and polypharmacy may be detrimental to the brain function and<br />
structure. We investigated the burden of polypharmacy on the structure<br />
of the brain, specifically on the amount of gray and white matter,<br />
in a population of patients who were referred to our memory clinic.<br />
Methods: We selected consecutive patients who visited the<br />
Radboud University Nijmegen Medical Centre memory clinic<br />
from 2007 to 2010 database. Baseline variables included demographics,<br />
medication list, and information on relevant co-morbidities.<br />
The level of education was scored by the system of Verhage.<br />
The structural MRI scans were segmented into gray matter (GM),<br />
white matter (WM) and CSF using the VBM toolbox in SPM5, and<br />
volumes were extracted. We calculated the GM and WM fraction<br />
by dividing the GM or WM volume by the intracranial volume<br />
(GM+ WM+CSF). The number of current, regularly-taken medication<br />
with a known systemic effect was counted. Topical, “as<br />
needed”, and supplemental medications (vitamins, minerals, and<br />
herbals) were excluded. We used a linear regression model to investigate<br />
the correlation between GM fraction, WM fraction and<br />
amount of medication, while controlling for age, sex, education and<br />
diagnosis.<br />
Results: We found a significant correlation between polypharmacy<br />
and GM (Pearson r = -0.149, p=0.002). These effects were independent<br />
of sex, age, education and diagnosis. For WM fraction, there<br />
was no correlation.<br />
Discussion: Our results indicate that the more medications a patient<br />
is taking, the more GM atrophy is present. However, further investigation<br />
of the effects of medications on brain atrophy is warranted.<br />
Physicians already should be cognizant of this association<br />
when treating elderly patients.<br />
C134<br />
MOCA & MMSE Comparison in Detection of Cognitive<br />
Impairment & Change in Very Old Age.<br />
A. Mohammed, 1 S. Kabsoun, 1 B. Leonard, 2 W. Nieri. 1,2 1. Geriatric,<br />
Banner Geriatric Fellowship Program, Sun city, AZ; 2. Banner Health<br />
Research Institute, Sun City, AZ.<br />
Background<br />
The Mini Mental State Exam (MMSE) is the most widely used<br />
screening test for dementia. However, research shows that it can underestimate<br />
cognitive impairment, varies within the population by<br />
age & education, and probably has limitations in assessing progressive<br />
cognitive decline. The Montreal Cognitive Assessment (MOCA)<br />
test may be superior to the MMSE in early detection of Alzheimer’s<br />
disease (AD), but little research has been done with it using very old<br />
subjects. We determined the efficacy of the MMSE and MOCA in detecting<br />
early signs of cognitive impairment and change in healthy subjects<br />
70-105 years old. We also determined whether level of physical<br />
activity was related to cognitive performance.<br />
Methods<br />
Subjects were in the longevity project at the Center for Healthy<br />
Aging, BSHRI. They were 70 years old or older with no dementia at<br />
enrollment, and had completed baseline, 2nd and 3rd annual assessments<br />
in cognitive, medical, and psychosocial domains. One hundred<br />
and forty-eight subjects met these criteria and were stratified by age<br />
decade. To assess relative efficacy, MMSE & MOCA scores were plotted<br />
for each subject, and the proportion performing at, below, or<br />
above standard cutoff scores was determined. To assess decline over<br />
1-year, difference scores were calculated separately for the MMSE &<br />
MoCA. Level of activity was measured with the Rapid Assessment of<br />
Physical Activity (RAPA), and scores were correlated with MoCA<br />
performance.<br />
Results<br />
A fair number of healthy 70, 80, 90 and 100 year-old subjects<br />
performed above the cutoffs on both the MMSE & MoCA. With increasing<br />
age, however, an increasing proportion performed below the<br />
MoCA cutoff while scoring above the cutoff for the MMSE, supporting<br />
previous findings of superiority of the MoCA over the MMSE in<br />
the younger old. In the same groups, 1-year change was negligible for<br />
the MMSE, while for the MoCA, scores were on average 1.3 points<br />
lower. Subjects who were more physically active scored higher on the<br />
MoCA, but only for 90- and 100-year olds.<br />
Conclusion<br />
This study suggests that the MoCA is a better instrument for detecting<br />
cognitive impairment compared to MMSE, even in the oldest<br />
old. The MoCA can be a good tool for monitoring cognitive changes<br />
over time, and thus can aid care planning in early dementia. Finally,<br />
increased physical activity may mitigate cognitive decline often associated<br />
with aging.<br />
AGS 2012 ANNUAL MEETING<br />
S177
P OSTER<br />
A BSTRACTS<br />
C135 Encore Presentation<br />
Wheelchair Wrist Drop among Nursing Home Residents.<br />
A. Komiyama. General Internal Medicine, Kawasaki Municipal Tama<br />
Hospital, Kawasaki, Japan.<br />
Background: In 1982 Hartigan first reported radial neuropathy<br />
in nursing home residents that was associated with the use of a wheelchair<br />
and later termed “wheelchair wrist drop”. Two additional case<br />
reports have been published, bringing the total to 14 patients. Unfortunately,<br />
the most recent study published in 2009 was unaware of previous<br />
ones; thus wheelchair wrist drop appears to remain underrecognized.<br />
Furthermore, although cases of wheelchair wrist drop may be<br />
relatively common and overlooked in nursing homes, neither its frequency<br />
nor demographics of the study population has been documented.<br />
Objectives: To prospectively delineate frequency and contributing<br />
factors of wheelchair wrist drop as well as clinical characteristics<br />
of the study population in a nursing home.<br />
Methods: Subjects were 311 elderly residents, mean age 81.9 and<br />
female 63.7%, admitted to a nursing home from February 2005 to December<br />
2008. During this period of 47 months the residents were subjected<br />
to a comprehensive geriatric assessment at admission and 3-<br />
month intervals and watched for any adverse events. Radial nerve<br />
palsy was diagnosed clinically by the characteristic features including<br />
selective weakness of wrist and finger extensors; precise sensory findings<br />
were difficult to interpret in this population. The residents with<br />
wheelchair wrist drop did not undergo an EMG in consideration of<br />
their overall condition.<br />
Results: Examination of the study population shows moderate<br />
dementia with a mean Mini-Mental State Examination score of<br />
10.6/30 and impaired mobility and dependence with a mean score of<br />
29.6/91 on the motor domain of Functional Impairment Measure; 193<br />
residents (62.1%) routinely used wheelchair. Several months after<br />
admission, five female residents (2.6% of wheelchair users) developed<br />
radial neuropathy, resulting from leaning against the armrest.<br />
The contributing factors appeared to be immobility and lateral body<br />
tilt due to frailty in three and those due to parkinsonism in two. All<br />
but one improved one month later; one markedly frail resident experienced<br />
recurrence with residual weakness. For 23 months from February<br />
2007 no more wrist drop occurred in wheelchair users.<br />
Conclusion: 2.6% of wheelchair users suffered from wrist drop in<br />
the first half of the observation period in a nursing home. Recognition<br />
of wheelchair wrist drop and its risk factors among care staffs could<br />
likely have prevented from further development of this syndrome.<br />
C136<br />
The contribution of executive function and brain volume to gait<br />
speed in older adults with and without cerebral infarction.<br />
B. Manor, V. Novak. Harvard Medical School, Boston, MA.<br />
Background: Gait impairment is common in older adults, especially<br />
following cerebral infarction. The compensatory role of central<br />
locomotor circuits on the control of gait remains unclear. We examined<br />
the dependence upon executive function and non-infarcted regional<br />
brain tissue volumes for the control of gait speed in healthy<br />
older adults and those with right or left-hemisphere middle cerebral<br />
artery (MCA) infarct. Methods: Healthy older adults (n=55,<br />
age=65±8 years) and individuals with right MCA infarct (n=19,<br />
age=65±8 years, 7±6 years post-stroke) or left MCA infarct (n=20,<br />
age=65±8 years, 7±6 years post-stroke) were recruited. Gait speed<br />
was calculated from an indoor walk at preferred speed. Executive<br />
function was measured with the trail making test. Cortical gray matter<br />
volumes within non-infarcted brain regions (i.e., the cerebellum<br />
and occipital lobes) were quantified from anatomical 3T MRIs. Results:The<br />
right and left infarct groups had similar infarct volumes and<br />
time since stroke. Gait speeds were slower (p
P OSTER<br />
A BSTRACTS<br />
C138<br />
Improvement in Functional Independence Measure (FIM) scores of<br />
dementia patients on a Medical Psychiatric Unit.<br />
C. A. Fabrizio, 1 C. G. Lyketsos, 2 E. S. Oh. 2 1. University of Medicine<br />
and Dentistry of New Jersey- School of Osteopathic Medicine,<br />
Stratford, NJ; 2. Psychiatry, Medicine, Pathology, The Johns Hopkins<br />
University School of Medicine, Baltimore, MD.<br />
Supported By: 2011 MSTAR Program at Johns Hopkins<br />
Background:Physical therapy may be effective for functional recovery<br />
in older patients with dementia, yet research on this topic has<br />
been limited. The goal of this study is to examine the association between<br />
number of physical therapy sessions and improvement in functional<br />
outcomes on an interdisciplinary medical psychiatry unit.<br />
Methods:Retrospective data (1/2008 to 6/2011) were collected<br />
from medical records. Patients were categorized as having movement<br />
disorder (MD, N=8) or “no movement disorder”(NMD,N=27). FIM<br />
scores included transfer (FIM BCW–Bed, Chair, Wheelchair:1-7),<br />
ambulation distance (FIM D–Distance:1-3), and level of independence<br />
in ambulation (FIM DS–Distance Score:1-7). Statistics were<br />
performed using GraphPad Prism and STATA.<br />
Results:Compared to the admission FIM scores, scores in all<br />
three categories significantly improved in both groups with exception<br />
of FIM BCW score in MD (Table 1). Linear regression adjusting for<br />
age, gender, number of physical therapy sessions, comorbidities, medication<br />
and MMSE scores did not change the effect sizes.<br />
Conclusion:Although dementia patients in our medical psychiatry<br />
unit improved in most measures of the FIM, we did not find a specific<br />
association between these outcomes and a number of clinical<br />
variables including the number of physical therapy sessions. Further<br />
analyses are being conducted to investigate the effects of other clinical<br />
variables at this time. However, these effects may also be the result<br />
of the comprehensive care that they receive from geriatricians,<br />
geriatric psychiatrists, therapists, and nurses on the interdisciplinary<br />
team, rather than one specific intervention.<br />
Table 1 Improvements in Functional Independence Measure Scores<br />
at Discharge<br />
C139<br />
Practice effects: A unique cognitive variable?<br />
C. Callister,K.Duff.Neurology, University of Utah, Salt Lake City, UT.<br />
Supported By: AFAR MSTAR Summer 2011 grant; National<br />
Institute on Aging<br />
BACKGROUND:<br />
Practice effects are improvements in cognitive performance due<br />
to repeat testing with the same materials. These improvements are<br />
present in cognitively normal older adults, but mostly absent in patients<br />
with dementia. Practice effects can also predict further decline<br />
in patients with Mild Cognitive Impairment. However, it is unclear<br />
what variables (e.g., demographic, patient characteristic, other cognitive<br />
abilities) moderate practice effects. We hypothesized that practice<br />
effects would be related to age, education, and baseline cognitive<br />
functioning.<br />
METHODS:<br />
268 community-dwelling older adults (mean age=77.3 years,<br />
mean education=15.3 years) participated in this study. During a baseline<br />
visit, demographic information (age, gender, education), patient<br />
characteristics (depression, premorbid IQ, global cognition), and<br />
baseline cognitive measures of memory, executive functioning, and<br />
processing speed were collected. The participants returned a week<br />
later and repeated the same battery of cognitive tests. To quantify<br />
practice effects, 1-week scores were divided by baseline scores. Correlates<br />
of practice effects and demographic, patient characteristic and<br />
other cognitive variables were examined with Pearson correlations<br />
and chi-square tests.<br />
RESULTS:<br />
Practice effects were not significantly related to age, gender, education,<br />
depression, cognitive status, or pre-morbid IQ. Overall,<br />
practice effects were also not related to baseline cognitive performances.<br />
CONCLUSIONS: Practice effects were not related to most demographics,<br />
patient characteristics, and baseline cognitive measures.<br />
This suggests that practice effects may be a unique cognitive variable<br />
that is not confounded by variables that typically influence other cognitive<br />
performances. Overall, this makes the interpretation of practice<br />
effects more straightforward.<br />
C140<br />
Validity of Computer-Based Mental Status Exam Screening in the<br />
Geriatric Population.<br />
C. L. Duncan, T. K. Malmstrom, G. T. Grossberg, J. E. Morley.<br />
Division of <strong>Geriatrics</strong> - Internal Medicine, Saint Louis University<br />
School of Medicine, St. Louis, MO.<br />
Supported By: Medical Student Training in Aging Research<br />
(MSTAR) program 2011 summer scholarship awarded by <strong>American</strong><br />
Federation for Aging Research (AFAR) to Catherine L. Duncan<br />
B.S. (SLU SOM MSII)<br />
Background: Dr. Oz developed a computerized mental status<br />
exam based on the Saint Louis University Mental Status (SLUMS)<br />
Exam and made it readily available on his website<br />
(http://www.doctoroz.com/quiz/memory-quiz). We have examined<br />
the validity of his screen against the SLUMS along with another<br />
computerized version developed by Saint Louis University (SLU)<br />
for the initial screening of cognitive impairment in the geriatric<br />
population.<br />
Methods: The SLUMS exam was administered to 100 participants<br />
recruited from SLU Geriatric Medicine and Geriatric Psychiatry<br />
clinics, followed by one of two randomly chosen computerized<br />
adaptations (50% given the Dr. Oz Memory Quiz and 50% given the<br />
Self-Administered VA-SLUMS Exam) to those scoring ≥ 12/30 on<br />
the SLUMS after a designated duration (minimum t=15 minutes, median<br />
t =65 minutes).<br />
Results: Neither computerized exam showed positive sensitivity<br />
or specificity compared to the paper SLUMS (AUC≤0.5), but positive<br />
correlations were seen between the total scores of both the Self-Administered<br />
VA-SLUMS and the Dr. Oz computerized versions compared<br />
to the paper SLUMS (r=0.726 and r=0.691, respectively). Additionally,<br />
the Self-Administered VA-SLUMS showed a modest<br />
increase in the weighted measures of agreement (κ=0.38) compared<br />
to the Dr. Oz Memory Quiz (κ=0.29).<br />
Conclusions: While neither computerized exam showed positive<br />
sensitivity or specificity compared to the paper SLUMS, positive correlations<br />
were seen between the total scores, with the Self-Administered<br />
VA-SLUMS showing a modest increase in both measure of<br />
agreement and correlation of total scores compared to the Dr. Oz<br />
Memory Quiz. Specific modifications to each computerized exam are<br />
recommended as well as an increase in sample size and in the duration<br />
of wait time between paper and computerized testing. Further<br />
study with implementation of the suggested changes is necessary with<br />
the hope of refining these computerized SLUMS exams to become<br />
valid and useful preliminary screens for cognitive impairment in the<br />
geriatric population.<br />
AGS 2012 ANNUAL MEETING<br />
S179
P OSTER<br />
A BSTRACTS<br />
C141<br />
Contribution of brain imaging to the understanding of Alzheimer<br />
disease-related gait disorders, a systematic review.<br />
C. Annweiler, 1,2 O. Beauchet, 2 R. Bartha, 3 M. Montero-Odasso. 1 1.<br />
Department of Medicine, Division of Geriatric Medicine, The<br />
University of Western Ontario, London, ON, Canada; 2. Department<br />
of Internal Medicine and <strong>Geriatrics</strong>, Angers University Hospital,<br />
Angers, France; 3. Center for Functional and Metabolic Mapping,<br />
Robarts Research Institute, London, ON, Canada.<br />
Background. Although Alzheimer disease-related gait disorders<br />
(ADRGD) are common, determining their origin is a goal yet to be<br />
reached. In particular, which brain structures and underlying lesions<br />
are involved in ADRGD remains unknown. Our objective was to systematically<br />
review all published data that examined the associations<br />
between gait disorders and brain imaging in patients with Alzheimer<br />
disease (AD).<br />
Methods. We conducted a Medline and Cochrane Library search<br />
indexed under the MeSH terms “Gait” OR “Gait Disorders, Neurologic”<br />
OR “Walking” combined with “Brain Mapping” OR “Magnetic<br />
Resonance Imaging” OR “Tomography, X-Ray Computed” OR “Tomography,<br />
Emission-Computed, Single-Photon” OR “Positron-Emission<br />
Tomography” OR “Nuclear Medicine” OR “Brain” combined<br />
with “Alzheimer disease” OR “Dementia”.<br />
Results. Of the 465 selected studies, 3 observational studies met<br />
the selection criteria. The number of participants ranged from 2 to 42<br />
community-dwelling AD patients (29% to 100% female). ADRGD<br />
(i.e., shorter stride length) were associated with a high visual score of<br />
white matter lesions, mainly in the medial frontal lobes and basal ganglia.<br />
The nigrostriatal dopamine system was unaffected. Finally,<br />
ADRGD (i.e., shorter stride length and higher stride length variability)<br />
correlated with lower hippocampal volume and function.<br />
Conclusions. ADRGD could be explained by a high burden of<br />
subcortical hyperintensities on the frontal-subcortical circuits together<br />
with hippocampal atrophy and hypometabolism.<br />
C142<br />
Does the Veterans Affairs Saint Louis University Mental Status<br />
(SLUMS) Exam predict the course of cognitive impairment?<br />
D. M. Cruz, 1 C. M. Allen, 1 T. K. Malmstrom, 1 N. Tumosa, 1,2 J. E. Morley<br />
. 1 1. <strong>Geriatrics</strong>, Saint Louis University, St. Louis, MO; 2. GRECC, St<br />
Louis VAMC Jefferson Barracks Division, Saint Louis, MO.<br />
Supported By: No financial disclosure.<br />
Background: The Veterans Affairs Saint Louis University Mental<br />
Status (SLUMS) exam is a screening tool developed for the detection<br />
of cognitive impairment which showed better sensitivity and<br />
specificity for the detection of both dementia and mild cognitive impairment<br />
(MCI) than the Mini-Mental State Exam (MMSE). This<br />
study explores the SLUMS exam’s potential to identify the clinical<br />
course of MCI and dementia in patients with cognitive impairment<br />
after 7.5-years.<br />
Methods: Patients (N=533) at the Geriatric Research, Education<br />
and Clinical Center at the Veterans Affairs Hospital St. Louis,<br />
MO were screened for cognitive dysfunction in 2003 using both the<br />
SLUMS exam and the MMSE. In 2010 the rates of mortality, institutionalization<br />
and change in SLUMS exam score were evaluated as<br />
outcome measures. In this longitudinal study the associations between<br />
outcome measures, MMSE and SLUMS exam total scores, individual<br />
item scores, and cognitive status were examined using Kaplan-Meier<br />
curves and Cox proportional-hazards regression.<br />
Results: Five hundred thirty three charts were reviewed:<br />
176/533(33%) patients had died and 31/526 (6%) were institutionalized<br />
during the 7.5-year follow-up period. All subjects were male,<br />
with a mean age of 75 years, and most had high school education or<br />
greater (71%). MMSE dementia and SLUMS exam dementia<br />
(p34%) was found among stroke caregivers.<br />
To understand caregiver depression, we investigated depression<br />
risk factors among stroke patients and their caregivers.<br />
Method: In the national telephone survey for stroke caregivers’<br />
experience,we indentified caregivers ofVeterans who had the first-time<br />
stroke during 2000 and 2006. The level of depression was measured by<br />
the 10-item CESD scale.The social support measure was the sum of 12<br />
items. Bivariate analyses identified significant risk factors with depression.<br />
Adjusting for covariates, logistic regression was applied to assess<br />
the relationship between social support and depression; and ordinal repeated<br />
measure analysis was used to test for interaction effects between<br />
social support and race on 10 items of depression scale simultaneously.<br />
Results: Among 261 caregiver-Veteran dyads, there were 62%<br />
whites, 17% blacks, and 21% Puerto Ricans caregivers (mean<br />
age=65). An increased likelihood of being depressed was found in the<br />
following caregivers’ characteristics (p values ranged from
P OSTER<br />
A BSTRACTS<br />
ever, whether these cognitive impairments are due to effects of surgery,<br />
anesthesia, or perioperative confounders is unknown. In order<br />
to study these associations, appropriate behavioral neuroscience experiments<br />
must be characterized to reliably model the effects of anesthesia<br />
in laboratory animals. The primary objective of this study was<br />
to determine if isoflurane anesthesia was associated with spatial reference<br />
memory deficits in young or aged rats.<br />
METHODS: Eleven 12-week-old and eleven 20-month-old<br />
male Fischer 344 rats were randomly assigned to anesthesia for 2<br />
hours with 1.2% isoflurane or a control group that breathed 30%<br />
oxygen alone. Twenty-four hours following anesthesia, retention<br />
memory was evaluated using a Morris Water Maze (MWM) task.<br />
RESULTS: While there were differences in the performance of<br />
young when compared to aged rats, there were no significant differences<br />
between isoflurane and control groups on any measure of the<br />
MWM performance at either age. These data suggest that isoflurane<br />
anesthesia does not lead to reference memory deficits in young or<br />
aged rats as investigated using a MWM task.<br />
CONCLUSIONS: This study demonstrates that some memory<br />
domains are not impaired following isoflurane anesthesia in young or<br />
aged rats.<br />
C145<br />
Self-reported school performance and risk for Alzheimer’s disease in<br />
older adults.<br />
E. Guh, A. E. Sanders, MD MS. Albert Einstein College of Medicine,<br />
Bronx, NY.<br />
Supported By: Ms. Guh is supported by the Medical Student<br />
Training in Aging Research program of the <strong>American</strong> Federation<br />
for Aging Research (MSTAR-AFAR).<br />
Dr. Sanders receives salary and research support from the Einstein<br />
CTSA Grant UL1 RR025750 and KL2 RR025749 and TL1<br />
RR025748 from the National Center for Research Resources<br />
(NCRR), a component of the National Institutes of Health (NIH),<br />
and NIH roadmap for Medical Research.<br />
The Einstein Aging Study is funded by the NIH/NIA (P01<br />
AG03949; PI Richard Lipton, MD).<br />
The contents of this manuscript are solely the responsibility of the<br />
authors and do not necessarily represent the official view of the<br />
NCRR or NIH.<br />
Background: Previous research has shown a low level of education<br />
to be a risk factor for Alzheimer’s disease (AD). The Aging, Demographics,<br />
and Memory Study identified self-assessed below-average<br />
school performance as a possible risk factor for AD. We<br />
attempted to replicate these findings in a diverse urban cohort.<br />
Methods: The Einstein Aging Study is a community-based longitudinal<br />
study of aging and cognition in the Bronx, NY. Participants<br />
self-reported previous school performance (A student, B student,<br />
etc.) and were categorized into groups of “above average,” “average,”<br />
“below average,” and those who stated they “did not know.” Reading<br />
level was measured by the WRAT-3 reading subscore. Using ‘average’<br />
performance as the reference group, we used univariate logistic regression<br />
to examine the risk of AD in the ‘above average’ and ‘below<br />
average’ groups. A subsequent nested logistic regression model adjusted<br />
for age, sex, race, years of education, and reading level.<br />
Results: Of the 1,520 participants with data on self-reported<br />
school performance (mean age, 78.2 years; 61% female; 27% black),<br />
67 developed AD. At baseline, 342 (23%) reported ‘above-average’<br />
school performance, 785 (52%) were ‘average,’ 359 (24%) were<br />
‘below-average,’ and 34 (2%) ‘did not know.’ In the univariate model,<br />
participants who had ‘below average’ school performance were 2.2<br />
times more likely to develop AD than those with ‘average’ performance<br />
(odds ratio (OR) 2.2, 95% confidence interval (CI) 1.2-4.1,<br />
p=0.01). A second model that adjusted for age, sex, race, and years of<br />
formal education revealed a similar risk (OR 2.2, 95% CI 1.2-4.3,<br />
p=0.02). It also showed a relationship between years of formal education<br />
and risk for AD (OR 0.9, 95% CI 0.9-1.0, p=0.15). However, additional<br />
adjustment for reading level attenuated the risk and decreased<br />
the statistical significance for ‘below average’ performers<br />
developing AD (OR 1.9, 95% CI 1.0-3.8, p=0.06). The relationship between<br />
years of formal education and risk for AD also was no longer<br />
present (OR 1.0, 95% CI 0.9-1.1, p=0.79). In all models, there was no<br />
significant risk associated with ‘above average’ performance when<br />
compared to ‘average’ performance.<br />
Conclusion: Participants who reported ‘below average’ school<br />
performance had an increased risk in developing AD. We suggest<br />
reading level may be a mediator of the relationship between self-reported<br />
school performance and risk for AD.<br />
C146<br />
Incidence, Predictors and Prognosis of Delirium in a Geriatric<br />
Cardiac Intensive Care Unit.<br />
E. Mossello, L. Pecorella, C. Giulietti, G. Toffanello, F. Caldi,<br />
S. Fumagalli, P. Valoti, M. Cavallini, N. Zaffarana, M. Belladonna,<br />
S. Francini, M. Rimediotti, A. Mello, N. Marchionni, M. Di Bari. Unit<br />
of Gerontology and Geriatric Medicine, Department of Critical Care<br />
Medicine and Surgery, University of Florence, Florence, Italy.<br />
Supported By: Foundation Cassa di Risparmio di Pistoia e Pescia<br />
Background: In patients admitted to an Intensive Care Unit<br />
(ICU), delirium has a prevalence from 20% to 80% and a definite<br />
negative prognostic impact. Few data are available on the specific setting<br />
of Cardiac ICU (CICU). Aims of the study were to: 1) estimate<br />
prevalence and incidence of delirium in a Geriatric CICU, 2) identify<br />
its risk factors, and 3) assess its prognostic impact.<br />
Methods: The presence of delirium was identified with the systematical<br />
application of Confusion Assessment Method-ICU. On admission<br />
pre-morbid disability, dementia (Informant Questionnaire on<br />
Cognitive Decline, IQCODE), multimorbidity (Charlson Index, CI),<br />
and acute physiologic derangement on admission (APACHE II) were<br />
assessed. Invasive procedures were recorded.<br />
Results: Out of 373 patients (mean age 79 years; pre-existing dementia<br />
26%), 18% showed delirium (8% prevalent on admission,<br />
10% incident during hospital stay). In a logistic regression model, independent<br />
predictors of delirium (OR, 95%CI) included age (1.07,<br />
1.02-1.13), APACHE-II (1.10, 1.04-1.16), dementia (2.97, 1.58-5.60),<br />
CI (1.22, 1.05-1.41) and clinical diagnosis [ST-elevation myocardial<br />
infarction (STEMI) (6.40, 2.40-17.07) or respiratory failure (8.49,<br />
1.54-46.85) vs. Non-STEMI]. Predictors of incident delirium were the<br />
same, though dementia had a reduced predictive value. The use of invasive<br />
procedures (arterial and central venous catheter, nasogastric<br />
tube, urinary catheter, intra-aortic balloon counterpulsation, and orotracheal<br />
intubation) was associated with subsequent delirium, independently<br />
of clinical status on admission. Delirium, especially its incident<br />
form, was associated with prolonged hospitalization (p
P OSTER<br />
A BSTRACTS<br />
nal process can present as hip pain, though usually with neurological<br />
and systemic symptoms.<br />
CASE: An 80 year old Caucasian man with a history of sarcoidosis,<br />
pulmonary embolism, and atrial fibrillation on anticoagulation,<br />
was admitted to the hospital with progressive left hip pain. He<br />
had been treated initially with pain medications by his primary physician<br />
for presumed osteoarthritis. His pain worsened over several<br />
months and became associated with left lower extremity swelling, difficulty<br />
walking with left foot drop, and generalized weakness. His<br />
physical exam was remarkable for mildly distended abdomen with<br />
firmness in the left lower quadrant without hepatosplenomegaly, mild<br />
left lower extremity edema, decreased hip range of motion without<br />
pain, and mild weakness with left dorsiflexion. Digital rectal exam<br />
showed bright red blood. His labs revealed leukocytosis of 12,000,<br />
anemia with a hemoglobin of 11, normal platelet count, and<br />
supratherapeutic INR of 6.5. A lower extremity ultrasound revealed<br />
an acute proximal left lower extremity DVT. A large left retroperitoneal<br />
mass involving the iliopsoas muscle and surrounding vasculature<br />
was found on CAT scan of the abdomen and pelvis. He also had<br />
bowel wall thickening in the distal sigmoid colon and at the splenic<br />
flexure. A colonoscopy was performed and showed two separate<br />
masses involving the colon. Biopsies done via both ultrasound guidance<br />
and colonoscopy were positive for Burkitt lymphoma. He received<br />
chemotherapy and was discharged home under hospice care.<br />
DISCUSSION: Burkitt lymphoma is rare in older adults. It usually<br />
occurs in adults less than 35 years of age. It often presents with<br />
abdominal symptoms such as pain, ascites, or gastrointestinal bleeding.<br />
The left hip pain, swelling, and leg weakness in this patient was<br />
atypical and was due to the involvement of the left iliopsoas muscles<br />
and surrounding nerves and vasculature.<br />
CONCLUSION: In an elderly patient with chronic unilateral<br />
hip pain and atypical clinical signs and symptoms such as foot drop,<br />
leg swelling and focal weakness, consider an intra-abdominal or<br />
pelvic infiltrative process.<br />
C149<br />
Pulse wave velocity varies within the cardiac cycle.<br />
A. K. Reddy, 1 C. J. Hartley, 1 G. E. Taffet. 1,2 1. Medicine (CVR),<br />
Baylor College of Medicine, Houston, TX; 2. Medicine (<strong>Geriatrics</strong>),<br />
Baylor College of Medicine, Houston, TX.<br />
Supported By: NIH<br />
Aortic pulse wave velocity (PWV), an index of arterial stiffness,<br />
is measured using the foot-to-foot (Ff) pulse transit time (PTT) of the<br />
flow velocity waveform at two aortic sites and the separation distance<br />
(Sd) between these sites (PWV=Sd/PTT). It has been shown that<br />
PWV is directly proportional to pressure (Kim et al., J Human Hypertens,<br />
21:141-48, 2007), from a low at end-diastole to a high at endsystole<br />
within each cardiac cycle. But the velocity foot occurs at enddiastolic<br />
pressure and therefore Ff-PWV may underestimate the<br />
overall PWV (and stiffness). PWV can also be determined from aortic<br />
impedance (Imp) as PWV = Zc/ρ, where Zc = average of impedance<br />
moduli from 2nd-10th harmonics (see figure) (Reddy et al., Am<br />
J Physiol HCP, 285:H1464-70, 2003). Since Imp-PWV is determined<br />
from several harmonics we believe that it is a better representation of<br />
vessel stiffness than Ff-PWV.<br />
We determined Imp-PWV (figure) in 5 young (lower dashed<br />
line; 282±10) and 6 old (upper dotted line; 444±59) mice and Ff-PWV<br />
in 3 young (286±14) and 3 old (416±22) mice. PWV determined by<br />
both methods was not significantly different in the young mice because<br />
at young age lower overall PWV may be closer to Ff-PWV. In<br />
the old mice Imp-PWV was higher but was not significant perhaps<br />
due to large variability. Higher values Imp-PWV in old mice may represent<br />
the increase in the magnitude of the higher harmonics caused<br />
by stiffer arteries in old age.<br />
C148<br />
Association of Vitamin D deficiency and In-Hospital Mortality in<br />
Elderly Patients with Heart Failure.<br />
A. Ali, N. Abi Rafeh, A. Abdo, J. Ross, V. Hak, D. P. Seminara,<br />
A. Szerszen. <strong>Geriatrics</strong>, Staten Island University Hospital, Staten<br />
Island, NY.<br />
Background: Vitamin D deficiency has been implicated in the<br />
pathogenesis of symptomatic heart failure. Low levels of 25-Hydroxyvitamin-D<br />
(25(OH)D) are associated with poor long term prognosis<br />
in heart failure. The relationship of low 25(OH)D levels and in-hospital<br />
mortality in elderly patients admitted with acute heart failure is<br />
not well studied.<br />
Objective: The study aims to assess the association of 25(OH)D<br />
deficiency and in-hospital mortality in elderly population admitted<br />
with heart failure and to determine the association between<br />
25(OH)D levels and Ejection Fraction (EF), Brain Natriuretic Peptide<br />
(BNP), and New York Heart Association (NYHA) functional<br />
classification.<br />
Methods and Results: This was a cross-sectional observational<br />
pilot study. Twenty patients with acute heart failure were recruited in<br />
the study. The mean age of the patients was 84 (65-96) yrs. Subjects<br />
were divided into two groups based on their 25(OH)D levels of less<br />
than 20mg/dl or more than 20mg/dl. There was a trend towards higher<br />
BNP level in the 25(OH)D deficiency group (1946 ± 1531 pg/ml vs.<br />
808 ± 302 pg/ml; p= 0.07). There was no correlation between<br />
25(OH)D levels and EF or NYHA functional class. However, Sixty<br />
two percent of patients died in-hospital in 25(OH)D deficiency group<br />
as compared to none in normal 25(HO)D levels group (p=0.026).<br />
Conclusion: A low 25(OH)D level is associated with high inhospital<br />
mortality in elderly patients admitted with acute heart failure.<br />
The 25(OH)D level may be used as a prognostic maker for inhospital<br />
mortality in elderly patients with heart failure.<br />
C150<br />
Antibiotic Utilization in ICU Patients Requiring Mechanical<br />
Ventilation.<br />
B. Chen, M. Restrepo. School of Medicine, UTHSCSA, San<br />
Antonio, TX.<br />
Supported By: MSTAR program through the National Institute<br />
of Aging<br />
PURPOSE: Infection is a major concern in health care but especially<br />
in the ICU and those on mechanical ventilation. There are limited<br />
data available regarding antibiotic utilization and the impact on<br />
clinical outcomes in the ICU setting, but particularly on patients requiring<br />
mechanical ventilation. We Assess antibiotic utilization and<br />
the impact on clinical outcomes in hospitalized ICU patients who required<br />
mechanical ventilation.<br />
S182<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
METHODS: We conducted a retrospective observational cohort<br />
study of VA MICU patients in the year of 2007. We included patients<br />
who were on >18 years and on mechanical ventilators for >24<br />
hrs. We looked into the antibiotic use and microbial culture to ultimately<br />
evaluate the clinical outcomes (length of stay and mortality)<br />
of these patients. [|11|]<br />
RESULTS: We identified 157 ICU patients who required mechanical<br />
ventilation. 95% of the patients received at least one dose of<br />
antibiotic therapy. The most common antibiotics were vancomycin<br />
and pip/tazo and tobramycin. The use of antibiotic was related to positive<br />
microbial cultures (p= 0.04). Adequate therapy is associated<br />
with positive cultures (p
P OSTER<br />
A BSTRACTS<br />
project, we attempt to understand some of the barriers against the efficacy<br />
of skin cancer prevention strategies.<br />
METHODS<br />
A 26 question survey-based descriptive and prospective study<br />
was performed on 140 Mohs surgery-treated patients at UCSD. Data<br />
was analyzed using percentages and estimated confidence intervals<br />
for population proportions.<br />
RESULTS<br />
51% of participants mentioned their doctor as a source of skin<br />
cancer prevention information. 73% of the 140 study participants<br />
were aware of sunblock as a protective strategy, and 76% of people in<br />
this group report current usage of sunblock. Participants who were<br />
able to name ≥2 preventative strategies had higher self-ratings of utilization<br />
of those strategies than people who could only name 1 preventative<br />
strategy. 43% of the people not using sunblock were unsure<br />
that sunblock actually works, and 52% of them thought it was too<br />
messy and oily. 65% of all participants improved in their self-rating of<br />
utilization of preventative strategies post skin cancer diagnosis.<br />
CONCLUSIONS<br />
The results of our survey study show that the majority of people<br />
who know of successful protective strategies are actually using them,<br />
and an awareness of a larger number of preventative strategies is related<br />
to a higher chance of utilization. However, most of the behavior<br />
improvement occurred after diagnosis of skin cancer, which suggests<br />
that people are not considering their risk of skin cancer as an imminent<br />
threat during early life. Therefore, in order to set up a future<br />
framework to decrease the incidence of skin cancer in the aging population,<br />
we recommend increasing the number of sun safety educational<br />
campaigns as well as encouraging physicians to be more active<br />
at educating patients on skin cancer risk.<br />
C155<br />
Maintaining and Respecting an Older Adults’ Life While It Is<br />
Ending: Challenges Faced by Family Members.<br />
C. R. Van Son, S. Izumi. College of Nursing, Washington State<br />
University, Spokane, WA.<br />
Supported By: <strong>American</strong> Nurses Foundation<br />
Hospice and Palliative Nurses Association<br />
Background: Efforts towards the improvement of end of life<br />
care must be accelerated to meet the needs of our rapidly aging society.<br />
Older adults with chronic conditions experience a longer trajectory<br />
with acute exacerbations and recovery, with progressive functional<br />
declines occurring over months and years. Palliative care<br />
adaptations are still needed to meet the needs of older adults going<br />
through prolonged and uncertain trajectory at the end of life. A gap<br />
exists between the focus on palliative care by healthcare<br />
providers/systems and the need for maintaining and optimizing daily<br />
life for older adults. The objective of this presentation is to describe<br />
the gap from the family member’s perspective.<br />
Methods: Qualitative descriptive study using semi-structured interviews<br />
with 23 family members of deceased older adults with various<br />
chronic conditions. Secondary analysis of the interview data was<br />
conducted using qualitative thematic analysis approach.<br />
Results: Family members shared the challenges they faced while<br />
they were facilitating the care of older family members who were<br />
dying. Although families were aware of the downward decline, they<br />
still recognized the importance of keeping daily routines to maintain<br />
the quality and function of the older adult’s life. However, once an acknowledgement<br />
of dying was made by the healthcare provider/system,<br />
the palliative care approach was instituted and not always<br />
adapted to optimize function and daily routines of older adults. Families<br />
reported that healthcare providers often: 1) relegated the older<br />
adult to a bedbound status while they were still able to be actively<br />
mobile; 2) failed to inquire about or respond to daily routines that<br />
would enhance daily life; 3) dismissed older adults as being cognitively<br />
impaired when they were not; and 4) neglected to prevent or<br />
address treatable geriatric conditions such as delirium.<br />
Conclusions: End of life for older adults occurs over weeks,<br />
months, and even years. Therefore, palliative care approaches must<br />
consider this longer trajectory and adapt to meet the older adults’<br />
and their family members’ needs.<br />
C156<br />
Impact of financial exploitation on the health of older women.<br />
C. P. Mouton. Dean’s Office, Meharry Medical College, Nashville, TN.<br />
Supported By: National Institutes of Health<br />
Background: Financial abuse (FA) and exploitation is a growing<br />
problem. Nationally, an estimated 12.3 % of elder abuse victims are<br />
victims of FA. However, little is known about the effects of FA on independently<br />
functioning older women.<br />
Objectives: To determine the effect of FA on health status and<br />
quality of life in a cohort of functionally independent older women.<br />
Design: Cross-sectional survey<br />
Setting: The local Observational Study Cohort of the Women’s<br />
Health Initiative in San Antonio, Texas<br />
Participants: Using this cohort, we surveyed over 1200 women,<br />
aged 50-79 years old.<br />
Measurements: We asked these women about their exposure of<br />
FA prior to the survey and currently. Women were also asked about<br />
their health status using the SF-36.<br />
Results: Of the 1271 women surveyed, 2.9% being forced to sign<br />
documents they did not understand, 3.6% were forced to give up<br />
property, 32% had money borrowed, and 2% had finances controlled<br />
against their wishes. Being forced to sign documents was associated<br />
with lower role-physical, pain, general health and physical component<br />
summary scores. Giving up property was associated with lower<br />
role-physical, social functioning, role-emotional, mental health, and<br />
mental component summary scores. Having money borrowed was associated<br />
with lower role-physical, role-emotional, and mental component<br />
summary scores. Having finances controlled was associated with<br />
lower social functioning, role-emotional, and mental component summary<br />
scores.<br />
Conclusion: Experiencing financial abuse is associated with<br />
lower sexual health status and poor quality of life in older women.<br />
C157<br />
Micronutrient Deficiencies in Palliative Care Patients.<br />
C. Petit, A. F. Leone. Palmetto Health - USC School of Medicine,<br />
Columbia, SC.<br />
Background: As health providers attempt to mitigate and ease<br />
discomfort, suffering and pain in the palliative care patient, it becomes<br />
imperative to investigate and treat all factors that might be<br />
contributing to distress. Unconsciously, we tend to assume that nutritional<br />
deficiencies are isolated to populations from third world countries,<br />
those who underwent bariatric weight loss procedures or those<br />
with know malabsorption syndromes. Current studies are proving this<br />
idea to be a myth.<br />
Methods: In an effort to provide comprehensive care, patients<br />
with symptoms suggestive of deficiency states, who were expected to<br />
live for at least one month, underwent a nutritional assessment to<br />
screen for micronutrient deficiencies seen by a single provider of a<br />
Palliative Care Consultant Service. It was the intent to replace any<br />
nutritional paucity. Those who underwent screening, directed by<br />
symptom constellation, underwent analysis of various micronutrients<br />
including Vitamins B1, B2, B3, B6, B12, C, Vitamin D, ascorbic acid,<br />
CoQ10, Zinc, pre-albumin and albumin.<br />
Results: 58 sequential referrals in May and June of this year underwent<br />
chart reviewed. 13 were suspected to have a life expectancy<br />
S184<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
of less than 1 month and did not undergo nutritional assessment beyond<br />
protein malnutrition. The remaining underwent targeted evaluation<br />
based on symptom constellation. 82.9% were found to have at<br />
least one identified nutritional deficiency. Of those, 38.2% had a single<br />
nutrient deficiency. 23.5% had two, 32.4% had three and 5.9%<br />
had 4 deficiencies.<br />
Conclusions: Micronutrient deficiencies are more prevalent in<br />
the Palliative care population than previously believed. Appropriate<br />
testing allows targeted, evidence based, replacement which should in<br />
turn ameliorate suffering. All too often palliative care is perceived as<br />
an approach that limits curative care focus, but resolution of deficiencies<br />
seems to establish a bridge of trust between the practitioner, the<br />
patient and the family who perceive the health practitioner to be fully<br />
invested in the care of the patient.<br />
C158<br />
Aging with Disabilities: Comparing symptoms and quality of life<br />
indicators of individuals aging with disabilities to U.S. general<br />
population norms.<br />
D. Amtmann, S. Borson, R. Salem, K. L. Johnson, A. Verrall.<br />
Rehabilitation Medicine, University of Washington, Seattle, WA.<br />
Supported By: The contents of this abstract were developed under a<br />
grant from the Department of Education, NIDRR grant number<br />
H133B080024. However, those contents do not necessarily represent<br />
the policy of the Department of Education, and you should not assume<br />
endorsement by the Federal Government.<br />
Background: Advances in medical care and rehabilitation have<br />
extended the lifespan of people with long-term physical disabilities.<br />
However, quantifying the excess burden of symptoms in persons<br />
aging with disabilities has been hindered by lack of common metrics<br />
across measures and clinical populations. The NIH-funded PROMIS<br />
initiative used modern psychometric methods to develop instruments<br />
that do use a common metric and provide US population<br />
norms for many important domains. The objective of the current<br />
study was to construct profiles of symptoms and QoL indicators in<br />
persons aging with a long-term disability and to compare them to US<br />
population norms.<br />
Methods: PROMIS short forms measuring 7 symptoms or QoL<br />
indicators (fatigue, pain interference with activities, physical and social<br />
function, depression, and sleep and wake disturbance) were completed<br />
by individuals with muscular dystrophy (264), multiple sclerosis<br />
(481), post-polio syndrome (445), and spinal cord injury (323)<br />
(total N=1513) participating in an ongoing longitudinal survey. Individuals<br />
aged 45-94 were included in this analysis. Scores for the overall<br />
sample, by diagnostic group and by age categories, were compared<br />
to the PROMIS US population norms.<br />
Results: Compared to the US general population, individuals<br />
aging with disabilities reported a higher symptom burden and<br />
poorer QoL on 6 of 7 measures (all p
P OSTER<br />
A BSTRACTS<br />
Methods: Two hundred and four volunteers at McLaren Regional<br />
Medical Center in Flint, Michigan, in May 2011, were<br />
mailed an anonymous survey. The RAND 36–Item Health Survey<br />
(Version 1.0) was used as the instrument for quality of life measurement.<br />
The demographic questions included: gender, age, marital<br />
status, ethnicity, completed level of education and house–hold<br />
income. The responses were collected for eight weeks. We analyzed<br />
demographic variables and compared them between our<br />
mean and those of the general elderly volunteering population,<br />
obtained from the literature. Analysis of quality of life data is<br />
pending.<br />
Results: One hundred and three participants returned completed<br />
surveys, resulting in a 45% response rate. 91% were female,<br />
ages 65 to 94, with the majority (38%) in the 75-84 range. 91% were<br />
Caucasian; 55% were single, as opposed to residing with someone or<br />
married. Majority had either completed the 12th grade (38%) or<br />
some college (35%). 28% had an annual income range in the<br />
$20–34,000, though a significant proportion chose not to provide this<br />
information.<br />
Conclusion: National data tends to group older volunteering<br />
adults into one large category of 65 years and older, however, we<br />
were able to break this group down and revealed the demographic<br />
variables. Additionally, as opposed to the current research which suggests<br />
that those with higher educational and income levels make up<br />
the general volunteering population, our research indicates that it is<br />
those which fall in the middle range on both items who choose to participate<br />
in volunteering activity.<br />
C161<br />
The Relationship Between Body Weight and Quality of Life in<br />
Older Adults with Medicare Supplement Insurance.<br />
K. Hawkins, 1 F. G. Bottone Jr, 1 S. Musich, 1 R. J. Ozminkowski, 1,2<br />
Y. Cheng, 1 R. J. Migliori, 2 C. S. Yeh. 3 1. Advanced Analytics,<br />
OptumInsight, Ann Arbor, MI; 2. UnitedHealth Group Alliances,<br />
Minnetonka, MN; 3. AARP Services, Inc., Washington, DC.<br />
Supported By: UnitedHealth Group and AARP Services, Inc. (ASI).<br />
The objective of this study was to estimate the relative impact<br />
that each body mass index (BMI) category has on health-related<br />
quality of life. A mail survey was sent to 60,000 adults with an<br />
AARP®-branded Medicare Supplement Insurance (i.e. Medigap)<br />
plan provided by UnitedHealthcare Insurance Company (for New<br />
York residents, UnitedHealthcare Insurance Company of New York)<br />
in 10 states. The Medicare Health Outcomes Survey instrument was<br />
used, but renamed the Health Update Survey, for use with a Medigap<br />
sample. Casemix-adjusted comparisons were made between each<br />
BMI category versus those with normal BMI.A total of 22,827 (38%)<br />
eligible sample members responded to the survey. Respondents had<br />
the following BMI categories: 2.2% were underweight, 37.0% were<br />
overweight, 18.5% were obese, 1.9% were morbidly obese, 38.5% had<br />
a normal BMI and 1.9% were missing BMI information. Factors associated<br />
with being underweight or carrying excess body weight were<br />
generally consistent with past reports. Quality of life was assessed<br />
using the average physical component scores (PCS) and mental component<br />
scores (MCS) obtained from the VR-12 health status tool. Respondents’<br />
PCS values were 5.01, 0.16, 3.60 and 9.50 points lower on<br />
average, respectively, for the underweight, overweight, obese and<br />
morbidly obese BMI categories, compared to the normal BMI group.<br />
Respondents’ MCS values were 3.28, +0.52, 0.32 and 1.39 points<br />
lower on average, respectively for the underweight, overweight,<br />
obese and morbidly obese BMI categories, compared to the normal<br />
weight group. The greatest impact on quality of life was on those in<br />
the underweight and morbidly obese categories, with the greater negative<br />
impacts were on the physical rather than mental aspects of quality<br />
of life.<br />
C162<br />
The Responsiveness of Quality of Life Measures in Patients with<br />
Alzheimer’s Disease: Results from the Canadian Alzheimer’s<br />
Disease Quality of Life Study.<br />
G. Naglie, 1,2 D. Hogan, 5 M. Krahn, 3,4 S. Black, 4 M. Freedman, 4<br />
L. Beattie, 6 M. Borrie, 7 A. Byszewski, 8 C. MacKnight, 9 C. Patterson, 10<br />
H. Bergman, 11 J. Irvine, 12 P. Ritvo, 12 D. Streiner, 10 J. Comrie, 12<br />
M. Kowgier, 4 G. Tomlinson. 3,4 1. Baycrest, Toronto, ON, Canada; 2.<br />
Toronto Rehab, Toronto, ON, Canada; 3. Toronto General Research<br />
Institute, Toronto, ON, Canada; 4. University of Toronto, Toronto, ON,<br />
Canada; 5. University of Calgary, Calgary, AB, Canada; 6. University<br />
of British Columbia, Vancouver, BC, Canada; 7. University of Western<br />
Ontario, London, ON, Canada; 8. University of Ottawa, Ottawa, ON,<br />
Canada; 9. Dalhousie University, Halifax, NS, Canada; 10. McMaster<br />
University, Hamilton, ON, Canada; 11. McGill University, Montreal,<br />
QC, Canada; 12. York University, Toronto, ON, Canada.<br />
Supported By: Canadian Institutes of Health Research, Alzheimer<br />
<strong>Society</strong> of Canada and the University Health Network Geriatric Fund.<br />
Purpose: To assess the responsiveness of a variety of generic and<br />
disease-specific quality of life (QOL) measures in patients with<br />
Alzheimer’s disease (AD).<br />
Methods: We recruited 272 community-living AD patients and<br />
their caregivers from clinics across Canada. Patients with MMSE<br />
scores > 10 rated their QOL using the EQ-5D, Quality of Well-Being<br />
scale, a visual analogue scale and the QOL in AD (QOL-AD) instrument.<br />
Caregivers rated patient’s QOL using these measures as well as<br />
the Health Utilities Index (HUI) and Short-Form-36. QOL and patients’<br />
cognition (AD Assessment Scale-Cognitive), function (Disability<br />
Assessment for Dementia) and neuropsychiatric symptoms<br />
(Neuropsychiatric Inventory and Geriatric Depression Scale) were<br />
assessed at baseline, 6, 12 and 24 months. We evaluated internal responsiveness<br />
using the standardized effect size and the standardized<br />
response mean. We assessed external responsiveness using receiver<br />
operating characteristic (ROC) curves for the QOL measures based<br />
on a decline or no decline in a composite score based on the first principal<br />
component of the core dementia symptoms.<br />
Results: At baseline, patients’ mean age was 82.8, 50.2% were<br />
female and mean MMSE was 20.2. For patient self-ratings, the QOL<br />
measures did not exhibit meaningful responsiveness over time. For<br />
caregiver ratings of patient QOL: the internal responsiveness of the<br />
QOL measures at 12 and 24 months was small (0.12 to 0.28) and small<br />
to moderate (0.22 to 0.59), respectively; the external responsiveness<br />
at 12 and 24 months was greatest for the EQ-5D, QOL-AD and HUI,<br />
with areas under the ROC curves of 0.67 to 0.77.<br />
Conclusions: Over 24 months of follow-up, patient self-ratings of<br />
QOL did not exhibit meaningful responsiveness, while caregiver ratings<br />
of patient QOL with the QOL-AD, HUI and EQ-5D exhibited<br />
moderate responsiveness.<br />
C163<br />
Physical Therapy Interventions Utilizing Dual Task Phenomenon to<br />
Decrease Cognitive-motor Interference in a Person Status-post<br />
Intercerebral Hemorrhage: a Case Report.<br />
A. Tilsley, G. L. Raymond. Physical Therapy, Samuel Merritt<br />
University, Oakland, CA.<br />
BACKGROUND: Cognitive-motor interference (CMI) is a<br />
phenomenon in which the simultaneous performance of a motor and<br />
cognitive task interferes with the performance of one or both tasks.<br />
CMI can occur after a stroke, increasing a person’s risk of falls as they<br />
may be unable to react to unexpected challenges during ambulation.<br />
The objective of this case report is to demonstrate how the theory of<br />
CMI was used to develop interventions aimed at decreasing a patient’s<br />
fall risk.<br />
DESIGN: Case report.<br />
SETTING: Acute rehabilitation in Northern California.<br />
S186<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
PARTICIPANT: 57-year-old female with a hemorrhage in the<br />
basal ganglia.<br />
INTERVENTION: Interventions were aimed at addressing balance<br />
and gait. CMI was addressed during functional activities that required<br />
multitasking. Dual task challenges include carrying objects in<br />
her hands, carrying a tray with various items, and talking or answering<br />
questions while ambulating. Dual task challenges progressed along<br />
with gait interventions by utilizing different surfaces and environments.<br />
MEASUREMENTS: Timed Up and Go (TUG), TUG manual,<br />
TUG cognitive, Dynamic Gait Index (DGI).<br />
RESULTS: TUG improved from 14 to 10 seconds, TUG manual<br />
from 15 to 10 seconds, TUG cognitive from 21 to 13 seconds. Dynamic<br />
Gait Index increased from 14 to 21.<br />
CONCLUSION: After using the dual task paradigm to create<br />
interventions focused on decreasing the extent of CMI without deterioration<br />
of either motor or cognitive task, the patient showed improvements<br />
in independence and safety during ambulation and transfers<br />
and decreased risk of falls.<br />
C164 Encore Presentation<br />
Functional Trajectories of Elderly Patients admitted in a Geriatric<br />
Rehabilitation Unit after discharge of acute hospitalization.<br />
E. Martínez, 1,2 J. Sánchez Rodríguez, 1 N. Albiol Tomàs, 1 R. Audi<br />
Ferrer, 1 J. García Navarro. 2 1. Geriatric Department, Hospital de la<br />
Santa Creu, Tortosa, Tarragona, Spain; 2. Grup Sagessa, Reus,<br />
Tarragona, Spain.<br />
Background:The aim of this study is to analyze which factors<br />
evaluated during the Comprehensive Geriatric Assessment(CGA),<br />
performed at acute care by a geriatric team, predict functional trajectories<br />
in elderly patients transferred to a Geriatric Rehabilitation<br />
Unit(GRU).<br />
Methods: Prospective study. All acute hospitalized patients evaluated<br />
(June - December 2010) and transferred to our GRU were included<br />
and followed-up till discharge. Collected data: age, sex, diagnostic<br />
groups (orthopedics, stroke, others); functional status –<br />
activities of daily living (ADLs) previous to acute hospitalization,in<br />
acute care and at discharge (Barthel index,BI). Comorbidity (modified<br />
Charlson Index),dementia,delirium in acute care, length of stay<br />
in acute and rehabilitation units,laboratory data (Hematocrit,Albumin,Total<br />
Proteins, ESR,CRP),polipharmacy and if patient lives<br />
alone.<br />
Statistical Analysis: Characteristics of ability in ADLs patients<br />
groups were compared using t-test to evaluate differences in means<br />
and chi-square test to evaluate differences in percentages; and multivariate<br />
analysis by logistic regression.SPSS v.17 software.<br />
Results: 174 patients evaluated; 12.6 % died; Mean age: 77 years<br />
(±17.5); 48.3% male. Length stay in acute care:12.3 days (± 10.4),<br />
length in GRU: 56 days (± 51.9). Previous BI mean 78.6 (± 22.3);BI in<br />
acute care mean 27.2 (±26.2);BI at discharge 49.2 (± 36.3). Independent<br />
ability to walk: previous: 70.7%, in acute care: 3.4%, at discharge:<br />
37.9%. Patients with dementia: 25.3%,delirium: 25.9%; polipharmacy:<br />
71.3%,living alone 35.6%. Diagnosis groups: Orthopedic<br />
33.5%, stroke 22.9%, cardiovascular and others 32.9%. Modified<br />
Charlson Index: mean 1.8 (±1.2).<br />
In multivariate analysis, factors related to walk independent<br />
were absence of dementia and short lengths of stay in GRU. Dementia,Cardiopathy<br />
and long length of stay in acute care were associated<br />
with poor functional prognosis. The functional decline in acute care<br />
should explain 15% of functional trajectory (Pearson coeff. correlation<br />
0.38).<br />
Conclusions: The probability to walk independent was low in<br />
demented patients with long length of stay in the GRU. The best ability<br />
in ADLs was achieved in patients with a short length of stay in<br />
acute care, with orthopedic diagnosis on admission and no comorbidity<br />
as dementia, delirium and heart disease.<br />
C165<br />
Factors associated with acute care readmissions from a skilled<br />
nursing facility.<br />
R. Y. Blake, K. Fairfield, H. Wierman, R. Marino. <strong>Geriatrics</strong>, Maine<br />
Medical Center, Portland, ME.<br />
Background:<br />
Readmission from skilled nursing facilities (SNF) to acute care<br />
hospitals is costly, disruptive, and may serve as a marker of poor quality<br />
care. This study was designed to investigate risk factors for readmission<br />
in a single small, suburban skilled nursing facility.<br />
Methods:<br />
We conducted a retrospective chart review of all admissions to a<br />
SNF in Maine within a one year period (N=130). We excluded four<br />
patients with incomplete data (final N=126). Data collected included<br />
patient age, gender, day and month of admission, days from SNF admission<br />
to first physician contact, and admitting primary and secondary<br />
diagnoses. For patients who were readmitted to an acute care facility<br />
within 30 days, we reviewed hospital admission records to<br />
determine primary readmission diagnosis. We used descriptive statistics<br />
(chi square, t-test) for data analyses.<br />
Results:<br />
The mean age of the population was 82 years, with a range of 50-<br />
99. The majority were women (79/126, 63%). The overall 30-day readmission<br />
rate was 13% (17/126). A significantly higher proportion of<br />
men were readmitted vs. women (21% vs. 9%, p=0.05). 63% (12/17)<br />
of readmissions were attributable to patients admitted during the<br />
months of December, January, and March. There was a mean of 1.8<br />
+/- 1.7 days from SNF admission to initial physician contact, and this<br />
was similar for readmitted vs. non-readmitted patients (2.3 +/-1.8 vs.<br />
1.8 +/- 1.7, p=0.35). Specific primary diagnoses associated with the<br />
highest readmission rates included GI bleed (2/5, 40%), pneumonia<br />
(3/9, 33%), CAD (1/3, 33%), UTI (3/10, 30%), and CHF (2/9, 22%).<br />
At the time of acute hospital readmission, top diagnoses were similar,<br />
also including pneumonia (4/17, 24%), CHF (2/17, 12%), and GI<br />
bleed (12%), with the addition of multifactorial delirium (12%). Patients<br />
who were ultimately readmitted had significantly more active<br />
comorbidities (8.0 +/- 2.7) than those were not readmitted (6.3 +/-<br />
2.3), p=0.02.<br />
Conclusions:<br />
In this population, patients at higher risk for readmission include<br />
males, those with a higher number of active comorbidities, and<br />
patients with a primary diagnosis of GI bleed, infection (UTI, pneumonia),<br />
or cardiovascular disorder (CAD, CHF). Closer attention to<br />
these higher risk patients, in conjunction with strict adherence to established<br />
guidelines and standards of care, may help to minimize unnecessary<br />
acute care hospital readmissions in the future.<br />
Poster Session D<br />
Friday, May 4<br />
3:00 pm – 4:30 pm<br />
D1<br />
Amiodarone-induced Rhabdomyolysis.<br />
E. C. Ong, 1 N. Maheshwari, 1 A. Sy, 1 E. Roffe, 2 S. Chaudhari, 1,2<br />
D. Kumari, 2 S. Mushiyev. 1 1. Internal Medicine, Metropolitan Hospital<br />
Center, New York, NY; 2. Geriatric Medicine, Metropolitan Hospital<br />
Center, New York, NY.<br />
Introduction: Rhabdomyolysis is a condition characterized by<br />
muscle necrosis causing release of muscle enzymes into the circulation,<br />
resulting in elevated serum creatinine kinase (CK) levels. It is<br />
rarely caused by Amiodarone. We present a case of an elderly male<br />
with amiodarone-induced rhabdomyolysis.<br />
AGS 2012 ANNUAL MEETING<br />
S187
P OSTER<br />
A BSTRACTS<br />
Case: A 78 year-old male with history of coronary artery disease,<br />
hypertension and chronic atrial fibrillation was admitted following a<br />
fall without major injury. He presented with a two-month history of<br />
progressive muscle weakness and pain resulting in difficulty in ambulation.<br />
He underwent coronary artery bypass graft two months prior.<br />
Medications included cardizem, digoxin, warfarin, simvastatin, amiodarone.<br />
Physical examination was remarkable for generalized muscle<br />
tenderness and decreased muscle strength of 3-4/5 in all four extremities.<br />
Laboratory tests showed elevated CK of 10,280, aspartate<br />
aminotransferase of 563, alanine aminotransferase of 403, alkaline<br />
phosphatase of 99, normal renal function. Urinalysis showed large<br />
blood with 5-10 red blood cells. Simvastatin was stopped and patient<br />
was started on intravenous hydration. His CK level transiently decreased<br />
to 8,900, but on the third day it increased to 11,600. Intravenous<br />
hydration was continued and bicarbonate drip was started.<br />
Patient’s family later reported that amiodarone was just recently<br />
started after the bypass graft two months prior. Amiodarone was<br />
stopped and the patient’s clinical status steadily improved. By day<br />
seven, his CK level dropped to 700.<br />
Discussion: The severity of rhabdomyolysis ranges from asymptomatic<br />
elevations in serum muscle enzymes to life-threatening cases<br />
with extreme enzyme elevations, electrolyte imbalances and renal<br />
failure. Classic presentation includes myalgia, red to brown urine due<br />
to myoglobinuria, and elevated serum CK levels. Many drugs are<br />
known to cause rhabdomyolysis including statins, colchicine, and cocaine.<br />
Few cases of amiodarone-induced rhabdomyolysis have been<br />
reported. In this case, the patient continued showing worsening CK<br />
levels in spite of stopping the statin. His clinical status and CK level<br />
dramatically improved upon discontinuation of amiodarone. Physicians<br />
must keep in mind that amiodarone can be one of the uncommon<br />
causes of rhabdomyolysis.<br />
D2<br />
Chronic Subdural Hygroma presenting as Dementia.<br />
E. C. Ong, 1 N. Maheshwari, 1 E. Roffe, 2 S. Chaudhari, 1,2 D. Kumari, 2<br />
M. Belal. 1 1. Internal Medicine, Metropolitan Hospital Center, New<br />
York, NY; 2. Geriatric Medicine, Metropolitan Hospital Center, New<br />
York, NY.<br />
Introduction: Chronic subdural hygroma is common among elderly<br />
individuals. It is a lesser-known potentially reversible cause of<br />
dementia. We present a case of an elderly male with chronic subdural<br />
hygroma presenting as dementia.<br />
Case: An 81 year-old male with medical history of mild hypertension<br />
was brought in by his daughter to Geriatric clinic to establish<br />
medical care. Patient was recently seen by psychiatry and neurology<br />
due to insomnia and agitation (especially at night), started on Memantine<br />
and Donepezil for diagnosis of Dementia. Physical examination<br />
was unremarkable except for disorientation to place and time, inability<br />
to do three-item recall, and Mini-mental state examination<br />
score of 17/30. Laboratory tests were normal including thyroid functions,<br />
vitamin B12, and Syphillis IgG. CAT scan of the brain revealed<br />
chronic subdural hygroma overlying the right cerebral convexity with<br />
midline shift, moderate cerebral and cerebellar atrophy. Patient was<br />
referred to neurosurgery clinic, however patient and family refused to<br />
undergo any neurosurgical intervention. Repeat brain CAT scan<br />
showed increase in subdural hygroma with possible subacute and/or<br />
acute component, but patient had no worsening of clinical<br />
signs/symptoms on subsequent clinic follow-ups. Patient will be followed<br />
in neurosurgery, neurology and geriatric clinic with serial brain<br />
CAT scan.<br />
Discussion: Chronic subdural hygroma is a subdural collection<br />
of cerebrospinal fluid (CSF). This results from sudden decrease in<br />
pressure by ventricular shunting leading to leak of CSF from the subarachnoid<br />
space into the subdural space especially in cases with moderate<br />
to severe brain atrophy. Elderly patients are prone to develop<br />
hygromas owing to frequent falls sustaining head trauma, and significant<br />
cerebral atrophy related to old age. Large hygromas may cause<br />
secondary localized mass effects on the adjacent brain parenchyma<br />
causing neurologic symptoms. Global deficits such as disturbances of<br />
consciousness are more common than focal deficits. Brain CAT scan<br />
would show crescent-shaped extra-axial lesions. Surgical evacuation<br />
is recommended if there is evidence of moderate to severe cognitive<br />
impairment or progressive neurologic deterioration. Physicians<br />
should recognize chronic subdural hygroma as a reversible cause of<br />
dementia among the geriatric population.<br />
D3<br />
Actinomyces israelii - A rare cause of prosthetic joint infection in<br />
the elderly.<br />
G. Gulati, S. Gulati, D. Powell. Internal Medicine, The Reading<br />
Hospital and Medical Center, West Reading, PA.<br />
INTRODUCTION: Actinomyces prosthetic joint infections are<br />
extremely rare, described in only half a dozen case reports in medical<br />
literature. Our case describes a patient who presented with new onset<br />
prosthetic joint infection with no identifiable local or systemic source<br />
or trauma.<br />
CASE PRESENTATION: A 72 year old male with a history of<br />
left total hip replacement in 2002 presented to the hospital with a one<br />
month history of night sweats and progressively worsening pain in the<br />
left leg. He denied any fever, trauma or injury to the affected side. On<br />
physical exam, he had a temperature of 38.7 degrees Celsius and a<br />
pulse of 115 per minute. Musculoskeletal examination was significant<br />
for a tender left hip joint at the groin with limited range of motion.<br />
On laboratory work up, he had an ESR of 82mm/sec, CRP of 15<br />
mg/dL and leukocytosis of 31,300/cu mm with 90% neutrophils. CT<br />
scan of the hip revealed an attenuated fluid-filled distended region<br />
anterior to the hip prosthesis and muscular asymmetry suspicious for<br />
an abscess. Surgical arthrotomy of the left hip joint with debridement<br />
was done. On histopathology, the specimen showed granulation tissue<br />
with acute-on-chronic inflammation and grew Actinomyces israelli<br />
on cultures. He was started on ampicillin and later switched to doxycycline<br />
due to a significant allergic reaction to the former for 6 weeks.<br />
He was discharged with instructions for outpatient follow up for prosthesis<br />
removal.<br />
DISCUSSION: Actinomyces israelii, a gram positive anaerobic<br />
bacterium, causes infections involving the oral cervicofacial area,<br />
lungs and abdomen. Involvement of the musculoskeletal system is<br />
rare and attributable to adjacent soft tissue infections, occasionally to<br />
local trauma or hematogenous spread. Late infections of prosthetic<br />
joints have been described in literature as spread from an extra articular<br />
site. Diagnosis is established by bacteriological identification<br />
using sterile cultures showing characteristic appearance and sulfur<br />
granules. Penicillins are the mainstay of treatment, and use of tetracycline<br />
class has been reported in cases of penicillin allergy. A combination<br />
of medical and surgical therapy with consideration for prosthesis<br />
removal needs to be considered. Some experts recommend prolonged<br />
antibiotic courses for better results. Early recognition of this<br />
entity even in the absence of an obvious predisposing cause is required<br />
for early diagnosis and institution of therapy.<br />
D4<br />
Confusion, ataxia and psychosis - amphetamine toxicity in the<br />
elderly.<br />
G. Gulati, S. Gulati. Internal Medicine, The Reading Hospital and<br />
Medical Center, West Reading, PA.<br />
INTRODUCTION: Amphetamine abuse is the primary cause<br />
of emergency visits in 73,400 patients per year in the United States.<br />
Classic presentations include psychosis, agitation and sympathomimetic<br />
signs.<br />
CASE PRESENTATION: A 62 year old male with a past history<br />
of recreational drug abuse presented with acute onset unsteady<br />
S188<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
gait, word finding difficulty and erratic speech, with mild confusion<br />
and confabulation. Fixed delusions were also noted, as well as visual<br />
and auditory hallucinations. He and his accompanying family denied<br />
any recent alcohol use. On physical exam, he had a blood pressure of<br />
186/105, and neurological examination revealed hypertonia, positive<br />
Romberg’s test and abnormal heel to toe test as well as incoordination<br />
of movements. He also had some cog wheeling and would fall<br />
backwards on standing, which did not change with eyes being open or<br />
closed. Laboratory evaluation revealed stable CBC with differential,<br />
normal electrolytes, mild transaminitis, a negative blood alcohol level,<br />
negative Lyme test and RPR serology. It was however positive for<br />
amphetamines in the urinary drug screen. The patient was treated<br />
with as needed lorezapam and haloperidol. Over the next day or two<br />
he improved significantly and his problems including ambulatory<br />
dysfunction had resolved.<br />
DISCUSSION: Confusion, ataxia and psychosis are symptoms<br />
common to alcohol withdrawal, drug ingestion and other rarer medical<br />
conditions. Elucidating a cause becomes vital in the elderly where<br />
this triad may be a common presentation. It is important to remember<br />
to obtain a drug screen in a patient where symptoms don’t fit in<br />
and common diagnoses such as alcohol withdrawal seem less likely,<br />
even in extremes of age. Early interventions with atypical antipsychotics<br />
and benzodiazepines are warranted and bring about improvement<br />
in symptoms.<br />
D5<br />
An Interesting Case of Ankle Pain in an Arthritic Older Adult.<br />
I. Sulapas, D. S. Edwards, B. G. Jones. Family & Community Medicine,<br />
Texas Tech University Health Sciences Center, Lubbock, TX.<br />
Supported By: This project has received no funding.<br />
Introduction: Osteochondritis dissecans (OCD) of the talus is<br />
more commonly seen in the adolescent and young male population,<br />
but should be in the differential for ankle pain in an older adult.<br />
History: A 60-year-old Hispanic male presented with complaints<br />
of left ankle pain for the last 3 months. He has a long past medical history<br />
of diabetes (HbA1c 7.0%), coronary artery disease with stents,<br />
hypertension, osteoarthritis, stroke, and peripheral vascular disease.<br />
He is poorly compliant with his medications. The patient stated that<br />
he has never had an evaluation of his left ankle and denied any<br />
trauma to the foot. He is currently wheelchair bound secondary to a<br />
stroke four years ago. An angiogram two months prior to initial visit<br />
showed that his lower legs are well perfused. He described the ankle<br />
pain as sharp, located in the left medial ankle region with swelling,<br />
non-radiating, and pain only when he is bearing any weight. He denied<br />
any tingling sensation to his feet, as well as any locking or catching<br />
of his left ankle. Findings: On physical exam, there was 1+ edema<br />
on the medial portion of left ankle, 2+ pulses on left posterior tibialis<br />
and dorsalis pedis arteries, and brisk capillary refill noted. There was<br />
tenderness on both the tibiotalar joint and the medial malleolus, and<br />
full ankle passive and active range of motion. His sensation was intact,<br />
and 3/5 motor strength. A radiograph of the left ankle revealed a<br />
large subchondral bone defect extending into the articular surface of<br />
the talar dome and joint effusion (Stage IIb). A subsequent MRI<br />
showed a 1.5 cm osteochondral defect of the medial portion of the<br />
talus extending to the articular surface without definite evidence of<br />
collapse.<br />
Discussion: Clinicians should include OCD in the differential diagnosis<br />
for chronic ankle pain in an older adult. OCD is a relative<br />
rare disorder that is characterized by an area of subchondral bone<br />
that undergoes necrosis. The adult form of OCD is commonly seen in<br />
patients from 16 to 50 years of age. Knee joints are most common,<br />
with 75% of cases reported, followed by the elbow (6%), then ankle<br />
4%). The talus supports the axial load during weight-bearing, so it<br />
plays a vital role in ankle motion. Treatment involves immobilization<br />
and observation, however if symptoms persist or grinding or catching<br />
develops, an orthopedic consult is warranted for arthroscopic drilling<br />
versus bone graft.<br />
D6<br />
“Doc, I want to die”: the ethical dilemma of a patient’s right to<br />
refuse life-saving treatment due to a death wish.<br />
J. K. Yuen, 1 K. Covinsky, 1,2 R. Sudore. 2,1 1. <strong>Geriatrics</strong>, UCSF, San<br />
Francisco, CA; 2. VAMC, San Francisco, CA.<br />
Case: A 64 year-old recently widowed man presented with fever,<br />
weight loss and abdominal pain. CT scan revealed multiple liver abscesses.<br />
Infectious Disease thought that drainage and antibiotics<br />
would be curative and that no treatment would be fatal. The patient<br />
initially consented to drain placement but later refused further drain<br />
manipulation, antibiotics and antidepressants stating, “I have nothing<br />
to live for” and “I want to die.” Psychiatry evaluation revealed that he<br />
had a long history of depression and refusal of medical and psychiatric<br />
treatment. Multiple discussions took place over two weeks between<br />
the patient and his primary team, Palliative Care, and Psychiatry.<br />
All providers agreed that he expressed a clear choice and<br />
understood the risks of his decision. Yet, there were conflicting opinions<br />
regarding his decision-making capacity. Some providers were<br />
deeply disturbed by the patient’s irrational choice and felt that his depression<br />
and passive suicidal ideation rendered him incapable of<br />
making decisions. Others felt that the patient retained valid internal<br />
reasoning as evidenced by his clear and consistent thought process.<br />
The ethics committee deliberated and deferred the capacity determination<br />
to the primary team who felt the patient retained capacity. The<br />
patient opted for comfort care, antibiotics were discontinued, and the<br />
patient was transferred to an inpatient hospice unit.<br />
Discussion: This case highlights the dilemma between the ethical<br />
principles of beneficence and honoring patients’ autonomy to refuse<br />
treatment – in this case, for a curable and otherwise fatal condition in<br />
the setting of depression and a wish to die. A diagnosis of depression<br />
is not sufficient to render someone incapable of decision making. To<br />
have capacity, patients must demonstrate reasoning as defined as consistency<br />
of choice and the ability to weigh the risks, benefits and consequences<br />
of decisions. Disagreement arises over whether the determination<br />
of intact reasoning should be based upon a patient’s<br />
internal values and worldview or whether the external rationality of<br />
the patient’s decision in the context of societal norms should also be<br />
considered. Although the patient in this case made a choice that is<br />
considered highly irrational by many, it was determined that he<br />
demonstrated intact reasoning and the capacity to refuse treatment.<br />
D7<br />
Rapid Onset Hyponatremia After Initiating TMP/SMX and<br />
Citalopram.<br />
J. M. Redding, 1 S. Nichols, 2 S. Hallen. 1 1. Dept. of <strong>Geriatrics</strong>, Maine<br />
Medical Center, Portland, ME; 2. Dept. of Pharmacy, Maine Medical<br />
Center, Portland, ME.<br />
TMP/SMX-induced hyponatremia, while rare, is a likely underdiagnosed<br />
event. By decreasing aldosterone-mediated sodium reabsorption<br />
in the collecting duct, TMP/SMX, in synergy with other<br />
serum sodium-lowering medications, such as selective serotonin reuptake<br />
inhibitors (SSRIs), may cause severe hyponatremia.<br />
A 79-year-old female was admitted with weakness, confusion,<br />
and a serum sodium of 119mEq/L (140 mEq/L 10 days prior to admission.)<br />
Citalopram and TMP/SMX had been initiated 7 and 3 days<br />
prior, respectively. On exam, the patient appeared euvolemic. Laboratory<br />
data revealed hypotonic hyponatremia (serum osmolality=248mOsm/kg)<br />
with a creatinine clearance of 36ml/min. A head<br />
CT was normal. Both medications were discontinued on admission.<br />
Initial therapy with 0.9% NaCl resulted in a decreased sodium level<br />
of 117mEq/L after 4 hours. A slow infusion of 3% NaCl then increased<br />
her sodium to 129meq/L (12mEq/L in 24hrs). She was transitioned<br />
to a fluid restriction of 1.5L/day and her sodium increased further<br />
to 136mEq/L by hospital day 4, with resolution of her symptoms.<br />
The patient developed severe, rapid onset hyponatremia after<br />
initiating TMP/SMX in addition to citalopram. We hypothesize that<br />
AGS 2012 ANNUAL MEETING<br />
S189
P OSTER<br />
A BSTRACTS<br />
two synergistic mechanisms caused the hyponatremia. The first was<br />
the syndrome of inappropriate antidiuretic hormone (SIADH) secondary<br />
to citalopram. Her presentation is consistent with SIADH as<br />
evidenced by euvolemia, low serum osmolality, and worsening hyponatremia<br />
with a normal saline challenge. We find support for a second<br />
mechanism from the unusually rapid and severe onset of the<br />
SSRI-induced SIADH. The addition of TMP/SMX may have worsened<br />
the hyponatremia through trimethoprim-mediated aldosterone<br />
antagonism. Consistent with this hypothesis, the patient showed rapid<br />
improvement of her hyponatremia by hospital day 4, when citalopram<br />
was still present in her serum while TMP/SMX was already<br />
eliminated. (Given the patient’s age and renal function, TMP/SMX’s<br />
T½=18hrs and citalopram’s T½=50hrs.)<br />
The potential synergism between TMP/SMX and citalopram, as<br />
observed in this case, merits a warning as a potential drug interaction.<br />
Providers should take care when adding TMP/SMX to a regimen containing<br />
other potentially hyponatremia-inducing medications, particularly<br />
in cases of renal dysfunction.<br />
D8<br />
Missed Diagnosis of Waldenstrom’s Macroglobulinemia and<br />
Systemic Amyloidosis in a Patient Diagnosed as Follicular<br />
Lymphoma.<br />
J. Silvestre, S. Saad. Montefiore Medical Center / Albert Einstein<br />
College of Medicine, Bronx, NY.<br />
Supported By: No financial disclosures<br />
Waldenstrom’s Macroglobulinemia (WM) is a rare lymphoplasmacytoid<br />
malignancy present in 2.5/million/year. Of these, < 5% develop<br />
systemic amyloidosis (AL). We present a case of WM complicated<br />
by AL, erroneously diagnosed as a benign follicular lymphoma.<br />
Cardiac amyloidosis and WM were found on postmortem pathology.<br />
Case: A 79 year old male was transferred from a nursing home<br />
because of fever and hypotension.<br />
His past medical history included hypertension, seizure disorder,<br />
anemia, peptic ulcer disease, Parkinson’s disease. Patient had an excellent<br />
functional and cognitive status until diagnosed with follicular<br />
center lymphoma with M-gammopathy by biopsy 15 months before<br />
presentation. On retrospective analysis, flow cytometry was CD10+,<br />
CD19+, and CD20+. PET CT scan showed minimal involvement of<br />
retroperitoneal lymph nodes but no hepatosplenomegaly. Bone scan<br />
was negative, IgM > 5 g/dL, and beta-2-microglobulin was elevated.<br />
He had received one month of rituximab. Soon afterwards, he developed<br />
diverticular perforation requiring colostomy. Later, a delayed<br />
colostomy reversal surgery was complicated by sepsis and acute kidney<br />
injury, needing dialysis. Subsequent clinical course worsened with<br />
functional decline and multiple admissions due to urinary tract infections,<br />
C. difficile diarrhea, and health care associated pneumonia.<br />
Hospital Course: On the Emergency Department, the patient<br />
was hypotensive and unresponsive. Laboratory data showed pyuria,<br />
leukocytosis, and anemia. Electrocardiogram showed normal sinus<br />
rhythm. Chest X-ray showed mild congestive heart failure. Prior<br />
echocardiogram showed normal function but left ventricular hypertrophy.<br />
The patient was fluid resuscitated and treated with broad<br />
spectrum antibiotics for presumed sepsis. Later he defervesced and<br />
stabilized, however his heart failure worsened. His overall prognosis<br />
remained poor. Palliative care was instituted and he expired 12 days<br />
after admission.<br />
On postmortem pathology, extensive systemic amyloidosis was<br />
found and significant cardiac involvement was reported. Lymphoplasmacytoid<br />
cells were identified, suggestive of WM.<br />
Discussion -<br />
When patients with lymphoma and gammopathy develop symptoms<br />
of heart failure, AL should be suspected since it drastically reduces<br />
the survival. Expression of CD10 and CD23 may be found in 10<br />
to 20% of cases and should not exclude WM. Coexistence of WM and<br />
AL carry a grim prognosis.<br />
D9<br />
Topical clindamycin phosphate use for chest wall follicultis<br />
complicated by severe Clostridium difficle infection.<br />
J. Palla, 1 S. M. Imam, 1,2 S. B. Johnson. 3,4 1. <strong>Geriatrics</strong>, Edward Hines<br />
VA Hospital, Hines, IL; 2. Internal Medicine, Loyola university<br />
Hospital, Maywood, IL; 3. Infectious Disease, Edward Hines VA<br />
Hospital, Hines, IL; 4. Infectious Disease, Loyola university Hospital,<br />
Maywood, IL.<br />
Back ground: Topical application of clindamycin is not a well<br />
recognized risk for Clostridium difficile infection (CDI) but the association<br />
has been reported. We report a rare case of severe CDI following<br />
topical clindamycin phosphate use.<br />
Case report: A 62 year old male resident of a nursing home was<br />
transferred to the emergency room with fever, hypotension and<br />
tachycardia. He had history of Hartmann’s Colostomy done 4 months<br />
ago for recurrent diverticulitis followed by severe CDI. No history of<br />
exposure to antibiotics in the past 4 months or any other symptoms<br />
were elicited. Medication review did show 1% clindamycin phosphate<br />
ointment prescribed 3 weeks ago for chest wall folliculitis.<br />
Physical exam was non-contributory. Initial workup showed leukocytosis<br />
and a normal chest x-ray. Although bacterial sepsis was suspected<br />
initially, he developed loose colostomy output shortly after<br />
presentation and the white blood count increased to 23000 per cc 3 .<br />
Oral vancomycin treatment was started for suspected CDI and the diagnosis<br />
was confirmed by stool C.difficile toxin assay. The leukocytosis<br />
and loose colostomy output improved within 48 hrs. He was transferred<br />
back to the nursing home, where the clindamycin ointment was<br />
identified as a possible trigger for the colitis and was discontinued.<br />
Discussion: Twenty cases of topical clindamycin related diarrhea<br />
and two case reports of proven CDI were published from 1978 to<br />
1986. Pharmacokinetic and pharmacodynamic studies after topical<br />
clindamycin application have shown detectable serum concentrations<br />
and presumptive effects on intestinal flora. Animal studies have<br />
shown that the lethal dose applied topically to hamsters was similar to<br />
doses given to humans for treatment of acne. It is important to recognize<br />
this potential side effect of topical administration of clindamycin<br />
and use it cautiously, particularly in patients at high risk for CDI.<br />
D10<br />
Uncommon causes of intractable hallucinations in the demented<br />
elderly.<br />
K. Alagiakrishnan. Medicine, University of Alberta, Edmonton, AB,<br />
Canada.<br />
Introduction: Hallucinations are false sensory perceptions or experiences<br />
that a person sees, hears, smells or feels something but do<br />
not exist. It can be the result of the brain changes in dementia or as a<br />
result of medical problems. In this report, three uncommon causes of<br />
hallucinations in dementia patients are presented.<br />
Case reports:<br />
Case 1:<br />
A 75 year old female came for cognitive assessment. She had<br />
cognitive decline for the past two years. For the past four months, patient<br />
smelled sour gas (olfactory hallucinations) in the basement and<br />
it was thought to be due to confusion, which was secondary to dementia.<br />
A short course of antipsychotics did not help with the symptom.<br />
On one occasion, patient called the police for this problem. At<br />
that time a neurologist saw the patient in the ER and was sent home<br />
with a suspicion of query small stroke. During our assessment, we<br />
found no history of epilepsy or psychiatric disorders. There was no evidence<br />
of delirium or no neurological deficits were seen. MRI of the<br />
head showed large infiltrating mass involving both cerebral hemispheres<br />
and the differential diagnosis was an astrocytoma or possible<br />
lymphoma.<br />
Case 2:<br />
S190<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
An 80 year old woman, with a known history of dementia for<br />
the past five years, came for assessment of visual hallucinations (seeing<br />
a man through her bedroom window daily for the past nine<br />
months). No history of vision problems or psychiatric disorders.<br />
Cholinesterase inhibitor and antipsychotic treatment did not help<br />
with the visual hallucinations. A CT head taken at that time compared<br />
with the previous CT scan taken before one year showed an<br />
occipital lobe infarct, which might be contributing to these visual<br />
hallucinations.<br />
Case 3:<br />
An 84 year old male with a known history of dementia for the<br />
past 3 years came with a history of buzzing sound in the head (auditory<br />
hallucinations) for the past 5 months. Antipsychotic management<br />
did not help with the problem. A complete assessment including<br />
CT scan did not show any acute findings, except decreased hearing in<br />
both ears. Patient was sent to an audiologist and with the help of<br />
hearing aids, patient’s symptom got better.<br />
Conclusion:<br />
Psychotic behaviors may pose more challenges than cognitive<br />
decline for the demented patients as well as their caregivers. When<br />
demented patients present with intractable hallucinations, not responding<br />
to medical management, rare and unusual causes of hallucinations<br />
should be considered.<br />
D11<br />
Effect of language in cognitive testing of a bilingual older adult.<br />
K. Berg, 1 S. Mejnartowicz, 1 B. Olmedo, 1 L. Walke. 1,2 1. Yale School of<br />
Medicine, New Haven, CT; 2. VA Connecticut, West Haven, CT.<br />
Supported By: The authors have no financial disclosures to report<br />
Objective: Recognize potential language bias in cognitive testing<br />
of bilingual older adults<br />
Case: An 80-year-old Hispanic veteran was brought to the geriatrics<br />
consult clinic for a cognitive assessment. He graduated high<br />
school in Puerto Rico and had worked in English speaking settings in<br />
the United States for over 60 years. During the initial visit, he scored<br />
18/30 on the English language Mini-Mental State Examination with<br />
deficits in orientation (-8), recall (-3) and constructional praxis (-1).<br />
Three months later we administered the Saint Louis University Mental<br />
Status in English to better evaluate executive function. He scored<br />
13/30 with deficits in story comprehension (-6), recall (-4), orientation<br />
(-2), animal generation (-2), reverse digit span (-1), and clock drawing<br />
(-2) and was started on a cholinesterase inhibitor. At his 6-month<br />
visit, we repeated both tests in Spanish. Using the validated Spanish<br />
MMSE his score improved from 18/30 to 21/30 with changes in orientation<br />
(+2) and constructional praxis (+1). An on-site certified translator<br />
converted the SLUMS into Spanish making two cultural<br />
changes to the content: the characters “Jack and Jill” were changed to<br />
“Maria and Jose” and instead of a stockbroker, Maria was described<br />
as a businesswoman who owned a factory. On the Spanish version of<br />
the SLUMS, the patient’s score improved from 13/30 to 22/30 with the<br />
greatest changes in story comprehension (+4), clock drawing (+2), animal<br />
generation (+1), recall (+1) and attention (+1).<br />
Discussion: The 9-point difference on the SLUMS and 3-point<br />
difference on the MMSE illustrate several understudied issues regarding<br />
cognitive testing and among bilingual older adults. First, the<br />
effect of language may be more pronounced in tests of executive dysfunction,<br />
language generation and comprehension, which are core<br />
domains of cognition. Second, little is known about the effect of bilingualism<br />
on the aging brain or if there is a differential impact of cognitive<br />
deficits on the languages spoken by bilingual older adults, and<br />
these areas merit research. Lastly, because testing in the patient’s<br />
non-native language may misrepresent cognitive deficits, clinicians<br />
should attempt to administer language appropriate cognitive tests before<br />
making diagnostic and therapeutic decisions.<br />
D12<br />
Acute Encephalopathy as a complication of Small Bowel<br />
Obstruction.<br />
K. P. McIntosh, C. Rommesser, T. Caprio. Medicine, University of<br />
Rochester School of Medicine & Dentistry, Rochester, NY.<br />
Supported By: HRSA GTPD Grant #D01HP08792<br />
Background:<br />
We present a case of acute encephalopathy seen in a patient<br />
with a small bowel obstruction. The gastrointestinal tract has been<br />
classically seen as the main source of circulating and excretion of ammonia.<br />
This small molecule crosses the blood-brain barrier and is absorbed<br />
and metabolized by the astrocytes, a population of cells in the<br />
brain that constitutes 30% of the cerebral cortex. It is hypothesized to<br />
be a minor contributor in the cascade leading to encephalopathy associated<br />
with acute illness.<br />
Case Presentation:<br />
A 74 year old female nursing home resident with a history of f<br />
incisional and umbilical hernia repair was acutely admitted to the<br />
hospital with abdominal pain, nausea, and bilious vomiting and subsequently<br />
found to have a complete small bowel obstruction on CT<br />
scan. During her hospital course as the patient’s obstruction was<br />
medically managed via decompression, she ultimately developed significantly<br />
elevated ammonia levels, diffuse encephalopathy, and ultimately<br />
developed status epileptic. Her ammonia level at the time of<br />
her coma presentation was 193 mcg/dL. Her status epilepticus resolved<br />
with antiepileptic medications and with resolution of her small<br />
bowel obstruction she was treated with lactulose to help mitigate additional<br />
production of toxic ammonium metabolites. She improved<br />
significantly with concurrent rapid resolution of her elevated ammonia<br />
levels.<br />
Discussion:<br />
This case presents a unique presentation that shows an uncommon<br />
but likely complication of having an acute small bowel obstruction.<br />
Traditionally focus has been on hepatic impairments in clearance<br />
of ammonia containing metabolites as the primary cause of<br />
encephalopathy. However, it is necessary to be mindful of the significant<br />
role the small bowel plays in eliminating and producing toxic<br />
levels of ammonia. This case also illustrated the challenge of trying to<br />
reduce ammonia products with laxative in the setting of an immotile<br />
bowel due to the obstruction. The question of whether surgical correction<br />
a small bowel obstruction would have lessened the risk of encephalopathy<br />
is also a question that needs to be addressed in this setting.<br />
There needs to be a timeline developed of how long to pursue<br />
the medical management that addresses correcting the obstruction<br />
while simultaneously attempting to mitigate the toxin production<br />
contributing to a worsening encephalopathy.<br />
D13<br />
When a Good Story Gives the Wrong Impression: An Atypical<br />
Presentation of Complete Heart Block.<br />
K. James, I. Kopits. Department of Medicine-Section of <strong>Geriatrics</strong>,<br />
Boston University Medical Center , Boston, MA.<br />
Introduction: Syncope is a common clinical event in geriatric<br />
medicine and increases three-fold in patients over 80 years of age.<br />
The ability to risk stratify patients to outpatient versus inpatient management<br />
is critically important.<br />
Case Report: An 89 year old man with a history of diverticular<br />
bleeds, hypertension and an MI 15 years prior, presented for evaluation<br />
of nausea and dry heaves. His symptoms began suddenly and persisted<br />
episodically throughout the day. He was unable to take any<br />
food or medications by mouth and developed mild diffuse abdominal<br />
pain. He denied dizziness, palpitations or chest pain and had no postural<br />
changes in blood pressure or pulse. In clinic he began belching<br />
loudly. He then became pale and diaphoretic followed shortly by loss<br />
of postural tone. He was unresponsive for approximately 10 seconds<br />
AGS 2012 ANNUAL MEETING<br />
S191
P OSTER<br />
A BSTRACTS<br />
then awoke spontaneously and continued to wretch. His mental status<br />
was at baseline and he reported feeling well as he was taken to the ED<br />
for further evaluation. EKG was notable for first degree AV block<br />
(PR interval 224ms, unchanged from prior). Results of a CBC, serum<br />
chemistries, Echocardiogram (done one month prior), and abdominal<br />
CT scan were normal. He was able to eat and drink and had no further<br />
syncopal episodes during 8 hours of observation in the ED. Our<br />
clinical impression was reflex mediated vasovagal syncope secondary<br />
to significant upper gastrointestinal distress. Despite this benign explanation<br />
of his syncope, the ED physician admitted him to a telemetry<br />
bed. Hours later he displayed multiple episodes of complete heart<br />
block (CHB), with one episode resulting in loss of consciousness followed<br />
by vomiting.A temporary pacing wire was placed followed by a<br />
permanent pacemaker the next day. He experienced complete resolution<br />
of his GI symptoms following pacemaker implantation.<br />
Conclusion: Current practice guidelines emphasize the preeminence<br />
of an accurate history in determining the etiology of syncope.<br />
This patient’s atypical presentation of CHB mimicked reflex mediated<br />
vasovagal syncope. His age and remote history of MI led to his<br />
admission, though it seems likely that many physicians would have<br />
discharged this patient. This case demonstrates the importance of<br />
maintaining a high index of suspicion for atypical presentations of arrhythmic<br />
syncope in very elderly patients with cardiac risk factors.<br />
D14 Encore Presentation<br />
A fatal case of treatment resistant C. difficile colitis.<br />
K. S. Malik, M. Reisner ( AGS-F ). internal medicine, jersey city medical<br />
center, Jersey City, NJ.<br />
Introduction: C.diff colitis is frequently associated with previous<br />
antibiotic use especially in the elderly population and those with recent<br />
exposure to hospitals, nursing homes and daycare centers. The<br />
“National Prevalence Study of C.Diff in U.S. Healthcare Facilities”<br />
indicates that 13 out of every 1,000 inpatients were either infected or<br />
colonized with C.Diff. Mortality rate as high as 25% in elderly patients<br />
who are frail and immuno-compromised.<br />
Recurrence occurs in approximately 25 percent of cases. Oral<br />
vancomycin is the preferred therapy for severe or refractory cases.<br />
Combination of oral vancomycin and intravenous metronidazole for<br />
patients of C. diff with ileus is shown to be very effective. Efficacy of<br />
this treatment in geriatric population is still questionable.<br />
We present a treatment resistant case of C.diff colitis.<br />
Case Description: Ms L was a 95 year old female with a history<br />
of dementia and recent appendectomy who presented with C.diff colitis<br />
to the hospital. Her colitis resolved after 10 days course of<br />
Metronidazole.<br />
Approximately 4 weeks later Ms. L developed watery diarrhea,<br />
five to six times a day associated with weight loss. There were no<br />
symptoms of nausea, vomiting, abdominal pain, fever, chills or rash.<br />
Upon arrival in ER, she was thermodynamically stable, Normal<br />
physical exam with leukocytosis of 16. Patient was admitted and<br />
Metronidazole restarted.<br />
Stool for C.diff toxin was positive. Within 48 hours, her condition<br />
deteriorated. WBC rose from 16 to 50 and progressed to septic shock.<br />
Ms L was transferred to MICU and aggressive intravenous fluid therapy<br />
with vasopressors and oral vancomycin was added to the regimen.<br />
Subsequently she developed diffuse abdominal tenderness.<br />
WBC further increased to 112 with lactic acidosis of 11. Despite the<br />
classic presentation of C.Diff, leukocytosis of 112 prompted an evaluation<br />
for acute leukemia, and a flow cytometry was done which was<br />
normal.<br />
CAT scan of the abdomen revealed diffuse pseudomembranous<br />
colitis; developed multiorgan failure, ARDS and deceased within 96<br />
hours of admission.<br />
Conclusion:<br />
C. diff colitis is associated with significant mortality in the geriatrics<br />
patients. Extensive leukocytosis is associated with poor prognosis.<br />
Decreased immunity and multiple co morbidities are responsible<br />
for this increased incidence in the elderly population. The clinical syndrome<br />
of chronic C. diff and the best treatment options in this population<br />
group needs to be further investigated.<br />
D15<br />
Diabetes is Associated with Functional Impairments in HIV+ Older<br />
Adults.<br />
K. Shah, 1 T. N. Hilton, 2 A. E. Luque, 1 W. J. Hall. 1 1. Medicine,<br />
University of Rochester, Rochester, NY; 2. Physical therapy, Ithaca<br />
College, Rochester, NY.<br />
Supported By: This abstract was supported in part by the University<br />
of Rochester Developmental Center for AIDS Research (NIH<br />
P30AI078498)and John A Hartford Foundation Center for<br />
Excellence in Geriatric Medicine and Training.<br />
BACKGROUND: The prevalence of glucose intolerance and<br />
diabetes in HIV+ patients has increased dramatically following the<br />
widespread use of highly active antiretroviral therapy and the improved<br />
survival rate in this population. The risk is further exacerbated<br />
as this population ages. Although it is known that HIV+ patients<br />
are at increased risk of frailty, little is known regarding the<br />
impact of diabetes on physical function in HIV+ older adults (HOA).<br />
PURPOSE: To explore the nature of functional impairment in HOA<br />
with glucose intolerance status as measured by having diabetes.<br />
METHODS: Twenty HOA (mean age=60 y; 30% female) participated<br />
in a case-control study at an urban HIV clinic. Ten HOA with<br />
diabetes were matched to ten HOA controls without diabetes on age,<br />
gender and BMI. Subjective and objective measures of functional status<br />
were evaluated using the Physical Performance Test (PPT),<br />
graded treadmill test, isokinetic dynamometer, gait speed, balance<br />
and functional status questionnaires (FSQ). Body composition was<br />
evaluated using DXA. Muscle quality was evaluated by determining<br />
the ratio of leg strength to leg lean mass. RESULTS: The two groups<br />
were comparable in duration of HIV, CD4 count and viral load. Compared<br />
with matched controls, the case patients had lower scores in<br />
PPT, peak aerobic power, and FSQ (p
P OSTER<br />
A BSTRACTS<br />
agent has been rarely described in female residents of long-term care<br />
facilities.<br />
Case<br />
74 year old woman with moderate dementia admitted from<br />
home because of need for increased supervision. The patient developed<br />
more frequent episodes of urinary incontinence and she was<br />
treated for two urinary tract infections. About nine months after admission,<br />
a urogynecology nurse practitioner recommended a regimen<br />
of treatment including tamsulosin. In addition geriatrics staff reviewed<br />
the case and recommended stopping nortriptyline, which the<br />
patient was taking for depression. The tamsulosin was well-tolerated,<br />
and the patient had decreased daytime incontinence and the patient<br />
felt she was able to void more easily.<br />
Discussion:<br />
Tamsulosin (“Flomax”) is an alpha-blocker, thought to function<br />
at the bladder neck, leading to improved urine flow. Its use is controversial<br />
in women: there are few high quality studies involving women<br />
and many geriatricians have concerns about the potential side effects<br />
(e.g. orthostatic hypotension, increased congestive heart failure incidence).<br />
Tamsulosin has been recommended by some urologists in<br />
certain women with functional or anatomical bladder outlet obstruction,<br />
but its use has been rarely described in older women in nursing<br />
facilities.<br />
Conclusion:<br />
In this case, tamsulosin was used as part of a multidisciplinary<br />
intervention lead by a urogynecology nurse practitioner involving a<br />
search for causes, behavioral modifications, and medication adjustment.<br />
While this woman’s symptoms improved on tamsulosin, and the<br />
medication was well-tolerated, its role in the care of women with<br />
functional and anatomical obstruction remains controversial, and<br />
there is little good evidence demonstrating its benefits. Further research<br />
is needed to determine which women will most benefit from<br />
its use.<br />
D17<br />
Breast implant herniation masquerading coronary heart disease in<br />
an elderly woman.<br />
L. C. Andrade, 1 M. Raji, 1 J. G. Alamo. 2 1. Internal Medicine/<br />
<strong>Geriatrics</strong>, UTMB, Galveston, TX; 2. None, Pearland, TX.<br />
INTRODUCTION: Breast Implant complications and symptoms<br />
of coronary heart disease are rarely considered to have features<br />
in common. This report describes a case of a 69 year old Caucasian female<br />
with past medical history relevant for hyperlipidemia and overweigh,<br />
who presented with symptoms resembling coronary heart disease.<br />
Results of the physical examination were relatively benign. A<br />
Dobutamine Stress Test showed normal Ejection Fraction of 55%<br />
and was negative for inducible ischemic and wall motion abnormality.<br />
The patient had a Mammogram which showed bilateral<br />
silicone/saline implants and herniation medially of the left implant.<br />
She subsequently underwent bilateral breast implant removal with<br />
no complications.<br />
By this case presentation we want to discuss the evidence linking<br />
late breast implant complications with associated coronary symptoms.<br />
DISCUSSION: This case report illustrates that breast implant<br />
complications can present with atypical symptoms in the elderly<br />
which can mimic coronary heart disease. The elderly represent the<br />
fastest-growing segment of the <strong>American</strong> population and one that<br />
had breast implants inserted when younger. Breast reconstruction<br />
has also become a standard part of the care for female patients with<br />
breast cancer, the incidence of which increases with age. It is especially<br />
important not to confuse angina-like symptoms related to herniating<br />
breast implants with those related to heart disease. Heart disease<br />
is the number one killer of women. However, like our patient, if<br />
the stress and other cardiac tests are negative, breast implant herniations<br />
should be considered as part of the differential diagnosis of<br />
chest pain in older women with implant.<br />
CONCLUSIONS: Our patient with chest pain secondary to herniated<br />
breast implant presented with several misleading features of<br />
coronary syndrome. Negative workup with regard to coronary artery<br />
disease prompted us to look for integrity of the breast implants, which<br />
led to the correct diagnosis and guided the patient’s intervention.<br />
Late complications of breast implants should be a consideration on<br />
the differential diagnosis in patients with a history of breast implants<br />
presenting with chest pain. However, coronary heart disease work up<br />
should always be considered and cardiac causes ruled out first, prior<br />
to assuming the problem is solely due to the breast implant or some<br />
other non-cardiac problems.<br />
D18<br />
Insidious TB Meningitis in the Elderly.<br />
M. Chelagiri, A. Date, J. Shimonov, D. Asnis, A. Vela, D. Dave,<br />
H. Sharma, J. Campanova. <strong>Geriatrics</strong> Division, Flushing Hospital<br />
Medical Center, Flushing, NY.<br />
Introduction : Tuberculosis (TB) is a major global public health<br />
issue. Although pulmonary TB has declined in the last decade in US,<br />
the number of central nervous system (CNS)TB has remained the<br />
same. It accounts for 6% of all extra-pulmonary infection and 1% of<br />
all cases of TB diagnosed in the US. CNS TB includes: meningitis, tuberculoma<br />
and abscess. In the elderly, CNS TB can be subtle; leading<br />
to death in weeks if untreated.<br />
Case Report: 66 y/o healthy Asian Indian male, presented with<br />
progressive malaise, weakness, intermittent headache, high grade<br />
fevers, chills and productive cough for 12 days. Recent immigrant denies<br />
sick contacts. CT Chest revealed bilateral diffuse nodular inflammatory<br />
lesions consistent with miliary pattern. PPD and HIV were<br />
negative; quantiferon was positive. Sputum AFB x 3 were negative.<br />
Pleural biopsy showed necrotizing granulomas with AFB stain positive.<br />
RIPE was prescribed for miliary TB. The neurological status deteriorated<br />
with progressive malaise, headache, seizures, and confusion.<br />
CT Head revealed hydrocephalus. He was started on keppra,<br />
corticosteroids and intubated. Ventriculostomy drain was placed to<br />
relieve intracranial pressure. CSF analysis: low glucose, elevated protein,<br />
lymphocytic pleocytosis. AFB stain negative. MTB by PCR negative<br />
but AFB cultures in broth grew Mycobacterium tuberculosis by<br />
DNA probe. MRI brain confirmed meningeal disease and hydrocephalus.<br />
Subsequently, he was extubated and mental status improved,<br />
although residual neurological sequelae remained.<br />
Discussion: The BMRC classification is useful for prognosis and<br />
therapy: Stage 1-Lasts 2-3 weeks, malaise, lassitude, fever, anorexia,<br />
headache and personality change, Stage 2–Meningeal irritation, protracted<br />
headache, vomiting and cranial nerve palsies, and Stage 3-<br />
Clouding of sensorium, stupor, coma, seizures and hemiparesis. Risk<br />
factors are immigration from TB prevalent areas, crowded living,<br />
HIV, drug resistance. The worst prognostic factor for TB meningitis is<br />
the level of consciousness during the time treatment commenced.<br />
Conclusion: The most important determinant for the development<br />
of CNS TB has always been age. CNS TB is often not diagnosed<br />
promptly due to the nonspecific and subtle clinical features. Geriatricians<br />
must consider reactivation of TB in patients presenting with<br />
neurological symptoms from endemic regions. Early recognition and<br />
timely treatment is critical to prevent mortality and morbidity.<br />
D19<br />
Avoiding snap judgments: decreased oral intake resulting in<br />
admission to a geropsychiatric unit.<br />
M. Bednarczyk, 1 J. Chang, 2 M. Gorbien, 1 J. C. Olson, 1 M. J. Leiding. 1<br />
1. <strong>Geriatrics</strong>, Rush University Medical Center, Chicago, IL; 2. Family<br />
Medicine, Mt. Sinai Hospital, Chicago, IL.<br />
Background: Decreased oral intake and weight loss are common<br />
symptoms in the elderly, frequently attributed to depression,<br />
AGS 2012 ANNUAL MEETING<br />
S193
P OSTER<br />
A BSTRACTS<br />
cancer, non malignant GI disorders, and medication side effects. In a<br />
quarter of patients, no identifiable cause is found. However, somatic<br />
diseases may be mislabeled as a psychiatric disorder because specific<br />
organic symptoms may be overlooked or misinterpreted by physicians,<br />
psychiatrists, or by the patients themselves.<br />
Design/Methods: Case Reports of three patients admitted in a<br />
Geriatric Psychiatry Unit at RUMC<br />
Results:<br />
Patient #1: 95 y.o. female with decreased hearing and visual acuity,<br />
GERD admitted following suicide attempt by ingesting a bottle of<br />
Advil, complaining of regurgitation, cough and dysphagia. Videofluoroscopic<br />
swallow study showed large air filled esophagus and lack of<br />
peristaltic movement concerning for Zenker’s diverticulum. Patient<br />
declined further work up, her symptoms were managed conservatively.<br />
Patient #2: 74 y.o. female with HTN, DM2 presented with weakness,<br />
weight loss, sore throat, recurrent emesis for 2 months. She expressed<br />
paranoid thoughts of “aliens in her stomach.” Her family believed<br />
she was anorexic. She was diagnosed with gastric<br />
adenocarcinoma compressing the esophagus, necessitating G- tube<br />
and esophageal stent placement.<br />
Patient #3: 80 y.o. female nursing home resident with weight loss,<br />
depression, complaining of food sticking in her chest. Although a barium<br />
swallow was concerning for an esophageal stricture, EGD was<br />
negative. Ultimately, her symptoms resolved as her depression was<br />
treated.<br />
Relevance: Unintentional weight loss may lead to significant<br />
morbidity and mortality in elderly patients if left untreated. Although<br />
this is frequently attributed to an underlying psychiatric disorder,<br />
these diagnoses require absence of somatic disease. Two of these patients<br />
had a somatic cause for their illness, while in the last patient<br />
medical work up was necessary to verify a psychiatric cause of her decline.<br />
As geriatricians, we are taught to not overlook psychosocial<br />
causes of these symptoms. Nevertheless, a careful medical investigation<br />
to exclude a possible somatic disease mimicking a psychiatric disorder<br />
in elderly patients is essential.<br />
D20<br />
A Suspicious Case of Syncope: Can Factitious Disorder Occur in<br />
Persons with Dementia?<br />
M. Grammas, A. Donahue, M. Drickamer. Yale University School of<br />
Medicine, New Haven, CT.<br />
CASE: An 88-year-old man with a history of atrial fibrillation,<br />
dementia and depression presented with frequent episodes of loss of<br />
consciousness. He had several prior negative evaluations. Patient was<br />
OX3 and had a normal physical exam. He had mild, asymptomatic<br />
postural BP changes. CXR, head CT, ECG, echocardiogram and labs<br />
were normal. He scored 24/30 on MMSE with deficits in short-term<br />
recall and visual-spatial domains. His clock drawing showed perfect<br />
planning and ordering of numbers but incorrect hand placement.<br />
During the hospitalization, he had several episodes of loss of<br />
consciousness, some while supine, others when arising to stand. Vital<br />
signs, telemetry review, pacemaker interrogation, and continuous<br />
video EEG monitoring revealed no explanation.After emerging from<br />
one episode, the patient remarked, “You know I am faking all of this.<br />
I like to see you people come around.” Psychiatry consult stated that<br />
due to his dementia, he did not have the capacity to feign an illness.<br />
DISCUSSION: Transient loss of consciousness is not an uncommon<br />
presenting symptom among older adults. The most common<br />
causes are orthostasis, carotid hypersensitivity and cardiac abnormalities.<br />
Nonsyncopal causes include seizures, metabolic, intoxication<br />
and psychogenic. History and physical reveals the diagnosis in approximately<br />
half of cases. Imaging, cardiac and neurologic evaluations<br />
should be performed as indicated. While the spectrum of<br />
feigned medical illnesses are diagnoses of exclusion, they should also<br />
be considered when symptoms persist despite adequate evaluation.<br />
Simulated diseases arise from either unconscious or conscious behaviors.<br />
Among the conscious simulated diseases is factitious disorder,<br />
the intentional production of symptoms for a primary gain, to achieve<br />
the sick role. It is estimated that factitious disorder may account for<br />
as many as 5% of all physician visits with neurologic symptoms being<br />
among the most common. There is scant literature on whether factitious<br />
disorders occur in patients with dementia. Based on fMRI studies,<br />
the act of deception is associated with increased activity in prefrontal<br />
and anterior cingulate cortices, areas involved in executive<br />
function. Our patient, independent of ADLs and some IADLs and<br />
able to follow multiple step instructions, demonstrated a number of<br />
behaviors supporting executive function sufficient to consciously<br />
feign symptoms of illness.<br />
D21<br />
An unexpected death over 3000 miles from home: the importance of<br />
advance care planning.<br />
M. Koya. Internal Medicine, University of Washington, Seattle, WA.<br />
Case: A 66-year-old woman walked in with her husband to the<br />
emergency department complaining of dyspnea. Within an hour of arriving,<br />
the patient became hypoxemic and hypotensive requiring intubation<br />
and initiation of vasoactive agents. Workup revealed severe<br />
biventricular failure with an atrial septal defect (ASD) and a large<br />
right to left shunt. The patient was admitted to the cardiac intensive<br />
care unit (CICU). The husband stated to the on-call resident that they<br />
were visiting from New York, and her only past medical history was a<br />
remote history of breast cancer. They had never discussed advanced<br />
care planning. Efforts were made to contact her primary oncologist to<br />
obtain records; however this was unsuccessful. The husband asked the<br />
resident to “do whatever is necessary” and the patient underwent<br />
intra-aortic balloon pump and Swan-Ganz catheter placement. When<br />
she still did not improve, the team prepared for an ASD repair, but<br />
the patient was too unstable to leave the CICU. With the team’s recommendation,<br />
the husband and other family members who telephoned<br />
from New York agreed to withdraw care and the patient died<br />
immediately.<br />
After her death, medical records from her oncologist revealed<br />
that the patient was diagnosed with Stage II breast cancer over 10<br />
years ago and was status post chemotherapy. She was then lost to follow-up.<br />
Recently, she was discovered to have metastatic disease and<br />
heart failure with a cardiac shunt. Although she was prescribed cardiac<br />
medications, the patient declined to take them. She had never informed<br />
her husband about her cardiac condition.<br />
Discussion: This case illustrates the importance of advance care<br />
planning. The patient was more than 3000 miles away from her home,<br />
became critically ill very rapidly, and had not discussed her medical<br />
conditions or her wishes with her legal next of kin, her husband. Advance<br />
care planning helps ensure that patients have their wishes followed<br />
in the event they are unable to make their own decision at time<br />
of acute illness. In a study of adults 60 years or age or older, subjects<br />
who had living wills were more likely to want and receive limited care<br />
or comfort care than all care possible(1). Given her history of noncompliance<br />
with medical recommendations, there is a strong possibility<br />
that the patient would not have wished for many of the interventions<br />
that were administered. (1) Silverira et al. N Engl J Med. 2010<br />
Apr 1;362(13):1211-8<br />
D22<br />
Not Your Ordinary Syncopal Event: A Case of Aortocaval Fistula.<br />
M. Wirt, L. Cox-Vance. UPMC, Pittsburgh, PA.<br />
Syncope, a common presenting symptom, challenges providers<br />
to determine the underlying cause and any increased risk for death.<br />
Abdominal aortic aneurysm (AAA) rupture and related complications<br />
can be missed if not considered in the patient presenting with<br />
syncope.<br />
A 76 yo man with hypertension, coronary artery disease and<br />
atrial fibrillation presented to the emergency room after a syncopal<br />
S194<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
episode. He was alert and coherent but noted to be diaphoretic,<br />
tachycardic and hypotensive with an irregular pulse. EKG revealed<br />
supraventricular tachycardia which converted to sinus tachycardia<br />
with IV adenosine. His hypotension remained refractory to normal<br />
saline boluses and a norepinephrine infusion was added with resultant<br />
blood pressure stabilization. Initial laboratory evaluation revealed<br />
normal electrolytes, hematocrit of 40%, WBC 14.8 x 10^9 /L,<br />
Troponin I 0.10ng/ml and INR 1.4. A repeat EKG showed atrial fibrillation<br />
with diffuse ST depression. Chest x-ray was without acute<br />
changes. The patient was transferred to the intensive care unit (ICU)<br />
with preliminary diagnoses of hypotension, elevated troponin and<br />
atrial fibrillation.<br />
During initial ICU assessment, a pulsatile abdominal mass was<br />
noted. Urgent CT angiography revealed an 8.7 X 8 cm infrarenal<br />
AAA with contrast leaking into the right common iliac vein and inferior<br />
vena cava. The patient underwent emergent open repair of the<br />
ruptured AAA and aortocaval fistula with grafting of the right iliac<br />
and left common femoral arteries. The bowel was noted to be dusky<br />
necessitating urgent left hemicolectomy and sigmoidectomy.<br />
The patient returned to the intensive care unit where he remained<br />
intubated but responsive. He continued to require pressor<br />
support and required massive blood product transfusion. Within several<br />
hours, evidence of ongoing bowel ischemia was noted with discussion<br />
of further debridement of the bowel. The patient’s family declined<br />
further aggressive care and the patient died approximately 30<br />
hours after the initial syncopal event.<br />
This case illustrates the importance of careful differential diagnosis<br />
and thorough physical examination in the evaluation of patients<br />
presenting with syncope. AAA rupture, with or without the rare complication<br />
of aortocaval fistula, must be considered in the syncope differential<br />
as the rapidity of diagnosis and surgical intervention significantly<br />
impacts survival.<br />
D23<br />
Dementia and “Delirium” Due to Whole Brain Radiation in a<br />
Cancer Survivor.<br />
M. Elarabi, M. Brennan. Baystate Medical Center, Springfield, MA.<br />
Introduction<br />
Radiation therapy (RT) is important in treating CNS tumors.<br />
Sufficient doses of RT eradicate neoplasms but will inexorably damage<br />
normal tissue. Controversy persists around the impact of RT on<br />
the adult brain. The authors report a case of a patient with recurrent<br />
admissions for “delirium” that proved to be due to ongoing radiation<br />
induced damage.<br />
Case<br />
A 67 year old man had a craniopharyngioma resection and RT<br />
25 years ago; he had hypopituitarism, stroke, and dementia and was<br />
admitted twice in a month with profound stupor and excessive daytime<br />
sleepiness. On the first occasion he was intubated for airway protection.<br />
The geriatrics team was asked to assess his delirium. His physical<br />
examination was only remarkable for gait ataxia. His MMSE was<br />
28/30; a Geriatric Depression Scale was negative but a urinalysis was<br />
positive. An MRI revealed atrophy, old lacunar infarcts and chronic<br />
white matter changes suggesting small vessel ischemia. A video EEG<br />
revealed mild to moderate diffuse cerebral dysfunction. A<br />
polysomnogram showed mild OSA and an irregular sleep cycle. His<br />
cognitive impairment, hypersomnolence and loss of circadian rhythm<br />
proved to be due to a damaged hypothalamic pituitary axis as a result<br />
of his tumor and RT induced brain injury.<br />
Discussion<br />
There are 3 types of radiation injury: acute, early delayed and<br />
late delayed. Late delayed injury is irreversible, occurs 6 months to<br />
many years later and primarily damages the white matter causing atrophy,<br />
leukoencephalopathy, neurocognitive decline and hypothalamic-pituitary<br />
and endocrine dysfunction. The proposed etiology is<br />
vascular and likely results from damage to capillary endothelial cells,<br />
increased microvascular permeability and impaired blood brain barrier<br />
integrity leading to ischemia. Analyzing the impact of RT is confounded<br />
by injury from cerebrovascular disease, baseline impairments<br />
in cognition and multifactorial interactions of tumor, surgery,<br />
chemotherapy and steroids.<br />
Conclusion<br />
Tools to measure and identify radiation effects are underdeveloped.<br />
Long term studies that carefully assess baseline cognition and<br />
changes over time are critically needed or the eventual result of high<br />
dose RT may be a demented, bedridden patient who is cancer free.<br />
With more aggressive forms of RT and improved survival rates, geriatricians<br />
will be seeing increasing numbers of elders with RT induced<br />
cognitive injury. Geriatricians must learn to recognize and manage<br />
the resulting deficits.<br />
D24<br />
Severe Consequence of Acquired Diaphragmatic Hernia After<br />
Reconstructive Surgery for Chest Wound Dehiscence After<br />
Coronary Artery Bypass Surgery.<br />
M. Izhar, 1,2 A. Gupta, 1,2 F. Aziz, 1,2 R. J. Beyth, 1,3 M. K. Bautista. 1,2 1.<br />
GRECC, NF/SGVHS, Gainesville, FL; 2. Dept of Aging and<br />
<strong>Geriatrics</strong>, University of Florida, Gainesville, FL; 3. Dept of Medicine,<br />
University of Florida, Gainesville, FL.<br />
Introduction: Diaphragmatic hernia is a rare surgical complication<br />
of reconstructive surgery for wound dehiscence after coronary<br />
artery bypass surgery (CABG). This case illustrates anterior chest<br />
wall hernia, a severe consequence of diaphragmatic hernia in an older<br />
patient after CABG.<br />
Case: A 70 year old man had CABG in 2007 which was complicated<br />
by sternal wound dehiscence after severe coughing. Six days<br />
after CABG, he underwent sternal debridement, omental transposition<br />
and secondary closure of the mediastinum. Three weeks later, he<br />
developed diaphragmatic hernia with the small bowel displaced into<br />
the anterior mediastinum. He also developed anterior chest wall hernia<br />
which grew over time to the size of 6x8 cm. In 2011 he was hospitalized<br />
for acute cholecytitis. Two days after undergoing percutaneous<br />
cholecystostomy tube placement, he developed acute abdomen. Exploratory<br />
laparotomy revealed the cholecystostomy tube traversing<br />
through the small bowel. The cholecytectomy tube was removed and<br />
the small bowel was resected. Over the next 10 days, his anterior chest<br />
wall hernia enlarged significantly to the size of 20x16 cm. CT scan of<br />
chest revealed a large diaphragmatic hernia with the small bowel extending<br />
up to the clavicles. He was not felt to be a surgical candidate<br />
due to lack of acute respiratory distress and his significantly altered<br />
anatomy. He was treated conservatively with indefinite use of the<br />
chest binder and discharged home.<br />
Discussion: Diaphragmatic hernia is a rare but recognized complication<br />
after cardiothoracic surgery. Its published rates range from<br />
2.7 % to 11.7%. During surgery, the omentum is transposed either<br />
through an incision in the anterior diaphragm or through the upper<br />
end of the laparotomy incision and a subcutaneous tunnel. The omentum<br />
can reach the suprasternal notch, thereby allowing the reconstruction<br />
of an extensive defect. In this case the surgical incision in<br />
the anterior diaphragm may have been too large resulting in the gastrointestinal<br />
herniation into the chest wall. Future studies are needed<br />
to evaluate the risks and benefits of surgery such as this among older<br />
adults who may have a high risk for post-operative complications<br />
after CABG.<br />
D25<br />
The role of PC-MRI in the differential diagnosis between<br />
Alzheimer’s disease and NPH.<br />
J. Zmudka. Amiens University Hospital, Amiens, France.<br />
Introduction:<br />
AGS 2012 ANNUAL MEETING<br />
S195
P OSTER<br />
A BSTRACTS<br />
The diagnosis of Alzheimer’s disease (AD) and normal pressure<br />
hydrocephalus (NPH), as several neurodegenerative diseases, mainly<br />
based on clinical examination, neuropsychological assessment and<br />
conventional imaging, remains difficult.<br />
The aim of this study is to demonstrate the role of Phase-contrast<br />
magnetic resonance imaging (PC-MRI) in the assessment of<br />
cerebral flows, and in consequence in the differential diagnosis between<br />
AD and NPH.<br />
Materials and methods:<br />
Our population consisted of 20 AD patients (mean age: 80 ± 5<br />
years) and 13 NPH (mean age: 70 ± 6 years). Patients were categorized<br />
during a special consultation by a neuropsychologist and a geriatrician.<br />
All the patients underwent cerebral MRI using a 3T-scanner including<br />
PC-MRI imaging for CSF and blood flows quantification.<br />
They were compared with a population (n = 12) of age-matched<br />
healthy elderly (HE) (mean age: 71 ± 9 years) with normal neurological<br />
and neuropsychological screening results (MMSE).<br />
PC-MRI acquisition was then performed in addition of classical<br />
morphological sequences. The PC-MRI sections were positioned at<br />
the cervical level to investigate cerebral vascular input flows from internal<br />
carotids and vertebral vessels. PC-MRI was also performed at<br />
the aqueductal and cervical levels to measure the CSF flows. Afterwards,<br />
PC-MRI images were analyzed to calculate global arterial flow<br />
curves during cardiac cycle (cc). NPH, MA, HE populations were<br />
compared.<br />
Results:<br />
There was no statistical difference of the mean arterial CBF between<br />
the 3 groups (in ml/min): MA (495 ± 84), NPH (450 ± 129) and<br />
HE (509 ± 108).<br />
Cervical CSF flow analysis showed also similar values for all<br />
3 groups (in μl/cc): MA (530 ± 210), NPH (455 ± 133) and HE<br />
(457 ± 154).<br />
In contrast, NPH presented significantly the highest aqueductal<br />
CSF stroke volume (167 μl/cc ± 89) compared to AD (50 ± 30) and<br />
HE (34 ± 17) (P < 0, 05).<br />
Conclusion:<br />
CSF flows quantification can be helpful for aetiological and differential<br />
diagnosis between AD and NPH, especially in case of enlargement<br />
of lateral ventricles.<br />
D26<br />
The First Intervention Study in Elder Self-Neglect: A Randomized<br />
Clinical Trial to Improve Vitamin D Levels.<br />
J. Burnett, 1,4 A. E. Hochschild, 1,4 S. M. Smith, 2,4 A. L. Stotts, 1,4<br />
P. M. Diamond, 3,4 C. B. Dyer. 1,4 1. Internal Medicine, UT Health,<br />
Houston, TX; 2. National Aeronautics and Space Administration<br />
(NASA), Houston, TX; 3. Health Promotoin and Behavioral Sciences,<br />
UT, School of Public Health, Houston, TX; 4. Texas Elder Abuse and<br />
Mistreatment Institute (TEAM), Houston, TX.<br />
Supported By: The National Institute on Aging. Grant # 1R21<br />
AG033261-01A1<br />
Background: Despite high mortality rates, elder self-neglect is<br />
characterized by refusal of medical and social interventions. To date<br />
there have been no tested clinical interventions in elders who selfneglect.<br />
Previous TEAM Institute research has shown significantly<br />
low vitamin D levels in this population. This study aimed to determine<br />
the feasibility of a clinical intervention. Replacement of vitamin<br />
D was chosen because of its ease of administration and favorable<br />
safety profile. Methods: A randomized clinical trial using directly observed<br />
therapy of vitamin D was conducted using 50 elders, >65 years<br />
of age, with Adult Protective Services (APS) validated self-neglect. A<br />
staggered intervention with waiting controls was used to maximize<br />
statistical power. One-third (n=17) of the group was administered<br />
50,000 IU vitamin D2 (ergocalciferol) monthly and the remainder<br />
(n=33) were administered 400 IU monthly. Serum 25-OH vitamin D<br />
was assessed at baseline and 5-months. Results: 69% agreed to participate<br />
in the study and of those n=40 (80%) remained at 5-months. At<br />
baseline, 12% (n=7) were deficient in vitamin D (
P OSTER<br />
A BSTRACTS<br />
D28<br />
Interactive video dance and cognition: baseline data.<br />
J. Jovancevic- Misic, S. A. Studenski, Y. Zheng, S. Perera. University<br />
of Pittsburgh, Pittsburgh, PA.<br />
Supported By: The research reported in this abstract was supported<br />
by NIH- Claude D Pepper Older <strong>American</strong>s Independence Center<br />
Grant, P30 AG024827, and by T32 grant (AG21885).<br />
Purpose: Though some evidence exists that physical exercise has<br />
the potential to affect cognitive function, the majority of evidence relates<br />
to the cognitive effects of fitness training. There is evidence that<br />
video games may induce cognitive improvement and generalize to<br />
daily function, but mostly do not involve physical exercise. Little is<br />
known of how combining these two types of training might impact<br />
cognition, or the role of participants’ cognitive status on their success.<br />
The purpose of this study is to examine the role of visual attention in<br />
learning to process visual info in interactive video dance. Relative<br />
value of participants’ previous experience with video games and<br />
some types of leisure activities in predicting their performance on the<br />
video dance was also investigated.<br />
Methods: This is a cross sectional analysis of the baseline data<br />
from a RCT Adherence and health effects of video dance exercise<br />
and brisk walking in postmenopausal women. We focus on the baseline<br />
data of the interactive video dance group. Participants were 46<br />
overweight, sedantary women aged 50-65. Repeatable Battery for the<br />
Assessment of Neuropsychological Status (RBANS) test, the Useful<br />
Field of View (UFOV) test and Leisure activity questionnaire were<br />
administered at baseline. Participants’ previous experience with<br />
video games, and ability to master the basics of interactive video<br />
based dance on the first day was noted.<br />
Results: We analyzed the association between two cognitive domains<br />
(attention and visuo-spatial) as measured by RBANS and attention<br />
deployment and visuo-spatial skills (UFOV). All domains<br />
were correlated (Table 1).<br />
Performance on cognitive tests as predictors of success in finishing<br />
video dance lessons the first day was analyzed. The test of divided<br />
attention (UFOV) and RBANS (attention) score tended to have an<br />
impact, though only RBANS effect was significant (p=0.03). Previous<br />
experience with dance and video games was found to have no effect<br />
on the success of video dance performance.<br />
Conclusions: Baseline data indicates that UFOV reflects some<br />
RBANS factors and as such may be related to early success with<br />
learning video dance. Further it would appear that no prior experience<br />
playing video games or dancing is necessary for mastering this<br />
new skill.<br />
D30 Encore Presentation<br />
Skeletal muscle sampling in elderly research participants with<br />
chronic disease.<br />
M. F. Lyles, J. L. Demons, K. M. Murphy, B. J. Nicklas. Internal<br />
Medicine, Wake Forest School of Medicine, Winston Salem, NC.<br />
Supported By: Claude Pepper Older <strong>American</strong>s Independence<br />
Center (1P30 AG21332, WFU General Clinical Research Center<br />
(M01-RR07122), National Institute on Aging (R37 AG018915)<br />
Deficits in skeletal muscle metabolism and function are major<br />
contributors to development of disability in older adults. The conduct<br />
of in vitro experiments of muscle metabolism and function is important<br />
for advancing understanding of aging-related disability progression.<br />
Percutaneous muscle biopsy techniques are widely utilized in<br />
studies of young and/or healthy persons, but are underutilized in the<br />
elderly, especially those with chronic illness, who are at the highest<br />
risk of becoming disabled. The goal of this project was to determine<br />
the feasibility, safety and tissue yield of muscle biopsies performed in<br />
older adults with common chronic diseases enrolled in several clinical<br />
trials. A total of 324 biopsies were performed in research participants<br />
with COPD, CHF, osteoarthritis or obesity, who were enrolled in clinical<br />
trials of weight loss and/or exercise training. Only minor modifications<br />
in safety procedures, such as adjustment of table position,<br />
were needed for biopsy performance in these patients. The average<br />
tissue yield of for all biopsies was 157±90 mg. Participants in which<br />
muscle was obtained (81%) were compared to those in which only<br />
adipose tissue was obtained (19%; Table 1). Successful acquisition of<br />
skeletal muscle was more challenging in women and in more obese<br />
participants. The return rate for post-intervention biopsy was >90%.<br />
Percutaneous muscle biopsy is a feasible, safe and acceptable procedure<br />
in older adults with chronic diseases and provides a tool to understanding<br />
the development of disability in this group.<br />
Characteristics of participants with and without muscle tissue yield<br />
*Average yield = 157±90 mg<br />
D31 Encore Presentation<br />
Extended-release memantine (28 mg, once daily) and sustained<br />
cognitive improvement: Post hoc responder analysis from a<br />
randomized trial in patients with moderate to severe Alzheimer’s<br />
disease.<br />
M. Tocco, 1 S. Hendrix, 2 M. L. Miller, 3 V. Pejovic, 3 S. M. Graham. 1 1.<br />
Forest Research Institute, Jersey City, NJ; 2. Pentara Corporation,<br />
Salt Lake City, UT; 3. Prescott Medical Communications Group,<br />
Chicago, IL.<br />
Supported By: Supported by Forest Laboratories, Inc.<br />
Background: Alzheimer’s disease (AD) trials routinely report<br />
mean score differences between treatment groups; however, it is also<br />
important to compare percentages of patients who respond to treatment.<br />
An extended-release (ER) formulation of memantine (28 mg,<br />
once daily) was recently approved in the US based on a 24-week, randomized,<br />
placebo-controlled trial (NCT00322153) in patients with<br />
moderate to severe AD concurrently taking a cholinesterase inhibitor.<br />
Memantine ER-treated patients significantly outperformed<br />
placebo-treated patients on several outcome measures, including the<br />
Severe Impairment Battery (SIB), an instrument for assessing cognition<br />
in severely demented patients. In this post hoc analysis, we determined<br />
the percentages of patients who achieved a positive response<br />
on the SIB and maintained it throughout the trial.<br />
Methods: Five SIB response levels to double-blind treatment<br />
were selected (improvements of ≥0, ≥5, ≥10, ≥15, and ≥20 points), corresponding<br />
to 0, 0.5, 1.0, 1.5, and 2.0 standard deviations of the observed<br />
baseline-to-endpoint score change. Numbers of patients (observed<br />
cases) in each group who attained such responses at Weeks 4,<br />
8, 12, or 18 and maintained them through Week 24 (Endpoint) were<br />
compared using Fisher’s exact test, without correcting for multiple<br />
comparisons.<br />
Results: The mean (± SD) Baseline SIB score for the intent-totreat<br />
population (N=661) was 76.1 ± 18.4. A total of 523 patients (memantine<br />
ER, 261; placebo, 262) had available SIB data at all visits.<br />
Significantly more patients in the memantine ER group than the<br />
placebo group maintained Week 8 SIB responses of ≥5 points (26.1%<br />
vs 17.0%; P=0.014) and ≥10 points (14.6% vs 7.6%; P=0.012) through<br />
Endpoint. Similar differences in response maintenance were observed<br />
for responses attained at Week 12 (≥5 points: 28.5% vs 19.9%,<br />
P=0.025; ≥10 points: 16.3% vs 8.2%, P=0.005; ≥15 points: 9.5% vs<br />
4.1%, P=0.015) and Week 18 (≥10 points: 18.8% vs 10.0%, P=0.004;<br />
≥15 points: 10.9% vs 4.5%, P=0.006). No other significant betweengroup<br />
differences were observed.<br />
Conclusions: In this post hoc analysis, memantine ER was associated<br />
with cognitive improvement attained after 8-18 weeks and sustained<br />
through study endpoint.<br />
AGS 2012 ANNUAL MEETING<br />
S197
P OSTER<br />
A BSTRACTS<br />
D32<br />
Comparison of Three Screening Tools to Predict Hospital<br />
Readmission and Mortality in Older Adults.<br />
M. Deschodt, 1,2 J. Flamaing, 2 N. Wellens, 1 S. Boonen, 2 P. Moons, 1<br />
K. Milisen. 1,2 1. Center for Health Services and Nursing Research,<br />
Katholieke Universiteit Leuven, Leuven, Belgium; 2. Department of<br />
Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium.<br />
Purpose: To compare the diagnostic characteristics of the Identification<br />
of Seniors At Risk (ISAR), the Flemish version of the Triage<br />
Risk Screening Tool (TRST), and the Variable Indicative of Placement<br />
Risk (VIP) to predict hospital readmission, alone or in combination<br />
with mortality, in hospitalized patients aged 75 years or older.<br />
Methods: Multicenter prospective cohort study with 30 days follow-up<br />
in 25 general hospitals in Belgium. Baseline data were gathered<br />
within 72 hours of admission. Readmission was defined as an unplanned<br />
hospital stay of at least 24 hours. Information was gathered<br />
by a nurse through patient or proxy interview at admission and<br />
through phone-call at follow-up. Eight hundred and sixty-eight questionnaires<br />
with complete screening were returned. Data of hospital<br />
readmission was available for 72.6% (n=630) of the patients. Besides<br />
analyses in surviving patients only (n=588), combined endpoint<br />
analyses (readmitted or dead) were performed.<br />
Results: Respectively 12.2% (n=72/588) and 6.7% (n=42/630) of<br />
the patients were readmitted or died within 30 days after hospital discharge.<br />
Sensitivity and NPV to predict readmission was high for<br />
ISAR cut off ≥2 (86% and 90%, resp.), TRST cut off ≥2 (71% and<br />
86%, resp.) and VIP cut off ≥1 (60% and 89%, resp.). Increasing the<br />
cut off score with one point had a positive effect on the specificity, but<br />
at the expense of the sensitivity for all three screening tools (69% for<br />
ISAR, 60% for VIP and 40.4% for TRST). Results of the combined<br />
endpoint analyses are shown in the table.<br />
Conclusion: All screening instruments showed good sensitivity<br />
and NPV, the two major characteristics for good screening tools, but<br />
hospital readmission alone or in combination with mortality in older<br />
patients seemed to be most accurately predicted by using the ISAR<br />
cut off ≥3. False positives could be filtered out according to the clinical<br />
expert opinion of a care team.<br />
D33<br />
Increased risk of hospital admission in Patients 65 years and older<br />
presenting to the emergency department.<br />
M. S. Radeos, I. Kariolis, A. Wasserman, K. Joshi, Z. Huang.<br />
Emergency Medicine, New York Hospital Queens, Flushing, NY.<br />
Background: US Emergency department (ED) visits by those 65<br />
years and older account for an estimated 17.5 million visits, or approximately<br />
15% of all visits. About 10.6 million of these are by those<br />
75 years and older.<br />
Objective: We sought to determine factors increase the risk of<br />
hospital admission among adults aged 65 years and older who present<br />
to the ED.<br />
Methods: Research associate (RA) administered a survey to a<br />
convenience sample of adults 65 years and older presenting to a<br />
Level I trauma center. We collected demographic and clinical variables.<br />
We present data as percentages and medians with interquartile<br />
range (IQR). We tested the<br />
univariate association with admission using t-test. Kruskal-Wallis,<br />
chi-square and fisher exact test as appropiate. We ran logistic regression<br />
models with 95% confidence intervals (CI).<br />
Results: We enrolled 1,329 subjects between 1/2010 and 11/2011.<br />
376 (28%) were age 65-74 and 953 (72%) were 75 and older. 59%<br />
were female, and 80% had either Medicare or Medicare plus a supplement.<br />
Race/ethnicity was 61% White, 12% Black, 11% Latino, and<br />
13% Asian. 15% had limited English proficiency. 56% of patients<br />
were admitted. 90% of patients lived independently. 92% had a PMD<br />
or regular health care provider (HCP). In a logistic model that included<br />
age categorory (65-74 versus 75+) sex, race, mode of arrival,<br />
living independently and prior visit to and ED or urgent care center<br />
within the previous week, only the previous ED or urgent care visit in<br />
the previous week was statistically significant, [OR 1.63, 95% CI<br />
[1.08, 2.44) P=0.019]<br />
Conclusion: Older patients who present to the ED have a very<br />
high admission rate suggesting a high acuity. Those who return to the<br />
ED within a week of ED or urgent care visit are at increased risk of<br />
admission to the hospital. This finding underestimates the true acuity,<br />
as many patients receive acute care and may be safely discharged<br />
to home. Future research should focus on interventions in this high<br />
risk group.<br />
D34<br />
Psychiatric Emergencies in the Suburbs: An EMS Response to the<br />
Distressed Senior.<br />
J. J. Bernick, 1,2 D. Dalbey, 2 M. Lester. 2 1. Internal Medicine, San<br />
Jacinto Methodist Hospital, Baytown, TX; 2. Emergency Medical<br />
Service, Health Department, City of Baytown, TX.<br />
Background: When confronted with the confused and agitated<br />
senior patient appreciation of their history and immediate medical<br />
status supply essential insight for patient stabilization. Geriatric patients<br />
with various chronic conditions, multiple medications, and limited<br />
functional reserve display increased susceptibility to psychiatric<br />
problems. The EMS frequently provides the initial evaluation of the<br />
distressed patient manifesting behavioral disorders. This study objective<br />
proposed to review and convey an awareness of the initial assessment<br />
of seniors with diverse psychiatric emergencies.<br />
Methods: This investigation examined the records of a suburban<br />
EMS in Harris County, Texas during a 46 month period commencing<br />
in January, 2008. The field encounters of community residing patients<br />
at least 60 years old receiving evaluation for psychiatric emergencies<br />
were analyzed. The EMS team recorded patient’s primary symptoms,<br />
history and physical findings, procedures performed, and response to<br />
their initial treatment. Event chronology considered the decision to<br />
transport the patient to the hospital.<br />
Results: During the study period, 206 geriatric patients obtained<br />
evaluation for psychiatric emergencies accounting for 11% of psychiatric<br />
calls. Anxiety disorders were the most common diagnosis presenting<br />
in (64)seniors (31% of calls) and the majority required hospital<br />
transport. The EMS treated patients (33) for both drug overdose<br />
and medication withdrawal. The presence of suicidal ideations(13%<br />
of calls), psychotic behavior(12%), and delirium(12%) affected a significant<br />
proportion of seniors requiring EMS care. The EMS attended<br />
an unexpected number of patients (8) threatening a weapon assault.<br />
Approximately 35% of patients receiving EMS triage acknowledged<br />
previous psychiatric disorders.<br />
Conclusion: The appearance of psychiatric symptoms in geriatric<br />
patients develops with dementia,adverse medication reactions,and family<br />
disputes. However, diminishing functional capacity creates an opportunity<br />
for behavioral issues to arise without prior warning. Caregivers<br />
often rely upon the EMS as the initial responder to meet their crisis.<br />
Health professionals early recognition and treatment of senior’s psychiatric<br />
issues enhances support to caregivers, promotes accurate physician<br />
treatment, and improves coordination of care among the health team.<br />
D35<br />
Emergency Department Prescribing and Continuity.<br />
L. Ragsdale, 1 C. Horney, 2 K. Schmader, 2 S. N. Hastings. 2 1. Surgery,<br />
Duke University, Durham, NC; 2. Medicine, Duke University,<br />
Durham, NC.<br />
Supported By: This research was conducted while Dr. Hastings was<br />
supported by a VA HSR&D Career Development Award (RCD<br />
06-019).<br />
Background<br />
S198<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
More than ½ of all older patients treated and released from the<br />
emergency department(ED) receive one or more prescriptions. The<br />
goals of this study were to describe medication prescribing and continuity<br />
of care for older patients treated and released from the ED.<br />
Methods<br />
We examined health system records of 308 patients ≥ 65 years old<br />
treated and released from an urban academic ED with 77,000 annual<br />
visits. Patients were excluded if they did not have at least one PCP visit<br />
in the 12 months preceding the index ED visit. Data were collected<br />
using a standardized chart abstraction tool. Medications were categorized<br />
according to the VA Medication Classification System, and continuity<br />
measures (1) ED contact with PCP; (2) ED visit acknowledgement<br />
by PCP; and (3) discharge drug documentation by PCP were<br />
based on Acute Care of the Elderly (ACOVE) Quality Indicators.<br />
Results<br />
Of 308 patients, 163 (53%) were prescribed at least one medication<br />
(total 260 drugs); 23.3% were prescribed 2 medications and 8%<br />
were prescribed ≥ 3. Overall, 89.2% of prescriptions were new medications<br />
for the patient. The most commonly prescribed drug class<br />
was central nervous system (CNS) medications (32.3%); 86.9% of<br />
these were opioid containing. Other commonly prescribed drug<br />
classes were antimicrobials (21.9%) and gastrointestinal medications<br />
(11.9%). Common indications for medications included non-urinary<br />
infections (17.3%), musculoskeletal pain (17.3%) and trauma<br />
(16.5%). The majority of prescriptions were written for a time limited<br />
course (91.1%); 46.6% had a specified schedule and 53.4% were as<br />
needed (prn). Of the scheduled drugs, the median days supply was 7<br />
(mode 7). Among prn drugs, the median days supply was 5 (mode 3).<br />
The ED provider note documented communication with patients’<br />
outpatient provider in 14.5% of visits (2.2% PCP; 12.3% specialist).<br />
Overall, 72.4% of patients had a PCP follow-up within 90 days of<br />
their ED visit. The PCP note acknowledged the ED visit in 46.1% of<br />
patients. Among patients prescribed medications in the ED (n=163),<br />
the PCP note acknowledged the new medications in 25.4% of cases.<br />
Conclusions<br />
ED providers frequently prescribe new CNS and antimicrobial<br />
medications for older patients treated and released from the ED.<br />
Lack of communication between providers in the care for this patient<br />
population was common. Further research is needed to determine<br />
how best to improve communication between the ED and PCPs.<br />
D36<br />
Vitamin D deficiency is associated with fall-related risk factors in<br />
home-bound older adults.<br />
J. L. Demons, 1 J. A. Tooze, 1 B. R. Davis, 1 R. Shertzer-Skinner, 1<br />
L. Kearsley, 2 R. Gottlieb, 2 J. D. Williamson, 1 D. K. Houston. 1 1. Sticht<br />
Center on Aging, Wake Forest University School of Medicine,<br />
Winston-Salem, NC; 2. Senior Services, Inc, Winston-Salem, NC.<br />
Supported By: Supported by the Wake Forest Translational<br />
Science Institute, Center for Integrative Medicine and Pepper<br />
Center (P30-AG21332)<br />
Background: Falls in the elderly are known to be costly to both<br />
the function of seniors and the medical system. Risk factors for falls<br />
that can be intervened upon, such as vitamin D deficiency, are sought<br />
by physicians. Older home-bound persons eligible to receive meals<br />
from a home meal delivery program (Meals on Wheels (MOW)) are<br />
at high risk for vitamin D deficiency due to the very nature of being<br />
home-bound and inability to provide their own nutrition. They are<br />
likely also at higher risk for falls considering their inability to move<br />
about in the community. We assessed several aspects of falls and fallrelated<br />
risk factors to determine if they were associated with vitamin<br />
D levels in MOW participants.<br />
Methods: 25-hydroxyvitamin D levels were assessed in seventytwo<br />
seniors being served by MOW in Forsyth Co, NC as part of baseline<br />
assessments for a vitamin D intervention study (mean age 77.3<br />
yrs; 76% women, 76% black). History of falls in the prior year and the<br />
seriousness of any fall that occurred were obtained by recall. Fear of<br />
falling and the Pepper Assessment Tool for Disability (PAT-D) were<br />
also obtained.<br />
Results: Vitamin D insufficiency (10-
P OSTER<br />
A BSTRACTS<br />
D38<br />
The burden of comorbid conditions and symptoms affecting quality<br />
of life in nursing home patients with dementia.<br />
J. M. Checchi, D. Peterson, J. Tjia. <strong>Geriatrics</strong>, University of<br />
Massachusetts Medical School, Worcester, MA.<br />
Supported By: This study was funded by a grant from the Agency<br />
for Healthcare Quality and Research.<br />
Background: While over 50% of nursing home (NH) residents<br />
in the US have dementia, the burden of comorbid conditions and<br />
symptoms affecting quality of life in this population is understudied.<br />
Further, comorbidity and symptom burden differences by severity of<br />
dementia remain unclear. The study aim is to describe differences in<br />
the prevalence of comorbidites and bothersome symptoms in a<br />
large, population-based sample of NH residents with differing stages<br />
of dementia.<br />
Methods: Data from the first full assessment of the Minimum<br />
Data Set (MDS) was used to identify a population of NH residents<br />
with dementia (Alzheimer’s type or other causes) from 5 states (PA,<br />
MA, CA, FL, MN) in 2008-2009. We used the Cognitive Performance<br />
Scale (CPS) to identify residents with mild-to-moderate (CPS 1-4)<br />
and advanced dementia (CPS 5-6), and to compare differences in the<br />
prevalence of comorbidites and bothersome symptoms (including<br />
pain, eating difficulties, and conditions indicative of potentially druginduced<br />
syndromes [e.g. dehydration, delusions, vertigo, syncope, unsteady<br />
gait, and vomiting]) using a χ2 test.<br />
Results: The study sample included 271,589 residents with mildmoderate<br />
dementia and 96,346 with advanced dementia (total<br />
n=367,935). The 10 most frequently reported comorbid conditions<br />
were hypertension (70.6%), osteoporosis (31.6%), arthritis (31.0%),<br />
anemia (29.7%), diabetes (27.3%), congestive heart failure (20.6%),<br />
hypothyroidism (20.4%), cerebrovascular accident [CVA] (19.2%),<br />
arrhythmia (18.6%), and COPD (17.2%). Residents with mild-moderate<br />
dementia had a higher incidence of each of these comorbidities<br />
except CVA (p
P OSTER<br />
A BSTRACTS<br />
patients transferred from acute care hospital to a GRU. The poorest<br />
prognosis is showed in hypoalbuminemic patients with delirium and<br />
the best in orthopaedic diagnosis group patients.<br />
D41<br />
Symptom Burden in Frail Hemodialysis Patients.<br />
K. Christianer, 1 R. Shengelia, 1 B. M. Eiss, 1 J. E. Roberts, 1 M. C. Reid, 1<br />
R. D. Adelman, 1 N. Berman. 1,2 1. Weill Cornell Medical College, New<br />
York, NY; 2. Rogosin Institute, New York, NY.<br />
Supported By: Supported by the Henry Adelman Fund for Medical<br />
Student Education in <strong>Geriatrics</strong> and the Jewish Foundation for the<br />
Education of Women<br />
Background: In 2008, there were 110,000 incident cases of<br />
ESRD, of which the fastest growing group are patients ages 65+.<br />
Many ESRD patients are placed on aggressive hemodialysis (HD)<br />
treatment, regardless of their comorbidities. Patients with ESRD experience<br />
high symptom burden, even when compared with other<br />
chronic, debilitating conditions, and HD itself can be associated with<br />
side effects (e.g. excess blood volume removal causing fatigue). This<br />
project investigated which symptoms are deemed most burdensome<br />
by HD patients and whether some symptoms may be related to HD<br />
treatment.<br />
Method: Participants were recruited from two outpatient dialysis<br />
clinics in New York City. All patients were receiving HD and categorized<br />
as “frail” (i.e. ineligible for transplant) by their treating<br />
nephrologist. Other eligibility criteria included fluency in English and<br />
intact cognition. Participants were interviewed using the Dialysis<br />
Symptom Index (DSI) and the MOS SF-36. Chart reviews identified<br />
comorbidity using the Charlson Comorbidity Index (CCI).<br />
Results: Of the 31 participants enrolled as of 12/1/11, the mean<br />
age is 71 (range 44-89); 39% are female and the mean CCI Score is 6.4<br />
(range 1-15). Patients reported a mean of 14 symptoms of the 30 that<br />
were asked. Symptoms with high prevalence were Feeling Tired or<br />
Lack of Energy (90%), Dry Skin (70%), Trouble Staying Asleep<br />
(65%), and Nausea (48%). Results of Worrying (61%) and Feeling<br />
Sad (58%) within the past week suggest high rates of depression.<br />
When asked which symptoms were felt to be HD treatment related,<br />
the most common responses were Feeling Tired or a Lack of Energy<br />
(93%), Muscle Cramps (90%), Feeling Anxious (77%) and Lightheadedness<br />
(67%).<br />
Our sample demonstrated higher symptom burden when compared<br />
with a general HD population 1 , with double-digit differences in<br />
prevalence of 20 symptoms, the most prominent being Feeling Sad<br />
(58% vs. 30%), Dry Skin (70% vs. 42%) and Dyspnea (48% vs. 21%).<br />
Conclusion: Frail ESRD patients receiving HD experience immense<br />
symptom burden, even when compared to the general HD<br />
population, and patients attributed many symptoms to HD itself.<br />
Many of the symptoms may be reduced by modifying treatment (e.g.<br />
reducing the time spent in HD).These pilot data support future efforts<br />
to investigate palliative care interventions in this target population.<br />
References:<br />
1 Abdel-Kader K, et al. Clin J Am Soc Nephrol 2009;4:1057-64<br />
D42<br />
Characteristics and Economic Burden of Elderly Patients with<br />
Hospital-Acquired Clostridium-difficile in a Managed Care Setting.<br />
M. E. Strauss, 1 R. Quimbo, 2 S. Palli, 2 J. Singer. 2 1. MESTRA<br />
Consulting, Inc.,White Plains, NY; 2. HealthCore, Inc.,Wilmington, DE.<br />
Supported By: Optimer Pharmaceuticals, Inc.<br />
BACKGROUND: Hospital-acquired C. difficile associated disease<br />
(CDAD) results in an estimated $1.3 billion in excess costs in the<br />
US. Elderly individuals ≥65 are at especially high risk of CDAD and<br />
its recurrence due to diminished immune response, multiple comorbidities,<br />
and increased exposure to health care facilities. This study describes<br />
the incremental economic burden of CDAD in hospitalized<br />
patients ≥65 from a managed care perspective. METHODS: Hospitalized<br />
patients ≥65 years of age with a 12 month pre-index eligibility<br />
between 1/1/2005 and 10/31/2010 were identified within the Health-<br />
Core Integrated Research Database (HIRD SM ). Cases with an inpatient<br />
diagnosis of CDAD (ICD 008.45) were matched to hospitalized<br />
controls without CDAD on a 1:3 match ratio based on: age±10, gender,<br />
and baseline/in-hospital comorbidities. Mean length of stay<br />
(LOS) and costs were calculated using multivariate GLM with a<br />
gamma distribution. Covariates were determined from univariate<br />
analysis of baseline characteristics. RESULTS: 10933 CDAD patients<br />
were matched to 32799 controls. While age (mean 80 (±7.9)), gender<br />
(62% female), and major comorbidity groups were well balanced,<br />
post-match disparities persisted (p
P OSTER<br />
A BSTRACTS<br />
rate was 21.9% for community dwellers and 34.4% for nursing home<br />
residents. Readmission rates for specific diagnoses among community-dwelling<br />
and nursing home patients were, respectively: 19% and<br />
43% for CHF, 12.8% and 22.5% for pneumonia, 13.6% and 35% for<br />
UTI, and 23.5% and 28% for GI bleed.<br />
Conclusions: Nursing home patients have a higher rate of readmission<br />
and in-hospital mortality than community-dwelling patients.<br />
Readmission rates for major diagnoses were uniformly higher for<br />
nursing home patients than for community dwellers.<br />
D44 Encore Presentation<br />
High Blood Pressure is Associated with Mortality only in Faster<br />
Walking Elderly Adults.<br />
M. Odden, 1,2 C. A. Peralta, 2 M. Haan, 3 K. Covinsky. 2 1. Public<br />
Health, Oregon State University, Corvallis, OR; 2. Medicine,<br />
University of California, San Francisco, San Francisco, CA; 3.<br />
Epidemiology and Biostatistics, University of California, San<br />
Francisco, San Francisco, CA.<br />
Supported By: Dr. Odden was supported by a Ruth L. Kirschstein<br />
National Research Service Award (T32HP19025).<br />
Background: The association between high blood pressure (BP)<br />
and risk of death varies by age and appears to be attenuated in some<br />
elderly adults. Walking speed is an excellent measure of functional<br />
status and may identify which elders may be most at risk for the adverse<br />
consequences of hypertension. We aimed to determine if the association<br />
between BP and mortality differed by walking speed in elderly<br />
adults.<br />
Methods: The study population included 2,340 persons ≥ 65<br />
years, with measured BP, in the National Health and Nutrition Examination<br />
Survey (NHANES) waves 1999-2000 and 2001-2002. Mortality<br />
data was linked to death certificate data in the National Death<br />
Index. Walking speed was measured over a 20-foot walk; 243 (8%)<br />
did not complete the walk for various safety and logistical reasons.<br />
Participants with walking speed above the mean (2.7 ft/sec) were<br />
classified as faster walkers. Potential confounders included age, sex,<br />
race, survey year, lifestyle and physiologic factors, chronic health conditions,<br />
and antihypertensive use.<br />
Results: There were 589 deaths recorded through December<br />
31st, 2006. Among faster walkers, those with elevated systolic BP<br />
(≥140 mmHg) had a higher mortality rate compared to those with<br />
systolic BP
P OSTER<br />
A BSTRACTS<br />
pare; (3) to get a sense of patient’s goals of care. Common reasons not<br />
to discuss included: (1) respect for patient’s cultural values; (2) patient’s<br />
lack of mental capacity to understand implications of prognosis;<br />
(3) difficulty estimating prognosis with non-specific disease/comorbidity.<br />
11 clinicians were not willing to discuss 5-year prognosis<br />
because they felt that they could not accurately prognosticate on that<br />
time frame and they did not think it would be useful for patients to<br />
receive uncertain information. All clinicians were willing to discuss<br />
prognosis with patients who have less than 1 year to live because it<br />
helps patients make critical decisions about their end of life care.<br />
CONCLUSIONS: Clinicians balance individual patient factors<br />
when deciding to discuss prognosis with their frail older patients. Clinicians<br />
identified a lack of accurate prognostic information as a barrier<br />
to discussing long-term prognosis with frail elders.<br />
D47<br />
Assessment of Advanced Care Planning Documentation for Patients<br />
Discharged to Hospice Care.<br />
M. E. Young, 1 E. Hurwitz, 2 S. H. Chao, 1 V. Parker, 1 W. Suen. 1 1.<br />
<strong>Geriatrics</strong>, Boston University, Boston, MA; 2. Internal Medicine,<br />
Boston University, Boston, MA.<br />
Background: Three components of advanced care planning<br />
(ACP) include choosing a health care agent, determining resuscitation<br />
wishes and delineating goals of care. During transitions of care,<br />
these three wishes should be documented in one place where the receiving<br />
providers can easily access the information. Methods: We performed<br />
an assessment of ACP documentation at our hospital. From<br />
2005-2010, 289 patients, 65 years of age and older, were discharged<br />
from Boston Medical Center to hospice care. Of these patients, fifty<br />
randomly selected discharge summaries were reviewed to look for<br />
the presence of the three defined components of ACP. If the ACP elements<br />
were not documented in the discharge summary, we searched<br />
the entire medical record for the location of documentation. Results:<br />
The majority (n=43) of the charts we reviewed did not include all<br />
three components of ACP in the discharge summary. When examining<br />
the entire medical record, we found at least one ACP element<br />
missing in 42% (n=21) of the charts. The discharge summary author<br />
most commonly missed documenting the health care agent. Patients<br />
with a documented palliative care consultation had more complete<br />
documentation of ACP than those without a palliative care consultation.<br />
Conclusions: Documentation of ACP is poor at the time of discharge.<br />
A palliative care consultation is associated with more complete<br />
documentation of ACP. We plan to implement an educational<br />
and technological intervention to encourage clearer and more complete<br />
documentation of ACP.<br />
D48<br />
Assessing the wish to die in elderly people.<br />
S. Monod, 1 E. Rochat, 2,1 C. Bula, 1 A. Durst, 1 B. Spencer. 3 1. Service of<br />
geriatric medicine, University of Lausanne Medical Center, Epalinges,<br />
Switzerland; 2. Chaplaincy Service, University of Lausanne Medical<br />
Center, Lausanne, Switzerland; 3. Institute of Social and Preventive<br />
Medicine, University of Lausanne, Lausanne, Switzerland.<br />
Background: The wish to die has mainly been studied in terminally-ill<br />
young adults. In elderly persons, factors associated with the<br />
wish to die are likely to differ from those observed in younger people.<br />
Since the most frequently used scale -“The Schedule of Attitudes Toward<br />
Hastened Death” (SAHD, Rosenfeld et al., 2000)- was previously<br />
used in terminally ill cancer or AIDS patients, its use in elderly<br />
people suffering from multiple comorbidities is problematic. The objectives<br />
of this study were 1) to adapt the SAHD for use in elderly<br />
people, 2) to develop a new instrument to assess patients’ attitudes towards<br />
death 3) to test the relevance/acceptability of these instruments.<br />
Methods:An adapted version of the SAHD to the elderly population<br />
(SAHD-OLD) was obtained by analyzing all items of the instrument<br />
in an interdisciplinary group of experts in geriatric care.<br />
Items were modified according to their relevance in elderly population.<br />
An instrument to assess patients’ attitudes towards death was<br />
built on previous qualitative work performed by Schroepfer. These 2<br />
instruments were subjected to cognitive testing in a convenience sample<br />
of 11 community-dwelling people (median age = 82 years; range<br />
76-91).<br />
Results: The SAHD-OLD was obtained by modifying those<br />
items addressing palliative care issues (eg. irreversible consequences<br />
of stopping treatment) and systematically replacing “illness/disease”<br />
by “health problems”. We expressed in statements the 6 categories<br />
identified by Schroepfer, and created instructions asking respondents<br />
to describe their current attitude towards death (Adapted<br />
Schroepfer). During cognitive testing, our sample assessed the<br />
SAHD-OLD and the Adapted Schroepfer as relevant for elderly<br />
people. Respondents judged these 2 instruments acceptable and appreciated<br />
the direct manner in which they addressed end of life issues.<br />
The opportunity to speak openly on this topic was welcomed.<br />
Conclusions: The SAHD-OLD and the Adapted Schroepfer<br />
seem promising instruments to assess the wish to die in elderly people<br />
suffering from multiple comorbidities. Preliminary results show good<br />
comprehension, high relevance and acceptability. Psychometric properties<br />
of the SAHD-OLD are currently being tested in a large sample<br />
of patients.<br />
D49<br />
ROS-Induced NADPH Oxidase Changes and the Aging Heart.<br />
M. E. DuMond. 1,2 1. Pathology, University of Washington, Seattle, WA;<br />
2. Stony Brook University, Stony Brook, NY.<br />
Supported By: MSTAR<br />
The aim of this work was to investigate the effects of increased<br />
Reactive Oxygen Species (ROS) on the levels of NADPH Oxidase 4<br />
(Nox4) and Nox4D in heart tissue. Nox4 is expressed in cardiomyocyte<br />
mitochondria, and its splice variant Nox4D localizes to the nucleus.<br />
Both are ROS generators suspected to be involved in redox signaling.<br />
Cellular damage incurred by chronic ROS overproduction is<br />
the causative agent of an alarming number of diseases and is the underlying<br />
culprit of aging. Understanding the redox signaling that mediates<br />
cellular changes induced by ROS is an important step in intervening<br />
in disease and aging. Potential mechanisms for the antioxidant<br />
effects of the mitochondrial-acting SS31 peptide (Szeto, H, 2006)<br />
were also investigated in this study. SS31 peptide has been shown to<br />
reduce the damaging effects of ROS in mitochondria and elsewhere<br />
in the cell, but its mechanism of action in mitochondria is currently<br />
unknown. In this study, wildtype mice were treated with Angiotensin<br />
II (AngII) using osmotic minipumps for drug delivery. AngII simulates<br />
aging and heart failure by inducing ROS-mediated tissue<br />
changes. Animals were treated with AngII, AngII + SS31 peptide, or<br />
saline. The heart tissue was collected at three timepoints: 3 day, 1<br />
week, and 4 weeks. The results were then evaluated by Western Blot<br />
and protein quantification, comparing treatment to saline controls.<br />
Nox4 was shown to be transiently decreased in AngII + SS31 peptidetreated<br />
mice early in treatment, but after 4 weeks of treatment, Nox4<br />
levels were elevated in both the AngII and AngII + SS31 peptide<br />
mice, suggesting that the rescuing antioxidant effects of SS31 peptide<br />
are eventually overcome by continuous ROS stimulation in response<br />
to AngII. These data suggest that there may be a critical window<br />
where the effects of increased ROS production are reversible, but<br />
over-induction of redox signaling for a prolonged period of time may<br />
result in a state of cellular immunity to the effects of SS31 peptide<br />
and intervening antioxidants. The roles of Nox4 and Nox4D in redox<br />
signaling are obfuscated by the apparent opposing early and late effects.<br />
However, one hypothesis to be further investigated is that a<br />
shift from one Nox4 splice variant to the other in response to increased<br />
ROS is a modulator of redox signaling, and this may be interrupted<br />
by SS31 peptide action.<br />
AGS 2012 ANNUAL MEETING<br />
S203
P OSTER<br />
A BSTRACTS<br />
D50<br />
A Pilot Study of Teaching Medical Interns to Compute Number-<br />
Needed to Treat (NNT) and Outcome Assessment.<br />
H. Cheng. Medicine, University of Virginia, Charlottesville, VA.<br />
Supported By: HRSA: Geriatric Academic Career Award<br />
Background: Communicating drug benefits is an important<br />
process in patient-centered decision making. Relative risk reduction<br />
(RRR) is usually reported in drug trials and is favorably used by patients<br />
and providers despite RRR is misleading. NNT, a better way to<br />
measure the drug effect size and potentially help patients and<br />
providers to make decision, is less reported, more difficult to be understood<br />
and less favorably used by patients and providers. Therefore,<br />
training medical interns to learn computing NNT can be very<br />
important.<br />
Methodology: A new 4 week mandatory geriatric EBM curriculum<br />
was offered for all medical interns, which was described previously<br />
(A57: 2009 AGS). Teaching computing NNT was the part of this<br />
EBM curriculum and briefly summarized in the following. 1. Needs<br />
assessment by pretest. Medical interns answered yes or no to the<br />
question, “I know how to compute NNT” and then asked to compute<br />
NNT based on a drug trial. 2. Computing NNT using another drug<br />
trial was taught to interns in a didactic lecture. 3. Interns practiced<br />
computing NNT using another drug trial and were asked to apply<br />
NNT in their required 2 geriatric presentations. 4. Outcomes were assessed<br />
by repeating pretest and computing NNT from a drug trial.<br />
McNemar test was used to compare the pre and post test of competence<br />
in computing NNT. κ was used to measure agreement between<br />
self-perceived competence and actual performance. 0.05 was chosen<br />
as statistical significance. SPSS was used for data analysis.<br />
Results: About half of 165 medical interns from 2007 to 2010<br />
completed pre and post-test. Improvement of self-perceived competence<br />
in computing NNT was much bigger than actual performance.<br />
There was slight agreement between self-perceived competence and<br />
actual performance (Table). 32% (28/87) interns overestimated their<br />
competence.<br />
Conclusions: The EBM curriculum improved the medical intern’s<br />
competence in computing NNT. However, actual performance<br />
test should be used to assess the teaching outcome.<br />
Perceived competence and actual performance on computing number-needed<br />
to treat (NNT)<br />
*pretest versus post-test either in self-perceived competence or actual<br />
performance<br />
** Agreement between self-perceived and actual performance in<br />
pre-test phase<br />
D51<br />
Will Learners Rate the Curriculum Differently When the Course<br />
Instructor Did the Evaluation? A Pilot Study of a New Geriatric<br />
Evidence-based Medicine (EBM) Curriculum.<br />
H. Cheng. Medicine, University of Virginia, Charlottesville, VA.<br />
Supported By: Geriatric Academic Career Award<br />
Background: There are different ways to evaluate a curriculum.<br />
Online evaluation or anonymous evaluation by the instructor or an<br />
evaluator has been used. However, it is unknown which way is accurate.<br />
The learners might say good things and might be falsely rated<br />
the curriculum when the course instructor does the evaluation. Consequently,<br />
this will have a negative effect on improving the curriculum.<br />
In this pilot study, I hypothesized that the medical interns might<br />
falsely rate a new geriatric EBM curriculum when the course instructor<br />
(Author) does the evaluation compared to the evaluation done by<br />
another person.<br />
Methodology: A new 4 week geriatric EBM curriculum was provided<br />
for all medical interns during the mandatory geriatric rotation,<br />
which was described previously (A57: 2009 AGS). At the end of rotation,<br />
each intern was asked to anonymously rate the educational<br />
value of the EBM curriculum done by the course instructor. The educational<br />
value of the curriculum was assessed with Likert scales (1-5)<br />
ranged from extremely valuable (5), very valuable (4), somewhat<br />
valuable (3), and minimally valuable (2) to not at all valuable (1). Another<br />
person who was not aware of this study did the same anonymous<br />
evaluation at the end of the rotation. Chi-square was used to<br />
test significance of two evaluations with SPSS (p
P OSTER<br />
A BSTRACTS<br />
derstanding the patient’s medical history, baseline cognitive and<br />
physical functionality, home medications, and social situation.<br />
Conclusion:<br />
CIR served as a useful tool to assess interns’ learning in a geriatrics<br />
rotation. Interns appear to be gaining knowledge and skills in<br />
keys areas of <strong>Geriatrics</strong> and are able to articulate how they would<br />
use these knowledge and skills in the future to better care for elderly<br />
patients.<br />
D53<br />
WWAMI Residency Graduates’ Self-reported Preparedness and<br />
Practice Before and After Implementation of a Family Medicine<br />
Residency Continuity Nursing Home Requirement.<br />
J. Raetz, J. Osborn, P. Ford, N. Stevens. Family Medicine, University of<br />
Washington, Seattle, WA.<br />
Background:<br />
Current GME programs will not produce enough geriatricians<br />
to meet the needs of the aging population. Primary care physicians<br />
must receive adequate training to fill this gap. In 2005 the Accreditation<br />
Council for Graduate Medical Education revised the requirements<br />
for family medicine residency training programs to include a<br />
two year continuity nursing home experience. Residents must care<br />
for at least two nursing home patients over a minimum of 24 consecutive<br />
months. The WWAMI Network consists of 18 family medicine<br />
residencies in Washington, Wyoming, Alaska, Montana, and Idaho.<br />
The WWAMII region routinely surveys graduates from the residency<br />
network to characterize preparedness and practice. We examined this<br />
survey data to see if any measurable change could be seen in graduate<br />
preparedness and practice after implementation of the new nursing<br />
home continuity requirement.<br />
Methods:<br />
We examined responses to the questions, “prepared for practice?”<br />
(5 point likert scale) and, “part of my practice?” (yes/no) under<br />
the section, “care of adults: nursing home” for graduates between the<br />
years 1997 and 2009. We then compared responses of physicians who<br />
graduated in 2007 or later with those who graduated prior to 2007.<br />
Results:<br />
Overall self-reported preparedness for nursing home practice<br />
was good and improved slightly after implementation of the ACGME<br />
requirement for a nursing home continuity experience. 795 graduates<br />
between 1997 and 2006 reported level of preparedness for nursing<br />
home care on the five point likert scale (average 3.51). 243 graduates<br />
between 2007 and 2009 reported level of preparedness for nursing<br />
home care on the five point likert scale (average 3.81). Practice in<br />
nursing homes decreased in the same time period. Of the 738 responses<br />
of graduates between 1997 and 2006, 46.39% practiced in<br />
nursing homes. Of the 233 responses of graduates between 2007 and<br />
2009, 28.01% practiced in nursing homes.<br />
Conclusions:<br />
A two year continuity nursing home experience in residency is<br />
associated with improvement in self-reported preparedness to practice<br />
in nursing homes. However, in the same time period fewer graduates<br />
are practicing in nursing homes. More research is needed to identify<br />
factors that increase the number of physicians practicing in<br />
nursing homes to better serve our aging population.<br />
D54<br />
Preferences, Availability, And Quality Of Interactive Teaching<br />
Materials Used By Geriatric Educators.<br />
J. D. Schlaudecker, 1 S. Talebreza, 2 W. Suen, 3 K. Anderson. 2 1.<br />
<strong>Geriatrics</strong>, University of Cincinnati, Cincinnati, OH; 2. <strong>Geriatrics</strong>,<br />
University of Utah, Salt Lake City, UT; 3. <strong>Geriatrics</strong>, Boston<br />
University, Boston, MA.<br />
Supported By: Reynolds Foundation<br />
GACA<br />
Background:<br />
The use of an interactive educational format has been shown to<br />
improve integration of learned material. However few studies have<br />
evaluated if geriatric educators are actually embracing this philosophy,<br />
utilizing interactive teaching techniques in educational venues,<br />
and which techniques are more commonly used.<br />
Methods:<br />
A cross-sectional sampling, using a 26-question Internet ‘Survey<br />
Monkey’ survey, of geriatric educators contacted through <strong>American</strong><br />
<strong>Geriatrics</strong> <strong>Society</strong> listservs was performed. Participant demographics<br />
and attitudes towards use of interactive educational modalities such<br />
as video clips, games, role-play, and creative writing were assessed<br />
during a two-week period in November 2011. Data was analyzed<br />
across response categories.<br />
Results:<br />
141 physicians responded. 64% had a CAQ in Geriatric Medicine.<br />
43% were past/present GACA recipients. 42% spent between ¼<br />
and ½ of time teaching a broad array of learners. 99% agreed with the<br />
statement: “I believe that trainees prefer interactive educational activities.”<br />
Results demonstrated a very high preference for interactive<br />
educational formats, but a much lower rating of quantity and quality<br />
of available resources. For example: 95% agreed with the statement:<br />
“I believe video clips may capture the trainees attention better than<br />
traditional lecture format”, but 63% felt the videos currently available<br />
were of insufficient quantity and quality, and 31% had created<br />
their own video materials. We will also present differences between<br />
GACA awardees, geriatricians, and different academic ranks in use of<br />
interactive educational techniques.<br />
Conclusion:<br />
Educators in graduate medical education routinely utilize a variety<br />
of interactive teaching techniques in diverse teaching settings,<br />
yet the majority of educators felt the number of interactive resources<br />
available were insufficient to meet their teaching needs. Promoting<br />
online educational resource sites, such as POGOe, and encouraging<br />
educators to submit interactive teaching material to these sites may<br />
facilitate the increased use of more effective interactive teaching<br />
techniques.<br />
D55<br />
A Training Model to Strengthen Team-based Primary Care for<br />
Older Rural Veterans.<br />
J. L. Howe, 1,2 J. L. Griffith. 1,2 1. <strong>Geriatrics</strong> and Palliative Medicine,<br />
Mount Sinai School of Medicine, New York, NY; 2. GRECC, James J.<br />
Peter VAMC, Bronx, NY.<br />
There is a severe shortage of healthcare professionals and interdisciplinary<br />
teams trained to provide services for the growing population<br />
of older <strong>American</strong>s. Forty percent of Veterans live in rural areas<br />
and require specialized geriatrics care, but rural practitioners are<br />
often not equipped with the knowledge and team training needed to<br />
serve complex healthcare needs. The Rural Interdisciplinary Team<br />
Training (RITT) Program, a component of the VHA Office of Rural<br />
Health Geriatric Scholars Program, strengthens interprofessional<br />
teams to better serve older adults at rural VA Community Based<br />
Outpatient Clinics (CBOCs) through a multi-modal educational intervention.<br />
Potential RITT training sites are identified through Scholars<br />
who participate in the educational program which includes attendance<br />
at an intensive geriatrics course and a quality improvement<br />
project. CBOC staff participate in team-based training to enhance<br />
communication, leadership, collaboration, conflict resolution, and<br />
problem solving skills in the care of older Veterans. Piloted in 2011,<br />
the RITT Program trained a total of 68 providers from five separate<br />
teams in rural clinics located in NYS, AZ, CA, WI and AR. The validated<br />
Team Development Measure is disseminated 30 days before<br />
and 30 days after the training intervention in order to assess team cohesion,<br />
communication, roles, and goals. For the RITT in WI, there<br />
was an average increase of 15.4% on practitioners’ self-rated levels of<br />
team development. Practitioners also complete a form 30 days after<br />
the training asking what changes are made in their practice as a result<br />
AGS 2012 ANNUAL MEETING<br />
S205
P OSTER<br />
A BSTRACTS<br />
of the education intervention. In WI, team members made changes in<br />
their practice by convening with the team, discussing options, and<br />
slowing down. The main barrier to implementation of the project is<br />
not enough support, time constraints, and staff absences. In 2012,<br />
RITT will be implemented at 10 additional sites with more clinical<br />
geriatric teaching content. In conclusion, RITT led to team-based<br />
practice changes in rural clinics and reinforced the other educational<br />
activities of the Geriatric Scholars Program. It also had a “spill over”<br />
effect by taking team training “on the road” to rural clinics where the<br />
Scholars’ colleagues did not have the opportunity to participate.<br />
D56<br />
G-FACTS - Point of Care Geriatric Resources with a Basic<br />
Science Twist.<br />
E. H. Duthie, 1 J. Rehm, 2 K. Denson, 1 S. Denson, 1 B. Wessel, 1<br />
D. Brown, 2 D. Simpson, 2 G. Colloborrative. 2 1. Medicine, Medical<br />
College of Wisconsin, Milwaukee, WI; 2. Academic Affairs<br />
Educational Services, Medical College of Wisconsin, Milwaukee, WI.<br />
Supported By: Reynolds Foundation; Health Services Resources<br />
Administration Geriatric Education Center; Department of<br />
Veterans Affairs; MCW Injury Research Center<br />
Introduction:<br />
<strong>Geriatrics</strong> related clinical training of residents and fellows continues<br />
to be in the crosshairs of competing forces ranging from new<br />
duty hour limitations and required ACGME/RRC topics to escalating<br />
clinical productivity expectations for teachers. Trainees now expect<br />
immediate access to point of care clinical resources to inform assessment,<br />
diagnosis and management decisions. Currently an array of<br />
e-based clinical resources are available but these resources often omit<br />
the underlying basic sciences to inform action and are highly variable<br />
in quality, level of evidence-based guidance and technology accessibility<br />
(e.g., instant search, access, down load ).<br />
Methods:<br />
Since 2000, Medical College of Wisconsin has successfully provided<br />
just-in time, point-of-care instruction through its End of<br />
Life/Palliative Care Resource Center (EPERC) Fast Fasts. These<br />
concise, practical, peer-reviewed, and evidence-based summaries on<br />
key topics have demonstrated an increase in intern medical knowledge<br />
and self-reported preparedness in symptom management skills.<br />
Adopting this model for geriatrics a blueprint of relevant topics was<br />
identified by a multi-specialty work group and agreement regarding<br />
format/layout to meet our criterion for point of care actional intelligence<br />
emerging from the sciences underlying medicine. Authored by<br />
multi-specialty team including medical students, residents, fellows<br />
and faculty, the fast facts cross specialties.<br />
Results:<br />
An interactive, searchable website houses the geriatric fast facts<br />
(<strong>Geriatrics</strong> Fast Facts) indexed by common geriatrics topics, ACGME<br />
competencies, organ system, and diseases. Fast facts are keyed as assessment,<br />
etiology, diagnosis, and/or management focused. Download<br />
time is seamless as file sizes and layout adapt to web or mobile devices.<br />
Examples of <strong>Geriatrics</strong> Fast Facts include rib fractures, pharmacologic<br />
aspects of drug clearance in elderly patient with reduced function,<br />
gait and balance assessment, and hypertension with positive<br />
reviews from faculty and residents alike.<br />
Discussion:<br />
<strong>Geriatrics</strong> Fast Facts address the“mobile access now”point-of-care<br />
needs of trainees and faculty alike.The incorporation of the sciences underlying<br />
geriatrics provides a unique and added value for residency/fellowship<br />
programs seeking to fulfill ACGME RRC requirements.<br />
D57<br />
Confusion about Delirium.<br />
J. Defillo Draiby, M. Drickamer. <strong>Geriatrics</strong>, Yale School of Medicine,<br />
New Haven, CT.<br />
Delirium is an important clinical syndrome in the elderly and<br />
is related to increased mortality and hospital length of stay, long<br />
term functional and cognitive decline and institutionalization. Despite<br />
being responsible for higher mortality rates than sepsis or<br />
myocardial infarction, delirium is often not diagnosed or improperly<br />
addressed. We evaluated resident’s level of knowledge and<br />
confidence in regards to delirium in order to inform future formative<br />
interventions.<br />
Methods: A web-based questionnaire was given to third year<br />
medical residents. Chief Residents emailed all residents with information<br />
on the nature of the survey with a brief explanation of the importance<br />
of delirium. The 15 questions were designed to elicit basic<br />
knowledge in diagnosis, predisposing and precipitating factors; prevalence,<br />
prevention, management, attitudes and beliefs. The responses<br />
were tabulated in tables and interpreted by consensus.<br />
Results: 30 0f 45 residents completed the survey. 72 % had never<br />
used a delirium assessment tool. 50 % did not feel they have a good<br />
working knowledge of the diagnosis of delirium. 49% thought they<br />
did not have adequate training in delirium with only 33% feeling<br />
comfortable managing it. Half thought delirium is under-recognized<br />
in the emergency department. 77% of resident thought that staffing<br />
constraints augment the need for restraints. 1/3 of our participants<br />
would use a high dose haloperidol or benzodiazepine to control hyperactive<br />
delirium. Delirium features was described as altered level<br />
of consciousness and fluctuating in 67% of the respondent. The predisposing<br />
factors most frequently recognized were age (27%) and<br />
baseline cognitive status (27%). Of precipitating factors, acute illness<br />
was the most recognized (77%) followed by medications (67%) and<br />
environment (60%).<br />
Conclusion: The study illustrates the deficits of third year medical<br />
residents in regards to delirium. They expressed concern about<br />
the adequacy of their baseline knowledge and most were unaware of<br />
any validated instrument to diagnose delirium. Half felt that they did<br />
not have enough training in delirium and only 1/3 of the residents felt<br />
confident in managing delirium. This lack of confidence is accompanied<br />
by lack of awareness of predisposing and precipitating factors of<br />
delirium all of which impact the care of the hospitalized elderly. The<br />
study is important in creating future educational interventions to solidify<br />
Geriatric teaching in our institution.<br />
D58<br />
Living the Life of an Older Adult Resident in a Nursing Home:<br />
Applying Learning by Living© Methods.<br />
K. F. Janes, 1 M. R. Gugliucci. 2 1. School of Social Work, University of<br />
Maine, Orono, ME; 2. College of Osteopathic Medicine, University of<br />
New England, Biddeford, ME.<br />
Supported By: Lakewood Continue Care Center<br />
University of New England College of Osteopathic Medicine<br />
Background: Only three percent of social work students choose<br />
a career in the aging field and yet between 8,000 and 10,000 people<br />
are turning 65/day. There is a critical need for social workers to be<br />
trained in gerontology. This study determined if Learning by Living©<br />
research protocols could be applied to enhance learning for an MSW<br />
student about aging.<br />
Methods: A qualitative ethnographic/biographic research design<br />
was applied, whereby a social work student volunteered to live as an<br />
elder resident in a nursing home for 12 days, 24/7, complete with medical<br />
diagnoses and “standard” procedures of care (toileting, transferring,<br />
bathing, feeding, etc). Qualitative data (field notes) included<br />
subjective and objective reporting of observations and experiences.<br />
Field notes were analyzed applying content analysis, thematic categorization<br />
and coding using manual analysis methods, and QSR N-Vivo<br />
Research Software.<br />
Results: Data stages included: Pre-admission; daily life; the<br />
“Ahaa” moment; and discharge. Themes included: Frustration, de-<br />
S206<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
pendence, depression, social dynamics; dignity, and friendships.<br />
Learning outcomes from living the life of an older nursing home resident<br />
included increased understanding and knowledge about patient/resident<br />
resilience, cross-generational relationships, verbal/ nonverbal<br />
communication skills and thorough professional development.<br />
These insights far exceed what is taught in the classroom.<br />
Conclusions: This life altering experience strengthened the student’s<br />
knowledge, compassion, and empathy for the aging population.<br />
Living as an older adult, aided in acquiring effective communication<br />
skills, confidence to relate with nursing home residents as individuals,<br />
and has advanced learning regarding the intricate levels of family dynamics<br />
in relation to professional caregivers.<br />
D59<br />
Development of an Interdisciplinary Curriculum in Frailty.<br />
K. Thompson, M. Huisingh-Scheetz, L. Mailliard, P. Rush. Section of<br />
<strong>Geriatrics</strong> and Palliative Medicine, University of Chicago, Chicago, IL.<br />
Supported By: Health Resources and Service Administration,<br />
Geriatric Academic Career Award<br />
Background:<br />
Frailty is a geriatric syndrome characterized by exhaustion,<br />
weakness, weight loss, slow gait speed, and low activity. Identifying<br />
frailty improves prognostication and decision-making in older<br />
adults. Internal medicine (IM) resident education on frailty and interdisciplinary<br />
(ID) teams, a vital component of care for frail patients,<br />
is limited.<br />
Methods<br />
An ID curriculum in frailty was created using Kern et al.’s approach<br />
to curriculum development. Problem identification and needs<br />
assessment was performed, including: 1.) Meeting with the IM residency<br />
program director to assess curricular content and gaps. 2.)<br />
Group meetings with residents to assess pre-curriculum exposure to<br />
frailty and ID teams. Goals and objectives for curriculum were based<br />
on needs assessment. Educational strategies were developed to reflect<br />
goals and objectives. Curriculum was implemented for IM residents<br />
and other learners. Evaluation and feedback from learners was<br />
collected.<br />
Results:<br />
Needs Assessment: IM residents received no exposure to frailty<br />
in their formal curriculum and had minimal opportunity to work with<br />
an ID team.<br />
Objectives: After participation, IM residents will be able to:<br />
1.) Define frailty, identify frail patients; 2.) Perform functional<br />
and cognitive assessment; 3.) Appreciate importance of ID care<br />
for frail patients; 4.) Appreciate relevance of frailty to future<br />
practice.<br />
Educational Strategies: Didactic lecture, observed clinical experience<br />
and ID team experience with feedback, pre/post-testing.<br />
Implementation: From July 1 to December 31, 2011, 22 learners<br />
completed curriculum: 17 IM residents, 1 PM&R resident, 2 social<br />
work interns, 1 physical therapist, 1 medical student.<br />
Evaluation and Feedback: Learner satisfaction survey results<br />
centered on awareness of frailty as a geriatric syndrome and appreciation<br />
of ID care. Representative quotes include: “I had never heard of<br />
frailty. Now I not only know what frailty is, I have completed a frailty<br />
evaluation,” and “I really enjoyed participating in the [ID] team<br />
meeting. I learned about a lot of options for patients that I never<br />
knew existed.”<br />
Conclusions<br />
This ID Curriculum in Frailty is an innovative forum for residents<br />
to learn about frailty and practice ID care. Results suggest that<br />
satisfaction with this educational experience is high. Future work will<br />
quantify improvements in knowledge, skills, and attitudes, and expand<br />
evaluation to other learners.<br />
D60<br />
ASSESSING 5 GERIATRIC DRIVEN BASIC SCIENCE<br />
CONCEPTS IN GME.<br />
K. Denson, 1,2 D. Steven, 1,2 E. H. Duthie, 1,2 D. Braza, 4,2 S. Gehl, 3,2<br />
B. Vasudev, 1,2 T. Webb, 5,2 A. Witt, 3,2 D. Brown, 2 J. Rehm, 2 B. Wessel, 1,2<br />
D. Simpson, 2,3 G. Colloborative. 2 1. Medicine, Medical College of<br />
Wisconsin, Milwaukee, WI; 2. Educational Services Academic Affairs,<br />
Medical College of Wisconsin, Milwaukee, WI; 3. Family and<br />
Community Medicine, Medical College of Wisconsin, Milwaukee, WI;<br />
4. Physical Medicine and Rehabilitation, Medical College of<br />
Wisconsin, Milwaukee, WI; 5. Surgery, Medical College of Wisconsin,<br />
Milwaukee, WI.<br />
Supported By: Reynolds Foundation; Health Services Resources<br />
Administration Geriatric Education Center; Department of<br />
Veterans Affairs<br />
Purpose/Objective:<br />
Geriatric quality care requires that residents/fellows solutions<br />
are based on strong basic science underpinnings. We were unable to<br />
identify reliable or valid clinically-oriented, basic science-related<br />
knowledge assessment tools. In response, we created an examination,<br />
to assess underlying basic science concepts/themes linked to clinically<br />
oriented conditions.<br />
Method:<br />
We identified five basic science geriatrics concepts: impaired<br />
homeostasis; connective tissue changes; post-mitotic tissue predilection<br />
for age changes; cellular replication and control of mitotic<br />
processes; and immunosenescence. We then developed a test blueprint<br />
with two dimensions: five “cross-cutting” geriatric related basic<br />
science themes and 13 common geriatric conditions/diseases/illnesses.<br />
We then generated 26 multiple choice questions (MCQ’s) as 13-<br />
item pairs: the first question assessed the clinical condition/disease/illness<br />
and the second question in the pair assessed the associated underlying<br />
basic science. The examination was piloted using third-year<br />
medical students (N=68). Using item statistics selected questions<br />
were revised. The examination was then administered to<br />
residents/fellows in family medicine, general surgery, nephrology, and<br />
physical medicine and rehabilitation.<br />
Results:<br />
Fifty (50) residents/fellows completed the examination. Average<br />
time to complete was < 25 minutes. Mean performance was 57.7%<br />
correct (range 34% - 77%). There was no significant difference between<br />
clinical and basic science items scores (p > .05) nor were there<br />
significant differences between specialties. The overall exam reliability<br />
is in moderate range (> .71).<br />
Conclusions:<br />
A paired clinical and underlying science MCQ type examination<br />
provides a reliable assessment of residents’ and fellows’ knowledge of<br />
clinical geriatric medicine content in relationship to five underlying<br />
basic science associated geriatric concepts. The no differences finding<br />
between specialties or by item type (clinical versus basic science)<br />
adds further evidence to support examination generalizability across<br />
specialties.<br />
D61<br />
A Three-Year Competency-Based <strong>Geriatrics</strong> Curriculum for<br />
Internal Medicine Residents.<br />
K. Callahan, K. B. Feiereisel, J. Williamson, F. S. Watkins,<br />
H. H. Atkinson. Wake Forest University School of Medicine, Winston-<br />
Salem, NC.<br />
Background: Graduate medical educators struggle to meet the<br />
Accreditation Council for Graduate Medical Education (ACGME)<br />
competencies; geriatricians have a unique opportunity to infuse<br />
geriatrics content while helping to meet ACGME requirements. We<br />
describe a 3-year geriatrics curriculum that incorporates ACGME<br />
AGS 2012 ANNUAL MEETING<br />
S207
P OSTER<br />
A BSTRACTS<br />
and geriatrics competencies for Internal Medicine (IM) residents<br />
and engages residents in self-reflection and quality improvement activities.<br />
Methods: Along with IM residency leaders, a curriculum was<br />
developed in 2008 employing spaced learning in geriatrics across<br />
three years. Interns complete an Ambulatory <strong>Geriatrics</strong> Experience<br />
(AGE): nursing home, primary care, consultations, house calls<br />
and palliative care. PGY-2 residents staff the Acute Care for the<br />
Elderly (ACE) unit; they also conduct a chart audit and patient<br />
survey on their own ambulatory panel through the ABIM Practice<br />
Improvement Module for the Care of the Vulnerable Elderly<br />
(CoVE PIM). In the capstone activity, PGY-3 residents utilize<br />
clinic site-based aggregate CoVE PIM data to reflect on their performance<br />
gaps in quality of care for older adults. Each site develops<br />
a clinic-specific QI intervention targeting systemic, sustainable<br />
improvement.<br />
Results: As of spring 2011, 84 residents completed AGE, 56 completed<br />
ACE, and 28 completed the CoVE PIM. Interns’ satisfaction<br />
score averages 6.9 out of 9 and PGY-2 residents rank the ACE unit<br />
6.75 out of 9 (satisfactory-superior). Residents expressed confidence<br />
in “assessing functional status” with a “more complete approach to<br />
patient care”. Comparison of CoVE PIM quality measures between<br />
the 2006 and 2010 cohorts yielded no significant difference in patient<br />
satisfaction or physician communication scores. Screening practices<br />
for cognitive impairment (2% to 19%) and falls (8% to 30%) improved<br />
at one resident clinic (p=0.01), but not the other.<br />
Conclusions: A 3-year residency curriculum in geriatrics that<br />
meets all ACGME and geriatrics competencies was well received by<br />
residents, who feel they learn key elements of geriatrics. The CoVE<br />
PIM prepares residents for independent self-reflective practice and<br />
supports the institutional QI mission. After one CoVE PIM cycle, residents’<br />
screening behaviors improved in one of two clinics; future<br />
measures will assess the impact of this continued curriculum on<br />
learner knowledge, patient QOC and satisfaction with care.<br />
D62<br />
ICE: Introducing First-Year Medical Residents to<br />
Interprofessional Teams.<br />
K. D. Sheppard, C. R. Ford, K. Foley, L. Mitchell, C. Harada,<br />
A. Rothrock, P. Sawyer, C. S. Ritchie. University of Alabama at<br />
Birmingham, Birmingham, AL.<br />
Introduction:<br />
Interprofessional education (IPE) occurs “when students from<br />
two or more professions learn about, from, and with each other to enable<br />
effective collaboration and improved health outcomes”. The<br />
IPE Collaborative Expert Panel identified core competencies for IPE<br />
which is the foundation of the Interprofessional Clinical Experience<br />
(ICE) at UAB. The ICE was developed to educate trainees from multiple<br />
healthcare professions on the importance of interprofessional<br />
team meetings for effective patient care. The experience’s objectives<br />
include: introducing trainees to other healthcare professions; participating<br />
in an interprofessional team meeting; and providing trainees<br />
with the opportunity to develop a patient-centered care plan. This<br />
study describes the differences between first year medical residents’<br />
attitudes and those of other disciplines’ trainees.<br />
Methods:<br />
Six disciplines participate in ICE: dentistry, medicine, nutrition,<br />
occupational therapy (OT), optometry, and social work. Each discipline<br />
sends 1-2 trainees to interview an identified nursing home resident<br />
over a 1-week period. Trainees then convene for a preceptor-led<br />
team meeting to present findings and assemble a patient care plan.<br />
Trainees complete a 10-item survey which assesses the trainees’ interpretation<br />
of the various team roles and the need for effective communication.<br />
Results:<br />
Preliminary results over seven sessions have shown that medical<br />
residents highly ranked the importance of the roles of medicine, nursing,<br />
OT, physical therapy and social work as 4.57/5 for older adult<br />
healthcare. Other disciplines differed by listing nutrition and pharmacy<br />
as highly important as well as medicine, nursing, and OT. Both<br />
medical residents and other trainees highly valued interprofessional<br />
team meetings and interprofessional care as well as the importance<br />
of effective communication with older adults and healthcare professionals.<br />
Conclusion:<br />
Both medical residents and other trainees value interprofessional<br />
team meetings. The medical residents have differing interpretations<br />
of the roles of healthcare professionals. This presentation will<br />
delineate the difference in the residents’ attitudes versus the other<br />
participating disciplines towards interprofessional teams and the<br />
need for effective communication.<br />
D63<br />
Medical student geriatric education and mentorship: the Student-<br />
Senior Connection Project.<br />
L. K. Byerly, 1 K. Anderson, 1 J. Zelaya, 1 A. Dworkin, 1 M. Anthony, 1<br />
H. McNett, 1 S. Devarajan. 1,2 1. School of Medicine, Oregon Health &<br />
Science University, Portland, OR; 2. Family Medicine, Oregon Health<br />
& Science University, Portland, OR.<br />
Background: <strong>Geriatrics</strong> focusing on healthy seniors is an underrepresented<br />
topic in medical school education. An elective focusing<br />
on the relationship between medical students and community<br />
dwelling independently living seniors has never been offered at Oregon<br />
Health & Science University School of Medicine (OHSU<br />
SOM), and the Student-Senior Connection Project (SSCP) was created<br />
to pair OHSU medical students and senior “mentors” from the<br />
community with the goal of fostering relationships and learning<br />
partnerships.<br />
Methods: First and second year OHSU SOM students (n=11;<br />
30.2±6 years, 55% female, 82% White) voluntarily participated in<br />
the yearlong program in which they were randomly paired with a<br />
mentor (n=15; 84.5±9 years, 66% female, 100% White) at a local<br />
continuing care retirement community (CCRC). Over the course<br />
of 8 months, mentors and students met for 6 afternoon sessions<br />
that included formal didactic instruction and informal mentoring.<br />
A variety of professionals lectured on topics including: Quality of<br />
Life, Exercise, Perceptions of Aging, Transitions of Care, Nutrition,<br />
and Death & Dying. Students also took part in CCRC events.<br />
At the end of the program, students completed reflective feedback<br />
forms.<br />
Results: Program completion was 100%. Feedback showed<br />
the “Perceptions of Aging” session was both the most important<br />
and interesting topic for students’ medical education, and (60%)<br />
of students were affirmed in the prospect of including geriatrics in<br />
their primary care practices or amongst their specialty choices.<br />
Student reflections demonstrated several overarching themes: a<br />
deeper understanding of aging well, appreciation of exposure to<br />
an active retirement community, and the value of student-mentor<br />
relationships.<br />
Conclusions: This program was a unique elective experience for<br />
OHSU medical students and the first of its kind for medical students<br />
in the Northwest. The pilot year of the program demonstrated the<br />
utility of introducing students to a group of lively, older adults. Students<br />
expressed a strongly positive view of aging upon program completion.<br />
As the students spent time in their mentors’ community, they<br />
formed meaningful relationships as well as an appreciation of the<br />
strengths and talents of a population that is not well-represented in<br />
their medical school education.<br />
S208<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
D64<br />
Hospice and Palliative Medicine Toolkit of Assessment Methods.<br />
L. J. Morrison, 1,2 E. Carey, 3 E. Chittenden, 4,5 S. Block. 4,6 1. Baylor<br />
College of Medicine, Houston, TX; 2. The Methodist Hospital,<br />
Houston, TX; 3. Mayo Clinic, Rochester, MN; 4. Harvard Medical<br />
School, Boston, MA; 5. Massachusetts General Hospital, Boston, MA;<br />
6. Dana Farber Cancer Institute, Boston, MA.<br />
Supported By: Dr. Morrison’s work was supported by funds from<br />
the Division of State, Community, and Public Health, Bureau of<br />
Health Professions (BHPr), Health Resources and Services<br />
Administration (HRSA), Department of Health and Human<br />
Services (DHHS), under grants K01 HP 00077 and K01 HP 00117,<br />
Geriatric Academic Career Award. The information or content and<br />
conclusions are those of the author and should not be construed as<br />
the official position or policy of, nor should any endorsements be inferred<br />
by the BHPr, HRSA, DHHS or the U.S. Government.<br />
Background: Hospice and Palliative Medicine (HPM) was recognized<br />
as an ACGME subspecialty in 2006. As existing fellowship<br />
programs transitioned to the ACGME framework, the HPM Competencies<br />
Project Workgroup defined competencies and measureable<br />
outcomes in line with the ACGME Outcome Project (1). The final<br />
step was to develop an assessment toolkit to guide HPM fellow evaluation.<br />
Methods: The Workgroup reviewed candidate assessment tools<br />
organized by ACGME competency domain from within and outside<br />
the field. This included known unpublished tools, published tools, and<br />
tools from evaluation websites. HPM educators were invited to submit<br />
tools in a call to the field. In reviewing instruments, the Workgroup<br />
used characteristics of a good instrument (1,2) and developed<br />
criteria to inform HPM-specific tool selection.<br />
Results: Sixty-four tools were identified, but most had very poor<br />
fit with criteria. Very few were specific to HPM. Many key HPM subcompetencies<br />
were not evaluable with the instruments. Most importantly,<br />
tool validation was lacking. We identified, by consensus, the<br />
two best assessment methods for each ACGME competency domain<br />
and 18 instruments for inclusion in the Toolkit. Ten were newly created<br />
by the Workgroup and eight were adapted from existing tools.<br />
The Workgroup developed the Master Assessment Table. This new<br />
tool lists the most important, representative subcompetencies for<br />
each ACGME competency per Workgroup consensus. These are considered<br />
exemplar skills that will reflect broader mastery of the entire<br />
competency domain. Recommended assessment methods are also indicated.<br />
Conclusions: The Toolkit of Assessment Methods provides guidance<br />
to HPM fellowship directors and faculty in assessing competency-based<br />
performance for fellows. Psychometric evaluation is<br />
needed. New tools are also needed to address competency areas not<br />
covered by existing tools. Despite these limitations, the Toolkit has<br />
the potential for broad application and can be used flexibly to guide<br />
assessment of learners by ACGME competency domain across levels,<br />
disciplines, and fields.<br />
References:<br />
1. ACGME Outcome Project Web site. Available at:<br />
www.acgme.org/Outcome. Accessed December 5, 2011.<br />
2. Epstein RM. Assessment in medical education. N Engl J Med.<br />
2007;356:387-396.<br />
D65<br />
Training health professionals to screen, manage and report age<br />
related driving disorders (ARDDs).<br />
L. Hill, 1 J. Rybar, 1 T. Styer, 1 R. Coimbra, 2 K. Patrick. 1 1. Family and<br />
Preventive Medicine, UCSD, San Diego, CA; 2. Surgery, University of<br />
California, San Diego, San Diego, CA.<br />
Supported By: State of California Office of Traffic Safety<br />
Background: Older adults have a higher prevalence of health<br />
and functional impairments that interfere with their ability to drive<br />
safely. If left unaddressed, these problems pose a risk of driving-related<br />
injury, not only to the individuals themselves, but also to their<br />
families and to others who share the road with them. Physicians and<br />
other health professionals receive little training on research and management<br />
of ARDDs. Research suggests that the topic is often avoided<br />
by both parties, and that physicians are not aware of the AMA guidelines,<br />
posted online since 2003, or the mandated reporting required in<br />
some states. The purpose of this report is to describe the results of a<br />
professional training curriculum addressing this issue.<br />
Methods: The curriculum was developed and administered over<br />
the last 4 years to 1202 health professionals. The training was developed<br />
and modified from the <strong>American</strong> Medical Association (AMA)<br />
2003 guidelines for physicians (http://www.nhtsa.dot.gov/people/injury/olddrive/OlderDriversPlan).<br />
Training was provided in a variety<br />
of formats, from in-office seminars to grand rounds. The interactive<br />
program included pocket guides, case studies, resources and videos.<br />
Results: Confidence in the ability to screen seniors increased<br />
from 17% to 72%. The change from baseline screening to intent to<br />
screen increased from 27% to 55%. Ninety one percent of participants<br />
agreed or strongly agreed that they had a better understanding<br />
of California’s mandated reporting laws post training. Ninety two<br />
percent of participants post training agreed or strongly agreed that<br />
they had a better understanding of the medical conditions and medications<br />
that may impair older adults’ ability to drive safely.<br />
Attitudes on California’s mandated reporting laws for lapses of<br />
consciousness (LOC) were favorable, though baseline comprehensive<br />
of the laws was low. While California is one of only 9 states that<br />
mandates LOC reporting (including dementia), physicians felt supported<br />
by the laws.<br />
Conclusions: Physicians responded favorably to training on<br />
ARDDs and mandated reporting, with increases in understanding<br />
and intent to change behavior.<br />
D66<br />
An Innovative Approach to Teaching Delirium Using Standardized<br />
Patients.<br />
L. Wilson, E. Roberts, A. Caprio, G. Winzelberg, J. Busby-Whitehead.<br />
UNC Chapel Hill, Chapel Hill, NC.<br />
Supported By: Supported by: The Donald W. Reynolds Foundation<br />
BACKGROUND: Delirium is a serious, under-diagnosed medical<br />
condition that affects up to 1/3 of hospitalized elders. Physicians<br />
from specialties outside of <strong>Geriatrics</strong> need the skill set to prevent, diagnose,<br />
evaluate, and treat delirium. Attending physicians in specialty<br />
fields may have the opportunity to teach their learners about delirium,<br />
but they may not have the knowledge base for this task. PUR-<br />
POSE: To develop an innovative curriculum using standardized patients<br />
(SPs) for specialty faculty learners (FLs) in order to solidify<br />
their knowledge and increase their confidence in teaching about<br />
delirium. METHODS: FLs designated as Reynolds Specialty Faculty<br />
Scholars on the UNC-CH Donald W. Reynolds Foundation grant,<br />
“Next Steps in Physicians’ Training in <strong>Geriatrics</strong>,” participated in this<br />
workshop. Small groups of FLs rotated through 3 different stations of<br />
delirious SPs. Prior to “seeing” each patient, the FLs reviewed the<br />
“chart,” learning the SP’s past medical history, recent labs and vitals,<br />
and medication administration record. Using this information, they<br />
determined a pretest probability that the SP would have delirium and<br />
identified predisposing and precipitating factors for this condition.<br />
One FL in each group interviewed the patient using the Confusion<br />
Assessment Method to diagnose delirium while being observed by<br />
others in the group and a consulting Geriatrician. A family member<br />
of the SP answered questions to provide information about the SP’s<br />
baseline functional status and risk factors for delirium. After the interview,<br />
the FLs developed a management plan and identified a oneminute<br />
teaching point from the case to instruct learners about delirium.<br />
The consulting Geriatrician provided feedback and made<br />
recommendations. OUTCOMES: Eighteen FLs from Hematology-<br />
Oncology, Physical Medicine and Rehabilitation, Trauma and Critical<br />
AGS 2012 ANNUAL MEETING<br />
S209
P OSTER<br />
A BSTRACTS<br />
Care Surgery, Emergency Medicine, Hospital Medicine, and the Office<br />
of Graduate Medical Education completed the workshop. Feedback<br />
was overwhelmingly positive. These high level academic leaders<br />
in their specialty fields all acknowledged that the direct hands on<br />
learning session enhanced their skills for recognizing and diagnosing<br />
delirium as well as gave them the tools for teaching others. CON-<br />
CLUSION: This curriculum provides an active learning environment<br />
with SPs to teach FLs about delirium. These sessions may be replicated<br />
in other settings and with other disciplines.<br />
D67<br />
Simulation Fosters Interprofessional Skills among Nursing,<br />
Pharmacy and Medical Students.<br />
L. C. Hutchison, 1,3 P. S. Ragsdale, 2 S. N. Berryman, 2 T. J. Bilbruck. 4 1.<br />
College of Pharmacy, University of Arkansas for Medical Sciences,<br />
Little Rock, AR; 2. College of Nursing, UAMS, Little Rock, AR; 3.<br />
Donald W. Reynolds Institute on Aging, UAMS, Little Rock, AR; 4.<br />
College of Medicine, UAMS, Little Rock, AR.<br />
Background: Opportunities to learn effective team skills in the<br />
entry-level curricula are sparse. We integrated human patient simulators<br />
into an interprofessional education experience to train nursing,<br />
pharmacy and medical students interprofessional skills in their geriatric<br />
curricula.<br />
Methods: Two unfolding cases provide simulations for nursing<br />
students (N4s) in their geriatric course. N4s alternatively perform assessments<br />
on the simulated patient or watch via remote camera. Following<br />
this, pharmacy (P4s) and medicine (M4s) students join the N4s<br />
for a simulated staff meeting. N4s present their findings and assessment,<br />
answering questions from the other disciplines. The staff meeting<br />
ends with a delineated plan of care for the patient. The case unfolds<br />
with the patient’s arrival at the simulated emergency<br />
department. N4s perform initial assessment of the simulated patient<br />
and are joined by the P4s and M4s to continue assessment and implementation<br />
of a new plan of care. The simulation ends with initiation<br />
of antibiotics for treatment. At the conclusion of the simulation students<br />
meet to discuss what went well and what could be improved.<br />
Results: 69 students participated in 6 sessions of 9-13 students.<br />
There were 53 N4s, 7 P4s, 3 post-graduate year 1 pharmacy residents<br />
and 6 M4s.Student evaluations of the experience are shown in the table.<br />
Conclusions: Combining high-fidelity simulations of geriatric<br />
patients with interprofessional interactions was well-received by students<br />
from nursing, pharmacy and medicine. This process allows students<br />
from multiple professions to learn and practice different team<br />
skills prior to beginning their professional practice.<br />
D68<br />
Hazards of Hospitalization: A Novel <strong>Geriatrics</strong> Curriculum for<br />
Internal Medicine Interns.<br />
L. Martinez, M. T. Heflin. Department of Medicine, Division of<br />
<strong>Geriatrics</strong>, Duke University, Durham, NC.<br />
Introduction: Older hospitalized adults are susceptible to complications,<br />
termed “hazards of hospitalization” (HOH), which are associated<br />
with poor patient outcomes including increased mortality.<br />
Despite these adverse outcomes, house staff knowledge about their<br />
patient’s risk factors for developing HOH is lacking. The goal of this<br />
novel curriculum is to improve Internal Medicine (IM) intern knowledge<br />
and skills about HOH in elderly inpatients in order to ultimately<br />
improve patient care and patient outcomes.<br />
Methods: We implemented this curriculum at our institution for<br />
IM interns rotating on the <strong>Geriatrics</strong> Inpatient Consult service. Instructional<br />
content and references are posted online and a pocketcard<br />
is provided for review on 10 hazards (delirium, pressure ulcers,<br />
urinary issues, functional decline, falls, polypharmacy,<br />
dehydration/malnutrition, infection, depression, and goals of care).<br />
For each patient the intern follows on the consult service, a topic<br />
checklist is completed by the intern and reviewed by the <strong>Geriatrics</strong><br />
attending and/or fellow to ensure all HOH have been discussed. They<br />
are also directly observed performing the Confusion Assessment<br />
Method (CAM). Knowledge and self-efficacy towards HOH are<br />
measured in pre- and post-tests (knowledge) and pre- and post- self<br />
efficacy surveys (5 point Likert scale: 1= No confidence to 5=Completely<br />
confident).<br />
Results: To date, 8 learners have completed the curriculum. All<br />
demonstrated increased confidence in their ability to manage HOH<br />
after completion of the curriculum, with the most dramatic increases<br />
seen in delirium (pre 2.50 to post 4.00), urinary issues (2.10 to 3.60),<br />
and functional decline (2.00 to 3.75). Interns are able to more accurately<br />
define HOH as well as identify the correct components of the<br />
CAM. Prior to the rotation, all interns either strongly disagreed (5/8)<br />
or disagreed (3/8) that they felt confident in performing the CAM<br />
compared to afterwards in which all either agreed (1/8) or strongly<br />
agreed (7/8).<br />
Conclusion: Implementation of this curriculum has demonstrated<br />
improvement in intern knowledge and self-efficacy regarding<br />
HOH. While a relatively small number of interns have participated to<br />
date, we anticipate reaching up to 38 by the end of the current academic<br />
year. Next steps include measuring application of these principles<br />
through review of documentation of HOH in older adults cared<br />
for by interns in future inpatient rotations.<br />
D69<br />
Incorporating Evidence-Based Medicine in a Geriatric Medicine<br />
Clerkship.<br />
M. van Zuilen, 1 J. C. Palacios, 1,2 M. J. Mintzer. 1,2 1. University of<br />
Miami Miller School of Medicine, Miami, FL; 2. GRECC, VA Health<br />
Care System, Miami, FL.<br />
INTRODUCTION:<br />
As part of a 4-week geriatric medicine clerkship, students at the<br />
UMMSM complete an evidence-based medicine assignment on a<br />
clinical question arising during rounds in the medical, psychological,<br />
social, economic, or functional domains. This paper presents the structure<br />
and components of this assignment, student performance data,<br />
and feedback from students.<br />
METHODS:<br />
During the clerkship orientation, students receive an overview<br />
of the EBM assignment with sample PICO questions from several<br />
domains. They are instructed to frame a clinical question for one of<br />
their patients, search for the best evidence, critically appraise the validity<br />
and clinical relevance of the evidence, and apply it to their patient.<br />
Students submit a structured critical appraisal of topic form and<br />
deliver a 10-minute slide presentation to their peers and course faculty,<br />
followed by a brief Q&A and feedback session. To promote<br />
group participation, student peers ask questions before faculty members<br />
comment and provide feedback. An 8-item evaluation form is<br />
used to rate students’ performance with 5 scorable categories (unsatisfactory<br />
– excellent) for each item. Although we evaluate the basic<br />
EBM skills (framing a question and conducting a search), emphasis is<br />
placed on the critical appraisal and the discussion of patient specific<br />
factors (risks, values, preferences) in applying the evidence.<br />
RESULTS:<br />
Since 2010, 203 students have completed the EBM assignment.<br />
Although most clinical questions pertained to the medical domain,<br />
students have also addressed issues in the psychological, social, economic<br />
and functional domains. The overall quality of the presentations<br />
has been high (average score is 89.8; range is 68-100). The main<br />
contributors to poor performance are formulating a question that is<br />
not clinically meaningful and failing to address patient specific fac-<br />
S210<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
tors. Student feedback indicates they recognize the value of enhancing<br />
their EBM skills, but that they find the assignment time consuming<br />
and the presentation difficult to deliver effectively in 10-minutes.<br />
DISCUSSION:<br />
The EBM assignment in our clerkship builds on prior course<br />
work and paper-based EBM exercises in the pre-clinical years. Students<br />
are able to effectively deliver a clinically meaningful presentation<br />
in a relatively short amount of time. This approach can be easily<br />
adapted by other programs seeking to incorporate EBM into their<br />
curricula.<br />
D70 Encore Presentation<br />
Hearing impairment in the elderly – unheard of in basic and further<br />
nursing education.<br />
M. Decker-Maruska, 2 M. Lerch. 1 1. Geriatric Dept., Protestant<br />
Hospital Bethanien, Iserlohn, Germany; 2. Geriatric Depart., St.<br />
Barbara Hospital, Attendorn, Germany.<br />
Introduction: With nearly 1 million dementia patients, focus on<br />
the special demands of these patients in nursing education grows.<br />
Compared to its high prevalence (approx. 13 Million) hearing impairment<br />
patients are still not recognized in all stages of nursing education.In<br />
the current education, still centred on the anatomy and physiology<br />
of the ear, rarely featuring the basic concept of a hearing aid,<br />
the auditive sensory loss and its consequences is often not an issue,<br />
neither in basic nor in further education.<br />
Methods: After developing a practice oriented educational concept<br />
for the care of hearing impaired geriatric patients, the authors interviewed<br />
105 certified nursing staff from different fields of care (35<br />
from a geriatric ward, a nursing home, a normal hospital ward) with a<br />
minimum working experience between one and four years with a<br />
standardized questionnaire (prevalence, detection, problem recognition<br />
and focus in formal education) before and 3 month after a 2 day<br />
training in specialized care for hearing impaired elderly patients.<br />
Results: In all fields the perceived prevalence grew after the<br />
training workshop (36%=> 67%). The ability to recognize a patient<br />
with a hearing impairment increased significantly in the nursing<br />
home and geriatric sub-group. Especially the ability to evaluate required<br />
repetitions and frequent misunderstandings as signs of hearing<br />
impairment picked up (23%=> 52%). We found a difference between<br />
staff from nursing homes and the geriatric ward opposed to<br />
staff from the normal ward in addressing the major care problems in<br />
hearing impaired elderly patients. Nursing home and geriatric ward<br />
staff recognized the time requirements of handicap-oriented communication<br />
as the core problem, where as the normal ward staff put their<br />
emphasis on technical aids.<br />
Evaluating how much effort was spent on the teaching of sensory<br />
deficiencies overall and on hearing impairment and the conceptual<br />
requirements linked to it in education, especially the staff from<br />
the geriatric wards and the normal wards saw the urgent need for further<br />
nursing education in that particular field.<br />
Conclusion:<br />
To improve the quality of the care process our interviews revealed<br />
the need for more practice-oriented educational concepts developing<br />
competence in recognition, handicap-oriented communication,<br />
and the handling of technical aids required by the auditory<br />
impaired elderly.<br />
D71<br />
Teaching Safe Transitions of Care: An Interdisciplinary Case Based<br />
Approach.<br />
R. K. Miller, E. Goren, C. Whitehouse, A. Norris, J. S. Myers.<br />
Medicine, University of Pennsylvania, Philadelphia, PA.<br />
Background:<br />
Coordinating transitions of care at hospital discharge is essential<br />
to achieve safe, high quality, patient-centered care. The requisite<br />
knowledge and skills in how to execute such a transition are not traditionally<br />
taught to medical trainees. In our experience when they are<br />
taught, they rarely take advantage of the expertise of the interdisciplinary<br />
teams which coordinate these transitions. We sought to design,<br />
implement, and assess an interdisciplinary-led, case-based curriculum<br />
in safe hospital discharge transitions for internal medicine<br />
interns.<br />
Methods:<br />
The curriculum included a brief lecture and case-based session.<br />
The 15 minute lecture reviewed key concepts in hospital discharge<br />
transitions, introduced the interdisciplinary care team roles, and provided<br />
a brief introduction to upcoming small group session. The 40<br />
minute case-based session was conducted with small groups of 6-8 interns..<br />
Each group included a physician moderator, social worker,<br />
clinical pharmacist, and a home care nurse. Two cases were presented,<br />
highlighting the roles of each professional, and emphasizing key high<br />
risk discharge issues.<br />
Results:<br />
Fifty-six interns participated in the curriculum and completed a<br />
satisfacation survey using a 5 point LIkert scale. 24 (42.8%) agreed<br />
and 31 (55.3%) strongly agreed that the session enhanced their ability<br />
to identify threats to a safe hospital discharge. 33 (58.9%) agreed<br />
and 23 (41%) strongly agreed that, after attending the session, they<br />
felt more confident in understanding the roles of other health care<br />
professionals who participate in the discharge process. 8 (14.2%)<br />
agreed and 48 (85.7%) strongly agreed that they believe that the use<br />
of other healthcare professionals to teach this topic was effective.<br />
Conclusion: An interdisciplinary curriculum on teaching safe<br />
transitions of care was well received by internal medicine interns and<br />
resulted in increased confidence in knowledge of discharge transitions,<br />
ability to identify threats to a safe hospital discharge, and the<br />
roles of the physician and other healthcare professionals in the discharge<br />
process. Future directions include expanding the curriculum<br />
to include other residency programs and developing other novel ways<br />
to incorporate interdisciplinary teaching into graduate medical education<br />
training.<br />
D72<br />
Internal Medicine Resident Senior Community Service Learning<br />
Experience.<br />
R. K. Miller, G. True, J. Groce-Martin, J. C. Johnson. Medicine,<br />
University of Pennsylvania, Philadelphia, PA.<br />
Supported By: Donald W. Reynolds Foundation<br />
Background: We developed, piloted, and evaluated a program to<br />
provide a service-learning and community-based, interactive experience<br />
focused on Geriatric Medicine and ACGME core competencies<br />
to medical residents. Service-based learning promotes core competencies<br />
by enriching learners’ experiences, promoting understanding<br />
of community resources and cultural norms, providing help to service<br />
agencies and communities, and developing leadership and professional<br />
skills.<br />
Methods: We developed and piloted a service-based community<br />
learning program with 20 Internal Medicine residents of the University<br />
of Pennsylvania. The program, which consisted of a half-day<br />
morning session, was embedded in a local senior center or senior<br />
housing facility. A community outreach coordinator of the Division of<br />
<strong>Geriatrics</strong> orchestrated program implementation, assisted in site selection,<br />
and facilitated communication between the project leader<br />
and key contacts at each site. At the site, residents toured the facility,<br />
learned about the mission and activities of the site, and gave a supervised<br />
presentation or “brown-bag” review for the seniors on a <strong>Geriatrics</strong><br />
topic. A ten-minute presentation on local senior resources<br />
ended the experience.<br />
Results:<br />
Resident evaluation of the community based learning and service<br />
experience was administered electronically via an IRB-approved<br />
AGS 2012 ANNUAL MEETING<br />
S211
P OSTER<br />
A BSTRACTS<br />
survey using the internal medicine evaluation system. Of 19 evaluations<br />
received, 84% (16) of the internal medicine residents found the<br />
tour of the facility informative; 42% (8) of the residents agreed or<br />
strongly agreed that the service they performed expanded their<br />
knowledge of senior health issues; 68% (13) of the residents agreed<br />
or strongly agreed that this interaction with the seniors helped them<br />
learn more about communicating with older patients. Themes from<br />
open-ended questions included increased knowledge in senior community<br />
resources and facilities, enjoyment of interactions and learning<br />
from seniors outside a hospital setting.<br />
Conclusion:<br />
Overall, this pilot program of service-based community learning<br />
provided residents with insight into the lived environment and<br />
community resources available to seniors while increasing awareness<br />
of the importance of effective communication with seniors. Future<br />
directions include having all trainees perform an aging presentation,<br />
expansion of topics, and obtaining evaluations from the seniors at<br />
the sites.<br />
D73<br />
Pilot Formative Hybrid Simulation for Sub Interns.<br />
S. McGee, 1 W. Gammon, 1 M. Keough, 1 C. Burnham, 1 S. Chimienti, 1<br />
M. Yazdani, 1 J. Gallagher, 1 J. Reidy, 1 M. Zanetti, 1 A. Fabiny, 2<br />
J. Gordon, 2 J. Gurwitz, 1 M. Pugnaire. 1 1. OEA, UMMS, Worcester,<br />
MA; 2. Harvard Medical School, Boston, MA.<br />
Supported By: A University of Massachusetts Medical School<br />
(UMMS) initiative supported by the Donald W. Reynolds<br />
Foundation<br />
Background/Method: Building on the work of our Reynolds<br />
partners at Harvard Medical School, this Pilot Formative Hybrid<br />
Simulation OSCE experience was developed to incorporate more<br />
formative clerkship experiences within the new UMMS curriculum.<br />
This simulation, which utilizes both standardized patients and a mannequin,<br />
involves a case of an elderly patient presenting to the ED in<br />
respiratory distress with end stage COPD who no longer wishes life<br />
prolonging interventions such as bipap or intubation. Students work<br />
in teams of two: one student assesses the patient in the ED and then<br />
completes a hand-off to the second student who assesses the patient<br />
in the ICU . Students are assessed on their ability to conduct a focused<br />
interview, develop an appropriate differential diagnosis and<br />
identify the goals of care. The experience concludes with students debriefing<br />
with 2 faculty, a geriatrician and a hospitalist or palliative<br />
care specialist.<br />
Methods: Medical sub interns at one UMMS clinical site participate<br />
in this experience as part of the required 4 week medical sub internship.<br />
Students complete an evaluation immediately following the<br />
debriefing session.<br />
Results: Fifty-eight sub-interns have participated in the experience<br />
to date. Preliminary analysis of a small sample of learners<br />
(n=10) demonstrated that: 1) 100% felt that the session was “presented<br />
in a way that helped me integrate knowledge, ideas and skills<br />
with other disciplines” and; 2) 90% found it “useful to debrief and review<br />
[their] own performance.” Selected responses from students regarding<br />
the strength of this experience included, “Challenging experience.<br />
Worthwhile to see these kind of scenarios in a consequence free<br />
environment” and “…practicing end of life discussions in a ‘safer’ setting<br />
than the hospital”.<br />
Conclusions: Sub-interns viewed the Pilot Formative Hybrid<br />
Simulation OSCE experience as valuable. Preliminary data suggest<br />
that they valued the opportunity to practice interviewing skills and<br />
medical decision making at the end-of -life in the safe environment of<br />
the UMMS Simulation Center.<br />
AAMC Geriatric Competencies: #19 Assess and provide initial<br />
management of pain and non-pain symptoms based on patient’s goals<br />
of care<br />
D74<br />
Faculty Development Program for Non Geriatricians: Evaluation of<br />
Gait and Fall Risk, Function and Cognition.<br />
S. McGee, J. Gurwitz, C. Burnham, M. Keough, S. Pasquale,<br />
B. L. Robuccio, M. Pugnaire. OEA, UMMS, Worcester, MA.<br />
Supported By: A University of Massachusetts Medical School<br />
(UMMS) initiative supported by the Donald W. Reynolds<br />
Foundation<br />
Background: As part of the UMMS Donald W Reynolds funded<br />
initiative at UMMS a 60 min interactive faculty development program<br />
was developed and piloted for a diverse group of faculty serving<br />
as mentors/advisors to UMMS medical students. This program included<br />
the Competency Certification in Gait and Fall Risk<br />
Evaluation© workshop materials presented at the 2010 AGS Annual<br />
meeting as well as commonly used functional and cognitive assessment<br />
tools.<br />
Methods: Faculty completed surveys rating their knowledge of<br />
the importance and components of gait and fall risk assessment, functional<br />
and cognitive assessment, and their confidence in performing<br />
these assessments prior to and immediately following the faculty development<br />
workshop. Self-selected into two groups, faculty attended<br />
two sequential workshop presentations: Gait and Fall Risk Assessment,<br />
and Functional Assessment and the Mini-Cog.<br />
Results: Thirteen faculty attendees represented multiple specialties<br />
and subspecialties including psychiatry, pediatrics, radiation oncology<br />
and gynecology. Overall, faculty reported significantly increased<br />
knowledge specific to the importance of performing gait and<br />
fall risk assessment, and their confidence to do so, as a result of the<br />
workshop session. Eighty-five percent of those in attendance reported<br />
the session to be valuable to both their clinical and teaching<br />
responsibilities.<br />
Conclusions: A brief faculty development program for a diverse<br />
group of faculty serving as medical student mentors/advisors was very<br />
well received, and improved their knowledge and confidence in performing<br />
commonly used assessment tools for older adults.<br />
AAMC Geriatric Competencies: #7 Perform and interpret a<br />
cognitive assessment, #9 Assess and describe baseline and current<br />
functional abilities and #12 Ask about falls and watch a patient rise<br />
from a chair and walk then record and interpret the findings.<br />
D75<br />
Frailty and Body Mass Index in Community Dwelling<br />
Octogenarians, Nonagenarians and Centenarians.<br />
J. Ceimo, 1 N. Bravo, 1 B. Leonard, 1 T. Minani, 1 K. O’Connor, 1<br />
L. Evans, 1 D. Coon, 2 W. Nieri. 1 1. Center for Healthy Aging, BSHRI,<br />
Sun City, AZ; 2. College of Nursing and Health Innovation, ASU,<br />
Phoenix, AZ.<br />
Background: Research in frailty has attempted to determine<br />
both a consensual diagnosis and its component parts. Prior studies<br />
show frailty associated with extremes of BMI (U-shaped curve). Not<br />
everyone with BMIs < 20 or > 30 is frail. We propose that stable BMI<br />
through mid- and late adult life (age 50 and up) may identify a subset<br />
> 80 years in whom outlying BMIs were a less significant contributor<br />
to frailty.<br />
Methods: This cross-sectional study on community dwelling 80+<br />
year olds is part of a larger longitudinal study on healthy aging (O’-<br />
Connor et al, 2009). Participants lived in Arizona, were interviewed in<br />
person, and had an MMSE >17.<br />
Height/weight was taken from the initial and second annual<br />
exams (year three). Height/weight data at age 50 was based on participants’<br />
recall. Body Mass Index (BMI) was divided into four categories:<br />
1) < 20, 2) 20-25, 3) 26-30, and 4) > 30. Frailty was determined<br />
from 34 selected deficits associated with physiologic decline and increased<br />
mortality.An individual’s total points divided by total number<br />
of deficits yielded a Frailty Index (FI) from 0.0 to 1.0; higher scores in-<br />
S212<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
dicated greater frailty. Descriptive and non-parametric statistical<br />
analysis was performed using SPSS software and Mann Whitney U.<br />
Results: 202 subjects living independently (62% female, mean<br />
age 92) were included. 61 were octogenarians, 69 nonagenarians, and<br />
10 centenarians. Initial mean BMI ranged from 25.2 in octogenarians<br />
to 22.4 in centenarians with no significant drift between years one and<br />
three. Correlated to BMI at age 50, those with < one SD were less<br />
likely to be frail or were less frail. We confirmed prior observations<br />
that strength training correlated with decreased frailty across all ages.<br />
A U shaped curve correlating frailty/BMI held true for subjects up to<br />
age 89. BMI flattened after age 90, suggesting the impact of BMI on<br />
frailty is less.<br />
Conclusions: Frailty correlates with advancing age; BMI does<br />
not. Much effort is spent to obtain/maintain normal BMIs in the elderly.<br />
Our study identifies a subset of elders with outlying BMIs in<br />
whom BMI is not a significant contributor to frailty. Prolonged activity<br />
at a stable BMI may produce physical conditioning that is beneficial.<br />
Avoidance of frailty in this group should stress continued activity<br />
over caloric manipulation.<br />
D76<br />
Orthostatic Hypotension, its risk factors, and the need for its<br />
measurements in the hospital.<br />
J. Chohan, K. Samtani, E. Baum, S. Snyder, N. Kayani, L. Benedict,<br />
S. Hazelet. Post Acute and Senior Services, Summa Health System,<br />
Akron, OH.<br />
Objectives: To investigate the correlation between falls and orthostatic<br />
hypotension (OH) and to examine the benefits of measuring<br />
orthostatic vital signs on admitted patients at high risk for a fall. Design:<br />
Cross-sectional study. Measurements: Patients at high risk included<br />
those: > 65 years old who have fallen in the last 2 months or<br />
had an admitting diagnosis of a fall, syncope, or pre-syncope. Blood<br />
Pressure (BP) was measured in the supine position and after 2 minutes<br />
of sitting and 2 minutes of standing within 24 hours of admission.<br />
Orthostatic hypotension was defined as 20-mmHg decline in Systolic<br />
BP and/or a 10-mmHg decline in diastolic BP from a supine to sitting,<br />
or sitting to<br />
standing position. Results: While 200 people qualified for the<br />
study, only 99 people had orthostatic vital signs measured and of<br />
those 30 people were orthostatic positive. Only five of the 30 were<br />
non-community dwelling patients. 84% of patients had documented<br />
hypertension, 37% had documented heart failure, 23% had anemia<br />
(HgB90) on admission. Of<br />
those who were orthostatic positive, only 1 had a documented fall<br />
while hospitalized. Conclusion: We saw no correlation between falls<br />
and OH, however, anti-hypertensive medications were held on admission<br />
for OH positive patients and a thorough medication reconciliation<br />
was done on discharge through interdisciplinary communication<br />
and physician notification. These results suggest that orthostatic<br />
vital signs should be measured on patients who are at high risk for a<br />
fall to improve their in-patient admission and discharge medication<br />
assessment.<br />
D77<br />
A comparison of different target criteria for geriatric care.<br />
J. van Kempen, 1 H. Schers, 2 R. Melis, 1 M. Olde Rikkert. 1 1.<br />
Department of Geriatric Medicine, Radboud University Nijmegen<br />
Medical Centre, Nijmegen, Netherlands; 2. Department of Primary<br />
Care, Radboud University Nijmegen Medical Centre, Nijmegen,<br />
Netherlands.<br />
Background: There are several instruments for the identification<br />
of frail elderly. None of these aims to identify frail elderly in primary<br />
care to select them for integrated care. Therefore, we developed a<br />
pragmatic identification method, the Easycare-TOS (Two-step Older<br />
people Screening). It optimally uses information that is readily available<br />
to the family physician and takes health and psychosocial aspects<br />
into account. We studied how frail elderly identified with Easycare-<br />
TOS scored on other criteria for geriatric care: disability, multimorbidity<br />
and Fried Frailty criteria.<br />
Methods: Elderly from 4 health centers were included (n=591,<br />
mean age 77 (SD5), 56% women). They were screened with Easycare-TOS.<br />
Additional data were collected for determining multimorbidity<br />
(CIRS-G score ≥2 on ≥2 items), disability (KATZ15 ≥4) and<br />
Fried frailty criteria. We compared the results on the different criteria<br />
in our study population using a Venn diagram.<br />
Results: Figure 1 shows the Venn diagram. The group frail according<br />
to just Easycare-TOS (n=139) had a mean CIRS-G score of<br />
10 (SD4) compared to 14 (SD4) in the group frail according to Fried<br />
(n=58).There was no difference in psychosocial status.The group with<br />
comorbidity and no frailty (n=222) had a mean CIRS-G of 9 (SD3).<br />
Conclusion: Elderly who were frail according to Fried were<br />
more physical frail than elderly who were frail according to Easycare-<br />
TOS solely. Elderly with merely comorbidity had least physical problems.<br />
Follow-up data should show whether Easycare-TOS is able to<br />
identify elderly who will benefit from integrated care.<br />
D78<br />
Fall Stop...MOVE STRONG program to reduce fall risk among<br />
community dwelling older adults.<br />
J. Prager, J. Kardachi, C. Carlucci, S. M. Bradley. <strong>Geriatrics</strong>, Mount<br />
Sinai Hospital, New York, NY.<br />
Background: Falls is a leading cause of injury and death in older<br />
adults. Approximately, one third of community-dwelling people over<br />
65 years of age fall each year resulting in a significant source of morbidity<br />
and mortality, an important threat to patient safety. Exercise<br />
programs have been shown to reduce rate of falls. The Fall<br />
Stop…MOVE STRONG program is an exercise and education based<br />
fall prevention program. The core content of the program includes a<br />
graduated individualized exercise program, which targets strengthening,<br />
coordination, flexibility, and balance with concurrent education<br />
about personal and environmental fall risk factors and safety strategies<br />
lasting 75 minutes each session. The purpose of this study is to<br />
evaluate if Fall Stop…MOVE STRONG decrease fall risk in community<br />
dwelling older patients.<br />
Methods: Fall Stop...MOVE STRONG if offered over a 12 week<br />
period three times a year in an urban geriatric academic practice. Patients<br />
were approached for participation and consent was obtained.<br />
The measures of functional assessment, falls risk, and fear of falling<br />
were obtained before and after falls prevention program including<br />
The Functional Reach Test, The Four Square Step Test, The Timed Up<br />
AGS 2012 ANNUAL MEETING<br />
S213
P OSTER<br />
A BSTRACTS<br />
& Go Test, and The Modified Fall Efficacy Scale. Questions about<br />
medications, depression, functional status, and history of previous<br />
falls were asked.<br />
Results: 14 patients thus far have completed the Fall<br />
Stop…MOVE STRONG program. Average age of population is 79<br />
years old. Functional Reach Test improved 2 cm. 77% of the participants<br />
at high or moderate risk for falls (
P OSTER<br />
A BSTRACTS<br />
P
P OSTER<br />
A BSTRACTS<br />
binge drinking daily. One week prior to admission he slipped on wet<br />
concrete floor suffering a small forehead laceration but refused medical<br />
attention.Admission vital signs were within normal limits.The patient<br />
was alert and well oriented,but agitated,rude,cursing and laughing.He<br />
made self-deprecating comments, dirty jokes and mocked<br />
physicians of “being stupid”.The pupils were anisocoric but reactive<br />
to light and the extraocular movements were intact. He had a regular<br />
cardiac rhythm, and clear lungs. Strength was 5/5 in the upper extremities<br />
and 4/5 in the lower extremities.Cranial nerves II-XII were<br />
grossly intact and the DTR’s +2 throughout. He had a Glasgow coma<br />
scale of 15/15,a MMSE of 28/30 and a normal Geriatric Depression<br />
Scale.Laboratory work up revealed slight hyponatremia<br />
(132mmol/L),a compensated metabolic alkalosis and mild hypoxemia.A<br />
brain CT scan demonstrated a right chronic subdural<br />
hematoma with evidence of re-bleeding. Haldol 2 mg every 12 hours<br />
was administered that controlled his aggressiveness and hallucinations,but<br />
his inappropriate behavior and bouts of laughter continued.<br />
Eight hours after the hematoma was evacuated all inappropriate behavior<br />
resolved.Involuntary emotional expression disorder is a distressing<br />
disorder that is frequently overlooked and misdiagnosed.The<br />
clinical impact can be severe,with unremitting and persistent symptoms<br />
that can be disabling to patients.<br />
D85 Encore Presentation<br />
Psychoeducational Interventions for Caregivers of Seniors: A<br />
Systematic Review.<br />
K. Aung, K. Stevens. UT Health Science Center at San Antonio, San<br />
Antonio, TX.<br />
Supported By: This research was supported by the MESA Center<br />
for Health Disparities, which was funded by a grant from the<br />
National Institute for Nursing Research.<br />
Background: Psychoeducational interventions are structured<br />
programs designed to train caregivers to effectively deal with problems<br />
associated with caregiving. By teaching specific skills to manage<br />
stress on an ongoing basis, such interventions could improve caregiver<br />
depression, caregiver burden, the level of perceived stress, anxiety,<br />
and coping skills. Objective: To assess the effects of psychoeducational<br />
interventions compared to the standard levels of knowledge<br />
provision in enhancing the support and guidance offered to caregivers<br />
of seniors. Methods: Electronic searches of Medline, EM-<br />
BASE, the Cochrane Central Register of Controlled Trials, the<br />
CINAHL, and PsycINFO were undertaken, supplemented by crossreference<br />
searching. All relevant randomized controlled trials were<br />
selected. Quasi-randomized trials, non-randomized trials and observational<br />
studies were excluded. Data were extracted from included<br />
papers. Risk of bias in the included studies was assessed using the<br />
methodology of the Cochrane Collaboration. Data from all trials<br />
were synthesized and summarized. Results: All included trials involved<br />
caregiving to seniors with dementia. Inadequate reporting of<br />
incomplete outcome data increases the risk of attrition bias. Failure to<br />
report allocation concealment led to difficulty in judging the risk of<br />
selection bias. The nature of intervention, duration of intervention<br />
and tools used for measurement of outcomes were different across<br />
the trials. Marked heterogeneity of interventions and outcome measures<br />
across the trials precluded pooling of data and conducting metaanalysis.<br />
Psycho-educational intervention probably has a positive effect<br />
on caregiver depression and possibility has positive effects on<br />
caregiver burden, coping, perceived stress, and anxiety but the effects<br />
were not consistent across the studies. Most of the intervention programs<br />
resulted in improvement of some domains of caregiver outcomes<br />
rather than globally. Conclusions: Psychoeducational interventions<br />
could be potentially useful but interventions should be<br />
customized in accordance with the particular needs of the individual<br />
caregivers. Lack of consistency of beneficial effects on some outcomes<br />
across different studies and the potential risks for selection<br />
and attrition bias prohibited us from drawing firm conclusions. More<br />
well-designed, conducted and reported randomized studies investigating<br />
the effectiveness of psychoeducational interventions are<br />
needed.<br />
D86 Encore Presentation<br />
Medication Reconciliation in Transition of Care: Broken Telephone<br />
or Patient Safety Goal?<br />
L. Sinvani, 1 J. Beizer, 4 M. Akerman, 2 L. Lutsky, 3 C. Cal, 3 Y. Dlugacz, 3<br />
K. Masick, 3 R. Shah, 1 G. Wolf-Klein. 1 1. NSLIJ Health System, New<br />
Hyde Park, NY; 2. Feinstein Institute for Medical Research,<br />
Manhasset, NY; 3. Krasnoff Quality Mgt. Institute, Great Neck, NY; 4.<br />
College of Pharmacy, St. John’s University, Queens, NY.<br />
BACKGROUND: There has been a dearth of studies on the<br />
transition of older patients from hospital admission to subacute rehabilitation<br />
and discharge home. We studied medication discrepancies<br />
across a large Health Care system.<br />
METHODS: Chart review utilizing randomized electronic medical<br />
records (EMR) and paper chart medication reconciliation lists<br />
across three transitions: hospital admission to discharge (time I), hospital<br />
discharge to sub-acute rehab (time II) and sub-acute rehab admission<br />
to discharge home or long term care (time III). Medication<br />
discrepancies were grouped as intentional or unintentional.<br />
RESULTS: In the 44 charts analyzed, average age was 71.4<br />
(range: 41-91), with 68% female, 77.3% surgery versus 22.7% medicine.<br />
Median stay in the hospital was 5.5 days and 14.5 days in skilled<br />
facilities. Total number of medications documented at time I, II, and<br />
III were 284, 472, and 545 respectively. Total medication discrepancies<br />
were 358 (time I), 318 (time II), and 330 (time III); 100% of patients’<br />
records had drug discrepancies and 58% were unintentional.<br />
When analyzing average number of medications per patient at each<br />
transition, time I increased from 6.5 to 10.7 (p
P OSTER<br />
A BSTRACTS<br />
was determined in a cohort of older adults seeking care in an outpatient<br />
incontinence clinic.<br />
Methods: Medication consumption was analyzed from 142 older<br />
patients aged 60+ participating in a longitudinal cohort study of urge<br />
and mixed incontinence recruited from outpatient incontinence clinics.<br />
The International Consultation on Incontinence Questionnaire-<br />
ICIQ-UI-SF was used to detect the severity of incontinence. Descriptive<br />
statistics were used to analyze prevalence of drug use. Regression<br />
analyses sought to determine an association between any putative<br />
medication use and the severity of incontinence.<br />
Results: Participants had a mean age of 71 ± 7years and 83%<br />
were female. The mean number of comorbid conditions was 5±3, and<br />
patients consumed on average 7± 4 different medications. The prevalence<br />
of medications precipitating lower urinary tract symptoms was<br />
54%. Overall, 21% of patients used benzodiazepines, 13% ACE inhibitors,<br />
12% calcium channel blockers, 11% estrogens, 10% other<br />
antidepressants, 5% NSAIDS, 4% other GABAergic medication, 3%<br />
loop diuretics, and 1% alpha-blockers,. There was no association between<br />
the severity of incontinence and any medication use.<br />
Conclusion: The prevalence of use of medications potentially<br />
causing or exacerbating lower urinary tract symptoms in the elderly is<br />
high. Discontinuation or substitution of these medications should be<br />
attempted as part of the first-line treatment approach for older adults<br />
seeking care for bladder symptoms.<br />
KEY WORDS: Older adult, lower urinary tract symptoms,<br />
medication<br />
D88<br />
Association of executive function impairment, history of falls and<br />
physical performance: a population-based study in Eastern France.<br />
S. W. Muir, 1 O. Beauchet, 3 C. Annweiler, 1,3 M. Speechley, 2<br />
M. Montero Odasso. 1,2 1. Geriatric Medicine, University of Western<br />
Ontario, London, ON, Canada; 2. Epidemiology & Biostatistics,<br />
University of Western Ontario, London, ON, Canada; 3. Neuroscience,<br />
University of Angers, Angers, France.<br />
Background: An emerging area of interest in falls research is impaired<br />
cognition that disturbs higher levels of control of balance and<br />
gait on fall risk. Postural stability is a complex skill involving the coordination<br />
of motor and sensory systems in perceiving environmental<br />
stimuli and responding to perturbations to control body movement.<br />
Executive function (EF) is required for divided attention and responding<br />
to changes within the environment. The objectives of this<br />
study were to estimate: 1) the prevalence of impaired EF, 2) the association<br />
between impaired EF and falls, and 3) the association of impaired<br />
EF and physical function used in the evaluation of fall risk.<br />
Methods: Cross-sectional study of 5097 older adults without dementia<br />
received a comprehensive geriatric assessment (July 2008 to December<br />
2010). The assessment included cognitive testing (Clock<br />
Drawing Test, CDT), physical performance testing (Timed Up & Go<br />
Test (TUGT) and grip strength), and self-report of falls in the previous<br />
12 months. A modified Poisson regression evaluated the association<br />
between impaired EF and falls. Linear regression evaluated the<br />
association between impaired EF and the TUGT and grip strength.<br />
Results: Using the CDT, 25% had impaired EF. The prevalence of any<br />
fall in the last year was 27% and 35% among those with and without<br />
abnormal EF respectively. In the adjusted modified Poisson analysis,<br />
impaired EF was associated with any fall [RR=1.13, 95%CI (1.03,<br />
1.25)], serious fall-related events [RR=1.30, 95%CI (1.02, 1.66)], but<br />
recurrent falls was not significant [RR=1.13, 95%CI (0.93, 1.37)]. In<br />
the adjusted linear regression, impaired EF was associated with a<br />
longer time to complete the TUG, indicating a worse performance,<br />
and diminished grip strength compared to people with normal EF.<br />
Conclusions: Impaired EF in the absence of dementia was prevalent,<br />
one quarter of studied sample of community-dwelling older adults,<br />
and has a strong association to falls, fall-related injuries and decreased<br />
ability on physical performance testing. The use of the clock<br />
drawing test is a reliable and easy to administer EF test that can be<br />
used routinely in comprehensive fall risk evaluations.<br />
D89<br />
A comparison of cognitive and manual dual-task challenges on gait<br />
in people with Mild Cognitive Impairment: a cross-sectional study.<br />
S. W. Muir, 1,3 K. Gopaul, 3 M. Montero Odasso. 1,2 1. Geriatric<br />
Medicine, University of Western Ontario, London, ON, Canada; 2.<br />
Epidemiology & Biostatistics, University of Western Ontarion,<br />
London, ON, Canada; 3. Gait & Brain Lab, Lawson Health Research<br />
Institute, London, ON, Canada.<br />
Background: Gait impairment is a prevalent feature among<br />
older adults with cognitive impairment. Assessing gait using the dualtask<br />
paradigm, a secondary cognitive or manual task, evaluates the interaction<br />
between cognition and mobility. Dual-task testing also provides<br />
a valid means to identify fall risk by exposing mobility deficits.<br />
Comparative studies on differential effects by the type of dual-tasks<br />
have been restricted to cognitive tests on gait. The objective was to<br />
evaluate the effect of manual and cognitive dual-task challenges on<br />
gait in people with Mild Cognitive Impairment (MCI). Methods:<br />
Cross-sectional study of 57 adults with MCI (mean age=75.4 (6.4))<br />
and 25 cognitively normal controls (mean age=71.5 (4.1)). Gait was<br />
assessed using an electronic walkway under single, dual-task (counting<br />
backward from 100 by ones, counting backwards from 100 by sevens,<br />
and carrying a glass of water) and multi-task test conditions. Gait<br />
velocity and dual-task cost were the main outcome measures. An adjusted<br />
repeated measure ANOVA was performed to assess the effect<br />
of cognitive group and walking condition. Results: Gait velocity was<br />
significantly slower in the MCI group in all tests. The manual dualtask<br />
confers a challenge not different from the cognitive dual-task of<br />
counting backwards by ones while walking for people with MCI and<br />
normal cognition. Performance of the more complex cognitive task of<br />
serial seven subtractions produced a significant reduction in gait velocity<br />
in both groups, but there was a greater dual-task cost in the<br />
MCI group at 31.8%. Dual-task costs are additive under simple manual<br />
and cognitive challenges. The addition of the simple manual task<br />
to serial seven subtraction while walking did not add to dual-task gait<br />
costs but did negatively affect the cognitive performance in people<br />
with MCI.<br />
Conclusions: This study has demonstrated that not all dual-task<br />
challenges are equivalent in their ability to challenge an individual<br />
and identify deficits. This lack of interchangeability of tasks, between<br />
manual and cognitive secondary tasks and among cognitive tasks, is<br />
important for translating research into clinical practice by providing a<br />
graded progression of task difficulty.<br />
D90<br />
CHARACTERISTICS OF FRAIL PATIENTS IN A GERIATRIC-<br />
HIV PROGRAM: THE EXPERIENCE OF AN URBAN<br />
ACADEMIC CENTER AT ONE YEAR FOLLOW-UP.<br />
M. A. Ruiz , E. Aguilar, P. Sirisha, M. Frontini, C. Cefalu . Medicine,<br />
Louisiana State University Health Sciences Center, New Orleans, LA.<br />
Purpose of Study:<br />
To determine the prevalence and severity of frailty and its associated<br />
factors in patients >60 infected with HIV in an urban academic<br />
center.<br />
Methods Used:<br />
A total of 80 patients > 60 years infected with HIV were<br />
screened and 26 patients were transferred to our newly created <strong>Geriatrics</strong>-HIV<br />
Frailty program. We divided this group of already frail patients<br />
in three different subgroups; the mildly, moderately and the<br />
very frail groups based on the number of domains failed during the<br />
initial geriatrics screening.<br />
Summary of Results:<br />
AGS 2012 ANNUAL MEETING<br />
S217
P OSTER<br />
A BSTRACTS<br />
The percentages of mildly, moderately, and severely frail elderly<br />
patients in our cohort were 20% 50% and 30% respectively. Cognitive<br />
impairment (30%), multiple co-morbidities (60%), and history of<br />
AIDS-related opportunistic infections (40%) were correlated with<br />
frailty status. Smoking was highly prevalent in all groups. The average<br />
number of medications used per patient was 8.1 with 65% of patients<br />
being compliant with their regimens.<br />
Conclusions:<br />
We found that cognitive impairment, presence of co-morbidities,<br />
high number of medications used, and past history of any opportunistic<br />
infection are factors prevalent in severely frail patients infected<br />
with HIV in our cohort. The significance of these factors in<br />
development and progression of frailty syndrome in HIV-positive patients<br />
needs to be elucidated.<br />
D91<br />
Outcomes for elderly breast cancer patients in Louisiana.<br />
M. A. Ruiz , D. Williams, C. Cefalu. Medicine, Louisiana State<br />
University Health Sciences Center New Orleans, New Orleans, LA.<br />
Introduction: Breast cancer is common in the United States and<br />
Europe. Worldwide, the incidence of breast cancer has increased at<br />
annual rate of 3.1% and mortality from breast cancer has increased at<br />
an annual rate of 1.8%. Elderly breast cancer patients are diagnosed<br />
with a higher stage of disease, undergo less surgery and receive hormonal<br />
treatment as monotherapy more frequently This population<br />
also has a decreased relative survival. This study was designed to review<br />
differences if any in diagnosis, treatment modalities and survival<br />
between elderly >65 and young
P OSTER<br />
A BSTRACTS<br />
Results: 22 (33.9%) of the subjects were non-frail, 31 (47.7%)<br />
were pre-frail, and 12 (18.5%) were frail. 39 (60%) were female and<br />
the mean age was 80.6 ±6.4. Transferrin (ng/mL) increased significantly<br />
by frailty status (non-frail: 43.4 ±11.4, pre-frail: 54.3 ±11.9, frail:<br />
58.3 ±10.2, p
P OSTER<br />
A BSTRACTS<br />
other forms of technology. Interviews were recorded and transcribed.<br />
Responses were analyzed qualitatively using grounded theory.<br />
Results: 10 participants comprised the analytic sample. Mean<br />
age of participants was 71 years. 80 percent were female. All identified<br />
as Asian, Black, or Latino. Three main themes emerging from the<br />
interviews included: (1) enhanced social engagement, (2) intellectual<br />
stimulation, and (3) empowerment derived from social and cultural<br />
integration. A majority of participants expressed interest in using the<br />
Internet for communication purposes. Many of the respondents felt<br />
there was educational value to be gained from using the Internet to<br />
find information; respondents expressed a desire to continue learning<br />
through use of the computer at home or taking additional courses.<br />
Most reported self-perceived improvement in confidence and competency<br />
in using a new tool. Participants reported feeling they belonged<br />
to a community from which they were once excluded after completing<br />
the course. Perceived sense of enhancement to their cognitive and<br />
functional abilities also emerged as a major theme.<br />
Conclusion: The use of computers and the Internet can produce<br />
functional, psychological, and social effects unique to elders entering<br />
a world of new languages, structures, and social interactions. Further<br />
exploration into quality of life impacts for isolated elders using the<br />
computer and Internet is needed.<br />
D97 Encore Presentation<br />
What are Hospice Providers Doing to Reach African <strong>American</strong>s . . .<br />
and what works?<br />
K. S. Johnson, 1,2 M. N. Kuchibhatla, 2 J. A. Tulsky. 2 1.<br />
Medicine/<strong>Geriatrics</strong>, Duke University, Durham, NC; 2. Center for<br />
Aging, Duke University, Durham, NC.<br />
Supported By: Beeson Career Development Award in Aging<br />
Research (5K08AG028975)<br />
National leaders recommend that hospices develop practices<br />
and policies which increase access to care for minorities.The extent to<br />
which hospices employ strategies to reach African <strong>American</strong>s, a group<br />
historically underrepresented in hospice, has not been well-described.<br />
Objective: To describe hospice providers’ strategies to increase<br />
service to African <strong>American</strong>s.<br />
Methods: Survey of North and South Carolina hospices. We<br />
used Spearman correlations to examine the association between<br />
provider practices and: (1) commitment to increasing service to<br />
African <strong>American</strong>s; (2) % of African <strong>American</strong>s served by the hospice<br />
based on 2008 Medicare Data.<br />
Results: Of 80 hospices (65% response rate) surveyed, 78% reported<br />
strategies to increase service to African <strong>American</strong>s, but only<br />
20% reported that strategies were reviewed to determine effectiveness.<br />
Most participated in education/outreach: 73% with nursing<br />
homes; 68% with churches; 56% with physicians; 55% with hospitals;<br />
20% with civic groups. Hospices endorsing greater commitment to increasing<br />
service to African <strong>American</strong>s more often participated in outreach<br />
to churches and civic groups (r=0.28 – 0.36, p
P OSTER<br />
A BSTRACTS<br />
of all strokes in the elderly. Warfarin anticoagulant therapy reduces<br />
annual ischemic stroke risk by about two thirds in AF patients. With<br />
institution of coverage for medications by Medicare Part D program<br />
introduced in 2006, we wanted to know whether rates of warfarin use<br />
were higher than previously reported after institution of the program.We<br />
also used the Medicare Part D prescription drug data to examine<br />
national warfarin use by patient characteristics and geographic<br />
location.<br />
Methods: We conducted a retrospective cohort study of 41,447<br />
Medicare beneficiaries aged 66 and older with at least 2 atrial fibrillation<br />
diagnoses in 2008 and at least 1 in 2008. All subjects were enrolled<br />
in Medicare Part D by 2008. Chi-square test was used to examine<br />
differences in warfarin use (defined as 2 warfarin prescriptions in<br />
2008) by patient characteristics (age, ethnicity, sex, Medicaid eligibility,<br />
entering Part D coverage gap, comorbidities, having contraindications<br />
to warfarin, and seeing a cardiologist or a PCP) and by Hospital<br />
Referral Regions. Hierarchical generalized linear models were used<br />
to examine how patient characteristics impact the likelihood of warfarin<br />
use only among patients with no warfarin contraindications, a<br />
sample size of 34,947.<br />
Results: The overall use rate was 66.8%. In bivariate analysis,<br />
patients who received warfarin therapy were more likely [P
P OSTER<br />
A BSTRACTS<br />
D102<br />
Clinician’s perception of infections and laboratory utilization at a<br />
long term care facility.<br />
J. Kopacz, 1,5 P. D. Sychangco, 2 D. Russo, 2,5 Z. Huang, 2,5 N. Mariano, 1,3<br />
C. Urban, 1,3 S. Segal-Maurer. 1,4 1. Infectious Diseases Section, NYHQ,<br />
Flushing, NY; 2. <strong>Geriatrics</strong> Division, NYHQ, Flushing, NY; 3.<br />
Microbiology, NYHQ, Flushing, NY; 4. Medicine, Weill Cornell<br />
Medical College, New York, NY; 5. SCNR, Briarwood, NY.<br />
Introduction<br />
Infectious Diseases (ID) consults are not readily available in<br />
long term care facilities (LTCFs). This study assesses clinician perception<br />
of incidence and prevalence of infections, laboratory utilization<br />
and use of antibiotics at a LTCF.<br />
Materials and Methods<br />
A two-step study was conducted at a 320-bed, hospital-affiliated<br />
LTCF: 1. Six month retrospective analysis of all microbiologic specimens<br />
; 2. 14 question IRB approved survey assessing number of patients<br />
treated, use of diagnostic tests, perceived frequency of infections,<br />
and choice of antibiotics. Answer choices included “never,<br />
rarely, sometimes, often, always.” Clinicians did not have access to retrospective<br />
laboratory data collection.<br />
Results<br />
All 11 LTCF healthcare (HCWs) providers (9 MDs, 2 RNP)<br />
completed the survey. Blood tests were ordered with a change in<br />
physical exam by 8 HCWs “often” and 3 “always” (chest radiographs<br />
infrequently). All HCWs stated urine infections were most common<br />
and they “always” ordered urinalysis (UA) to accompany urine cultures<br />
(UCx). Of 435 UCx specimens, 264 (61%) were positive. Of<br />
these, 236 (89.4%) had an accompanying UA (85% positive). Six<br />
HCWs ordered blood cultures (BCx) “often” and all stated “sometimes”<br />
or “rarely” found the results helpful. Of 167 patients who had<br />
BCxs, 13 (7.7%) were positive with 3 (1.8%) considered true bacteremia<br />
(6 of 13 patients received unnecessary treatment). Perceived<br />
C difficile infection (CDI) prevalence was over 25% and all HCWs<br />
“often” ordered CDI assays. Of 889 CDI assays sent, 94 (11%) were<br />
positive (by ELISA). In spite of CDI concern, fluoroquinolones were<br />
the most frequently prescribed antibiotics. All HCWs stated they<br />
would use an antibiogram if available.<br />
Conclusions<br />
Positive UAs correlated well with positive UCx, obviating use of<br />
routine UAs for all patients. BCx were rarely positive and not clinically<br />
useful, consistent with clinicians’ impression (cost savings<br />
$1,895). CDI rates may be underestimated with ELISA assay and education<br />
is required to limit use of CDI associated antibiotics. HCW<br />
education via an antibiotic stewardship program would improve laboratory<br />
utilization and antibiotic use, help reduce nosocomial infections,<br />
and lead to cost savings.<br />
D103<br />
Nursing home improvement collaborative to reduce potentially<br />
avoidable hospital transfers.<br />
R. Tena-Nelson, 4 K. Santos, 4 L. Herndon, 5 E. Weingast, 2 S. Amrhein, 4<br />
K. S. Boockvar, 2,1 J. Ouslander. 3 1. JJP VA Medical Center, Bronx,<br />
NY; 2. Jewish Home Lifecare, New York, NY; 3. Florida Atlantic<br />
University, Boca Raton, FL; 4. Continuing Care Leadership<br />
Coalition, New York, NY; 5. Massachusetts Senior Care Foundation,<br />
Boston, MA.<br />
Supported By: New York State Departments of Health and Labor<br />
Background: Nursing home (NH) residents experience frequent<br />
hospital transfers, some avoidable. Interventions to Reduce Acute<br />
Care Transfers (INTERACT) provides tools and strategies to assist<br />
NH staff in early identification, communication, and documentation<br />
of changes in resident status.<br />
Objective: To implement INTERACT among members of Continuing<br />
Care Leadership Coalition (CCLC), a NY metropolitan area<br />
NH provider association, and evaluate educational and hospitalization<br />
impacts.<br />
Methods: Funding was obtained from a NY State health workforce<br />
training grant. Members of CCLC were invited to participate<br />
regardless of their baseline transfer rate. 13 education sessions (7 inperson)<br />
were conducted over 1 year. Sessions engaged NH executives,<br />
department heads, front-line nursing staff and their labor union,<br />
and staff from NHs’ partner hospitals. Topics included the INTER-<br />
ACT implementation process; use of simple standardized communication<br />
tools, advance care planning tools, care paths, and change in<br />
condition support tools; quality review of hospital transfers; exercises<br />
for refining clinical skills; teamwork; and lessons learned. One session<br />
used a high-fidelity patient case simulator.<br />
Results: There were 150 participants from 32 facilities. 94% of<br />
NHs were non-profit with 331 beds on average. After training 84%<br />
of participants responded that they were more confident in educating<br />
others about interventions to reduce preventable hospitalizations.<br />
Eighty percent indicated that their organization had a plan in<br />
place to coordinate INTERACT efforts in the next 3 months with a<br />
referring hospital. NHs reported high acceptance of, and compliance<br />
with, use of INTERACT tools. To date, two NHs reported 37% and<br />
18% reductions in hospital transfers as compared to the year prior to<br />
implementation.<br />
Conclusions: Use of a collaborative model among a group of<br />
urban nursing homes resulted in good acceptance and uptake of the<br />
INTERACT intervention. The program has the potential to impact<br />
NH resident care through standardized approaches to communication,<br />
early identification of clinical issues, decision-support, and support<br />
for stronger partnerships between acute and post-acute care<br />
providers.<br />
D104<br />
The PEACE Pilot Study: Convergence of <strong>Geriatrics</strong> and<br />
Palliative Care.<br />
K. R. Allen, 1,2 S. M. Radwany, 2,3 D. J. Kropp, 3,2 D. Ertle, 4<br />
S. Fosnight, 2,3 P. Moore, 2 S. E. Hazelett. 2 1. <strong>Geriatrics</strong> & LifeLong<br />
Health, Riverside Health System, Newport News, VA; 2. Summa<br />
Health System, Akron, OH; 3. DFCM, NEOMED, Rootstown, OH; 4.<br />
Area Agency on Aging 10B, Uniontown, OH.<br />
Supported By: National Palliative Care Research Center<br />
(NPCRC)and<br />
The Summa Foundation<br />
Background: Although geriatrics and palliative care are distinct<br />
disciplines, the populations they serve often overlap, especially for<br />
home-bound patients with chronic life-threatening illness.<br />
Purpose: To describe the feasibility of a randomized pilot study<br />
testing the effectiveness of a geriatrics/palliative care (PC) hybrid intervention<br />
to deliver early in-home interdisciplinary care management<br />
to improve the quality of PC in Ohio’s community-based longterm<br />
care Medicaid waiver program, PASSPORT.<br />
Methods: New PASSPORT enrollees were randomized to the<br />
intervention (n=40) or usual care (n=40). The intervention involves<br />
an in-home geriatrics/PC needs assessment by a trained PASSPORT<br />
case manager (CM). The CM presents the findings to an interdisciplinary<br />
team who devise an individualized care plan based on the consumer’s<br />
goals and best practice guidelines. The CM implements the<br />
plan with the consumer, family and primary care physician (PCP).<br />
The primary outcomes upon which we expected our intervention to<br />
have a positive effect include: 1) Symptom management, 2) Quality of<br />
life, 3) Mood, 4) Decision making/care planning, and 5) Spirituality.<br />
Results: No significant differences were found between groups<br />
regarding baseline demographics. At 6 months no differences were<br />
found in performance of ADLs or IADLs. Mean differences and 95%<br />
confidence intervals were calculated for each of the primary outcomes.<br />
All confidence intervals included zero indicating no significant<br />
S222<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
difference between groups. We have demonstrated the feasibility of<br />
the PEACE intervention with respect to enrollment rate, appropriateness<br />
of the inclusion/exclusion criteria, ability of CMs to implement<br />
the intervention and willingness of PCPs to participate. Elements<br />
requiring revision in larger RCT include selection of different<br />
outcome measures, the use of dedicated palliative care CMs and incorporation<br />
of in-home evaluations by pharmacists, pastoral care and<br />
palliative care RN team members.<br />
Discussion: The outcome measures used in this pilot appeared<br />
to be more appropriate for a population at the end of life. More appropriate<br />
outcomes for our population would include medication appropriateness,<br />
goal attainment, completion/honoring of ADs, quality<br />
of life and symptom assessment tools with less focus on end of life.<br />
D105<br />
Prevalence of Very Low Bed Use to Prevent Bed-Related Fall-<br />
Injury in Hospitals: Preliminary Findings.<br />
L. C. Mion, 1 R. I. Shorr, 2 A. F. Minnick, 1 M. Dietrich, 1 G. Hunt, 1<br />
B. Donaghey. 1 1. Vanderbilt University, Nashville, TN; 2. University of<br />
Florida, Gainesville, FL.<br />
Background: Annually 1 million hospital patients fall with a<br />
10% injury rate. Hospital fall prevention has been only modestly effective<br />
despite >20 years effort. Very Low Beds (VLB) have been<br />
used in long term care settings and expert panels suggest VLBs to<br />
prevent fall injury for hospitals. Only one study exists of VLBs in hospitals<br />
and found no impact on fall-injury rates. Further, a growing<br />
number of reports indicate adverse events for patients, staff and families.<br />
Objective: To determine prevalence of VLB use in NICHE hospitals<br />
(Nurses Improving Care of Hospitalized Elders), impact on<br />
fall-injury rates, and adverse events to patients, families and staff.<br />
Methods: A web-based survey was distributed to 288 NICHE Coordinators<br />
in November 2011. Survey items determined VLB prevalence,<br />
criteria for use, types of units deployed, effect on fall-injury rates, and<br />
adverse events as a direct result of VLB. Descriptive analyses were<br />
performed using SPSS.<br />
Results: To date, there have been 131 responses (45%). Of these,<br />
29 sites (22%) used VLBs; 17 (59%) with padded floor mats. 41%<br />
own and 59% rent VLBs. Most (74%) do not track patient use or<br />
number of bed-days of use (88%). Only 19% track effectiveness of<br />
VLB. General medical and surgical units were the most frequent<br />
users (56%); 31% used in ICUs. Most (60%) have used VLBs for 3+<br />
years. Most (63%) have no policy or procedure for use. 52% of sites<br />
reported at least one patient VLB-event with falls (21%). Staff events<br />
included: injury (10%), falling/tripping (20%), and difficulty maneuvering<br />
equipment (24%). 35% of the sites noted family VLB-events.<br />
52% believe VLB benefits outweigh VLB risks for adults 65. Fall rates ranged from 1 to 4.5 and fall-injury<br />
rates ranged from 0.5 to 1.5/1000 patient-days. Added comments expressed<br />
concerns over costs and staff consistent use of the beds because<br />
of ‘hassles’ for nurses in procurement and transfers.<br />
Conclusions: Less than 1/4 of NICHE respondents use VLBs.<br />
No consistent criteria or procedure was evident. Few track use or effectiveness.<br />
However, most believe the benefits outweigh the risks for<br />
older patients. Adverse events occurred in up to 52% of the sites. Similar<br />
to studies on hip pads, staff adherence was a concern. Carefully<br />
designed studies are necessary prior to policy changes to incorporate<br />
VLBs in acute care settings.<br />
D106<br />
Geriatric Home Care Reduces Hospitalizations in Very Frail Elderly<br />
in Toledo, Spain.<br />
C. Castillo, C. Rodriguez, C. García, A. Bartolomé, M. Diaz de Cerio,<br />
C. Gómez, M. Cuadrado, M. Gomez, B. Aguirre, A. Carbonell.<br />
<strong>Geriatrics</strong>, Hospital Virgen del Valle, Toledo, Toledo, Spain.<br />
Authors: C.Castillo, C.Rodriguez, C.García,A.Bartolomé, M.Diaz<br />
de Cerio, C.Gómez, M.Cuadrado, M.Gomez, B.Aguirre,A. Carbonell<br />
Institution: Hospital Virgen del Valle, Spain<br />
Introduction: The goal in Geriatric Home Care (GHC) is to improve<br />
quality of life for patients and their families when they face a<br />
non-curable life threatening disease. It is not easy to keep patients<br />
with multiple chronic diseases at home because of their complex<br />
treatments and the difficulty determining terminality; therefore, patients<br />
are frequently hospitalized and very often die in the hospital.<br />
We studied the functional status and the number of hospitalizations<br />
of non-oncologic patients admitted in our GHC Unit.<br />
Methods: We reviewed the charts of 519 patients. We excluded<br />
oncologic patients. In the analysis we included main diagnosis, reason<br />
for admission in our GHC Unit, the New York Heart Association<br />
scale (NYHA), use of home oxygen, the Global Deterioration Scale<br />
(GDS), the Barthel index, the number of hospitalizations 12 months<br />
before and 12 months after admission in GHC, the presence of<br />
anorexia and/or disfagia, and the Charlson Index.<br />
Results: 238 patients were non-oncologic. 32% were admitted as<br />
non-oncologic palliative patients. Mean age was 85.53 (SD 5.6) mean<br />
time of stay in GHC was 5.2 months (SD 5.5). 20% of the 238 patients<br />
had a NYHA of III-IV. 24% of the patients were on home oxygen. Severe<br />
dementia was present in 18% of the patients. Severe dependency<br />
was found in 52%. Anorexia and/or disfagia were present in 25% of<br />
the patients. Charlson index above three was found in 31% of individuals.<br />
Before admission in GHC mean number of hospitalizations<br />
was 1.94 (SD 1.84; 95% CI 1.61-2.07) and after GHC it was 0.8 (SD<br />
1.4; 95% CI 0.7-1.075), therefore we achieved a 55% reduction in the<br />
number of hospital admissions. 52% of patients died during their stay<br />
in GHC, of which 32% died at home.<br />
Conclusions: In our GHC Unit Geriatricians manage very old<br />
patients with severe advanced chronic diseases who are hospitalized<br />
very often. After being evaluated by GHC the number of hospitalizations<br />
is reduced and an important percentage of patients die at home,<br />
reducing inadequate use of health system resources. In the future, we<br />
should potentiate care giver support at home in order to improve our<br />
goal of reducing hospital use by this population.<br />
D107<br />
Palliative Oncologic Patients Die at Home and Palliative Nononcologic<br />
Patients Die in the Hospital.<br />
C. Castillo, C. Rodriguez, C. García, A. Bartolomé, M. Diaz de Cerio,<br />
C. Gómez, M. Cuadrado, M. Gómez, B. Aguirre, A. Carbonell.<br />
<strong>Geriatrics</strong>, Hospital Virgen del Valle, Toledo, Toledo, Spain.<br />
Background: It is relatively easy to determine terminality in an<br />
oncologic disease, but it is difficult with non-oncologic diseases, therefore<br />
patients are frequently hospitalized and very often die in the<br />
hospital. In our Geriatric Home Care Unit (GHC) our goal is to improve<br />
the quality of life of our patients, and prevent inadequate use of<br />
health care resources. We studied the number of hospitalizations of<br />
oncologic and non-oncologic patients admitted in our GHC.<br />
Methods: We reviewed the charts of oncologic and non-oncologic<br />
patients followed in our GHC between 2008 and 2010 and collected<br />
demographic data such as age and sex, time followed by GHC,<br />
the number of hospitalizations 12 months before and 12 months after<br />
admission in GHC, the number of deaths and where the patients died.<br />
Results: We studied 519 patients of which 281 were oncologic<br />
and 238 were non-oncologic. Of the oncologic patients, mean age was<br />
83 (SD 5.2), 64% were men and their mean time in GHC was 4<br />
months (SD 4.2). Mean number of hospitalizations 12 months before<br />
admission in GHC was 1.34 (SD 1.32; 95% CI 1.16-1.46) and 12<br />
months after admission was 0.5 (SD 0.9; 95% CI 0.44-0.65); this result<br />
represented a 60% reduction in the number of hospitalizations. 90%<br />
of patients died, and 76% of deaths were at home. Of the non-oncologic<br />
patients, mean age was 85.5 (SD 5.6), 56% were women and<br />
mean time in GHC was 5.25 months (SD 5.5). Mean number of hospitalizations<br />
12 months before GHC was 1.94 (SD 1.84; 95% CI 1.61-<br />
2.07) and 12 months after GHC it was 0.8 (SD 1.4; 95% CI 0.7-1.075);<br />
AGS 2012 ANNUAL MEETING<br />
S223
P OSTER<br />
A BSTRACTS<br />
this result represented a 55% reduction in the number of hospitalizations.<br />
52% of the patients died and 32% died at home.<br />
Conclusions: Even though oncologic patients and frail patients<br />
with multiple chronic advanced diseases share similar symptoms at<br />
the end of life, it is easier to keep oncologic patients at home till they<br />
die. Most likely, this is because in non-oncologic patients it is more<br />
difficult to determine whether a relapse is irreversible or not. We believe<br />
that with better support and education to main care givers we<br />
can improve achieving goals of management.<br />
D108<br />
Improving care Through Collaboration: The Development of a Post-<br />
Acute Care Coordination Network.<br />
J. Chohan, W. Zafirau, S. Hazelet. Post Acute and Senior Services,<br />
Summa Health System, Akron, OH.<br />
Background: Healthcare reform is going to require integration<br />
of services across the continuum of care to improve both efficiency<br />
and quality.<br />
Purpose: This paper describes a unique collaboration between<br />
an acute care hospital and 26 neighboring skilled nursing facilities<br />
(SNF) whose purpose was to improve communication between these<br />
providers in an effort to improve quality of care, reduce hospital<br />
length of stay, optimize transitions and reduce readmission rates for<br />
at risk patients.<br />
Methods: Formation of the Care Coordination Network (CCN)<br />
which implemented electronic communications between facilities, a<br />
standardized transfer form from the hospital to SNF, and a standardized<br />
change in condition form for transfer from the SNF to the<br />
hospital.<br />
Results: The hospital’s average length of stay was reduced from<br />
7.52 days in 2002 to 7.2 days in 2010. Furthermore, the 31 day readmission<br />
rate for post acute patients who were discharged to a skilled<br />
facility dropped from 26% to 20% in 2010. The mortality rate for<br />
cases readmitted to the hospital began at 9% in 2003 and has fluctuated<br />
over the years studied between 12.5% to as low as 7%. At the<br />
end of the study, the readmission rate was at 9% in 2010.<br />
Conclusions: Participation in a Care Coordination Network is<br />
mutually beneficial for hospitals, SNFs, and at risk patients. Hospitals<br />
benefitted from a shorter length of stay, improved bed capacity, and<br />
fewer readmission rates. SNFs benefitted by having increased referrals<br />
from the hospital, more streamlined census management, as well as<br />
improved ability to classify patients into Resource Utilization Groups<br />
due to improved information exchange. Finally, patients were clearly<br />
provided with improved quality of care with these implementations.<br />
D109<br />
A Transformational Model of Caring for independent older adults -<br />
The COLLAGE and Vitality 360 Program.<br />
J. Fonseka, 1 R. Schreiber, 1,3 A. Russotto, 2 R. Jones, 2 A. Rosenberg, 2<br />
M. Bryan, 2 J. Morris. 2 1. Department of Medicine, Hebrew Senior<br />
Life, Boston, MA; 2. Institute For Aging Research, Hebrew Senior<br />
Life, Boston, MA; 3. Medicine, Harvard Medical School, Boston, MA.<br />
Supported By: Hebrew SeniorLife<br />
Background: Vitality 360 is an innovative program of self engagement<br />
that was developed at Hebrew SeniorLife and piloted at<br />
Orchard Cove (OC), a continuing care community (CCRC) in Canton,<br />
MA. OC is part of a consortium of housing and CCRC sites<br />
called COLLAGE .COLLAGE utilizes the Community Health Assessment<br />
(CHA) measurement tool, to identify opportunities of<br />
health and wellness programs to meet the ever changing needs of<br />
older adults living independently. The CHA is administered yearly<br />
and was developed by InterRAI (An International organization of<br />
clinicians and researchers). It is a comprehensive assessment of an individuals’<br />
physical, mental, spiritual, vocational and social status.<br />
After the CHA is done, the patient is offered access to the Vitality<br />
360 program. A Vitality Coach (VC) works with the individual to understand<br />
what their life goals are, and identifies barriers to reaching<br />
these goals. A Vitality plan is developed and monitored collaboratively<br />
over the year.<br />
Methods: 189 residents at OC Independent living were enrolled<br />
in COLLAGE. Out of the 189 residents, 90 patients were identified<br />
but only 69 could be matched on the basis of baseline characteristics<br />
to residents from comparison COLLAGE sites, where Vitality 360<br />
was not available.The broad categories of goals identified by the Vitality<br />
Coach were physical and mental health, volunteering, lifelong<br />
learning, spiritual and life enrichment<br />
Results: Outcomes monitored included changes in residents<br />
self-reported mood problems, health status, satisfaction with life and<br />
fitness participation. There were significant improvements in some of<br />
these parameters and overall quality of life.<br />
Conclusions: Based on these findings, the COLLAGE and Vitality<br />
360 program can positively impact residents’ quality of life by empowering<br />
them to focus on goals that are most important to them.<br />
This resulted in improved satisfaction with life. This model of engagement<br />
warrants further study as an intervention in community<br />
dwelling older adults to enhance quality of life.<br />
D110<br />
Patient- And Family-Centered Rounds On A Geriatric Inpatient<br />
Service: Resident And Staff Perspectives Of Bedside Rounds.<br />
J. D. Schlaudecker, 1 A. Stecher, 2 K. Meganathan. 1 1. <strong>Geriatrics</strong>,<br />
University of Cincinnati, Cincinnati, OH; 2. University of Cincinnati<br />
College of Medicine, Cincinnati, OH.<br />
Supported By: GACA<br />
Reynolds Foundation<br />
Background: Patient- and family-centered rounds (PFCR) is a<br />
model for empowering patients and families and improving communication<br />
and care in an academic, inpatient setting. While well studied<br />
in the pediatric setting, little is known about the application of PFCR<br />
to the geriatric population.<br />
Methods: In summer 2011, 86 unique encounters of 13 residents<br />
and 10 staff were surveyed immediately following a beside PFCR experience.<br />
For comparison, 71 unique encounters of 11 residents and<br />
14 staff on another service that does not use PFCR completed the<br />
survey.<br />
Results: 94% of residents experiencing PFCR found the process<br />
beneficial to patients, compared to 80% of residents practicing traditional<br />
rounds. 92% of residents experiencing PFCR found the process<br />
beneficial to other residents, compared to 80% practicing traditional<br />
rounds. 90% of residents participating in PFCR said the process improved<br />
relationships with patients and families. 63% of residents in<br />
PFCR agreed that PFCR improved resident education, compared to<br />
traditional rounds. 84% of residents in PFCR gained a “better understanding<br />
about patients compared to traditional rounds”. 96% of this<br />
group agreed they were working as a part of a team, compared to<br />
70% of residents in traditional rounds. 100% of residents in the<br />
PFCR group agreed with the idea that PFCR “enhances my ability to<br />
communicate with patients”.<br />
100% of staff in the PFCR group agreed “my questions were answered<br />
about the patient”, “I am working as a part of a team”, “I understand<br />
the patients care plan for the rest of the day better than had<br />
I not participated in PFCR”, “PFCR enhances my ability to address<br />
fears and worries of patients”, and “PFCR improves communication<br />
between the members of the care team.”<br />
Conclusions: The positive responses of those participating in<br />
PFCR indicate that PFCR can lead to positive care experiences for<br />
resident and staff of geriatric patients. Compared to traditional<br />
rounds, PFCR is at least as beneficial for both residents and staff in<br />
enhancing communication, education, and teamwork. More research<br />
is needed with a larger sample to investigate how PFCR outcomes<br />
S224<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
and satisfaction compare to traditional care, but the potential for care<br />
improvement, enhanced education, and improved resident and staff<br />
satisfaction in inpatient geriatric care is great.<br />
D111<br />
Implementation of a Community-Hospital Partnership to Improve<br />
Transitions from Hospital to Home.<br />
J. L. Thorud, 1 A. K. Hochhalter, 1,2 A. B. Stevens, 1,2 H. R. McGhee. 3 1.<br />
Scott & White Healthcare, Temple, TX; 2. Texas A&M Health Sciences<br />
Center, Temple, TX; 3. Central Texas Aging and Disability Resource<br />
Center, Belton, TX.<br />
Supported By: Project is supported by grants from the U.S.<br />
Administration on Aging and the Center for Technology and Aging.<br />
Background: The objective of the Texas ADRC Evidence-Based<br />
Care Transition Program is to reduce hospital readmissions by educating<br />
and empowering patients to manage their healthcare needs. The<br />
program employs the evidence-based Care Transitions Intervention®.<br />
Methods: Eligible patients, age 60 or older and hospitalized at<br />
the participating hospital, are identified through referrals from hospital<br />
personnel and auto-generated reports of electronic medical record<br />
data. Intervention services are offered to eligible patients in the hospital<br />
or by phone after discharge. The free, 30-day program consists of<br />
a home visit and two follow-up phone calls which focus on goal setting<br />
and four “pillars”: creating an accurate medication list, preparing<br />
for and attending a follow-up medical appointment, identifying signs<br />
of exacerbation (“red flags”), and using a personal health record. The<br />
program evaluation follows the RE-AIM framework to assess the potential<br />
value of the program for improving the health of communities;<br />
aspects of program reach into the target population and program<br />
adoption are described in this presentation.<br />
Results: After six months of operation, 39% (467/1183) of patients<br />
referred to the program were eligible and 35% (N=165) enrolled.<br />
The average age of enrollees was 73; 85% were white; 14%<br />
were Hispanic or Latino; 59% were female; and 93% lived in a small<br />
metro area with fewer than one million residents. The Patient Activation<br />
Assessment, a coach-rated assessment of the degree to which patients<br />
participated in the program, showed that over 50% of participants<br />
were actively engaged in the program. Of the 89% of patients<br />
who set a goal, 67% either met or made “a lot of progress” in meeting<br />
it. Readmissions to the same hospital within 30 days were 13.6% for<br />
patients who completed all intervention contacts compared to 23.4%<br />
for those who were eligible but did not enroll.<br />
Conclusions: To date, the program has successfully reached a<br />
large number of patients. The evaluation reveals a need to either increase<br />
program uptake among eligible patients or offer different<br />
types of care transitions interventions for those who choose to decline<br />
services. The next phase will expand the program into additional<br />
hospitals and embed additional coaches within the ADRC offices in<br />
communities.<br />
D112<br />
The Inpatient Hospital Experience of Caregivers of Older Adults: A<br />
Qualitative Study.<br />
J. A. Steimle, 1 J. Colburn, 2 C. Christmas. 2 1. Ohio University Heritage<br />
College of Osteopathic Medicine, Athens, OH; 2. Division of Geriatric<br />
Medicine and Gerontology, Johns Hopkins University School of<br />
Medicine, Baltimore, MD.<br />
Supported By: <strong>American</strong> Federation for Aging Research and<br />
National Institute on Aging<br />
Purpose: The purpose of this study is to interview caregivers of<br />
older adults to learn more about their experiences of having their loved<br />
ones in the hospital, and to suggest ways to improve that experience.<br />
Methods: Caregivers were referred by the patient’s geriatricians<br />
or solicited via flier posted in the clinic and were administered semistructured,<br />
recorded, and transcribed interviews to better understand<br />
their perceptions of the hospital experience.<br />
Results: 25 interviews were analyzed. The average age of patients<br />
was 83 and that of caregivers was 59. 16 caregivers were daughters<br />
or daughters-in-law, 5 were spouses, 2 were sons, 1 was a niece,<br />
and 1 was a state provided caregiver.<br />
On a burden scale with a maximum 16 points, 15 caregivers(60%)<br />
reported low levels of burden (0-8) while 10 (40%) reported<br />
high levels of burden (9-16). Caregivers performed an average<br />
of 6.5 activities of daily living (ADLs) in the home setting but 3.2<br />
in the hospital setting. The majority of caregivers rated the transition<br />
to home very highly according to the 3 question Care Transition<br />
Measure.<br />
6 themes emerged from the analysis of the semi-structured interviews<br />
with caregivers: communication, hospital setting, quality of<br />
care, outpatient care and transition, caregiver involvement, and sensitivity<br />
to the patient’s unique medical conditions.A range of comments<br />
within each theme suggested heterogeneity of experience for the<br />
caregivers. The most common suggestions to improve the hospital experience<br />
when directly asked was to improve communication as well<br />
as to have patience and understanding with patients and caregivers.<br />
Conclusions: In this study of caregivers of older adults after a recent<br />
hospitalization, we found that there remain many challenges<br />
around communication between caregivers and the medical team<br />
both during the hospital stay and at discharge. This analysis suggests<br />
that interventions designed to enhance the education of hospital<br />
providers about communicating with caregivers and about the special<br />
needs of older adults could improve the hospital experience for older<br />
adults and their caregivers.<br />
D113<br />
Identifying Waste in a <strong>Geriatrics</strong> Home Care Practice’s Laboratory<br />
Ordering Process Using Lean Techniques.<br />
J. A. Eng, 1,2 R. M. Zitnay, 1 K. James, 1 M. Sissoko, 1 M. Young, 1<br />
G. Gupte, 2 W. Suen. 1 1. Medicine-<strong>Geriatrics</strong>, Boston University School<br />
of Medicine, Boston, MA; 2. Boston University School of Public<br />
Health, Boston, MA.<br />
Supported By: John A. Hartford Foundation, Health Resources and<br />
Services Administration<br />
Background: “Lean” is a quality improvement philosophy that<br />
focuses on maximizing customer value while minimizing waste<br />
throughout a system. Eliminating waste, or non-value-added steps,<br />
decreases cost, time, and resources needed to perform services. The<br />
main aim of this study is to identify ways to improve the routine laboratory<br />
ordering process in a geriatrics home care practice using the<br />
lean techniques of process mapping and identifying wastes. Methods:<br />
The authors identified and contacted various stakeholders to map the<br />
routine laboratory ordering process from when the clinician placed<br />
an order until receipt of results. The authors collected time stamped<br />
data for 8 key steps in orders placed by two clinicians over 30 days.<br />
The authors analyzed the time data, identified non-value added steps,<br />
and further refined athe process map. Results: The authors collected<br />
data on 23 laboratory orders. Examples of non-value added steps<br />
identified from the process map included creation of a printed order<br />
sheet, walking the printed order sheet from the printer to the secretary’s<br />
bin, waiting for the secretary to pick up the order sheet, having<br />
variation in secretarial verification of account status, faxing of the<br />
order to thean outside laboratory, and waiting for the fax confirmation.<br />
Of the 8 steps tracked, authors identified order wait time in the<br />
secretary’s bin (average 29.89 hours, range from 0.08 to 74.90 hours,<br />
n=16) as the non-value added step that would be most readily modified.<br />
Conclusion: Lean techniques, such as using process mapping and<br />
identifying non-value added steps, are useful for recognizing the inefficiencies<br />
in home care laboratory ordering practices. Future plans include<br />
restructuring the process and better utilizing electronic medical<br />
records systems to reduce waste in the routine home care laboratory<br />
ordering process.<br />
AGS 2012 ANNUAL MEETING<br />
S225
P OSTER<br />
A BSTRACTS<br />
D114<br />
Fall Reduction in an ACE Unit-A Model for Quality Improvement<br />
1,2 J.R Ortiz, 1,2T. Efeovbokham, 1 C.Stephens-Kelly, I,Rohner<br />
1,2Theodore Suh 1 UT Health Science Center in San Antonio &<br />
2CSRHCC.<br />
J. R. Ortiz, 1,2 T. Efeovbokham, 1,2 C. Stephens-Kelly, 1 I. Rohner, 2<br />
T. Suh . 1,2 1. <strong>Geriatrics</strong>, UTHSCSA, San Antonio Texas, TX; 2.<br />
<strong>Geriatrics</strong>, Cristus Santa Rosa, San Antonio, TX.<br />
PURPOSE: Identifying specific risk factors for those who fall in<br />
a hospital Acute Care of the Elderly (ACE) Unit can lead to a targeted<br />
intervention to prevent falls among hospitalized older adults.<br />
BACKGROUND: Falls are a common problem in hospitalized<br />
older adults, with about a third of hospital falls resulting in injuries<br />
such as fractures, head and soft tissue trauma, which contribute to increased<br />
length of stay (LOS), impaired rehabilitation, greater comorbidity,<br />
more transitions to long-term care and greater hospital costs.<br />
The main risk factors for falls in the hospital include gait instability,<br />
confusion, urinary incontinence, previous falls and certain drugs.<br />
METHODS: At the start of this study, our 10-bed ACE Unit at<br />
Christus Santa Rosa Hospital-City Centre had the highest fall rate in<br />
the hospital at just over 10 /1000 bed days. Our goal was to lower the<br />
fall rate to 3.4 /1000 bed days. The ACE team developed a multicomponent<br />
intervention, consisting of differentiating very high from high<br />
fall risk patients, hourly rounding and mandatory use of bed alarms<br />
for very high fall risk patients, and an incentive for ACE Unit nurses<br />
consisting of a free lunch at the end of a month without any falls.<br />
RESULTS: This intervention began on March 1/2011. For over 4<br />
consecutive months (March-June), there were no falls in our ACE<br />
Unit. We had one fall each in the months of July-Sept. and no falls in<br />
Oct. For the last quarter (July-Oct.), the fall rate for our ACE Unit<br />
was 3.5 /1000 bed days. The estimated cost to implement this change<br />
was $850, plus $100 monthly to maintain it. If a fall adds an average of<br />
4 days to the LOS, each prevented fall saves ~$12,800. If one conservatively<br />
estimates that 2 falls were prevented monthly with this intervention,<br />
then the annual projected cost savings is over $307,000.<br />
CONCLUSION: Specific strategies to reduce falls in hospitalized<br />
older adults have been successful. Differentiating those at highest<br />
risk for falls is essential. Increased nurse rounding and diligent<br />
bed alarm use for those at highest fall risk can reduce falls. A nominal<br />
reward to nursing staff for their efforts to reduce falls was also effective.<br />
There are potentially large cost savings to hospital from the prevention<br />
of falls and resulting injuries.<br />
D115<br />
CARE: A Volunteer Approach to Reducing Delirium in the<br />
Emergency Department.<br />
J. Arnold, M. Sanon, A. Chun. Department of <strong>Geriatrics</strong> and Palliative<br />
Medicine, Mount Sinai School of Medicine, New York, NY.<br />
Supported By: The Medical Student Training in Aging Research<br />
program of the the <strong>American</strong> Federation for Aging Research<br />
The emergency department is a critical point of care for the elderly<br />
and delirium is of particular concern in the chaotic ED environment.<br />
Patients who develop delirium in the ED have been shown to<br />
be at increased risk of adverse outcomes, have a more complicated<br />
clinical course, and a higher likelihood of being sedated to control agitation.<br />
The Care and Respect for Elders with Emergencies (CARE)<br />
program is an ongoing effort jointly developed by the Department of<br />
Geriatric and Palliative Medicine and Department of Emergency<br />
Medicine at The Mount Sinai Medical Center specifically designed to<br />
reduce the incidence of delirium in the ED. CARE adapts the successful<br />
approaches from inpatient volunteer programs to the ED environment.<br />
The goals of this retrospective cohort study were to understand<br />
which elderly ED patients were being visited by CARE<br />
volunteers and to characterize their clinical outcomes compared the<br />
the general elderly ED population for evidence that the volunteer<br />
program was having an impact on delirium. We looked at EMR data<br />
from 8009 visits to the ED by elderly patients over an 11 month period<br />
which included 104 volunteer visited patient visits. We found significant<br />
differences in the ethnic composition of the volunteer visited<br />
and non-visited populations with volunteers less likely to visit Hispanic<br />
patients. Volunteer visited patients had lower ESI scores at<br />
triage (were more urgently ill), had significantly longer ED lengths of<br />
stay, were significantly more likely to be admitted to the hospital and<br />
more likely to return to the ED within 30 days. Despite a seemingly<br />
more complicated clinical course, volunteer visited patients were less<br />
likely to be sedated during their ED visit. The results of this study<br />
agree with the expectation that volunteers are visiting more acutely<br />
ill patients but also raise questions about the selection bias that warrants<br />
further investigation. While the intentional and potentially unintentional<br />
volunteer assignment bias limits the value of comparing<br />
clinical course, the difference in sedation rate suggests that the<br />
CARE volunteer program may be reducing the incidence of delirium<br />
in the ED.<br />
D116<br />
Palliative Care Interventions in Advanced Chronic Diseases: A<br />
Systematic Review.<br />
J. E. Roberts, M. C. Reid, R. D. Adelman. Weill Cornell Medical<br />
College, New York, NY.<br />
PURPOSE: Palliative care’s (PC) potential to improve quality<br />
of life and provide symptom relief has received increased attention,<br />
but it remains unclear how commonly such interventions target diverse<br />
chronic illnesses. This study determines the occurrence and efficacy<br />
of PC interventions for chronic non-cancer and cancer disorders.<br />
METHODS: PubMed, MEDLine, CINAHL and Abstracts in<br />
Social Gerontology were searched (1/80-10/11) where terms included<br />
palliative care, chronic obstructive pulmonary disease (COPD), end<br />
stage renal disease (ESRD), advanced heart disease (AHD) and cancer.<br />
Studies were limited to English-language papers reporting on<br />
multi-component PC interventions for adults with cancer, COPD,<br />
ESRD or AHD. Study quality was assessed.<br />
RESULTS: 1613 citations were identified. 41 met eligibility criteria<br />
and described 35 unique interventions. 21 targeted patients with<br />
cancer, and fewer targeted patients with AHD (n=4), ESRD (n=6), or<br />
multiple diseases (n=4). No study enrolled COPD patients exclusively,<br />
but multiple disease interventions included COPD patients.<br />
Five were RCTs and 30 were observational studies. Four of 30 observational<br />
studies and 4 of 5 RCTs were of high methodologic quality.<br />
Interventions were delivered in inpatient units (43%), outpatient<br />
clinics (51%), and home visits (46%), and by nurses (34%), physicians<br />
and nurses (17%), physicians (6%), or multidisciplinary teams<br />
(43%). The mean number of intervention components was 3.8 (range<br />
2-7), common components included symptom management (77%),<br />
advance care planning (49%), psychological support (49%), and care<br />
coordination (43%). Symptom burden was the most common outcome<br />
(46%), followed by medical care utilization (34%) and care satisfaction<br />
(31%). Fifteen studies reported improvements on all or<br />
most outcomes, 12 reported some improvements, and 1 showed no<br />
improvements. The most common symptom improvements were in<br />
pain (n=9) and nausea (n=7). Advance care planning increased as a<br />
result of interventions in 6 studies spanning all disease categories.<br />
CONCLUSIONS: Most PC interventions continue to target patients<br />
with cancer. While 77% report positive effects, methodologic<br />
quality was judged to be poor and only 14% employed an RCT design.<br />
Over half lacked data on the schedule and intensity of the intervention<br />
sufficient for replication. Research on multi-component PC<br />
interventions targeting chronic non-cancer illnesses and employing<br />
rigorous research methods is urgently needed.<br />
D117<br />
Home Based Transitional Care.<br />
J. Leland, J. Cariaga, D. Davis. James A Haley VA, Tampa, FL.<br />
June Leland MD, Jose Cariaga MD, Darlene Davis MHA<br />
S226<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
James A. Haley VA Tampa FL<br />
Background:<br />
Nationally, 20% of veterans discharged from a VA inpatient<br />
care unit are readmitted within 60 days of discharge. As a quality improvement<br />
program, the Tampa VA initiated a Home Based Transitional<br />
Care Program to support discharged veterans during the first<br />
28 days following a hospital discharge.<br />
Program Description:<br />
The program is consult based and provides for an in home visit<br />
by an RN and Kinesiotherapist. The RN visit which occurs within 4<br />
days of discharge includes medication reconciliation, review and reinforcement<br />
of discharge orders, identification of clinical status changes,<br />
offering and coordination of enrollment for chronic care programs<br />
such as CCHT, HBPC, MFH and/ or purchased home care services.<br />
The RN provides follow-up care and case management for up to 28<br />
days. The kinesiotherapist performs a home safety evaluation (environmental<br />
and functional assessments); fall risk assessment, and recommends<br />
or orders necessary equipment for home safety. The team<br />
members provide follow-up care and education for up to 28 days.<br />
Outcomes:<br />
Veterans serve as their own baseline for rate of readmission for<br />
a maximum of 6 months prior to the index discharge during which the<br />
HBTC consult was placed. A readmission rate is established for each<br />
veteran during a time frame equal to the amount of time that has<br />
passed since the veteran was seen by the HBTC team for up to a maximum<br />
of 6 months.<br />
Analysis was completed on 120 patients seen Oct 2010 thru Sept<br />
2011. Readmission rates were reduced by 28% at 14 days, 33% from<br />
15-30 days, and 68% over 30 days. There was a 50% reduction in bed<br />
days of care.<br />
For those evaluated, 53% had medication errors identified, 56%<br />
were recommended additional home services, 39% were issued nursing<br />
supplies, 73% were issued DME, and 100% were educated regarding<br />
medication and home safety.<br />
From program participant surveys:<br />
85% felt comfortable after hospital discharge.<br />
100% felt HBTC staff was professional.<br />
30% claimed HBTC staff taught them something new.<br />
100% endorsed that medications were explained thoroughly.<br />
95% stated that HBTC increased their satisfaction with the VA.<br />
55% claimed that their HBTC visits prevented them from going<br />
back into the hospital.<br />
100% of veterans who were provided with supplies stated that<br />
the usage of equipment or supplies was properly demonstrated.<br />
D118<br />
Multi-faceted effort to improve Hospitalized senior care at a large<br />
Tertiary teaching medical center.<br />
S. Soryal, 1 K. Padua. 2 1. <strong>American</strong> <strong>Geriatrics</strong> <strong>Society</strong>, Milwaukee, WI;<br />
2. geriatrics, Aurora health care, milwukee, WI.<br />
Supported By: non<br />
Our model of care was created to improve senior care in a large<br />
tertiary care hospital focusing on three different efforts.<br />
The first effort is implementing the ACE Concept on almost all<br />
hospital floors. The Acute Care for The Elders concept focuses on<br />
prepared environment with standard equipment for seniors, patientcentered<br />
interdisciplinary care, medical review by a geriatrician as<br />
part of the interdisciplinary team, and early discharge planning. Our<br />
ACE Concept was implemented on sixteen different medical floors<br />
(fourteen of them were medical surgical floors, one medical intensive<br />
care unit, and one inpatient rehab unit).<br />
Geriatricians lead the team utilizing an innovative electronic<br />
medical record tool called ACE tracker, which in real-time identifies<br />
high risks patients for complications in the hospital.<br />
The second effort was the collaboration with the hospitalist<br />
group by attending the morning rounds once a week in a geriatric<br />
hospitalist rounds discussing patients who are in the hospital who are<br />
80 years and older. The geriatrician will also use ACE tracker to identify<br />
high risks patients for complications and use the opportunity as<br />
an educational time for group of nine hospitalist.<br />
The third effort was to start ACE consult service and accept referrals<br />
from admitting physicians to help manage complex patients in<br />
the hospital. Most of the reasons for referrals were to manage delirium,<br />
agitation, dementia, functional decline, frailty, polypharmacy,<br />
identify goals and plans of care, and discharge planning. Physicians<br />
who requested referrals were hospitalist, family practices physicians,<br />
internal medicine physicians, cardiologists, physiatrists, critical care<br />
specialists, neuro-surgeons, and orthopedic surgeons.<br />
After one Year the ACE program showed improvement in<br />
processes of care by decreasing Foley catheter use, reducing restraint<br />
use for non-ICU floors and increase in PT/OT and social<br />
service referrals.<br />
The <strong>Geriatrics</strong> hospitalist round have helped the hospitalists as<br />
they care for seniors and they expressed their satisfaction thru a survey<br />
conducted.<br />
The ACE program has seen 478 consults in its first Year and<br />
Geriatricians were able to show cost savings for patients seen on consult<br />
service( 252 $ per patient ) and reducing length of stay by one day.<br />
D119<br />
Using Cognitive Screens to Predict Pillbox Organizational Skills.<br />
K. J. Anderson, 1,2 A. Huie-Li, 3 C. Willmore. 4 1. Clinical Pharmacy,<br />
Cross Road Medical Center, Glennallen, AK; 2. Pharmacists Int’l<br />
Consulting Specialists, University Place, WA; 3. Clinical Pharmacy, VA<br />
Connecticut Healthcare System, New Haven, CT; 4. Pharmacology,<br />
Union University, Jackson, TN.<br />
Supported By: This study was funded by Blue and You Foundation<br />
for a Healthier Arkansas.<br />
Background:Proactive assessment of medication management<br />
skills can mitigate adverse medication-related events thereby reducing<br />
incidence of emergent care or exacerbation of chronic<br />
disease.Brief cognitive/pillbox skill screens were correlated with pillbox<br />
loading accuracy for predictive value using the patient’s medications.Methods:We<br />
conducted a prospective, cross-sectional, pilot<br />
study in a rural primary care clinic.Inclusion criteria:diagnosis of diabetes<br />
and ability to load a pillbox with >1 medication. Cognitive/literacy/pillbox<br />
skills screens were administered during 3 visits over a ~6<br />
mo period.Pillbox assessment (personal medications loaded in a 28-<br />
compartment pillbox) was initiated when the patient presented with<br />
medications. Average completion time was ~30 min scored by Pillbox<br />
Fill (PBF) method.Screens administered: Mini-Cog=Three Item Recall<br />
and Clock Draw Test (short and long-term memory); Medication<br />
Transfer Screen=MTS (decipher 4 prescriptions, sequence and locate<br />
pills in a pillbox, count); Medi-Cog=Mini-Cog+MTS, Medication<br />
Safety Screen=MEDScreen (Three Item Recall and MTS SF - abbreviated<br />
2-question MTS); 4 o’clock screen=FIR+CDT+AFS (Four Item<br />
Recall, Clock Draw Test, and Animal Fluency Screen); and MTS-<br />
Bean Fill=MTS BF (decipher 4 prescriptions, sequence and locate<br />
beans in a pillbox, count).Results: Forty-nine patients completed the<br />
study: ave age 60, (range 36-84 yrs); 55% AA and 45% White; 71% F;<br />
47% with
P OSTER<br />
A BSTRACTS<br />
D120<br />
Geropsychiatric NP Practice in LTC: Not Just a Med Check.<br />
K. A. Bickerstaff, G. Rogers, C. Chaperon. Community Based<br />
Health, University of Nebraska Medical Center College of Nursing,<br />
Omaha, NE.<br />
Supported By: HRSA Grant 1 D62 HP 15054-01-00<br />
Purpose: This pilot study examined the effectiveness of a<br />
Geropsychiatric Nurse Practitioner in a Long Term Care facility.<br />
Background: Older residents of long term care facilities have<br />
numerous challenging unmet physical and mental health needs. Medications<br />
are frequently used as a rapid resolution to manage mood<br />
and behavioral symptoms. Studies have shown that many of the medications<br />
available are not appropriate for a population over the age of<br />
65. Among the adverse effects can be delirium, life-threatening side<br />
effects, and serious drug-drug interactions as well as a decrease in active<br />
socialization.<br />
Methods: Core interventions that all participants received were<br />
a gold standard comprehensive psychiatric exam and review of all<br />
psychotropic medications. Validated tools used included MDS3<br />
BIMS, MDS3 Behavior, MDS3 Mood, and MDS3 ADLs during time<br />
period of one year.<br />
Design: Retrospective Chart Review of 10% of randomly selected<br />
residents seen by a Geropsychiatric NP in a long term care facility<br />
over a one year period.<br />
Setting: A corporately owned, 150 bed, inner city skilled nursing<br />
home in a large mid-western city.<br />
Population: N=14 long term care facility residents over age 65<br />
seen after referral by staff for evaluation and treatment of cognition,<br />
mood, or behavioral symptoms.<br />
Outcomes:<br />
1. Numbers and types of psychotropic medications used.<br />
2. Mental health modalities ordered by Geropsychiatric NP:<br />
non-pharmacological interventions, cognitive therapy, and increased<br />
socialization.<br />
3. MDS3 Domains of Cognition, Behavior, and ADL function<br />
over a one year period.<br />
Preliminary Results: Analysis of MDS3 records for 3 residents<br />
show positive trends of improved mood and behavior while maintaining<br />
cognition and function. Overall unnecessary psychotropic medications<br />
were eliminated or doses reduced on average of one med discontinued<br />
and 1.3 dose reductions per resident. Each resident had<br />
one added psychotropic medication during the year appropriate for<br />
current symptoms at the time. Each resident received individualized<br />
cognitive, behavioral, and socialization therapy on a monthly basis by<br />
a Geropsychiatric NP.<br />
Conclusion: Geropsychiatric NP intervention may decrease unnecessary<br />
medication use among elderly residents of long term care<br />
facilities and improve both mood and social behaviors.<br />
Key Words: geropsychiatric, nursing, practice<br />
D121<br />
The importance of medication reconciliation in post-hospitalization<br />
patients in an ambulatory geriatric clinic in Singapore.<br />
K. Tan, T. Tan. Department of Geriatric Medicine, Tan Tock Seng<br />
Hospital, Singapore, Singapore.<br />
Even though medication reconciliation is an essential part of<br />
clinical practice, it is often neglected in a busy ambulatory practice.<br />
Older adults who had a recent hospitalization for acute illnesses often<br />
had their medications changed or doses adjusted during the hospital<br />
stay. With these changes, older adults may face medication-related<br />
problems which may lead to poor outcomes if not addressed.<br />
Objective:<br />
To investigate the incidence of medication discrepancies and<br />
medication related problems in older adults post hospitalization.<br />
Methods:<br />
All patients with scheduled appointment at the outpatient geriatric<br />
medicine clinic at Tan Tock Seng Hospital were screened for a<br />
recent admission (within the prior 3 months).<br />
Patients identified were interviewed by a clinical pharmacist on<br />
the day of the appointment prior to their doctor’s consultation. Any<br />
medication discrepancies as compared to the discharge medication<br />
list and medication-related problems noted during the interview will<br />
be highlighted to the patient’s physician. These issues will be examined<br />
in this pilot study.<br />
Results:<br />
295 patients (65.4% female, mean [S.D.] age, 82.3 [7.8] years)<br />
were reviewed between the months of November 2010 to June 2011.<br />
146 patients (49.5%) have 1 or more medication discrepancies detected<br />
during the interview by the pharmacist.<br />
Medication discrepancies due to medication changes by patients<br />
or their caregivers accounted for 58.9% of the discrepancies identified.<br />
These discrepancies include omission of medications that should<br />
be continued (54.3%), failure to discontinue medications that were<br />
stopped during the admission (22.8%), and administering medications<br />
at the wrong doses or frequency (22.8%).<br />
The remaining 41.1% of the medication discrepancies were secondary<br />
to prescribing or dispensing errors made during hospitalization<br />
(40.0%) or changes made by physicians from another specialty<br />
(21.7%) or institution (38.3%) after the discharge from the hospital.<br />
Conclusion:<br />
Medication discrepancies are highly prevalent in older adults in<br />
the post-hospitalization period. Medication reconciliation is an essential<br />
tool at identifying these discrepancies so that it can be addressed<br />
to improve patient safety and quality of patient care.<br />
D122<br />
Clostridium difficile-Associated Disease Recurrence in US Long<br />
Term Care Facilities.<br />
H. Friedman, 1 P. Navaratnam, 1 G. Reardon, 2 K. P. High, 3 M. Strauss. 4<br />
1. DataMed Solutions LLC, Hillard, OH; 2. Informagenics, LLC,<br />
Columbus, OH; 3. Wake Forest School of Medicine, Winston Salem,<br />
NC; 4. Optimer Pharmaceuticals, Inc, San Diego, CA.<br />
Supported By: Optimer Pharmaceuticals provided funding for<br />
this study.<br />
Howard Friedman, Prakash Navaratnam, and Gregory Reardon are<br />
paid consultants engaged by Optimer. Marcie Strauss is an employee<br />
of Optimer. Kevin P. High served on the Optimer Advisory<br />
Council and is a consultant for Optimer.<br />
BACKGROUND: Predictors of recurrent Clostridium difficileassociated<br />
disease (rCDAD) and its association with patient characteristics,<br />
resource utilization, and outcomes in the long term care<br />
(LTC) setting were assessed. METHODS: Demographics, Minimum<br />
Data Set (MDS) 2.0 assessments, and pharmacy records of residents<br />
were analyzed (AnalytiCare LTC database). Residents with an MDS<br />
CDAD code (1/01/07–9/30/10; earliest=index date), ≥1 MDS assessment<br />
≤120 days both pre-and post-index, and metronidazole (MET)<br />
or vancomycin (VAN) received ±7 days of index date were included.<br />
Patients were censored at the earliest of: discharge with no re-admission<br />
≤30 days, latest MDS+90 days, end of study, or death. rCDAD<br />
was defined as MET or VAN being dispensed after >28 day washout<br />
after last fill/refill for the initial episode. Descriptive statistics were<br />
used to compare patient characteristics and resource utilization between<br />
rCDAD and non-rCDAD cohorts. Cox proportional hazard<br />
analysis of index drug cohorts were constructed to identify predictors<br />
of time to recurrence. RESULTS: Of 1145 selected CDAD patients,<br />
225 (19.7%) had ≥1 rCDAD before censoring. Mean age (77–78 y)<br />
and Charlson Comorbidity Index scores (mean=3.0) were similar for<br />
both rCDAD and non-rCDAD cohorts. Prevalence of 26 different comorbidities<br />
was also similar for rCDAD and non-rCDAD cohorts;<br />
most common were recent urinary tract infection (54% and 51%, re-<br />
S228<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
spectively), diabetes mellitus (40% and 45%), and congestive heart<br />
failure (31% and 37%). The rCDAD cohort had an 86% longer preindex<br />
length of stay (LOS) in the LTC facility (P
P OSTER<br />
A BSTRACTS<br />
In addition to 7 specific factors that patients identify as probable<br />
cause, a miscellaneous category exists for qualitative explanation.<br />
Furthermore, objective factors such as number of prescribed medications,<br />
primary care visit between hospitalizations, and mental health<br />
or cognitive diagnoses are also tracked for these individuals.<br />
Results: While no specific factors have been isolated as a primary<br />
cause for readmission, patient feedback such as pre-mature discharge,<br />
quality of post-discharge care, and medication issues are<br />
being reviewed. Preliminary results show patients believe their condition<br />
will require readmission (28.33%) while some patients believe<br />
they were discharged prematurely (26.67%). When paired with the<br />
objective data collected as noted above, we surmise that embracing<br />
the patient and family perspective in discharge planning may reduce<br />
the likelihood of their readmission.<br />
Conclusions: Bringing the patient and family’s perspective into<br />
care promotes a holistic approach to healthcare that enhances successful<br />
discharge planning. The role of social work in completing<br />
these assessments from a psychosocial perspective has been a successful<br />
model in our institution in obtaining this information as they<br />
are then also able to implement clinical interventions and connect<br />
persons with appropriate resources that will reduce the likelihood of<br />
a readmission.<br />
D126<br />
Identification of medication discrepancies in discharge paperwork<br />
among patients in the CO-OPERATE <strong>Geriatrics</strong>/Surgery comanagement<br />
program.<br />
L. M. Walke, 1,2 R. A. Rosenthal, 1,2 M. F. Perkal, 1,2 S. Jeffery, 1,3<br />
M. Maiaroto, 1 R. Marottoli. 1,2 1. VA Connecticut, West Haven, CT; 2.<br />
Yale School of Medicine, New Haven, CT; 3. Univ of CT, Storrs, CT.<br />
Background: Accurate communication regarding medication<br />
regiments is critical to efforts to decrease preventable rehospitalizations<br />
as older adults transition across treatment environments. Electronic<br />
medical records (EMR) can improve communication between<br />
providers and patients but discrepancies in medication list documentation<br />
may thwart these efforts.<br />
Aim: To describe the prevalence of medication discrepancies in<br />
the documentation provided to surgical patients and nursing agencies<br />
or facilities at discharge.<br />
Methods: Surgery patients aged ≥70 years with an expected<br />
peri-operative course ≥ 48 hours are eligible for CO-OPERATE, a<br />
co-management program between geriatrics and surgery. The geriatrics<br />
team consists of a geriatrician, geriatric NP and clinical pharmacist.<br />
We examined the EMR of CO-OPERATE patients discharged<br />
home with nursing services or to nursing facility for<br />
discrepancies in the medication lists included in the patient discharge<br />
instructions and the W10. A medication discrepancy was defined as<br />
the omission of a medication on either list or differing dosing instructions.<br />
Various surgical subspecialties participate in CO-OPERATE<br />
including General Surgery, Cardiothoracic, Orthopaedics, Plastics,<br />
Urology, and Vascular.<br />
Results: The average age of our patients was 83.5 years. All were<br />
discharged on ≥5 medications; 65% received ≥10 medications. In the<br />
first year of the program, ≥1 medication discrepancy between the<br />
W10 and patient discharge instructions was noted for 30% of patients<br />
regardless of the number of medications prescribed. Discrepancies in<br />
documentation occurred most frequently for pain medications, antidepressants,<br />
and vitamins to supplement deficiencies.<br />
Conclusion: Almost two thirds of the surgical patients in our comanagement<br />
program were discharged with ≥10 medications; discrepancies<br />
in documentation varied by medication class. Determining<br />
if other factors contribute to discrepancies, and grading the severity<br />
of discrepancies, may help target our quality improvement efforts.<br />
Redesigning the EMR to alert clinicians of discrepancies in discharge<br />
documentation could improve communication between providers<br />
while aiding efforts to decrease adverse drug effects and preventable<br />
hospitalizations among older adults transitioning through the continuum<br />
of care.<br />
D127<br />
Breaking Down the Silos in Geriatric Inpatient Care.<br />
L. Tank, M. Parulekar, J. Previdi, N. Benoit, A. Sarkar, L. Mansour.<br />
<strong>Geriatrics</strong>, Hackensack University Medical Center, Hackensack, NJ.<br />
Background: Incidence of delirium is high in elderly patients<br />
and it is associated with increased mortality and morbidity and increases<br />
length of stay.<br />
Objective: To integrate Hospital Elder Life program (HELP) in<br />
Geriatric Service Line (GSL) to improve perceptions of care, treatment<br />
and services for geriatric patients (age 70yrs and over) by preventing<br />
delirium, functional decline and length of stay (LOS) in hospital<br />
setting.<br />
Method: The GSL with HELP presented a proposal for disease<br />
specific certification (DSC) for Joint Commission on the Accreditation<br />
of Healthcare Organization (JCAHO).Random sample of 40 patients<br />
per month on 6 HELP units were enrolled using the inclusion<br />
criteria (70 year or older with at least one risk factor such as cognitive<br />
impairment, mobility impairment, vision impairment, hearing<br />
impairment, dehydration, and should be able to communicate verbally<br />
or in writing) through nursing assessment, in multidisciplinary<br />
rounds, and/or by chart review. Metrics included were number of indwelling<br />
urinary catheter days, fall and pressure ulcer rate and use of<br />
psychotropic medication (Haldol, Ativan, Ambien, and Benadryl)<br />
and LOS.<br />
Results: Data was collected from January–August 2011.The<br />
mean indwelling Foley days was 3.4, mean fall rate was 0.6%, pressure<br />
ulcer rate was 0.3%, mean rate of psychotropic meds used was<br />
13.75% and LOS was 3.7 on HELP units as compared to 6.2 on other<br />
units (40% reduction).<br />
Conclusion: The GSL in addition to the multidisciplinary team<br />
has HELP volunteers which has made this a unique model and has<br />
received the distinct honor by JCAHO for disease specific certification<br />
in geriatrics, 1st in the nation.<br />
D128<br />
MEDICAL SERVICE USE IN DEPRESIVE PATIENTS<br />
RECRUITED AT A COLLABORATIVE CARE<br />
MANAGEMENT PROGRAM IN AMBULATORY ELDERLY.<br />
M. Schapira, M. Smietniansky, M. F. Albornoz, P. Hernan,<br />
D. Matusevich, C. Guerra, J. Esteban, M. E. Ramos, L. Camera.<br />
Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.<br />
Supported By: Hospital Italiano de Buenos Aires<br />
CONTEXT: Depression is a common disorder among older<br />
adults sustaining high morbidity, mortality and health care utilization.<br />
Nonetheless, depression remains underdiagnosed and undertreated<br />
leading to adverse outcomes.<br />
In a previous interventional study, we demonstrated that using a<br />
managed care approach depression a reduction of the depressive<br />
symptoms in our population. However, we did not evaluated outcomes<br />
related to medical service use.<br />
OBJETIVES: To determine the rates of medical services utilization<br />
including consults and in depressive patients recruited from our<br />
“Collaborative Care Management Program”.<br />
METHODS: A before/after study was designed to assess the impact<br />
of multifactorial interventions in older adults with depression.<br />
PARTICIPANTS: 91 patients aged 65 and older referred to the<br />
program by primary care physician, with a diagnosis of clinical depression<br />
at baseline assessment. Age mean 77 years. Female 72%.<br />
Intervention: Patients were recruited for an initial comprehensive<br />
geriatric evaluation. Intervention patients had bimonthly followup<br />
visits, social evaluation, access to psychiatric consultation, support<br />
S230<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
of antidepressant management and/or psychotherapy, weekly phone<br />
interviews to assess the course of the symptoms and/or detect any<br />
other problem, and weekly round case discussion with multidisciplinary<br />
team.<br />
Main outcomes measures: Medical records were reviewed from<br />
one year prior to and one year after the recruitment in order to<br />
measure overall consultations, consultations wih primary care physicians<br />
and specialists, consultations to emergency room (ER) and<br />
hospitalizations.<br />
RESULTS: Overall the following outcomes were significantly<br />
reduced in the intervention group: consultations (p=0.001); consultations<br />
with primary care (P=0.001);consultations with specialists<br />
(P=0.002) and admission at ER (P=0.004) . There was not significantly<br />
reduced in hospitalizations.<br />
CONCLUSIONS: Our findings suggest that the intervention<br />
could be effective in reducing health care utilization. These findings<br />
are beyond the improving achieved in depressive symptoms as was<br />
previously proved in our setting.<br />
D129<br />
Does a Palliative Care Consult decrease the cost of caring for<br />
hospitalized patients with Dementia?<br />
M. Araw, 1 C. Araw, 1 T. Mir, 1 T. Liberman, 1 M. Saad, 2 L. Corrado, 1<br />
C. Sison, 3 G. Wolf-Klein. 1 1. NSLIJ Health System, New Hyde Park,<br />
NY; 2. St. John’s University, Queens, NY; 3. Feinstein Institute for<br />
Medical Research, Manhasset, NY.<br />
Introduction: Caring for the 5.4 million <strong>American</strong>s with<br />
Alzheimer’s dementia (AD) is estimated at 183 billion dollars/year.<br />
The study aims to compare the impact of a Palliative Care Consult<br />
(PCC) on the pharmacy cost in hospitalized AD patients.<br />
Methods: Retrospective study of hospitalized elderly patients<br />
with end stage dementia who received a PCC between January 1,<br />
2010 and October 1, 2011. Statistical methods used were Signed-rank<br />
test and McNemar’s test.<br />
Results: Of the 60 patients studied, average age was 86 (range:<br />
70-100) with 27% male and 73% female, 54% white and 20% black.<br />
Eighty seven percent were discharged; 37% of the discharged patients<br />
were transferred to skilled nursing facilities and 22% went<br />
home with home care services or with home hospice (18%). Most patients<br />
(70%) had DNR with 38% signing after PCC. Median time between<br />
date of admission and PCC was 3 days (range: 1-25). When<br />
comparing pharmacy cost before and after PCC, the average cost per<br />
patient per day prior to PCC was $31.16 ± $24.71 and $20.83 ± $19.56<br />
post PCC (p=.003). When looking specifically at pharmacy cost per<br />
category before and after PCC, antibiotic class cost was $9.32 ± $14.94<br />
vs. $6.42 ± $10.65; cardiac medication class cost was $1.15 ± $2.75 vs.<br />
$0.71 ± $1.36; analgesic class cost was $1.36 ± $5.07 vs. $2.35 ± $5.35<br />
(p
P OSTER<br />
A BSTRACTS<br />
D132 Encore Presentation<br />
A multicomponent delirium management program improves<br />
functional outcomes in hospitalized older persons.<br />
M. Chong, 1 M. Chan, 1 L. Tay, 1 J. Kang, 2 H. Han, 2 Y. Ding, 1 T. Tan. 1 1.<br />
Department of Geriatric Medicine, Tan Tock Seng Hospital,<br />
Singapore, Singapore; 2. Nursing Service, Tan Tock Seng Hospital,<br />
Singapore, Singapore.<br />
Supported By: This study was funded by Ministry of Health<br />
(Singapore) Health Quality Improvement Fund (HQIF)<br />
Introduction:<br />
Delirium is associated with poor survival, functional outcomes<br />
following acute hospitalisation episode. The Geriatric Monitoring<br />
Unit (GMU) models after the Delirium Room with adoption of core<br />
interventions from Hospital Elder Life Program and use of evening<br />
bright light therapy to consolidate circadian rhythm and improve<br />
sleep. This study set out to examine if this multicomponent GMU<br />
program improved outcomes in delirious elderly patients compared<br />
to usual care.<br />
Methods:<br />
We studied delirious patients (pre-GMU) admitted to geriatric<br />
department one-month before GMU implementation (n=47) and recruited<br />
GMU patients over an 11-month period (n=84). Baseline demographics,<br />
Charlson comorbidity and severity of illness index (SII),<br />
duration of delirium, functional status (modified Barthel Index<br />
(MBI) on admission/ discharge), falls, physical injuries, pressure ulcer<br />
and nosocomial infection rate were collected.<br />
Results:<br />
Significant male preponderance were noted with slightly higher<br />
Charlson comorbidity (3.6 vs 2.1), SII score (2.2 vs 2.1) and pre-existing<br />
dementia (72.3% vs 66.7%) in GMU patients. GMU patients had<br />
significantly shorter delirium period compared to pre-GMU patients<br />
(7.6 vs 15.1 days). GMU patients showed greater functional improvement<br />
on MBI (19.3+1.9) compared to pre-GMU patients (7.5+11.2).<br />
No patients in GMU were physically restrained compared to 44.7% in<br />
the pre-GMU group. Falls rates were similar in both groups with no<br />
injuries sustained. GMU patients had a significantly lower pressure<br />
ulcer (61.7% vs 1.2%) and nosocomial infection rate (23.4% vs 1.2%).<br />
Conclusion:<br />
This study shows initial evidence for benefits of multicomponent<br />
delirium management program. It adheres to geriatric principles<br />
of restraint-free environment while addressing patient safety concerns.<br />
Clinical benefits included shorter delirium duration, increased<br />
functional gains with decreased complications of immobility.<br />
D133<br />
Innovative Home-Visit Based Medicine Resident Curriculum<br />
Decreases CHF Patients’ 30-Day Readmissions & Improves Patient<br />
Education.<br />
O. B. Lahoud, 1 A. Siddique, 1 S. Goldberg, 1 M. Hecht. 1,2 1. Internal<br />
Medicine, Maimonides Medical Center, Brooklyn, NY; 2. Division of<br />
<strong>Geriatrics</strong>, Maimonides Medical Center, Brooklyn, NY.<br />
Background: Improving transitional care from hospital to home<br />
has been a focus of CMS to reduce costs and readmissions. Naylor<br />
and Coleman showed improvements in transitional care in chronic<br />
care patients; a review by Buchanan outlines teaching interventions<br />
involving residents. Record reported decreased readmissions in CHF<br />
patients via a resident education curriculum involving phone call follow-ups<br />
to patients post-discharge. We propose a resident curriculum<br />
model focused on patient education and home visits.<br />
Methods: Maimonides Medical Center developed an 8-week<br />
curriculum for medicine residents with 3 primary goals: 1)Improve<br />
patient education via IHI Teach Back Method using a 4-item questionnaire,<br />
2)Educate residents on optimal CHF management based<br />
on ACC/AHA guidelines, 3)Involve residents in PI, 4)Visit patients at<br />
home to ensure safe transition and provide further patient education.<br />
Results: We demonstrated 1)Improved patient education, 2)Decreased<br />
CHF patients 30-day readmissions, 3)Improved Resident<br />
transitional care knowledge (data not shown).<br />
Conclusion: A curriculum focused on transitional care can be<br />
implemented in a residency program to improve CHF patient education<br />
and readmission rate via emphasis on teach back and home visits.<br />
We are currently investigating this model in other chronic diseases.<br />
References: Jencks et al. NEJM 2009;360(14):1418-1428.<br />
Naylor et al. J Am Geriatr Soc. 2004;52(5):675-684.<br />
Coleman. J Am Geriatr Soc. 2003;51(4):549-555.<br />
Buchanan et al. Acad Med. 2011;86:628-639.<br />
Record et al. Arch Int Med. 2011;117(9):858-859.<br />
D134<br />
Geriatric Palliative Care- A two year review of a new service.<br />
M. Lerch. Geriatric Dept., Protestant Hospital Bethanien Iserlohn,<br />
Iserlohn, Germany.<br />
Background:The demographic change does not only alter the<br />
approach to rehabilitation and geriatric care but also indicates the<br />
need for a different view concerning end-of life policies for the elderly<br />
and the oldest old. In conventional palliative care settings elderly<br />
patients and there needs are not rarely insufficiently represented.<br />
Therefore two years ago our clinic implemented a new geriatric<br />
palliative care service on a redesigned 6 bed ward to cater for this<br />
clientele bringing together the geriatric team effort and the palliative<br />
knowledge and training for the senior patient<br />
Methods: Review of the geriatric palliative patients considering<br />
age, sex, main diagnosis, main symptoms that led to the admission,<br />
number of admissions and discharges in to home care, scores<br />
for self-sufficiency (Barthel), disease progress (ECOG), pain (VAS),<br />
depression(GDS), cognition (MMST, Clock completion) and nutrition<br />
(MNA)<br />
Results: From September 2009 until September 2011, 91 palliative<br />
care patients (52 male, 39 female) with a mean age of 72,4, were<br />
admitted into the new service, with a return rate of 1,6. 58 were able to<br />
return to a self-determined life.The mean stay was 12,4 days.Approx.<br />
91 % of the admissions were due to a cancer (lung 20,9%, abdominal<br />
17,3%, prostate 12,7%, 41 % various cancer varieties), 5,4 % were<br />
due to cardiovascular diseases and 2,7 % due to end-stage dementia.<br />
The main symptoms that led to the admission were pain, nausea<br />
and cachexia. The mean Barthel score at admission was 50,2 and 52,1<br />
at discharge, the mean GDS was 6,79, the mean MMST 21,1 and the<br />
clock completion test 3,6, where as the nutrition was low with a MNA<br />
of 6,31<br />
Conclusions:Geriatric patients with an end-of life situation, especially<br />
those without a cancer, are in need of a multiprofessional<br />
geriatric team to address immobility and lack of self-sufficiency and<br />
the cognitive decline as well as the pain relief, symptom control and<br />
S232<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
nutrition. In this combination a temporal or permanent return to the<br />
home care setting and a self-determined life is feasible even in the<br />
oldest patients and the growing number of patients with cardiovascular<br />
diseases and dementia<br />
D135<br />
A Retrospective Case Control Study Comparing Actual Total Costs<br />
of Acute Care for Elders (ACE) Interdisciplinary Consult Team<br />
Patients with Matched Controls at the University of Wisconsin<br />
Hosptial and Clinic (UWHC).<br />
M. J. Siebers, 1,2 M. Brenny-Fitzpatrick, 3 A. Bhattacharya. 3 1. Division<br />
of <strong>Geriatrics</strong> and Gerontology, University of Wisconsin School of<br />
Medicine and Public Health, Madison, WI; 2. GRECC, Middleton VA<br />
Hosptial, Madison, WI; 3. University of Wisconsin Hosptial and<br />
Clinics, Madison, WI.<br />
The ACE interdisciplinary team has consulted on patients at the<br />
UWHC since 2006. The UWHC is a teriary care teaching hospital.<br />
The ACE consult team sees hospitalized patients over the age of 64<br />
years at the request of the attending physician on each ward service.<br />
The ACE team consists of a full-time advanced practice RN and a<br />
part-time team pharmactist, social worker, geriatrician and physical<br />
therapist. The geriatrician’s time is supported by billings from the<br />
ACE consult; other team members are supported by the UWHC. The<br />
ACE team consults on patients 5 days a week and meets weekdays to<br />
review each ACE consult patient both for the initial evaluation and<br />
follow-ups. The ACE program has seen 1807 ACE consult patients<br />
through June 2011. From the 1192 intial ACE team consults on<br />
unique patients, 382 ACE consult patients were matched with hospitalized<br />
control patients for age within 5 years, gender, severity of illness<br />
(3M APRDGR), primary DGR and year of hosptial stay. The<br />
cases and contols were compared by activity based accounting for actual<br />
total costs and length of stay (LOS). The average actual total cost<br />
for the hospital stay was $3,039 less for the patients seen by the ACE<br />
interdisciplinary consult team than it was for the matched controls (pvalue=0.006).<br />
The LOS was 0.13 days less for the ACE interdisciplinary<br />
consult patients compared to controls (NS). For the 1194 unique<br />
ACE consult patients seen, the ACE team consultation saved<br />
$3,622,488 in total actual costs since 2006 or $695,295.20 in cost reductions<br />
per year. The savings for the hospital was over $500,000 per<br />
year when the cost of the ACE interdisciplinary program (primarily<br />
the salaries of the professionals on the ACE team) was taken into account.<br />
The total actual cost savings for the ACE team consult is<br />
clearly not all related to reduction in the LOS. Medication changes<br />
for the ACE consults are the most common recommendation. They<br />
may account for some of the ACE interdisciplinary consult team’s reduction<br />
in total actual cost for each elderly patient seen in the hospital.<br />
We believe that geriartic care is improved at UWHC, not just<br />
money saved, by the ACE consult.<br />
D136<br />
Delirium Prevention Protocol Implementation in the Acute Care for<br />
the Elderly (ACE) Unit: Using a Culturally Competent Approach<br />
and Quality Improvement Tools.<br />
M. Dang, 1 S. Oakes, 1,2 I. Rohner. 2 1. School of Medicine, UTHSCSA,<br />
San Antonio, TX; 2. Acute Care of the Elderly (ACE) Unit, Christus<br />
Santa Rosa- City Centre, San Antonio, TX.<br />
Supported By: MSTAR, AFAR.<br />
Aim: To increase the utilization of the cognition and mobility<br />
components of the delirium prevention protocol to 90% in the next 3<br />
months at the ACE unit at Christus Santa Rosa City Centre by using<br />
a culturally competent approach.<br />
Background: Delirium is a major problem in hospitals. Prevention<br />
is a key component and using quality improvement tools and culturally<br />
competent approaches to prevent delirium enhances patient<br />
care. Interdisciplinary teams are vital in order to make sustainable<br />
changes towards patient safety. Due to the lack of attention in preventing<br />
delirium, especially in culturally Hispanic settings, this project<br />
focuses on engaging both English and Spanish speaking patients and<br />
their families.<br />
Methods: An inter-professional task force was formed at the<br />
ACE unit. Using quality improvement tools, pre and post intervention<br />
methods were as follows: a “fish bone” analysis was done to identify<br />
barriers in delirium prevention and observations on the staff’s<br />
cognition and mobility strategies were measured. After team analysis,<br />
a focus on education and family involvement were chosen for interventions<br />
consisting of nurse training sessions on utilization of the<br />
mini-cog exam. Furthermore, medical students were trained to do the<br />
CAM (confusion assessment method) on all admissions and bilingual<br />
white boards with the 6 areas of the prevention protocol to use as<br />
part of the hourly rounds were designed to educate patients and caregivers<br />
as well as bilingual brochures on delirium.<br />
Results: Compliance increased for the mobility protocol from<br />
0% to 80%. Engaging the patient/family in stimulating activities increased<br />
from 0% to 67%. Using the CAM to screen for delirium increased<br />
the least from 0% to 23%. Compliance in orienting the patient<br />
to date and/or location increased from 0% to 58% with the<br />
second highest increase and compliance in orienting the patient to<br />
person increased from 28% to 68%.<br />
Conclusions: The prevention protocol relies heavily on individuals<br />
rather than being inherent to the system, as seen in compliance to<br />
the CAM. Results also showed that families are more involved if the<br />
language barriers are addressed. Tools that are bilingual can facilitate<br />
care of the patient and standardization of educational tools for the<br />
student learners rotating in the ACE unit is vital.<br />
D137<br />
Prevalence and Correlates of Alcohol Use Among Older Taiwanese<br />
Adults: Analyses of the 2005 Taiwan National Health Interview<br />
Survey (NHIS).<br />
J. C. Lin, 1 A. A. Moore. 2,3 1. Internal Medicine, Cheng Ching Hospital,<br />
Taichung, Taiwan; 2. David Geffen School of Medicine, UCLA, Los<br />
Angeles, CA; 3. Integrated Substance Abuse Programs, UCLA, Los<br />
Angeles, CA.<br />
Background: Correlates of alcohol use have been examined extensively<br />
among younger adults and older adults; however, most studies<br />
have not included large samples of older Asian adults. This study<br />
evaluated the prevalence, socio-demographic, and health-related correlates<br />
of alcohol use among older Taiwanese adults using data from<br />
a national survey.<br />
Methods: Study sample included 2,727 individuals 65 years and<br />
older who participated in the 2005 NHIS, a cross-sectional survey of<br />
nationally representative household samples in Taiwan. Alcohol use<br />
was categorized into abstainers, infrequent drinkers (1-2 times per<br />
month), weekly drinkers (1-3 times per week), and daily drinkers.<br />
Due to small sample sizes, a category of frequent drinkers was created<br />
that combined weekly and daily drinkers for regression analyses.<br />
Multinominal logistic regression was performed to determine the<br />
socio-demographic and health-related correlates of the different categories<br />
of alcohol use.<br />
Results: Almost 80% of older Taiwanese adults were abstainers,<br />
10.2% were infrequent drinkers, 3.5% were weekly drinkers, and<br />
6.5% were daily drinkers. Individuals who were younger, male, those<br />
with good or better self-perceived health, and current smokers had<br />
increased odds of being drinkers. Individuals with more years of education<br />
had increased odds of being infrequent drinkers compared to<br />
those with lower education; however, this association was not observed<br />
among the frequent drinkers. Individuals who were former<br />
smokers or current betel nut users had increased odds of being frequent<br />
drinkers compared to abstainers.<br />
AGS 2012 ANNUAL MEETING<br />
S233
P OSTER<br />
A BSTRACTS<br />
Conclusions: There were similarities between the socio-demographic<br />
and health-related correlates of alcohol use among older Taiwanese<br />
adults and older adults from other ethnicities. Former or current<br />
use of other substances was also associated with more frequent<br />
alcohol use. Future studies should evaluate whether the effect of alcohol<br />
use on health-related outcomes among older Asian adults<br />
would differ from older adults of other ethnicities.<br />
D138<br />
Quality of Hospice Care for Patients with Dementia.<br />
J. Albrecht, 1 J. C. McGregor, 2,3 E. K. Fromme, 3 D. S. Lee, 2,3<br />
J. P. Furuno. 2,3 1. University of Maryland, Baltimore, MD; 2. Oregon<br />
State Univeristy, Portland, OR; 3. Oregon Health & ScienceUniveristy,<br />
Portland, OR.<br />
Background: Patients with dementia comprise an increasing<br />
percentage of hospice recipients; yet research on the quality of hospice<br />
care for patients with dementia is lacking. We used data from the<br />
2007 National Hospice and Home Care Survey (NHHCS) to compare<br />
quality of care in dementia patients to all other hospice patients.<br />
Methods: The 2007 NHHCS is a nationally-representative sample<br />
of 4,733 U.S. hospice discharges. Data were collected through inperson<br />
interviews with agency directors and staff and patient medical<br />
records. A current primary diagnosis of dementia was defined as<br />
ICD-9 codes: 290.0, 290.42, 294.8, 294.9, 331.0, 331.11, 331.4, 331.82,<br />
and 331.9. Quality indicators were compared between patients with<br />
and without dementia. These include: transfer to hospice in the last 3<br />
days of life, tube feeding, depression, absence of an advanced directive<br />
or do not resuscitate (DNR) order, stage II or greater pressure<br />
ulcers, use of emergent care, antibiotic receipt, continuity of residence<br />
and pain reported at last assessment. All estimates were weighted to<br />
account for the survey’s complex sampling design. Chi-square and<br />
Student’s t-tests were used for comparisons, and statistical significance<br />
was defined as p
P OSTER<br />
A BSTRACTS<br />
physicians. Implementation of strategies to improve recognition of<br />
cognitive impairment may improve care of these patients, particularly<br />
at the time of hospital discharge.<br />
D141<br />
Arizona Alzheimer’s Registry: Strategy and Outcomes.<br />
K. T. Saunders, 1 C. Holt, 2 J. B. Langbaum, 2 W. Chen, 2 N. High, 2<br />
C. Langlois, 2 M. Sabbagh, 3 P. N. Tariot. 2 1. College of Medicine,<br />
University of Arizona, Phoenix, AZ; 2. Banner Alzheimer’s Institute,<br />
Phoenix, AZ; 3. Banner Sun Health Research Institute, Sun City, AZ.<br />
Supported By: NIA ADCC P30 AG19610, State of Arizona<br />
Medical Student Training in Aging Research (MSTAR) Program<br />
Background: The Arizona Alzheimer’s Consortium (AAC) is a<br />
statewide Alzheimer’s disease (AD) research consortium funded by<br />
NIA and the state of Arizona. In 2007 the AAC created a screening<br />
and referral process for people interested in participating in AD related<br />
research, as well as a relational database called the Arizona<br />
Alzheimer’s Registry (AAR). The goals of the AAR were to increase<br />
awareness of AD research and accelerate enrollment into AAC clinical<br />
research projects. The AAR matched Registrants to AAC research<br />
according to interest, location, and eligibility.<br />
Methods: Enrollment was by open invitation to volunteers age<br />
50 and older. Registrants were recruited by community outreach,<br />
mass mailings, earned and paid media, and the Internet. Those interested<br />
received a welcome packet, consent, and questionnaire, which<br />
were reviewed by trained staff via telephone prior to brief cognitive<br />
screening. Evaluation of medical history, cognitive status, and interests<br />
resulted in the Registrant being referred to existing AAC studies<br />
or being held for future referral.<br />
Results: 2263 people contacted the AAR; all but 231 were given<br />
a welcome packet. 1257 consented and 1182 underwent an initial cognitive<br />
screening. Earned media was the most effective recruitment<br />
strategy. Participants had a mean age of 68.1 (SD 10.6), 97% were<br />
Caucasian, had 15.2 (SD 2.7) mean years of education, and 60% were<br />
female. 30% reported a family history of dementia, 20% reported a<br />
diagnosis of cognitive impairment or dementia, and 70% subjectively<br />
reported normal cognition. The initial telephone assessment revealed<br />
681 with no impairment, 269 with possible cognitive impairment, and<br />
234 with possible dementia. 301 were referred to AAC sites.<br />
Conclusion: The AAR exceeded its goals of increasing awareness,<br />
Registry recruitment and research referral. This model was well<br />
received by the community and served as a mechanism for volunteers<br />
to explore their own cognitive status while making a contribution to<br />
the scientific community. The established infrastructure and experiences<br />
gained from the AAR will serve as the prototype for the webbased<br />
Alzheimer’s Prevention Registry, a national registry focusing<br />
on AD prevention research.<br />
D142<br />
Prevalence of Disruptive Behaviors Among PACE Participants.<br />
K. Kwak, 1 M.Trahan, 2 M. McNabney. 2 1. Stony Brook University<br />
School of Medicine, Stony Brook, NY; 2. Division of Geriatric<br />
Medicine and Gerontology, Johns Hopkins University, Baltimore, MD.<br />
Supported By: Johns Hopkins University; MSTAR Program<br />
Background: Disruptive behaviors occur in approximately 63%<br />
of adult day center participants. The Program for the All-inclusive<br />
Care of the Elderly (PACE) is a capitated and comprehensive service<br />
delivery system for older adults. PACE participants attend an adult<br />
day center where all care is coordinated and provided in order for<br />
participants to continue living in the community. The rate of disruptive<br />
behaviors among a PACE population is unknown.<br />
Objective: To study the frequency and type of disruptive behaviors<br />
typically displayed among PACE participants.<br />
Methods: This study took place at one PACE location in Maryland.<br />
To measure disruptive behaviors in PACE participants, we used<br />
the Cohen-Mansfield Agitation Inventory-Community (CMAI-C),<br />
consisting of 36 agitation items.<br />
Results: One hundred forty-two PACE participants (79% female)<br />
were included in the study. Dementia was present in 67<br />
(47%) participants. Among all the participants attending the PACE<br />
day center, 35.9% (45% with dementia and 28% without dementia)<br />
displayed at least one disruptive behavior once a week. The<br />
most frequently rated disruptive behavior was verbally non-aggressive<br />
behaviors (e.g., constant, unwarranted requests for attention,<br />
restless).<br />
Conclusions: PACE dementia participants display less disruptive<br />
behavior than seniors attending traditional day centers and residents<br />
living in nursing homes. From a psychosocial perspective, these<br />
results suggest that PACE might be better equipped to meet the physical,<br />
emotion, or social needs of participants when compared to traditional<br />
models of care.<br />
D143<br />
Guideline quandary in VTE prophylaxis management in elective<br />
joint replacement.<br />
J. Prager. <strong>Geriatrics</strong>, Mount Sinai Hospital, New York, NY.<br />
Introduction:<br />
Managing VTE prophylaxis from an evidence based approach,<br />
guidelines have been created from within both the <strong>American</strong> College<br />
of Chest Physicians (ACCP) and the <strong>American</strong> Academy of Orthopedic<br />
Surgeons (AAOS). Elective joint replacement epitomizes multidisciplinary<br />
care between orthopedics and internists to manage VTE prophylaxis<br />
concurrently while following conflicting recommendations.<br />
Case:<br />
An 85 year old female with a history of osteoarthritis presented<br />
to a tertiary care center for a scheduled left total hip arthroplasty for<br />
worsening symptoms of osteoarthritis. Patient was admitted to the orthopedic<br />
service. Post-operative day 0, patient was started on aspirin<br />
325mg BID for 35 days for VTE prophylaxis. On post-operative day<br />
9, patient’s hemoglobin had steadily decreased to 8.3 g/dl from a<br />
baseline of 12.7 g/dl. Patient was transfused 1 unit of packed red<br />
blood cells. Patient was discharged home with instructions to follow<br />
up with primary physician. Prior to patient’s appointment, patient<br />
called the primary physician’s office on a Saturday reaching the on<br />
call provider describing asymmetric leg swelling of post-operative<br />
leg. The on-call physician recommended for the patient to go to emergency<br />
room for evaluation for VTE, which was negative on ultrasound.<br />
Discussion:<br />
The ACCP recently updated VTE prophylaxis in 2008 categorizing<br />
elective joint replacement as a high risk procedure necessitating<br />
low molecular weight heparin i.e. enoxaparin, fondaparinux, or warfarin<br />
with an INR goal of 2.5. ACCP recommends against aspirin as<br />
VTE prophylaxis for elective joint replacement. Orthopedic concerns<br />
rest heavily on the underestimation of bleeding complications with<br />
evidence showing a 9% bleeding risk with 10 day course of ACCP<br />
recommended VTE prophylaxis coupled with 4.7% readmission rate<br />
in a study of 290 patients. AAOS recommendations are founded on<br />
evaluating patient’s risk of VTE combined with risk of bleeding. Aspirin<br />
remains as a treatment despite randomized controlled trials<br />
demonstrating superiority of low molecular weight heparin in secondary<br />
outcomes. Who should manage VTE prophylaxis? The longstanding<br />
internist or the current orthopedic surgeon? With the advent<br />
of newer agents i.e. rivaroxaban, the interest of patient safety is paramount<br />
to arrive at a unifying management protocol to decrease VTE<br />
post elective joint replacement while minimizing peri-operative<br />
bleeding.<br />
AGS 2012 ANNUAL MEETING<br />
S235
P OSTER<br />
A BSTRACTS<br />
D144<br />
The Use of 308nm Excimer Laser as an Effective and Safe<br />
Treatment for Psoriasis in the Geriatric Population.<br />
J. W. Wong, 1,2 J. Koo. 2 1. University of Utah School of Medicine, San<br />
Francisco, CA; 2. Dermatology, University of California San<br />
Francisco, San Francisco, CA.<br />
Supported By: Photomedex supports this research.<br />
Introduction: In dermatology, one of the most common and miserable<br />
skin conditions is psoriasis. Geriatric patients suffer from psoriasis<br />
with a greater proportion than any younger age group because<br />
psoriasis is a chronic disease. Psoriasis is one condition which tends to<br />
become more generalized and severe with age. The worst and most<br />
miserable type of psoriasis is generalized plaque psoriasis, which is almost<br />
uniformly treated with immunosuppressants such as methotrexate,<br />
cyclosporine, and biologic agents. However, geriatric patients are<br />
most at risk for lifelong systemic immunosuppression. Due to the risk<br />
of cancer, infection, heart disease, and other comorbidities, there is a<br />
great need to find a way to treat geriatric patients with generalized<br />
psoriasis that is not immunosuppressive and with less systemic risks.<br />
Excimer laser is an ideal treatment. It is more powerful than traditional<br />
UVB or PUVA phototherapy because it is a targeted treatment<br />
that only exposes thick psoriasis plaques to therapy and is not<br />
limited to side effects such as causing noninvolved skin to burn. Thus,<br />
more aggressive amount of energy can be delivered to the plaques.<br />
Our study has shown that the use of the 308nm excimer laser in combination<br />
with topical therapy achieves better therapeutic efficacy<br />
than any available biologic agents in half of the time with no possibility<br />
of systemic side effects. Methods: Moderate-to-severe psoriasis patients<br />
have been recruited for the study. 308 nm excimer laser is used<br />
twice weekly until reaching 75% or better improvement according to<br />
the psoriasis area and severity index (PASI 75) for a maximum of 12<br />
weeks. Patients are instructed to apply clobetasol spray twice daily<br />
for the first 4 weeks (Weeks 1-4), then calcitriol ointment for the next<br />
4 weeks (Weeks 5-8), and finally, both clobetasol spray and calcitriol<br />
ointment for the last 4 weeks (Weeks 9-12). Results: Of the 14 patients<br />
enrolled, 85% have achieved great improvement (PASI 75) in<br />
only 6 weeks as compared to etanercept, adalimumab, and ustekinumab<br />
where no more than 68% achieve PASI 75 in double the time<br />
(12 weeks). Conclusion: Our study shows promising results that geriatric<br />
patients with generalized psoriasis can be treated most conveniently<br />
with an external therapeutic modality with essentially no systemic<br />
side effects and no immunosuppression.<br />
D145<br />
Cardiac structure and function and renal insufficiency in the oldest old.<br />
J. Stessman, 1 Y. Maaravi, 1 J. M. Jacobs, 1 D. Leibowitz. 2 1. Institute for<br />
Aging Research, Department of <strong>Geriatrics</strong> and Rehabilitation,<br />
Hadassah-Hebrew University Medical Center, Jerusalem, Israel; 2.<br />
Heart Institute, Hadassah-Hebrew University Medical Center,<br />
Jerusalem, Israel.<br />
Background:<br />
People over the age of 85 are the world’s most rapidly growing<br />
age group and have a high incidence of both cardiovascular disease<br />
and chronic kidney disease (CKD). The relationship of abnormalities<br />
in cardiac structure and function and renal insufficiency in this age<br />
group is unclear. The objective of this study was to examine the association<br />
between renal function and cardiac structure and function in<br />
an age-homogenous, community-dwelling population of subjects<br />
born in 1920-1921.<br />
Methods:<br />
Subjects were recruited from the Jerusalem Longitudinal Cohort<br />
Study. Echocardiography was performed with a portable<br />
echocardiograph at the subjects place of residence. Standard<br />
echocardiographic assessment of cardiac structure and function was<br />
performed. Glomerular filtration rate (GFR) was assessed by the<br />
Cockroft-Gault formula with abnormal GFR defined as ≤ 60<br />
ml/min/1.73 m2.<br />
Results:<br />
310 subjects (146 males, 164 females) were enrolled in the study.<br />
There were no significant differences between subjects with normal<br />
and abnormal GFR in indices of cardiac structure. Ejection fraction<br />
(57.0 ± 10.4% vs. 54.4 ± 10.3%; p < 0.08) and indices of diastolic function<br />
(E:e’ 12.4 ± 5.0 vs. 12.3 ± 4.6; p = 0.89) were not significantly different<br />
between the two groups.<br />
Conclusions:<br />
Our study did not demonstrate an association between reduced<br />
GFR and echocardiographic indices of systolic and diastolic function<br />
in a community-dwelling population of the oldest old.<br />
D146<br />
Mass Houdini:The Case of the Disappearing Duodenal Mass.<br />
L. M. Thomas, A. Prakash, K. Ramasamy, J. Smith, H. Choudhry.<br />
Bayonne Medical Center, Bayonne, NJ.<br />
Case Presentation:This is a case of 72 year old female presenting<br />
to the ER with right upper quadrant abdominal pain radiating to the<br />
back and vomiting for the past 3 weeks.She had difficulty in tolerating<br />
food due to the vomiting.No history of diarrhea,fever,chills or urinary<br />
complaints.Her past history was significant for uterine cancer diagnosed<br />
15 years ago,treated with hysterectomy and brachytherapy,CAD<br />
s/p CABG and osteoarthritis for which she is on NSAIDS for the past<br />
10 years.Her physical examination was unremarkable.CBC,amylase,lipase<br />
and liver function tests were within normal limits.Her K(5.8)and<br />
creatinine(2.4)levels were elevated.CT abdomen showed diffuse,infiltrative<br />
mass encircling the duodenum,invading the pancreatic head and<br />
gallbladder.With a working diagnosis of adenocarcinoma arising from<br />
the duodenum,infiltrating the pancreas and gall bladder,a biopsy was<br />
done.Biopsy samples showed extensive chronic duodenitis with gastric<br />
heterotopias and gastric mucus cell metaplasia.With a benign result on<br />
biopsy,a diagnosis of penetrating duodenal ulcer was made.The patient<br />
was kept NPO and was started on TPN and IV PPIs.She responded<br />
well and was symptomatically better. After one week,she was started<br />
on a diet and was able to tolerate the intake.Repeat CT scan done two<br />
months later, showed complete resolution of the previously seen duodenal<br />
mass and she remains asymptomatic till now.Discussion:Peptic<br />
ulcer disease in the elderly can present as an intra abdominal mass simulating<br />
malignancy due to penetration of surrounding tissues leading to<br />
inflammation and adhesions.Studies show that even though the prevalence<br />
of active duodenitis is low in chronic NSAIDS users,local ulceration<br />
can take place and is dose dependent. Conclusion:This case illustrates<br />
that awareness of this uncommon complication of peptic gastro<br />
duodenal ulcer disease is helpful in the diagnosis of this benign lesion.<br />
An unnecessary invasive procedure and incorrect treatment strategy<br />
can be avoided by making a firm diagnosis with the help of biopsy.<br />
D147<br />
The effect of cholinesterase inhibitors on cardiovascular health.<br />
M. George, 1 G. Azhar, 1 A. Balamurugan, 2 J. Wei. 1 1. <strong>Geriatrics</strong>,<br />
University of Arkansas for Medical Sciences, Little Rock, AR; 2.<br />
Family and Preventive Medicine, University of Arkansas for Medical<br />
Sciences, Little Rock, AR.<br />
Background: Cholinesterase inhibitors (donepezil, rivastigmine,<br />
galantamine) are often prescribed to slow the progression of demen-<br />
S236<br />
AGS 2012 ANNUAL MEETING
P OSTER<br />
A BSTRACTS<br />
tia in geriatric patients, but they may be associated with cardiovascular<br />
side effects that increase morbidity. Currently, there are few specific<br />
criteria to assess the risks and benefits of cholinesterase inhibitors<br />
and there is insufficient data regarding monitoring for<br />
potential cardiovascular side effects.<br />
Methods: We sought to evaluate cardiovascular side effects such<br />
as bradycardia, syncope, near-syncope, dizziness or falls that might be<br />
associated with taking cholinesterase inhibitors. The electronic medical<br />
records (EMR) of all patients from the Reynolds Institute on<br />
Aging (RIOA) who completed a clinic visit during the period of August<br />
1, 2009 to October 31st 2009 and who were taking cholinesterase<br />
inhibitors were reviewed. The medical history of these patients before<br />
and after initiation of cholinesterase inhibitors was examined.<br />
Results: The EMR of 82 patients who were taking<br />
cholinesterase inhibitor were retrospectively reviewed. The mean age<br />
of patients was 81 years. The patients were predominantly female<br />
(73%) and were white (79%). Memory loss/disorder (59%) was the<br />
most common reason for initiation of cholinesterase inhibitor, followed<br />
by Alzheimer’s disease (21%) and some form of dementia<br />
(17%). Four patients were deceased since the index clinic visit (5%).<br />
The common new cardiovascular symptoms reported after the initiation<br />
of cholinesterase inhibitor were: bradycardia – 9% (N=7); atrial<br />
fibrillation or arrhythmia – 5% (N=4); syncope or near syncope– 4%<br />
(N=3); sick sinus syndrome – 2.4% (N=2). Dizziness was reported in<br />
13 % of the patients (N=11). Falls were reported by 11% of the patients<br />
(N=9). Sinus bradycardia (15%) (N=12) was the most common<br />
new EKG finding, followed by bundle branch block (7%) (N=6) and<br />
atrial fibrillation (4%) (N=3).<br />
Conclusions: Cardiovascular side effects of cholinesterase inhibitors<br />
are common, morbid and under-appreciated. More studies<br />
are needed to better understand this problem. Monitoring for potential<br />
cardiovascular side effects of cholinesterase inhibitors will enhance<br />
compliance and maximize benefits in vulnerable older patients<br />
with cognitive impairment while preventing potentially devastating<br />
cardiovascular complications.<br />
D148<br />
Screening, Diagnosis, and Treatment of Osteoporosis in Patients<br />
with Dementia.<br />
L. J. Gleason, K. R. McCormick, J. Frankel, S. M. Friedman.<br />
Department of Medicine, University of Rochester, Highland Hospital,<br />
Rochester, NY.<br />
Background: Older adults with dementia are at higher risk for<br />
fractures than cognitively intact individuals and some studies have<br />
shown that these patients are less frequently screened and receive<br />
fewer treatments for osteoporosis.<br />
Objective: To examine rates of screening, diagnosis, and treatment<br />
of osteoporosis in older adults with and without dementia at an<br />
academic outpatient geriatric clinic.<br />
Methods: We performed a retrospective chart review of 440 patients<br />
ages ≥ 65 who entered into the Geriatric and Medicine Associate<br />
Practice (GAMA) between January 2000 and December 2007.<br />
Baseline characteristics were recorded including age, gender, body<br />
mass index (BMI), self-reported health status, and activities of daily<br />
living (ADLs). Patients with dementia were compared to those without<br />
cognitive impairment, with respect to the screening, diagnosis,<br />
and treatment of osteoporosis.<br />
Results: Of the 440 patients included in the study, the average<br />
age was 78.9 years old, 304 (69%) were women, 89% of patients were<br />
able to complete 5/5 ADLs, and 53 (12%) were diagnosed with dementia.<br />
We found that only 53 patients (12%) had a recorded DEXA<br />
scan within six months of enrollment in the clinic, and those with dementia<br />
were less likely to have had a DEXA scan (11.3% vs. 25.3%,<br />
p
P OSTER<br />
A BSTRACTS<br />
Methods: Cross-sectional analysis of a subset of the Canadian<br />
Study of Health and Aging (1996 wave) that completed a diagnostic<br />
cognitive assessment. Non-cancer pain was measured<br />
using the 5-point verbal descriptor scale, dichotomized into<br />
“no/very mild” versus “moderate” or greater pain. Cognitive status<br />
was clinically assessed and categorized as NCI, cognitive impairment<br />
no dementia (CIND), Alzheimer’s Disease (AD), and<br />
vascular dementia (VaD). Multivariable logistic regression was<br />
utilized to analyze the relationship between pain report and cognitive<br />
diagnosis controlling for covariates (demographics, comorbidity,<br />
IADL’s, and depression).<br />
Results: 1,658 (96.7%) of participants that completed a diagnostic<br />
cognitive assessment had their cognitive status designated and a<br />
pain measure completed. Overall, the frequency of pain report varied<br />
with cognitive status among the four groups, (Chi-square 9.16,<br />
p=0.02). 34.7% (263/757) of persons with NCI reported moderate or<br />
greater pain, compared to 39.1% (223/570) CIND (p=0.11), 28.5%<br />
(73/256) AD (p=0.08), and 40% (26/65) VaD (p=0.42). In the fullyadjusted<br />
multivariate model, compared with persons with NCI, the<br />
odds of reporting moderate or higher pain was not significantly different<br />
among persons with CIND OR=0.86 (0.65,1.13; p=0.28), AD<br />
OR=0.68 (0.44,1.04; p=0.08), or VaD OR=0.80 (0.36,1.80; p=0.59).<br />
Conclusion: A noteworthy proportion of older adults with and<br />
without dementia report moderate or greater pain and did not vary<br />
with cognitive status. Given that dementia represents a consistent risk<br />
factor the under identification and undertreatment of pain, efforts to<br />
improve pain management in this vulnerable population remain a<br />
high priority for future research.<br />
D151<br />
Help seeking for incontinence by adults with heart failure.<br />
K. Lindeman, 1 Y. Li, 2 M. H. Palmer. 2 1. University of North Carolina<br />
School of Medicine, Chapel Hill, NC; 2. School of Nursing, University<br />
of North Carolina, Chapel Hill, NC.<br />
Supported By: Detrol Clinical Research Program, 2005-2007;<br />
MSTAR, 2011 <strong>American</strong> Federation for Aging Research<br />
Background: Urinary incontinence (UI) and heart failure (HF)<br />
are both prevalent conditions that have significant impact on quality<br />
of life, but little information is available about HF patients seeking<br />
help for urinary incontinence. The objective of this study is to identify<br />
patient factors associated with help-seeking for UI in HF patients.<br />
Methods: This study is a secondary analysis of cross-sectional<br />
data collected between 2005 and 2007 in a 22 bed hospital unit and 2<br />
out-patient clinics for HF. Two hundred ninety six men and women<br />
that were 20 years or older with HF diagnosis participated in the original<br />
81-item survey. UI help-seeking was defined as an affirmative response<br />
to a single item on reporting UI to a doctor or nurse. Incontinence<br />
Impact Questionnaire-7 (IIQ-7) and the Urogenital Distress<br />
Inventory-6 (UDI-6) were used to assess level of impact of UI on<br />
quality of life.<br />
Results: 134 (45%) participants (median age 62 years; 45.5%<br />
male) had UI, 60 (44.8%) had at least two other urinary symptoms,<br />
and 45 (34%) sought help for UI. Bivariate analyses revealed that<br />
IIQ-7, UDI-6, presence of other urinary symptoms, and interaction<br />
between sex and age were significantly associated with help-seeking<br />
at p
P OSTER<br />
A BSTRACTS<br />
Results: For the first aim, time of day and mobility were significant<br />
predictors of positive affect displays;gender,age,and education were significant<br />
predictors of negative affect displays. The results of the second<br />
aim showed three distinctive trajectory groups for positive affect and<br />
two groups for negative affect. Positive affect comprised three groups: 1)<br />
a low stable group; 2) a fluctuating group displaying afternoon peaking;<br />
and 3) a fluctuating group displaying morning peaking. Negative affect<br />
included two groups: 1) a low stable group; and 2) a fluctuating group.<br />
Conclusions: The present study showed that people with dementia<br />
showed not only a considerable range of affect displays but also significant<br />
within-person variation in positive and negative affects.Therefore,<br />
a tailored intervention considering variations of affect display may<br />
be required to improve emotional well-being of people with dementia.<br />
D154<br />
Stress in Adult Children Caring for Older Parents with Dementia: A<br />
Pilot Study.<br />
L. M. Solberg, 1 L. B. Solberg, 2 E. N. Peterson. 1 1. Internal Medicine,<br />
Vanderbilt University, Nashville, TN; 2. Office of Research, Meharry<br />
Medical College, Nashville, TN.<br />
Supported By: Robert E. Wise M.D. Research & Education<br />
Institute, Lahey Clinic, Burlington, MA<br />
Background: Adults caring for parents and their own children<br />
are the “sandwich generation”. Their stress is noted in the behavioral<br />
sciences, but largely absent in medical literature. Clinical experiences<br />
showed adult children accompanying parents with dementia on clinic<br />
visits verbalized distress. The objective of this IRB-approved descriptive<br />
survey was to determine among a convenience sample of adult<br />
children caring for their parent with dementia the prevalence and<br />
severity of emotional and social changes and financial burden since<br />
assuming caregiver role.<br />
Methods: The study took place at a geriatric private practice.<br />
Adult children caregivers completed a 51-item survey (Cronbach’s<br />
alpha .80) on impact of the caregiving role on emotion, stress, and finances<br />
and coping mechanisms. Of those surveyed 85/95(89%) were<br />
returned. 45/85(47%) respondents were primary caregivers of demented<br />
elderly parents and 18/45(47%) were of the “sandwich generation.”<br />
Descriptive statistics were conducted using SPSS.<br />
Results: On average caregivers were 54 years old, 36/45(80%)<br />
women, 28/45(62%) were married, 38/45(84%) had children,<br />
18/45(47%) were “sandwich generation.” There was no significant difference<br />
in mean caregiver burden between the sandwich generation and<br />
non-sandwich generation adult children. Caregivers reported little impact<br />
on their professional lives. Over a third reported stress in caring for<br />
the older adults’ daily needs, felt more irritable, and more feelings of<br />
anxiety. 53% reported taking their parent to doctors’ appointments was<br />
emotionally difficult. Participating in activities of interest/hobbies decreased,<br />
but not time spent with friends. Helpful services were seminars<br />
on care of demented parents (58%),meetings with social workers for resource<br />
availability (63%), and seminars on coping mechanisms (53%).<br />
Conclusions: Adult children caring for demented parents experienced<br />
stress, anxiety, and sadness. Caregivers’ emotions were negatively<br />
impacted but not their finances or careers. Emotional stress decreased<br />
activities of interests, but not social interactions. Clinicians<br />
need to direct attention to the caregivers’ emotional well being as<br />
part of routine care of the elderly. Helpful coping mechanisms were<br />
identified by the respondents. Further program development to support<br />
adult children caregivers may be beneficial.<br />
D155<br />
Driving Habits of Seniors Over 80 and the Perceptions of Their<br />
Relatives: When and How Should They Stop?<br />
M. Majid, 1 N. Arif, 1 M. Akerman, 2 C. Nouryan, 1 G. Wolf-Klein. 1 1.<br />
North Shore-LIJ Health System, New Hyde Park, NY; 2. Feinstein<br />
Institute for Medical Research, Manhasset, NY.<br />
INTRODUCTION: The safety of older drivers has become an<br />
increasing issue of concern in today’s environment. We surveyed drivers<br />
over 80 years old and family members to explore driving habits<br />
and comfort levels of both.<br />
METHODS: Surveys were distributed in a geriatric outpatient<br />
practice and subacute rehab facility to patients over the age of 80 who<br />
were still driving and who were accompanied by a family member.<br />
RESULTS: Of the 74 surveys completed, drivers were, on average,<br />
85.5 yo, male (57%), and college or graduate school educated<br />
(69%); 81% rated driving as important or essential. Half (49%) reported<br />
driving with passengers. Most (65%) drove at least 5 days a<br />
week, and on highways (81%), in rain (78%), at night (59%) or in<br />
snow (41%). A quarter (24%) admitted getting lost and 27% reported<br />
having a fall. When asked who they would rely on if they could<br />
no longer drive, 43% indicated children, 26% friends, 16% car service,<br />
and 14% spouse.<br />
When comparing surveys between octogenarian drivers and relatives,<br />
81% rated themselves as “good” or “excellent” drivers while<br />
relatives rated them significantly less (58%, p=0.0342). When asked if<br />
the subject should still be driving, 11% of drivers and 42% of relatives<br />
answered “no” or “not sure” (p=0.0027).<br />
When asked which medical conditions would force driving cessation,<br />
drivers had lower percentages than their relatives for all answers<br />
except visual loss as follows: worsening medical conditions<br />
(32% v 62% respectively, p=0.0104); hearing loss (14% v 32%,<br />
p=0.0531); mobility issues (35% v 54%, p=0.1016); and visual loss<br />
(59% v 59%, p=1.00). When asked whether “anyone ever recommended<br />
that you/they stop driving”, 13.5% of drivers and 23% of relatives<br />
answered “yes” to the question (p=0.3594). Drivers reported<br />
that recommendations to stop driving only came from children<br />
(100%), but their relatives reported that spouses (11%), children<br />
(67%) and friends (22%) had all advised in on the subject.<br />
CONCLUSION: In general, octogenarian drivers were rarely<br />
told to stop driving. They rated themselves as significantly better drivers<br />
than their relatives did, and seldom admitted that they should not<br />
be driving, despite their relatives’ opinion.<br />
D156<br />
Evidence for “accelerated aging” in older adults with disability?<br />
I. R. Molton, M. C. Goetz, M. Jensen, A. M. Verrall. Rehabilitation<br />
Medicine, University of Washington, Seattle, WA.<br />
Supported By: This project is supported by a grant from the<br />
Department of Education, NIDRR grant number H133B080024.<br />
BACKGROUND: Improvements in medical care have led to<br />
longer life-spans for people with disabilities acquired early in life.<br />
However, there is some evidence that these improvements in<br />
longevity are offset by increased rates of medical conditions, due to a<br />
more rapid decline of organ system functioning in persons with disability.<br />
This phenomenon has been called “accelerated aging.” However,<br />
the existence of this phenomenon has not been adequately established<br />
in large samples with adequate age-matched controls.<br />
METHODS: The present study assessed self-reported rates of<br />
certain medical conditions in a large national sample of people with<br />
either spinal cord injury (n=540), post-polio syndrome (446), muscular<br />
dystrophy (382) or multiple sclerosis (640), and compared them to<br />
normative data taken from the National Health Interview Survey<br />
(NHIS) of more than 21,000 adults. Health conditions assessed included<br />
hypertension, coronary artery disease, cancer, diabetes, pain<br />
conditions, and vision trouble. Comparisons were conducted in four<br />
age bands: 18-44, 45-65, 65-75, 75+. Chi-square and independent samples<br />
t-tests were used for all analyses.<br />
RESULTS:Participants in the experimental sample were primarily<br />
Caucasian (92%) and female (63.3%), with an average age of 54.5 years.<br />
Results suggested that, across age bands, individuals with disabilities reported<br />
greater rates of hypertension, arthritis, joint pain and difficulties<br />
with vision (all p values < 0.05). However, in more advanced age bands<br />
(65-75 and 75+), adults with disabilities also reported greater frequency<br />
of organ system diseases (diabetes, coronary artery disease, and cancer)<br />
than were present in age matched national norms (all p values < 0.01).<br />
AGS 2012 ANNUAL MEETING<br />
S239
P OSTER<br />
A BSTRACTS<br />
CONCLUSIONS: These results lend support to the idea of “accelerated<br />
aging” of organ systems in persons growing older with longstanding<br />
physical disabilities. Health care providers should be aware<br />
of the special medical needs associated with organ system decline in<br />
these individuals.<br />
D157<br />
Brain Grey Matter Volume of the Putamen and Clinical Correlates<br />
of Motor Skill in Walking.<br />
J. M. VanSwearingen, 1 S. Perera, 2 C. Rosano, 3 H. J. Azenstein, 4<br />
J. S. Brach, 1 S. A. Studenski. 2 1. Physical Therapy, University of<br />
Pittsburgh, Pittsburgh, PA; 2. Geriatric Medicine, University of<br />
Pittsburgh, Pittsburgh, PA; 3. Epidemiology, University of Pittsburgh,<br />
Pittsburgh, PA; 4. Psychiatry, University of Pittsburgh, Pittsburgh, PA.<br />
Supported By: Pittsburgh Older <strong>American</strong>’s Independence Center, 1<br />
P30 AG024827; K23 AG026766<br />
Background: Grey matter volume (GMV) of the whole brain<br />
and regions has been associated with age-related changes in gait and<br />
motor sequence learning. It is unclear if whole brain or regional<br />
GMV relates to motor skill of walking. We examined the relation of<br />
GMV in the putamen, involved in selection, timing and automaticity<br />
of well-learned motor sequences, with clinical correlates of motor<br />
skill in walking in older adults with mobility limitations.<br />
Methods: We used baseline data from a RCT of exercise interventions<br />
in older adults with slow gait who also completed structural<br />
brain imaging (n=41, mean age 76.7±5.6).Automatic labeling pathway<br />
method was used to determine total brain volume, whole brain GMV<br />
and GMV of the putamen and additional brain regions associated<br />
with age-related changes in gait from the structural MRI. The GMV<br />
in the additional regions was included to determine if a relation to the<br />
putamen was unique or generalized. Motor skill in walking (energy<br />
cost of walking, stance time variability [STV] and the Figure of 8 Walk<br />
[F8W] cadence) and gait speed were recorded in a different session.<br />
Partial correlations, controlling for age, gait speed and total brain volume<br />
(GMV+WMV+CSF) were used to determine the adjusted correlations<br />
(r) between brain GMV and motor skill in walking.<br />
Results: Controlling for age, gait speed and total brain volume,<br />
putamen GMV was related to all measures of motor skill in walking:<br />
energy cost of walking (r=-.33, p=.040), STV (r=.37, p=.020), and<br />
F8Wcadence (r=-.44, p=.005). Whole brain GMV was related only to<br />
F8W cadence (r=-.38, p=.016). The only other regions associated with<br />
motor skill in walking were the precentral region related to STV<br />
(r=.33, p=.029), and the hippocampus related to F8W cadence (r=-.33,<br />
p=.046).<br />
Conclusion: GMV in the putamen was associated with most clinical<br />
measures of motor skill in walking. Age-related changes in brain<br />
circuits for motor sequence task performance may be a central contributor<br />
to the timing and coordination difficulties in gait of older<br />
adults. The putamen may be an important brain region of interest in<br />
future studies to determine whether interventions that improve<br />
motor skill in walking also change the brain.<br />
D158<br />
Aging with Longstanding Physical Disability: A Focus Group Study.<br />
K. Yorkston, A. Verrall, K. L. Johnson. Rehabilitation Medicine,<br />
University of Washington, Seattle, WA.<br />
Supported By: This project was funded by a grant from the<br />
Department of Education, NIDRR grant number H133B080024.<br />
Background: People aging with longstanding physical disability<br />
must deal with competing trajectories. Physical function is declining<br />
while confidence in the ability to cope is improving. Social support is<br />
likely to decline with retirement & aging significant others while<br />
medical management is improving thus increasing life expectancy.<br />
Methods: Four focus groups were conducted soliciting advice for<br />
health care teams seeing patients aging with a longstanding disability.<br />
Participants included people with spinal cord injury (N = 7), postpolio<br />
syndrome (N = 7), multiple sclerosis (N = 5), and muscular dystrophy<br />
(N = 4). All were at least 45 years of age and living with their<br />
disability for at least 8 years. Focus groups transcripts were reviewed<br />
and coded using Atlas.ti and a framework of themes was developed.<br />
Results: Four major themes emerged which are described in<br />
Table 1.<br />
Conclusions: Health care providers should acknowledge the<br />
skills that people with longstanding disability bring to the task of prioritizing<br />
their goals and managing their condition. Healthcare<br />
providers can assist them in developing individualized self-management<br />
interventions that help to maintain function and independence<br />
as they age.<br />
Table 1. Focus Group Themes<br />
D159<br />
Motor Learning Ability in Walking Relates to Physical Function in<br />
Older Adults.<br />
M. Zaldana, 2 J. M. VanSwearingen, 1 S. A. Studenski, 2 J. S. Brach. 1 1.<br />
Physical Therapy, University of Pittsburgh, Pittsburgh, PA; 2.<br />
Geriatric Medicine, University of Pittsburgh, Pittsburgh, PA.<br />
Supported By: Research/Grant Support: Pittsburgh Older<br />
<strong>American</strong>’s Independence Center, 1 P30 AG024827; Pitt Clinical<br />
Research Training- <strong>Geriatrics</strong>/Gerontology T32 AG021885; K23<br />
AG026766<br />
Background: Motor learning is important in the recovery or<br />
adaptation of performance in daily life after age-related changes in<br />
neuromotor function. Backward walking is a motor task with a similar<br />
motor sequence and complexity as forward walking but less practiced<br />
(ie less skilled). We examined the relation of changes in gait<br />
variability, an indicator of motor skill learning, over repeated trials of<br />
backward walking to physical function in older adults.<br />
Methods: Community-dwelling older adults (77.1 years±6.1,<br />
n=67) independent in ambulation performed 4 repeated trials of<br />
straight path backward walking and usual walking over a computerized<br />
walkway. Mean backward and usual walking gait speed and<br />
mean gait variability (stance time standard deviation, STV) for the<br />
first two and last two trials of backward walking were calculated.<br />
Mean percent change in STV between the first and last two trials of<br />
backward walking represented motor learning ability. Physical function<br />
in daily life, the Late-Life Function and Disability Instrument<br />
overall functioning (LLFDI total) was recorded in the same session.<br />
A linear regression model was used to examine the contribution of<br />
motor learning in walking ability to physical function in daily life,<br />
controlling for age, usual gait speed and backward walking gait speed.<br />
Results: Motor learning ability in walking independently contributed<br />
to physical function, while controlling for age, usual and<br />
backward gait speed. The mean percent change in STV contributed<br />
(β=-.22, p=.03) to the variance in LLFDI total beyond age and usual<br />
gait speed (β=.53, p
P OSTER<br />
A BSTRACTS<br />
D160<br />
Outcome of Older Patients Undergoing Total Hip or Total Knee<br />
Arthroplasty.<br />
R. V. Samala, 1 J. O. Ciocon, 2 P. Patel, 3 D. Galindo, 2 J. Loquias. 2 1. The<br />
Harry R. Horvitz Center for Palliative Medicine, Cleveland Clinic,<br />
Cleveland, OH; 2. <strong>Geriatrics</strong>, Cleveland Clinic Florida, Weston, FL; 3.<br />
Orthopedics, Cleveland Clinic Florida, Weston, FL.<br />
Background: In spite of the proven benefits of total joint arthroplasty,<br />
doubts about pain relief, progression of ambulation, and maintenance<br />
or improvement of functional capacity pervade. The present<br />
study aimed to determine the outcome of older patients undergoing<br />
primary elective total hip (THA) or total knee arthroplasty (TKA)<br />
for osteoarthritis<br />
Methods: A cross-sectional study was done at Cleveland Clinic<br />
Florida which included adults 65 years and older who underwent<br />
THA or TKA between July 1, 2010 and February 28, 2011. Patients<br />
with other inflammatory joint diseases, acute fracture, or revision surgery<br />
were excluded. Medical records were reviewed and telephone<br />
interviews were conducted at 6 and 12 weeks post-surgery. Outcome<br />
measures were pain level, living condition, ambulation status, and<br />
functional status.<br />
Results: Fifty three participants completed the study; mean age<br />
was 73 years, 49% were female, and 43% had THA. There were significantly<br />
more patients who were pain-free, neither bound to wheelchair<br />
nor bed, and independently functional at home by 12 weeks.<br />
There were significantly more THA patients who ambulated independently<br />
than those who required an aid (p
P OSTER<br />
A BSTRACTS<br />
Aggressive treatment of many cancers includes surgical interventions,<br />
with accompanying risks of morbidity and mortality. There is<br />
substantial heterogeneity in older adults’ functional reserve and ability<br />
to tolerate and recover from major physiological stressors. Geriatric<br />
assessment has developed in the gerontology literature as an important<br />
prognostic tool to risk-stratify community-dwelling older<br />
adults. These principles have been explored with the goal of identifying<br />
patient-level risk factors for adverse surgical outcomes. In this review,<br />
we examined the utility of components of a Comprehensive<br />
Geriatric Assessment (CGA) as predictors of adverse outcomes<br />
among older patients undergoing major surgery.<br />
Methods: Medline, EMBASE, and the Cochrane Library were<br />
searched for prospective studies examining components of CGA<br />
among geriatric patients undergoing elective surgery. Outcome parameters<br />
included 30 day postoperative complications and mortality,<br />
and discharge to a non-home care institution. Within and across the<br />
studies, we evaluated which CGA components were associated with<br />
the outcome(s) of interest.<br />
Results: The initial search identified 125 potentially relevant articles,<br />
of which ten articles based on seven studies met criteria for<br />
evaluation. Across the studies, chronological age was consistently<br />
found not to be an independent predictor of poor outcomes. Dependencies<br />
in ADLs and cognitive impairment were associated with increased<br />
incidence of complications and mortality. Impairment in<br />
IADLs was also associated with discharge to non-home care institutions<br />
in two studies.<br />
Conclusions: Across a diversity of surgical settings and patient<br />
populations, the results of these studies support an association between<br />
poor functional status and adverse geriatric surgical outcomes.<br />
These consistent results argue for inclusion of focused geriatric assessment<br />
as part of routine presurgical care in older adults. In addition,<br />
the development of targeted interventions for vulnerable individuals<br />
so identified may provide innovative means of mitigating the<br />
risk of major surgical interventions for this increasing proportion of<br />
the population.<br />
D164 Encore Presentation<br />
A Pooled Analysis of Surgical Complications: Results from the<br />
RECORD Program.<br />
M. R. Lassen, 1 M. Gent, 2 A. K. Kakkar, 3,4 B. I. Eriksson, 5<br />
S. D. Berkowitz, 6 A. Turpie. 2 1. Glostrup Hospital, Glostrup,<br />
Denmark; 2. McMaster University, Hamilton, ON, Canada; 3.<br />
Thrombosis Research Institute, London, United Kingdom; 4.<br />
University College London, London, United Kingdom; 5. Sahlgrenska<br />
University Hospital, Mölndal, Sweden; 6. Bayer HealthCare<br />
Pharmaceuticals, Montville, NJ.<br />
Supported By: This research was funded by Bayer HealthCare<br />
Pharmaceuticals Inc. and Janssen Research and Development, LLC.<br />
Background: Surgical complications after total hip or total knee<br />
arthroplasty (THA or TKA) are a primary concern for surgeons and<br />
can increase the cost and length of hospitalization, re-admission rates,<br />
and incur additional surgeries. Such complications include a wide<br />
range of conditions including bleeding, infection, and hemarthrosis.<br />
The phase III RECORD program investigated the oral, direct Factor<br />
Xa inhibitor rivaroxaban for the prevention of venous thromboembolism<br />
after THA (RECORD1, 2) or TKA (RECORD3, 4). The<br />
focus of this analysis from the pooled data from the four RECORD<br />
studies was to investigate whether rivaroxaban regimens are similar<br />
to enoxaparin regimens in the incidence of surgical complications<br />
after THA and TKA.<br />
Methods: Patients (N=12,729) were randomized to receive rivaroxaban<br />
10 mg once daily for 35±4 days or enoxaparin 40 mg once<br />
daily for 35±4 days (RECORD1) or 12±2 days followed by placebo<br />
(RECORD2). In RECORD3 and 4 patients received prophylaxis for<br />
12±2 days with rivaroxaban 10 mg once daily or enoxaparin 40 mg<br />
once daily (RECORD3) or enoxaparin 30 mg twice daily<br />
(RECORD4). Surgical safety outcomes were analyzed in the safety<br />
population over the total treatment duration pool.<br />
Results: The incidence of serious adverse events related to surgery,<br />
such as post-procedural infection, operative hemorrhage, wound<br />
dehiscence, postoperative wound infection, incision site hemorrhage,<br />
and hemarthrosis, was similar in the rivaroxaban (30/6,183: 0.49%)<br />
and enoxaparin (35/6,200: 0.56%) groups.<br />
Conclusions: These data suggest that surgical safety outcomes<br />
are unlikely to differ between rivaroxaban and enoxaparin<br />
regimens.<br />
S242<br />
AGS 2012 ANNUAL MEETING
A UTHOR<br />
Abadir, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B55, B61<br />
Abarca-Gomez, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C39<br />
Abbott, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B122<br />
Abbott, R D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B124, C53<br />
Abdo, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C148<br />
Abi Rafeh, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C148<br />
Abraham, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A125<br />
Abrams, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P39<br />
Abreu Lanfranco, O E . . . . . . . . . . . . . . . . . . . . . . . . . . . .A48*<br />
Abreu-Lanfrranco, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B35<br />
Acquista, D A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C63<br />
Adachi, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51<br />
Adelman, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P36<br />
Adelman, R D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D41, D116<br />
Adeniye, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C147*<br />
Adepoju, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C49<br />
Ador-Dionisio, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C147<br />
Africa, B L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A3*, A4*<br />
Agarwal, S J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A163*<br />
Agbor-Bawa, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A100<br />
Agnew, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B25*<br />
Aguilar, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D90<br />
Aguirre, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D106, D107<br />
Ahalt, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C105<br />
Ahl, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C36<br />
Ahmad, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63*<br />
Ahmed, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C82*<br />
Ahmed, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117<br />
Ahmed, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B77<br />
Ahsan, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B68<br />
Aizenstein, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B163<br />
Ajmal, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C112<br />
Akerman, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D86, D155<br />
Akintan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A28<br />
Akintan, A I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C5*<br />
Al-Mallah, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A161<br />
Alagiakrishnan, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D10*<br />
Alamo, J G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D17<br />
Albaba, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B23*, B24*<br />
Albiol Tomàs, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C164, D40<br />
Albornoz, M F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D128<br />
Albrecht, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D138*<br />
Alessi, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B89, B158<br />
Alexandra, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51<br />
Algase, D L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D153<br />
Ali, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C148*<br />
Alirhayim, Z . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A161<br />
Allegre, A A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A62<br />
Allen, C M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C142*<br />
Allen, K R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D104*<br />
Allman, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B127<br />
Allman, R M . . . . . . . . . . . . . . . . . . . . . . . . . . .A50*, B92, P13<br />
Almeida, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B148*<br />
Almeida, L M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C50<br />
Alston, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37, C41<br />
Alweis, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A17<br />
Alwine, L K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A34<br />
Amdur, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A95<br />
Aminbakhsh, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A104*<br />
Amjad, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B52*<br />
I NDEX<br />
Ammann, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B58*<br />
Amrhein, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D103<br />
Amtmann, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C158*<br />
Amuan, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A45<br />
Anand, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B12, C3<br />
Anderson, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C45<br />
Anderson, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D54, D63<br />
Anderson, K J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D119*<br />
Anderson, R A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C74<br />
Anderson-Malico, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C58<br />
Andrade, L C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D17*<br />
Andresen, E M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P32<br />
Andrew, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B149, D150<br />
Ang, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A15, A32*<br />
Angeles, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A3, A8, B16<br />
Anger, J T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B80<br />
Ankuda, C K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B50*<br />
Annweiler, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C141*, D88<br />
Anthony, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D63<br />
Antony, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C76<br />
Appa, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C33<br />
Arabelo, H . . . . . . . . . . . . . . . . . . . . . . . . . . . .A3, A4, A8, C16<br />
Arabelo, H A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B16<br />
Arai, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C42<br />
Arakawa, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A94*<br />
Araujo, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A49<br />
Araw, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D129<br />
Araw, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D129*<br />
Archbald-Pannone, L . . . . . . . . . . . . . . . . . . . . . . . . . . . .B137*<br />
Ard, K L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A96<br />
Arenson, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A84, C76*<br />
Argento, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A101<br />
Arif, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C130, D155<br />
Arling, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B110<br />
Arnold, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D115*<br />
Aronson, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P39<br />
Arora, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A6<br />
Arora, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A19*, C13<br />
Arshad, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B16*<br />
Arya, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />
Ashraf, M S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A146*<br />
Ashton-Miller, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D80<br />
Asik, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A141<br />
Aslam, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21*<br />
Asnis, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />
Assal, M F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A25<br />
Asthana, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C117<br />
Atkinson, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A72<br />
Atkinson, H H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D61<br />
Atreya, A R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C13*<br />
Atwood, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A138<br />
Aubry-Rozier, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D149<br />
Audi Ferrer, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C164<br />
Auerbach, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P37<br />
Aung, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B38*, D85*<br />
Aung, Z . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A104<br />
Austin, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A80<br />
Avelino-Silva, T J . . . . . . . . . . . . . . . . . . . . .A54*, A55*, A81*<br />
Awasthi, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C3<br />
Azenstein, H J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D157<br />
*Indicates presenting author<br />
AGS 2012 ANNUAL MEETING<br />
S243
A UTHOR<br />
I NDEX<br />
Azhar, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D147<br />
Aziz, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C12, C25*, D24<br />
Bachuwa, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A148<br />
Bae, S Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A143*<br />
Bai, X . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B123<br />
Baiduc, B Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C16*<br />
Baillargeon, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D99<br />
Bakchine, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />
Baker, L D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />
Baker, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C65<br />
Balamurugan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D147<br />
Ball, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A125<br />
Balzi, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />
Bangalore, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A52*<br />
Bangs, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C36<br />
Banks, W A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A131<br />
Bansal, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C120<br />
Bansal, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B13*, C125<br />
Barash, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C62<br />
Barchielli, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />
Barco, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B92*<br />
Barczi, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C117<br />
Barlow, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B30*<br />
Barnes, C A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C121<br />
Barnes, D E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A149<br />
Baron, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A75, A76, A79<br />
Barr, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B168<br />
Barre, L K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B37<br />
Barrett, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A64<br />
Barrick, A L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A38<br />
Barrientos-Calvo, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C39<br />
Bartels, S J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B37<br />
Bartha, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C141<br />
Bartolomé, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D106, D107<br />
Basic, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A116<br />
Basu, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C21*<br />
Bateman, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A38<br />
Batsis, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B37*<br />
Bauer, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48<br />
Bauer, D C . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B49, B81, B109<br />
Baum, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D76<br />
Bautista, M K . . . . . . . . . . . . . . . . . . . . . . . . . . . .C12, C25, D24<br />
Bavendam, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />
Bayer-Carter, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />
Bea, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P31<br />
Beaman, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P14<br />
Beattie, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />
Beauchet, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C141, D88<br />
Beben, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A25*<br />
Becker, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B131<br />
Becker, Y T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D162<br />
Bednarczyk, M . . . . . . . . . . . . . . . . . . . . . . .A5, A6, C18, D19*<br />
Beeber, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C119<br />
Beeber, A S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B113, B114<br />
Beizer, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D86<br />
Belal, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C3, D2<br />
Bell, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B122, B124, C53<br />
Bell, C L . . . . . . . . . . . . . . . . . . . . . . . . . . . .B68, B120*, B157*<br />
Belladonna, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />
*Indicates presenting author<br />
S244<br />
AGS 2012 ANNUAL MEETING<br />
Bellantoni, M R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D98*<br />
Bellantonio, S . . . . . . . . . . . . . . . . . . . .A1, A2, A15, B17, D16<br />
Bellelli, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />
Belleville, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C137<br />
Belza, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C111<br />
Benedict, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D76<br />
Benigno, D G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B8*<br />
Benizry, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A47<br />
Bennett, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B170<br />
Benoit, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D127<br />
Bentov, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P19<br />
Berg, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D11*<br />
Berger, A E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B139<br />
Berges, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C92<br />
Bergman, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />
Bergman, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A109<br />
Berkowitz, S D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D164<br />
Berlowitz, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B167<br />
Berman, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D41<br />
Bernick, J J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D34*<br />
Berry, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P33<br />
Berryman, S N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D67<br />
Berthoud, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D149<br />
Bertrand, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B113, B114<br />
Betz, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B145*, P6*<br />
Beyea, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B63*<br />
Beyth, R J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C12, C25, D24<br />
Bhagavan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A1*, A2*<br />
Bhandari, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C120<br />
Bharel, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A90, A96<br />
Bhat, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C16<br />
Bhattacharya, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D135<br />
Bhattacharya, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A78<br />
Bhattacharya, S B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A78*<br />
Bickerstaff, K A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D120*<br />
Bickmore, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P9<br />
Biedron, C . . . . . . . . . . . . . . . . . .A43*, A44*, A48, B35, C101<br />
Bierrenbach, A L . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A54, A55<br />
Bilbruck, T J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D67<br />
Black, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />
Black, S E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />
Blackstone, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A121, C58<br />
Blake, R Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C165<br />
Blanchard, G P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A68, C81*<br />
Blaum, C . . . . . . . . . . . . . . . . . . . . . . . . . . . .B47, B78, B112, P8<br />
Blazey-Martin, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A96<br />
Bliwise, D L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B76<br />
Bloch, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A149<br />
Block, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D64<br />
Bocirnea, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C87*<br />
Boersma, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P15<br />
Boeve, B F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D92<br />
Bogaisky, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D43<br />
Boling, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A120, D95<br />
Bonavitacola, P J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A68*<br />
Bonner, L M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />
Bonsall, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B67<br />
Boockvar, K S . . . . . . . . . . . . . . . . . . . . . . . . . . . .A126, D103*<br />
Bookhart, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C54, C93<br />
Boonen, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D32
A UTHOR<br />
I NDEX<br />
Bopp, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B159, B164<br />
Borker, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A69*<br />
Borrie, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />
Borson, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A135, C158<br />
Boscardin, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B31<br />
Boscardin, W J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P1<br />
Bottone Jr, F G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C161*<br />
Boudreau, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36<br />
Boudreau, R M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B109, P30<br />
Bouldin, E L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P32*<br />
Boustani, M A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A47, A88<br />
Bowers, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C103<br />
Bowling, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B127*<br />
Boxer, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P22*<br />
Boyd, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C104<br />
Brach, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B161, B163, B166<br />
Brach, J S . . .A158, B79, B156, B165, D157, D159, P24*, P30<br />
Bradley, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />
Bradley, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P12<br />
Bradley, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D78<br />
Brangman, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B13, C125<br />
Braun, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B157<br />
Braun, U . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A27, D83<br />
Bravo, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D75<br />
Braza, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D60<br />
Breeding, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D93<br />
Brennan, M . . . . . . . . . . . .A32, B14, B19, C21, C23, C28, D23<br />
Brennan, M J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A19, C13<br />
Brenny-Fitzpatrick, M . . . . . . . . . . . . . . . . . . . . . . . . . . . .D135<br />
Bresee, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B80<br />
Brett, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P37<br />
Bridges, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C117<br />
Briesacher, B A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C106<br />
Brignole, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A86<br />
Brimacombe, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C124<br />
Broce, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B138<br />
Brooks, D B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A82<br />
Brown, A F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A98<br />
Brown, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B92<br />
Brown, C J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P13*<br />
Brown, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D56, D60<br />
Brown, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />
Brown, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B121<br />
Brown, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B99*<br />
Brown, R T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A90*, A96*<br />
Brummel-Smith, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C65<br />
Brunker, C P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C109<br />
Brunson, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C45<br />
Brunton, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B146<br />
Bryan, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D109<br />
Buchbinder, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B27<br />
Bueno, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B152<br />
Bukata, S v . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A20<br />
Bula, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B84, C128, D48<br />
Burgio, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132<br />
Burke, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C10*<br />
Burkett, J G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D95*<br />
Burleson, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A138<br />
Burnett, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B75, B93, D26*<br />
Burnham, C . . . . . . . . . . . . . . . . . . . . . . . .A68, C81, D73, D74<br />
Burns, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C89<br />
Burrows, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P37<br />
Bursztyn, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B134<br />
Burton, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D92<br />
Busby-Whitehead, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D66<br />
Bushan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C63*<br />
Buslovich, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A123*<br />
Butler, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B151<br />
Byerly, L K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D63*<br />
Bylow, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P4<br />
Bynum, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B6<br />
Byszewski, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />
Cabral, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B167<br />
Cagle, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B98*<br />
Cal, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117, D86<br />
Caldi, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />
Callaghan, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />
Callahan, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A99, B110<br />
Callahan, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A72, D61*<br />
Callister, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C139*<br />
Camargo, K R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C50<br />
Camera, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D128<br />
Campanova, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />
Campbell, K H . . . . . . . . . . . . . . . . . . . .B111*, D152*, D162*<br />
Campbell, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A47*, A88*<br />
Campbell, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A83<br />
Campusano, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C40<br />
Canaday, D H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B57<br />
Cao, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C1<br />
Cao, Q . . . . . . . . . . . . . . . . . . . . . . . . . .A80, B71*, B154*, C14<br />
Caprio, A . . . . . . . . . . . . . . . . . . . . . . . . . . .B20, B63, C41, D66<br />
Caprio, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B62, D12<br />
Caprio, T v . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A20<br />
Caprio, T V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A12<br />
Caputo, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />
Carbonell, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D106, D107<br />
Cardona, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B9*, C152*<br />
Carey, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D64<br />
Cariaga, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D117<br />
Carlini, A R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162<br />
Carlson, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63<br />
Carlson, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P12<br />
Carlucci, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D78<br />
Carnahan, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P31<br />
Carr, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B98<br />
Carrabba, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />
Carson, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B168<br />
Carthen, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A4<br />
Caruso, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P37<br />
Carvalho, A C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C44<br />
Caserotti, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P30<br />
Cassidy, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C101<br />
Castillo, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D106*, D107*<br />
Castillo, R C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162<br />
Catuogno, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />
Cauley, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48<br />
Cauley, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P31<br />
Cavallini, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />
Cefalu, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D90, D91<br />
*Indicates presenting author<br />
AGS 2012 ANNUAL MEETING<br />
S245
A UTHOR<br />
I NDEX<br />
Ceimo, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D75*<br />
Celeste, R K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C46<br />
Cha, S S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B23, B24, D92<br />
Chakka, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B4*, C8<br />
Chakka, A K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B64<br />
Chami, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A43, A44<br />
Chan, K C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C159<br />
Chan, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D132<br />
Chang, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B104<br />
Chang, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C27*<br />
Chang, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D19<br />
Chang, M T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D92*<br />
Chang, S S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B45*<br />
Chao, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B15, P37<br />
Chao, S H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D47<br />
Chaperon, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D120<br />
Charness, A L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D139<br />
Charvat, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A160<br />
Chataut, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A5*, A6*<br />
Chatterjee, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A89*<br />
Chatterjee, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B161<br />
Chau, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A104<br />
Chaudhari, S . . . . . . . . . . . . . . . . . . . . . .A9, B12, C24, D1, D2<br />
Chaudhry, A H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A92<br />
Chaudhry, S I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D140<br />
Chaudhuri, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C94<br />
Chauhan, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B104*<br />
Chaves, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B1, B2<br />
Chawla, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C56*<br />
Cheadle, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B139<br />
Checchi, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D38*<br />
Chelagiri, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18*<br />
Chen, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C150*<br />
Chen, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C22*<br />
Chen, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B57<br />
Chen, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132<br />
Chen, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B119<br />
Chen, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B122, C53<br />
Chen, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D141<br />
Chen, X . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A38<br />
Chen, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A127*<br />
Cheng, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P9<br />
Cheng, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D50*, D51*<br />
Cheng, H S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A93<br />
Cheng, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B61*<br />
Cheng, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C161<br />
Chenna, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A72*<br />
Cherr, G S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B146<br />
Cheung, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100<br />
Cheung, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A98*<br />
Chew, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B167<br />
Chez, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A154<br />
Chi, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C108<br />
Chiao, Y A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B142<br />
Chikwe, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A164<br />
Chimienti, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D73<br />
Chippendale, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B26*<br />
Chittenden, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D64<br />
Cho, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A107<br />
Chodos, A H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C11*<br />
*Indicates presenting author<br />
S246<br />
AGS 2012 ANNUAL MEETING<br />
Chodosh, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B105<br />
Chohan, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D76*, D108*<br />
Chong, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C40<br />
Chong, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D132*<br />
Chongkrairatanakul, N . . . . . . . . . . . . . . . . . . . . . . . . . .A156*<br />
Chopra, T . . . . . . . . . . . . . . . . . . . . . . . . .A43, A44, A48, C101<br />
Choudhry, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D146<br />
Christianer, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D41*<br />
Christmas, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D112<br />
Chun, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D115<br />
Chung, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A107<br />
Cigolle, C . . . . . . . . . . . . . . . . . . . . . . . . . .B47, B78*, B112, P8<br />
Ciocon, J O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A14, D160*<br />
Civin, C I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B139<br />
Clark, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B51<br />
Clark, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B101, C58*, C89*<br />
Clark, E M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A70<br />
Clarrett, D M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B169*<br />
Cleinman, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P29*<br />
Clevenger, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A40*<br />
Clough-Gorr, K M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P3<br />
Cluff, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C132<br />
Cobbs, E L . . . . . . . . . . . . . . . . . . . . . . . .A112, A121, C58, C68<br />
Cobian, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100<br />
Cocanour, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C45<br />
Cochran, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A146<br />
Cochrane, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A150, B44<br />
Coeli, C M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C50<br />
Cohen, C I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A39<br />
Cohen, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A38<br />
Coimbra, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D65<br />
Colburn, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D112<br />
Coll, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A26<br />
Collins, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C73, C76<br />
Colloborative, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D60<br />
Colloborrative, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D56<br />
Colon Cartagena, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B19*<br />
Colon-Emeric, C . . . . . . . . . . . . . . . . . . . . . . . .B28, C74*, P45<br />
Colon-Nieves, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C72<br />
Combest, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C98<br />
Comrie, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />
Conell-Price, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P1<br />
Conley, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36<br />
Connor, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B105<br />
Constantine, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . .A97*, C63<br />
Coon, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D75<br />
Cooper, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A73<br />
Cooper, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C132<br />
Corazzini, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C74<br />
Corbie-Smith, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A94<br />
Corcoran, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C64<br />
Cordts, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B117<br />
Cornejo, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A68<br />
Cornell, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B62*<br />
Cornely, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C37<br />
Corrado, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117, D129<br />
Corrigan, M V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C87<br />
Cotrell, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C79<br />
Counsell, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P14<br />
Counsell, S R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A84, P44
A UTHOR<br />
I NDEX<br />
Covinksy, K E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A105<br />
Covinsky, K . . . . . . . . . . . . . . . . . . . . . . . . . .B31, B98, D6, D44<br />
Cox-Vance, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D22<br />
Craft, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />
Crist, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B155<br />
Croft, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A164<br />
Crook, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C37<br />
Crosby, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C144<br />
Crowe, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A50<br />
Cruz, D M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C142<br />
Cruz, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A41<br />
Cruz, N M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B139*<br />
Cruz-Knight, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C67<br />
Cuadrado, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D106, D107<br />
Culley, D J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C144<br />
Cummings, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B154<br />
Cummings, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27*<br />
Curb, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B120, B157<br />
Curb, J D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C53<br />
Curcio, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C38<br />
D’Agostino, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B128<br />
D’Amico, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C85<br />
D’Silva, K A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B136*<br />
D’Souza, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B118*<br />
Dahiya, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A30, A141*<br />
Dahm, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B136<br />
Dalal, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A140*<br />
Dalbey, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D34<br />
Dale, W . . . .A103, A110*, B3, B91, B111, B149, B150, B171,<br />
D150, D152, D162, P4<br />
Daly, J W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A25<br />
Damaraju, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C54, C93<br />
Damodarasamy, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P19<br />
Dang, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D136*<br />
Dang, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100*<br />
Daniels, M J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P32<br />
Danve, A S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C3*<br />
Darvin, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D93<br />
Date, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />
Dave, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />
Davis, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P23<br />
Davis, B R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D36<br />
Davis, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D117<br />
Davis, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B157<br />
Davis, K L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A102, B153<br />
Dayanand, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100<br />
De Beritto, T V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A136*<br />
De Marchi, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C46<br />
de Rekeneire, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B43*<br />
Deal, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37, C41<br />
Deban, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A109<br />
Debonnaire, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C80<br />
DeCaria, J E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B82*<br />
DeCherrie, L V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D101<br />
Decker-Maruska, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D70<br />
Defillo Draiby, J . . . . . . . . . . . . . . . . . . . . . . . . . . .D57*, D82*<br />
DeGolia, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A69<br />
DeJesus, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A114*<br />
delCarmen, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A77<br />
Demiris, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C94<br />
Demons, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A72<br />
Demons, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . .D30, D36*, P23<br />
Demontiero, O . . . . . . . . . . . . . . . . . . . . . . . .B140*, C129, P15<br />
Dennis, R a . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B164<br />
Dennis, R A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B159<br />
Denson, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D56, D60*, P35<br />
Denson, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D56<br />
Dentino, A N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C69*<br />
Desai, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D162<br />
Desai, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A105<br />
Deschodt, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D32*<br />
Dethmers, D L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A103<br />
Detroyer, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C80*<br />
Devarajan, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D63<br />
Dey, A B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A89, A157<br />
Di Bari, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41*, C146<br />
Diamond, P M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D26<br />
Diaz de Cerio, M . . . . . . . . . . . . . . . . . . . . . . . . . . .D106, D107<br />
Dietrich, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D105<br />
DiGuiseppi, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P6<br />
Dillon, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A39<br />
Dimaano, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B85*<br />
Dinescu, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A112, C68*<br />
Ding, Q . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C1*<br />
Ding, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D132<br />
Diniz, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B1, B2<br />
Diniz, A R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C44*<br />
Diniz, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B1, B2<br />
Dlugacz, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117, D86<br />
Dobbels, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C80<br />
Doberman, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B117<br />
Dobracki, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B73*<br />
Dodson, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D140*, P2*<br />
Dohrenwend, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C160<br />
Dolansky, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A160<br />
Donaghey, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D105<br />
Donahue, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D20<br />
Dong, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A73<br />
Dong, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B66<br />
Dong, X . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A111*<br />
Donohue, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B49, B109<br />
Donovan, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B22, C106<br />
Dorr, D A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C109*<br />
dos Santos, C M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C46*<br />
Dosa, D M . . . . . . . . . . . . . . . . . . . . . . . . .B34*, B121*, C110*<br />
Dowal, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B119<br />
Downs, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />
Drickamer, M . . . . . . . . . . . . . . . . . . . . . . .B65, D20, D57, D82<br />
Drost, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B69<br />
Dubbert, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B164<br />
DuBeau, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A64, A65, B5<br />
DuBeau, C E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34*<br />
Dubin, L J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D125*<br />
Dubina, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B80*<br />
Duff, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C139<br />
Duggal, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A105<br />
DuMond, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D49*<br />
Dunbar, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C119*<br />
Duncan, C L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C140*<br />
*Indicates presenting author<br />
AGS 2012 ANNUAL MEETING<br />
S247
A UTHOR<br />
I NDEX<br />
Dunn, C M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A126<br />
Dunton, N E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P32<br />
Duque, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B140, C129, P15*<br />
Durst, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D48<br />
Duthie, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P35, P35<br />
Duthie, E H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D56, D60<br />
Dworkin, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D63<br />
Dyer, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A46, B75<br />
Dyer, C B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B93, D26<br />
Eaton, W W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C48<br />
Ebbert, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A78<br />
Echt, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P33*<br />
Eckmann, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A166<br />
Eckstrom, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C79*<br />
Edes, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A108*, B115, P10<br />
Edwards, D S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D5<br />
Efeovbokham, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D114<br />
Efeovbokhan, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A23<br />
Efeovbokhan, U T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A31<br />
Efoevobokhan, U T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C122<br />
Efron, D T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162<br />
Egras, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C73<br />
Eisenhower, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C85*<br />
Eiss, B M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D41<br />
El Zammar, Z . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C125<br />
Elarabi, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D23*<br />
Ely, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A47<br />
Emmett, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A99<br />
Eng, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P40<br />
Eng, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A85, D113*, P3*<br />
Eng, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A78<br />
Engel, P A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A113*<br />
Engelberg, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B51<br />
Erickson, M A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A131<br />
Eriksson, B I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D164<br />
Erlichman, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C44<br />
Ernst, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B32*<br />
Ersek, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B149, D150<br />
Erslon, M G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A163<br />
Ertle, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D104<br />
Escamilla, A G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A43, A44<br />
Escarce, J J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A98<br />
Eskildsen, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B67*<br />
Espinal, C M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C17*, C122*<br />
Espino, D V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C47<br />
Espinoza, S . . . . . . . . . . . . . . . .A87, A119*, C96, D93*, D94*<br />
Esteban, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D128<br />
Evans, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D75<br />
Evans, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A122*<br />
Fabiny, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D73<br />
Fabrizio, C A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C138*<br />
Faigman, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C105<br />
Fain, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A125<br />
Fairfield, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C165<br />
Fan, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B72<br />
Fan, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B3, B91<br />
Farber, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A18, D124<br />
Farber, M O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A47<br />
*Indicates presenting author<br />
S248<br />
AGS 2012 ANNUAL MEETING<br />
Farias, L L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A81<br />
Farrell, T W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A82*, A83*<br />
Faselis, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A95<br />
Faulk, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A146<br />
Faurot, MPH, PA, K R . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A36<br />
Fedarko, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B59<br />
Federman, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P43<br />
Feiereisel, K B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D61<br />
Feldman, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C38<br />
Feldman, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B108<br />
Felice, F M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C61*<br />
Felix, M.D., A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A36<br />
Feng, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C143<br />
Feng, M A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D163*<br />
Feng, Z . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B121<br />
Fernandes, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A147*<br />
Fernandez, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B123<br />
Fernandez, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C66<br />
Fernández Aviles, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B152<br />
Ferrucci, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B99, P29, P30<br />
Finkelstein, E . . . . . . . . . . . . . . . . . . . . . . . . . . . .C113*, C126*<br />
Fischman, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A18<br />
Fiutem, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P22<br />
Flacker, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A124<br />
Flamaing, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D32<br />
Fleegle, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C73<br />
Fletcher, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A95<br />
Fogel, J F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C77<br />
Foley, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D62<br />
Foley, K T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P13<br />
Fong, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B124<br />
Fonseka, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D109*<br />
Ford, C R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D62<br />
Ford, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D53<br />
Forman, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A144, C151*<br />
Fortinsky, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B151<br />
Fosnight, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D104<br />
Fox, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B111, B146<br />
Fox, C S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B128<br />
Foy, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C106<br />
Fracchia, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />
Fraenkel, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P28<br />
Francini, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />
Franco, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C24*<br />
Franco, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P35<br />
Francois, S J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B165*<br />
Frankel, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B95, D148<br />
Fraser, S A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A109<br />
Freedman, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />
Frentzel, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C49<br />
Fried, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B52, B53, P2<br />
Friedman, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D122, D123<br />
Friedman, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C82<br />
Friedman, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A20, D148<br />
Friedman MD, MPH, AGSF, S M . . . . . . . . . . . . . . . . . . . .B95<br />
Frisoli, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B1*, B2*, C44<br />
Frölich, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />
Fromme, E K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D138<br />
Frontini, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D90<br />
Fuez, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P5
A UTHOR<br />
I NDEX<br />
Fujikami, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C91*<br />
Fukushima, F B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C50<br />
Fuller, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C126<br />
Fumagalli, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />
Fung, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B89<br />
Fung, C H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B158*<br />
Furman, C D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A22<br />
Furuakwa, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C42<br />
Furuno, J P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D138<br />
Gagnon, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B86<br />
Galecki, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B47<br />
Galicia-Castillo, M C . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B148<br />
Galindo, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D160<br />
Gallagher, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D73<br />
Gallego, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51*, D39<br />
Galli, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B72<br />
Galvez, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B67<br />
Galvin, J E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A139<br />
Gammon, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D73<br />
Gan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P41<br />
Ganem, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A54, A55<br />
Ganesan, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P41<br />
Gangavati, A S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C71*<br />
Ganz, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C127<br />
Ganz, D A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B106<br />
Gao, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C15*<br />
Gao, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A88<br />
Garcia, C H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C96*<br />
Garcia, N I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A59*<br />
García, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D106, D107<br />
García - Cárdenas, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51<br />
García Navarro, J . . . . . . . . . . . . . . . . . . . . . . . . . . . .C164, D40<br />
García-Cardenas, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D39<br />
Gardner, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C123*<br />
Garfinkel, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C49<br />
Garner, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B164<br />
Garner, K K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B159<br />
Garrido, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B4<br />
Garrido, A I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C8*<br />
Gau, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A144, C151<br />
Gaubert-Dahan, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A33<br />
Ge, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C1<br />
Gehl, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D60<br />
Gelfman, L P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C66<br />
Genao, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B40*<br />
Gensini, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />
Gent, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D164<br />
George, L V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C32<br />
George, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D147*<br />
George, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C98<br />
Gerding, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C37*<br />
Gi, B H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A93<br />
Gil, L A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A54, A55, A81<br />
Gill, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B43<br />
Gill, T M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B45, P28<br />
Gilliam, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B20<br />
Gilligan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A125<br />
Gilmore, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C103<br />
Giordano, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C76<br />
Giulietti, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />
Givens, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B50<br />
Gleason, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132<br />
Gleason, L J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D148*<br />
Gleich, G J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B135<br />
Goedken, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B115<br />
Goel, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A125<br />
Goetz, M C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D156<br />
Gold, M S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A34<br />
Goldberg, R J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B46<br />
Goldberg, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D133<br />
Goldenberg, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C153*<br />
Goldenheim, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B102*<br />
Goldman, H B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C35<br />
Goldstein, D J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B125<br />
Goldstein, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P2<br />
Golightly, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B133<br />
Golightly, Y M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21<br />
Gomez, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D106<br />
Gómez, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D106, D107<br />
Gómez, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D107<br />
Gomez-Marin, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100<br />
Gommers, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C80<br />
Gomolin, I H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C100<br />
Gonzales, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A116*<br />
Goode, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132<br />
Goodson, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A149*<br />
Goodwin, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D99<br />
Goodwin, J S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B107*, P11*<br />
Gopalraj, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C6<br />
Gopaul, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D89<br />
Gorawara-Bhat, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A103*<br />
Gorbach, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C37<br />
Gorbien, M . . . . . . . . . . . . . . . . . . . . . . . . . . .A5, A6, C18, D19<br />
Gordon, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37, C41<br />
Gordon, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D73<br />
Goren, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D71<br />
Gorospe, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B56*<br />
Gosian, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155<br />
Gottesman, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C89<br />
Gottesman, E M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A126<br />
Gottlieb, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D36, P23<br />
Gottlieb, S H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C15<br />
Gottschalk, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D161<br />
Goubran, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B162<br />
Gould, E M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A35<br />
Grady, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C33<br />
Graham, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D31<br />
Grammas, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D20*<br />
Grandinetti, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B157<br />
Grandinetti, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B157<br />
Graves, A D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B64<br />
Gray, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P31<br />
Gray, S L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B81<br />
Green, P S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />
Greene, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B11<br />
Greene, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B87*<br />
Gregg, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P29<br />
Gregory, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />
Greysen, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A105*<br />
*Indicates presenting author<br />
AGS 2012 ANNUAL MEETING<br />
S249
A UTHOR<br />
I NDEX<br />
Griebling, T L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />
Griffith, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D55<br />
Grissom, C K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P20<br />
Griswold, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P29<br />
Groce-Martin, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D72<br />
Grooms, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C20<br />
Grossberg, G T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C140<br />
Grossman, S N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A128<br />
Gruber-Baldini, A L . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B168*<br />
Gruenewald, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B32<br />
Gryczynski, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B117<br />
Guerra, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D128<br />
Guerrant, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B137<br />
Gugliucci, M R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D58<br />
Guh, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C145*<br />
Gulati, G . . . . . . . . . . . . . . . . . . . . . . . . . . .A16, A17, D3*, D4*<br />
Gulati, S . . . . . . . . . . . . . . . . . . . . . . . . . . .A16*, A17*, D3, D4<br />
Guo, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A104<br />
Guo, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A87*<br />
Gupta, A . . . . . . . . . . . . . . . . . . .B143*, C12*, C25, C130, D24<br />
Gupta, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A16<br />
Gupte, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A85, D113<br />
Gure, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B47*, B78<br />
Gurnani, A S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A139<br />
Gurwitz, J . . . . . . . . . . . . . . . .A64, A68, C81, C106, D73, D74<br />
Gurwitz, J H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B46<br />
Gutierrez, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B152<br />
Gutkoski, T P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A57*<br />
Guzik, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C130*<br />
Gyurmey, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A26*<br />
Ha, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B47, B78<br />
Haan, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D44<br />
Habegger, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A38*<br />
Hackney, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C84<br />
Haddon, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B114<br />
Hade, E M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B120<br />
Haider, A H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162<br />
Hajduk, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B46<br />
Hajjar, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C73<br />
Hak, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C148<br />
Halade, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A87, D93<br />
Hall, M H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B94<br />
Hall, W J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D15<br />
Hallen, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D7<br />
Halm, E A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A60<br />
Halphen, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B93<br />
Hambridge, H L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162<br />
Hamdan, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A86, B90<br />
Hameed, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A118*<br />
Hamrick, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B71<br />
Han, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D132<br />
Han, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P28<br />
Hanlon, J T . . . . . . . . . . . . . . . . . . . . . . . . . . . .B49, B81, B109*<br />
Hanoi, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B12<br />
Hans, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B84, D149<br />
Hanson, A J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18*<br />
Hanson, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C115<br />
Hanson, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B20<br />
Hanson, L C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B116<br />
*Indicates presenting author<br />
S250<br />
AGS 2012 ANNUAL MEETING<br />
Harada, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D62<br />
Hardy, S E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A52, A159*<br />
Haring, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B100*<br />
Harrigan, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B157<br />
Harris, E S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P20<br />
Harris, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A137*, B48<br />
Harris, T B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P30<br />
Harrold, L R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C106<br />
Hartley, C J . . . . . . . . . . . . . . . . . . . . . . . . . . . .A62, C61, C149<br />
Hartvigson, P E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A131*<br />
Harvath, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C79<br />
Harvey, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A134*<br />
Hasan, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B103<br />
Hashim, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A92*<br />
Hastings, S N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A42*, D35<br />
Hathaway, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B6*<br />
Haukoos, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P6<br />
Hausman, D B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48<br />
Hausman, S P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C132<br />
Haut, E R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162<br />
Hava, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A36*<br />
Hawkins, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C161<br />
Hawley, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C107<br />
Hayashi, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B60*, C1<br />
Hayes, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A80, B71<br />
Hayley, D C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C124*<br />
Hayward, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C121*<br />
Hazelet, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D76, D108<br />
Hazelett, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A67, B69<br />
Hazelett, S E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D104<br />
Hazuda, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C96, D94<br />
Hecht, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D133*<br />
Heckler, C E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B3<br />
Hede, S V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A62*<br />
Heflin, M T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D68<br />
Heh, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A144*, C151<br />
Heilman, K M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C12<br />
Heim, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A132<br />
Heinen, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A74, A106<br />
Hemmerich, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B171*<br />
Henault, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P9<br />
Hendrix, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D31<br />
Herbert, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D81*<br />
Herman, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155<br />
Hernan, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D128<br />
Herndon, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D103<br />
Herr, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B149, D150<br />
Hersh, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C73<br />
Hess, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />
Hess, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C107<br />
Hesse, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A156<br />
Hewston, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C76<br />
Hibbs, R M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A158*<br />
High, K P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D122*, D123*<br />
High, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D141<br />
Higuchi, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B122*<br />
Hile, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B96<br />
Hile, E S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B79*, P30*<br />
Hilgert, J B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C46<br />
Hill, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D65*
A UTHOR<br />
I NDEX<br />
Hillstrom, T J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C121<br />
Hilton, T N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D15<br />
Hirani, S A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162*<br />
Hirano, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95<br />
Hirsch, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C88<br />
Hirsch, C H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C45*<br />
Hobgood, C D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B29<br />
Hobgood, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A120*<br />
Hochhalter, A K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D111<br />
Hochschild, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B75<br />
Hochschild, A E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D26<br />
Hodroge, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A91*<br />
Hogan, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />
Holcombe, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P16<br />
Holcroft, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A109<br />
Holland, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A28, C5<br />
Holmes, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A39<br />
Holt, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D141<br />
Holtz, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B144<br />
Hoover, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A145<br />
Hopper, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B53*<br />
Horney, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A42, D35<br />
Hornyak, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P24<br />
Hornyak, V A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B166*<br />
Horton, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A41*, A45*<br />
Horwitz, L I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A105<br />
Hosler, M R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A23<br />
Hossain, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P10<br />
Houston, D K . . . . . . . . . . . . . . . . . . . . . . . . . . .B48, D36, P23*<br />
Hovanes, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C103<br />
Howard, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B11*<br />
Howe, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D55*<br />
Howell, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132<br />
Howell, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C72<br />
Hshieh, T T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B119*<br />
Hsieh, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C73<br />
Hsu, D C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C88*<br />
Hu, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B70<br />
Huang, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C33*, P25*<br />
Huang, D L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C111*, C159*<br />
Huang, E S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D152<br />
Huang, Z . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D33, D102<br />
Hubbs, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D161*<br />
Hughes, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B123*<br />
Hughes, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C4<br />
Hughes, T B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C104<br />
Hugo, F N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C46<br />
Hui, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B130<br />
Hui, S L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A47<br />
Huie-Li, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D119<br />
Huisingh-Scheetz, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D59<br />
Hummel, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B47<br />
Hung, W W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A126*, P43*<br />
Hunold, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B27<br />
Hunt, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D105<br />
Hurwitz, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D47<br />
Husain, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C103<br />
Hutchison, L C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D67*<br />
Hwang, U . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B30<br />
Hyde, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B34, P39<br />
Hyer, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B121<br />
Hylek, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B167<br />
Ifon, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A121<br />
Iloabuchi, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B4, C8<br />
Iloabuchi, T C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P44*<br />
Iloputaife, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B86<br />
Imam, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D9<br />
Imam, S N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C55<br />
Imran, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C55<br />
Ina, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B60<br />
Inaba, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B68, B124*<br />
Inghan, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B1<br />
Inouye, S K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B119<br />
Into, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A138<br />
Intrator, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B34, C110<br />
Ioannidis, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51<br />
Iraqi, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C4*<br />
Ireton, E S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A59<br />
Irvine, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />
Irving, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C80<br />
Isaacs, C G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B27*<br />
Isabelle, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A109<br />
Islam, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B74*, C83*<br />
Itticheria, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C6*<br />
Iturrino, D M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D84<br />
Iwata, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D52*<br />
Izhar, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C12, C25, D24*<br />
Izumi, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A151*, C155<br />
Jaber, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B14*<br />
Jaccard-Ruedin, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C128<br />
Jackson, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P37<br />
Jacob-Filho, W . . . . . . . . . . . . . . . . . . . . . . . . . . .A54, A55, A81<br />
Jacobs, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B134*, D145<br />
Jahn, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155<br />
Jain, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B59<br />
James, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A85, D13*, D113<br />
James, T C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A84*<br />
Jamshed, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A66*, B70<br />
Janardhanan, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A39*<br />
Janes, K F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D58*<br />
Jaume-Anselmi, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C152<br />
Javelot, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D37<br />
Jawad, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D130*<br />
Jeffery, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D126<br />
Jenkins, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B7*<br />
Jennings, J R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A132<br />
Jensen, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C117<br />
Jensen, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D156<br />
Jerome, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A39<br />
Jette, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B160<br />
Jetter, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A86, B90<br />
Jiang, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C153<br />
Jinhui, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51<br />
Johansen, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A68<br />
John, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B138<br />
John, P M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D152<br />
Johnson, E F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B88<br />
Johnson, J C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D72<br />
*Indicates presenting author<br />
AGS 2012 ANNUAL MEETING<br />
S251
A UTHOR<br />
I NDEX<br />
Johnson, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A124, P25<br />
Johnson, K L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C158, D158<br />
Johnson, K S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A42, D97*<br />
Johnson, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C101<br />
Johnson, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P6<br />
Johnson, S B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D9<br />
Johnson, T M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />
Johnson, II, T M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B76<br />
Johnston, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B108<br />
Johnston, C W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C75*<br />
Jolly, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37*, C41<br />
Jonas, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A154<br />
Jones, B G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C69, D5<br />
Jones, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A95, D109<br />
Joosten, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C80<br />
Jordan, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B133<br />
Jordan, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21<br />
Jordan, Q . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A124<br />
Joseph, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B17<br />
Josephson, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B89, B158<br />
Josephson, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D162<br />
Joshi, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D33<br />
Jouldjian, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B89, B158<br />
Jovancevic- Misic, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D28*<br />
Juncos, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B76<br />
June, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155<br />
Justice, A C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A105<br />
Kabsoun, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C134<br />
Kaiser, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A112, C68<br />
Kakkar, A K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D164<br />
Kakwan, U . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A27*<br />
Kalayjian, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B141*<br />
Kalender-Rich, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C124<br />
Kalender-Rich, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B66*<br />
Kalva, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P20<br />
Kamal, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B124<br />
Kamholz, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B118<br />
Kamm, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B171<br />
Kanaan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B22, C106<br />
Kang, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D132<br />
Kaplan, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C113<br />
Kaplowitz, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C113<br />
Kapoor, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B167*<br />
Karanam, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100<br />
Kardachi, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D78<br />
Kariolis, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C63, D33*<br />
Karter, A J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D152<br />
Karumanchi, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C55<br />
Karunadharma, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P19<br />
Kashan, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A148*<br />
Kashyap, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D87*<br />
Katon, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A135<br />
Katon, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B42<br />
Katz, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B167<br />
Katz, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C110<br />
Kaul, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C120*<br />
Kaushik, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A29*<br />
Kawai, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B147*<br />
Kay, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C35<br />
*Indicates presenting author<br />
S252<br />
AGS 2012 ANNUAL MEETING<br />
Kayani, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D76<br />
Kayani, N A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A67*, B69*<br />
Kaye, K S . . . . . . . . . . . . . . . . . . . . .A43, A44, A48, B35, C101<br />
Kearsley, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D36, P23<br />
Kelley, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B104<br />
Kelley, A S . . . . . . . . . . . . . . . . . . . .A70, C66*, D101, P7*, P43<br />
Kelley, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A142*<br />
Kelley, S D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A163<br />
Kelz, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C64<br />
Kennedy, G J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A123<br />
Kennedy, R E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A50<br />
Kenny, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P22<br />
Kenny, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B72<br />
Keough, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D73, D74<br />
Kerins, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D140<br />
Kerr, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B112, P8<br />
Kerr, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B155<br />
Khalid, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A161<br />
Khalili, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A40<br />
Khan, A . . . . . . . . . . . . . . . . . . . . . . . . . .A68, B80, C72*, C99*<br />
Khan, B A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A47<br />
Khan, S A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P21<br />
Kheirbek, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A95*<br />
Khoo, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A116<br />
Khosla, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A19<br />
Khosravanipour, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B67<br />
Kiel, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P33<br />
Kiely, D K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A90, A96<br />
Kikuchi, E L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A81<br />
Kilpatrick, B S . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A102, B153<br />
Kim, D H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B33*<br />
Kim, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95*, D80<br />
Kim, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95<br />
Kim, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A164*<br />
Kind, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C103<br />
Kind, A J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C117*<br />
Kindler, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P4<br />
King, A C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A149<br />
King, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C103*<br />
King, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155<br />
kinosian, b . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B115*, P10*<br />
Kinosian, B . . . . . . . . . . . . . . . . . . . . . . . . . . .A108, C114, P40*<br />
Kinzie, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A146<br />
Kirk, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63<br />
Kirschenbaum, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B126<br />
Kistler, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B113, B114<br />
Kistler, C E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B27, C107*<br />
Kitt, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C23*<br />
Kitzman, D W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48<br />
Klay, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D16<br />
Klepac, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A108<br />
Kline, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C57<br />
Knebl, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A134<br />
Knell, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A100<br />
Knight, S J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P5<br />
Knoefel, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B162<br />
Ko, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A18<br />
Kochersberger, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C110<br />
Kodama, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C42<br />
Koh, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P41
A UTHOR<br />
I NDEX<br />
Kohn, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B143<br />
Kojima, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C53*<br />
Kojima, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95<br />
Komiyama, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C135*<br />
Koo, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D144<br />
Kopacz, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D102*<br />
Kopits, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D13<br />
Kopits, I M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B160*<br />
Korc-Grodzicki, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A165<br />
Kordahl, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C117<br />
Kosc, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C132<br />
Kostas, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C116<br />
Kostas, T R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B97*<br />
Kothari, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A11*<br />
Kotwal, A A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A110<br />
Kowgier, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />
Koya, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D21*<br />
Kozikowski, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C57<br />
Krahn, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />
Krall, D M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C144*<br />
Kraus, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />
Kraus, S R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />
Kraus, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B133<br />
Kraus, V B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21<br />
Kravvariti, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C112*<br />
Kressig, R W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />
Krieg, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D149<br />
Krieg, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B84, D149*<br />
Krishna, A . . . . . . . . . . . . . . . . . . . . . . . . . . . .A43, A44, C101*<br />
Kristof, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B151*<br />
Kritchevsky, S B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48<br />
Kropp, D J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D104<br />
Kuchibhatla, M N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D97<br />
Kulkarni, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A9<br />
Kulkarni, S P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C3<br />
Kuller, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36<br />
Kumar, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C98*<br />
Kumar, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A157<br />
Kumar, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A157*<br />
Kumari, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A9, B12, D1, D2<br />
Kunik, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B54<br />
Kuo, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B107, D99, P11<br />
Kurata, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A61*<br />
Kusz, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C160<br />
Kwak, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D142*<br />
Lachs, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P42*<br />
Lachs, M S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C102<br />
LaCroix, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B44, B120, P31<br />
LaCroix, A Z . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A150<br />
Lagoo-Deenadayalan, S . . . . . . . . . . . . . . . . . . . . . . . . . . .B170<br />
Lahoud, O B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D133<br />
Lai, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C91<br />
Laird, R D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B116<br />
Laiteerapong, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D152<br />
LaMantia, M A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B29*<br />
LaMori, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C54, C93<br />
Lampert, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P2<br />
Lamy, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B84, D149<br />
Landay, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B141<br />
Landerman, L R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A42<br />
Lands, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A91, A142, A143<br />
Lane, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B130<br />
Langa, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B47<br />
Langa, K M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A56<br />
Langbaum, J B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D141<br />
Langlois, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D141<br />
Lansing, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C59<br />
Lapane, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D95<br />
Lapid, M I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D92<br />
Lasater, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C79<br />
Lassen, M R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D164*<br />
Laszlo, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B84<br />
Lathia, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C147<br />
Lau, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B149<br />
Launer, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B122, C53<br />
Laura, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B63<br />
Le, M T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B125*<br />
Le, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C94<br />
Leal, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A152, A153<br />
Leavitt, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D92<br />
Lecea, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A148<br />
Lederman, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B141<br />
Lee, D S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D138<br />
Lee, H B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C48<br />
Lee, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D153*, P39<br />
Lee, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B105, P38<br />
Lee, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B78<br />
Lee, R H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P45*<br />
Lee, S . . . . . . . . . . . . . . . . . . . . . . . . . . .A15*, A32, B17*, D130<br />
Lee, S J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P1*<br />
Lee, T . . . . . . . . . . . . . . . . . . . . . .A80*, A107*, B71, C55, D79<br />
Lehana, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51<br />
Leibowitz, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D145<br />
Leiding, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A5, A6, C18<br />
Leiding, M J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D19<br />
Leiferman, K M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B135<br />
Leiter, A C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B126*<br />
Leland, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D117*<br />
Lemay, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C106*<br />
Leng, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63<br />
Leo-Summers, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B43, P28<br />
Leon, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C89<br />
Leonard, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C134, D75<br />
Leone, A F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C157<br />
Leong, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A104<br />
Lepcha, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A112*<br />
Lerch, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D70*, D134*<br />
Leslee, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C33<br />
Lessard, D M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B46<br />
Lesser, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C130<br />
Lester, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D34<br />
Lester, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C100<br />
Leucker, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A24*<br />
Levenson, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B103*<br />
Leverenz, J B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />
Levey, A I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B11<br />
Levin, M A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P27<br />
Levin, S N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B46*<br />
Levine, A C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B126<br />
*Indicates presenting author<br />
AGS 2012 ANNUAL MEETING<br />
S253
A UTHOR<br />
I NDEX<br />
Levine, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D45*<br />
Levine, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P37*<br />
Levy, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B115<br />
Lewis, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C107<br />
Li, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63<br />
Li, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C132*<br />
Li, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B169<br />
Li, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A129<br />
Li, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D151<br />
Liang, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B78<br />
Liang, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A98<br />
Liao, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A57<br />
Liberman, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117, D129<br />
Lichtenberg, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A44, C101<br />
Lidsky, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B170<br />
Limaye, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A75*, A76*, A79<br />
Limm, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C104*<br />
Lin, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B55<br />
Lin, F R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B169<br />
Lin, H M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P27<br />
Lin, J C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D137*<br />
Lin, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A128*<br />
Lin, P S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A93<br />
Lin, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A39<br />
Lin, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C24<br />
Lin, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A81<br />
Lin, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D99<br />
Lindeman, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D151*<br />
Lindenberger, E . . . . . . . . . . . . . . . . . . . . . . . . .B101, C58, C66<br />
Lindsey, M L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A87, B142<br />
Lingler, J H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A71<br />
Lipman, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C60*<br />
Lipsitz, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B86, C71<br />
Lipsitz, L A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B33<br />
Lisse, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A145<br />
Litrivis, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D124<br />
Little, M B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A166<br />
Liu, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C67*<br />
Liu, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B128*<br />
Liu, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C108*<br />
Liu, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P32<br />
Liu, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C36<br />
Livote, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B101, C89, P43<br />
Loehrer, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B130<br />
Logio, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A77, P36<br />
Long, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C131<br />
Longenecker, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C26*<br />
Longstreth, W T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A98<br />
Loquias, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D160<br />
Lough, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B86*<br />
Louie, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C37<br />
Lowenstein, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B145, P6<br />
Lowery, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D99*<br />
Lowman, J D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P13<br />
Lowry, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C124<br />
Lowry, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B161*<br />
Loza-Diaz, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C129*, P15<br />
Lu, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C52*<br />
Lu, P H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A136<br />
Lui, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C53<br />
*Indicates presenting author<br />
S254<br />
AGS 2012 ANNUAL MEETING<br />
Lum, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C7*<br />
Luna, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C29*<br />
Luo, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C1<br />
Luong, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D124*<br />
Luque, A E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D15<br />
Lutsky, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D86<br />
Luz, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C90<br />
Lyass, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B128<br />
Lyketsos, C G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C138<br />
Lyles, M F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D30*<br />
Lyons, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C76<br />
Ma, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B168<br />
Maaravi, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D145<br />
MacKenzie, T A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B37<br />
Mackin, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P39<br />
MacKnight, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />
MacLean, E W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B129*<br />
Macnow, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C64*<br />
Madan, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A115*<br />
Madero, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A133<br />
Madrigal-Leer, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C39*<br />
Magaziner, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B168<br />
Maheshwari, N . . . . . . . . . . . . . . . . . . . . . . .A9*, B12*, D1, D2<br />
Mahnken, J D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B66<br />
Mahoney, J F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A71<br />
Maiaroto, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D126<br />
Mailliard, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D59<br />
Majeski, J D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C44<br />
Majid, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D155*<br />
Major, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B84*<br />
Makela, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C29<br />
Makris, U E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P28*<br />
Malik, K S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D14*<br />
Mallon, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100<br />
Malmstrom, T K . . . . . . . . . . . . . . . . . . . . . . . . . . . .C140, C142<br />
Malone, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C72, C99<br />
Manchester, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A65<br />
Manini, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B120<br />
Manocha, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B13, C125*<br />
Manor, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B86, C136*<br />
Manov, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A13<br />
Mansour, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C2, C56, D127<br />
Manu, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C59*<br />
Manwani, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63, B61<br />
Manwani, B R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B55*<br />
Marallag, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P19*<br />
Marcantonio, E R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B168<br />
Marchionni, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41, C146<br />
Marcum, Z A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B49*<br />
Mariano, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D102<br />
Marino, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C165<br />
Marottoli, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D126<br />
Marottoli, R A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A49*<br />
Marszalek, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117<br />
Marszalek-Litauska, A . . . . . . . . . . . . . . . . . . . . . . . . . . . .C57*<br />
Martelli, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A109*<br />
Martin, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B89, B158<br />
Martinez, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B123<br />
Martinez, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D52, D68*
A UTHOR<br />
I NDEX<br />
Martínez, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C164*<br />
Martínez Almazán, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D40<br />
Masaki, K . . . . . . . . . . . . . . . . . . . . . . . .B68, B120, B122, B157<br />
Masaki, K H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C53<br />
Masick, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D86<br />
Massaro, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B128<br />
Mather, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A119<br />
Matining, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B141<br />
Matti-Orozco, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A8, C16<br />
Mattox, K M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C32<br />
Matusevich, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D128<br />
Mazor, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C106<br />
McBride, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B116*<br />
McCann, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B62<br />
McCormick, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C82<br />
McCormick, K R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D148<br />
McCormick MD, PhD, K R . . . . . . . . . . . . . . . . . . . . . . . . .B95<br />
McCranor, B J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B139<br />
McCreath, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B106<br />
McCullough, L B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B54<br />
McCullough, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B18*<br />
McDonough, C M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B160<br />
McGarry, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P7<br />
McGee, S . . . . . . . . . . . . . . . .A64, A65, A68, C81, D73*, D74*<br />
McGhee, H R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D111<br />
McGlann, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A43, A44<br />
McGough, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C94<br />
McGregor, J C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D138<br />
McIntosh, K P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D12*<br />
McLean, S A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B27<br />
McMahan, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P5<br />
McMahon, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D79<br />
McNabney, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D142, P40<br />
McNamara, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C59<br />
McNett, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D63<br />
Medina Munoz, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C55<br />
Meeks, W M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P29<br />
Meganathan, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D110<br />
Mehr, D R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C49*<br />
Mehta, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A77, P36<br />
Mejnartowicz, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D11<br />
Melis, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A74, A106, D77<br />
Mello, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />
Melstrom, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B171<br />
Men, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P20<br />
Mendieta F., M G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B152*<br />
Merkin, S S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A98<br />
Messina, F C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B29<br />
Meulenbroek, O V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C133<br />
Meyers, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A102<br />
Meyers, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B153<br />
Mi, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P44<br />
Miao, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B31<br />
Migliori, R J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C161<br />
Milisen, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C80, D32<br />
Miller, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B67<br />
Miller, B L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A128<br />
Miller, D K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B29<br />
Miller, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C37<br />
Miller, M L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D31<br />
Miller, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A27<br />
Miller, R K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D71*, D72*<br />
Mills, W L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155*, B54*<br />
Min, L . . . . . . . . . . . . . . . . . . . . . . .B39*, B47, B78, B112*, P8*<br />
Minani, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D75<br />
Minnick, A F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D105<br />
Mintzer, M J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D69<br />
Mion, L C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D105*, P32<br />
Mir, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117, D129<br />
Mitchell, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B113, B114<br />
Mitchell, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D62<br />
Mitchell, S L . . . . . . . . . . . . . . . . . . . . . . . . . . . .A90, A96, B50<br />
Mitnitski, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A122<br />
Modak, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B138<br />
Mody, L . . . . . . . . . . . . . . . . . . . . . . .A44, B35, B39, C59, C101<br />
Moed, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B160<br />
Moffett, H H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D152<br />
Mohammed, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C134*<br />
Mohile, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B3, B91<br />
Mohile, S G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A110<br />
Mohler, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A125<br />
Moiduddin, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C55*<br />
Mold, J W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B111<br />
Molinuevo, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />
Molton, I R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D156*<br />
Moncada, L V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B8<br />
Monette, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A109<br />
Monette, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A109<br />
Monod, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B84, C128, D48*<br />
Montero Odasso, M . . . . . . . . . . . . . . . .B74, C83, D88*, D89*<br />
Montero-Odasso, M . . . . . . . . . . . . . . . . . . . . . . . . . .B82, C141<br />
Montine, T J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />
Montz, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B144<br />
Moodhe, N E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A126<br />
Moons, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D32<br />
Moore, A A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A57, D137<br />
Moore, C C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C47*<br />
Moore, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D104<br />
Moore, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37, A160, C41<br />
Mor, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B121<br />
Morano, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A126<br />
Moreira, D C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C50<br />
Moreno, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C11<br />
Moret, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C128*<br />
Morgan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A113<br />
Morgan, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A73<br />
Morgan, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132<br />
Morley, J E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C140, C142<br />
Morris, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D109<br />
Morrison, L J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D64*<br />
Morrow, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B3<br />
Mossello, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146*<br />
Moudouni, D K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C49<br />
Mouton, C P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C156*<br />
Moye, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155, B54<br />
Moylan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P39<br />
Muir, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B74, C83<br />
Muir, S W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D88, D89<br />
Mulgund, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51<br />
Mulligan, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155<br />
*Indicates presenting author<br />
AGS 2012 ANNUAL MEETING<br />
S255
A UTHOR<br />
I NDEX<br />
Mulsant, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C137<br />
Mungthin, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A130<br />
Muntner, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B127<br />
Murabito, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B128<br />
Murphy, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A65<br />
Murphy, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A46<br />
Murphy, K M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D30<br />
Murray, M D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A88<br />
Mushiyev, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B12, D1<br />
Musich, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C161<br />
Muss, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37, C41<br />
Mustian, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B3<br />
Myers, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />
Myers, J S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D71<br />
Mysiw, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B120<br />
Nace, D A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A71<br />
Nadkarni, N K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B163*<br />
Naeim, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B91<br />
Naessens, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C115<br />
Naessens, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A127<br />
Nagaraja, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A125*, A145*<br />
Naglie, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162*<br />
Naik, A D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155, B54<br />
Najm, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A154*<br />
Nakagawa, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A18*, B101*<br />
Nanda, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A83<br />
Naqvi, S S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A22*<br />
Nassef, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A38<br />
Nathan, S N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A21*<br />
Nau, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36<br />
Navaratnam, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D122, D123<br />
Nazir, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B64*, C8<br />
Neal, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C79<br />
Neamtu, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C20*<br />
Neiberg, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48<br />
Nelson, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B133<br />
Nelson, A E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21<br />
Nelson, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C36*<br />
Neukam, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B155*<br />
Newman, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36, B49<br />
Newman, A B . . . . . . . . . . . . . . . . . . . . . . . . . . .B81, B109, P30<br />
Newman, D K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />
Newman, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B108*<br />
Newman, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A80<br />
Newton, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B33<br />
Ng, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B140<br />
Ng, W K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C86<br />
Nguyen, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P35*<br />
Nguyen, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A128<br />
Ni, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B160<br />
Nicholas MD, MPH, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . .B95<br />
Nichols, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D7<br />
Nicklas, B J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D30<br />
Nicolas, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B87<br />
Nidadavolu, L S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P21*<br />
Niedernhofer, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36<br />
Niedernhofer, L J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P21<br />
Nielsen, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D163<br />
Nieri, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C134, D75<br />
*Indicates presenting author<br />
S256<br />
AGS 2012 ANNUAL MEETING<br />
Nijgha, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D83<br />
Nitta, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C42*<br />
Nnodim, J O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D80*<br />
Nonnenmacher, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D37<br />
Norman, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P34*<br />
Norris, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D71<br />
Norris, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A39<br />
Nouryan, C . . . . . . . . . . . . . . . . . . . . . . . . . . . .C57, C130, D155<br />
Novak, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C136<br />
Nurpeisov, V . . . . . . . . . . . . . . . . . . . . . . . . . . .A28*, A58*, C5<br />
Nutescu, E A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C54, C93<br />
Nwaiwu, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C49<br />
Nye, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B71<br />
O’Brien, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P1<br />
O’Connor, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D75<br />
O’Halloran, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B72*<br />
O’Leary, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B53<br />
O’Toole, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A69<br />
Oakes, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A115, D136<br />
Oakes, T M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C36<br />
Oates, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B102<br />
Obering, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A78, A100<br />
Odden, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D44*<br />
Ogbevire, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B150<br />
Oh, E S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C138<br />
Ohl, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A105<br />
Ohuabunwa, U . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B67<br />
Ohuabunwa, U K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A124*<br />
Okoronkwo, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B142*<br />
Okura, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A56*<br />
Olde Rikkert, M . . . . . . . . . . . . . . . . . . . . . . . .A74, A106, D77<br />
Olde Rikkert, M G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C133<br />
Oleson, E . . . . . . . . . . . . . . . . . . . . . . . . . .A64*, A65*, B5, C81<br />
Olmedo, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D11<br />
Olsen, G S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C109<br />
Olson, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A5, A6, C18<br />
Olson, J C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D19<br />
Omonte, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51, D39*<br />
Ong, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A9, B12<br />
Ong, E C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D1*, D2*<br />
Ooi, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A30*, A141<br />
Ootsuki, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C42<br />
Oreja, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51, D39<br />
Ornstein, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D101<br />
Orso, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />
Ortiz, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D39<br />
Ortiz, J R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D114*<br />
Ortiz - Alonso, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51<br />
Orwig, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B168<br />
Osborn, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D53<br />
Ostfeld-Johns, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B95*<br />
Ostir, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C92*<br />
Otero, D M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C19*<br />
Otsuka, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A12*<br />
Ouchida, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A77, P36*<br />
Ouslander, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D103<br />
Ouslander, J G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />
Owens, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A132<br />
Ozminkowski, R J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C161
A UTHOR<br />
I NDEX<br />
Paasche-Orlow, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P9*<br />
Pacchia, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B90<br />
Pacchia, C F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A86<br />
Padala, K P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B159, B164<br />
Padala, P R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B159, B164*<br />
Padilha, D P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C46<br />
Padua, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C99, D118*<br />
Pagel, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C99<br />
Palacios, J C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D69<br />
Palla, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D9*<br />
Palla, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D79<br />
Pallan, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51*<br />
Palli, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D42<br />
Palmer, M H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D151<br />
Palsson, O S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B129<br />
Pan, C X . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A118, C63<br />
Pan, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37, C41<br />
Pandey, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A121*, C58<br />
Pandya, N . . . . . . . . . . . . . . . . . . . . . .A102*, B153*, C54, C93<br />
Panzer, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A138*<br />
Paolo, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B66<br />
Papademetriou, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A95<br />
Pappas, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B170<br />
Paquin, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B97<br />
Paquin, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C116*<br />
Pardasaney, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B160<br />
Park, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B42*, B89*<br />
Parker, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B57*<br />
Parker, M M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D152<br />
Parker, R W . . . . . . . . . . . . . . . . . . . . . . . . . . . .A31, C17, C122<br />
Parker, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B102, D47<br />
Parson, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D95<br />
Parulekar, M . . . . . . . . . . . . . . . . . . . . . . . . . . .C2, C56, D127*<br />
Pasquale, D A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A7<br />
Pasquale, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D74<br />
Patel, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C5<br />
Patel, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A96<br />
Patel, N K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C17, C122<br />
Patel, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D160<br />
Patel, R K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C35<br />
Patel, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A119<br />
Patrick, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D65<br />
Patrick, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B162*<br />
Patterson, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />
Paul, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C67<br />
Paulk, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A60<br />
Payne, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B67<br />
Pearman, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A91<br />
Pecanac, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C103<br />
Pecorella, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />
Peddagovindu, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B5*<br />
Peduzzi, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A49<br />
Pejovic, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D31<br />
Pekmezaris, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C57, C130<br />
Pena, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P17*<br />
Peña-Cruz, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B139<br />
Pénard, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B72<br />
Penfield, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B56<br />
Peng, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B105*<br />
Peniston, J H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A34<br />
Penmetsa, G K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B10*<br />
Penrod, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P43<br />
Perahia, D G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C36<br />
Peralta, C A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D44<br />
Pereira, F A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P17<br />
Pereira, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B27<br />
Pereira, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117*, C57<br />
Perera, S . . . . . . .B49, B79, B81, B94, B96, B156, B161, B163,<br />
D28, D157, P24<br />
Pereyra, N F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B152<br />
Perez, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B4, C8<br />
Pergolizzi, J V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A35<br />
Periyakoil, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B147<br />
Perjar, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B133*<br />
Perkal, M F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D126<br />
Perkins, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A47<br />
Peron, E P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B81*<br />
Perry, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A74, A106<br />
Peterson, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B85<br />
Peterson, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D38<br />
Peterson, E N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D154<br />
Peterson, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A78<br />
Petit, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C157*<br />
Peto, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C37<br />
Petrella, R J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B82<br />
Petrovitch, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B122, B124<br />
Pettinger, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P31<br />
Petz, S D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C111<br />
Pham, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A62<br />
Phelan, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D81<br />
Phillips, A T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P27*<br />
Phillips, C D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C49<br />
Philp, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C131*<br />
Pickens, S L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B93*<br />
Pickney, C M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C101<br />
Piecre, J R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B88<br />
Pierre-Jacques Williams, M . . . . . . . . . . . . . . . . . . . . . . . .C109<br />
Pignone, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C107<br />
Pillemer, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C102, P42<br />
Pina, I L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P22<br />
Pinheiro, R S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C50<br />
Pinheiro, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C74, D52<br />
Pinidbunjerdkool, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A130<br />
Pinkerton, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B137<br />
Pinto, E T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C44<br />
Planoutis, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P16<br />
Platts-Mills, T F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B27<br />
Poddig, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D79<br />
Polite, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P4<br />
Pomidor, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C65*<br />
Poole, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A38<br />
Poon, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D83<br />
Poorzand, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A128<br />
Porter, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C74<br />
Powell, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D3<br />
Prager, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D78*, D143*<br />
Prakash, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D146<br />
Prerost, F J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C62*<br />
Previdi, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D127<br />
Protas, E J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D139<br />
*Indicates presenting author<br />
AGS 2012 ANNUAL MEETING<br />
S257
A UTHOR<br />
I NDEX<br />
Pschirer, J P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A71<br />
Psillides, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C2*<br />
Pugh, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B38<br />
Pugh, M J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A45<br />
Pugnaire, M . . . . . . . . . . . . . . . . . . . .A64, A68, C81, D73, D74<br />
Punjabi, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B59<br />
Putnam, B D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C14*<br />
Puymbroeck, M V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C143<br />
Quimbo, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D42<br />
Qureshi, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A161*<br />
Rabinovitch, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P19<br />
Radeos, M S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D33<br />
Radke, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A53<br />
Radwany, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D104<br />
Raetz, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D53*<br />
Ragsdale, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B28*, D35*<br />
Ragsdale, P S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D67<br />
Rahbar, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A48, B35*<br />
Rahgoshay, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A12, A20*<br />
Rahman, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C115<br />
Rahman, A S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A127<br />
Raji, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D17, D99<br />
Raju, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A166*<br />
Ramasamy, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A48, B35<br />
Ramasamy, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D146<br />
Ramaswamy, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A70*<br />
Ramirez, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B106<br />
Ramirez-Rivera, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C152<br />
Ramos, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D128<br />
Ramsaroop, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A77*, P36<br />
Ramsdale, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P4*<br />
Ramsden, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P34<br />
Ramsey, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C48*<br />
Ramsey, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A146<br />
Rana, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A13*, C85<br />
Rana, S S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A13<br />
Rand, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C104<br />
Rankin, K P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A128<br />
Rao, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P14<br />
Rashad, M A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A8*<br />
Raskin, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C36<br />
Rastogi, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C121<br />
Rasu, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A100<br />
Ratnarajah, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C30*, C40*<br />
Rawl, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B130<br />
Raymond, G L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C163<br />
Raziano, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P40<br />
Reardon, G . . . . . . . . . . . . . . . . . . . . .C54*, C93*, D122, D123<br />
Reckrey, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B18<br />
Reckrey, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D101*<br />
Recto, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C112<br />
Redding, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D7*<br />
Reddy, A K . . . . . . . . . . . . . . . . . . . . . . . . . . .A62, C61, C149*<br />
Reed, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P19<br />
Regev, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B54<br />
Rehm, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D56*, D60<br />
Reichstadt, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A25<br />
Reid, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C113, D45<br />
*Indicates presenting author<br />
S258<br />
AGS 2012 ANNUAL MEETING<br />
Reid, M C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D41, D116<br />
Reidy, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D73<br />
Reisner ( AGS-F ), M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D14<br />
Renner, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B133<br />
Renner, J B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21<br />
Rennke, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C108<br />
Resnick, N M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B81, B94<br />
Restrepo, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C150, D130<br />
Resurreccion, I P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C31*<br />
Reuben, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B112, P8<br />
Reuben, D B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B106*, P38<br />
Rhodes, R L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A60*<br />
Rianon, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A46*, A100*<br />
Richardson, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D93<br />
Richardson, J K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D80<br />
Richter, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />
Richter, H E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132*<br />
Riggs, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B130*<br />
Rigler, S K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B66<br />
Rimediotti, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />
Rimler, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B67<br />
Rios, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51<br />
Rios Rojas, L E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C100*<br />
Rios-Bedoya, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C90<br />
Ritchie, C S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D62<br />
Ritchie, E K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C38*<br />
Rittman, M R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C143<br />
Ritvo, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />
Rivara, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B131<br />
Rivera, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P39*<br />
Rivera, K B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D84*<br />
Rizzoli, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B58<br />
Robben, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A74*, A106*<br />
Roberts, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D66<br />
Roberts, J E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D41, D116*<br />
Robertson, I H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B72<br />
Robinson, M J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C36<br />
Robison, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B151<br />
Roboz, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C38<br />
Robuccio, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C81<br />
Robuccio, B L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D74<br />
Rochat, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D48<br />
Rochat, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B84<br />
Rockwood, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A122<br />
Rodgers, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A101*<br />
Rodriguez, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D106, D107<br />
Roffe, E . . . . . . . . . . . . . . . . . . . . . . . . . . .A9, B12, C3, D1, D2<br />
Rogers, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D120<br />
Rogers, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />
Roggin, K K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B171<br />
Rohan, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C38<br />
Rohner, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D114, D136<br />
Roiland, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C103<br />
Rommesser, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D12<br />
Rondina, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P20*<br />
Roos, B A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100<br />
Rosano, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B163, D157<br />
Rose, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C76<br />
Rosen, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C102*, P42<br />
Rosen, H J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A128
A UTHOR<br />
I NDEX<br />
Rosenberg, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D109<br />
Rosenberg, D E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C111<br />
Rosenthal, R A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D126<br />
Ross, G W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C53<br />
Ross, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C148, D130<br />
Ross, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B122<br />
Ross, W G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B124<br />
Rosso, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A78<br />
Roth, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B106<br />
Roth, D L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P13<br />
Rothenberg, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B117*<br />
Rothrock, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D62<br />
Rowan, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D83<br />
Rowe, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B63<br />
Roy, C N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B139<br />
Ruby, C M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B81<br />
Rudolph, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . .B83, B97, C116<br />
Rue, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B131<br />
Ruiz, M A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D90*, D91*<br />
Rummans, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D92<br />
Rush, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D59<br />
Russell, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B102<br />
Russell, M Q . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D131*<br />
Russo, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C14, D102<br />
Russo, D J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A118<br />
Russotto, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D109<br />
Rustgi, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P12*<br />
Rybar, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D65<br />
Rye, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B11<br />
Saad, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117, D129<br />
Saad, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D8<br />
Sabbagh, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D141<br />
Sabillo, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A14*<br />
Sachdeva, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C28*<br />
Sachs, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B110<br />
Sachs, G A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B144<br />
Saczynski, J S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B46<br />
Sadak, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A135*<br />
Saengwanitch, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A130<br />
Saifan, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C40<br />
Saito, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95<br />
Sajid, S S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B3*<br />
Sakely, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C85<br />
Salem, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C158<br />
Salow, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B83, C116<br />
Salter, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63<br />
Salzman, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C73*<br />
Samala, R V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A14, D160<br />
Samtani, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D76<br />
Sánchez G., E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B152<br />
Sánchez Rodríguez, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C164<br />
Sánchez Rodríguez, J L . . . . . . . . . . . . . . . . . . . . . . . . . . .D40*<br />
Sanchez-Reilly, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D130<br />
Sanders, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36*<br />
Sanders, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B40<br />
Sanders, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C62<br />
Sanders, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A86*, B90*<br />
Sanders, P W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B127<br />
Sanders, MD MS, A E . . . . . . . . . . . . . . . . . . . . . . . . . . . .C145<br />
Sandhu, S K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C87<br />
Sangarlangkarn, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B65*<br />
Sanon, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D115<br />
Santoro, G M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />
Santos, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D103<br />
Santos-Modesitt, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A149<br />
Sarkar, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C2, C56, D127<br />
Sarkar, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A134<br />
Sarzynski, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C90*<br />
Satchidanand, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B146*<br />
Satterfield, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P30<br />
Saunders, K T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D141*<br />
Sawyer, P . . . . . . . . . . . . . . . . . . . . . . . . . .A50, B92, B127, D62<br />
Scarborough, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B170*<br />
Schancupp, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D139*<br />
Schapira, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D128*<br />
Scheider, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A120<br />
Schein, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C54, C93<br />
Schers, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A74, A106, D77<br />
Schillerstrom, J E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B125<br />
Schlaudecker, J D . . . . . . . . . . . . . . . . . . . .C118, D54*, D110*<br />
Schmader, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B40, D35<br />
Schmotzer, B J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P22<br />
Schneider, E B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162<br />
Schnittker, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D98<br />
Schreiber, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D109<br />
Schubert, C C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P14*<br />
Schwartz, A V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P30<br />
Schwartz, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B144<br />
Schwartz, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B145, P6<br />
Segal-Maurer, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D102<br />
Seguin, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C27<br />
Selvage, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D79*<br />
Selwyn, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A46<br />
Seminara, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C30, C40<br />
Seminara, D P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C148<br />
Serra, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51, D39<br />
Setters, B . . . . . . . . . . . . . . . . . . . .A24, C6, C9, C10, C20, C26<br />
Severson, R . . . . . . . . . . . . . . . . . . . . . . . . . . . .A43, A44, C101<br />
Sevilla, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B80<br />
Sewell, D D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A25<br />
Shah, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B18<br />
Shah, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D15*<br />
Shah, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C115<br />
Shah, N D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A127<br />
Shah, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D86<br />
Shah, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A124, B59*<br />
Shany-Ur, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A128<br />
Sharma, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C129, P15<br />
Sharma, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />
Sharma, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C19<br />
Sharma, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B143, C29, C130<br />
Sharma, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D16<br />
Shawn, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A133<br />
Shea, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48<br />
Shega, J . . . . . . . . . . . . . . . . . . . . . . . . . . .B149*, B150*, D150*<br />
Shega, J W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B111<br />
Sheikh, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A146<br />
Shengelia, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D41<br />
Sheppard, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C160*<br />
*Indicates presenting author<br />
AGS 2012 ANNUAL MEETING<br />
S259
A UTHOR<br />
I NDEX<br />
Sheppard, K D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D62*<br />
Sherer, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A73<br />
Sheridan, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A129*<br />
Sherman, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C112<br />
Shertzer-Skinner, R . . . . . . . . . . . . . . . . . . . . . . . . . . .D36, P23<br />
Sheyner, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C32*<br />
Shi, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B133<br />
Shi, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A73*<br />
Shi, X . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21<br />
Shield, R R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A83<br />
Shier, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C127<br />
Shimonov, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />
Shipley, A J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B154<br />
Shirley, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B88*<br />
Shirley, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A133<br />
Shklar, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A165<br />
Shorr, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B49<br />
Shorr, R I . . . . . . . . . . . . . . . . . . . . . . . . .B81, B109, D105, P32<br />
Shreve, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A108<br />
Siddique, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D133<br />
Sideman, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B9<br />
Sieber, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D161<br />
Siebers, M J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D135*<br />
Siegler, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A77, P36<br />
Silliman, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B102, B167, P9<br />
Silliman, R A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P3<br />
Silverstein, J H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P27<br />
Silvestre, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D8*<br />
Simon, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B117<br />
Simon, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P32<br />
Simonsick, E . . . . . . . . . . . . . . . . . . . . . . . . .B49, B99, P29, P30<br />
Simonsick, E M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B81, B109<br />
Simonson, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C79<br />
Simpkins, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A134<br />
Simpson, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D56, D60<br />
Simpson, K M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C74<br />
Sims, R V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A50<br />
Singer, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D42<br />
Singh, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A48, B35<br />
Singh, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A26, C72<br />
Sinha, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A66<br />
Sinha, S K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B70, P34<br />
Sink, K M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A72, B48<br />
Sinvani, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D86*<br />
Sirisha, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D90<br />
Sison, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D129<br />
Sissoko, M . . . . . . . . . . . . . . . . . . . . . . . . . . .A85, B138*, D113<br />
Sithinamsuwan, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A130*<br />
Siu, A L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P43<br />
Skarf, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B83<br />
Skinner, J S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P7<br />
Skopeljia, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A88<br />
Sloane, P D . . . . . . . . . . . . . . . . . . . . . . . . . .A38, B113*, B114<br />
Sloane, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A42<br />
Smietniansky, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D128<br />
Smiley-Oyen, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B161<br />
Smith, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B98<br />
Smith, A K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B31*, D46<br />
Smith, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D146<br />
Smith, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C76<br />
*Indicates presenting author<br />
S260<br />
AGS 2012 ANNUAL MEETING<br />
Smith, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C117<br />
Smith, S G . . . . . . . . . . . . . . . . . . . . . . . . .A75, A76, A79, B111<br />
Smith, S M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D26<br />
Smoller, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B120<br />
Snyder, E A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B20*<br />
Snyder, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D76<br />
Snyderman, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C73<br />
Sobel, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A43, A44<br />
Sobie, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A140<br />
Soch, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A59<br />
Solberg, L B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D154<br />
Solberg, L M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D154*<br />
Somogyi, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />
Song, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C62<br />
Sori, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />
Soria, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51, D39<br />
Soryal, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D118<br />
Soto, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C77*<br />
Speechley, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D88<br />
Speice, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B62<br />
Spencer, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D48<br />
Spencer, F A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B46<br />
Spencer, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A113<br />
Spini, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />
Spira, A P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C48<br />
Spritzler, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B141<br />
Sreenivas, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A157<br />
Stallard, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C114<br />
Staskin, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C35<br />
Stecher, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D110<br />
Stecher, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C118*<br />
Steel, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C2, C56<br />
Steimle, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D112*<br />
Stein, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B67<br />
Stein, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B96*<br />
Steinman, M . . . . . . . . . . . . . . . . . . . . . . . . . . .B87, C108, D43*<br />
Steinman, M A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B85<br />
Stephens-Kelly, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D114<br />
Stessman, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B134, D145*<br />
Steven, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D60<br />
Stevens, A B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D111<br />
Stevens, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D85<br />
Stevens, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D53<br />
Stewart, J T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C32<br />
Stieglitz, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A60<br />
Stijacic-Cenzer, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P1<br />
Stoll, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D149<br />
Stone, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C49<br />
Stotts, A L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D26<br />
Stover, K T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C32<br />
Strauss, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D122, D123<br />
Strauss, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D42*<br />
Streiner, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />
Strohmaier, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />
Strong, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B123<br />
Strotmeyer, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B49<br />
Strotmeyer, E S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B109, P30<br />
Studenski, S . . . . . . . . . . . . . . . . . . . . . . . . . . . .B96, B166, P24<br />
Studenski, S A . . . . . . . .A158, A159, B79, B156, B163, B165,<br />
C133, D28, D157, D159, P30
A UTHOR<br />
I NDEX<br />
Stump, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B110<br />
Styer, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D65<br />
Subak, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P25<br />
Sudore, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D6<br />
Sudore, R L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P5*<br />
Suelzer, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P14<br />
Suemoto, C K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A81<br />
Suen, W . . . . . . . . . . . . . . . . . . . . . . . . .A85*, D47, D54, D113<br />
Suh, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D114<br />
Suh, T T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A23*, B9<br />
Sulapas, I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D5*<br />
Sullivan, D H . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B159*, B164<br />
Sun, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />
Sun, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A165*<br />
Sunday, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117, C63<br />
Supiano, M A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A82<br />
Suraj, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A133*<br />
Suriyaarachchi, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P15<br />
Sustakoski, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B156*<br />
Sutter, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P14<br />
Suzuki, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95<br />
Swami, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A53*<br />
Swanson, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B161, C115<br />
Swanson, K M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A127<br />
Sweeney, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P39<br />
Sy, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D1<br />
Sychangco, P D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D102<br />
Syed, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A127, C115*<br />
Syed, Q . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A10*, C55<br />
Szerszen, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C30, C40, C148<br />
Szychowski, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132<br />
Szydlowski, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P40<br />
Tadd, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C131<br />
Taffet, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D83<br />
Taffet, G E . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A62, C61, C149<br />
Taffet, J D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C61<br />
Tai, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A124<br />
Takahashi, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C115<br />
Takahashi, P Y . . . . . . . . . . . . . . . . . . . . . . . . . .A127, B23, B24<br />
Takenaka, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B157<br />
Talati, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A69<br />
Talebreza, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D54<br />
Talsania, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A1<br />
Tamblyn, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B77<br />
Tamura, B K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B68<br />
Tan, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B107<br />
Tan, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D121*<br />
Tan, R S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C22<br />
Tan, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D121, D132<br />
Tancredi, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C88<br />
Tank, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C2, C56, D127<br />
Tannenbaum, C . . . . . . . . . . . . .B25, B77*, C35*, C137*, D87<br />
Tanner, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B124<br />
Tariot, P N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D141<br />
Tay, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D132<br />
Taylor, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B162<br />
Taylor, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37, C41<br />
Tegeler, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A99*, B64<br />
Temkin-Greener, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P40<br />
Tena-Nelson, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D103<br />
Teng, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A136<br />
Teodoro, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A6<br />
Teodoro, C D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C18*<br />
Teresi, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C102, P42<br />
Terrien, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C81<br />
Terrin, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B168<br />
Terriquez, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A145<br />
Thai, J N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D46*, D96*<br />
Thaipisuttikul, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A139<br />
Thembani, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C129<br />
Thomas, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B121<br />
Thomas, L M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D146*<br />
Thomas, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117<br />
Thompson, H J . . . . . . . . . . . . . . . . . . . . . . . . . . . .B131*, C94*<br />
Thompson, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D59*<br />
Thornton, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B7<br />
Thorpe, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B99<br />
Thorud, J L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D111*<br />
Tian, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B160<br />
Tidwell, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D130<br />
Tillou, A K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A57<br />
Tilsley, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C163*<br />
Tims, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A48, B35<br />
Tingus, K D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A136<br />
Tiwari, S C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A157<br />
Tjia, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B22*, C106, D38<br />
Tocco, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D31*<br />
Toffanello, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />
Tomlinson, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />
Tong, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C35<br />
Tooze, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48, D36, P23<br />
Toscano, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A54, A55<br />
Toussi, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C133*<br />
Towle, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B52<br />
Towle, V R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D140<br />
Trahan, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D142<br />
Trieu, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C127*<br />
Trochimowicz, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C132<br />
Troke, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B144*<br />
Trotti, L M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B76<br />
True, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D72<br />
Truong, T N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D140<br />
Tryzelaar, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D16*<br />
Tsai, E C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />
Tseng, T J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A93*<br />
Tu, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B110, P44<br />
Tubach, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A33<br />
Tucker, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C9*<br />
Tulsky, J A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D97<br />
Tumosa, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C142<br />
Tuqan, A T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P38*<br />
Turker, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P16*<br />
Turner, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B75*<br />
Turner, B J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B38<br />
Turner, M S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B129<br />
Turpie, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D164<br />
Twersky, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B118<br />
Tyagi, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B94*<br />
*Indicates presenting author<br />
AGS 2012 ANNUAL MEETING<br />
S261
A UTHOR<br />
I NDEX<br />
Ukritchon, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A130<br />
Umland, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C76<br />
Unroe, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B110*<br />
Unverzagt, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A88<br />
Uphold, C R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C143*<br />
Urban, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D102<br />
Valades, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51, D39<br />
Valcour, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B87<br />
Valley, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P6<br />
Valone, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C62<br />
Valoti, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />
van den Heuvel, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B25<br />
Van Hala, S N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A82<br />
van Kempen, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D77*<br />
Van Ness, P H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P2<br />
van Nieuwenhuijzen, L . . . . . . . . . . . . . . . . . . . . . . . . . . . .A74<br />
van Reenen, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P40<br />
Van Son, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A151<br />
Van Son, C R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C155*<br />
Van Swearingen, J M . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B163<br />
van Zuilen, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D69*<br />
Vanguri, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A68<br />
vanLondon, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B96<br />
VanSwearingen, J . . . . . . . . . . . . . . . . . . . . . .B79, B161, B166<br />
VanSwearingen, J M . . . . . . . .A158, B156, D157*, D159, P24<br />
Varma, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A9<br />
Vassar, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B105<br />
Vassar, S D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A98<br />
Vasudev, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D60<br />
Vaughan, C P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B76*, C84*<br />
Vaynshteyn, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C40<br />
Vela, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />
Vernon, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P19<br />
Verrall, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C158, D158<br />
Verrall, A M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D156<br />
Verscheure, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P34<br />
Vest, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P22<br />
Vickrey, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B105<br />
Vidal, E I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C50*<br />
Vidán, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D39<br />
Vidan - Astiz, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51<br />
Vidán A., M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B152<br />
Vig, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B51*<br />
Vij, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B143<br />
Villareal, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A78<br />
Villarreal, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D130<br />
Villas Boas, P J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C50<br />
Vitale, C A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C59<br />
Voisine, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A2<br />
Volbrecht, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C99<br />
von Humboldt, S . . . . . . . . . . . . . . . . . . . . . . . . .A152*, A153*<br />
Wagle, K C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D83*<br />
Waite, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A138<br />
Walder, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155<br />
Walke, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D11<br />
Walke, L M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D126*<br />
Walker, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A7*<br />
Walston, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B55, B61<br />
*Indicates presenting author<br />
S262<br />
AGS 2012 ANNUAL MEETING<br />
Walter, B K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />
Walter, L C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D46, P1<br />
Wan, Z . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C1<br />
Wang, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B56<br />
Wang, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P41<br />
Ward, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C119<br />
Washington, F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A115<br />
Wasilenko, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B155<br />
Wasmund, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B90<br />
Wasmund, S L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A86<br />
Wasserman, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D33<br />
Waters, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A112<br />
Waters, T M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P32<br />
Watkins, F S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D61<br />
Watson, G S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />
Wayne, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B86<br />
Webb, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D60<br />
Weber, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P45<br />
Wee, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P41*<br />
Wei, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D147<br />
Wei, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A102, B153<br />
Weiner, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B149, D150<br />
Weiner, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B130<br />
Weingast, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D103<br />
Weintraub, N T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P38<br />
Weir, C R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A82<br />
Wellens, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D32<br />
Wenger, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B112, P8<br />
Wenger, N S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B106<br />
Wert, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B166, P24<br />
Wessel, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D56, D60<br />
Wessell, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B63<br />
Westmoreland, G R . . . . . . . . . . . . . . . . . . . . . . . . . . .A84, B64<br />
Westphal, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D37*<br />
Wetle, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A83<br />
Wey, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B123<br />
Weyrich, A S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P20<br />
Wheaton, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D16<br />
White, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C45<br />
White, S E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D46<br />
White-Chu, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C78*<br />
Whitehead, W E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B129<br />
Whitehouse, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D71<br />
Whitson, H E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A42, B40<br />
Wieland, G D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C114*<br />
Wieman, M S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A34*, A35*<br />
Wierman, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C165*<br />
Wiggins, J E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D125<br />
Wilkinson, C W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />
Williams, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A70<br />
Williams, B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C105*<br />
Williams, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D91<br />
Williams, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37<br />
Williams, G R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C41*<br />
Williams, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A121<br />
Williams, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A75, A76, A79*<br />
Williams, PhD, S W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A36<br />
Williamson, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48, D61<br />
Williamson, J D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D36, P23<br />
Willmore, C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D119
A UTHOR<br />
I NDEX<br />
Wilson, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D66*<br />
Wilson, N L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B54<br />
Wilson, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B171<br />
Wilson, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48*<br />
Windham, B G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P29<br />
Winter, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B102, P9<br />
Winzelberg, G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B63, D66<br />
Wirt, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D22*<br />
Wirtz, H S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P31*<br />
Witt, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D60<br />
Wo, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A132*<br />
Wolf-Klein, G . . . .A117, B143, C57, C130, D86, D129, D155<br />
Wolmark, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A33*<br />
Wong, C L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B136<br />
Wong, J W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B135*, D144*<br />
Wong, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A129<br />
Wong, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C86<br />
Wongvarcharoen, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B122<br />
Wood, R C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C47<br />
Woods, N F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A150*, B44<br />
Wright, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C132<br />
Wright, R M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A71*<br />
Wroe, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B91*<br />
Wu, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C43*<br />
Wu, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C52<br />
Wyman, J F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />
Xuan, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A60<br />
Yadlosky, L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A132<br />
Yaffe, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A149<br />
Yamaguchi, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B60<br />
Yan, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A98<br />
Yanamadala, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B118<br />
Yang, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B55<br />
Yang, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P30<br />
Yang, Z . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A40<br />
Yao, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B126<br />
Yazdani, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D73<br />
Ye, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A31*, A115<br />
Yechoor, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A62<br />
Yeh, C S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C161<br />
Yeh, V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A160*<br />
Yeo, C Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C86*<br />
Yeung, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C27<br />
Yin, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B70*<br />
Yorkston, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D158*<br />
Yoshida, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95<br />
Yoshida, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95<br />
Young, B A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C159, D152<br />
Young, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A101<br />
Young, L J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C143<br />
Young, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A85, D113<br />
Young, M E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D47*<br />
Yuasa, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B68*<br />
Yuen, J K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D6*<br />
Yulico, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A165<br />
Zaas, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B40<br />
Zafar, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A80<br />
Zaffarana, N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />
Zafirau, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D108<br />
Zaldana, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D159*<br />
Zamrini, E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B10<br />
Zanetti, M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A64, C81, D73<br />
Zaslavsky, O . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A150, B44*<br />
Zeballos, P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A66<br />
Zelaya, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D63<br />
Zerah, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A33<br />
Zhang, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C1, P18<br />
Zhang, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A154<br />
Zhang, X . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C1<br />
Zheng, Y . . . . . . . . . . . . . . . . . . . . . .B49, B81, B96, B109, D28<br />
Zhou, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C90<br />
Zickmund, S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B79<br />
Zierath, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B131<br />
Zimmerman, G A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P20<br />
Zimmerman, K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B83*<br />
Zimmerman, S . . . . . . . . . . . . . . . . . . . . . . . .A38, B113, B114*<br />
Zirker, W . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B73<br />
Zitnay, R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B15*<br />
Zitnay, R M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A85, D113<br />
Zmudka, J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D25*<br />
Zone, J J . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B135<br />
Zulifiqar, A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B75<br />
Zweig, Y . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A139*<br />
*Indicates presenting author<br />
AGS 2012 ANNUAL MEETING<br />
S263
K EYWORD<br />
25-hydroxyvitamin D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P23<br />
30 day readmission . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B102<br />
α-synuclein . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B123<br />
AAMC Geriatric Competencies . . . . . . . . . . . . . . . .A75, A79<br />
Accelerometer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B165<br />
Access . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A108, A127<br />
Accidental Falls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P32<br />
ACE inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B85<br />
Ace unit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D114<br />
Acetylcholinesterase inhibitors . . . . . . . . . . . . . . . . . . . . .D82<br />
ACGME Competencies . . . . . . . . . . . . . . . . . . . . . . . . . . .D61<br />
ACGME competency . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A70<br />
Achalasia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A7<br />
Acinetobacter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C152<br />
ACOVE measures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D35<br />
Actinomyces israelli . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D3<br />
Action Potential Duration . . . . . . . . . . . . . . . . . . . . . . . .A140<br />
Activity of Daily Living . . . . . . . . . . . . . . . . . . . . . . . . . . . .B33<br />
Acupuncture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C2<br />
Acute . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D118<br />
Acute Care . . . . . . . . . . . . . . . . . . . . . . . . . . .C51, D115, D135<br />
Acute Care consults . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A120<br />
Acute care transfers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A115<br />
Acute coronary syndromes . . . . . . . . . . . . . . . . . . . . . . . . .B41<br />
Acute illness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D39<br />
Acute leukemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C38<br />
Acute musculoskeletal pain . . . . . . . . . . . . . . . . . . . . . . . .B27<br />
Adenocarcinoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C17<br />
Adjustment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A152, A153<br />
ADLs/IADLs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B98<br />
Admission . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D33<br />
ADR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C100<br />
Adult Protective Services . . . . . . . . . . . . . . . . . . . . . . . . . .B93<br />
Adult Still’s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B17<br />
Advance care planning . . . .A80, B52, B53, B63, B101, B104,<br />
C58, C75, P5<br />
Advance directive . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C59<br />
Advanced care planning . . . . . . . . . . . . . . . . . . . . . . . . . . .D21<br />
Adverse health outcomes . . . . . . . . . . . . . . . . . . . . . . . . . .A93<br />
Advocacy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C105<br />
African <strong>American</strong> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D95<br />
Age . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D80<br />
Age differences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A166<br />
Aged . . . . . . . . . . . . . . . .A33, A54, A90, A96, B49, B109, C46<br />
Aggression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P42<br />
Aging . . . . . . . . .A49, A152, B55, B60, B79, C39, C158, D156,<br />
D158, P5, P30<br />
Aging research . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P16<br />
Alcohol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A57, D137<br />
Aldosteronism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B8<br />
ALLOPURINOL . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A11, C5<br />
ALS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A13<br />
Altered mental status . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C16<br />
Alzheimer’s disease . . . . . . . . .A129, A134, C141, C162, D25,<br />
D27, D31, P18<br />
Ambulatory Curriculum . . . . . . . . . . . . . . . . . . . . . . . . . . .A65<br />
Amiodarone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D1<br />
Amputation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C12<br />
I NDEX<br />
Amyloid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C3, P18<br />
Amyloid-beta . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A131<br />
Analgesia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B27<br />
Anatomy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A68<br />
Anemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C87<br />
Anemia of inflammation . . . . . . . . . . . . . . . . . . . . . . . . . .B139<br />
Anesthesia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C40<br />
Anesthesiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P27<br />
Anesthetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C144<br />
Angiodysplasia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A6<br />
Angiomyolipoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C30<br />
Animal model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B58<br />
Anosognosia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A128<br />
Antibiotic Resistance . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C101<br />
Antibiotic resistant organisms . . . . . . . . . . . . . . . . . . . . . .B39<br />
Antibiotic Stewardship . . . . . . . . . . . . . . . . . . . . . .C101, D102<br />
Antibiotics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C150<br />
Antibiotics use . . . . . . . . . . . . . . . . . . . . . . . . . .A43, A44, C49<br />
Anticholinergic medications . . . . . . . . . . . . . . . . . . . . . . .B168<br />
Anticholinergics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C35, P31<br />
Anticoagulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C71<br />
Antipsychotics . . . . . . . . . . . . . . . . . . . .A101, B22, C106, D37<br />
Anxiety . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A103, C20<br />
Aortic impedance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C149<br />
Apache score . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C152<br />
Aphasia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A22<br />
ApoE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36<br />
Apolipoprotein E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P18<br />
Apoptosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A129<br />
Appropriate documentation . . . . . . . . . . . . . . . . . . . . . . . . .A2<br />
Arrhythmia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A17, A140<br />
Arterial stiffness . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C61, C149<br />
Arteriovenous malformation . . . . . . . . . . . . . . . . . . . . . . . .A9<br />
Arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B92, C25<br />
Arthroplasty . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D164<br />
Asian . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A97<br />
Aspergilloma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A23<br />
Aspirin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D143<br />
Assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C77, D52<br />
Assessment Tools . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B70<br />
Ataxia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D4<br />
Atheroclerosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36<br />
Athlete . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A27<br />
Atrial fibrillation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B12<br />
Atrial Fibrillation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C45<br />
Attention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D28<br />
Atypical antipsychotic . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D79<br />
AUSCAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21<br />
Autoimmune skin disease . . . . . . . . . . . . . . . . . . . . . . . . .B135<br />
Autoinmune . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C8<br />
Automobile driving . . . . . . . . . . . . . . . . . . . . . . .A49, B145, P6<br />
Autonomic dysfunction . . . . . . . . . . . . . . . . . . . . . . . . . . . .B90<br />
Autophagy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P17<br />
B 12 deficiency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A58<br />
Babesiosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B14<br />
Back Pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P28<br />
Balance confidence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B96<br />
Barriers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C57<br />
Basal Insulin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A102<br />
S264<br />
AGS 2012 ANNUAL MEETING
K EYWORD<br />
I NDEX<br />
Behavioral intervention . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P9<br />
Behavioral Symptoms of Dementia . . . . . . . . . . . . . . . . .B118<br />
Benzodiazepines . . . . . . . . . . . . . . . . . . . . . . . . . . . .A101, B89<br />
Bereavement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D130<br />
Bilateral . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B9<br />
Bilingualism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D11<br />
Biomarker . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21, B59<br />
Biomarkers . . . . . . . . . . . . . . . . . . . . . . . . . . . .B133, C62, D93<br />
Bipolar disorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C48<br />
Bisphosphonates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C27<br />
Bladder dysfunction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C35<br />
Blisters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C8<br />
Blood pressure . . . . . . . . . . . . . . . . .A26, A132, C44, D44, P29<br />
BMI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D75<br />
Bone metastases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B126<br />
Bone mineral density . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51<br />
Bone Mineral Desity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B23<br />
BOO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B136<br />
Botulinum toxin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A7<br />
BPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B136<br />
BPSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C42<br />
Bradycardia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A62, D147<br />
Brain imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D157<br />
Brain mapping . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C141<br />
Brain Tumors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A25, D23<br />
Breast cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D91, P3<br />
Breast Implant Herniation . . . . . . . . . . . . . . . . . . . . . . . . .D17<br />
Built environment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C111<br />
Bullous pemphigoid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B135<br />
C-reactive protein . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C88<br />
C.diff . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D14<br />
CADASIL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A24<br />
Calcium channel blocker . . . . . . . . . . . . . . . . . . . . . . . . . . .B60<br />
Caloric-restriction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P19<br />
Cancer . . . . . . . . . . . . . . . . . . . . . . . .A155, B51, B91, B96, C41<br />
Cancer screening . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B144<br />
Capacity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B54<br />
Capacity to consent . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A159<br />
Capgras syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A139<br />
Cardiac . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A160<br />
Cardiac aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B142<br />
Cardiac amyloidosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D8<br />
Cardiac function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D145<br />
Cardiac surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A164<br />
Cardiothoracic surgery . . . . . . . . . . . . . . . . . . . . . . . . . . .A166<br />
Cardiovascular . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C61<br />
Cardiovascular Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . .B48<br />
Cardiovascular Medications . . . . . . . . . . . . . . . . . . . .B81, C43<br />
Care coordination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P41<br />
Care management . . . . . . . . . . . . . . . . . . . . . . . . . .A113, C109<br />
Care transition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A127, P41<br />
Care Transitions . .A126, B67, B103, C103, C115, C116, D111<br />
Caregiver . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C143, D112<br />
Caregiver burden . . . . . . . . . . . . . . . . .B151, C86, D101, D154<br />
Caregiver experience . . . . . . . . . . . . . . . . . . . . . . . .B151, C113<br />
Caregiver health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C113<br />
Caregiver stress . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C91, D85<br />
Caregivers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B98<br />
Caregiving . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D85<br />
Case Report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A8, C17<br />
Case study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D5<br />
Case-based learning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B65<br />
Catheter Directed Thrombolysis (CDT . . . . . . . . . . . . . .A18<br />
Cause of death . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A56<br />
Cellular senescence . . . . . . . . . . . . . . . . . . . . . . . . . . .B56, P21<br />
Census Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D108<br />
Cerebral . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C3<br />
Cerebral cortical thickness . . . . . . . . . . . . . . . . . . . . . . . .A132<br />
Charles Bonnet Syndrome . . . . . . . . . . . . . . . . . . . . . . . . .D92<br />
Charlson index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B95<br />
Chemotherapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C38<br />
CHF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C148<br />
Chief resident . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P37<br />
China . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A73<br />
Cholinesterase inhibitor . . . . . . . . . . . . . . . . .D27, D83, D147<br />
Cholinesterase inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . .C32<br />
Chronic ankle pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D5<br />
Chronic bronchiectasis . . . . . . . . . . . . . . . . . . . . . . . . . . . .A23<br />
Chronic care model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A125<br />
Chronic disease . . . . . . . . . . . . . .A108, B49, C104, D30, D106<br />
Chronic disease management . . . . . . . . . . . . . . . . . . . . . .D100<br />
Chronic hip pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C147<br />
Chronic Illness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A154, B53<br />
Chronic kidney disease . . . . . . . . . . .B111, B127, B128, D152<br />
Chronic obstructive pulmonary disease . . . . . . . . . . . . . . .B45<br />
Chronic pain . . . . . . . . . . . . . . . . . . . . . . . . . . .A166, B38, D45<br />
Citalopram . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D7<br />
Clinical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C19<br />
Clinical Course . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C150<br />
Clinical Economics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P10<br />
Clinical outcome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B137<br />
Clinical trial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A149, C34<br />
Clinical Trials . . . . . . . . . . . . . . . . . . . . . . . . . . .A94, B25, D141<br />
Clinics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P15<br />
Clostridium difficile . . . . . . .B137, C37, D9, D42, D122, D123<br />
CNS aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A137<br />
Co-management program . . . . . . . . . . . . . . . . . . . . . . . . .D126<br />
Co-morbidity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B112, P8<br />
Cochlear implantation . . . . . . . . . . . . . . . . . . . . . . . . . . . .B169<br />
Code status . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B65<br />
Code Status Discussions . . . . . . . . . . . . . . . . . . . . . . . . . . .A59<br />
Cognition . . . . . . . . . . . . . . . . . . . . . . . . .C136, D28, D31, D88<br />
Cognitive Abilities Screening Instrument . . . . . . . . . . . . .D11<br />
Cognitive assessment . . . . . . . . . . . . . . . . . . . . . . . .B108, D11<br />
Cognitive Complications . . . . . . . . . . . . . . . . . . . . . . . . . .A163<br />
Cognitive decline . . . . . . . . . . . . . . . . . . . . . . .C21, C133, C137<br />
Cognitive Dysfunction . . . . . . . . . . . . . . . . . . . . . . . . . . . .D161<br />
Cognitive function . . . . . . . . . . .A107, A159, B32, B122, B166<br />
Cognitive impairment . . . . . .A47, A56, A88, A123, B46, B47,<br />
B78, C89, D140<br />
Cognitive screening . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D119<br />
Cognitive tests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A50<br />
Cognitive-motor interference . . . . . . . . . . . . . . . . . . . . . .C163<br />
Collaboration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A74<br />
Collaborative care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A114<br />
Collagen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P19<br />
Colon cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A28, B130<br />
Colon cancer prevention . . . . . . . . . . . . . . . . . . . . . . . . . . .P16<br />
Colorectal Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P4<br />
AGS 2012 ANNUAL MEETING<br />
S265
K EYWORD<br />
I NDEX<br />
Colorectal cancer screening . . . . . . . . . . . . . . . . . . . . . . .C107<br />
Communication . . . . . . . . . . . . . . . . . . . . . . . .A151, B100, C66<br />
Communication skills . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A70<br />
Community . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B54<br />
Community dwelling elderly . . . . . . . . . . . . . . . . . . . . . . . .D43<br />
Community Education . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C75<br />
Community partnerships . . . . . . . . . . . . . . . . . . . . . . . . . .D111<br />
Community programs . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D72<br />
Community-dwelling elderly . . . . . . . . . . . . . . . . . . .B80, D36<br />
Comorbidities . . . . . . . . . . . . . . . . . . . . .B45, B129, D38, D139<br />
Comorbidity . . . . . . . . . . . . . . . . . . . . . . . . . . . .B42, B167, C82<br />
Comorbidity index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B95<br />
Competence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D57<br />
Competency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C65<br />
Complex patient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P43<br />
Complexity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A84, C72<br />
Complications of hospitalization . . . . . . . . . . . . . . . . . . . .D68<br />
Comprehensive Geriatric Assessment . .C164, D40, D163, P4<br />
Computational Models . . . . . . . . . . . . . . . . . . . . . . . . . . .A140<br />
Computerized Cognitive Assessment . . . . . . . . . . . . . . .C140<br />
Confusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D4<br />
Congestive heart failure . . . . . . . . . . . . . . . . . . . . . . . . . .D140<br />
Congnitive impairement . . . . . . . . . . . . . . . . . . . . . . . . . .C134<br />
Conjoint analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C107<br />
Constipation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A3<br />
Consultation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A113<br />
Consultation Service . . . . . . . . . . . . . . . . . . . . . . . .A116, A120<br />
Consults . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D135<br />
Consumer-targeted information . . . . . . . . . . . . . . . . . . . . .B77<br />
Continence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B25<br />
COPD severity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B45<br />
Copyright . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B108<br />
Coronary Artery Disease . . . . . . . . . . . . . . . . . . . . . . . . . .D17<br />
Cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A108<br />
Cost-effectiveness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P45<br />
COVE-PIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A64<br />
CPOE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C100<br />
Creutzfeldt-Jakob disease . . . . . . . . . . . . . . . . . . . . . . . . . .B10<br />
Cryptococcal Meningoencephalitis . . . . . . . . . . . . . . . . . .C31<br />
CSF protein 14.3.3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B10<br />
CT scan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B140<br />
Curriculum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A69, B68, C68<br />
Curriculum evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P35<br />
Curriculum in skin and wound care . . . . . . . . . . . . . . . . . .C78<br />
Deacetylase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P17<br />
Death at home . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D107<br />
Decision making . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B144<br />
Decision making capacity . . . . . . . . . . . . . . . . . . . . . . . . . .C60<br />
Decision-making . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B20, P5<br />
Decision-making capacity . . . . . . . . . . . . . . . . . . . . . . . . . . .D6<br />
Deep vein thrombosis (DVT . . . . . . . . . . . . . . . . . . . . . . .A18<br />
Delirium . . . . .A165, B83, B119, B168, C23, C80, C146, D40,<br />
D57, D66, D83, D115, D127, D132<br />
Delirium screening . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B29<br />
Demented Parents, Stress . . . . . . . . . . . . . . . . . . . . . . . . .D154<br />
Dementia . . . .A22, A39, A40, A99, A107, A130, A135, A138,<br />
A157, B20, B50, B105, B121, B122, B125, B148, C5, C11,<br />
C14, C18, C20, C21, C32, C42, C89, C91, C117, C138, C142,<br />
C145, D2, D10, D20, D38, D83, D129, D142, D147, D148,<br />
D150, D153<br />
Dementia behaviors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C102<br />
Dementia care . . . . . . . . . . . . . . . . . . . . . . . .B118, C119, D138<br />
Dementia with Lewy Bodies . . . . . . . . . . . . . . . . . . . . . . .A139<br />
Demetia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C19<br />
Demyelinating . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A16<br />
Dental care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A39<br />
Dental residency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C68<br />
Depression . . . . . . . . . .A114, C9, C18, C55, C88, C143, D128<br />
Depressive symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B26<br />
Design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D95<br />
Desire for hastened death . . . . . . . . . . . . . . . . . . . . . . . . . .D48<br />
Diabetes . . . . . . . . . .A50, A102, B140, C112, D15, D94, D152<br />
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C159<br />
Diagnosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A33, B136<br />
Diastolic dysfunction . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B142<br />
Diastolic function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A62<br />
Diclofenac . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A34<br />
Dietary vitamin D intake . . . . . . . . . . . . . . . . . . . . . . . . . . .C53<br />
Diffuse Lewy Body Dementia . . . . . . . . . . . . . . . . . . . . . .B13<br />
Diphragmatic Hernia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D24<br />
Direct observation . . . . . . . . . . . . . . . . . . . . . . . . . . . .C66, P36<br />
Disability . . . .B31, B33, B158, B160, C52, C158, D156, D158<br />
Discharge Communication . . . . . . . . . . . . . . . . . . . . . . . .C103<br />
Disruptive Behavior . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D142<br />
Driving . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D155<br />
Driving assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A133<br />
Driving cessation . . . . . . . . . . . . . . . . . . . . . . . . . . . .A49, B145<br />
Driving clinic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A133<br />
Driving safety . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D65<br />
Drug addiction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A10<br />
Drug prescribing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D35<br />
Drug Reaction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C7<br />
Drug-induced stuttering . . . . . . . . . . . . . . . . . . . . . . . . . . .A14<br />
Dual eligible population . . . . . . . . . . . . . . . . . . . . . . . . . .A125<br />
Dual Stiffness flooring . . . . . . . . . . . . . . . . . . . . . . . . . . . .B162<br />
Dual-tasks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D89<br />
Duloxetine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C36<br />
Duodenum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D146<br />
Dynapenia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B2<br />
Dysphagia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B18, C25<br />
E-learning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C80<br />
Early intervention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C131<br />
Early Onset Dementia . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A24<br />
Early readmission . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D43<br />
Earthquiake . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C42<br />
Echocardiography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D145<br />
Economic burden . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D42<br />
ECT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C18<br />
Education . . . .A67, A72, A73, A81, B67, B69, B70, C64, C71,<br />
C72, C74, C77, C98, C106, D57, D66, P34<br />
Education in nursing home care . . . . . . . . . . . . . . . . . . . .A115<br />
Education of med. students, residents and fellows . . . . .D110<br />
Educational assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . .D64<br />
Educational innovation . . . . . . . . . . . . . . . . . . . . . . . . . . . .D56<br />
S266<br />
AGS 2012 ANNUAL MEETING
K EYWORD<br />
I NDEX<br />
Educational intervention . . . . . . .B101, D56, D60, D85, D136<br />
Effectiveness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D50<br />
Elder abuse . . . . . . . . . . . . . . . . . . . . . . . . . . . .B125, C156, P42<br />
Elder mistreatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C102<br />
Elder Self Neglect . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B75<br />
Elder Self-Neglect . . . . . . . . . . . . . . . . . . . . . . . . . . . .B93, D26<br />
Elderly . . . . . .A5, A27, A31, A34, A95, A147, B14, B73, C15,<br />
C40, C71, C98, C112, C160, D42, D90, D91, D121, D124<br />
ElderQuest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C65<br />
Elective joint replacement . . . . . . . . . . . . . . . . . . . . . . . .D143<br />
Electronic Medical Record . . . . . . . . . . . . . . .B23, B24, C123<br />
Electronic medical records . . . . . . . . . . . . . . . . . . . . . . . .B104<br />
Emergencies . . . . . . . . . . . . . . . . . . . . . . . . . . . .A54, A55, D34<br />
Emergency . . . . . . . . . . . . . . . . . . . . . . . . . . . .B170, C122, D33<br />
Emergency department . . . . . . . . .A40, A41, B29, B30, D115<br />
Emergency medicine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A42<br />
Emotion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D153<br />
Emotionalism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D84<br />
EMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D34<br />
Encepalitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A17<br />
Encephalopathy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B11, D12<br />
End of life . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B98, C57<br />
End of life care . . . . . . . . . . . . . . . . . . . . . . . . .A151, B52, D97<br />
End of life decision making . . . . . . . . . . . . . . . . . . . . . . . . . .P2<br />
End of life pain control . . . . . . . . . . . . . . . . . . . . . . . . . . . .C28<br />
End stage renal disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A9<br />
End-of-life . . . . . . . . . . . . . . . . . . . . . . . . .A19, B31, C13, D46<br />
End-of-life care . . . . . . . . . . . . . . . . . . . . . . . .B154, C14, D134<br />
Endothelial senescence . . . . . . . . . . . . . . . . . . . . . . . . . . . .B60<br />
Enrollment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B150<br />
Epidemiology . . . . . . . . . . . . . . . . . .B46, B127, D37, D44, P32<br />
Epidural abscess . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C16<br />
Erythroid maturation . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B139<br />
Ethical conflicts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C14<br />
Ethics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A19, C60<br />
Ethnic/Racial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A46<br />
Ethnogeriatrics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A32<br />
Evacuation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B121<br />
Evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D51<br />
Evaluation of fellowship programs . . . . . . . . . . . . . . . . . . .P38<br />
Evidence Based Medicine . . . . . . . . . . . . . . . . . . . . . . . . . .D69<br />
Evidence based practice . . . . . . . . . . . . . . . . . . . . . . . . . . .C79<br />
Excimer laser . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D144<br />
Executive Dysfunction . . . . . . . . . . . . . . . . . . . . . . . . . . .A123<br />
Executive Function . . . . . . . . . . . . . . . . . . . . . . . . . .B93, B163<br />
Exercise . . . . . . . . . . . . . . . . . . . . .A149, A160, C95, D28, P24<br />
Factitious disorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D20<br />
Factor Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C46<br />
Faculty Development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D74<br />
Fail elderly . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C10<br />
Failure to thrive . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A8<br />
Fall . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P33<br />
Fall injury prevention . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B162<br />
Fall prevention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D114<br />
Fall reduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D114<br />
Fall Risk Assessment . . . . . . . . . . . . . . . . . . . . .A72, C94, D89<br />
Falls . . . . . . .A138, A147, B28, B72, B82, B88, C36, C74, C77,<br />
D76, D78, D81, D88, D139, P15, P23, P31, P45<br />
Falls prevention . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C79, C127<br />
Falls risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D36, P29<br />
Family . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A151, C21<br />
Family caregiver . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A61<br />
Family members . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D155<br />
Family members’ perceptions . . . . . . . . . . . . . . . . . . . . . .C155<br />
Family-centered . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C118<br />
Fear of falling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B166<br />
Feeding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B20<br />
Fellow education . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A85, D64<br />
Female urinary incontinence . . . . . . . . . . . . . . . . . . . . . . .D16<br />
Ferritin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B138<br />
Fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B5, B113<br />
Finger-stick burden . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B153<br />
Focus Groups . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D158<br />
Foley Catheter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A146<br />
Food access . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C111<br />
Foot . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C12<br />
Foreign-born elders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A32<br />
Fracture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A20, A51, D148<br />
Fractures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C129, P15, P31<br />
Fragility fractures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A156<br />
Frail . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />
Frail elderly . . . . . . . . . . . . . . . . . . . . . . . . . . . .A74, A106, D41<br />
Frail older adults . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D104<br />
Fraility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C122<br />
Frailty . . . . .A87, A93, A122, A164, B58, B61, B74, B78, B86,<br />
C82, C83, D59, D75, D77, D90, D93, D94<br />
Frontotemporal Dementia . . . . . . . . . . . . . . . . . . . . . . . .A128<br />
Functional ability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C155<br />
Functional Assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . .A37<br />
Functional assessment OSCE . . . . . . . . . . . . . . . . . . . . . . .A82<br />
Functional decline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D39<br />
Functional disparities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B99<br />
Functional gastrointestinal disorder . . . . . . . . . . . . . . . . .B129<br />
Functional history taking . . . . . . . . . . . . . . . . . . . . . . . . . .A76<br />
Functional Impairment . . . . . . . . . . . . . . . . . . . . . . . . . . . .B31<br />
Functional Independence Measure . . . . . . . . . . . . . . . . .C138<br />
Functional Performance . . . . . . . . . . . . . . . . . . . . . . . . . . .A93<br />
Functional Reach Test . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D78<br />
Functional Recovery . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C164<br />
Functional status . . . . . . . . . . . . . . . . . . . . . . . . . . . .B39, B125<br />
Functional test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B156<br />
Gait . . . .A158, B82, B161, B163, C83, C136, C141, D80, D89,<br />
D157, P24<br />
Gait abnormality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P30<br />
Gait analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C94<br />
Gait Imbalance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B16<br />
Gait speed . . . . . . . . . . . . . . . . . . . . . . . .B128, B156, C92, D44<br />
Game . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C65<br />
Gastrointestinal bleeding . . . . . . . . . . . . . . . . . . . . . . . . . . .A9<br />
Gender . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D39<br />
Gene polymorphism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C1<br />
Geriatric . . . . . . . . . . . . .A34, A35, A71, B73, B135, C88, D79<br />
Geriatric Emergency Medicine . . . . . . . . . . . . . . . . . . . . . .B28<br />
Geriatric Assesment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B171<br />
Geriatric assessment . . . . . . . . . .A165, C41, D162, D163, P14<br />
Geriatric assessment skills . . . . . . . . . . . . . . . . . . . . .A75, A79<br />
Geriatric competencies . . . . . . . . . . . . . . . . . . .A72, C73, D61<br />
Geriatric conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P8<br />
AGS 2012 ANNUAL MEETING<br />
S267
K EYWORD<br />
I NDEX<br />
Geriatric curriculum . . . . . . . . . . . . . . . . . . . . . . . . . .B64, D68<br />
Geriatric Education . . . . . . . . . . . . . .B62, B66, C69, D67, P35<br />
Geriatric Emergency Medicine . . . . . . . . . . . . . . . . . . . . .D35<br />
Geriatric Medicine Clerkship . . . . . . . . . . . . . . . . . . . . . . .D69<br />
Geriatric Oncology . . . . . . . . . . . . . . . . .A37, C38, C41, D163<br />
Geriatric opd . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A89<br />
Geriatric outpatient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C86<br />
Geriatric outpatient clinic . . . . . . . . . . . . . . . . . . . . . . . . .C128<br />
Geriatric outpatients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C85<br />
Geriatric population . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D144<br />
Geriatric service . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D134<br />
Geriatric syndromes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A90<br />
Geriatric Tool . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A66<br />
Geriatric training . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B71<br />
Geriatric trauma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A120<br />
<strong>Geriatrics</strong> . . . . . .A10, A39, A109, B102, C56, C67, C68, C115,<br />
C157, D51, D96, D104, P1, P27<br />
<strong>Geriatrics</strong> education . . . . . . . . . . . .A69, C124, D56, P37, P38<br />
<strong>Geriatrics</strong> focus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C123<br />
<strong>Geriatrics</strong> knowledge assessment . . . . . . . . . . . . . . . . . . . .P38<br />
<strong>Geriatrics</strong> Population . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D14<br />
<strong>Geriatrics</strong>/Frail Elders . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D46<br />
Geropsychiatric . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D120<br />
GI Bleed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C26<br />
GI Bleeding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A6<br />
Glucocorticoids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A51<br />
Goal-setting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A106<br />
Goals of care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A2, B18<br />
Goals-of-care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A19<br />
Graduate medical education . . . . . . . . . . . . . . . . . . . . . . . .D60<br />
Gray Matter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C133<br />
Group visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C91<br />
Guidelines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B148<br />
Hand off communications . . . . . . . . . . . . . . . . . . . . . . . . .B103<br />
HBPC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P10<br />
Health Care Expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P7<br />
Health care utilization . . . . . . . . . . . . . . . . . . . . . .A125, D101<br />
Health disparities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D98<br />
Health economics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B115<br />
Health Information Exchange . . . . . . . . . . . . . . . . . . . . .A126<br />
Health Information Technology . . . . . . . . . . . . . . . . . . . . . .P9<br />
Health literacy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C96<br />
Health related outcomes . . . . . . . . . . . . . . . . . . . . . . . . . .D123<br />
Health service use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A42<br />
Health services research . . . . . . . . . . . . . . . . . . . . . . .B115, P7<br />
Health services use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A96<br />
Health status . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C96, C156<br />
Health-related quality of life . . . . . . . . . . . . . . . . . . . . . . .C159<br />
Healthcare cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A104<br />
Healthcare costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P43<br />
Healthy aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D63<br />
Hearing impairment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D70<br />
Heart block . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C10<br />
Heart failure . . . .A33, A161, B46, B47, B85, C15, D21, D151,<br />
P2, P22<br />
Heart rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C44<br />
HELP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D127<br />
Hemodialysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D41<br />
Hemorrhage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C3<br />
Herpes Zoster . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A53<br />
High dose statins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C125<br />
Hip Fracture . . . . . . . . .B23, B24, B168, C40, C47, C50, D161<br />
Hip prosthesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D3<br />
Hippocampal sclerosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C19<br />
Hispanics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C96<br />
HIV . . . . . . . . . . . . . . . . . . . . . . . .A105, B87, B141, D15, D90<br />
HIV-Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63<br />
HIV/AIDS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A94<br />
Hodgkin Lymphoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A15<br />
Home and Community based care . . . . . . . . . . . . . . . . . . .B81<br />
Home care . . . . . . . . . . . . . . . . . . . . . . .A61, C55, D106, D113<br />
Home visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C132<br />
Home Visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C124, D133<br />
Homebound . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D101<br />
Homecare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A121, D117<br />
Homeless persons . . . . . . . . . . . . . . . . . . . . . . . . . . . .A90, A96<br />
Homeostenosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A68<br />
Hospice . . . . . . .A60, A97, A99, B102, B110, B148, C57, C63,<br />
D47, D97<br />
Hospice Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B117<br />
Hospice quality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D138<br />
Hospice/Palliative Care . . . . . . . . . . . . . . . . . . . . . . . . . . . .P12<br />
Hospital . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A112, B88<br />
Hospital care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A105<br />
Hospital discharge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C108<br />
Hospital Elder Life Program . . . . . . . . . . . . . . . . . . . . . . .B119<br />
Hospital falls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D105, P32<br />
Hospital readmission . . . . . . . . . . . . . . . . . . . . . . . . . .D32, P44<br />
Hospital Readmissions . . . . . . . . . . . . . . . . . . . . . . . . . . . .C115<br />
Hospital transfer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D103<br />
Hospitalization . . . . . .A101, B116, C87, C92, D106, P13, P40<br />
Hospitalized elderly . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D129<br />
House call . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B116<br />
House calls program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C126<br />
Housecalls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P10<br />
Huddle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A112<br />
Hygroma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D2<br />
Hyperammonemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A3<br />
Hypercalcemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A15, B6<br />
Hypercoagulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A142<br />
Hyperferritinemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B17<br />
Hypernatremia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A12<br />
Hypersensitivity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A30<br />
Hypertension . . . . . . . . . . . . . . . . . . . . . . .A50, A95, B8, B134<br />
Hypoactive Delirium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A4<br />
Hypoglycemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C112<br />
Hypomagnesemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A29<br />
Hyponatremia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A147, D7<br />
ICU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C150<br />
IEED . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D84<br />
IgG2 deficiency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A23<br />
IL-6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63<br />
Imipenem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A4<br />
Immigrant elders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A32<br />
Immune activation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B141<br />
Immune response . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B141<br />
Immunosenescence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B57<br />
Implantable cardioverter defibrillator . . . . . . . . . . . . . . . . .P2<br />
S268<br />
AGS 2012 ANNUAL MEETING
K EYWORD<br />
I NDEX<br />
Implantable Loop Recorders . . . . . . . . . . . . . . . . . . . . . . .A86<br />
Improving Quality of Care . . . . . . . . . . . . . . . . . . . . . . . . .A38<br />
In-hospital Mortality . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C148<br />
Inappropriate medication . . . . . . . . . . . . . . . . . . . . . . . . . .B77<br />
Inappropriate Medications . . . . . . . . . . . . . . . . . . . .B34, C110<br />
Inappropriate prescribing . . . . . . . . . . . . . . . . . . . .B113, B114<br />
Incidence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C54<br />
Incontinence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132<br />
Infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D3<br />
Infection, antibiotic use, hospitalization . . . . . . . . . . . . . .C59<br />
Infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C56<br />
Inflammation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A87, B131<br />
Inflammatory arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A89<br />
Information exchange . . . . . . . . . . . . . . . . . . . . . . . . . . . .D108<br />
Information systems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C131<br />
Injurious Falls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C45<br />
Injury . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A57, D105<br />
Injury prevention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D65<br />
Innovation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C69<br />
Inpatient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C118, D118<br />
Inpatient managment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B35<br />
Inpatient palliative care . . . . . . . . . . . . . . . . . . . . . . . . . . .C157<br />
Inpatient Stay . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D112<br />
Insidious . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />
Insomnia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A45, B89, B94<br />
Integrated care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D77<br />
Integrative Medicine . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A154<br />
Intensive Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146, D21<br />
Interactive teaching . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D54<br />
Interdisciplinary care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D59<br />
Interdisciplinary team . . . . . . . . . . . . . . . . . . . . . . . . .A71, D71<br />
Interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A69<br />
Interleukin-6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B139<br />
Internal medicine residency . . . . . . . . . . . . . . . . . . . . . . . .A66<br />
Internal Medicine Residents . . . . . . . . . . . . . . . . . . .D61, D72<br />
Interprofessional . . . . . . . . . . . . . . .A78, A84, C81, C118, D67<br />
Interprofessional communication . . . . . . . . . . . . . . . . . .D110<br />
Interprofessional education . . . . . .A74, C73, C76, C79, C81,<br />
D62, P39<br />
Interprofessional teams . . . . . . . . . . . . . . . . . . . . . . . . . . .D110<br />
Interprofessional Teamwork . . . . . . . . . . . . . . . . . . . . . . . .D55<br />
Intervention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D116<br />
Intracranial hemorrhage in Elder Fallers . . . . . . . . . . . . .C45<br />
Intractable hallucinations . . . . . . . . . . . . . . . . . . . . . . . . . .D10<br />
Irritable bowel syndrome . . . . . . . . . . . . . . . . . . . . . . . . .B129<br />
ITP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A11<br />
Japanese-<strong>American</strong> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B124<br />
JCAHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D127<br />
Journals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C56<br />
Karnofsky Performance Status . . . . . . . . . . . . . . . . . . . . . .A37<br />
Kidney tranplant . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D162<br />
Kidney transplant . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A141<br />
Knee Osteoarthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B82<br />
Knee pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95<br />
Knowledge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C106<br />
Knowledge assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . .D60<br />
Knowledge Translation . . . . . . . . . . . . . . . . . . . . . . . . . . .B119<br />
Laboratory test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D113<br />
Lactobacillus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B15<br />
Late onset rheumatoid arthritis . . . . . . . . . . . . . . . . . . . . .A89<br />
Leadership . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P37<br />
Learning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C144<br />
Length of Stay . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A36, P12<br />
Lens transparency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B36<br />
Leukemia cutis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B7<br />
Lichen Planus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C7<br />
Life sustaining interventions . . . . . . . . . . . . . . . . . . . . . . .B154<br />
Life-space . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B92<br />
Life-sustaining treatment . . . . . . . . . . . . . . . . . . . . . . . . . . .D6<br />
Lipedema . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A31<br />
Lithium toxicity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A12, A14<br />
Long Term Care . . . . . . . . . . . .A38, A102, B115, D122, D123<br />
Long term care facility . . . . . . . . . . . . . . . . . . . . . .C101, D102<br />
Long-term care . . . . . . . . . . . . . . . . . . . . .B153, C54, C78, C93<br />
Long-term care financing . . . . . . . . . . . . . . . . . . . . .C114, D98<br />
Long-term care insurance . . . . . . . . . . . . . . . . . . . . . . . . .A107<br />
Longitudinal analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B44<br />
Longitudinal cohort study . . . . . . . . . . . . . . . . . . . . .B134, C53<br />
Longitudinal curriculum . . . . . . . . . . . . . . . . . .A75, A76, A79<br />
Longitudinal study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C137<br />
Longterm-care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A118<br />
Loss of consciousness . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D20<br />
Low bed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D105<br />
Low income seniors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P44<br />
Low-density lipoprotein receptor-related protein-1 . . .A131<br />
Lower extremity function . . . . . . . . . . . . . . . . . . . . . . . . . .D94<br />
Lung cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C4<br />
Lung Transplantation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B40<br />
Lupus anticoagulant . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A91<br />
Lymphoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C147, D8<br />
Macrophage Activation Syndrome . . . . . . . . . . . . . . . . . . .B17<br />
Malaise . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />
Male osteoporosis . . . . . . . . . . . . . . . . . . . . . . . . . .A148, B143<br />
Malignancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B6, B138, D146<br />
Malnutrition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C39<br />
Mammography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B107<br />
Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D132<br />
Mandated reporting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D65<br />
Mania . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C48<br />
Matrix Metalloproteinase . . . . . . . . . . . . . . . . . . . . . . . . .B142<br />
May-Thurner syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . .A18<br />
Measurement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B156<br />
Mechanical ventilation . . . . . . . . . . . . . . . . . . . . . .A117, A118<br />
Medical decision making . . . . . . . . . . . . . . . . . . . . . . . . . .B111<br />
Medical decision-making . . . . . . . . . . . . . . . . . . . . . . . . . . .B51<br />
Medical education . . . . . . . . . .A71, A83, C66, C67, C73, D59<br />
Medical intensive care unit . . . . . . . . . . . . . . . . . . . . . . . .D130<br />
Medical Interns . . . . . . . . . . . . . . . . . . . . . . . . .D51, D52, D68<br />
Medical student education . . . . . . . . . . . . . . . . . . . . . . . . .D63<br />
Medical Students . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D69<br />
Medicare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D99<br />
Medicare Part D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B109<br />
Medication . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B109, C90, D87<br />
Medication adherence . . . . . . . . . . . . . . . . . . . .A88, B49, B75<br />
Medication compliance . . . . . . . . . . . . . . . . . . . . . . . . . . . .B75<br />
Medication discontinuation . . . . . . . . . . . . . . . . . . . . . . . . .C85<br />
AGS 2012 ANNUAL MEETING<br />
S269
K EYWORD<br />
I NDEX<br />
Medication discrepancy . . . . . . . . . . . . . . . . . .B97, D86, D121<br />
Medication Errors . . . . . . . . . . . . . . . . . . . . . . . . . . . .A41, B34<br />
Medication mismanagment . . . . . . . . . . . . . . . . . . . . . . . .D119<br />
Medication reconciliation . . . . . . . . . . . . . . .C116, D86, D121<br />
Medication Review . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B97<br />
Medication safety . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B38<br />
Medication titration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C10<br />
Medications . . . . . . . . . . . . . . . . . . . . . . . . . . .B83, C108, D126<br />
Memantine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D31<br />
Memory . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C35, C144<br />
Memory loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A136, C89<br />
Mentorship . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A83<br />
Metabolic syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D79<br />
Metformin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A29, A58<br />
Mexican-<strong>American</strong> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C47<br />
Microglia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A137<br />
MicroRNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P21<br />
Mild Cognitive Impairment . . . . . . . . . . . . . . . . . .A136, C142<br />
Mild cognitive impairment (MCI . . . . . . . . . . . . . . . . . . .C139<br />
Mini-mental state exam . . . . . . . . . . . . . . . . . . . . . . . . . . .B108<br />
Mitochondria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B55, B61<br />
MMP-9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A87<br />
MMSE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C134<br />
MNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C39<br />
Mobile phones . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100<br />
Mobility . . . . . . . . . . . . . . . . . . . . . . . .B92, B127, C92, P3, P13<br />
Mobility Assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B79<br />
Mobility disability . . . . . . . . . . . . . . . . . . . . . . . . . .B128, C111<br />
MOCA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C134<br />
Model of care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B118, D109<br />
Mortality . . . . . .A95, A122, A162, B37, B42, B47, B78, B120,<br />
B134, B149, B157, B170, C44, C47, C48, C50, C51, D32,<br />
D40, D161<br />
Motor learning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D159<br />
Motor skill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B161, D157<br />
Multi-disciplinary team model . . . . . . . . . . . . . . . . . . . . .C132<br />
Multimodal Education . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D55<br />
Multimorbidity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C52, C104<br />
Multiple Myeloma ( MM . . . . . . . . . . . . . . . . . . . . . . . . . . . .A5<br />
Muscle biopsy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D30<br />
Musculoskeletal pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C27<br />
Myeloproliferative . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A142<br />
Myeloproliferative syndrome . . . . . . . . . . . . . . . . . . . . . .A143<br />
Myocardial infarction . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C146<br />
NAMCS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A100<br />
National survey . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B71<br />
Natural Disasters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C23<br />
Navigator . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C81<br />
Neighborhood socioeconomic status . . . . . . . . . . . . . . . . .A98<br />
Neuropsychiatric symptoms . . . . . . . . . . . . . . . . . . . . . . . .A25<br />
Neuropsychological Testing . . . . . . . . . . . . . . . . . . . . . . .A136<br />
Nicastrin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A129<br />
Nocturia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B76, B94<br />
Non cancer pain . . . . . . . . . . . . . . . . . . . . . . . . . . . .B150, D150<br />
Non-malignant pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A100<br />
Non-prescribing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B85<br />
Nonagenarians . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A55<br />
Noncancer pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B149<br />
Nonlinear . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C15<br />
Nontuberculous mycobacterial infection . . . . . . . . . . . .A145<br />
Nonverbal physician-patient communication . . . . . . . . .A103<br />
Normal aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A68<br />
Normal Pressure Hydrocephalus . . . . . . . . . . . . . . . . . . . .D25<br />
NOSOCOMIAL INFECTIONS . . . . . . . . . . . . . . . . . . .B137<br />
NSAIDs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A100, C27<br />
Number needed to treat . . . . . . . . . . . . . . . . . . . . . . . . . . .D50<br />
Nurse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C129<br />
Nurse Practitioner . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P11<br />
Nursing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D120<br />
Nursing education . . . . . . . . . . . . . . . . . . . . . . . . . . . .C80, D70<br />
Nursing home . . . . . . .A99, B34, B39, B50, B68, B110, B121,<br />
C49, C110, C120, D53, D58, D103, P33, P42<br />
Nursing home admission . . . . . . . . . . . . . . . . . . . . . . . . . . .D98<br />
Nursing home care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A115<br />
Nursing home residents . . . . . . . . . . . . . . . . . . . . . . .C59, D43<br />
Nursing homes . . . . . . . . . . . . . . . . . .B113, B114, C102, C135<br />
Nutrition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B164<br />
Nutritional deficiency . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C157<br />
Obesity . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B32, B37, C1, C161<br />
Observational study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B44<br />
Obstructive sleep apnea . . . . . . . . . . . . . . . . . . . . . . . . . . .B158<br />
Occupational Therapy . . . . . . . . . . . . . . . . . . . . . . . . . . . .A157<br />
Octogenarians . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D155<br />
Octreotide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A6<br />
Older Adult . . . . . . . . . . . . . . . . . . . . . . . . .A57, B145, D87, P6<br />
Older adult, lower urinary tract symptoms . . . . . . . . . . . .D87<br />
Older adults . . . . . . . .B29, B96, B99, B130, B165, B169, D30,<br />
D45, D137, D160<br />
Older women . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B25<br />
Oldest old octagenarians nonagenarians . . . . . . . . . . . . .B147<br />
Omeprazole . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C9<br />
On-call . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B68<br />
Opioids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A35<br />
Oral chemotherapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B130<br />
Oral Health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A38, C159<br />
Orthostatic Hyoptension . . . . . . . . . . . . . . . . . . . . . . . . . . .D76<br />
Orthostatic hypotension . . . . . . . . . . . . . . . . . . . . . . .B90, P29<br />
OSCE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A81<br />
Osteoarthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . .B21, B133, C2<br />
Osteochondritis dissecans . . . . . . . . . . . . . . . . . . . . . . . . . . .D5<br />
Osteopontin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B59<br />
Osteoporosis . . . . . . .A46, B1, B84, B132, C129, D148, D149<br />
Osteoporosis related fractures . . . . . . . . . . . . . . . . . . . . .A156<br />
Osteoporosis screening . . . . . . . . . . . . . . . . . . . . . . . . . . .A148<br />
Osteosarcopenia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B1<br />
Outcomes . . . . . . . . . . . . . . . . . . . . . . . . .A48, A118, B35, D91<br />
Outcomes assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B22<br />
Outdoor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B155<br />
Outpatient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C90<br />
Overuse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B107<br />
Oxidative stress . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A131<br />
PACE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D142, P40<br />
Paced respiration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C33<br />
Pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155<br />
Pain Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B30<br />
Palliative care . . . . . .A60, A97, B83, C120, C132, C155, D41,<br />
D47, D104, D107, D116, D130, D134<br />
S270<br />
AGS 2012 ANNUAL MEETING
K EYWORD<br />
I NDEX<br />
Palliative care consult . . . . . . . . . . . . . . . . . . . . . . . . . . . .B147<br />
Palliative care education . . . . . . . . . . . . . . . . . . . . . . .B71, D64<br />
Palliative consult . . . . . . . . . . . . . . . . . . . . . . . . . . .A117, D129<br />
Palliative surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C13<br />
Pancreas cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B171<br />
Pancreatic mass . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C4<br />
Parasitic Infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A8<br />
Parasthesia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C6<br />
Parkinson’s disease . . . . . . . . . . . . . . . .B76, B123, C84, D139<br />
Parkinson’s Disease . . . . . . . . . . . . . . . . . . . . . . . . . . .B124<br />
Patient adherence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B158<br />
Patient engagement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D111<br />
Patient preferences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C107<br />
Patient Safety . . . . . . . . . . . . . . . . . . . . . .A41, B77, B88, B103<br />
Patient Satisfaction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B30<br />
Patient-centered . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C121<br />
Patient-centered care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C76<br />
PC-MRI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D25<br />
Pelvic floor symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . .B132<br />
Peripheral nerve . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P30<br />
Peripheral Neuropathy . . . . . . . . . . . . . . . . . . . . . . . . . . . .B16<br />
Personal Competency Rating Scale . . . . . . . . . . . . . . . . .A128<br />
Perturbation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D80<br />
Pharmacoepidemiology . . . . . . . . . . . . . . . . . . . . . .A45, A114<br />
Pharmacokinetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A35<br />
Pharmacology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B69<br />
Pharmacy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D82<br />
Phenotypes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A150<br />
Phone call . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C108<br />
Physical activity . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A98, B155<br />
Physical activity/Exercise . . . . . . . . . . . . . . . . . . . . . . .C98, P9<br />
Physical function . . . . . .A158, B120, B146, B166, D15, D159<br />
Physical Performance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P22<br />
Physical restraint . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A61<br />
Physical Therapy . . . . . . . . . . . . . . . . . . . . . . . . . . .C138, C163<br />
Physician assisted suicide . . . . . . . . . . . . . . . . . . . . . . . . . .B154<br />
Pillbox skills . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D119<br />
Pilot trial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C33<br />
Platelet Monocyte Aggregates . . . . . . . . . . . . . . . . . . . . . . .P20<br />
Platelets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P20<br />
Pneumonia . . . . . . . . . . . . . . . . . . . . . . . . .A48, B35, C43, D37<br />
Pneumonitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A30<br />
POEMS Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B16<br />
POGOe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D54<br />
Policy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C105<br />
Polycythemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A143<br />
Polyneuropathy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A16<br />
Polypharmacy . . . . . . . . . . . . . . . . . . . . .B87, B97, C116, C133<br />
Polyuria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B12<br />
Popliteal Vein Aneurysm . . . . . . . . . . . . . . . . . . . . . . . . . . . .B9<br />
Positive aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A150, B44<br />
Post Acute care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B64<br />
Post-acute care . . . . . . . . . . . . . . . . . . . . . . . .A52, A159, C164<br />
Post-treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A155<br />
Postmenopausal women . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C1<br />
Postoperative . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A163<br />
Postoperative mortality . . . . . . . . . . . . . . . . . . . . . . . . . . .A165<br />
Posttraumatic stress disorder . . . . . . . . . . . . . . . . . . . . . . .C11<br />
Postural complexity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B86<br />
Potentially Inappropriate . . . . . . . . . . . . . . . . . . . . . . . . . .A45<br />
PPA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A22<br />
Practice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D120<br />
Practice effects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C139<br />
Practice redesign . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B106<br />
Prediction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B33<br />
Prediction of mortality . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B95<br />
Prehypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A132<br />
Pressure ulcers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C50<br />
Prevelance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D150<br />
Preventing Delirium . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D136<br />
Prevention . . . . . . . . . . . . . . . . . . . . . . . .C153, D131, D141, P1<br />
Preventive . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C120<br />
Preventive care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B144<br />
Primary care . . . . . . . . . . . . . . .A113, A127, C109, C123, D77<br />
Prisoner . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C105<br />
Problem awareness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D70<br />
Prognosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A122, D46<br />
Program of All-inclusive Care for the Elderly . . . . . . . .C119<br />
Propofol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P27<br />
Prospective cohort . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P28<br />
Prospective cohort study . . . . . . . . . . . . . . . . . . . . . . . . . .B131<br />
Prostate cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A103, B126<br />
Prostatic acid phosphatase . . . . . . . . . . . . . . . . . . . . . . . .B126<br />
Prosthetic Joint Infection . . . . . . . . . . . . . . . . . . . . . . . . . . .B15<br />
Protective factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C62<br />
Proteinuria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B122<br />
Proteomics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D93<br />
Proton pump inhibitor . . . . . . . . . . . . . . . . . . . . . . . . . .C9, C85<br />
Provider factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A124<br />
Proxy decision making . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B50<br />
Pruritus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B7<br />
PSA screening . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A110<br />
Pseudoachalasia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B18<br />
Psoas sign . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A92<br />
Psoriasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D144<br />
Psychiatric . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D34<br />
Psychiatric illness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D19<br />
Psychological health . . . . . . . . . . . . . . . . . . . . . . . .A110, A130<br />
Psychosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D4<br />
Psychosocial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D125<br />
Psychotropic drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P33<br />
PTSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D82<br />
Public policy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C113<br />
Pulmonary embolus . . . . . . . . . . . . . . . . . . . . . . . . . .A142, C30<br />
Pulse wave velocity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C149<br />
QoL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C158<br />
Qualitative Research . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C127<br />
Qualitative study . . . . . . . . . . . . . . . . . . . . . . . . . . . .D52, D112<br />
Quality Improvement . . . . . . .A85, A104, A126, B104, B114,<br />
D103, D113, D136, P34<br />
Quality indicator . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C110<br />
Quality Indicators . . . . . . . . . . . . . . . . . . . . . . .A109, B112, P8<br />
Quality measure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B38<br />
Quality of care . . . . . . . . . . . . . . . . . . . . . . . .B106, C104, D140<br />
Quality of Life . . . . . . .A152, A153, A154, A157, B152, B155,<br />
C22, C46, C156, C161, C162, D38, D109, D152<br />
Quality-of-Life . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C13<br />
Question Bank . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B66<br />
AGS 2012 ANNUAL MEETING<br />
S271
K EYWORD<br />
I NDEX<br />
Race . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A47, B99<br />
Racial disparities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D97<br />
Radial neuropathy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C135<br />
Radiotherapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D23<br />
Randomized Clinical Trial . . . . . . . . . . . . . . . . . . . . . . . . . .D26<br />
Randomized controlled trial . . . . . . . . . . . . . . . . . .B150, D50<br />
Rapamycin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B123, P19<br />
Rash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C8<br />
RCT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P24<br />
Re-hospitalization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C130<br />
Reaction Time . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B124<br />
Reactive Oxygen Species . . . . . . . . . . . . . . . . . . . . . . . . . .D49<br />
Readmission . . . . . . . . . .A123, A161, B116, C165, D124, P14<br />
Readmissions . . . . . . . . . . . . . . . . . . . . . . . . . .C99, C121, D125<br />
Recognition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C12<br />
Reconciliation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C90<br />
Reconstructive surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . .D24<br />
Recruitment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D95<br />
Recurrence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D122<br />
REDD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B4<br />
Referral . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P12<br />
Reflective journaling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A83<br />
Regional . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D99<br />
Regional Variation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P11<br />
Registry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D141<br />
Regulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P11<br />
Rehabilitation . . . . . . . . . .A146, A160, A161, C84, C130, P13<br />
Rehabilitation center . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A156<br />
Reimbursement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C109<br />
Relocation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C82<br />
Remaining life expectancy . . . . . . . . . . . . . . . . . . . . . . . . .B111<br />
Renal function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D145<br />
Renin-angiotensin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B55<br />
Renin-angiotensin system . . . . . . . . . . . . . . . . . . . . . . . . . .B61<br />
Reproductive hormone . . . . . . . . . . . . . . . . . . . . . . . . . . . .C22<br />
Research . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D58<br />
Research Participation . . . . . . . . . . . . . . . . . . . . . . . . . . . .A94<br />
Residency training . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A80<br />
Resident Education . . . . . . . . . . . .A65, B66, D71, D133, P36<br />
Responsiveness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C162<br />
Resting metabolic rate . . . . . . . . . . . . . . . . . . . . . . . . . . . .B159<br />
Restorative sleep . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C62<br />
Restricting fatigue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B43<br />
Resuscitation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C63<br />
Resveratrol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P16<br />
Retroperitoneal bleed . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A92<br />
Review . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A88<br />
Revisit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D33<br />
Rhabdomyolysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D1<br />
Rheumatoid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C25<br />
Rheumatological diseases . . . . . . . . . . . . . . . . . . . . . . . . .A145<br />
Risk factor assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D88<br />
Risk Factors . . . . . . . . . . . . . . . . . . . . . . . . .D76, D81, P28, P44<br />
Risk Stratification . . . . . . . . . . . . . . . . . . . . . . . . . . . .B24, B41<br />
Risks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A163<br />
RITUXIMAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A11<br />
Rivaroxaban complications . . . . . . . . . . . . . . . . . . . . . . . .D164<br />
Rivastigmine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D27<br />
Roles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A84<br />
Rotation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D53<br />
Rural Health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D55<br />
Rural older adults . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C151<br />
Safety awareness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A138<br />
Safety net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A60<br />
Sandwich Generation . . . . . . . . . . . . . . . . . . . . . . . . . . . .D154<br />
Sarcodynapenia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B2<br />
Sarcoidosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B6<br />
Sarcopenia . . . . . . . . . . . . . . . . . . . . . . . . . . . .B1, B2, B37, B58<br />
Score . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C51<br />
Screening . . . . . . . . . . . .B54, B105, B107, B143, D149, P1, P6<br />
Screening tools . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D32<br />
Seeking help . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D151<br />
Self care capacity competencies . . . . . . . . . . . . . . . . . . . . .A76<br />
Self neglect . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A111<br />
Self-assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C131<br />
Self-rated health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B105, P3<br />
Self-Report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B79<br />
Seniors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C75<br />
Sensitivity and specificity . . . . . . . . . . . . . . . . . . . . . . . . .A158<br />
Sepsis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C16, P20<br />
Septic arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A1<br />
Septuagenarian . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C22<br />
Seriously ill inpatient . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B147<br />
Serum anticholinergic activity . . . . . . . . . . . . . . . . . . . . . .C137<br />
Service learning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D72<br />
Shared decision making . . . . . . . . . . . . . . . . . . . . . . . . . . . .B27<br />
Shingles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A53<br />
Short Physical Performance Battery . . . . . . . . . . . . . . . . . .B3<br />
Side effects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C29<br />
Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D67<br />
Simulation OSCE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D73<br />
Sirtuin 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P17<br />
Skilled Nursing Facilities . . . . . . . . . . . . . . . . . . . . . . . . . .C103<br />
Skilled nursing facility . . . . . . . . . . . . . . . . . . . . . . . . . . . .C165<br />
Skin cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C153<br />
Sleep . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A149, B76<br />
Sleep apnea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A143, B89<br />
Sleep-disordered breathing (SDB . . . . . . . . . . . . . . . . . . .B59<br />
Sliding-scale insulin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B153<br />
SLUMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C140<br />
SLUMS exam . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C142<br />
Small bowel obstruction . . . . . . . . . . . . . . . . . . . . . . . . . . .D12<br />
Small cell cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C4<br />
Smoothness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B161<br />
Social Isolation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D96<br />
Social services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C126<br />
Social support . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A105<br />
Social Work . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D58<br />
Socioeconomic status . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B32<br />
SPIKES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A70<br />
Spironolactone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B8<br />
Spontaneous tumor lysis . . . . . . . . . . . . . . . . . . . . . . . . . . . .A5<br />
Standardized Patients . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D66<br />
Statins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C43<br />
Sternoclavicular joint . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A1<br />
Stroke . . . . . . . . . . . . . . . . . . . . .A36, B120, C136, C143, C163<br />
Student Attitudes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A73<br />
Students . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P39<br />
Sub-acute . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C87<br />
S272<br />
AGS 2012 ANNUAL MEETING
K EYWORD<br />
I NDEX<br />
Sub-acute care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C130<br />
Subclavian stenosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A26<br />
Subcortical hyperintensities . . . . . . . . . . . . . . . . . . . . . . .B163<br />
Subdural hematoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D84<br />
Successful Aging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A153<br />
Suicidal ideation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D6<br />
Suicide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D131<br />
Sunblock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C153<br />
Superior opthalmic vein thrombosis . . . . . . . . . . . . . . . . .A91<br />
Surgery . . . . . . . . . . . . . . . . . . .A109, B167, B170, B171, D126<br />
Surgical complications . . . . . . . . . . . . . . . . . . . . . . . . . . . .B169<br />
Surgical inpatients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A116<br />
Survey . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C63, D156<br />
Survival . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C17<br />
Sustained attention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B72<br />
Syncope . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D13, D22<br />
Systematic review . . . . . . . . . . . . . . . . . . . . . .B22, C127, D116<br />
Systems based practice . . . . . . . . . . . . . . . . . . . . . . . . . . . .A77<br />
Systems-based practice . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P36<br />
T cell . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B57<br />
Tachycardia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C20<br />
Tai chi . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B86<br />
Taiwanese . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D137<br />
Tamsulosin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D16<br />
TB Meningitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D18<br />
TBI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162<br />
Team care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B106<br />
Team-based care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C76<br />
Technology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D96<br />
Telehealth . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D100<br />
Telemedicine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D45<br />
Terminal illness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C28<br />
Terry’s nails . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A28<br />
Tertiary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D118<br />
Thai traditional music . . . . . . . . . . . . . . . . . . . . . . . . . . . .A130<br />
Thermal therapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C95<br />
Timed Up & Go Test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D78<br />
TMP/SMX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D7<br />
TNF-R1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A63<br />
Topical clindamycin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D9<br />
Total actual costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D135<br />
Total hip arthroplasty . . . . . . . . . . . . . . . . . . . . . . . . . . . .D160<br />
Total knee arthroplasty . . . . . . . . . . . . . . . . . . . . . . . . . . .D160<br />
Total mortality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C53<br />
Transcatheter aortic valve . . . . . . . . . . . . . . . . . . . . . . . . .B152<br />
Transcriptome, mouse . . . . . . . . . . . . . . . . . . . . . . . . . . . .A137<br />
Transfer of care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A116<br />
Transition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A121<br />
Transition of care . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B19, D86<br />
Transitional Care . . . . . . . . . . . . . . . .C117, D108, D117, D133<br />
Transitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A112, C121<br />
Transitions of care . . . . . . . . .A119, A124, B157, C122, C124,<br />
D47, D71<br />
Traumatic brain injury . . . . . . . . . . . . . . . . . . . . . . .A27, B131<br />
Treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D14<br />
Treatment refusal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C60<br />
Triple Antithrombotic Therapy . . . . . . . . . . . . . . . . . . . . . .C26<br />
TSS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B4<br />
Tube feeding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B157<br />
Ulcer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D146<br />
Unbefriended . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C11<br />
Undergraduate medical education . . . . . . . . . . . . . . . . . . .P35<br />
Underweight . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C161<br />
Unexplained Falls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A86<br />
Unintentional weight loss . . . . . . . . . . . . . . . . . . . . . . . . . .D19<br />
Unplanned . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D124<br />
Unresponsiveness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C24<br />
Unsteadiness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A52<br />
Urinary Catheters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P34<br />
Urinary incontinence . . . . . . .B80, B81, C33, C84, D151, P25<br />
Urinary tract infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C49<br />
Urinary tract infections . . . . . . . . . . . . . . . . . . . . . . . . . . .A146<br />
Utilization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A121, B112<br />
Vaccination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A53<br />
Variability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C83<br />
Venous thromboembolism . . . . . . . . . . . . . . . .B167, C54, C93<br />
Vertebral fracture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D149<br />
VES-13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B91, P4<br />
Veterans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B101<br />
Veterans Health Administration . . . . . . . . . . . . . . . . . . . .C117<br />
Video . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C69, D54<br />
Visual hallucinations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D92<br />
Visual impairment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D92<br />
Vitamin D . . . . . . . . . .A104, B48, B140, C55, C148, P22, P45<br />
Vitamin D deficiency . . . . . . . . . . . . . .A46, A144, C151, D36<br />
Vitamin D Replacement . . . . . . . . . . . . . . . . . . . . . . . . . . .D26<br />
Vitamin D supplement . . . . . . . . . . . . . . . . . . . . . . . . . . . .C151<br />
Vitamin D supplementation . . . . . . . . . . . . . . . . . . .A144, P23<br />
Volunteering . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C160<br />
VTE prophylaxis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D143<br />
Vulnerability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B91<br />
Vulnerable elderly . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C34<br />
Waldenstrom’s macroglobulinemia . . . . . . . . . . . . . . . . . . .D8<br />
Walking ability . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B146, D159<br />
Warfarin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A92, C93, D99<br />
Wear time . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B165<br />
Weekend . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A162<br />
Weight loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B73, C32<br />
Wheelchair wrist drop . . . . . . . . . . . . . . . . . . . . . . . . . . . .C135<br />
Wii Fit technology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B3<br />
Wish to die . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D48<br />
Withdrawal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A117<br />
Wood . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B14<br />
Work force . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D53<br />
Wound dehiscence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D24<br />
Zarit Burden Inventory . . . . . . . . . . . . . . . . . . . . . . . . . . . .C86<br />
Zoledronic Acid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B5<br />
Zolpidem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B11<br />
Zoonoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A21<br />
AGS 2012 ANNUAL MEETING<br />
S273
This page intentionally left blank